13. 多発性硬化症／視神経脊髄炎 Disease details / Clinical trials / Drug dev / DR info
臨床試験数 : 3,340 / 薬物数 : 2,163 - (DrugBank : 383) / 標的遺伝子数 : 241 - 標的パスウェイ数 : 238
薬物ごとの開発者（Primary Sponsor）、臨床試験情報（抜粋）です。
(-)-trans-delta-9-Tetrahydrocannabinol
Bionorica research GmbH
2007 Phase 3 EUCTR2006-004255-38-DK Austria;Denmark;Germany;
2007 - EUCTR2006-004255-38-DE Austria;Germany;
2007 - EUCTR2006-004255-38-AT Austria;Germany;
(IM) AVONEX®
Trio Medicines Ltd.
2001 Phase 1 NCT01863069 United Kingdom;
(R) 3-(5-Dimethylcarbamoyl-pent-1-enyl)-N-(2-hydroxy-1- methylethyl) benzamide
Canbex Therapeutics Ltd
2015 Phase 2 EUCTR2014-004412-11-GB United Kingdom;
/0.5ml GA
Teva Pharmaceutical Industries Ltd.
2012 - EUCTR2011-005550-57-PL Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
2012 - EUCTR2011-005550-57-LV Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
2012 - EUCTR2011-005550-57-GR Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Greece;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
2012 - EUCTR2011-005550-57-EE Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
2012 - EUCTR2011-005550-57-BG Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
/0.5ml glatiramer acetate
Teva Pharmaceutical Industries Ltd.
2012 - EUCTR2011-005550-57-PL Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
2012 - EUCTR2011-005550-57-LV Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
2012 - EUCTR2011-005550-57-GR Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Greece;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
2012 - EUCTR2011-005550-57-EE Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
2012 - EUCTR2011-005550-57-BG Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
0,5 mg Fingolimod
Novartis Pharmaceuticals
2016 Phase 4 NCT02575365 Turkey;
032166011
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy;
033283045
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy;
034091165
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy;
035418060
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy;
1 - Andrographis paniculata p/st extract
Universidad Austral de Chile
2012 Phase 1/Phase 2 NCT02280876 Chile;
1-{6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-3-pyridinyl}-2-pyrrolidinone
GlaxoSmithKline Research & Development Ltd
2013 Phase 2 EUCTR2012-003627-38-GB Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
2013 Phase 2 EUCTR2012-003627-38-BG Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
2013 - EUCTR2012-003627-38-SE Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
2013 - EUCTR2012-003627-38-DE Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
2013 - EUCTR2012-003627-38-CZ Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
10 milligram (mg) fampridine-SR (4-aminopyridine, 4-AP)
Acorda Therapeutics
2003 Phase 2 NCT00053417 Canada;United States;
10000IU vitamin D
University College Dublin
2012 Phase 1/Phase 2 NCT01728922 Ireland;
11C-ACETATE
department of neurology, Osaka university school of medicine
2015 - JPRN-UMIN000018154 Japan;
11C-BMS-986196
Bristol-Myers Squibb
2021 Phase 1 NCT05064436 United Kingdom;United States;
11C-MCI
National Institute of Mental Health (NIMH)
2022 Phase 2 NCT05062083 United States;
11C-PBR28
Massachusetts General Hospital
2020 Phase 4 NCT04230174 -
11C-PIB
ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
2009 - EUCTR2008-004174-40-FR France;
11C]-PK-11195
AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA
2016 Phase 2 EUCTR2015-001202-34-IT Italy;
11C]flumazenil
VU University medical center Amsterdam
2017 Phase 4 EUCTR2017-002636-16-NL Netherlands;
13-PCV Booster
Hoffmann-La Roche
2015 Phase 3 NCT02545868 Canada;United States;
13-valent pneumococcal conjugate vaccine (13-PCV)
Novartis Pharmaceuticals
2018 Phase 3 NCT03650114 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
1393641-34-3
GENEURO SA
2016 Phase 2 EUCTR2015-004059-29-IT Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
14C]-RPC1063 Solution (0.1 mg/mL) for Oral Administration
Celgene International II Sàrl
2016 Phase 1 EUCTR2016-003073-18-GB United Kingdom;
18F-DPA-714 and 18F-FDG
Assistance Publique - Hôpitaux de Paris
2012 - NCT02305264 France;
18F-PM-PBB3
Chang Gung Memorial Hospital
2020 Phase 1/Phase 2 NCT04242056 -
18F]DPA-714
VU University Medical Center
2014 - EUCTR2014-002547-17-NL Netherlands;
19 nor vitamin d
University of Wisconsin, Madison
1998 Phase 1 NCT01257958 United States;
2 - Excipients
Universidad Austral de Chile
2012 Phase 1/Phase 2 NCT02280876 Chile;
2 mA Transcranial Direct Current Stimulation
University of Iowa
2020 - NCT04391023 United States;
2-(2-(2-Amino-9H-purin-9-yl)ethyl)-1,3-propanediol diacetate ester
Queen Mary University London
2019 Phase 2 EUCTR2019-000169-19-GB United Kingdom;
2-CdA, 2-chloro-2'-deoxy-beta-D-adenosine
MERCK SERONO SA
2011 Phase 3 EUCTR2009-017978-21-IT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Finland;Georgia;Germany;Greece;India;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Portugal;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States Minor Outlying Islands;
2-CdA, 2-chloro-2'-deoxy-ß-D-adenosine
MERCK SERONO SA
2011 Phase 3 EUCTR2009-017978-21-IT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Finland;Georgia;Germany;Greece;India;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Portugal;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States Minor Outlying Islands;
2-CdA, 2-chloro-2?-deoxy-beta-D-adenosine
Merck Serono S.A. - Geneva
2011 Phase 3 EUCTR2009-017978-21-ES Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2-CdA, 2-chloro-2?-deoxy-ß-D-adenosine
Merck Serono S.A. - Geneva
2011 Phase 3 EUCTR2009-017978-21-ES Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2-CdA, 2-chloro-2’-deoxy-beta-D-adenosine
Merck Serono S.A. - Geneva
2012 Phase 3 EUCTR2009-017978-21-PT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2012 Phase 3 EUCTR2009-017978-21-PL Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2012 Phase 3 EUCTR2009-017978-21-GR Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-SE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-LV Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-GB Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-FI Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-EE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-DK Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-BG Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-BE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-AT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 - EUCTR2009-017978-21-LT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 - EUCTR2009-017978-21-CZ Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2010 Phase 3 EUCTR2009-017978-21-DE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2-CdA, 2-chloro-2’-deoxy-ß-D-adenosine
Merck Serono S.A. - Geneva
2012 Phase 3 EUCTR2009-017978-21-PT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2012 Phase 3 EUCTR2009-017978-21-PL Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2012 Phase 3 EUCTR2009-017978-21-GR Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-SE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-LV Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-GB Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-FI Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-EE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-DK Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-BG Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-BE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-AT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 - EUCTR2009-017978-21-LT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 - EUCTR2009-017978-21-CZ Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2010 Phase 3 EUCTR2009-017978-21-DE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2-chloro-2'-deoxy-beta-D-adenosine (2-CdA)
Merck Serono S.A. - Geneva
2009 Phase 3 EUCTR2008-003706-33-GB Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2-chloro-2'-deoxy-ß-D-adenosine (2-CdA)
Merck Serono S.A. - Geneva
2009 Phase 3 EUCTR2008-003706-33-GB Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2-chloro-2'-deoxyadenosine (2-CdA)
MERCK KGAA
2018 Phase 4 EUCTR2017-002631-42-IT Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;
Merck KGaA
2018 Phase 4 EUCTR2017-002632-17-SK Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-SE Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-PT Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-NL Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-LT Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-HU Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Ireland;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-GR Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-GB Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-FR Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-FI Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-ES Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-DK Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-CZ Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-BE Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-AT Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2-chloro-2'-deoxyadenosine, 2CdA
Merck Serono International S.A.
2006 - EUCTR2004-005148-28-LT Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
2005 - EUCTR2004-005148-28-FI Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
2005 - EUCTR2004-005148-28-EE Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
2005 - EUCTR2004-005148-28-DK Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
2005 - EUCTR2004-005148-28-CZ Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
2005 - EUCTR2004-005148-28-BE Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
Merck Serono International, a branch of Laboratoires Serono S.A.
2005 Phase 3 EUCTR2004-005148-28-GB Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Slovakia;United Kingdom;
Merck Serono International, a branch of Laboratories Serono S.A.
2005 - EUCTR2004-005148-28-DE Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
Serono International S.A.
2006 Phase 3 EUCTR2004-005148-28-SK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Slovakia;United Kingdom;
2006 - EUCTR2004-005148-28-LV Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
2005 - EUCTR2004-005148-28-AT Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
2-chloro-2?-deoxy-beta-D-adenosine
Merck Serono International
2009 - EUCTR2008-003706-33-ES Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2-chloro-2?-deoxy-ß-D-adenosine
Merck Serono International
2009 - EUCTR2008-003706-33-ES Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2-chloro-2’-deoxy-beta-D-adenosine
Merck Serono International
2010 - EUCTR2008-003706-33-GR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2009 Phase 3 EUCTR2008-003706-33-FR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
Merck Serono S.A. - Geneva
2009 - EUCTR2008-003706-33-NO Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-003706-33-AT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2-chloro-2’-deoxy-beta-D-adenosine (2-CdA)
Merck Serono S.A. - Geneva
2009 Phase 3 EUCTR2008-003706-33-BE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2009 - EUCTR2008-003706-33-SE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2009 - EUCTR2008-003706-33-DE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2009 - EUCTR2008-003706-33-CZ Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2009 - EUCTR2008-003706-33-BG Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2008 - EUCTR2008-003706-33-FI Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2008 - EUCTR2008-003706-33-EE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
Merck Serono SA - Geneva
2009 - EUCTR2008-003706-33-PT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2-chloro-2’-deoxy-ß-D-adenosine
Merck Serono International
2010 - EUCTR2008-003706-33-GR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2009 Phase 3 EUCTR2008-003706-33-FR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
Merck Serono S.A. - Geneva
2009 - EUCTR2008-003706-33-NO Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-003706-33-AT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2-chloro-2’-deoxy-ß-D-adenosine (2-CdA)
Merck Serono S.A. - Geneva
2009 Phase 3 EUCTR2008-003706-33-BE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2009 - EUCTR2008-003706-33-SE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2009 - EUCTR2008-003706-33-DE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2009 - EUCTR2008-003706-33-CZ Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2009 - EUCTR2008-003706-33-BG Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2008 - EUCTR2008-003706-33-FI Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2008 - EUCTR2008-003706-33-EE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
Merck Serono SA - Geneva
2009 - EUCTR2008-003706-33-PT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2-chloro-2’-deoxyadenosine (2-CdA)
Merck KGaA
2018 Phase 4 EUCTR2017-002631-42-SE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002631-42-HU Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002631-42-GB Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002631-42-FR Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002631-42-FI Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002631-42-CZ Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002631-42-BE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002631-42-AT Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;
Merck Serono International S.A.
2008 - EUCTR2007-000381-20-NL Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Netherlands;Portugal;United Kingdom;
2008 - EUCTR2007-000381-20-GR Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Netherlands;Portugal;United Kingdom;
2007 Phase 3 EUCTR2007-000381-20-FR Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lithuania;Netherlands;Portugal;United Kingdom;
Merck Serono S.A. - Geneva
2008 Phase 3 EUCTR2007-000381-20-GB Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2008 Phase 3 EUCTR2007-000381-20-BE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-000381-20-PT Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Netherlands;Portugal;United Kingdom;
2008 - EUCTR2007-000381-20-LV Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-000381-20-LT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-000381-20-EE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-000381-20-DK Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-000381-20-DE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-000381-20-CZ Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-000381-20-BG Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2007 - EUCTR2007-000381-20-FI Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2007 - EUCTR2007-000381-20-AT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States;
200106 or EMD 28162
Merck Serono
2011 - EUCTR2010-020328-23-LV Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2011 - EUCTR2010-020328-23-LT Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2010 Phase 2 EUCTR2010-020328-23-DK Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2010 - EUCTR2010-020328-23-FI Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
Merck Serono SA - Geneva, an affiliate of Merck KGaA
2012 Phase 2 EUCTR2010-020328-23-PT Austria;Belgium;Denmark;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2011 - EUCTR2010-020328-23-AT Austria;Belgium;Denmark;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
23-PPV
Hoffmann-La Roche
2015 Phase 3 NCT02545868 Canada;United States;
23-valent pneumococcal polysaccharide vaccine
Biogen
2015 Phase 2 NCT02097849 United States;
23-valent pneumococcal polysaccharide vaccine (23-PPV)
Novartis Pharmaceuticals
2018 Phase 3 NCT03650114 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
25OH-Vitamin D
Charité - Universitätsmedizin Berlin
2011 Phase 2 EUCTR2011-002785-20-DE Germany;
2B3-201
BBB-Therapeutics B.V.
2013 Phase 1 NCT02048358 Netherlands;
3,4-diaminopyridine
Assistance Publique - Hôpitaux de Paris
2005 Phase 3 NCT00190268 France;
University of Aarhus
2006 Phase 2 NCT00342381 Denmark;
4 mA Transcranial Direct Current Stimulation
University of Iowa
2020 - NCT04391023 United States;
5000IU vitamin D
University College Dublin
2012 Phase 1/Phase 2 NCT01728922 Ireland;
52069.00.01
Philipps-Universität Marburg
2010 - EUCTR2009-011088-35-DE Germany;
9060X
Allergan
2008 - EUCTR2006-006299-39-NL France;Netherlands;
2008 - EUCTR2006-006299-39-FR France;Netherlands;
Allergan Ltd.
2013 - EUCTR2012-000957-30-PT Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States;
2013 - EUCTR2012-000957-30-GB Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States;
2012 - EUCTR2012-000957-30-CZ Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States;
2012 - EUCTR2012-000957-30-BE Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States;
A4I Antagonist
Hoffmann-La Roche
2007 Phase 2 NCT00104143 Bulgaria;Canada;Czech Republic;Finland;Germany;Poland;Russian Federation;Slovakia;Spain;United Kingdom;United States;
AB1010
AB Science
2022 Phase 3 EUCTR2021-000639-30-ES Bulgaria;Canada;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-003735-32-SK Argentina;Belgium;Brazil;Bulgaria;Canada;Colombia;Germany;Greece;Italy;Mexico;Slovakia;Spain;Switzerland;United Kingdom;
2015 Phase 3 EUCTR2012-003735-32-GR Argentina;Belgium;Brazil;Bulgaria;Czech Republic;Germany;Greece;Hungary;Italy;Mexico;Slovakia;Spain;United Kingdom;
2015 Phase 3 EUCTR2010-021219-17-BG Argentina;Bosnia and Herzegovina;Brazil;Bulgaria;France;Germany;Greece;Hungary;Italy;Mexico;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Tunisia;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2010-021219-17-GR Bulgaria;Germany;Greece;Poland;Slovakia;Spain;Turkey;
2013 - EUCTR2010-021219-17-PL Czech Republic;France;Germany;Greece;Poland;Romania;Slovakia;Spain;
2012 Phase 3 EUCTR2010-021219-17-SK Argentina;Bosnia and Herzegovina;Brazil;Bulgaria;France;Germany;Greece;Hungary;Italy;Mexico;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-021219-17-ES Bulgaria;Czech Republic;France;Germany;Greece;Poland;Romania;Slovakia;Spain;United States;
2011 Phase 3 EUCTR2010-021219-17-DE Argentina;Bosnia and Herzegovina;Brazil;Bulgaria;France;Germany;Greece;Hungary;Italy;Mexico;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Tunisia;Ukraine;United Kingdom;United States;
ABR-215062
TEVA
2005 - EUCTR2004-003943-28-IT Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
Teva Pharmaceutical Industries Ldt
2005 Phase 2 EUCTR2005-004334-41-IT Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
ABR-215062 sodium salt
Teva Pharmaceutical Industries Ltd
2010 Phase 3 EUCTR2009-015815-42-SK Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Poland;Slovakia;Spain;
2010 Phase 3 EUCTR2009-015815-42-PL Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States;
2010 Phase 3 EUCTR2009-015815-42-LT Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States;
2010 Phase 3 EUCTR2009-015815-42-EE Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States;
2010 Phase 3 EUCTR2009-015815-42-CZ Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States;
2010 Phase 3 EUCTR2009-015815-42-BG Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States;
2010 Phase 3 EUCTR2009-012989-30-SE Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-012989-30-FR Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2010 Phase 3 EUCTR2009-012989-30-BG Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-012989-30-AT Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-012989-30-NL Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-012989-30-LT Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-012989-30-HU Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-012989-30-GB Austria;Bulgaria;Canada;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-012989-30-ES Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2009 Phase 3 EUCTR2009-012989-30-EE Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-012989-30-CZ Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 - EUCTR2009-011234-99-DE Germany;
2008 - EUCTR2007-003226-19-PT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-003226-19-LT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-003226-19-BG Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 Phase 3 EUCTR2007-003226-19-FR Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 Phase 3 EUCTR2007-003226-19-ES Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-SE Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-NL Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-LV Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-HU Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-GB Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-EE Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-DE Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-CZ Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-AT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2006 Phase 2 EUCTR2005-004334-41-GB Czech Republic;Germany;Hungary;Israel;Italy;Poland;Russian Federation;Spain;United Kingdom;
2006 Phase 2 EUCTR2005-004334-41-ES Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
2006 Phase 2 EUCTR2005-004334-41-DE Czech Republic;Germany;Hungary;Israel;Italy;Russian Federation;Spain;United Kingdom;
2006 Phase 2 EUCTR2005-004334-41-CZ Czech Republic;Germany;Hungary;Israel;Italy;Russian Federation;Spain;United Kingdom;
2005 Phase 2 EUCTR2005-004334-41-HU Czech Republic;Germany;Hungary;Israel;Italy;Russian Federation;Spain;United Kingdom;
2005 Phase 2 EUCTR2004-003943-28-GB Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
2005 Phase 2 EUCTR2004-003943-28-ES Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
2005 - EUCTR2004-003943-28-HU Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
2005 - EUCTR2004-003943-28-DE Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
2005 - EUCTR2004-003943-28-CZ Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
ABT-555
AbbVie
2016 Phase 1 NCT02601885 United States;
2015 Phase 1 NCT02606630 United Kingdom;
ABT-874/Human monoclonal antibody against IL-12
AbbVie (prior sponsor, Abbott)
2004 Phase 2 NCT00086671 Canada;Germany;Netherlands;United Kingdom;United States;
ABX-1431 HCl
Abide Therapeutics
2017 Phase 1 NCT03138421 United Kingdom;
ACT-1
Actelion Pharmaceuticals Ltd
2015 Phase 3 EUCTR2012-000540-10-LV Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-LT Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-GR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-FR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-FI Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-CZ Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
ACT-128800
ACTELION Pharmaceuticals Ltd
2010 Phase 2 EUCTR2009-011470-15-PL Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 2 EUCTR2009-011470-15-NL Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 2 EUCTR2009-011470-15-HU Australia;Austria;Bulgaria;Canada;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 2 EUCTR2009-011470-15-GB Austria;Bulgaria;Canada;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 2 EUCTR2009-011470-15-FI Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 2 EUCTR2009-011470-15-DE Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 2 EUCTR2009-011470-15-CZ Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 2 EUCTR2009-011470-15-BG Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 2 EUCTR2009-011470-15-AT Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 - EUCTR2009-011470-15-ES Austria;Bulgaria;Czech Republic;Finland;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
ACTELION Pharmaceuticals Ltd.
2010 Phase 2 EUCTR2009-011470-15-SE Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
Actelion Pharmaceuticals Ltd
2015 Phase 3 EUCTR2012-000540-10-SE Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-PT Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-PL Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-LV Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-LT Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-HU Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-HR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-GR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-FR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-FI Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-ES Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-DE Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-CZ Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2010 Phase 2 EUCTR2008-006786-92-FR Austria;Belgium;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-011470-15-IT Austria;Bulgaria;Czech Republic;Finland;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2009 Phase 2 EUCTR2008-006786-92-ES Austria;Belgium;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2009 Phase 2 EUCTR2008-006786-92-CZ Austria;Belgium;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2009 Phase 2 EUCTR2008-006786-92-BE Austria;Belgium;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-006786-92-SE Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-006786-92-PL Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-006786-92-NL Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-006786-92-HU Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-006786-92-GB Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-006786-92-FI Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-006786-92-BG Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-006786-92-AT Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
Actelion Pharmaceuticals Ltd.
2019 Phase 3 EUCTR2012-000541-12-HR Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Mexico;Poland;Portugal;Russian Federation;Spain;Switzerland;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004719-10-PT Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004719-10-LV Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004719-10-HU Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004719-10-HR Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004719-10-GR Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004719-10-GB Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004719-10-FI Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004719-10-CZ Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004719-10-BG Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2012-000541-12-BE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States;
2017 Phase 3 EUCTR2016-004719-10-SE Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-004719-10-PL Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-004719-10-LT Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-004719-10-ES Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2012-000541-12-PL Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States;
2017 Phase 3 EUCTR2012-000541-12-FR Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States;
2017 Phase 3 EUCTR2012-000541-12-FI Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States;
2017 Phase 3 EUCTR2012-000541-12-BG Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States;
2016 Phase 3 EUCTR2012-000541-12-PT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States;
2016 Phase 3 EUCTR2012-000541-12-HU Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States;
2016 Phase 3 EUCTR2012-000541-12-GR Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States;
2016 Phase 3 EUCTR2012-000541-12-ES Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States;
2016 Phase 3 EUCTR2012-000541-12-DK Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States;
2016 Phase 3 EUCTR2012-000541-12-DE Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States;
2016 Phase 3 EUCTR2012-000541-12-CZ Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States;
2016 Phase 3 EUCTR2012-000541-12-AT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States;
2009 - EUCTR2008-006786-92-IT Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
ACT-128800 Dose 1
Actelion
2009 Phase 2 NCT01006265 Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
ACT-128800 Dose 2
Actelion
2009 Phase 2 NCT01006265 Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
ACT-128800 Dose 3
Actelion
2009 Phase 2 NCT01006265 Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
ACTH
Neurologique Foundation, Inc.
2009 Phase 2/Phase 3 NCT00947895 United States;
Providence Health & Services
2015 Phase 3 NCT02315872 United States;
University of Minnesota
2013 Phase 2 NCT01950234 United States;
University of Southern California
2009 Phase 1 NCT01049451 United States;
ACTHAR Gel (ACTH)
University of Colorado, Denver
2013 Phase 4 NCT01838174 United States;
ACTOS (Pioglitazone)
University of Illinois at Chicago
2003 Phase 1 NCT00242177 United States;
ADS-5102
Adamas Pharmaceuticals, Inc.
2015 Phase 2 NCT02471222 United States;
ADS-5102,
Adamas Pharmaceuticals, Inc.
2018 Phase 3 NCT03567057 Canada;United States;
2018 Phase 3 NCT03436199 Canada;United States;
AERT, (R)-Baclofen
Osmotica Pharmaceutical US LLC
2018 Phase 3 EUCTR2017-004101-40-PL Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2018 Phase 3 EUCTR2017-004101-40-HR Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2018 Phase 3 EUCTR2017-004101-40-BG Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2018 Phase 3 EUCTR2017-004100-22-PL Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2018 Phase 3 EUCTR2017-004100-22-HR Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2018 Phase 3 EUCTR2017-004100-22-BG Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
AGEE cream
University of Nebraska
2010 Phase 4 NCT00988988 United States;
AHSC
University Medical Centre Hamburg-Eppendorf
2020 Phase 2 EUCTR2016-001166-29-DE Germany;
AIMSPRO
Daval International Limited
2008 Phase 2 EUCTR2006-006872-39-GB United Kingdom;
AIN
NOVARTIS FARMA
2013 - EUCTR2012-004019-29-IT Argentina;Canada;Colombia;Finland;Germany;Italy;Japan;Poland;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
AIN457
NOVARTIS FARMA
2013 - EUCTR2012-004019-29-IT Argentina;Canada;Colombia;Finland;Germany;Italy;Japan;Poland;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
Novartis Farmacéutica, S.A.
2013 - EUCTR2012-004019-29-ES Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
Novartis Pharma AG
2013 Phase 2 EUCTR2012-004019-29-CZ Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
2013 Phase 2 EUCTR2012-004019-29-BE Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
2013 - EUCTR2012-004019-29-SE Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
2013 - EUCTR2012-004019-29-PT Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
2013 - EUCTR2012-004019-29-PL Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
2013 - EUCTR2012-004019-29-FI Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
2013 - EUCTR2012-004019-29-DE Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
Novartis Pharma K.K.
2013 Phase 2 JPRN-JapicCTI-132178 -
Novartis Pharma Services AG
2012 - EUCTR2011-001629-25-CZ Czech Republic;Russian Federation;Ukraine;
2009 Phase 2 EUCTR2009-011626-34-SE Czech Republic;Sweden;
2009 - EUCTR2009-011626-34-CZ Czech Republic;Russian Federation;Serbia;Sweden;Ukraine;
Novartis Pharmaceuticals
2013 Phase 2 NCT01874340 Belgium;Canada;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
2012 Phase 2 NCT01433250 Czech Republic;Russian Federation;Ukraine;
2009 Phase 2 NCT01051817 Czech Republic;Russian Federation;Serbia;Sweden;Ukraine;
ALKS 8700
Biogen
2017 Phase 3 NCT03093324 Germany;Poland;United States;
2015 Phase 3 NCT02634307 Belgium;Bulgaria;Canada;Germany;Poland;Russian Federation;Serbia;Spain;Ukraine;United States;
ALKS 8700 Delayed Release (DR)
Alkermes, Inc.
2019 Phase 3 EUCTR2017-001294-16-DE Germany;Poland;United States;
2017 Phase 3 EUCTR2017-001294-16-PL Germany;Poland;United States;
ALKS 8700 Delayed Release (DR) Capsule
Alkermes, Inc.
2016 Phase 3 EUCTR2015-005160-41-PL Belgium;Bulgaria;Canada;Germany;Poland;Russian Federation;Serbia;Spain;Ukraine;United States;
2016 Phase 3 EUCTR2015-005160-41-ES Belgium;Bulgaria;Canada;Germany;Poland;Russian Federation;Serbia;Spain;Ukraine;United States;
2016 Phase 3 EUCTR2015-005160-41-BG Belgium;Bulgaria;Canada;Germany;Poland;Russian Federation;Serbia;Spain;Ukraine;United States;
2016 Phase 3 EUCTR2015-005160-41-BE Belgium;Bulgaria;Canada;Germany;Poland;Russian Federation;Serbia;Spain;Ukraine;United States;
Biogen Idec Research Limited
2016 Phase 3 EUCTR2015-005160-41-DE Belgium;Bulgaria;Canada;Germany;Poland;Russian Federation;Serbia;Spain;Ukraine;United States;
ALTRI FARMACI DEL SISTEMA NERVOSO
GLAXO SMITHKLINE
2004 - EUCTR2004-000374-31-IT Italy;
ALXN1210
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 3 EUCTR2019-003352-37-IT Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States;
Alexion Pharmaceuticals, Inc.
2020 Phase 3 EUCTR2019-003352-37-PL Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-003352-37-NL Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Russian Federation;Spain;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-003352-37-ES Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Russian Federation;Spain;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-003352-37-DK Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-003352-37-DE Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-003352-37-AT Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States;
AMILORIDE HYDROCHLORIDE, 2 H2O
Universitätsklinik für Neurologie, Medizinische Universität Wien
2013 - EUCTR2012-005113-39-AT Austria;
AN100226
Biogen Idec Limited
2011 - EUCTR2010-024000-10-ES Belgium;Germany;Italy;Spain;
2011 - EUCTR2010-024000-10-DE Belgium;Germany;Italy;Spain;
2011 - EUCTR2010-024000-10-BE Belgium;Germany;Italy;Spain;
Biogen Idec Ltd.
2004 - EUCTR2004-000047-18-SE Sweden;
AN100226, BG00002
Biogen Idec Limited
2012 Phase 3 EUCTR2010-021978-11-IE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2012 - EUCTR2010-021978-11-BE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 Phase 3 EUCTR2010-021978-11-GB Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 Phase 3 EUCTR2010-021978-11-ES Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 Phase 3 EUCTR2010-021978-11-DK Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 Phase 3 EUCTR2010-021978-11-CZ Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 - EUCTR2010-021978-11-SE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 - EUCTR2010-021978-11-PL Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 - EUCTR2010-021978-11-FI Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 - EUCTR2010-021978-11-DE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Iraq;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
Biogen Idec Research Limited
2019 Phase 3 EUCTR2018-002145-11-NL Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States;
2019 Phase 3 EUCTR2018-002145-11-FR Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Spain;United Kingdom;United States;
2019 Phase 3 EUCTR2018-002145-11-ES Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States;
2019 Phase 3 EUCTR2018-002145-11-DE Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States;
2015 Phase 4 EUCTR2013-004622-29-DK Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2015 Phase 4 EUCTR2013-004622-29-DE Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2015 - EUCTR2013-005586-39-DE Germany;Italy;United States;
2014 Phase 4 EUCTR2013-004622-29-SE Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2014 Phase 4 EUCTR2013-004622-29-GB Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2014 Phase 4 EUCTR2013-004622-29-ES Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2014 Phase 4 EUCTR2013-004622-29-CZ Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2014 - EUCTR2013-004622-29-IT Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2013 - EUCTR2012-005082-13-IT Italy;
ANK-700
Anokion SA
2020 Phase 1 NCT04602390 United States;
ARICEPT
OSPEDALE S. RAFFAELE
2008 - EUCTR2008-001940-38-IT Italy;
ARN-6039
Arrien Pharmaceuticals
2016 Phase 1 NCT03237832 -
ARZERRA - 100 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONE(VETRO) - 5 ML(20MG/ML) 3 FLACONI
NOVARTIS PHARMA SERVICES AG
2017 Phase 3 EUCTR2015-005419-33-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
ARZERRA - 1000 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) - 50 ML (20 MG/ML) 1 FLACONCINO + 2 KIT DI PROLUNGA
NOVARTIS PHARMA SERVICES AG
2017 Phase 3 EUCTR2015-005418-31-IT Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
ASA
Biogen Idec Research Limited
2014 - EUCTR2013-001895-40-IE Ireland;United Kingdom;
ASB-683699
GLAXO SMITHKLINE
2004 - EUCTR2004-000374-31-IT Italy;
ATA188
Atara Biotherapeutics
2017 Phase 1/Phase 2 NCT03283826 Australia;United States;
ATG
Baylor College of Medicine
1999 Phase 2 NCT00040482 United States;
ATL1102
Antisense Therapeutics Ltd.
2007 Phase 2 EUCTR2006-004736-79-SK Czech Republic;Slovakia;
2007 - EUCTR2006-004736-79-CZ Czech Republic;
ATX-MS-1467
Apitope Technology (Bristol) Ltd.
2010 Phase 1 NCT01097668 Russian Federation;United Kingdom;
Merck KGaA
2014 Phase 2 NCT01973491 Germany;
2013 Phase 2 EUCTR2013-002916-28-LV Latvia;Russian Federation;
AUBAGIO - 14 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BISTER (ALU/ALU) PERFORATO MONODOSE - 10 X 1 COMPRESSA
NOVARTIS PHARMA SERVICES AG
2017 Phase 3 EUCTR2015-005419-33-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
2017 Phase 3 EUCTR2015-005418-31-IT Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
AUBAGIO - 14 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (ALU/ALU) - 28 COMPRESSE
UNIVERSITÀ CATTOLICA DEL SACRO CUORE- POLICLINICO A. GEMELLI
2016 Phase 4 EUCTR2016-001515-20-IT Italy;
AUTOLOGOUS T-LYMPHOCYTES
ImCyse S.A
2014 Phase 1;Phase 2 EUCTR2014-001081-99-BE Belgium;
AV605
Avigen Inc
2007 Phase 2 EUCTR2007-001031-63-CZ Czech Republic;Germany;
2007 - EUCTR2007-001031-63-DE Germany;
AVONEX - 30 MCG (6 MILIONI UI) POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 4 FLACONI CON DISPOSITIVO BIOSET + 4 SIRINGHE PRERIEMPITE USO INTRAMUSCOLARE
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy;
AVONEX 30 microgramos/0,5 ml (Interferón Beta - 1a) Solución inyectable
Biogen Idec Ltd
2010 Phase 3 EUCTR2009-012500-11-ES Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom;
AVONEX 30 µg/0,5 ml solution for injection
Università degli Studi Aldo Moro
2019 Phase 3 EUCTR2017-005129-18-IT Italy;
AVONEX IM 4SIR 30MCG/0,5ML 4AG
Universita di Firenze
2006 - EUCTR2006-004937-13-IT Italy;
AVONEX*IM 4SIR 30MCG/0,5ML+4AG
TEVA ITALIA srl
2008 - EUCTR2007-005450-23-IT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
AVONEX®
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-003008-38-IT Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
Biogen Idec Research Limited
2020 Phase 3 EUCTR2018-003008-38-DE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-SK Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-PT Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-HU Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-HR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-GR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-ES Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;
2019 Phase 3 EUCTR2018-003008-38-CZ Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;
2019 Phase 3 EUCTR2018-003008-38-BG Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-BE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
- Phase 3 EUCTR2018-003008-38-FR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
AVP-923
Avanir Pharmaceuticals
2011 Phase 2 NCT01324232 Argentina;Czech Republic;Czechia;Germany;Poland;Spain;United Kingdom;United States;
2002 Phase 3 NCT00050232 United States;
Avanir Pharmaceuticals, Inc.
2012 Phase 2 EUCTR2011-002178-22-GB Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States;
2012 - EUCTR2011-002178-22-PL Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States;
2012 - EUCTR2011-002178-22-CZ Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States;
2011 Phase 2 EUCTR2011-002178-22-ES Argentina;Bulgaria;Czech Republic;Poland;Spain;United Kingdom;United States;
AZATIOPRINA HEX. 50CPR 50MG BL
Universita di Firenze
2006 - EUCTR2006-004937-13-IT Italy;
Abatacept
National Institute of Allergy and Infectious Diseases (NIAID)
2010 Phase 2 NCT01116427 Canada;United States;
Abobotulinumtoxin A
Neurology Center of New England P.C.
2018 Phase 3 NCT03585569 United States;
Acetaminophen Tab
Columbia University
2019 Phase 1/Phase 2 NCT03824938 United States;
Acetazolamide
The University of Texas Health Science Center, Houston
2016 Phase 2 NCT02466074 United States;
Acetylsalicylic acid
Biogen
2014 Phase 4 NCT02090413 Ireland;United Kingdom;
Acetylsalicylic acid at 1st visit,
Columbia University
2017 Early Phase 1 NCT03051646 United States;
Aciclovir
Genzyme, a Sanofi Company
2014 Phase 4 NCT02205489 Belgium;France;Netherlands;Spain;
Aclasta 5 mg Infusionslösung
Novartis Pharma GmbH
2010 - EUCTR2009-011888-37-DE Germany;
Aclasta 5mg solution for infusion
North Bristol Trust
2009 - EUCTR2008-005304-93-GB United Kingdom;
Acthar
OhioHealth
2014 - NCT02258217 United States;
Acthar Gel
Aaron Miller
2013 - NCT01900093 United States;
Tanner Foundation for Multiple Sclerosis
2013 - NCT01906684 United States;
Active Comparator receiving Extavia®
Charite University, Berlin, Germany
2013 Phase 2/Phase 3 NCT01647880 Germany;
Active Control
Biogen
2014 Phase 1 NCT02201849 United States;
Acyclovir
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
2015 Phase 1 NCT02583594 Spain;
2014 Phase 1 NCT02282826 Germany;
Sanofi
2016 Phase 1 NCT02977533 Germany;
Ad26.COV2.S
National Institute of Allergy and Infectious Diseases (NIAID)
2021 Phase 2 NCT05000216 United States;
Adderall XR
London Health Sciences Centre
2012 Phase 2/Phase 3 NCT01667484 Canada;
Sarah Morrow
2016 Phase 2/Phase 3 NCT02676739 Canada;
Adrenocorticotropic hormone (ACTH) gel (H.P. Acthar®)
Weill Medical College of Cornell University
2016 Phase 4 NCT02446886 United States;
Albumin (Human) , United States Pharmacopeia (USP)
Grifols Therapeutics Inc.
2002 Phase 2 NCT00220779 Austria;Canada;Czech Republic;Germany;Greece;Hungary;Israel;Poland;Slovakia;Sweden;United Kingdom;United States;
Albuterol
National Institute of Allergy and Infectious Diseases (NIAID)
2001 - NCT00039988 United States;
Alcohol Wipes vs. No Alcohol Wipes
Teva Neuroscience, Inc.
2004 Phase 4 NCT00220922 United States;
Alemtuzumab
Cambridge University Hospitals NHS Foundation Trust
2012 Phase 1/Phase 2 NCT01712945 United Kingdom;
Cambridge University Hospitals NHS Foundation Trust and University of Cambridge
2012 Phase 2 EUCTR2011-005606-30-GB United Kingdom;
Central Texas Neurology Consultants
2011 Phase 3 NCT01333358 -
GENZYME CORPORATION
2017 Phase 3 EUCTR2016-003100-30-IT Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
Genzyme Corporation
2017 Phase 3 EUCTR2016-003100-30-PT Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-NO Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-NL Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-GR Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-GB Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-ES Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-DE Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-BE Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-AT Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
2015 Phase 3;Phase 4 EUCTR2013-003884-71-NL Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Czechia;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2015 Phase 3;Phase 4 EUCTR2013-003884-71-DK Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2009-010788-18-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2015 - EUCTR2013-003884-71-BE Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;
2014 Phase 4 EUCTR2014-000092-62-NL Belgium;France;Netherlands;Spain;Switzerland;
2014 Phase 4 EUCTR2014-000092-62-FR Belgium;France;Netherlands;Spain;Switzerland;
2014 Phase 4 EUCTR2014-000092-62-ES Belgium;France;Netherlands;Spain;Switzerland;
2014 Phase 4 EUCTR2014-000092-62-BE Belgium;France;Netherlands;Spain;Switzerland;
2014 Phase 3;Phase 4 EUCTR2013-003884-71-IT Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;
2014 Phase 3;Phase 4 EUCTR2013-003884-71-HR Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2014 Phase 3;Phase 4 EUCTR2013-003884-71-DE Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2014 Phase 3;Phase 4 EUCTR2013-003884-71-CZ Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2014 - EUCTR2013-003884-71-ES Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;
2011 Phase 3 EUCTR2009-010788-18-IT Austria;Belgium;Czech Republic;Denmark;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2010 Phase 3 EUCTR2009-010788-18-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-010788-18-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-010788-18-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-010788-18-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-010788-18-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-010788-18-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-010788-18-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 - EUCTR2009-010788-18-DK Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2008 Phase 3 EUCTR2007-001162-32-FR Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2008 Phase 3 EUCTR2007-001162-32-ES Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2008 Phase 3 EUCTR2007-001162-32-CZ Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2008 Phase 3 EUCTR2007-001162-32-BE Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2008 Phase 3 EUCTR2007-001161-14-FR Czech Republic;France;Germany;Poland;Sweden;United Kingdom;
2008 - EUCTR2007-001162-32-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-001162-32-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-001162-32-NL Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-001162-32-IT Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-001162-32-DK Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-001162-32-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-001162-32-AT Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-001161-14-SE Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom;
2008 - EUCTR2007-001161-14-PL Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom;
2008 - EUCTR2007-001161-14-DE Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom;
2008 - EUCTR2007-001161-14-CZ Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom;
2007 Phase 3 EUCTR2007-001162-32-GB Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-001161-14-GB Czech Republic;France;Germany;Poland;Sweden;United Kingdom;
- Phase 3 EUCTR2016-003100-30-PL Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
- Phase 3 EUCTR2016-003100-30-Outside-EU/EEA Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
- Phase 3 EUCTR2016-003100-30-FR Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
- Phase 3 EUCTR2016-003100-30-BG Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
Genzyme, a Sanofi Company
2009 Phase 3 NCT00930553 Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2007 Phase 3 NCT00548405 Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2007 Phase 3 NCT00530348 Argentina;Australia;Brazil;Canada;Croatia;Czech Republic;Former Serbia and Montenegro;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom;United States;
2002 Phase 2 NCT00050778 Croatia;Poland;Russian Federation;United Kingdom;United States;
Glostrup University Hospital, Copenhagen
2017 - NCT03193086 Denmark;
Hadassah Medical Organization
2015 - NCT02529839 -
Haukeland University Hospital
2018 Phase 3 NCT03477500 Denmark;Netherlands;Norway;Sweden;
Helse Bergen HF, Haukeland University Hospital
2018 Phase 3 EUCTR2017-001362-25-DK Denmark;Netherlands;
Queen Mary University of London
2017 - NCT03250169 United Kingdom;
R&D Addenbrookes Hospital
2008 Phase 2 EUCTR2005-002305-23-GB United Kingdom;
Seah Lim M.D.
2012 Phase 2 NCT01679041 United States;
Sheffield Teaching Hospitals
2020 Phase 3 EUCTR2019-001549-42-GB United Kingdom;
University Hospital Muenster
2015 Phase 4 NCT02419378 Germany;
University of Aarhus
2017 - NCT03806387 Denmark;
University of Chicago
2011 Phase 4 NCT01395316 -
University of Texas Southwestern Medical Center
2018 Phase 4 NCT03135249 United States;
Universitätsklinikum Hamburg-Eppendorf
2021 Phase 2 NCT04971005 Germany;
Alemtuzumab (GZ402673)
Genzyme, a Sanofi Company
2015 - NCT03774914 Austria;Belgium;Canada;Denmark;Germany;Italy;Spain;Sweden;United Kingdom;United States;
Alemtuzumab GZ402673
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
2015 Phase 4 NCT02255656 Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;Czechia;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Spain;Sweden;Ukraine;United Kingdom;United States;
2015 Phase 1 NCT02583594 Spain;
2014 Phase 4 NCT02205489 Belgium;France;Netherlands;Spain;
Alemtuzumab Injection
Maritime Neurology
2016 - NCT04633967 Canada;
Alemtuzumab Injection [Lemtrada]
University Hospital Muenster
2017 - NCT04082260 Germany;
Alemtuzumab immunotherapy
Samuel Forrester Hunter, MD, PhD
2012 Phase 1 NCT01624714 United States;
Alfuzosin
Capital District Health Authority, Canada
2007 Phase 2/Phase 3 NCT00688948 Canada;
All patients in the study will be treated with ocrelizumab
Providence Health & Services
2020 - NCT05081700 United States;
AlloRx
The Foundation for Orthopaedics and Regenerative Medicine
2022 Phase 1 NCT05003388 Antigua and Barbuda;
Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells
Genesis Limited
2015 Phase 1/Phase 2 NCT02418325 Trinidad and Tobago;
Novo Cellular Medicine Institute LLP
2015 Phase 1/Phase 2 NCT02587715 Trinidad and Tobago;
Allogeneic fecal microbiota
St. Petersburg State Pavlov Medical University
2019 Phase 1 NCT04203017 Russian Federation;
Alpha Lipoic Acid
Rebecca Spain
2018 Phase 1 NCT03493841 United States;
Alpha lipoic acid
University of Iowa
2010 Phase 1 NCT01381354 United States;
Alpha-lipoic acid
National Center for Complementary and Integrative Health (NCCIH)
1999 Phase 1/Phase 2 NCT00010842 United States;
Alpha1-antitrypsin
Stanford University
2014 Phase 1 NCT02087813 United States;
Amantadine
FONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR
2011 - EUCTR2010-023678-38-IT Italy;
Johns Hopkins University
2017 Phase 3 NCT03185065 United States;
American ginseng extract HT-1001
Oregon Health and Science University
2005 Phase 2 NCT00754832 United States;
Amiloride
UCL
2014 Phase 2 EUCTR2012-005394-31-GB United Kingdom;
University College, London
2014 Phase 2 NCT01910259 United Kingdom;
University of Oxford
2013 Phase 2 NCT01802489 United Kingdom;
Amiloride Hydrochloride
Oxford Racliffe NHS Trust
2008 - EUCTR2007-004051-11-GB United Kingdom;
Amilostad HCT tablets
Universitätsklinik für Neurologie, Medizinische Universität Wien
2013 - EUCTR2012-005113-39-AT Austria;
Amyvid radiopharmaceutical
Brain Health Alliance
2021 Early Phase 1 NCT04390009 United States;
Anakinra
National Institute of Neurological Disorders and Stroke (NINDS)
2019 Phase 1/Phase 2 NCT04025554 United States;
AndroGel Topical Gel
University of California, Los Angeles
2018 Phase 2 NCT03000127 United States;
Androgel 10 grams of gel containing 100 mg of testosterone
University of California, Los Angeles
2002 Phase 1/Phase 2 NCT00405353 United States;
Andrographolides
Innobioscience SpA
2014 Phase 1/Phase 2 NCT02273635 Chile;
Anesthetic Topical Adhesive Synera
Brown, Theodore R., M.D., MPH
2013 Phase 4 NCT01834586 United States;
Anti LP40 antibody, subclass IgG4 LA294
Eli Lilly and Company
2010 - EUCTR2008-007459-28-BG Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;
2009 Phase 2 EUCTR2008-007459-28-FR Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;
2009 - EUCTR2008-007459-28-HU Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;
2009 - EUCTR2008-007459-28-FI Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;
2009 - EUCTR2008-007459-28-DK Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;
2009 - EUCTR2008-007459-28-DE Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;
2009 - EUCTR2008-007459-28-CZ Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;
2009 - EUCTR2008-007459-28-BE Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;
Anti-CD25 Humanized Monoclonal Antibody
Protein Design Labs, Inc.
2006 - EUCTR2005-001567-55-DE Germany;Spain;United Kingdom;
2005 Phase 2 EUCTR2005-001567-55-GB Austria;Germany;Spain;United Kingdom;
2005 - EUCTR2005-001567-55-ES Germany;Spain;United Kingdom;
2005 - EUCTR2005-001567-55-AT Austria;Germany;Spain;United Kingdom;
Anti-CD52 monoclonal antibody
Cambridge University Hospitals NHS Foundation Trust and University of Cambridge
2012 Phase 2 EUCTR2011-005606-30-GB United Kingdom;
Anti-Thymocyte Globulin
Fred Hutchinson Cancer Research Center
2008 Phase 2 NCT00716066 United States;
Anti-thymocyte globulin
Fred Hutchinson Cancer Research Center
1997 Phase 1 NCT00014755 United States;
Anticholinergic medication
Wellspect HealthCare
2009 - NCT00913510 Belgium;France;Germany;Netherlands;United Kingdom;
Anticuerpo monoclonal anti-LINGO-1 humano
Biogen Idec Research Limited
2013 Phase 2 EUCTR2011-006262-40-ES Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
Antihistamine
Genentech, Inc.
2016 Phase 3 NCT02688985 Canada;Germany;Sweden;United States;
Hoffmann-La Roche
2020 Phase 3 NCT04548999 Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Peru;Poland;Portugal;Puerto Rico;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 NCT04544436 Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
Providence Health & Services
2020 Phase 3 NCT04175834 United States;
Antimycotic
Università Popolare Homo & Natura
2015 Phase 1 NCT02632591 Italy;
Antithymocyte
Dipartimento di Neuroscienze Oftalmologia e Genetica DINOG - Universita di Genova
2006 - EUCTR2006-002562-19-IT Italy;
Antithymocyte immunoglobulin (rabbit)
AZIENDA OSPEDALIERA DI PADOVA
- Phase 1 EUCTR2008-005773-35-IT Italy;
Anxiety/depression and work and activities
University Hospital, Strasbourg, France
2019 Phase 2 NCT03910738 France;
Apitox - pure honeybee toxin
Apimeds, Inc.
2019 Phase 3 NCT03710655 -
Arbaclofen
Osmotica Pharmaceutical US LLC
2018 Phase 3 NCT03319732 United States;
2018 Phase 3 NCT03290131 Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Serbia;United States;
2013 Phase 3 NCT01844232 Russian Federation;Ukraine;United States;
2012 Phase 3 NCT01743651 Russian Federation;Ukraine;United States;
Arbaclofen ER Tablets
Osmotica Pharmaceutical US LLC
2016 Phase 3 NCT02869425 United States;
Arbaclofen Extended Release Tablets
Osmotica Pharmaceutical US LLC
2018 Phase 3 EUCTR2017-004101-40-PL Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2018 Phase 3 EUCTR2017-004101-40-HR Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2018 Phase 3 EUCTR2017-004101-40-BG Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2018 Phase 3 EUCTR2017-004100-22-PL Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2018 Phase 3 EUCTR2017-004100-22-HR Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2018 Phase 3 EUCTR2017-004100-22-BG Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
Arbaclofen placarbil 15 mg BID
XenoPort, Inc.
2011 Phase 3 NCT01359566 United States;
Arbaclofen placarbil 30 mg BID
XenoPort, Inc.
2011 Phase 3 NCT01359566 United States;
Arbaclofen placarbil 45 mg BID
XenoPort, Inc.
2011 Phase 3 NCT01359566 United States;
Aricept 10 mg filmdragerade tabletter
Neurology Unit
2005 - EUCTR2005-003410-15-SE Sweden;
Aricept 5 mg filmdragerade tabletter
Neurology Unit
2005 - EUCTR2005-003410-15-SE Sweden;
Arm 1 - GEH120714 (18F) Injection
GE Healthcare
2013 Phase 1 NCT01738347 Canada;United States;
Armodafinil
University of Missouri, Kansas City
2009 Phase 2/Phase 3 NCT00981084 United States;
Arzerra
GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LTD.
2012 - EUCTR2011-002333-19-IT Canada;Czech Republic;Germany;Italy;Netherlands;Russian Federation;Spain;United States;
NOVARTIS PHARMA AG
2018 Phase 2 EUCTR2017-004702-17-IT Austria;Bulgaria;Czech Republic;Czechia;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
Novartis Farmacéutica S.A.
2020 Phase 3 EUCTR2019-001341-40-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Spain;Switzerland;Turkey;United Kingdom;United States;
Novartis Farmacéutica, S.A
2019 Phase 3 EUCTR2017-004703-51-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
Novartis Farmacéutica, S.A.
2018 Phase 2 EUCTR2017-004702-17-ES Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
2016 Phase 3 EUCTR2015-005419-33-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-ES Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
Novartis Pharma Services AG
2016 Phase 3 EUCTR2015-005419-33-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
Novartis Pharma AG
2021 Phase 3 EUCTR2019-001341-40-PL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001341-40-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Spain;Switzerland;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001341-40-IT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Spain;Switzerland;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001341-40-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Spain;Switzerland;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001341-40-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-HR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-FR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-FI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-DK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 2 EUCTR2017-004702-17-PL Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
2018 Phase 3 EUCTR2017-004703-51-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2018 Phase 3 EUCTR2017-004703-51-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2018 Phase 3 EUCTR2017-004703-51-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2018 Phase 3 EUCTR2017-004703-51-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2018 Phase 2 EUCTR2017-004702-17-LV Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
2018 Phase 2 EUCTR2017-004702-17-LT Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
2018 Phase 2 EUCTR2017-004702-17-EE Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
2018 Phase 2 EUCTR2017-004702-17-CZ Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
2018 Phase 2 EUCTR2017-004702-17-BG Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
2018 Phase 2 EUCTR2017-004702-17-AT Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
2017 Phase 3 EUCTR2015-005418-31-FR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;European Union;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-FR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;European Union;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-HU Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-GR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-BE Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
Novartis Pharma Services AG
2017 Phase 3 EUCTR2015-005419-33-HR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2015-005419-33-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2015-005419-33-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2015-005418-31-NL Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2015-005418-31-CZ Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-FI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-SK Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-SE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-PL Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-HR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-GB Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-EE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-DE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-BG Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
Arzerra®
GlaxoSmithKline Research and Development Limited
2012 - EUCTR2011-002333-19-CZ Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States;
2011 Phase 2 EUCTR2011-002333-19-DK Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States;
2011 - EUCTR2011-002333-19-NL Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States;
GlaxoSmithKline SA
2011 Phase 2 EUCTR2011-002333-19-ES Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States;
Aspirin 650mg Oral Capsule
Columbia University
2019 Phase 1/Phase 2 NCT03824938 United States;
Atacicept
EMD Serono
2009 Phase 2 NCT00853762 Australia;Belgium;Canada;Czech Republic;France;Germany;Lebanon;Lithuania;Netherlands;New Caledonia;Russian Federation;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2008 Phase 2 NCT00642902 Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Lebanon;Lithuania;Netherlands;Russian Federation;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
Merck Serono Geneva- an affiliate of Merck KGaA, Darmstadt Germany
2008 - EUCTR2007-003936-50-SE Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
Merck Serono International
2009 Phase 2 EUCTR2008-005021-11-FR Belgium;Czech Republic;France;Sweden;
2009 Phase 2 EUCTR2008-005021-11-CZ Belgium;Czech Republic;France;Sweden;
2009 - EUCTR2008-005021-11-SE Belgium;Czech Republic;France;Sweden;
Merck Serono International S.A.
2008 Phase 2 EUCTR2007-003936-50-FR Austria;Belgium;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2008 Phase 2 EUCTR2007-003936-50-ES Austria;Belgium;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-003936-50-NL Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
Merck Serono S.A. - Geneva
2008 - EUCTR2007-003936-50-GB Australia;Austria;Canada;Czech Republic;France;Lebanon;Lithuania;Netherlands;Russian Federation;Spain;Sweden;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-003936-50-AT Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
Merck Serono SA - Geneva, An affiliate of Merck KGaA, Darmstadt, Germany
2009 - EUCTR2008-005021-11-BE Belgium;Czech Republic;France;Sweden;
Merck Serono SA - Geneva, an affiliate of Merck KGaA, Darmstadt, Germany
2008 - EUCTR2007-003936-50-CZ Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-003936-50-BE Austria;Belgium;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
Merck Serono SA-Geneva
2008 - EUCTR2007-003936-50-LT Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
Atomoxetine
Icahn School of Medicine at Mount Sinai
2017 Phase 2 NCT03091400 United States;
Atorvastatin
DR DIMENSIONE RICERCA
2005 - EUCTR2005-001009-25-IT Italy;
National Institute of Allergy and Infectious Diseases (NIAID)
2005 Phase 2 NCT00094172 Canada;United States;
Sun Yat-sen University
2006 - NCT00818103 China;
University Hospital Inselspital, Berne
2005 Phase 2 NCT00942591 Switzerland;
Aubagio
F. HOFFMANN - LA ROCHE LTD.
2021 Phase 3 EUCTR2020-001168-28-IT Bulgaria;Denmark;Finland;France;Italy;Netherlands;United States;
2021 Phase 3 EUCTR2019-004857-10-IT Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States;
F. Hoffman-La Roche
2021 Phase 3 EUCTR2020-001168-28-DK Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Greece;India;Italy;Korea, Republic of;Mexico;Poland;Portugal;Russian Federation;Turkey;United Kingdom;United States;
F. Hoffmann-La Roche Ltd
2021 Phase 3 EUCTR2020-001168-28-BG Bulgaria;Finland;France;Netherlands;United States;
2021 Phase 3 EUCTR2019-004857-10-NL Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States;
2021 Phase 3 EUCTR2019-004857-10-HU Finland;France;Germany;Hungary;Netherlands;Portugal;United States;
2021 Phase 3 EUCTR2019-004857-10-DE Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States;
2020 Phase 3 EUCTR2019-004857-10-FI Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States;
GENZYME CORPORATION
2020 Phase 3 EUCTR2020-000637-41-IT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
Genzyme Corporation
2021 Phase 3 EUCTR2020-000644-55-DE Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000637-41-AT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000644-55-SK Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-PT Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-NL Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-LV Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-HU Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-GR Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-GB Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-FR Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-CZ Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000637-41-SE Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-PL Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-LT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-FI Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-DK Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-DE Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-CZ Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-BG Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2014 Phase 4 EUCTR2013-001439-34-IT Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Italy;Spain;Sweden;Switzerland;United Kingdom;United States;
2014 Phase 4 EUCTR2013-001439-34-GR Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
2014 Phase 4 EUCTR2013-001439-34-GB Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
2014 - EUCTR2013-001439-34-DE Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
2014 - EUCTR2013-001439-34-BE Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
2014 - EUCTR2013-001439-34-AT Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
2013 Phase 4 EUCTR2013-001439-34-SE Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
2013 Phase 4 EUCTR2013-001439-34-FI Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
2013 Phase 4 EUCTR2013-001439-34-ES Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Italy;Spain;Sweden;Switzerland;United Kingdom;United States;
MERCK HEALTHCARE KGaA
2020 Phase 3 EUCTR2019-004980-36-IT Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
MS Centrum, Department of Neurology, Sshlgrenska University Hospital
2018 Phase 4 EUCTR2016-004414-10-SE Sweden;
Merck Healthcare KGaA
2021 Phase 3 EUCTR2019-004980-36-SI Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-SK Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-PT Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-NO Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-LV Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-LT Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-GR Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-DE Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-BG Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004972-20-HU Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-004972-20-GB Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-004972-20-FI Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-004972-20-DE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-004972-20-CZ Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-004972-20-BG Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-004972-20-AT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2019-004972-20-BE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
Novartis Farmacéutica S.A.
2022 Phase 3 EUCTR2020-005929-89-ES Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States;
2022 Phase 3 EUCTR2020-005899-36-ES Slovakia;Spain;
Novartis Farmacéutica, S.A.
2016 Phase 3 EUCTR2015-005419-33-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-ES Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
Novartis Pharma Services AG
2016 Phase 3 EUCTR2015-005419-33-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
Novartis Pharma AG
2022 Phase 3 EUCTR2020-005929-89-SE Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States;
2022 Phase 3 EUCTR2020-005899-36-SK Argentina;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;France;Germany;Guatemala;Hong Kong;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;United Kingdom;United States;
2017 Phase 3 EUCTR2015-005418-31-FR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;European Union;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-FR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;European Union;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-HU Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-GR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-BE Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
Novartis Pharma Services AG
2017 Phase 3 EUCTR2015-005419-33-HR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2015-005419-33-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2015-005419-33-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2015-005418-31-NL Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2015-005418-31-CZ Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-FI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-SK Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-SE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-PL Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-HR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-GB Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-EE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-DK Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-DE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-BG Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
Aubagio 14 mg film-coated tablets
F. Hoffmann-La Roche Ltd
2021 Phase 3 EUCTR2019-004857-10-PT Finland;France;Germany;Netherlands;Portugal;United States;
Aubagio®
Actelion Pharmaceuticals Ltd
2015 Phase 3 EUCTR2012-000540-10-SE Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-PT Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-PL Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-LV Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-LT Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-HU Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-HR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-GR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-FR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-FI Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-ES Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-DE Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-CZ Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Autologous Bone Marrow-Derived Mononuclear Stem Cells
Genesis Limited
2015 Phase 1/Phase 2 NCT02418351 India;Trinidad and Tobago;
Novo Cellular Medicine Institute LLP
2015 Phase 1/Phase 2 NCT02587806 India;Trinidad and Tobago;
Autologous CD4+T cells stimulated and expanded ex vivo by a MOG peptide modified by the introduction of a thioreductase motif into the flanking residues of the T cell epitope
Imcyse SA
2015 Phase 1/Phase 2 NCT02427776 Belgium;
Autologous Hematopoietic Stem Cell
Makati Medical Center
2015 Phase 1 NCT03113162 Philippines;
Autologous Hematopoietic Stem Cell Transplantation
Fred Hutchinson Cancer Research Center
2008 Phase 2 NCT00716066 United States;
National Institute of Allergy and Infectious Diseases (NIAID)
2019 Phase 3 NCT04047628 United Kingdom;United States;
Universitätsklinikum Hamburg-Eppendorf
2021 Phase 2 NCT04971005 Germany;
Autologous Mesenchymal Cell Product
Imperial College London
2012 Phase 2 EUCTR2012-002357-35-GB United Kingdom;
Autologous Mesenchymal Stem Cells
Antonio Uccelli
2012 Phase 1/Phase 2 NCT01854957 Italy;
University of Jordan
2012 Phase 1/Phase 2 NCT01895439 Jordan;
Autologous Stem Cell Transplantation
Northwestern Memorial Hospital
2001 Phase 1 NCT00017628 United States;
Autologous Stem Cells
Northwestern University
2019 Phase 2/Phase 3 NCT03829566 United States;
2017 Phase 3 NCT03342638 United States;
Autologous VitD3 tolerogenic monocyte-derived dendritic cells loaded with a pool of myelin peptides (tolDC-VitD3)
Fundació Institut Germans Trias i Pujol
2017 Phase 1 NCT02903537 Spain;
Autologous adipose derived mesenchymal cells
American CryoStem Corporation
2014 Phase 1 NCT02326935 Cayman Islands;
Autologous adult mesenchymal stem cells from bone marrow expanded and cryopreserved
Banc de Sang i Teixits
2014 - EUCTR2012-000734-19-ES Spain;
Autologous bone marrow transplantation
Hadassah Medical Organization
2015 - NCT02529839 -
Autologous hematopoietic stem cell transplant
National Institute of Allergy and Infectious Diseases (NIAID)
2006 Phase 2 NCT00288626 United States;
Autologous hematopoietic stem cells
University Medical Centre Hamburg-Eppendorf
2020 Phase 2 EUCTR2016-001166-29-DE Germany;
Autologous mesenchymal stem cell transplantation
The Cleveland Clinic
2011 Phase 1 NCT00813969 United States;
Autologous mesenchymal stem cells
Albert Saiz
2010 Phase 2 NCT01228266 Spain;
Karolinska Institutet
2013 Phase 1/Phase 2 NCT01730547 Sweden;
2012 Phase 1 NCT03778333 Sweden;
Tianjin Medical University General Hospital
2013 Phase 2 NCT02249676 China;
Avonex
Biogen
2013 Phase 2 NCT01864148 Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
Biogen Idec
2010 Phase 3 NCT01181115 China;
Biogen Idec Research Limited
2013 Phase 2 EUCTR2011-006262-40-NL Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
Celgene International II Sàrl (CIS II)
2015 Phase 3 EUCTR2014-002320-27-PL Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-LV Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-LT Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-HU Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-HR Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-GB Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-BG Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2014-002320-27-PT Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2014-002320-27-EE Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2014 Phase 2;Phase 3 EUCTR2012-002714-40-SK Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2014 Phase 2;Phase 3 EUCTR2012-002714-40-GB Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2013 Phase 2;Phase 3 EUCTR2012-002714-40-HU Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2013 Phase 2;Phase 3 EUCTR2012-002714-40-BG Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2013 Phase 2;Phase 3 EUCTR2012-002714-40-BE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
Centrum Neurologii Krzysztof Selmaj
2016 Phase 2 EUCTR2016-002180-33-PL Poland;
F. Hoffman-La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-DE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
F.Hoffmann-La Roche Ltd.
2008 - EUCTR2007-006338-32-IT Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Russian Federation;Spain;Switzerland;Ukraine;United Kingdom;United States;
Genentech, Inc.
2008 Phase 2 NCT00676715 Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
Hoffman La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-SK Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 Phase 2 EUCTR2007-006338-32-GB Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 Phase 2 EUCTR2007-006338-32-FR Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Slovakia;Spain;United Kingdom;
2008 Phase 2 EUCTR2007-006338-32-ES Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Slovakia;Spain;United Kingdom;
2008 Phase 2 EUCTR2007-006338-32-DK Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 Phase 2 EUCTR2007-006338-32-CZ Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 Phase 2 EUCTR2007-006338-32-BG Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 Phase 2 EUCTR2007-006338-32-BE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-006338-32-NL Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Spain;United Kingdom;
2008 - EUCTR2007-006338-32-FI Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Spain;United Kingdom;
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden;
2017 Phase 4 EUCTR2016-003587-39-SE Sweden;
MedImmune LLC
2012 - EUCTR2011-005475-16-GB Austria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
Medizinische Universität Innsbruck
2014 Phase 4 EUCTR2012-005450-30-AT Austria;Sweden;
2014 - EUCTR2012-005450-30-SE Austria;Sweden;
Merck Healthcare KGaA
2020 Phase 3 EUCTR2018-004701-11-BG Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Montenegro;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-004700-19-BG Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;Italy;Kuwait;Lebanon;Lithuania;Mexico;Moldova, Republic of;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
Merck KGaA
2014 Phase 3 EUCTR2013-002351-15-AT Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-003126-83-HU Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-003126-83-GR Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-003126-83-ES Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-003126-83-DE Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-003126-83-BG Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-PT Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-LV Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-HU Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-ES Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-EE Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-BG Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain;
Novartis Farma
2013 - EUCTR2011-005677-23-IT Brazil;Canada;Italy;Latvia;Lithuania;Mexico;Spain;United States;Venezuela, Bolivarian Republic of;
Novartis Farmaceutica S.A.
2013 - EUCTR2011-005677-23-ES Brazil;Canada;Latvia;Lithuania;Mexico;Spain;United States;Venezuela, Bolivarian Republic of;
Novartis Pharma Service AG
2015 Phase 3 EUCTR2011-005677-23-HR Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005677-23-GB Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005677-23-EE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 - EUCTR2011-005677-23-RO Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2011-005677-23-DE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2011-005677-23-BG Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of;
2013 - EUCTR2011-005677-23-LV Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Novartis Pharma Services AG
2014 Phase 3 EUCTR2011-005677-23-PL Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005677-23-NL Austria;Brazil;Bulgaria;Canada;Croatia;Estonia;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005677-23-AT Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 - EUCTR2011-005677-23-SE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2011-005677-23-SK Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2011-005677-23-LT Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-001437-16-DE Australia;Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
2006 - EUCTR2006-000704-17-PT Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
PD Dr. Marcus Müller
2015 Phase 1 NCT02364986 Germany;
Receptos, Inc.
2015 Phase 3 EUCTR2014-002320-27-SE Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-NL Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-ES Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2014 Phase 2;Phase 3 EUCTR2012-002714-40-HR Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Ukraine;United Kingdom;United States;
2013 Phase 2;Phase 3 EUCTR2012-002714-40-IT Belgium;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Israel;Italy;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2013 Phase 2;Phase 3 EUCTR2012-002714-40-GR Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States;
2013 Phase 2;Phase 3 EUCTR2012-002714-40-ES Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States;
Saint Francis Care
2012 - NCT01641120 United States;
Teva Pharmaceutical Industries, Ltd.
2014 - EUCTR2013-002082-19-NL Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
2014 - EUCTR2013-002082-19-ES Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
2013 Phase 3 EUCTR2013-002082-19-GB Belgium;Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
2013 Phase 3 EUCTR2013-002082-19-BE Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2013-002082-19-SE Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2013-002082-19-FI Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2013-002082-19-DK Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
Turku University Hospital
2013 Phase 4 EUCTR2013-004626-28-FI Finland;
Avonex (Interferon beta 1a)
University of California, San Francisco
2006 Phase 2 NCT00501943 United States;
Avonex (interferon beta-1a), Biogen Idec Ltd
Bayer
2016 - NCT02749396 Finland;
Avonex 30 microgram/0.5 ml Solution for Injection
Teva Pharmaceutical Industries Ltd
2008 Phase 3 EUCTR2007-005450-23-SK Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Slovakia;Spain;
2008 - EUCTR2007-005450-23-LT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2008 - EUCTR2007-005450-23-EE Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2008 - EUCTR2007-005450-23-DE Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2008 - EUCTR2007-005450-23-CZ Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2008 - EUCTR2007-005450-23-BG Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
Avonex 30 microgramos/0.5 ml Solución para inyección
Teva Pharmaceutical Industries Ltd
2008 - EUCTR2007-005450-23-ES Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
Avonex and Topamax
Multiple Sclerosis Institute
2004 Phase 2 NCT00217295 United States;
Avonex prefilled syringe via manual IM injection
Biogen
2009 Phase 3 NCT00828204 United States;
Avonex/Betaseron/Copaxone/Rebif
Sheffield Teaching Hospitals NHS Foundation Trust
2013 Phase 2/Phase 3 NCT03133403 United Kingdom;
Avonex/Zocor
University of North Carolina
2004 Phase 4 NCT00146068 United States;
Avonex®
Biocad
2017 Phase 2/Phase 3 NCT02744222 Russian Federation;
EMD Serono
1999 Phase 3 NCT00292266 -
EMD Serono Research & Development Institute, Inc.
2019 Phase 3 NCT04032171 Germany;United States;
2019 Phase 3 NCT04032158 Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czechia;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Montenegro;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
Teva Branded Pharmaceutical Products R&D, Inc.
2014 Phase 3 NCT01975298 Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
2008 Phase 3 NCT00605215 Bulgaria;Croatia;Czech Republic;Czechia;Estonia;Georgia;Germany;Israel;Italy;Latvia;Lithuania;Macedonia, The Former Yugoslav Republic of;Montenegro;North Macedonia;Poland;Puerto Rico;Romania;Russian Federation;Slovakia;South Africa;Spain;Turkey;Ukraine;United States;
University Hospital Motol
2011 Phase 4 EUCTR2011-001956-12-CZ Czech Republic;
Avonex® monotherapy ( administered i.m. each week)
State University of New York at Buffalo
2005 - NCT00463710 United States;
Azathioprine
Isfahan University of Medical Sciences
2015 Phase 2/Phase 3 NCT03002038 Iran, Islamic Republic of;
The Ophthalmology Department of the Chinese Peoples Liberation Army Hospital
2019 Phase 4 ChiCTR1900025744 China;
2014 - ChiCTR-ICR-15007177 China;
Tianjin Medical University General Hospital
2017 Phase 2/Phase 3 NCT03350633 China;
Universita di Firenze
2006 - EUCTR2006-004937-13-IT Italy;
Azathioprine (AZA)
Hoffmann-La Roche
2021 Phase 3 NCT04660539 Bulgaria;Canada;Croatia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Puerto Rico;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Azithromycin
National Center for Research Resources (NCRR)
2001 Phase 2 NCT00043264 United States;
B001 injection
Shanghai Pharmaceuticals Holding Co., Ltd
2022 Early Phase 1 NCT05145361 China;
BAF312
NOVARTIS FARMA
2010 - EUCTR2009-014392-51-IT Finland;Germany;Hungary;Italy;Poland;Spain;
2009 - EUCTR2008-008719-25-IT Finland;Germany;Hungary;Italy;Spain;
NOVARTIS PHARMA SERVICES AG
2021 Phase 3 EUCTR2020-002700-39-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Novartis Farmacéutica S.A.
2021 Phase 3 EUCTR2020-002700-39-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Novartis Farmacéutica, S.A
2009 - EUCTR2008-008719-25-ES Finland;Germany;Hungary;Italy;Spain;
Novartis Pharma AG
2021 Phase 3 EUCTR2020-002700-39-SK Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-PT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-LV Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-LT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-HR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2020-002700-39-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2020-002700-39-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Novartis Pharma K.K.
2014 Phase 3 JPRN-JapicCTI-142447 -
Novartis Pharma Services AG
2010 Phase 2 EUCTR2009-014392-51-PL Canada;Finland;Germany;Hungary;Italy;Poland;Russian Federation;Spain;Turkey;United States;
2010 Phase 2 EUCTR2009-014392-51-HU Canada;Finland;Germany;Hungary;Italy;Poland;Russian Federation;Spain;Turkey;United States;
2010 Phase 2 EUCTR2009-014392-51-FI Canada;Finland;Germany;Hungary;Italy;Poland;Russian Federation;Spain;Turkey;United States;
2010 - EUCTR2009-014392-51-DE Canada;Finland;Germany;Hungary;Italy;Poland;Russian Federation;Spain;Turkey;United States;
2009 - EUCTR2008-008719-25-HU Finland;Germany;Hungary;Italy;Spain;
2009 - EUCTR2008-008719-25-FI Finland;Germany;Hungary;Italy;Spain;
- - EUCTR2008-008719-25-DE Finland;Germany;Hungary;Italy;Spain;
Novartis Pharmaceuticals
2021 Phase 4 NCT04792567 Germany;
2012 Phase 3 NCT01665144 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 2 NCT01185821 Canada;Finland;Germany;Hungary;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;Turkey;United States;
2009 Phase 2 NCT00879658 Canada;Finland;Germany;Hungary;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;Turkey;United States;
BAF312 0,25 mg tablet
Novartis Pharma Services AG
2012 - EUCTR2011-006043-30-NL Netherlands;
BAF312 1 mg tablet
Novartis Pharma Services AG
2012 - EUCTR2011-006043-30-NL Netherlands;
BAF312 4 mg tablet
Novartis Pharma Services AG
2012 - EUCTR2011-006043-30-NL Netherlands;
BAF312 hemifumarate
NOVARTIS FARMA
2012 - EUCTR2012-003056-36-IT Argentina;Australia;Austria;Bulgaria;Canada;Czech Republic;Egypt;Estonia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Farmacéutica S.A
2012 - EUCTR2012-003056-36-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Pharma Services AG
2015 - EUCTR2012-003056-36-FR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-PL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-IE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-EE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 - EUCTR2012-003056-36-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 - EUCTR2011-006043-30-NL Netherlands;
- Phase 3 EUCTR2012-003056-36-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
BAF312A
NOVARTIS FARMA
2012 - EUCTR2012-003056-36-IT Argentina;Australia;Austria;Bulgaria;Canada;Czech Republic;Egypt;Estonia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Farmacéutica S.A
2012 - EUCTR2012-003056-36-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Pharma GmbH
2021 Phase 4 EUCTR2020-005752-38-DE Germany;
Novartis Pharma Services AG
2015 - EUCTR2012-003056-36-FR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-PL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-IE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-EE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 - EUCTR2012-003056-36-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
- Phase 3 EUCTR2012-003056-36-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
BAT4406F
Bio-Thera Solutions
2019 Phase 1 NCT04146285 China;
BAY 79-4998
Bayer Vital GmbH
2006 - EUCTR2006-002361-39-DE Germany;
BAY86-5046
Bayer AG
2017 Phase 4 EUCTR2017-001176-31-GB Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2017 Phase 4 EUCTR2017-001176-31-FI Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2017 Phase 4 EUCTR2017-001176-31-DK Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2017 Phase 4 EUCTR2017-001176-31-CZ Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2017 Phase 4 EUCTR2017-001176-31-AT Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
Bayer HealthCare AG
2013 Phase 4 EUCTR2012-005262-35-GB Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2012-005262-35-IT Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
- - EUCTR2014-004613-93-Outside-EU/EEA China;
BAY86-5046_Interferon-beta-1b
Bayer
2007 - NCT01158183 United States;
BBR 2778
Fondation Charcot Stichting
2009 Phase 1;Phase 2 EUCTR2007-003086-40-BE Belgium;France;
2008 - EUCTR2007-003086-40-FR France;
BCD-033 (interferon beta 1a)
Biocad
2014 Phase 2/Phase 3 NCT02727907 Russian Federation;
BCD-054 180 mcg
Biocad
2017 Phase 2/Phase 3 NCT02744222 Russian Federation;
BCD-054 240 mcg
Biocad
2017 Phase 2/Phase 3 NCT02744222 Russian Federation;
BCD-063
Biocad
2013 Phase 3 NCT02753088 -
BCD-132
Biocad
2018 Phase 1 NCT03551275 Russian Federation;
BCD-132,
Biocad
2019 Phase 2 NCT04056897 Russian Federation;
BCG20-0134
BTG International Ltd
2009 Phase 2 EUCTR2009-011585-28-BE Belgium;European Union;France;Germany;Russian Federation;Spain;
2009 - EUCTR2009-011585-28-FR Belgium;France;Germany;Spain;
2009 - EUCTR2009-011585-28-DE Belgium;European Union;France;Germany;Russian Federation;Spain;
BEAM Regimen
Makati Medical Center
2015 Phase 1 NCT03113162 Philippines;
BETACONNECT
Bayer
2019 - NCT03808142 Germany;
2014 - NCT02247310 Austria;Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Czechia;France;Greece;Hungary;Italy;Netherlands;Spain;Switzerland;
BETACONNECT auto-injector.
Bayer
2014 - NCT02121444 Germany;
BETACONNECT device
Bayer
2016 - NCT02652091 United States;
BETAFERON - 15 FLACONCINI 0.25 MG + 15 FLACONCINI 2 ML
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy;
BETAFERON 250 mcg
SCHERING
2007 - EUCTR2006-005270-47-IT Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
BETAFERON 500 mcg
SCHERING
2007 - EUCTR2006-005270-47-IT Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
BETAFERON SC 15F 0,25MG 15SIR
Universita di Firenze
2006 - EUCTR2006-004937-13-IT Italy;
BETAFERON*15CONFEZ 0,25MG/ML+
AZIENDA OSPEDALIERA S. LUIGI GONZAGA
2011 - EUCTR2010-023677-19-IT Italy;
BETAFERON® (interferon beta-1b)
Ospedale Regionale di Lugano
2013 - EUCTR2012-004040-30-AT Austria;Switzerland;
BG-12 120
Northwestern University
2013 Phase 2 EUCTR2012-004165-41-GB United Kingdom;United States;
BG00002
BIOGEN IDEC LTD
2007 - EUCTR2005-004061-41-SE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2007 - EUCTR2005-004061-41-AT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Ireland;Italy;Spain;Sweden;United Kingdom;
2006 Phase 3 EUCTR2005-004061-41-GB Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 Phase 3 EUCTR2005-004061-41-BE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 - EUCTR2005-004061-41-IE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 - EUCTR2005-004061-41-HU Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 - EUCTR2005-004061-41-GR Austria;Czech Republic;Denmark;Finland;Germany;Greece;Ireland;Italy;Spain;Sweden;United Kingdom;
2006 - EUCTR2005-004061-41-FI Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 - EUCTR2005-004061-41-DK Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 - EUCTR2005-004061-41-DE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 - EUCTR2005-004061-41-CZ Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
Biogen Idec
2012 Phase 4 NCT02142205 Russian Federation;
Biogen Idec Limited
2011 - EUCTR2010-024000-10-ES Belgium;Germany;Italy;Spain;
2011 - EUCTR2010-024000-10-DE Belgium;Germany;Italy;Spain;
2011 - EUCTR2010-024000-10-BE Belgium;Germany;Italy;Spain;
Biogen Idec Research Limited
2019 Phase 3 EUCTR2018-002145-11-GB Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States;
BG00002 (natalizumab)
Biogen
2010 Phase 3 NCT01058005 Australia;Canada;Czech Republic;Finland;France;Hungary;Italy;Latvia;Poland;Slovenia;Spain;Sweden;United States;
2009 Phase 4 NCT00871780 Belgium;Mexico;Poland;Romania;Saudi Arabia;Ukraine;Venezuela;
2008 Phase 4 NCT00536120 United States;
2006 Phase 3 NCT00306592 Canada;United States;
BG00002-E (natalizumab high titer)
Biogen
2006 Phase 2 NCT00516893 United States;
BG00012
BIOGEN IDEC LTD
2010 Phase 3 EUCTR2008-004753-14-IT Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Ireland;Italy;Latvia;Netherlands;Slovakia;Spain;United Kingdom;
2008 - EUCTR2006-003696-12-IT Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;
BIOGEN IDEC RESEARCH LIMITED
2015 Phase 3 EUCTR2014-005624-98-IT Argentina;Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Kuwait;Lebanon;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States;
Biogen
2009 Phase 1 NCT00837785 Germany;United Kingdom;
2007 Phase 3 NCT00451451 Australia;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Costa Rica;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Ireland;Israel;Italy;Kazakhstan;Latvia;Lithuania;Macedonia, The Former Yugoslav Republic of;Mexico;Moldova, Republic of;New Zealand;Poland;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United States;
2007 Phase 3 NCT00420212 Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Guatemala;India;Israel;Italy;Kazakhstan;Macedonia, The Former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Virgin Islands (U.S.);
Biogen Idec
2004 Phase 2 NCT00168701 Czech Republic;Germany;Hungary;Netherlands;Poland;Russian Federation;Sweden;Switzerland;Turkey;United Kingdom;
Biogen Idec Inc.
2004 - EUCTR2004-000663-99-SE Hungary;Sweden;
2004 - EUCTR2004-000663-99-HU Hungary;Sweden;
2004 - EUCTR2004-000663-99-CZ Czech Republic;Hungary;Sweden;
Biogen Idec Italia S.r.l.
2015 - EUCTR2015-000303-21-IT Italy;
2013 Phase 3 EUCTR2013-001422-25-IT Italy;
Biogen Idec Limited
2010 Phase 3 EUCTR2008-004753-14-BG Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2008-004753-14-SK Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2008-004753-14-LV Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2008-004753-14-IE Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2008-004753-14-GB Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2008-004753-14-EE Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2008-004753-14-CZ Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2008-004753-14-BE Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2008-004753-14-AT Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
Biogen Idec LtD.
2007 Phase 3 EUCTR2006-003696-12-SK Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Slovakia;Sweden;United Kingdom;
Biogen Idec Ltd.
2010 Phase 3 EUCTR2008-004753-14-NL Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2008-004753-14-GR Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Ireland;Italy;Latvia;Netherlands;Slovakia;Spain;United Kingdom;
2009 Phase 3 EUCTR2008-004753-14-FR Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Ireland;Italy;Latvia;Netherlands;Slovakia;Spain;United Kingdom;
2009 Phase 3 EUCTR2008-004753-14-ES Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Ireland;Italy;Latvia;Netherlands;Slovakia;Spain;United Kingdom;
2009 Phase 3 EUCTR2008-004753-14-DE Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2009 - EUCTR2006-003696-12-BG Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;
2008 - EUCTR2006-003697-10-BG Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2008 - EUCTR2006-003696-12-NL Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;
2008 - EUCTR2006-003696-12-DE Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;
2007 Phase 3 EUCTR2006-003697-10-ES Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 Phase 3 EUCTR2006-003697-10-BE Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 Phase 3 EUCTR2006-003696-12-GB Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Slovakia;Sweden;United Kingdom;
2007 - EUCTR2006-003697-10-LV Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 - EUCTR2006-003697-10-IE Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 - EUCTR2006-003697-10-GR Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 - EUCTR2006-003697-10-EE Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 - EUCTR2006-003697-10-DE Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 - EUCTR2006-003697-10-CZ Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 - EUCTR2006-003696-12-SE Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;
2007 - EUCTR2006-003696-12-GR Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;
2007 - EUCTR2006-003696-12-CZ Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;
2007 - EUCTR2006-003696-12-BE Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;
2007 - EUCTR2006-003696-12-AT Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;
Biogen Idec Research Limited
2019 Phase 3 EUCTR2018-000516-22-PT Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-000516-22-HU Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-000516-22-EE Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States;
2017 Phase 3 EUCTR2013-002318-11-FR Belgium;Czech Republic;Denmark;France;Germany;Hungary;Italy;Poland;Serbia;Spain;Sweden;Ukraine;United Kingdom;
2016 Phase 3 EUCTR2015-003282-29-LV Belgium;Bulgaria;Czech Republic;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States;
2016 Phase 3 EUCTR2015-003282-29-DE Belgium;Bulgaria;Czech Republic;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States;
2016 Phase 3 EUCTR2015-003282-29-CZ Belgium;Bulgaria;Czech Republic;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States;
2016 Phase 3 EUCTR2015-003282-29-BG Belgium;Bulgaria;Czech Republic;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States;
2016 Phase 3 EUCTR2015-003282-29-BE Belgium;Bulgaria;Czech Republic;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States;
2016 Phase 3 EUCTR2015-001973-42-PL Belgium;Bulgaria;Croatia;Kuwait;Lithuania;Poland;United States;
2016 Phase 3 EUCTR2015-001973-42-LT Belgium;Bulgaria;Croatia;Kuwait;Lithuania;Poland;United States;
2016 Phase 3 EUCTR2015-001973-42-HR Austria;Belgium;Bulgaria;Canada;Croatia;Kuwait;Lithuania;Poland;Slovakia;Sweden;Turkey;United States;
2016 Phase 3 EUCTR2015-001973-42-BG Belgium;Bulgaria;Croatia;Kuwait;Lithuania;Poland;United States;
2016 Phase 3 EUCTR2013-002318-11-DE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States;
2016 - EUCTR2013-002318-11-ES Argentina;Belgium;Canada;Croatia;Czech Republic;Denmark;France;Hungary;Israel;Italy;Poland;Portugal;Romania;Serbia;Spain;Sweden;Turkey;United Kingdom;
2015 Phase 3 EUCTR2015-001973-42-BE Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Kuwait;Lithuania;Poland;Turkey;United States;
2015 Phase 3 EUCTR2014-004562-22-IT Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States;
2015 Phase 3 EUCTR2014-004562-22-DE Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States;
2015 Phase 3 EUCTR2014-004562-22-CZ Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States;
2015 Phase 3 EUCTR2014-004562-22-BE Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States;
2015 Phase 3 EUCTR2014-003021-18-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States;
2015 Phase 3 EUCTR2013-002318-11-PL Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States;
2015 Phase 2 EUCTR2014-005003-24-PL Australia;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Lithuania;Poland;Turkey;United Kingdom;
2015 Phase 2 EUCTR2014-005003-24-LV Australia;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Lithuania;Poland;Turkey;United Kingdom;
2015 Phase 2 EUCTR2014-005003-24-DE Australia;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Lithuania;Poland;Turkey;United Kingdom;
2015 Phase 2 EUCTR2014-005003-24-CZ Australia;Belgium;Bulgaria;Czech Republic;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Lithuania;Poland;Turkey;United States;
2015 Phase 2 EUCTR2014-005003-24-BG Australia;Belgium;Bulgaria;Czech Republic;France;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Poland;Turkey;United Kingdom;United States;
2015 Phase 2 EUCTR2014-005003-24-BE Australia;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Lithuania;Poland;Turkey;United Kingdom;
2015 - EUCTR2014-005624-98-HU Argentina;Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Kuwait;Lebanon;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States;
2015 - EUCTR2014-004562-22-HU Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States;
2015 - EUCTR2014-003021-18-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States;
2015 - EUCTR2014-003021-18-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States;
2015 - EUCTR2014-003021-18-PL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States;
2015 - EUCTR2014-003021-18-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States;
2015 - EUCTR2014-003021-18-IT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States;
2015 - EUCTR2014-003021-18-FI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States;
2015 - EUCTR2014-003021-18-DK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States;
2015 - EUCTR2014-003021-18-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States;
2015 - EUCTR2014-003021-18-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States;
2015 - EUCTR2014-003021-18-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States;
2014 Phase 4 EUCTR2013-001656-35-SK Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2014 Phase 4 EUCTR2013-001656-35-SI Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2014 Phase 4 EUCTR2013-001656-35-PT Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2014 Phase 4 EUCTR2013-001656-35-IT Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2014 Phase 4 EUCTR2013-001656-35-HU Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2014 Phase 4 EUCTR2013-001656-35-FR Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2014 Phase 4 EUCTR2013-001656-35-ES Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2014 Phase 4 EUCTR2013-001656-35-CZ Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2014 Phase 4 EUCTR2013-001656-35-BE Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2014 Phase 4 EUCTR2013-001656-35-AT Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2014 Phase 3 EUCTR2013-004533-32-PL Czech Republic;Japan;Korea, Republic of;Poland;Taiwan;
2014 Phase 3 EUCTR2013-004533-32-CZ Czech Republic;Japan;Korea, Republic of;Poland;Taiwan;
2014 Phase 3 EUCTR2013-002318-11-SE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States;
2014 Phase 3 EUCTR2013-002318-11-HU Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;
2014 Phase 3 EUCTR2013-002318-11-GB Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States;
2014 Phase 3 EUCTR2013-002318-11-DK Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States;
2014 Phase 3 EUCTR2013-002318-11-CZ Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States;
2014 Phase 3 EUCTR2013-002318-11-BE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States;
2014 - EUCTR2013-002318-11-IT Belgium;Czech Republic;Denmark;France;Hungary;Italy;Poland;Serbia;Sweden;Ukraine;United Kingdom;
2014 - EUCTR2013-001895-40-IE Ireland;United Kingdom;
2014 - EUCTR2013-001486-17-DE Germany;
- Phase 3 EUCTR2014-005624-98-EE Argentina;Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Kuwait;Lebanon;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States;
- Phase 3 EUCTR2014-005624-98-AT Argentina;Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Kuwait;Lebanon;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States;
BG00012 (DMF)
Biogen
2013 Phase 4 NCT01873417 United States;
BG00012 (DMF) (Tecfidera®.)
Multiple Sclerosis Center of Northeastern New York
2015 Phase 4 NCT02683863 United States;
BG0002 (natalizumab)
Biogen Idec
2009 - NCT00818038 United States;
BG9418 (interferon beta 1-a)
Biogen
2008 Phase 3 NCT00784836 United States;
BG9418 (interferon beta-1a)
Biogen
2009 Phase 3 NCT00828204 United States;
Biogen Idec
2004 - NCT00168714 United States;
BGC20-0134
BTG International Ltd
2009 - EUCTR2009-011585-28-ES Belgium;France;Germany;Spain;
BGG492
Novartis Pharmaceuticals
2016 Phase 2 NCT01649050 Germany;Russian Federation;
BHT-3009
Bayhill Therapeutics
2006 Phase 2 NCT00382629 -
2006 - EUCTR2005-001340-22-CZ Czech Republic;Finland;United Kingdom;
2005 Phase 2 EUCTR2005-001340-22-SK Czech Republic;Finland;Slovakia;United Kingdom;
2005 - EUCTR2005-001340-22-GB Czech Republic;Finland;United Kingdom;
2005 - EUCTR2005-001340-22-FI Czech Republic;Finland;United Kingdom;
BHT-3009-01
Bayhill Therapeutics
2004 Phase 1 NCT00103974 Canada;United States;
BIIB 017
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-003008-38-IT Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
BIIB017
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-003008-38-IT Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
Biogen
2013 Phase 3 NCT01939002 United States;
Biogen Idec LTD
2009 - EUCTR2008-006333-27-LV Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Latvia;Netherlands;Spain;United Kingdom;
Biogen Idec Limited
2012 Phase 3 EUCTR2010-024477-39-GR Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2010-024477-39-GB Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2012 - EUCTR2010-024477-39-CZ Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-024477-39-DE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-024477-39-BG Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-024477-39-LV Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-024477-39-ES Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-024477-39-EE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-024477-39-BE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2010 - EUCTR2008-006333-27-GR Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Latvia;Netherlands;Spain;United Kingdom;
2010 - EUCTR2008-006333-27-CZ Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2008-006333-27-GB Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2008-006333-27-ES Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Latvia;Netherlands;Spain;United Kingdom;
2009 - EUCTR2008-006333-27-NL Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2009 - EUCTR2008-006333-27-EE Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2009 - EUCTR2008-006333-27-BG Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2009 - EUCTR2008-006333-27-BE Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
- - EUCTR2008-006333-27-DE Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
Biogen Idec Research Limited
2020 Phase 3 EUCTR2018-003008-38-DE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-SK Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-PT Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-HU Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-HR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-GR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-ES Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;
2019 Phase 3 EUCTR2018-003008-38-CZ Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;
2019 Phase 3 EUCTR2018-003008-38-BG Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-BE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-000516-22-PT Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-000516-22-HU Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-000516-22-EE Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States;
- Phase 3 EUCTR2018-003008-38-FR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
Johns Hopkins University
2010 Phase 3 NCT01337427 United States;
BIIB017 (Peginterferon beta-1a)
Biogen Idec
2014 Phase 4 NCT02234869 -
BIIB017 (peginterferon beta-1a)
Biogen
2019 Phase 3 NCT03958877 Argentina;Australia;Belgium;Bulgaria;Croatia;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2009 Phase 3 NCT00906399 Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
BIIB017 (peginterferon beta-1a) Autoinjector
Biogen Idec
2012 Phase 1 NCT01610310 United States;
BIIB017 (peginterferon beta-1a) Pre-filled syringe (PFS)
Biogen Idec
2012 Phase 1 NCT01610310 United States;
BIIB019
BIOGEN IDEC RESEARCH LIMITED
2017 Phase 3 EUCTR2016-002820-10-IT Canada;Denmark;France;Germany;Italy;United Kingdom;United States;
BIOGEN IDEC RESEARCH LTD
2013 Phase 3 EUCTR2012-003176-39-IT Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Russian Federation;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
Biogen
2013 Phase 3 EUCTR2012-003176-39-HU Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 2 EUCTR2009-015318-23-GB Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom;
Biogen Idec Limited
2011 - EUCTR2010-023856-97-PL Czech Republic;Hungary;Poland;Russian Federation;United States;
2011 - EUCTR2010-023856-97-HU Czech Republic;Hungary;Poland;Russian Federation;United States;
2011 - EUCTR2010-023856-97-CZ Czech Republic;Hungary;Poland;United States;
Biogen Idec Ltd
2012 Phase 3 EUCTR2009-012500-11-SI Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-012500-11-GB Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-012500-11-FI Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 - EUCTR2009-012500-11-SE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 - EUCTR2009-012500-11-IE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 - EUCTR2009-012500-11-HU Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 - EUCTR2009-012500-11-DK Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 - EUCTR2009-012500-11-DE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 - EUCTR2009-012500-11-CZ Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
Biogen Idec Ltd.
2011 Phase 2 EUCTR2009-015318-23-DE Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom;
2010 Phase 2 EUCTR2009-015318-23-HU Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom;
2010 Phase 2 EUCTR2009-015318-23-CZ Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom;
2009 Phase 2 EUCTR2008-005559-46-GB Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
2009 - EUCTR2008-005559-46-HU Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
2009 - EUCTR2008-005559-46-DE Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
2009 - EUCTR2008-005559-46-CZ Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
Biogen Idec Research Limited
2017 Phase 3 EUCTR2016-002820-10-GB Canada;Denmark;France;Germany;Italy;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002820-10-DE Canada;Germany;Italy;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003176-39-SE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003176-39-PL Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003176-39-IE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003176-39-GR Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003176-39-GB Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003176-39-FR Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003176-39-ES Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003176-39-DK Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003176-39-DE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003176-39-CZ Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 - EUCTR2012-003176-39-FI Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
BIIB019 (Daclizumab High Yield Process)
Biogen
2010 Phase 3 NCT01064401 Argentina;Australia;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Egypt;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2009 Phase 2 NCT00870740 Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
2008 Phase 2 NCT00390221 Australia;Czech Republic;Former Serbia and Montenegro;Germany;Hungary;India;Poland;Russian Federation;Sweden;Turkey;Ukraine;United Kingdom;
BIIB019 (Daclizumab)
Biogen
2013 Phase 3 NCT01797965 Argentina;Australia;Brazil;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 NCT01462318 Czech Republic;Hungary;Poland;Russian Federation;United States;
2010 Phase 2 NCT01051349 Czech Republic;Czechia;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
BIIB033
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 2 EUCTR2017-001224-22-IT Australia;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
Biogen
2016 Phase 1 NCT02641041 United Kingdom;
2013 Phase 2 NCT01864148 Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
2010 Phase 1 NCT01244139 United States;
Biogen Idec Research Limited
2013 Phase 2 EUCTR2011-006262-40-NL Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
2013 Phase 2 EUCTR2011-006262-40-IT Canada;Czech Republic;Hungary;Italy;Netherlands;Russian Federation;Serbia;Spain;United Kingdom;United States;
2013 Phase 2 EUCTR2011-006262-40-HU Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
2013 Phase 2 EUCTR2011-006262-40-GB Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
2013 Phase 2 EUCTR2011-006262-40-ES Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
2013 Phase 2 EUCTR2011-006262-40-CZ Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
BIIB033 (ANTI-LINGO)
Biogen Idec Research Limited
2018 Phase 2 EUCTR2017-001224-22-PL Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
2018 Phase 2 EUCTR2017-001224-22-NL Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
2018 Phase 2 EUCTR2017-001224-22-DE Australia;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
2018 Phase 2 EUCTR2017-001224-22-BE Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
2017 Phase 2 EUCTR2017-001224-22-HU Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
2017 Phase 2 EUCTR2017-001224-22-ES Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
2017 Phase 2 EUCTR2017-001224-22-CZ Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
BIIB033 (ANTI-LINGO) - EV Substance Code SUB118957
Biogen Idec Research Limited
2017 Phase 2 EUCTR2017-001224-22-GB Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
BIIB033 (opicinumab)
Biogen
2017 Phase 2 NCT03222973 Australia;Belgium;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
2016 Phase 1 NCT02833142 United States;
BIIB041
Biogen Idec Research Limited
2015 Phase 3 EUCTR2013-003600-40-NL Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003600-40-GB Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003600-40-CZ Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003600-40-BG Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States;
2014 - EUCTR2013-003600-40-LT Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States;
2014 - EUCTR2013-003600-40-IT Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States;
2014 - EUCTR2013-003600-40-FI Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States;
2012 Phase 4 EUCTR2011-003507-38-GB Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom;
2012 Phase 4 EUCTR2011-003507-38-BE Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom;
2012 Phase 2 EUCTR2012-000368-90-BE Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom;
2012 - EUCTR2012-000368-90-NL Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom;
2012 - EUCTR2012-000368-90-GB Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom;
2012 - EUCTR2011-003507-38-PT Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom;
2012 - EUCTR2011-003507-38-NL Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom;
2012 - EUCTR2011-003507-38-DK Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom;
Cliniques Universitaires Saint-Luc, Neurologie
2013 - EUCTR2012-005076-34-BE Belgium;
BIIB041 (Fampridine-SR)
Biogen Idec
2010 Phase 3 NCT01235221 Canada;
BIIB041 (PR Fampridine)
Biogen
2012 Phase 2 NCT01597297 Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom;
BIIB041 (fampridine)
Biogen
2013 Phase 3 NCT01917019 Japan;
BIIB061
Biogen
2021 Phase 2 NCT04079088 -
2015 Phase 1 NCT02521545 United States;
BIIB133
Biogen Idec Research Limited
2020 Phase 2 EUCTR2019-001967-58-PL Belgium;France;Germany;Italy;Poland;Serbia;Spain;Switzerland;United States;
2020 Phase 2 EUCTR2019-001967-58-FR Belgium;France;Germany;Italy;Poland;Serbia;Spain;Switzerland;United States;
BIRT 2584 XX
BOEHRINGER ING.
2006 - EUCTR2005-005985-35-IT Czech Republic;Italy;Netherlands;
Boehringer Ingelheim
2006 - EUCTR2005-005985-35-NL Czech Republic;Italy;Netherlands;
Boehringer Ingelheim Ltd
2006 - EUCTR2005-005985-35-CZ Czech Republic;Italy;Netherlands;
BIRT 2584XX
BOEHRINGER ING.
2006 - EUCTR2005-005985-35-IT Czech Republic;Italy;Netherlands;
BMMNC
Chaitanya Hospital, Pune
2014 Phase 1/Phase 2 NCT01883661 India;
BMS 188667 (Abatacept)
Bristol-Myers Squibb
2001 Phase 2 NCT00035529 United States;
BNT162b2
National Institute of Allergy and Infectious Diseases (NIAID)
2021 Phase 2 NCT05000216 United States;
BORAGE OIL GLA
PALUPA Medical Ltd
2016 Phase 3 EUCTR2015-003147-19-GR Greece;
BOSWELAN
University Medical Center Eppendorf
- Phase 2 EUCTR2009-014724-32-DE Germany;
BOTOX®
Allergan
2008 - EUCTR2006-006299-39-NL France;Netherlands;
2008 - EUCTR2006-006299-39-FR France;Netherlands;
Allergan Ltd.
2013 - EUCTR2012-000957-30-PT Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States;
2013 - EUCTR2012-000957-30-GB Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States;
2012 - EUCTR2012-000957-30-CZ Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States;
2012 - EUCTR2012-000957-30-BE Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States;
BOTULINUM TOXIN A - HAEMAGGLUTININ COMPLEX
Ipsen Innovation
2016 Phase 3 EUCTR2015-003471-30-PT Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
2016 Phase 3 EUCTR2015-003471-30-PL Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
2016 Phase 3 EUCTR2015-003471-30-NL Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
2016 Phase 3 EUCTR2015-003471-30-IT Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
2016 Phase 3 EUCTR2015-003471-30-CZ Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
2016 Phase 3 EUCTR2015-000507-44-LT Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
2016 Phase 3 EUCTR2015-000507-44-FR Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
2016 Phase 3 EUCTR2015-000507-44-ES Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
2016 Phase 3 EUCTR2015-000507-44-DE Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
2016 Phase 3 EUCTR2015-000507-44-BE Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
BX-1
Bionorica SE
2020 Phase 3 EUCTR2018-000001-23-CZ Czech Republic;Hungary;Spain;
2019 Phase 3 NCT03756974 Czechia;Germany;Hungary;Poland;Spain;
2018 Phase 3 EUCTR2018-000001-23-HU Czech Republic;Hungary;Spain;
2018 Phase 3 EUCTR2018-000001-23-ES Hungary;Spain;
Bacille Calmette-Guerin vaccine
S. Andrea Hospital
2019 Phase 2 NCT03888924 Italy;
Bacille of Calmette-Guerin
S. Andrea Hospital
2001 Phase 2/Phase 3 NCT00202410 Italy;
Baclofen
DAIICHI SANKYO COMPANY, LIMITED
- Phase 4 JPRN-JapicCTI-050031 -
Osmotica Pharmaceutical US LLC
2012 Phase 3 NCT01743651 Russian Federation;Ukraine;United States;
Baclofen ER Capsules (GRS)
Sun Pharma Advanced Research Company Ltd.
2016 Phase 3 EUCTR2016-001356-22-HU Germany;Hungary;Russian Federation;Ukraine;United States;
Baclofen IR
Impax Laboratories, LLC
2009 Phase 2 NCT00914290 United States;
Baclofen Tablets USP
Sun Pharma Advanced Research Company Ltd.
2016 Phase 3 EUCTR2016-001356-22-HU Germany;Hungary;Russian Federation;Ukraine;United States;
Bafiertam
Banner Life Sciences LLC
2019 Phase 1 NCT04022473 United States;
Balance
Ankara Yildirim Beyazit University
2019 - NCT04408742 Turkey;
2019 - NCT04286828 Turkey;
2019 - NCT03945006 Turkey;
2016 - NCT03566251 Turkey;
Biruni University
2016 - NCT03436927 -
East Kent Hospitals University NHS Foundation Trust
2017 Phase 1 NCT05102682 United Kingdom;
Gazi University
2018 - NCT03584672 -
2018 - NCT03501342 Turkey;
Lama Saad El-Din Mahmoud
2020 - NCT04528121 Egypt;
Marquette University
2017 - NCT04719494 -
October 6 University
2017 - NCT03670459 Egypt;
Somogy Megyei Kaposi Mór Teaching Hospital
2018 - NCT04550650 Hungary;
University of Aarhus
2016 - NCT02870023 Denmark;
University of Colorado, Denver
2012 - NCT01698086 United States;
University of Iowa
2020 - NCT04391023 United States;
University of Nebraska
2013 - NCT01816100 United States;
Wayne State University
2020 - NCT03404388 United States;
Örebro County Council
2014 - NCT02209467 Sweden;
2012 - NCT01582126 Sweden;
Balance platform therapy
University Hospital of Ferrara
2017 - NCT03353974 Italy;
Baminercept
Biogen Idec
2010 Phase 1/Phase 2 NCT01181089 Canada;United Kingdom;
Baseline Treatment
Hoffmann-La Roche
2014 Phase 3 NCT02028884 France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;Ukraine;United Kingdom;United States;
Baseline disease modifying therapies (DMTs)
Novartis Pharmaceuticals
2021 Phase 4 NCT04792567 Germany;
Bazedoxifene Acetate
Riley Bove, MD
2019 Phase 2 NCT04002934 United States;
Beetainterferoni -1a
Turku University Hospital
2013 Phase 4 EUCTR2013-004626-28-FI Finland;
Belimumab
Johns Hopkins University
2021 Phase 2 NCT04767698 United States;
Tianjin Medical University General Hospital
2021 Phase 1/Phase 2 NCT05154734 China;
Best Available Therapy (BAT)
National Institute of Allergy and Infectious Diseases (NIAID)
2019 Phase 3 NCT04047628 United Kingdom;United States;
Beta-1b interferoni
Schering Oy
2006 - EUCTR2005-005211-21-FI Finland;
Beta-Interferon
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
Beta-alanine supplementation
Hasselt University
2017 - NCT03418376 Belgium;
Beta-interferon
Sun Yat-sen University
2006 - NCT00818103 China;
Betaconnect Autoinjector
Bayer
2015 - NCT02486640 Germany;
Betaconnect auto-injector
Bayer
2017 - NCT03134573 Germany;
Betaferon
Dansk Multipel Sclerose Center
2010 - EUCTR2009-016824-29-DK Denmark;
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden;
2017 Phase 4 EUCTR2016-003587-39-SE Sweden;
Medical University Innsbruck
2009 - EUCTR2009-013284-19-AT Austria;
Medizinische Universität Innsbruck
2014 Phase 4 EUCTR2012-005450-30-AT Austria;Sweden;
2014 - EUCTR2012-005450-30-SE Austria;Sweden;
NURON BIOTECH INC.
2012 - EUCTR2011-002683-24-IT Belarus;Bulgaria;Hungary;Italy;Russian Federation;Spain;
Nuron Biotech, Inc.
2012 - EUCTR2011-002683-24-HU Belarus;Bulgaria;Croatia;Georgia;Hungary;Italy;Lebanon;Poland;Russian Federation;Spain;Ukraine;
2012 - EUCTR2011-002683-24-ES Belarus;Bulgaria;Croatia;Georgia;Hungary;Italy;Poland;Russian Federation;Spain;Ukraine;
2012 - EUCTR2011-002683-24-BG Belarus;Bulgaria;Croatia;Georgia;Hungary;Italy;Lebanon;Poland;Russian Federation;Spain;Ukraine;
Schering Nordiska AB
2006 - EUCTR2005-001540-23-SE Denmark;Sweden;
2005 - EUCTR2005-001540-23-DK Denmark;Sweden;
Schering Oy
2006 - EUCTR2005-005211-21-FI Finland;
Turku University Hospital
2013 Phase 4 EUCTR2013-004626-28-FI Finland;
Betaferon 250 microgram/mL, powder and solvent for solution for injection.
Bayer HealthCare AG
2013 Phase 4 EUCTR2012-005262-35-ES Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
Betaferon 250 microgram/ml
Biogen Portugal
2016 Phase 4 EUCTR2016-000434-21-PT Portugal;
Octapharma AG
2015 Phase 3 EUCTR2012-005086-12-PL Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;Serbia;Ukraine;
2013 - EUCTR2012-005086-12-HU Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-DE Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-BG Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-AT Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
Betaferon 250 microgram/ml, powder and solvent for solution for injection
Bayer AG
2018 Phase 4 EUCTR2017-001176-31-PT Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2017 Phase 4 EUCTR2017-001176-31-GB Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2017 Phase 4 EUCTR2017-001176-31-FR Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2017 Phase 4 EUCTR2017-001176-31-FI Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2017 Phase 4 EUCTR2017-001176-31-ES Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2017 Phase 4 EUCTR2017-001176-31-DK Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2017 Phase 4 EUCTR2017-001176-31-CZ Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2017 Phase 4 EUCTR2017-001176-31-AT Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
Bayer HealthCare AG
2013 Phase 4 EUCTR2012-005262-35-GB Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2013 Phase 4 EUCTR2012-005262-35-CZ Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2012-005262-35-SI Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2012-005262-35-IT Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2012-005262-35-FI Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2012-005262-35-AT Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
Betaferon 250 microgramos
Schering AG
2007 Phase 3 EUCTR2006-005270-47-ES Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Betaferon 250mcg
Schering AG
2007 - EUCTR2006-005270-47-IE Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Betaferon 250µg
Bayer AB, Bayer Health Care, Bayer Schering Pharma
2007 - EUCTR2006-005270-47-SE Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Bayer Schering Pharma
2007 - EUCTR2006-005270-47-SI Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-HU Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
- - EUCTR2006-005270-47-DE Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Bayer Schering Pharma AG
2007 - EUCTR2006-005270-47-LV Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-GR Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-BE Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Schering AG
2007 Phase 3 EUCTR2006-005270-47-FR Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 Phase 3 EUCTR2006-005270-47-FI Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-NL Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-AT Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Betaferon 500 µg
Schering AG
2007 Phase 3 EUCTR2006-005270-47-ES Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Betaferon 500mcg
Schering AG
2007 - EUCTR2006-005270-47-IE Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
UCL Biomedicine R&D Unit
2006 - EUCTR2005-005751-18-GB United Kingdom;
Betaferon 500µg
Bayer AB, Bayer Health Care, Bayer Schering Pharma
2007 - EUCTR2006-005270-47-SE Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Bayer Schering Pharma
2007 - EUCTR2006-005270-47-SI Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-HU Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
- - EUCTR2006-005270-47-DE Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Bayer Schering Pharma AG
2007 - EUCTR2006-005270-47-LV Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-GR Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-BE Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Schering AG
2007 Phase 3 EUCTR2006-005270-47-FR Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 Phase 3 EUCTR2006-005270-47-FI Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-NL Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-AT Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Betaferon, BAY86-5046
Bayer
2019 - NCT03808142 Germany;
Betaferon/Betaseron
Bayer
2006 Phase 4 NCT00317941 France;
2003 Phase 4 NCT00206648 Canada;United States;
Betaferon®
University Hospital Motol
2011 Phase 4 EUCTR2011-001956-12-CZ Czech Republic;
Betaseron
Bayer HealthCare AG
- - EUCTR2014-004613-93-Outside-EU/EEA China;
Stuart D Cook MD
2003 Phase 4 NCT00176592 United States;
Teva Pharmaceutical Industries
2004 Phase 4 NCT00202995 Canada;United States;
Betaseron (Interferon beta-1b, BAY86-5046)
Bayer
2010 - NCT01031459 Canada;United States;
2002 Phase 2 NCT00893217 United States;
Betaseron (Interferon beta-1b, BAY86-5046), Bayer HealthCare AG
Bayer
2016 - NCT02749396 Finland;
Bevacizumab
Johns Hopkins University
2013 Phase 1 NCT01777412 United States;
Bexarotene
Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge
2015 Phase 2 EUCTR2014-003145-99-GB United Kingdom;
Bexsero
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 2;Phase 3 EUCTR2019-001829-26-IT Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States;
Biological samples
Centre Hospitalier Régional d'Orléans
2021 Phase 4 NCT04952766 France;
Biotin
University Hospital, Clermont-Ferrand
2018 - NCT03552211 France;
Bisacodyl
David Levinthal
2016 Phase 2 NCT02609607 United States;
Blood sample
Centre Hospitalier Universitaire de Saint Etienne
2020 Phase 2 NCT03983720 France;
University Hospital, Bordeaux
2021 - NCT04798651 France;
Blood samples
University Hospital, Bordeaux
2014 - NCT02142764 France;
Blood sampling
Centre Hospitalier Universitaire de Nimes
2013 Phase 3 NCT01817166 France;
Rennes University Hospital
2021 - NCT04697407 France;
BodyBio Balance Oil
Terry L. Wahls
2022 - NCT05007483 United States;
BodyBio PC
Terry L. Wahls
2022 - NCT05007483 United States;
Bone marrow autologous mesenchymal stem cells transplantation
Germans Trias i Pujol Hospital
2013 Phase 1/Phase 2 NCT02035514 Spain;
Bortezomib
Tianjin Medical University General Hospital
2015 Phase 2 NCT02893111 China;
Boswellia serrata extract PS0201Bo capsules
University Medical Center Eppendorf
- Phase 2 EUCTR2009-014724-32-DE Germany;
Boswellic acids (BOSWELAN)
Universitätsklinikum Hamburg-Eppendorf
2011 Phase 2 NCT01450124 Germany;
Botox
Krajská nemocnice Liberec, a.s.
2010 - EUCTR2009-012431-15-CZ Czech Republic;
Botox 100 UNT Injection
Brigitte Schürch
2021 Phase 4 NCT04819360 Switzerland;
Botulinum Toxin Type A 200U
Allergan
2009 Phase 3 NCT00876447 Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Czechia;France;Germany;Italy;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Singapore;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Botulinum Toxin Type A 300U
Allergan
2009 Phase 3 NCT00876447 Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Czechia;France;Germany;Italy;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Singapore;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Botulinum toxin
ALLERGAN
2008 - EUCTR2007-000192-42-IT France;Germany;Italy;Netherlands;Portugal;Spain;United Kingdom;
Botulinum toxin A
Sunnybrook Health Sciences Centre
2006 Phase 3 NCT01091727 Canada;
Botulinum toxin type A
Allergan
2008 - EUCTR2006-006299-39-NL France;Netherlands;
2008 - EUCTR2006-006299-39-FR France;Netherlands;
Ipsen
2016 Phase 3 NCT02660359 Argentina;Australia;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
2016 Phase 3 NCT02660138 Canada;Czech Republic;Czechia;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Turkey;United States;
2011 Phase 2 NCT01357980 Austria;Czech Republic;Czechia;France;Germany;Italy;Poland;
Botulinum toxin type A infiltrations
Aránzazu Vázquez Doce
2019 Phase 3 NCT04595045 Spain;
Brimonidine tartrate
Biogen
2016 Phase 4 NCT02568111 -
C1-esterase inhibitor (Cinryze)
Michael Levy
2013 Phase 1 NCT01759602 United States;
C105
Cognition Pharmaceuticals, LLC
2006 Phase 2 NCT00529581 United States;
CALCIO FOLINATO DC.IT
AZIENDA OSPEDALIERA SAN CAMILLO FORLANINI
2005 - EUCTR2005-006071-12-IT Italy;
CBD
Aarhus Universitetshospital
2018 Phase 2 EUCTR2018-002315-98-DK Denmark;
CC
University of Washington
2014 - NCT02137044 United States;
CCI-779
Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development
2005 - EUCTR2005-000171-18-FI Finland;
Wyeth is now a wholly owned subsidiary of Pfizer
2003 Phase 2 NCT00228397 -
CD
Sato Toshiyuki
2020 Phase 3 JPRN-jRCT2051210017 Japan;
CDP323
UCB Pharma
2008 Phase 1/Phase 2 NCT00726648 United Kingdom;
2007 Phase 2 NCT00484536 Belgium;Canada;Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom;United States;
2007 Phase 2 EUCTR2006-002204-33-ES Belgium;Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom;
2007 - EUCTR2006-002204-33-FI Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom;
UCB Pharma S.A.
2007 Phase 2 EUCTR2006-002204-33-GB Belgium;Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom;
2007 Phase 2 EUCTR2006-002204-33-FR Belgium;Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom;
2007 - EUCTR2006-002204-33-SE Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom;
2007 - EUCTR2006-002204-33-NL Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom;
2007 - EUCTR2006-002204-33-HU Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom;
2007 - EUCTR2006-002204-33-DE Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom;
2007 - EUCTR2006-002204-33-BE Belgium;Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom;
CELLCEPT
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France;
CETIRIZINE HYDROCHLORIDE
Biogen Idec Italia S.r.l.
2015 - EUCTR2013-001055-12-IT Italy;
CGP 77116
National Institute of Neurological Disorders and Stroke (NINDS)
1998 Phase 2 NCT00001781 United States;
CHR-1103 / GBR500
Genzyme Corporation
2015 Phase 2 EUCTR2014-003265-19-PL Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States;
2015 Phase 2 EUCTR2014-001643-20-SE Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States;
2015 Phase 2 EUCTR2014-001643-20-PL Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States;
2015 Phase 2 EUCTR2014-001643-20-DE Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States;
CIANOCOBALAMINA FU DC.IT
AZIENDA OSPEDALIERA SAN CAMILLO FORLANINI
2005 - EUCTR2005-006071-12-IT Italy;
CIC using LoFric Primo
Wellspect HealthCare
2009 - NCT00913510 Belgium;France;Germany;Netherlands;United Kingdom;
CITOCHINE ED IMMUNOMODULATORI
TEVA
2005 - EUCTR2004-003943-28-IT Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
CLOSTRIDIUM BOTULINUM TOXIN TYPE A
Ipsen Innovation
2016 Phase 3 EUCTR2015-003471-30-PT Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
2016 Phase 3 EUCTR2015-003471-30-PL Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
2016 Phase 3 EUCTR2015-003471-30-NL Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
2016 Phase 3 EUCTR2015-003471-30-IT Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
2016 Phase 3 EUCTR2015-003471-30-CZ Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
2016 Phase 3 EUCTR2015-000507-44-LT Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
2016 Phase 3 EUCTR2015-000507-44-FR Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
2016 Phase 3 EUCTR2015-000507-44-ES Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
2016 Phase 3 EUCTR2015-000507-44-DE Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
2016 Phase 3 EUCTR2015-000507-44-BE Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
2012 - EUCTR2010-023210-31-LT Austria;Czech Republic;Germany;Italy;Lithuania;
2012 - EUCTR2010-023210-31-DE Austria;Czech Republic;Germany;Italy;Lithuania;
2012 - EUCTR2010-023210-31-CZ Austria;Czech Republic;Germany;Italy;Lithuania;
2012 - EUCTR2010-023210-31-AT Austria;Czech Republic;Germany;Italy;Lithuania;
CNM-Au8
Clene Nanomedicine
2020 Phase 2/Phase 3 NCT04626921 Australia;
2018 Phase 2 NCT03536559 Australia;Canada;United States;
CNTO 1275
Centocor, Inc.
2004 Phase 2 NCT00207727 Australia;Canada;Czech Republic;Hungary;Poland;United Kingdom;United States;
CO-14
PEPTIMMUNE Inc
2008 - EUCTR2007-007759-15-HU Hungary;
COLECALCIFEROL CONCENTRATE (OILY FORM)
Javier Olascoaga Urtaza
2013 Phase 2 EUCTR2012-004602-97-ES Spain;
COP-1/Copolymer-1
TEVA Pharmaceutical Industries Ltd.
2007 - EUCTR2004-000463-94-HU Hungary;Italy;
2004 - EUCTR2004-000462-13-HU Hungary;Italy;
COPAXONE - 20 MG/ML SOLUZIONE INIETTABILE 28 SIRINGHE PRERIEMPITE
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain;
COPAXONE - 20 MG/ML SOLUZIONE INIETTABILE IN SIRINGHE PRERIEMPITE 30 SIRINGHE
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC
2015 Phase 4 EUCTR2015-000922-12-IT Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
COPAXONE - 40 MG/ML SOLUZIONE INIETTABILE IN
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain;
COPAXONE - 40 MG/ML SOLUZIONE INIETTABILE IN SIRINGA PRERIEMPITA 12 SIRINGHE PRERIEMPITE DA 1 ML CON AGO
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy;
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC
2015 Phase 4 EUCTR2015-000922-12-IT Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
COPAXONE 20 mg/ml solución inyectable en jeringa precargada
Biogen Idec Limited
2010 - EUCTR2009-015556-15-ES Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
COPAXONE*SC 28SIR 20MG/ML
Teva Pharmaceuticals Industries Ltd.
2006 - EUCTR2006-002037-20-IT Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
COVID-19 mRNA Vaccine (nucleoside modified)
Novartis Pharma GmbH
2021 Phase 4 EUCTR2020-005752-38-DE Germany;
Novartis Pharma Vertriebs GmbH
2021 Phase 4 EUCTR2021-000307-20-DE Germany;
COVID-19 mRNA vaccine (nucleoside-modified)
Novartis Pharma Vertriebs GmbH
2021 Phase 4 EUCTR2021-000307-20-DE Germany;
COVID-19 mRNA vaccine Moderna (CX-024414)
Novartis Pharma GmbH
2021 Phase 4 EUCTR2020-005752-38-DE Germany;
Novartis Pharma Vertriebs GmbH
2021 Phase 4 EUCTR2021-000307-20-DE Germany;
COVID-19 vaccination
Sheba Medical Center
2021 - NCT05075499 Israel;
COVID19 vaccine
Yale University
2021 - NCT05286242 United States;
CS-0777 tablets
Daiichi Sankyo Inc.
2008 Phase 1 NCT00616733 United States;
CSF sampling
Rennes University Hospital
2021 - NCT04697407 France;
CT103A cells
Tongji Hospital
2020 Early Phase 1 NCT04561557 China;
CYCLOPHOSPHAMIDE MONOHYDRATE
Uppsala l?ns landsting
2011 - EUCTR2010-023560-40-SE Brazil;Canada;Sweden;United States;
Caffeine
Biogen
2011 Phase 3 NCT01462318 Czech Republic;Hungary;Poland;Russian Federation;United States;
Calcium
Centre Hospitalier Universitaire de Nimes
2016 - NCT02636829 France;
Calcium and Vitamin D combination
Novartis
2010 Phase 3 NCT01166178 Germany;
Calcium carbonate
University Hospital of North Norway
2008 Phase 4 NCT00785473 Norway;
Calcium levofolinate
AZIENDA OSPEDALIERA SAN CAMILLO FORLANINI
2005 - EUCTR2005-006071-12-IT Italy;
Cannabidiol
GW Pharma Ltd
2007 Phase 3 EUCTR2006-005910-11-CZ Czech Republic;Germany;Italy;Spain;United Kingdom;
2006 Phase 3 EUCTR2005-005265-11-GB Czech Republic;France;United Kingdom;
2006 Phase 3 EUCTR2005-005265-11-FR Czech Republic;France;United Kingdom;
2006 - EUCTR2005-005265-11-CZ Czech Republic;France;United Kingdom;
2005 Phase 3 EUCTR2004-002509-63-GB Czech Republic;United Kingdom;
2005 - EUCTR2004-002509-63-CZ Czech Republic;United Kingdom;
GW Pharma Ltd.
2011 - EUCTR2011-000926-31-CZ Czech Republic;
2008 Phase 3 EUCTR2006-005910-11-GB Czech Republic;Germany;Italy;Spain;United Kingdom;
2008 - EUCTR2006-005910-11-DE Germany;Italy;Spain;United Kingdom;
2007 - EUCTR2007-002138-13-GB United Kingdom;
Cannabidiol (CBD)
Tiffany J. Braley, MD, MS
2022 Phase 2 NCT05269628 United States;
Cannabidiol / Dronabinol capsule 5 mg+2,
Aarhus Universitetshospital
2018 Phase 2 EUCTR2018-002315-98-DK Denmark;
Cannabidiol Botanical Drug Substance (CBD BDS)
Almirall Hermal GmbH
2016 Phase 4 EUCTR2015-004451-40-AT Austria;Czech Republic;
GW Pharma Limited
2022 Phase 3 EUCTR2020-004306-58-LT Bulgaria;Canada;Hungary;Italy;Lithuania;Spain;United Kingdom;United States;
2021 Phase 3 EUCTR2020-003271-18-ES Australia;Belgium;Czech Republic;Czechia;Poland;Spain;Sweden;United Kingdom;
2021 Phase 3 EUCTR2020-003271-18-CZ Australia;Belgium;Czech Republic;Czechia;Poland;Spain;Sweden;United Kingdom;
2021 Phase 3 EUCTR2019-002625-29-CZ Czech Republic;Czechia;Poland;United Kingdom;
2020 Phase 3 EUCTR2019-002625-29-PL Czech Republic;Czechia;Poland;United Kingdom;
2020 Phase 3 EUCTR2019-002625-29-GB Poland;United Kingdom;
GW Pharma Ltd
2020 Phase 3 EUCTR2019-002623-14-PL Czech Republic;Czechia;Poland;Romania;United Kingdom;United States;
2020 Phase 3 EUCTR2019-002623-14-GB Czech Republic;Poland;Romania;United Kingdom;United States;
2020 Phase 3 EUCTR2019-002623-14-CZ Czech Republic;Czechia;Poland;Romania;United Kingdom;United States;
Cannabidiol capsule
Aarhus Universitetshospital
2018 Phase 2 EUCTR2018-002315-98-DK Denmark;
Cannabis
Centre hospitalier de l'Université de Montréal (CHUM)
2021 Phase 3 NCT05092191 -
Cannabis Based Medicine Extract (Sativex)
AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA
2004 - EUCTR2005-000393-47-IT Italy;
Cannabis, Medical
OMNI Medical Services, LLC
2018 Phase 2 NCT03944447 United States;
Cannador
Gesellschaft fuer klinische Forschung e.V. (Society for Clinical Research)
2006 Phase 3 EUCTR2005-005263-29-GB United Kingdom;
Capacity of muscular oxygen extraction
Centre Hospitalier Universitaire de Saint Etienne
2020 Phase 2 NCT03983720 France;
Capsules with 160 mg Teavigo (at least EGCG)
Charite University, Berlin, Germany
2011 - NCT01417312 Germany;
Carbamazepine
Stine Maarbjerg, MD PhD
2012 - NCT04371575 -
Carbidopa
University of Miami
2018 Phase 1 NCT03266965 United States;
Carmustine
Fred Hutchinson Cancer Research Center
2008 Phase 2 NCT00716066 United States;
Carmustine, etoposide, cytarabine, and melphalan (BEAM)
National Institute of Allergy and Infectious Diseases (NIAID)
2006 Phase 2 NCT00288626 United States;
Carnosine, capsulle, 2 g/day, 8 weeks
University of Novi Sad, Faculty of Sport and Physical Education
2019 - NCT03995810 Serbia;
Cellular therapy with EBV specific autologous CTL infusion
Nantes University Hospital
2021 Phase 1 NCT02912897 France;
Ceralifimod
Merck KGaA
2014 Phase 3 EUCTR2013-002351-15-AT Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-003126-83-HU Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-003126-83-GR Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-003126-83-ES Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-003126-83-DE Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-003126-83-BG Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-PT Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-LV Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-HU Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-ES Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-EE Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-BG Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
Ceralifmod
Merck KGaA
2014 Phase 3 EUCTR2013-002351-15-AT Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-PT Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-LV Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-HU Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-ES Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-EE Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-BG Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
Cerebro-spinal fluid
University Hospital, Bordeaux
2021 - NCT04798651 France;
Cesamet™ (nabilone)
NEMA Research, Inc.
2006 Phase 4 NCT00381264 United States;
Ceterizine
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
2015 Phase 1 NCT02583594 Spain;
Cetirizina Mylan Generics
Biogen Idec Italia S.r.l.
2015 - EUCTR2013-001055-12-IT Italy;
Cetirizine
Genzyme, a Sanofi Company
2014 Phase 4 NCT02205489 Belgium;France;Netherlands;Spain;
Icahn School of Medicine at Mount Sinai
2014 Phase 1/Phase 2 NCT02865018 United States;
Charcoal
Sanofi
2013 Phase 3 NCT01863888 Belgium;Germany;Netherlands;
Cholecalciferol
Academic MS Center Limburg
2014 Phase 2 NCT02096133 Netherlands;
Johns Hopkins University
2010 Phase 1 NCT01024777 United States;
University Hospital of North Norway
2008 Phase 4 NCT00785473 Norway;
Cholecalciferol (Vitamin D3)
Merck KGaA
2009 Phase 2 NCT01198132 France;
Cholecalciferol, Vitamin D3
Merck Serono
2011 - EUCTR2010-020328-23-LV Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2011 - EUCTR2010-020328-23-LT Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2011 - EUCTR2010-020328-23-EE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2011 - EUCTR2010-020328-23-DE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2010 Phase 2 EUCTR2010-020328-23-DK Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2010 - EUCTR2010-020328-23-FI Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
Merck Serono SA - Geneva, an affiliate of Merck KGaA
2012 Phase 2 EUCTR2010-020328-23-PT Austria;Belgium;Denmark;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2011 - EUCTR2010-020328-23-AT Austria;Belgium;Denmark;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
Merck Serono SA-Geneva an affiliate of Merck KgaA, Darmstadt
2011 - EUCTR2010-020328-23-BE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal;
Merck Serono The Netherlands - a division of Merck B.V.
2011 - EUCTR2010-020328-23-NL Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal;
Cholestyramine
Sanofi
2014 Phase 1 NCT02046629 China;
2013 Phase 3 NCT01863888 Belgium;Germany;Netherlands;
Circadin ( INN= Melatonin)
North Bristol NHS Trust
2013 Phase 2 EUCTR2012-004183-21-GB United Kingdom;
Citalopram
Novartis Pharmaceuticals
2011 Phase 4 NCT01436643 Germany;
Cladribina
MERCK KGAA
2019 Phase 4 EUCTR2019-000069-19-IT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
Cladribina oral
Serono International, S.A.
2007 - EUCTR2006-003366-33-ES Italy;Spain;
Cladribine
Department of Neurology, Division of Clinical Neuroscience, Oslo University Hospital
2019 Phase 3 EUCTR2019-001505-24-NO Norway;
EMD Serono
2008 Phase 3 NCT00725985 Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czechia;Estonia;Finland;France;Georgia;Germany;India;Italy;Korea, Republic of;Lebanon;Macedonia, The Former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2005 Phase 3 NCT00213135 Canada;Switzerland;
EMD Serono Research & Development Institute, Inc.
2019 Phase 4 NCT03961204 Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Estonia;Finland;France;Georgia;Germany;Italy;Korea, Republic of;Lebanon;Lithuania;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2008 Phase 3 NCT00641537 Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;Former Serbia and Montenegro;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2006 Phase 2 NCT00436826 Italy;Russian Federation;Spain;United States;
Helse Bergen HF, Haukeland University Hospital
2018 Phase 3 EUCTR2017-001362-25-DK Denmark;Netherlands;
MERCK SERONO INTERNATIONAL SA
2008 - EUCTR2006-003366-33-IT Italy;Spain;
MERCK SERONO SA
2008 - EUCTR2007-000381-20-IT Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Netherlands;Portugal;United Kingdom;
2005 - EUCTR2004-005148-28-IT Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany
2019 Phase 1 NCT04086225 Germany;Poland;
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
2019 - NCT04934800 Austria;Greece;Italy;Norway;Poland;Portugal;Switzerland;
Merck KGaA
2008 Phase 1 NCT00938366 -
Merck KGaA, Darmstadt, Germany
2019 Phase 1 NCT03745144 Germany;Poland;
Merck Serono International S.A.
2006 - EUCTR2004-005148-28-LT Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
2005 - EUCTR2004-005148-28-FI Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
2005 - EUCTR2004-005148-28-EE Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
2005 - EUCTR2004-005148-28-DK Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
2005 - EUCTR2004-005148-28-CZ Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
2005 - EUCTR2004-005148-28-BE Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
Merck Serono International, a branch of Laboratoires Serono S.A.
2005 Phase 3 EUCTR2004-005148-28-GB Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Slovakia;United Kingdom;
Merck Serono International, a branch of Laboratories Serono S.A.
2005 - EUCTR2004-005148-28-DE Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
Oslo University Hospital
2019 Phase 3 NCT04121403 Norway;
Queen Mary University of London
2020 Phase 2 EUCTR2018-005038-39-GB United Kingdom;
Serono International S.A.
2006 Phase 3 EUCTR2004-005148-28-SK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Slovakia;United Kingdom;
2006 - EUCTR2004-005148-28-LV Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
2005 - EUCTR2004-005148-28-AT Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
Serono International, S.A.
2007 - EUCTR2006-003366-33-ES Italy;Spain;
University of Texas Southwestern Medical Center
2020 Phase 4 NCT04178005 United States;
Washington University School of Medicine
2019 Phase 4 NCT03963375 United States;
Cladribine (MAVENCLAD®)
Queen Mary University of London
2021 Phase 2/Phase 3 NCT04695080 United Kingdom;
Cladribine Oral Tablet
Claudio Gobbi
2020 - NCT04640818 Switzerland;
Cladribine Tablet
MERCK SERONO SA
2011 Phase 3 EUCTR2009-017978-21-IT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Finland;Georgia;Germany;Greece;India;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Portugal;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States Minor Outlying Islands;
Cladribine Tablets
EMD Serono Research & Development Institute, Inc.
2019 - NCT03933215 United States;
2019 - NCT03933202 United States;
Keith Edwards, M.D.
2020 Phase 4 NCT04550455 United States;
Cladribine tablets
MERCK KGAA
2021 Phase 4 EUCTR2020-003995-42-IT Australia;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland;
2021 Phase 4 EUCTR2020-003874-30-IT Austria;Czechia;Denmark;France;Hungary;Italy;Netherlands;Poland;Slovakia;Spain;
Merck Healthcare KGaA
2021 Phase 4 EUCTR2020-003995-42-HU Australia;Canada;Czech Republic;Finland;Germany;Hungary;Israel;
2021 Phase 4 EUCTR2020-003995-42-CZ Australia;Canada;Czech Republic;Finland;Germany;Hungary;Israel;
2021 Phase 4 EUCTR2020-003874-30-HU Hungary;
2021 Phase 4 EUCTR2020-003874-30-DK Denmark;Hungary;
2021 Phase 4 EUCTR2020-003874-30-CZ Czech Republic;Denmark;Hungary;Italy;
2020 Phase 4 EUCTR2020-003995-42-FI Australia;Canada;Finland;Germany;Israel;
2020 Phase 4 EUCTR2020-003995-42-DE Australia;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Poland;
Merck KGaA
2019 Phase 4 EUCTR2019-000069-19-SE Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2019 Phase 4 EUCTR2019-000069-19-PT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2019 Phase 4 EUCTR2019-000069-19-PL Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2019 Phase 4 EUCTR2019-000069-19-LT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2019 Phase 4 EUCTR2019-000069-19-HR Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2019 Phase 4 EUCTR2019-000069-19-ES Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2019 Phase 4 EUCTR2019-000069-19-EE Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2019 Phase 4 EUCTR2019-000069-19-CZ Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Italy;Korea, Republic of;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2019 Phase 4 EUCTR2019-000069-19-BG Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
Merck Serono S.A. - Geneva
2012 Phase 3 EUCTR2009-017978-21-PT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2012 Phase 3 EUCTR2009-017978-21-PL Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2012 Phase 3 EUCTR2009-017978-21-GR Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-SE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-LV Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-GB Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-FI Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-ES Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-EE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-DK Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-BG Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-BE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-AT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 - EUCTR2009-017978-21-LT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 - EUCTR2009-017978-21-CZ Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2010 Phase 3 EUCTR2009-017978-21-DE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
Merck, S.L.
2019 Phase 4 EUCTR2019-000069-19-AT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Italy;Korea, Republic of;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
Clemastine
University of California, San Francisco
2014 Phase 2 NCT02040298 United States;
Clemastine Milstein 1 mg, tabletten
Amsterdam University Medical Center
2022 Phase 3 EUCTR2021-003677-66-NL Netherlands;
Clemastine fumarate
National Institute of Allergy and Infectious Diseases (NIAID)
2017 Phase 1/Phase 2 NCT03109288 United States;
Cnp-MS-0601
Bionorica research GmbH
2007 Phase 3 EUCTR2006-004255-38-DK Austria;Denmark;Germany;
2007 - EUCTR2006-004255-38-DE Austria;Germany;
2007 - EUCTR2006-004255-38-AT Austria;Germany;
Coconut oil
University of Iowa
2010 Phase 1 NCT01381354 United States;
Coconut oil and epigallocatechin gallate
Fundación Universidad Católica de Valencia San Vicente Mártir
2018 Phase 2 NCT03740295 Spain;
Coenzyme Q
University of Iowa
2010 Phase 1 NCT01381354 United States;
Colecalciferol
AZIENDA OSPEDALIERA S. LUIGI GONZAGA
2011 - EUCTR2010-023677-19-IT Italy;
MERCK SERONO SA
2011 - EUCTR2010-020328-23-IT Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal;
University of Turku
2008 Phase 4 NCT01339676 Finland;
2008 Phase 2/Phase 3 NCT01432704 -
Combination Product: ofatumumab with AI
Novartis Pharmaceuticals
2018 Phase 2 NCT03560739 Austria;Bulgaria;Czechia;Estonia;Latvia;Lithuania;Russian Federation;Spain;United States;
Combination Product: ofatumumab with PRF
Novartis Pharmaceuticals
2018 Phase 2 NCT03560739 Austria;Bulgaria;Czechia;Estonia;Latvia;Lithuania;Russian Federation;Spain;United States;
Comirnaty Konzentrat zur Herstellung einer Injektionsdispersion
Novartis Pharma Vertriebs GmbH
2021 Phase 4 EUCTR2021-000307-20-DE Germany;
Continued Ocrelizumab
Johns Hopkins University
2021 Phase 2 NCT04767698 United States;
Copaxone
Amphia Ziekenhuis
2009 - EUCTR2009-013129-41-NL Netherlands;
Bayer
2003 Phase 3 NCT00099502 Argentina;Australia;Austria;Belgium;Brazil;Canada;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;Norway;Poland;Russian Federation;Slovenia;Spain;Sweden;Switzerland;Ukraine;United States;
Biogen Idec Limited
2010 - EUCTR2009-015556-15-SI Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States;
2010 - EUCTR2009-015556-15-SE Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States;
2010 - EUCTR2009-015556-15-PT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-NL Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-LV Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States;
2010 - EUCTR2009-015556-15-HU Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-GR Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-GB Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-FI Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-DK Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-DE Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-CZ Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States;
2010 - EUCTR2009-015556-15-AT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
Biogen Idec Ltd.
2008 - EUCTR2006-003697-10-BG Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 Phase 3 EUCTR2006-003697-10-ES Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 Phase 3 EUCTR2006-003697-10-BE Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 - EUCTR2006-003697-10-LV Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 - EUCTR2006-003697-10-IE Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 - EUCTR2006-003697-10-GR Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 - EUCTR2006-003697-10-EE Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 - EUCTR2006-003697-10-DE Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 - EUCTR2006-003697-10-CZ Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
EMD Serono
2013 Phase 2 NCT01963611 Bulgaria;Croatia;Czech Republic;Finland;Germany;Greece;Hungary;Italy;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States;
Glostrup Hospital, Dep. of Neurology
2009 - EUCTR2006-001827-21-DK Denmark;
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden;
2017 Phase 4 EUCTR2016-003587-39-SE Sweden;
Merck KGaA
2014 Phase 2 EUCTR2013-002283-25-GB Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2014 - EUCTR2013-002283-25-PL Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2014 - EUCTR2013-002283-25-GR Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2014 - EUCTR2013-002283-25-ES Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2014 - EUCTR2013-002283-25-BG Bulgaria;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States;
2013 - EUCTR2013-002283-25-IT Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2013 - EUCTR2013-002283-25-HU Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2013 - EUCTR2013-002283-25-FI Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2013 - EUCTR2013-002283-25-CZ Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
Merck Serono S.A. - Geneva
2010 - EUCTR2009-016087-37-GB France;Ireland;Italy;Spain;United Kingdom;
2009 - EUCTR2009-016087-37-ES France;Ireland;Italy;Spain;United Kingdom;
Nancy Hammond, MD
2007 - NCT00490906 United States;
Novartis Pharma Services AG
2012 - EUCTR2011-001437-16-DE Australia;Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
Peptimmune Inc.
2010 Phase 2 EUCTR2009-012716-40-SK Bulgaria;Czech Republic;Estonia;France;Germany;Poland;Slovakia;
2010 Phase 2 EUCTR2009-012716-40-DE Bulgaria;Czech Republic;Estonia;France;Germany;Poland;Slovakia;
2010 - EUCTR2009-012716-40-PL Bulgaria;Czech Republic;Estonia;France;Germany;Poland;
2010 - EUCTR2009-012716-40-FR Bulgaria;Czech Republic;Estonia;France;Germany;Poland;
2010 - EUCTR2009-012716-40-CZ Bulgaria;Czech Republic;Estonia;France;Germany;Poland;
2010 - EUCTR2009-012716-40-BG Bulgaria;Czech Republic;Estonia;France;Germany;Poland;
2009 - EUCTR2009-012716-40-EE Bulgaria;Czech Republic;Estonia;France;Germany;Poland;
Philipps-Universität Marburg
2010 - EUCTR2009-011088-35-DE Germany;
SYNTHON BV
2011 - EUCTR2011-000888-27-IT Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Romania;Russian Federation;Ukraine;United Kingdom;United States;
Stuart D Cook MD
2003 Phase 4 NCT00176592 United States;
Synthon BV
2012 - EUCTR2011-000888-27-GR Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-000888-27-DE Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2011-000888-27-RO Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2011-000888-27-GB Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2011-000888-27-EE Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2011-000888-27-CZ Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2011-000888-27-BG Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
The Walton Centre for Neurology and Neurosurgery
2005 Phase 4 EUCTR2004-004903-39-GB United Kingdom;
Turku University Hospital
2013 Phase 4 EUCTR2013-004626-28-FI Finland;
University at Buffalo
2007 - NCT00937157 United States;
University of California, Los Angeles
2007 Phase 2 NCT00451204 Canada;United States;
Università Popolare Homo & Natura
2015 Phase 1 NCT02632591 Italy;
VU University Medical Center
2014 - EUCTR2014-001012-19-NL Netherlands;
Copaxone 20 mg/ml
Octapharma AG
2015 Phase 3 EUCTR2012-005086-12-PL Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;Serbia;Ukraine;
2013 - EUCTR2012-005086-12-HU Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-DE Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-BG Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-AT Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
Teva Pharmaceutical Industries, Ltd
2016 Phase 4 EUCTR2015-000922-12-PL Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2016 Phase 4 EUCTR2015-000922-12-FR Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2016 Phase 4 EUCTR2015-000922-12-ES Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2016 Phase 4 EUCTR2015-000922-12-DE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2016 Phase 4 EUCTR2015-000922-12-BE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2015 Phase 4 EUCTR2015-000922-12-IE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2015 Phase 4 EUCTR2015-000922-12-HR Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2015 Phase 4 EUCTR2015-000922-12-FI Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2015 Phase 4 EUCTR2015-000922-12-AT Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
Copaxone 20 mg/ml Solution for Injection, pre-filled syringe
Teva Pharmaceutical Industries, Ltd.
2007 - EUCTR2006-002037-20-EE Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 Phase 3 EUCTR2006-002037-20-FI Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 Phase 3 EUCTR2006-002037-20-ES Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 - EUCTR2006-002037-20-LV Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 - EUCTR2006-002037-20-LT Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 - EUCTR2006-002037-20-HU Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 - EUCTR2006-002037-20-GB Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 - EUCTR2006-002037-20-DE Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 - EUCTR2006-002037-20-CZ Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 - EUCTR2006-002037-20-BE Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
Copaxone 20 mg/ml solución para inyección en jeringa precargada
Teva Pharmaceutical Industries, Ltd.
2006 Phase 3 EUCTR2006-002037-20-ES Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
Copaxone 20 mg/ml, Solution for Injection, pre-filled syringes
Teva Pharmaceutical Industries, Ltd.
2006 - EUCTR2006-002037-20-CZ Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
Copaxone 20mg/ml Solution for Injection, pre-filled syringe
Teva Pharmaceutical Industries, Ltd.
2006 - EUCTR2006-002037-20-LT Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
Copaxone 40 mg/ml
Teva Pharmaceutical Industries, Ltd
2016 Phase 4 EUCTR2015-000922-12-PL Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2016 Phase 4 EUCTR2015-000922-12-FR Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2016 Phase 4 EUCTR2015-000922-12-ES Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2016 Phase 4 EUCTR2015-000922-12-DE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2016 Phase 4 EUCTR2015-000922-12-BE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2015 Phase 4 EUCTR2015-000922-12-IE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2015 Phase 4 EUCTR2015-000922-12-HR Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2015 Phase 4 EUCTR2015-000922-12-FI Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2015 Phase 4 EUCTR2015-000922-12-AT Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
Copaxone 40 mg/ml solution for injection, pre-filled syringe
Università degli Studi Aldo Moro
2019 Phase 3 EUCTR2017-005129-18-IT Italy;
Copaxone subcutaneous injection syringe
TAKEDA PHARMACEUTICAL COMPANY LTD.
2015 - JPRN-JapicCTI-153058 -
Copaxone-Teva
Biocad
2013 Phase 3 NCT02753088 -
Copaxone®
Teva Branded Pharmaceutical Products R&D, Inc.
2015 Phase 4 NCT02499900 Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Italy;Mexico;Poland;Puerto Rico;Russian Federation;Spain;Turkey;United States;
Copolymer 1
National Center for Research Resources (NCRR)
1991 Phase 3 NCT00004814 -
Corticosteroid
University of New Mexico
2019 Phase 1/Phase 2 NCT03752307 United States;
Corticosteroids & tanCART19/20
Chinese PLA General Hospital
2018 Phase 1 NCT03605238 China;
Cranberry
Rennes University Hospital
2006 Phase 3 NCT00280592 France;
Creatine
University of Iowa
2010 Phase 1 NCT01381354 United States;
Curcumin
Merck KGaA, Darmstadt, Germany
2012 Phase 2 NCT01514370 Italy;
Cyclophosfamide
Dipartimento di Neuroscienze Oftalmologia e Genetica DINOG - Universita di Genova
2006 - EUCTR2006-002562-19-IT Italy;
Cyclophosphamide
AZIENDA OSPEDALIERA DI PADOVA
- Phase 1 EUCTR2008-005773-35-IT Italy;
Baylor College of Medicine
1999 Phase 2 NCT00040482 United States;
Fred Hutchinson Cancer Research Center
1997 Phase 1 NCT00014755 United States;
Hadassah Medical Organization
2015 - NCT02529839 -
Helse Bergen HF, Haukeland University Hospital
2018 Phase 3 EUCTR2017-001362-25-DK Denmark;Netherlands;
Northwestern Memorial Hospital
2001 Phase 1 NCT00017628 United States;
Northwestern University
2019 Phase 2/Phase 3 NCT03829566 United States;
2017 Phase 3 NCT03342638 United States;
OSPEDALE S. RAFFAELE
2007 Phase 2 EUCTR2007-000586-38-IT Italy;
Seah Lim M.D.
2012 Phase 2 NCT01679041 United States;
Stony Brook University
2003 Phase 2 NCT00296205 United States;
Cyclophosphamide (drug)
University Hospital, Bordeaux
2005 Phase 3 NCT00241254 France;
Cyclophosphamide and ATG
Haukeland University Hospital
2018 Phase 3 NCT03477500 Denmark;Netherlands;Norway;Sweden;
Cyclophosphamide and fludarabine
Tongji Hospital
2020 Early Phase 1 NCT04561557 China;
Cyclophosphamide monohydrate
Sheffield Teaching Hospitals
2020 Phase 3 EUCTR2019-001549-42-GB United Kingdom;
Cyclophosphamide/Glatiramer acetate
Johns Hopkins University
2010 Phase 2 NCT00939549 United States;
Cymbalta
Eli Lilly and Company
2008 - EUCTR2008-002560-34-BE Belgium;
Cytarabine
Fred Hutchinson Cancer Research Center
2008 Phase 2 NCT00716066 United States;
Cytolytic CD4+ T cells
ImCyse S.A
2014 Phase 1;Phase 2 EUCTR2014-001081-99-BE Belgium;
Cápsulas de Laquinimod
Teva Pharmaceutical Industries Ltd
2008 - EUCTR2007-005450-23-ES Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
Células madre mesenquimales
Fundació Clínic per a la Recerca Biomèdica
- - EUCTR2009-016442-74-ES Spain;
D Mannose
University College, London
2015 Phase 1 NCT02490046 United Kingdom;
D-BIOTINA
MEDDAY PHARMACEUTICALS
2017 Phase 3 EUCTR2016-000700-29-IT Australia;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States;
D-Biotin
MEDDAY PHARMACEUTICALS
2017 Phase 3 EUCTR2016-000700-29-IT Australia;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States;
D-aspartate
Merck KGaA, Darmstadt, Germany
2018 Phase 2 NCT03387046 Germany;Italy;
DAC HYP
BIOGEN IDEC RESEARCH LIMITED
2017 Phase 3 EUCTR2016-002820-10-IT Canada;Denmark;France;Germany;Italy;United Kingdom;United States;
Biogen Idec Research Limited
2017 Phase 3 EUCTR2016-002820-10-GB Canada;Denmark;France;Germany;Italy;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002820-10-DE Canada;Germany;Italy;United Kingdom;United States;
DAC-HYP
National Institute of Neurological Disorders and Stroke (NINDS)
2010 Phase 1 NCT01143441 United States;
DC-TAB
Delta Crystallon B.V.
2012 - EUCTR2011-004475-36-BG Bulgaria;
DEMESTRIL SEPTEM
OSPEDALI CIVILI DI LIONE
2007 - EUCTR2006-005460-30-IT Italy;
DEXTROMETHORPHAN HYDROBROMIDE
Avanir Pharmaceuticals, Inc.
2012 Phase 2 EUCTR2011-002178-22-GB Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States;
2012 - EUCTR2011-002178-22-PL Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States;
2012 - EUCTR2011-002178-22-CZ Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States;
DIBASE
AZIENDA OSPEDALIERA S. LUIGI GONZAGA
2011 - EUCTR2010-023677-19-IT Italy;
DIMETIL-FUMARATO
FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA
2017 Phase 4 EUCTR2017-000559-26-IT Israel;Italy;Switzerland;United States;
DMT
Merck KGaA
2012 - NCT01601119 United Kingdom;
VU University Medical Center
2020 - NCT04260711 Netherlands;
DMT continuation
Rennes University Hospital
2019 Phase 3 NCT03653273 France;
DPA-714 PET/MRI
University of Alabama at Birmingham
2019 Phase 1 NCT03759522 United States;
DUOC-01
Joanne Kurtzberg, MD
2021 Phase 1 NCT04943289 United States;
DYSPORT*SC IM 2FL 500U
IPSEN INNOVATION
2012 - EUCTR2010-023210-31-IT Austria;Czech Republic;Germany;Italy;Lithuania;
DYSPORT®
Ipsen Innovation
2016 Phase 3 EUCTR2015-003471-30-PT Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
2016 Phase 3 EUCTR2015-003471-30-PL Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
2016 Phase 3 EUCTR2015-003471-30-NL Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
2016 Phase 3 EUCTR2015-003471-30-IT Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
2016 Phase 3 EUCTR2015-003471-30-CZ Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
Daclizumab
Biogen
2017 Phase 3 NCT02881567 Canada;France;Germany;Italy;Puerto Rico;United Kingdom;United States;
Biogen Idec Research Limited
2017 Phase 3 EUCTR2016-002820-10-GB Canada;Denmark;France;Germany;Italy;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002820-10-DE Canada;Germany;Italy;United Kingdom;United States;
National Institute of Neurological Disorders and Stroke (NINDS)
2003 Phase 2 NCT00071838 United States;
Protein Design Labs, Inc.
2006 - EUCTR2005-001567-55-DE Germany;Spain;United Kingdom;
2005 Phase 2 EUCTR2005-001567-55-GB Austria;Germany;Spain;United Kingdom;
2005 - EUCTR2005-001567-55-ES Germany;Spain;United Kingdom;
2005 - EUCTR2005-001567-55-AT Austria;Germany;Spain;United Kingdom;
Daclizumab (Anti-CD25 Humanized Monoclonal Antibody)
PDL BioPharma, Inc.
2005 Phase 2 NCT00109161 Canada;United States;
Daclizumab HYP
BIOGEN IDEC LTD
2010 - EUCTR2009-012500-11-IT Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom;
Daclizumab HYP (DAC HYP
BIOGEN IDEC RESEARCH LTD
2013 Phase 3 EUCTR2012-003176-39-IT Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Russian Federation;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
Daclizumab HYP (DAC HYP)
Biogen
2013 Phase 3 EUCTR2012-003176-39-HU Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 2 EUCTR2009-015318-23-GB Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom;
Biogen Idec Limited
2011 - EUCTR2010-023856-97-PL Czech Republic;Hungary;Poland;Russian Federation;United States;
2011 - EUCTR2010-023856-97-HU Czech Republic;Hungary;Poland;Russian Federation;United States;
2011 - EUCTR2010-023856-97-CZ Czech Republic;Hungary;Poland;United States;
Biogen Idec Ltd
2012 Phase 3 EUCTR2009-012500-11-SI Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-012500-11-GB Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-012500-11-FR Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom;
2010 Phase 3 EUCTR2009-012500-11-FI Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-012500-11-ES Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-012500-11-SE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 - EUCTR2009-012500-11-IE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 - EUCTR2009-012500-11-HU Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 - EUCTR2009-012500-11-GR Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-012500-11-DK Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 - EUCTR2009-012500-11-DE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 - EUCTR2009-012500-11-CZ Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2006 Phase 2 EUCTR2006-001161-42-GB Czech Republic;Germany;Hungary;Sweden;United Kingdom;
Biogen Idec Ltd.
2011 Phase 2 EUCTR2009-015318-23-DE Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom;
2010 Phase 2 EUCTR2009-015318-23-HU Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom;
2010 Phase 2 EUCTR2009-015318-23-CZ Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom;
2009 Phase 2 EUCTR2008-005559-46-GB Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
2009 - EUCTR2008-005559-46-HU Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
2009 - EUCTR2008-005559-46-DE Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
2009 - EUCTR2008-005559-46-CZ Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
2008 - EUCTR2006-001161-42-HU Germany;Hungary;Sweden;United Kingdom;
2008 - EUCTR2006-001161-42-DE Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Sweden;Ukraine;United Kingdom;
2006 - EUCTR2006-001161-42-SE Germany;Hungary;Sweden;United Kingdom;
2006 - EUCTR2006-001161-42-CZ Czech Republic;Germany;Hungary;Sweden;United Kingdom;
Biogen Idec Research Limited
2013 Phase 3 EUCTR2012-003176-39-SE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003176-39-PL Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003176-39-IE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003176-39-GR Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003176-39-GB Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003176-39-FR Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003176-39-ES Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003176-39-DK Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003176-39-DE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003176-39-CZ Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 - EUCTR2012-003176-39-FI Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
Daclizumab High Yield Process
Biogen Idec Ltd.
2011 Phase 2 EUCTR2009-015318-23-DE Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom;
2010 Phase 2 EUCTR2009-015318-23-HU Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom;
2010 Phase 2 EUCTR2009-015318-23-CZ Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom;
Daclizumab wih Greek suffix
Biogen Idec Ltd
2012 Phase 3 EUCTR2009-012500-11-SI Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
Daclizumab with Greek suufix
Biogen Idec Ltd.
2009 Phase 2 EUCTR2008-005559-46-GB Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
2009 - EUCTR2008-005559-46-HU Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
2009 - EUCTR2008-005559-46-DE Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
2009 - EUCTR2008-005559-46-CZ Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
Dalfampridine
Acorda Therapeutics
2012 - NCT01535664 United States;
Johns Hopkins University
2014 Phase 2 NCT02166346 United States;
Oregon Health and Science University
2011 Phase 2 NCT01444300 United States;
State University of New York at Buffalo
2011 Phase 2/Phase 3 NCT02006160 United States;
VA Office of Research and Development
2015 Phase 2 NCT02391961 United States;
Washington University School of Medicine
2011 Phase 2/Phase 3 NCT01337986 United States;
Dalfampridine ER
Brown, Theodore R., M.D., MPH
2010 Phase 4 NCT01356940 United States;
Dalfampridine-ER
Acorda Therapeutics
2011 Phase 3 NCT01328379 United States;
Dantrolene
National Institute of Allergy and Infectious Diseases (NIAID)
2017 Phase 1/Phase 2 NCT03109288 United States;
Darifenacin
Bayer Vital GmbH
2006 - EUCTR2006-002361-39-DE Germany;
Darifenacin (BAY79-4998)
Bayer
2007 Phase 2 NCT00845338 Germany;
Dekristol 20000 IE
Merja Soilu Häninen
2007 - EUCTR2007-001958-99-FI Finland;
Dekristol® 400-Tabletten
Charité - Universitätsmedizin Berlin
2011 Phase 2 EUCTR2011-002785-20-DE Germany;
Dekristol®-Tablette 1 (400 IE)
Charité - Universitätsmedizin Berlin
2011 Phase 2 EUCTR2011-002785-20-DE Germany;
Delta-9-tetrahydrocannabinol
GW Pharma Ltd
2007 Phase 3 EUCTR2006-005910-11-CZ Czech Republic;Germany;Italy;Spain;United Kingdom;
2006 Phase 3 EUCTR2005-005265-11-GB Czech Republic;France;United Kingdom;
2006 Phase 3 EUCTR2005-005265-11-FR Czech Republic;France;United Kingdom;
2006 - EUCTR2005-005265-11-CZ Czech Republic;France;United Kingdom;
2005 Phase 3 EUCTR2004-002509-63-GB Czech Republic;United Kingdom;
2005 - EUCTR2004-002509-63-CZ Czech Republic;United Kingdom;
GW Pharma Ltd.
2011 - EUCTR2011-000926-31-CZ Czech Republic;
2008 Phase 3 EUCTR2006-005910-11-GB Czech Republic;Germany;Italy;Spain;United Kingdom;
2008 - EUCTR2006-005910-11-DE Germany;Italy;Spain;United Kingdom;
2007 - EUCTR2007-002138-13-GB United Kingdom;
Desloratadine given orally
Hoffmann-La Roche
2022 Phase 3 NCT05232825 Brazil;Canada;Czechia;Italy;Poland;Russian Federation;Spain;Turkey;Ukraine;United States;
Dexamethason
Department of Neurology UMCG
2006 - EUCTR2006-003113-40-NL Netherlands;
Dexamethasone
Department of Neurology UMCG
2006 - EUCTR2006-003113-40-NL Netherlands;
Dexamethasone given orally
Hoffmann-La Roche
2022 Phase 3 NCT05232825 Brazil;Canada;Czechia;Italy;Poland;Russian Federation;Spain;Turkey;Ukraine;United States;
Dexamethasone soduim phosphate
Hadassah Medical Organization
2008 Phase 1 NCT00674141 Israel;
Dexchlorpheniramine
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
2015 Phase 1 NCT02583594 Spain;
Dexrazoxane (DRZ) plus Mitoxantrone (MX)
PD Dr. Andrew Chan
2012 Phase 2 NCT01627938 Germany;
Dextromethorphan
Biogen
2011 Phase 3 NCT01462318 Czech Republic;Hungary;Poland;Russian Federation;United States;
Dextromethorphan hydrobromide 20 mg and quinidine sulfate
Avanir Pharmaceuticals
2007 Phase 3 NCT00573443 Argentina;Brazil;United States;
Dextromethorphan hydrobromide 30 mg and quinidine sulfate
Avanir Pharmaceuticals
2007 Phase 3 NCT00573443 Argentina;Brazil;United States;
Dextromethorphan/Quinidine
Avanir Pharmaceuticals, Inc.
2012 Phase 2 EUCTR2011-002178-22-GB Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States;
2012 - EUCTR2011-002178-22-PL Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States;
2012 - EUCTR2011-002178-22-CZ Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States;
Dextrometorfano/Quinidina
Avanir Pharmaceuticals, Inc.
2011 Phase 2 EUCTR2011-002178-22-ES Argentina;Bulgaria;Czech Republic;Poland;Spain;United Kingdom;United States;
Diazoxide
NEUROTEC PHARMA, S.L
2011 - EUCTR2010-023048-34-DE Germany;Spain;
Diclofenac sodium topical gel
Brown, Theodore R., M.D., MPH
2011 Phase 4 NCT01454791 United States;
Dietary Supplement: vitamin A
Tehran University of Medical Sciences
2010 Phase 4 NCT01705457 Iran, Islamic Republic of;
Dimethyl Fumarate (DMF)
Genesis Pharma CNS & Specialty
2016 - NCT03101735 Greece;
Hikma Pharmaceuticals LLC
2021 - NCT04468165 Algeria;Egypt;Jordan;
Dimethyl fumarate
Anders Svenningsson
2016 Phase 3 NCT02746744 Sweden;
Banner Life Sciences LLC
2017 Phase 1 NCT04570670 -
Biogen
2021 - NCT04756687 France;
2016 Phase 3 NCT02555215 Belgium;Bulgaria;Czech Republic;Czechia;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States;
2016 Phase 3 NCT02428218 -
2016 - NCT02969304 Germany;
2015 Phase 4 NCT02472938 -
2015 Phase 4 NCT02471560 Norway;
2015 Phase 4 NCT02410278 United States;
2015 Phase 4 NCT02343159 United States;
2015 Phase 4 NCT02090348 -
2015 Phase 3 NCT02525874 Belgium;Bulgaria;Croatia;Kuwait;Lithuania;Poland;Turkey;United States;
2015 Phase 3 NCT02430532 Austria;Belgium;Czech Republic;Netherlands;Poland;Slovakia;Sweden;United States;
2015 Phase 3 NCT02428231 Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States;
2015 Phase 2 NCT02410200 Belgium;Bulgaria;Czech Republic;Czechia;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States;
2015 Phase 2 NCT02097849 United States;
2015 - NCT02519413 United States;
2015 - NCT02323269 Canada;
2014 Phase 4 NCT02125604 Germany;
2014 Phase 4 NCT02090413 Ireland;United Kingdom;
2014 Phase 3 NCT02579681 Italy;
2014 Phase 3 NCT02283853 Argentina;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Romania;Serbia;Spain;Sweden;Turkey;United Kingdom;United States;
2014 - NCT02159573 United States;
2013 Phase 4 NCT01930708 Austria;Belgium;Canada;Czech Republic;Czechia;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2013 Phase 3 NCT01838668 Czech Republic;Czechia;Japan;Korea, Republic of;Poland;Taiwan;
2013 - NCT02047097 Argentina;Australia;Austria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Switzerland;United Kingdom;United States;
2013 - NCT01911767 Australia;Canada;France;Germany;Ireland;Italy;Poland;Spain;United Kingdom;United States;
2013 - NCT01903291 United States;
2010 Phase 2 NCT01156311 United States;
2009 Phase 3 NCT00835770 Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, The Former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;North Macedonia;Poland;Puerto Rico;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
Biogen Idec Inc.
2004 - EUCTR2004-000663-99-SE Hungary;Sweden;
2004 - EUCTR2004-000663-99-HU Hungary;Sweden;
2004 - EUCTR2004-000663-99-CZ Czech Republic;Hungary;Sweden;
Biogen Idec Italia S.r.l.
2015 - EUCTR2015-000303-21-IT Italy;
Fondation Ophtalmologique Adolphe de Rothschild
2017 Phase 4 NCT02901106 France;
Multiple Sclerosis Center of Northeastern New York
2015 Phase 4 NCT03092544 United States;
Northwestern University
2013 Phase 2 EUCTR2012-004165-41-GB United Kingdom;United States;
Oregon Health and Science University
2016 - NCT02644083 United States;
University Hospital Muenster
2015 Phase 4 NCT02461069 Germany;
University at Buffalo
2015 - NCT02686684 -
Virginia Simnad
2015 - NCT02736279 United States;
Dimethyl fumarate [DMF]
Biogen Idec Italia S.r.l.
2013 Phase 3 EUCTR2013-001422-25-IT Italy;
Dimetilfumarato
Biogen Idec Italia S.r.l.
2013 Phase 3 EUCTR2013-001422-25-IT Italy;
Diphenhydramine IV
Hoffmann-La Roche
2022 Phase 3 NCT05232825 Brazil;Canada;Czechia;Italy;Poland;Russian Federation;Spain;Turkey;Ukraine;United States;
Diphenydramine
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
Diroximel Fumarate (DRF)
Alkermes, Inc.
2017 Phase 3 EUCTR2017-001294-16-PL Germany;Poland;United States;
Diroximel fumarate
Alkermes, Inc.
2019 Phase 3 EUCTR2017-001294-16-DE Germany;Poland;United States;
Hanna Jerome Thomas
2021 Phase 3 JPRN-jRCT2051210115 China;Japan;
Dirucotide
Eli Lilly and Company
2007 Phase 2/Phase 3 NCT00870155 Canada;Denmark;Estonia;Finland;Germany;Latvia;Netherlands;Spain;Sweden;United Kingdom;
2006 Phase 2/Phase 3 NCT00869986 Bulgaria;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
2004 Phase 2/Phase 3 NCT00869726 Canada;Denmark;Estonia;Finland;Germany;Latvia;Netherlands;Spain;Sweden;United Kingdom;
Dirucotide acetate
BioMS Technology Corp
2007 - EUCTR2004-002571-16-GB Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2006 - EUCTR2004-002571-16-FI Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2006 - EUCTR2004-002571-16-EE Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2006 - EUCTR2004-002571-16-DK Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-002571-16-SE Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
Discontinuation of disease modifying therapy
University of Colorado, Denver
2017 Phase 4 NCT03073603 United States;
Disease Modifying therapy
Novartis Pharmaceuticals
2012 Phase 4 NCT01623596 Puerto Rico;United States;
Disease modifying treatment (DMT)
Novartis Pharmaceuticals
2022 Phase 4 NCT05090371 United States;
Domperidone
University of Calgary
2015 Phase 2 NCT02493049 Canada;
2015 Phase 2 NCT02308137 Canada;
Donepezil
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
1999 Phase 3 NCT00062972 United States;
Neurology Unit
2005 - EUCTR2005-003410-15-SE Sweden;
OSPEDALE S. RAFFAELE
2008 - EUCTR2008-001940-38-IT Italy;
Donepezil HCI (drug)
Neurognostics
2004 Phase 4 NCT00315367 United States;
Dosing Interruption of Natalizumab
Berkovich, Regina MD, PhD Inc.
2019 Phase 4 NCT04048577 United States;
Dotarem 0,5mmol/ml,
Universitätsklinikum Erlangen
2010 - EUCTR2009-014857-34-DE Germany;
Dronabinol
Bionorica Research GmbH
2007 Phase 3 NCT00959218 Germany;
Bionorica SE
2018 Phase 3 EUCTR2018-000001-23-ES Hungary;Spain;
Bionorica research GmbH
2007 Phase 3 EUCTR2006-004255-38-DK Austria;Denmark;Germany;
2007 - EUCTR2006-004255-38-DE Austria;Germany;
2007 - EUCTR2006-004255-38-AT Austria;Germany;
Echo Pharmaceuticals B.V.
2011 - EUCTR2010-022033-28-NL Netherlands;
Plymouth Hospitals NHS Trust
2006 - EUCTR2005-002728-33-GB United Kingdom;
Dronabinol 25 mg/ml, oral drops
Bionorica SE
2020 Phase 3 EUCTR2018-000001-23-CZ Czech Republic;Hungary;Spain;
2018 Phase 3 EUCTR2018-000001-23-HU Czech Republic;Hungary;Spain;
Dronabinol capsule 2,
Aarhus Universitetshospital
2018 Phase 2 EUCTR2018-002315-98-DK Denmark;
Drug - SHR1459
Reistone Biopharma Company Limited
2020 Phase 2 NCT04670770 China;
Duloxetine
Brown, Theodore R., M.D., MPH
2007 Phase 2/Phase 3 NCT00457730 United States;
Duloxetine Hydrochloride (HCI)
Eli Lilly and Company
2008 Phase 3 NCT00755807 Belgium;Canada;Poland;United States;
Dynamic Contrast-Enhanced Magnetic Resonance Imaging
University of Southern California
2011 - NCT02967380 United States;
Dynamic Vessel Analyzer (DVA)
Medical University of Vienna
2018 - NCT03401879 Austria;
Dysport
Aránzazu Vázquez Doce
2018 Phase 3 EUCTR2018-003231-30-ES Spain;
Ipsen Innovation
2012 - EUCTR2010-023210-31-LT Austria;Czech Republic;Germany;Italy;Lithuania;
2012 - EUCTR2010-023210-31-DE Austria;Czech Republic;Germany;Italy;Lithuania;
2012 - EUCTR2010-023210-31-CZ Austria;Czech Republic;Germany;Italy;Lithuania;
2012 - EUCTR2010-023210-31-AT Austria;Czech Republic;Germany;Italy;Lithuania;
Dysport®
Ipsen Innovation
2016 Phase 3 EUCTR2015-000507-44-LT Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
2016 Phase 3 EUCTR2015-000507-44-FR Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
2016 Phase 3 EUCTR2015-000507-44-ES Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
2016 Phase 3 EUCTR2015-000507-44-DE Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
2016 Phase 3 EUCTR2015-000507-44-BE Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
EBIXA
AZ. OSPEDALIERA GARIBALDI, S.LUIGI CURRO , ASCOLI TOMASELLI
2007 - EUCTR2007-000503-15-IT Italy;
HOSPICES CIVILS DE LYON
2015 Phase 2 EUCTR2014-005548-17-FR France;
OSPEDALE S. RAFFAELE
2008 Phase 2 EUCTR2008-000490-37-IT Italy;
ECP002A
Echo Pharmaceuticals B.V.
2011 - EUCTR2010-022033-28-NL Netherlands;
EGb 761® (Tanakan®)
Ipsen
2003 Phase 3 NCT00276341 France;
EHP-101 25 mg BID
Emerald Health Pharmaceuticals
2021 Phase 2 NCT04909502 -
EHP-101 25 mg OD
Emerald Health Pharmaceuticals
2021 Phase 2 NCT04909502 -
EHP-101 50 mg BID
Emerald Health Pharmaceuticals
2021 Phase 2 NCT04909502 -
EHP-101 50 mg OD
Emerald Health Pharmaceuticals
2021 Phase 2 NCT04909502 -
EK-12
Bosnalijek D.D
2019 Phase 3 NCT03283397 Turkey;
ELND002
Elan Pharmaceuticals
2010 Phase 1 NCT01318421 -
2010 Phase 1 NCT01144351 Canada;United States;
EMD 28162
Academic MS Center Limburg
- Phase 2 EUCTR2014-000728-97-NL Netherlands;
Merck Serono
2011 - EUCTR2010-020328-23-EE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2011 - EUCTR2010-020328-23-DE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
Merck Serono SA-Geneva an affiliate of Merck KgaA, Darmstadt
2011 - EUCTR2010-020328-23-BE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal;
Merck Serono The Netherlands - a division of Merck B.V.
2011 - EUCTR2010-020328-23-NL Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal;
EMSELEX 15 mg Retardtabletten
Bayer Vital GmbH
2006 - EUCTR2006-002361-39-DE Germany;
EMSELEX 7,5 mg Retardtabletten
Bayer Vital GmbH
2006 - EUCTR2006-002361-39-DE Germany;
ENA713
Novartis Pharma GmbH
- - EUCTR2008-007015-32-DE Germany;
ENDOXAN BAXTER
AZIENDA OSPEDALIERA DI PADOVA
- Phase 1 EUCTR2008-005773-35-IT Italy;
OSPEDALE S. RAFFAELE
2007 Phase 2 EUCTR2007-000586-38-IT Italy;
EPARMEFOLIN 30 CPR 0,1/0,
AZIENDA OSPEDALIERA SAN CAMILLO FORLANINI
2005 - EUCTR2005-006071-12-IT Italy;
EPO
Sun Yat-sen University
2006 - NCT00818103 China;
ESTRADIOL HEMIHYDRATE
Irina Elovaara
2015 - EUCTR2014-005129-10-FI Finland;
ETIMS
Universitätsklinikum Hamburg-Eppendorf
2010 Phase 1/Phase 2 NCT01414634 -
ETIMS (EDC-fixed autologous PBMCs coupled with 7 immunodominant myelin peptides in MS patients)
University Medical Center Hamburg-Eppendorf
2009 - EUCTR2008-004408-29-DE Germany;
EU/1/08/454/001-002, EU/1/08/454/005-007
University Hospital Motol
2011 Phase 4 EUCTR2011-001956-12-CZ Czech Republic;
EU/1/95/003/005-010
University Hospital Motol
2011 Phase 4 EUCTR2011-001956-12-CZ Czech Republic;
EU/1/97/033/002
University Hospital Motol
2011 Phase 4 EUCTR2011-001956-12-CZ Czech Republic;
EU/1/98/063/001-003
University Hospital Motol
2011 Phase 4 EUCTR2011-001956-12-CZ Czech Republic;
EU/1/98/063/004-006
University Hospital Motol
2011 Phase 4 EUCTR2011-001956-12-CZ Czech Republic;
EXTAVIA*SC 15FL 250MCG/ML+15SI
AZIENDA OSPEDALIERA S. LUIGI GONZAGA
2011 - EUCTR2010-023677-19-IT Italy;
Early Harvest Extra Virgin Olive Oil
Aristotle University Of Thessaloniki
2018 - NCT04120675 Greece;
Early Highly Effective Therapies Group
The Cleveland Clinic
2019 Phase 4 NCT03535298 United Kingdom;United States;
Eculizumab
Alexion Pharmaceuticals
2020 Phase 2/Phase 3 NCT04155424 Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States;
2015 Phase 3 NCT02003144 Argentina;Australia;Austria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Malaysia;Russian Federation;Singapore;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States;
2014 Phase 3 NCT01892345 Argentina;Australia;Austria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Malaysia;Russian Federation;Singapore;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States;
Mayo Clinic
2009 Phase 1/Phase 2 NCT00904826 United States;
Elezanumab
AbbVie
2019 Phase 2 NCT03737812 Canada;United States;
2018 Phase 2 NCT03737851 Canada;United States;
Encapsulated Baclofen
Impax Laboratories, LLC
2007 Phase 3 NCT00488839 Canada;Estonia;Latvia;Ukraine;United States;
Encapsulated Simvastatin tablets
Imperial College London
2007 Phase 2 EUCTR2006-006347-31-GB United Kingdom;
Endoxan - ciclofosfamide
Dipartimento di Neuroscienze Oftalmologia e Genetica DINOG - Universita di Genova
2006 - EUCTR2006-002562-19-IT Italy;
Enriched Hematopoetic Stem Cell Infusion
Talaris Therapeutics Inc.
2014 - NCT02084121 United States;
Enspryng
F. HOFFMANN - LA ROCHE LTD.
2021 Phase 3 EUCTR2021-001088-26-IT Canada;France;Germany;India;Italy;Korea, Republic of;Turkey;United States;
2021 Phase 3 EUCTR2020-003413-35-IT Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
F. Hoffmann-La Roche Ltd
2021 Phase 3 EUCTR2020-003413-35-HU Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-003413-35-BG Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2020-003413-35-PL Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Epigallocatechin-gallate (Sunphenon)
Charite University, Berlin, Germany
2007 Phase 1/Phase 2 NCT00525668 Germany;
Epo
IFSgGmbH, Institute for clinical research
2006 - EUCTR2005-005592-14-DE Germany;
Epoetin alfa
IFSgGmbH, Institute for clinical research
2006 - EUCTR2005-005592-14-DE Germany;
Epoetin beta
Walton Centre for Neurology and Neurosurgery
2008 - EUCTR2008-005125-11-GB United Kingdom;
Equal
GENEURO SA
2016 Phase 2 EUCTR2015-004059-29-IT Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
Erypo/Erypo FS
IFSgGmbH, Institute for clinical research
2006 - EUCTR2005-005592-14-DE Germany;
Erythropoietin
Rigshospitalet, Denmark
2009 Phase 2 NCT01144117 Denmark;
Escalation Therapies Group
The Cleveland Clinic
2019 Phase 4 NCT03535298 United Kingdom;United States;
Escitalopram
University of South Carolina
2009 Phase 3 NCT00965497 United States;
Escitalopram oxalate antidepressant
Weill Medical College of Cornell University
2004 Phase 4 NCT00151294 United States;
Esomeprazole
Genzyme, a Sanofi Company
2014 Phase 4 NCT02205489 Belgium;France;Netherlands;Spain;
Essential - hydroxytyrosol
University of Iowa
2010 Phase 1 NCT01381354 United States;
Essential fatty acids
National Center for Complementary and Integrative Health (NCCIH)
1999 Phase 1/Phase 2 NCT00010842 United States;
Estradiol
Hospices Civils de Lyon
2005 Phase 3 NCT00127075 France;
OSPEDALI CIVILI DI LIONE
2007 - EUCTR2006-005460-30-IT Italy;
Estriol
University of California, Los Angeles
2011 Phase 2 NCT01466114 United States;
2007 Phase 2 NCT00451204 Canada;United States;
Estroprogestins
S. Andrea Hospital
2002 Phase 2 NCT00151801 Italy;
Eszopiclone
University of Vermont
2006 - NCT00594087 United States;
Etifoxine
Imperial College London
2018 - NCT03850301 United Kingdom;
Etoposide
Fred Hutchinson Cancer Research Center
2008 Phase 2 NCT00716066 United States;
Evobrutinib
EMD Serono Research & Development Institute, Inc.
2019 Phase 3 NCT04032171 Germany;United States;
2019 Phase 3 NCT04032158 Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czechia;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Montenegro;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
MERCK HEALTHCARE KGaA
2020 Phase 3 EUCTR2019-004980-36-IT Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
2020 Phase 3 NCT04338061 Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Latvia;Lithuania;Malaysia;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Turkey;Ukraine;United States;
2020 Phase 3 NCT04338022 Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Czechia;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
Exelon transdermales Pflaster
Novartis Pharma GmbH
- - EUCTR2008-007015-32-DE Germany;
Exergame
University of Arizona
2014 - NCT02777060 United States;
Experimental Glatiramer Acetate
Teva Pharmaceutical Industries
2009 Phase 3 NCT00947752 United States;
Exposure to one or more disease-modifying drug(s)(DMDs) used to treat MS
University of British Columbia
1996 - NCT04472975 -
Extavia
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden;
2017 Phase 4 EUCTR2016-003587-39-SE Sweden;
Medizinische Universität Innsbruck
2014 Phase 4 EUCTR2012-005450-30-AT Austria;Sweden;
2014 - EUCTR2012-005450-30-SE Austria;Sweden;
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain;
Novartis Farma S.p.A.
2012 - EUCTR2010-023023-19-DE Germany;Italy;
Novartis Pharma Services AG
2012 - EUCTR2011-001437-16-DE Australia;Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
Extavia (interferon beta-1b), Novartis Pharma AG
Bayer
2016 - NCT02749396 Finland;
Extavia 250 microgram/ml
Octapharma AG
2013 - EUCTR2012-005086-12-HU Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-DE Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-BG Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-AT Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
Extavia 250 micrograms/ml
Biogen Portugal
2016 Phase 4 EUCTR2016-000434-21-PT Portugal;
Extavia®
Charite Universitaetsmedizin Berlin
2012 Phase 3 EUCTR2011-004787-30-DE Germany;
University Hospital Motol
2011 Phase 4 EUCTR2011-001956-12-CZ Czech Republic;
Extended release fampridine
Clinique Neuro-Outaouais
2013 Phase 4 NCT02146534 Canada;
Extended-release oxycodone
University of Rochester
2007 Phase 4 NCT00414453 United States;
Extended-release quetiapine fumarate
University of Calgary
2014 Phase 1/Phase 2 NCT02087631 Canada;
Extracorporeal Photopheresis
University of Utah
2014 - NCT02296346 United States;
F-18 3F4AP
Massachusetts General Hospital
2021 Phase 1 NCT04699747 United States;
F-18 FEDAA1106 (BAY85-8101)
Bayer
2009 Phase 1 NCT01031199 Australia;Sweden;
FAMPYRA - 10 MG - COMPRESSA A RILASCIO PROLUNGATO - USO ORALE - FLACONE (HDPE) 56 COMPRESSE (4 FLACONI DA 14)
IRCCS FONDAZIONE ISTITUTO NEUROLOGICO NAZIONALE C. MONDINO
2016 Phase 4 EUCTR2014-004650-34-IT Italy;
FINGOLIMOD HYDROCHLORIDE
Biogen Idec Research Limited
2015 Phase 4 EUCTR2013-004622-29-DK Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2015 Phase 4 EUCTR2013-004622-29-DE Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2014 Phase 4 EUCTR2013-004622-29-SE Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2014 Phase 4 EUCTR2013-004622-29-GB Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2014 Phase 4 EUCTR2013-004622-29-ES Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2014 Phase 4 EUCTR2013-004622-29-CZ Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2014 - EUCTR2013-004622-29-IT Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
NOVARTIS FARMA
2013 - EUCTR2012-000835-18-IT Australia;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
NOVARTIS FARMA S.p.A
2013 - EUCTR2012-005507-40-IT Italy;
NOVARTIS PHARMA SERVICES AG
2021 Phase 3 EUCTR2020-002700-39-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Novartis Farma
2013 - EUCTR2011-005677-23-IT Brazil;Canada;Italy;Latvia;Lithuania;Mexico;Spain;United States;Venezuela, Bolivarian Republic of;
Novartis Farma S.p.A.
2012 - EUCTR2010-023023-19-DE Germany;Italy;
Novartis Farma SpA
2014 - EUCTR2013-002660-17-IT Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom;
Novartis Farmaceutica S.A.
2013 - EUCTR2011-005677-23-ES Brazil;Canada;Latvia;Lithuania;Mexico;Spain;United States;Venezuela, Bolivarian Republic of;
Novartis Pharma GmbH
- - EUCTR2011-001692-39-DE Germany;
Novartis Pharma S.A.S
2011 Phase 4 EUCTR2011-001280-49-FR France;
Novartis Pharma Service AG
2015 Phase 3 EUCTR2011-005677-23-HR Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005677-23-GB Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005677-23-EE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 - EUCTR2011-005677-23-RO Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2011-005677-23-DE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2011-005677-23-BG Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of;
2013 - EUCTR2011-005677-23-LV Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Novartis Pharma Services AG
2015 - EUCTR2013-002660-17-PT Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom;
2015 - EUCTR2013-002660-17-DK Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom;
2014 Phase 3 EUCTR2011-005677-23-PL Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005677-23-NL Austria;Brazil;Bulgaria;Canada;Croatia;Estonia;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005677-23-AT Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 - EUCTR2011-005677-23-SE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2011-005677-23-SK Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2011-005677-23-LT Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-001442-15-SE Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom;
2012 - EUCTR2011-001437-16-DE Australia;Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
2011 - EUCTR2011-001442-15-HU Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom;
2011 - EUCTR2011-001442-15-GR Austria;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Spain;Sweden;Switzerland;United Kingdom;
2011 - EUCTR2011-001442-15-GB Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom;
2011 - EUCTR2011-001442-15-FI Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom;
2011 - EUCTR2011-001442-15-DE Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom;
2011 - EUCTR2011-001442-15-CZ Austria;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Spain;Sweden;Switzerland;United Kingdom;
2011 - EUCTR2011-001442-15-AT Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom;
Universitätsklinikum Münster
2014 - EUCTR2013-004616-21-DE Germany;
FISH OIL, RICH IN OMEGA-3-ACIDS
PALUPA Medical Ltd
2016 Phase 3 EUCTR2015-003147-19-GR Greece;
FISH OIL,RICH IN OMEGA 3 ACIDS
PALUPA Medical Ltd
2016 Phase 3 EUCTR2015-003147-19-GR Greece;
FLUOXETINE HYDROCHLORIDE
Novartis Pharma GmbH
- - EUCTR2011-001692-39-DE Germany;
FORMISTIN - 10 MG COMPRESSE RIVESTITE CON FILM 20 COMPRESSE
NOVARTIS PHARMA AG
2018 Phase 2 EUCTR2017-004702-17-IT Austria;Bulgaria;Czech Republic;Czechia;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
FTY720
NOVARTIS FARMA S.p.A
2013 - EUCTR2012-005507-40-IT Italy;
NOVARTIS PHARMA SERVICES AG
2021 Phase 3 EUCTR2020-002700-39-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Novartis
2010 Phase 3 NCT01127750 Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2007 Phase 2 NCT00537082 Japan;
2003 Phase 2 NCT00333138 Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom;
Novartis Farma
2013 - EUCTR2011-005677-23-IT Brazil;Canada;Italy;Latvia;Lithuania;Mexico;Spain;United States;Venezuela, Bolivarian Republic of;
Novartis Farma S.p.A.
2012 - EUCTR2010-023023-19-DE Germany;Italy;
Novartis Farmaceutica S.A.
2013 - EUCTR2012-000835-18-ES Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 - EUCTR2011-005677-23-ES Brazil;Canada;Latvia;Lithuania;Mexico;Spain;United States;Venezuela, Bolivarian Republic of;
Novartis Farmacéutica S.A
2008 - EUCTR2007-002627-32-ES Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
Novartis Farmacéutica, S.A.
2011 - EUCTR2011-001442-15-ES Austria;Czech Republic;Finland;France;Germany;Greece;Hungary;Israel;Italy;Spain;Sweden;Switzerland;United Kingdom;
2010 Phase 3 EUCTR2010-020515-37-ES Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
Novartis Pharma AG
2013 - EUCTR2012-000835-18-BE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-000835-18-FR Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 - EUCTR2007-002627-32-HU Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
2010 - EUCTR2007-002627-32-DK Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2009 Phase 3 EUCTR2007-002627-32-GB Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2009 - EUCTR2007-004122-24-HU Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2009 - EUCTR2007-004122-24-GR Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2009 - EUCTR2007-004122-24-EE Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2008 Phase 3 EUCTR2007-002627-32-FR Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-004122-24-NL Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2008 - EUCTR2007-004122-24-CZ Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2008 - EUCTR2007-004122-24-BE Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2008 - EUCTR2007-002627-32-NL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2008 - EUCTR2007-002627-32-FI Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2008 - EUCTR2007-002627-32-BE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2007 - EUCTR2005-000365-19-HU Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom;
2006 - EUCTR2005-000365-19-CZ Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom;
Novartis Pharma GmbH
2012 Phase 4 EUCTR2012-000674-31-DE Germany;Switzerland;
2012 Phase 4 EUCTR2012-000653-32-DE Germany;
2012 - EUCTR2012-002637-11-DE Germany;
2011 - EUCTR2011-002969-38-DE Germany;
Novartis Pharma S.A.S
2011 Phase 4 EUCTR2011-001280-49-FR France;
Novartis Pharma Service AG
2015 Phase 3 EUCTR2011-005677-23-HR Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005677-23-GB Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005677-23-EE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 - EUCTR2011-005677-23-RO Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2011-005677-23-DE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2011-005677-23-BG Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of;
2013 - EUCTR2011-005677-23-LV Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Novartis Pharma Services AG
2014 Phase 3 EUCTR2012-000835-18-DK Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005677-23-PL Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005677-23-NL Austria;Brazil;Bulgaria;Canada;Croatia;Estonia;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005677-23-AT Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 - EUCTR2012-000835-18-PL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2014 - EUCTR2011-005677-23-SE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-000835-18-DE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2011-005677-23-SK Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2011-005677-23-LT Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2013 - EUCTR2012-000835-18-NL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 - EUCTR2012-000835-18-HU Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 - EUCTR2012-000835-18-GB Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 - EUCTR2012-000835-18-CZ Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2010-020515-37-NO Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2012 - EUCTR2012-000835-18-SE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 - EUCTR2012-000835-18-FI Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020515-37-IE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020515-37-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2011 - EUCTR2011-001442-15-DE Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom;
2011 - EUCTR2010-020515-37-DK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-019029-32-SK Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 Phase 3 EUCTR2010-020515-37-SK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 Phase 3 EUCTR2010-020515-37-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-PT Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;Comoros;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2010 Phase 3 EUCTR2010-020515-37-HU Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-GR Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 Phase 3 EUCTR2010-020515-37-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-FR Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 Phase 3 EUCTR2010-020515-37-FI Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;Venezuela, Bolivarian Republic of;
2010 Phase 3 EUCTR2010-020515-37-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 2 EUCTR2010-019029-32-GR Austria;Belgium;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 Phase 2 EUCTR2010-019029-32-BE Austria;Belgium;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-SE Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-PT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-NL Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-IE Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-HU Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-GB Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-FI Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-DK Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-DE Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-CZ Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-AT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019028-30-GB Finland;France;Spain;United Kingdom;
2010 - EUCTR2010-019028-30-FR Belgium;Finland;France;Spain;United Kingdom;
2010 - EUCTR2010-019028-30-FI Finland;France;Spain;United Kingdom;
2010 - EUCTR2010-019028-30-BE Belgium;Finland;France;Spain;United Kingdom;
2009 - EUCTR2008-002096-27-AT Austria;Lithuania;Poland;United Kingdom;
2009 - EUCTR2007-002627-32-CZ Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2008 Phase 3 EUCTR2005-000365-19-GB Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Slovakia;Sweden;United Kingdom;
2008 - EUCTR2008-002096-27-PL Austria;Lithuania;Poland;United Kingdom;
2008 - EUCTR2008-002096-27-LT Austria;Lithuania;Poland;United Kingdom;
2008 - EUCTR2008-002096-27-GB Austria;Lithuania;Poland;United Kingdom;
2007 - EUCTR2006-000704-17-HU Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
2007 - EUCTR2006-000704-17-BE Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
2007 - EUCTR2005-000365-19-IE Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom;
2007 - EUCTR2005-000365-19-GR Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom;
2007 - EUCTR2005-000365-19-EE Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom;
2006 Phase 3 EUCTR2006-000704-17-GR Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
2006 Phase 3 EUCTR2005-000365-19-SK Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Slovakia;Sweden;United Kingdom;
2006 - EUCTR2006-000704-17-PT Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
2006 - EUCTR2006-000704-17-GB Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
2006 - EUCTR2006-000704-17-DE Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
2006 - EUCTR2006-000704-17-AT Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
2006 - EUCTR2005-000365-19-FI Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom;
2006 - EUCTR2005-000365-19-DE Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom;
2005 - EUCTR2005-000365-19-SE Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom;
- - EUCTR2007-002627-32-DE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Pharmaceuticals
2013 Phase 3 NCT01779934 Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 4 NCT01585298 Germany;
2008 Phase 3 NCT00731692 Australia;Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Services Pharma AG
2008 - EUCTR2007-002627-32-SE Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
NovartisPharma Services AG
2007 - EUCTR2005-000365-19-LT Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom;
Universitätsklinikum Münster
2014 - EUCTR2013-004616-21-DE Germany;
FTY720D
NOVARTIS FARMA
2013 - EUCTR2012-000835-18-IT Australia;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2011 - EUCTR2011-000770-60-IT Italy;
2011 - EUCTR2010-024017-31-IT Italy;
2010 Phase 3 EUCTR2010-020515-37-IT Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-023023-19-IT Germany;Italy;
2010 - EUCTR2010-019029-32-IT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-002627-32-IT Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
2006 - EUCTR2006-000704-17-IT Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
Novartis Farma SpA
2014 - EUCTR2013-002660-17-IT Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom;
Novartis Farmaceutica S.A.
2013 - EUCTR2012-000835-18-ES Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Farmacéutica S.A
2008 - EUCTR2007-002627-32-ES Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
Novartis Farmacéutica, S.A.
2010 Phase 3 EUCTR2010-020515-37-ES Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
Novartis Pharma AG
2013 - EUCTR2012-000835-18-BE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-000835-18-FR Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 - EUCTR2007-002627-32-HU Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
2010 - EUCTR2007-002627-32-DK Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2009 Phase 3 EUCTR2007-002627-32-GB Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2009 - EUCTR2007-004122-24-HU Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2009 - EUCTR2007-004122-24-GR Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2009 - EUCTR2007-004122-24-FI Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2008 Phase 3 EUCTR2007-002627-32-FR Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-004122-24-NL Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2008 - EUCTR2007-004122-24-FR Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2008 - EUCTR2007-004122-24-CZ Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2008 - EUCTR2007-004122-24-BE Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2008 - EUCTR2007-002627-32-NL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2008 - EUCTR2007-002627-32-FI Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2008 - EUCTR2007-002627-32-BE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2007 - EUCTR2005-000365-19-HU Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom;
2006 - EUCTR2005-000365-19-CZ Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom;
Novartis Pharma Services AG
2015 - EUCTR2013-002660-17-PT Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom;
2015 - EUCTR2013-002660-17-DK Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom;
2013 Phase 3 EUCTR2012-000835-18-DE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 - EUCTR2012-000835-18-NL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 - EUCTR2012-000835-18-GB Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 - EUCTR2012-000835-18-CZ Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2010-020515-37-NO Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2012 - EUCTR2012-000835-18-SE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 - EUCTR2012-000835-18-FI Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020515-37-IE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020515-37-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2011 - EUCTR2010-020515-37-DK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-019029-32-SK Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 Phase 3 EUCTR2010-020515-37-SK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 Phase 3 EUCTR2010-020515-37-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-PT Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;Comoros;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2010 Phase 3 EUCTR2010-020515-37-HU Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-GR Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 Phase 3 EUCTR2010-020515-37-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-FR Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 Phase 3 EUCTR2010-020515-37-FI Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;Venezuela, Bolivarian Republic of;
2010 Phase 3 EUCTR2010-020515-37-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 2 EUCTR2010-019029-32-GR Austria;Belgium;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 Phase 2 EUCTR2010-019029-32-BE Austria;Belgium;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-SE Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-PT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-NL Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-IE Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-HU Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-GB Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-FI Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-DK Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-DE Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-CZ Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-AT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019028-30-GB Finland;France;Spain;United Kingdom;
2010 - EUCTR2010-019028-30-FR Belgium;Finland;France;Spain;United Kingdom;
2010 - EUCTR2010-019028-30-FI Finland;France;Spain;United Kingdom;
2010 - EUCTR2010-019028-30-BE Belgium;Finland;France;Spain;United Kingdom;
2009 - EUCTR2008-002096-27-AT Austria;Lithuania;Poland;United Kingdom;
2009 - EUCTR2007-002627-32-CZ Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2008 Phase 3 EUCTR2005-000365-19-GB Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Slovakia;Sweden;United Kingdom;
2008 - EUCTR2008-002096-27-PL Austria;Lithuania;Poland;United Kingdom;
2008 - EUCTR2008-002096-27-LT Austria;Lithuania;Poland;United Kingdom;
2008 - EUCTR2008-002096-27-GB Austria;Lithuania;Poland;United Kingdom;
- - EUCTR2007-002627-32-DE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Services Pharma AG
2008 - EUCTR2007-002627-32-SE Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
Famciclovir
Queen Mary University London
2019 Phase 2 EUCTR2019-000169-19-GB United Kingdom;
Queen Mary University of London
2020 Phase 2 NCT05283551 United Kingdom;
Fampridine
Amsterdam University Medical Center
2022 Phase 3 EUCTR2021-003677-66-NL Netherlands;
Biogen
2015 - NCT01532154 France;Germany;United Kingdom;United States;
2014 Phase 3 NCT02219932 Argentina;Bulgaria;Czech Republic;Finland;Germany;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States;
2012 Phase 4 NCT01480076 Australia;Belgium;Denmark;France;Germany;Italy;Netherlands;Portugal;United Kingdom;United States;
2012 - NCT01480063 Argentina;Australia;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Ireland;Israel;Lebanon;Netherlands;Norway;Portugal;Spain;United Arab Emirates;
Centre Hospitalier Universitaire de Besancon
2014 Phase 4 NCT02849782 France;
Cliniques Universitaires Saint-Luc, Neurologie
2013 - EUCTR2012-005076-34-BE Belgium;
Genesis Pharma CNS & Specialty
2017 - NCT03164018 Greece;
University College Dublin
2014 Phase 4 NCT02208050 Ireland;
University of Southern Denmark
2018 - NCT03847545 Denmark;
Fampridine SR
London Health Sciences Centre
2012 Phase 2/Phase 3 NCT01667497 Canada;
Fampridine-SR
Acorda Therapeutics
2007 Phase 3 NCT00649792 Canada;United States;
2007 Phase 3 NCT00483652 Canada;United States;
2006 Phase 3 NCT00648908 Canada;United States;
2005 Phase 3 NCT00127530 Canada;United States;
University of Southern Denmark
2012 Phase 4 NCT01656148 Denmark;
Fampridine-SR b.i.d. (Twice Daily)
Acorda Therapeutics
2003 Phase 3 NCT00654927 Canada;United States;
Fampyra
BIOGEN IDEC RESEARCH LTD
2012 - EUCTR2012-000368-90-IT Belgium;Canada;Italy;Netherlands;Switzerland;United Kingdom;
2012 - EUCTR2011-003507-38-IT Australia;Denmark;Italy;Netherlands;Portugal;United Kingdom;
Biogen Idec Research Limited
2015 Phase 3 EUCTR2013-003600-40-NL Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003600-40-GB Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003600-40-CZ Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003600-40-BG Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States;
2014 - EUCTR2013-003600-40-LT Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States;
2014 - EUCTR2013-003600-40-IT Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States;
2014 - EUCTR2013-003600-40-FI Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States;
2012 Phase 4 EUCTR2011-003507-38-GB Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom;
2012 Phase 4 EUCTR2011-003507-38-BE Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom;
2012 Phase 2 EUCTR2012-000368-90-BE Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom;
2012 - EUCTR2012-000368-90-NL Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom;
2012 - EUCTR2012-000368-90-GB Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom;
2012 - EUCTR2011-003507-38-PT Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom;
2012 - EUCTR2011-003507-38-NL Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom;
2012 - EUCTR2011-003507-38-DK Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom;
Cliniques Universitaires Saint-Luc, Neurologie
2013 - EUCTR2012-005076-34-BE Belgium;
Medical University of Vienna
2015 - EUCTR2014-003498-41-AT Austria;
Odense University Hospital
2013 Phase 4 EUCTR2013-001409-10-DK Denmark;
St. Vincent's University Hospital
2012 Phase 4 EUCTR2011-002561-38-IE Ireland;
Sønderjylland Hospital, department of neurology
2013 Phase 4 EUCTR2011-002959-34-DK Denmark;
2012 - EUCTR2011-006151-10-DK Denmark;
Vestre Viken Hospital Trust
2012 - NCT01720849 Norway;
Fampyra 10 mg prolonged-release tablets
Amsterdam University Medical Center
2022 Phase 3 EUCTR2021-003677-66-NL Netherlands;
CHDR
2015 - EUCTR2015-000182-31-NL Netherlands;
Fampyra 10mg prolonged release tablets
Walton Centre Foundation Trust
2013 Phase 4 EUCTR2013-000529-30-GB United Kingdom;
Fatigue
University Hospital, Strasbourg, France
2019 Phase 2 NCT03910738 France;
Febuxostat
Tsukuba International Clinical Pharmacology Clinic
2016 - JPRN-UMIN000024312 Japan;
Fecal Microbial Transplants
Lawson Health Research Institute
2020 Phase 2 NCT04150549 -
Fecal Microbiota Transplantation (FMT) of FMP30 Donor Stool
Jeffrey Gelfand
2018 Phase 1 NCT03594487 United States;
Fecal microbial transplant (FMT)
Griffin Hospital
2019 Early Phase 1 NCT04096443 United States;
Fecal microbiota
Lawson Health Research Institute
2017 Phase 2 NCT03183869 Canada;
Femoston 1/10
Irina Elovaara
2015 - EUCTR2014-005129-10-FI Finland;
Femoston 2/10
Irina Elovaara
2015 - EUCTR2014-005129-10-FI Finland;
Fenebrutinib
Hoffmann-La Roche
2022 Phase 2 NCT05119569 -
2021 Phase 3 NCT04586023 Austria;Brazil;Bulgaria;Canada;Denmark;France;Greece;Guatemala;India;Italy;Korea, Republic of;Mexico;Poland;Russian Federation;Turkey;United Kingdom;United States;
2021 Phase 3 NCT04586010 Argentina;China;Finland;Germany;Hong Kong;Hungary;Italy;Netherlands;Peru;Portugal;Russian Federation;Spain;Switzerland;Taiwan;Ukraine;United States;
2020 Phase 3 NCT04544449 Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Puerto Rico;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
Feraheme
Stanford University
2014 - NCT01973517 United States;
Ferumoxytol
National Institute of Neurological Disorders and Stroke (NINDS)
2015 Phase 1 NCT02511028 United States;
Fexofenadine
Rigshospitalet, Denmark
2021 Phase 3 NCT04688788 Denmark;
Filgrastim
Fred Hutchinson Cancer Research Center
1997 Phase 1 NCT00014755 United States;
Northwestern Memorial Hospital
2001 Phase 1 NCT00017628 United States;
OSPEDALE S. RAFFAELE
2007 Phase 2 EUCTR2007-000586-38-IT Italy;
Sheffield Teaching Hospitals
2020 Phase 3 EUCTR2019-001549-42-GB United Kingdom;
Fingolimob
NOVARTIS PHARMA SERVICES AG
2021 Phase 3 EUCTR2020-002700-39-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Fingolimob (FTY)
University Hospital, Clermont-Ferrand
2016 Phase 4 NCT02769689 France;
Fingolimod
Biogen
2014 Phase 4 NCT02342704 Australia;Czech Republic;Czechia;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS UNIVERSITA' CATTOLICA DEL SACRO CUORE
2016 Phase 4 EUCTR2016-000708-26-IT Italy;
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
2017 Phase 4 NCT03345940 Italy;
Heinrich-Heine University, Duesseldorf
2013 Phase 4 NCT01755871 Germany;
Hoffmann-La Roche
2022 Phase 3 NCT05123703 Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
Isfahan University of Medical Sciences
2015 Phase 2/Phase 3 NCT02939079 -
Mitsubishi Tanabe Pharma Corporation
2014 Phase 1 NCT02193217 United Kingdom;
NOVARTIS FARMA
2011 - EUCTR2011-000770-60-IT Italy;
2010 Phase 3 EUCTR2010-020515-37-IT Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-IT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-002627-32-IT Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
2006 - EUCTR2006-000704-17-IT Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
Northwestern University
2013 Phase 2 EUCTR2012-004165-41-GB United Kingdom;United States;
Novartis
2011 - NCT01281657 Canada;United States;
2010 Phase 3 NCT01199861 Austria;Belgium;Canada;Finland;France;Guatemala;Poland;Spain;Switzerland;United Kingdom;
2008 Phase 3 NCT00662649 Australia;Belgium;Canada;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Sweden;Switzerland;Turkey;United Kingdom;
2008 Phase 2 NCT00670449 Japan;
2006 Phase 3 NCT00355134 Australia;Austria;Canada;Lithuania;Poland;Romania;Turkey;United Kingdom;United States;
2006 Phase 3 NCT00340834 Argentina;Australia;Austria;Belgium;Brazil;Canada;Egypt;France;Germany;Greece;Hungary;Italy;Korea, Republic of;Portugal;Puerto Rico;Spain;Switzerland;United Kingdom;United States;
2006 Phase 3 NCT00289978 Australia;Belgium;Canada;Czech Republic;Finland;France;Germany;Greece;Israel;Italy;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Sweden;Switzerland;Turkey;United Kingdom;
Novartis Farmaceutica S.A.
2013 - EUCTR2012-000835-18-ES Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Farmacéutica S.A
2008 - EUCTR2007-002627-32-ES Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
Novartis Farmacéutica S.A.
2011 Phase 3 EUCTR2011-003484-30-ES Australia;Spain;
Novartis Farmacéutica, S.A.
2010 Phase 3 EUCTR2010-020515-37-ES Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
Novartis Pharma AG
2013 - EUCTR2012-000835-18-BE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-000835-18-FR Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 - EUCTR2007-002627-32-HU Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
2010 - EUCTR2007-002627-32-DK Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2009 Phase 3 EUCTR2007-002627-32-GB Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2009 - EUCTR2007-004122-24-IE Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2009 - EUCTR2007-004122-24-EE Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2008 Phase 3 EUCTR2007-002627-32-FR Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-002627-32-NL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2008 - EUCTR2007-002627-32-FI Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2008 - EUCTR2007-002627-32-BE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2007 - EUCTR2005-000365-19-HU Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom;
2006 - EUCTR2005-000365-19-CZ Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom;
Novartis Pharma GmbH
2011 Phase 3 EUCTR2010-022066-28-DE Germany;
Novartis Pharma K.K.
2019 - JPRN-JapicCTI-194838 Japan;
Novartis Pharma Services AG
2014 Phase 3 EUCTR2012-000835-18-DK Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-000835-18-DE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 - EUCTR2012-000835-18-NL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 - EUCTR2012-000835-18-HU Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 - EUCTR2012-000835-18-GB Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 - EUCTR2012-000835-18-CZ Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2010-020515-37-NO Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2012 - EUCTR2012-000835-18-SE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 - EUCTR2012-000835-18-FI Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020515-37-IE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020515-37-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2011 - EUCTR2010-020515-37-DK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2010 Phase 3 EUCTR2010-020515-37-SK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 Phase 3 EUCTR2010-020515-37-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-PT Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;Comoros;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2010 Phase 3 EUCTR2010-020515-37-HU Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-GR Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 Phase 3 EUCTR2010-020515-37-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-FR Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 Phase 3 EUCTR2010-020515-37-FI Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;Venezuela, Bolivarian Republic of;
2010 Phase 3 EUCTR2010-020515-37-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 - EUCTR2010-019028-30-GB Finland;France;Spain;United Kingdom;
2010 - EUCTR2010-019028-30-FR Belgium;Finland;France;Spain;United Kingdom;
2010 - EUCTR2010-019028-30-FI Finland;France;Spain;United Kingdom;
2010 - EUCTR2010-019028-30-BE Belgium;Finland;France;Spain;United Kingdom;
2009 - EUCTR2008-002096-27-AT Austria;Lithuania;Poland;United Kingdom;
2009 - EUCTR2007-002627-32-CZ Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2008 Phase 3 EUCTR2005-000365-19-GB Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Slovakia;Sweden;United Kingdom;
2008 - EUCTR2008-002096-27-PL Austria;Lithuania;Poland;United Kingdom;
2008 - EUCTR2008-002096-27-LT Austria;Lithuania;Poland;United Kingdom;
2008 - EUCTR2008-002096-27-GB Austria;Lithuania;Poland;United Kingdom;
2007 - EUCTR2006-000704-17-HU Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
2007 - EUCTR2006-000704-17-BE Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
2006 Phase 3 EUCTR2006-000704-17-GR Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
2006 Phase 3 EUCTR2005-000365-19-SK Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Slovakia;Sweden;United Kingdom;
2006 - EUCTR2006-000704-17-PT Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
2006 - EUCTR2006-000704-17-GB Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
2006 - EUCTR2006-000704-17-DE Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
2006 - EUCTR2006-000704-17-AT Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
- - EUCTR2007-002627-32-DE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Pharmaceuticals
2021 Phase 4 NCT04667949 China;
2021 Phase 3 NCT04926818 Australia;Austria;Belgium;France;Germany;India;Latvia;Mexico;Poland;Portugal;Russian Federation;Slovakia;Spain;Turkey;United States;
2020 Phase 4 NCT04480853 Taiwan;
2020 - NCT05141669 United States;
2017 Phase 4 NCT03257358 United States;
2016 Phase 4 NCT02720107 Germany;
2015 Phase 4 NCT02373098 Turkey;
2014 Phase 4 NCT02232061 Belgium;Germany;Italy;
2014 Phase 3 NCT01941004 -
2013 Phase 4 NCT01621269 Germany;
2013 Phase 3 NCT01892722 Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2012 Phase 4 NCT01705236 Germany;Switzerland;
2012 Phase 4 NCT01623596 Puerto Rico;United States;
2012 Phase 4 NCT01578330 Turkey;
2012 Phase 4 NCT01534182 Russian Federation;
2012 Phase 3 NCT01633112 Argentina;Brazil;Canada;Chile;Mexico;Puerto Rico;United States;
2012 Phase 3 NCT01497262 Argentina;Brazil;Colombia;Costa Rica;Jordan;Malaysia;Mexico;Panama;Peru;
2011 Phase 4 NCT01436643 Germany;
2011 Phase 4 NCT01420055 France;
2011 Phase 4 NCT01333501 Germany;Italy;
2011 Phase 4 NCT01317004 Italy;
2011 Phase 4 NCT01310166 Germany;
2011 Phase 3 NCT01499667 Australia;Austria;Czech Republic;Finland;Germany;Greece;Hungary;Israel;Italy;Spain;Switzerland;
2011 - NCT01442194 Argentina;Australia;Canada;Chile;Mexico;Puerto Rico;United States;
2011 - NCT01285479 Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Cyprus;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Sweden;Switzerland;United Arab Emirates;United Kingdom;United States;
2010 Phase 4 NCT01216072 Canada;Puerto Rico;United States;
2010 Phase 3 NCT01201356 Argentina;Australia;Austria;Belgium;Brazil;Canada;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Services Pharma AG
2008 - EUCTR2007-002627-32-SE Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
University Hospital Muenster
2014 Phase 4 NCT02325440 Germany;
Università Popolare Homo & Natura
2015 Phase 1 NCT02632591 Italy;
VU University Medical Center
2014 - EUCTR2014-001012-19-NL Netherlands;
Fingolimod (FTY720)
Novartis Pharmaceuticals
2011 Phase 4 NCT01498887 Australia;Spain;
Fingolimod Hydrochloride
Novartis Pharma GmbH
2012 Phase 4 EUCTR2012-000674-31-DE Germany;Switzerland;
2012 Phase 4 EUCTR2012-000653-32-DE Germany;
2012 - EUCTR2012-002637-11-DE Germany;
2011 - EUCTR2011-002969-38-DE Germany;
Fingolimod hydrochloride
Novartis Pharma AG
2009 - EUCTR2007-004122-24-HU Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2009 - EUCTR2007-004122-24-GR Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2009 - EUCTR2007-004122-24-FI Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2008 - EUCTR2007-004122-24-SE Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2008 - EUCTR2007-004122-24-NL Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2008 - EUCTR2007-004122-24-GB Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2008 - EUCTR2007-004122-24-FR Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2008 - EUCTR2007-004122-24-CZ Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2008 - EUCTR2007-004122-24-BE Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
Novartis Pharma Services AG
2014 - EUCTR2012-000835-18-PL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2011 - EUCTR2010-019029-32-SK Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 Phase 2 EUCTR2010-019029-32-GR Austria;Belgium;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 Phase 2 EUCTR2010-019029-32-BE Austria;Belgium;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-SE Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-PT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-NL Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-IE Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-HU Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-GB Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-FI Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-DK Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-DE Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-CZ Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-AT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-004122-24-SK Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2008 - EUCTR2007-004122-24-DE Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
Fingolimodi
Turku University Hospital
2014 Phase 4 EUCTR2014-000296-12-FI Finland;
2013 Phase 4 EUCTR2013-004626-28-FI Finland;
Fingolmod
Novartis Farma SpA
2014 - EUCTR2013-002660-17-IT Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom;
Novartis Pharma Services AG
2015 - EUCTR2013-002660-17-PT Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom;
2015 - EUCTR2013-002660-17-DK Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom;
Firategrast
GlaxoSmithKline
2007 Phase 2 NCT00469378 Belgium;Czech Republic;Denmark;Norway;Sweden;
2006 Phase 2 NCT00395317 Australia;Austria;Canada;Finland;France;Germany;Italy;Lithuania;Netherlands;New Zealand;Norway;Poland;Russian Federation;Spain;United Kingdom;
Firategrast (USAN approved name)
GlaxoSmithKline Research & Development Ltd
2007 Phase 2 EUCTR2006-007057-42-CZ Belgium;Czech Republic;Denmark;Sweden;
2007 Phase 2 EUCTR2006-002633-20-GB Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom;
2007 Phase 2 EUCTR2006-002633-20-FR Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom;
2007 - EUCTR2006-007057-42-SE Czech Republic;Denmark;Sweden;
2007 - EUCTR2006-007057-42-DK Czech Republic;Denmark;Sweden;
2007 - EUCTR2006-007057-42-BE Belgium;Czech Republic;Denmark;Sweden;
2007 - EUCTR2006-002633-20-LT Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom;
2007 - EUCTR2006-002633-20-IT Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom;
2006 - EUCTR2006-002633-20-NL Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom;
2006 - EUCTR2006-002633-20-FI Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom;
2006 - EUCTR2006-002633-20-DE Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom;
2006 - EUCTR2006-002633-20-AT Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom;
GlaxoSmithKline S.A
2006 Phase 2 EUCTR2006-002633-20-ES Australia;Austria;Canada;Finland;France;Germany;Italy;Lithuania;Netherlands;New Zealand;Norway;Poland;Russian Federation;Spain;United Kingdom;
Firategrast gastro-retentive solution
GlaxoSmithKline
2011 Phase 1 NCT01416363 Australia;
Firategrast immediate release tablet
GlaxoSmithKline
2011 Phase 1 NCT01416363 Australia;
Firategrast modified release tablet
GlaxoSmithKline
2011 Phase 1 NCT01416363 Australia;
First line DMT
Novartis Pharmaceuticals
2021 Phase 3 NCT04788615 France;Germany;Spain;United Kingdom;
Fish oil concentrate
Oregon Health and Science University
2005 Phase 1/Phase 2 NCT00122954 United States;
Fludarabine
AZIENDA OSPEDALIERA DI PADOVA
- Phase 1 EUCTR2008-005773-35-IT Italy;
Hadassah Medical Organization
2015 - NCT02529839 -
Seah Lim M.D.
2012 Phase 2 NCT01679041 United States;
Flumazenil
Institut National de la Santé Et de la Recherche Médicale, France
2019 - NCT03825601 -
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
2013 - JPRN-UMIN000011111 Japan;
Fluoxetin Hexal
Novartis Pharma GmbH
- - EUCTR2011-001692-39-DE Germany;
Fluoxetine
Novartis Pharmaceuticals
2011 Phase 4 NCT01436643 Germany;
University College, London
2014 Phase 2 NCT01910259 United Kingdom;
Fluoxetine hydrochloride
UCL
2014 Phase 2 EUCTR2012-005394-31-GB United Kingdom;
Flupirtin
Charité-Universitätsmedizin Berlin
2007 Phase 2 EUCTR2006-005262-39-DE Germany;
Flupirtine
Charite University, Berlin, Germany
2007 Phase 2 NCT00623415 Germany;
Flupirtinmaleat
Charité-Universitätsmedizin Berlin
2007 Phase 2 EUCTR2006-005262-39-DE Germany;
FolateScan (Technetium Tc 99mEC20)
Mayo Clinic
2006 Phase 2 NCT00588393 United States;
Formulation A
GlaxoSmithKline
2007 Phase 1 NCT00548769 Czech Republic;Czechia;Germany;Poland;
Formulation B
GlaxoSmithKline
2007 Phase 1 NCT00548769 Czech Republic;Czechia;Germany;Poland;
Formulation C
GlaxoSmithKline
2007 Phase 1 NCT00548769 Czech Republic;Czechia;Germany;Poland;
Formulation D
GlaxoSmithKline
2007 Phase 1 NCT00548769 Czech Republic;Czechia;Germany;Poland;
Four-point cane (FPC)
Rowan University
2014 - NCT02227524 United States;
Fourier Domain Doppler Optical Coherence Tomography (FDOCT)
Medical University of Vienna
2018 - NCT03401879 Austria;
Full Spectrum vitamin
University of Iowa
2010 Phase 1 NCT01381354 United States;
Fully humanized anti-human IL-6 receptor (IL-6R) neutralizing monoclonal antibody
Chugai Pharmaceutical Co. Ltd
2015 Phase 3 EUCTR2013-003752-21-HU France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States;
2015 - EUCTR2013-003752-21-ES France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003752-21-IT France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;
G-CSF
Northwestern University
2019 Phase 2/Phase 3 NCT03829566 United States;
2017 Phase 3 NCT03342638 United States;
G2-SFM (IFN-beta-1a from clone 484-39,FBS-free process)
Serono International SA
2005 Phase 3 EUCTR2004-003799-13-GB Denmark;Ireland;Lithuania;Spain;Sweden;United Kingdom;
2005 Phase 3 EUCTR2004-003799-13-ES Denmark;Ireland;Lithuania;Spain;Sweden;United Kingdom;
2005 Phase 3 EUCTR2004-003799-13-DK Denmark;Ireland;Lithuania;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-003799-13-SE Ireland;Lithuania;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-003799-13-LT Ireland;Lithuania;Spain;Sweden;United Kingdom;
- Phase 3 EUCTR2004-003799-13-IE Denmark;Ireland;Lithuania;Spain;Sweden;United Kingdom;
GA
TEVA
2004 - EUCTR2004-000463-94-IT Hungary;Italy;
2004 - EUCTR2004-000462-13-IT Hungary;Italy;
Teva Pharmaceutical Industries Ltd.
2010 Phase 3 EUCTR2009-018084-27-IT Bulgaria;Czech Republic;Estonia;Germany;Hungary;Italy;Lithuania;United Kingdom;
Teva Pharmaceutical Industries, Ltd.
2010 Phase 3 EUCTR2009-018084-27-LT Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-018084-27-HU Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-018084-27-GB Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-018084-27-EE Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-018084-27-DE Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-018084-27-CZ Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-018084-27-BG Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States;
2007 - EUCTR2006-002037-20-EE Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 Phase 3 EUCTR2006-002037-20-FI Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 Phase 3 EUCTR2006-002037-20-ES Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 - EUCTR2006-002037-20-LV Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 - EUCTR2006-002037-20-LT Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 - EUCTR2006-002037-20-HU Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 - EUCTR2006-002037-20-GB Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 - EUCTR2006-002037-20-DE Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 - EUCTR2006-002037-20-CZ Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 - EUCTR2006-002037-20-BE Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
Teva Pharmaceuticals Industries Ltd.
2006 - EUCTR2006-002037-20-IT Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
GA 20 mg/mL
Teva Pharmaceutical Industries
2013 Phase 3 NCT01874145 United States;
GA 40 mg/mL
Teva Pharmaceutical Industries
2013 Phase 3 NCT01874145 United States;
GA Depot
Mapi Pharma Ltd.
2019 Phase 3 NCT04121221 Belarus;Bosnia and Herzegovina;Bulgaria;Estonia;Georgia;Israel;Moldova, Republic of;Russian Federation;Ukraine;United States;
2019 Phase 3 EUCTR2018-000284-93-EE Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Israel;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
2019 Phase 3 EUCTR2018-000284-93-BG Belarus;Bosnia and Herzegovina;Bulgaria;Estonia;Georgia;Israel;Moldova, Republic of;Montenegro;Russian Federation;Ukraine;United States;
2014 Phase 1/Phase 2 NCT02212886 Israel;
GA Depot 25mg once monthly
Mapi Pharma Ltd.
2017 Phase 2 NCT03362294 Israel;Moldova, Republic of;
GA Depot 40mg once monthly
Mapi Pharma Ltd.
2017 Phase 2 NCT03362294 Israel;Moldova, Republic of;
GADOVIST 1 mmol/ml solución inyectable en jeringa precargada/ cartucho precargado
Institut Diagnostic per la Imatge
2010 - EUCTR2009-016140-39-ES Spain;
GBP
Charité University Medicine Berlin
2010 Phase 4 EUCTR2008-005167-33-DE Germany;
GDC-0853
F. Hoffmann-La Roche Ltd
2022 Phase 2 EUCTR2021-003772-14-HR Croatia;Czechia;Egypt;Japan;Kenya;Morocco;Norway;Serbia;Slovakia;Slovenia;
GDC-0853 RO7010939
F. Hoffmann-La Roche Ltd
2021 Phase 3 EUCTR2019-003919-53-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-003919-53-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-003919-53-GR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-003919-53-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-003919-53-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-003919-53-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-003919-53-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-003919-53-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
GILENYA
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France;
GILENYA - 0.25 MG - CAPSULE RIGIDE - USO ORALE
F. HOFFMANN - LA ROCHE LTD.
2021 Phase 3 EUCTR2020-004128-41-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE
F. HOFFMANN - LA ROCHE LTD.
2021 Phase 3 EUCTR2020-004128-41-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE - BLISTER DIVISIBILE PER DOSE UNITARIA(PVC/PVDC/ALU) SCATOLA DA 7X1 CAPSULE
FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA
2017 Phase 4 EUCTR2017-000559-26-IT Israel;Italy;Switzerland;United States;
GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE - BLISTER(PVC/PVDC/ALU) SCATOLA DA 28 CAPSULE
FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS UNIVERSITA' CATTOLICA DEL SACRO CUORE
2016 Phase 4 EUCTR2016-000708-26-IT Italy;
GLATIRAMER ACETATE
Amphia Ziekenhuis
2009 - EUCTR2009-013129-41-NL Netherlands;
Biogen Idec
2010 - EUCTR2009-017490-38-DE Germany;Spain;
Biogen Idec Limited
2010 - EUCTR2009-015556-15-SI Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States;
2010 - EUCTR2009-015556-15-SE Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States;
2010 - EUCTR2009-015556-15-PT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-NL Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-LV Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States;
2010 - EUCTR2009-015556-15-HU Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-GR Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-GB Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-FI Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-ES Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-DK Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-DE Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-CZ Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States;
2010 - EUCTR2009-015556-15-AT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
Biogen Idec Ltd.
2007 Phase 3 EUCTR2006-003697-10-BE Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 - EUCTR2006-003697-10-LV Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden;
2017 Phase 4 EUCTR2016-003587-39-SE Sweden;
Mapi Pharma Ltd.
2019 Phase 3 EUCTR2018-000284-93-EE Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Israel;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
2019 Phase 3 EUCTR2018-000284-93-BG Belarus;Bosnia and Herzegovina;Bulgaria;Estonia;Georgia;Israel;Moldova, Republic of;Montenegro;Russian Federation;Ukraine;United States;
Novartis Pharma GmbH
2021 Phase 4 EUCTR2020-005752-38-DE Germany;
Peptimmune Inc.
2010 Phase 2 EUCTR2009-012716-40-SK Bulgaria;Czech Republic;Estonia;France;Germany;Poland;Slovakia;
2010 Phase 2 EUCTR2009-012716-40-DE Bulgaria;Czech Republic;Estonia;France;Germany;Poland;Slovakia;
2010 - EUCTR2009-012716-40-PL Bulgaria;Czech Republic;Estonia;France;Germany;Poland;
2010 - EUCTR2009-012716-40-FR Bulgaria;Czech Republic;Estonia;France;Germany;Poland;
2010 - EUCTR2009-012716-40-CZ Bulgaria;Czech Republic;Estonia;France;Germany;Poland;
2010 - EUCTR2009-012716-40-BG Bulgaria;Czech Republic;Estonia;France;Germany;Poland;
2009 - EUCTR2009-012716-40-EE Bulgaria;Czech Republic;Estonia;France;Germany;Poland;
Teva Pharmaceutical Industries, Ltd
2016 Phase 4 EUCTR2015-000922-12-PL Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2016 Phase 4 EUCTR2015-000922-12-FR Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2016 Phase 4 EUCTR2015-000922-12-ES Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2016 Phase 4 EUCTR2015-000922-12-DE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2016 Phase 4 EUCTR2015-000922-12-BE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2015 Phase 4 EUCTR2015-000922-12-IE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2015 Phase 4 EUCTR2015-000922-12-HR Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2015 Phase 4 EUCTR2015-000922-12-FI Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2015 Phase 4 EUCTR2015-000922-12-AT Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
Turku University Hospital
2013 Phase 4 EUCTR2013-004626-28-FI Finland;
GLATIRAMER ACETATO
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC
2015 Phase 4 EUCTR2015-000922-12-IT Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
GLATIRAMERO ACETATO
Biogen Idec Limited
2010 - EUCTR2009-015556-15-ES Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
Teva Pharmaceutical Industries, Ltd.
2006 Phase 3 EUCTR2006-002037-20-ES Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
GNbAC1
GENEURO SA
2017 Phase 2 EUCTR2016-004935-18-IT Bulgaria;Croatia;Czech Republic;Czechia;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
GeNeuro Australia PTY Ltd
2018 Phase 1 NCT03574428 Australia;
GeNeuro Innovation SAS
2021 Phase 2 EUCTR2021-001973-21-SE Sweden;
2020 Phase 2 EUCTR2019-004822-15-SE Sweden;
2012 Phase 2 NCT01639300 Switzerland;
2011 Phase 1 NCT01699555 -
GeNeuro SA
2017 Phase 2 EUCTR2016-004935-18-PL Bulgaria;Croatia;Czech Republic;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
2017 Phase 2 EUCTR2016-004935-18-HU Bulgaria;Croatia;Czech Republic;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
2017 Phase 2 EUCTR2016-004935-18-HR Bulgaria;Croatia;Czech Republic;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
2017 Phase 2 EUCTR2016-004935-18-ES Bulgaria;Croatia;Czech Republic;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
2017 Phase 2 EUCTR2016-004935-18-DE Bulgaria;Croatia;Czech Republic;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
2017 Phase 2 EUCTR2016-004935-18-CZ Bulgaria;Croatia;Czech Republic;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
2017 Phase 2 EUCTR2016-004935-18-BG Bulgaria;Croatia;Czech Republic;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
2016 Phase 2 NCT02782858 Bulgaria;Croatia;Czechia;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
2016 Phase 2 EUCTR2015-004059-29-PL Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
2016 Phase 2 EUCTR2015-004059-29-HU Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
2016 Phase 2 EUCTR2015-004059-29-HR Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
2016 Phase 2 EUCTR2015-004059-29-ES Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
2016 Phase 2 EUCTR2015-004059-29-EE Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
2016 Phase 2 EUCTR2015-004059-29-DE Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
2016 Phase 2 EUCTR2015-004059-29-CZ Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
2016 Phase 2 EUCTR2015-004059-29-BG Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
GNbAC1 Monoclonal Antibody
GeNeuro SA
2017 Phase 2 NCT03239860 Bulgaria;Croatia;Czechia;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
GSK1223249
GlaxoSmithKline
2011 Phase 1 NCT01435993 Germany;Italy;Norway;
2010 Phase 1 NCT01424423 Australia;
GSK1841157
GlaxoSmithKline Research and Development Limited
2012 - EUCTR2011-002333-19-CZ Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States;
2011 Phase 2 EUCTR2011-002333-19-DK Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States;
2011 - EUCTR2011-002333-19-NL Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States;
2011 - EUCTR2011-002333-19-DE Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States;
GlaxoSmithKline SA
2011 Phase 2 EUCTR2011-002333-19-ES Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States;
GSK2018682
GlaxoSmithKline
2010 Phase 1 NCT01431937 Australia;
2010 Phase 1 NCT01387217 Australia;
GSK2018682 CD2 Capsule
GlaxoSmithKline
2010 Phase 1 NCT01466322 Australia;
GSK2018682 CD3 micronised Tablet
GlaxoSmithKline
2010 Phase 1 NCT01466322 Australia;
GSK2018682 CD3 non-micronised Tablet in fed state
GlaxoSmithKline
2010 Phase 1 NCT01466322 Australia;
GSK239512
GlaxoSmithKline
2013 Phase 2 NCT01772199 Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
2013 Phase 1 NCT01802931 Australia;
GlaxoSmithKline Research & Development Ltd
2013 Phase 2 EUCTR2012-003627-38-GB Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
2013 Phase 2 EUCTR2012-003627-38-BG Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
2013 - EUCTR2012-003627-38-SE Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
2013 - EUCTR2012-003627-38-DE Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
2013 - EUCTR2012-003627-38-CZ Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
GlaxoSmithKline, S.A.
2012 - EUCTR2012-003627-38-ES Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
GSK2395612
GlaxoSmithKline Research & Development Ltd
2013 Phase 2 EUCTR2012-003627-38-BG Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
2013 - EUCTR2012-003627-38-SE Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
2013 - EUCTR2012-003627-38-DE Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
2013 - EUCTR2012-003627-38-CZ Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
GlaxoSmithKline, S.A.
2012 - EUCTR2012-003627-38-ES Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
GSK3888130B
GlaxoSmithKline
2021 Phase 1 NCT05131971 United Kingdom;
GTR.ace
SYNTHON BV
2011 - EUCTR2011-000888-27-IT Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Romania;Russian Federation;Ukraine;United Kingdom;United States;
Synthon BV
2012 - EUCTR2011-000888-27-GR Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-000888-27-DE Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2011-000888-27-RO Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2011-000888-27-GB Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2011-000888-27-EE Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2011-000888-27-CZ Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2011-000888-27-BG Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
GW-1000-02
GW Pharma Ltd
2007 Phase 3 EUCTR2006-005910-11-CZ Czech Republic;Germany;Italy;Spain;United Kingdom;
2006 Phase 3 EUCTR2005-005265-11-GB Czech Republic;France;United Kingdom;
2006 Phase 3 EUCTR2005-005265-11-FR Czech Republic;France;United Kingdom;
2006 - EUCTR2005-005265-11-CZ Czech Republic;France;United Kingdom;
2005 Phase 3 EUCTR2004-002509-63-GB Czech Republic;United Kingdom;
2005 - EUCTR2004-002509-63-CZ Czech Republic;United Kingdom;
GW Pharma Ltd.
2008 Phase 3 EUCTR2006-005910-11-GB Czech Republic;Germany;Italy;Spain;United Kingdom;
2008 - EUCTR2006-005910-11-DE Germany;Italy;Spain;United Kingdom;
2007 - EUCTR2007-002138-13-GB United Kingdom;
GW Pharmaceuticals Ltd.
2002 Phase 3 NCT01606176 United Kingdom;
2002 Phase 3 NCT01606137 United Kingdom;
2001 Phase 3 NCT01610713 United Kingdom;
2001 Phase 3 NCT01610700 United Kingdom;
2001 Phase 3 NCT01610687 United Kingdom;
GYLENIA
NOVARTIS FARMA
2011 - EUCTR2011-001442-15-IT Australia;Austria;Czech Republic;Finland;Germany;Greece;Hungary;Israel;Italy;Spain;Sweden;United Kingdom;
GYLENIA 0,
Novartis Farmaceutica S.A.
2013 - EUCTR2012-000835-18-ES Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
GZ402668
Genzyme, a Sanofi Company
2014 Phase 1 NCT02282826 Germany;
Sanofi
2016 Phase 1 NCT02977533 Germany;
GZ402673
Genzyme Corporation
2017 Phase 3 EUCTR2016-003100-30-PT Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-NO Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-NL Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-GR Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-GB Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-ES Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-DE Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-BE Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-AT Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
2015 Phase 3;Phase 4 EUCTR2013-003884-71-NL Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Czechia;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2015 Phase 3;Phase 4 EUCTR2013-003884-71-DK Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2015 - EUCTR2013-003884-71-BE Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;
2014 Phase 4 EUCTR2014-000092-62-NL Belgium;France;Netherlands;Spain;Switzerland;
2014 Phase 4 EUCTR2014-000092-62-FR Belgium;France;Netherlands;Spain;Switzerland;
2014 Phase 4 EUCTR2014-000092-62-ES Belgium;France;Netherlands;Spain;Switzerland;
2014 Phase 4 EUCTR2014-000092-62-BE Belgium;France;Netherlands;Spain;Switzerland;
2014 Phase 3;Phase 4 EUCTR2013-003884-71-IT Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;
2014 Phase 3;Phase 4 EUCTR2013-003884-71-HR Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2014 Phase 3;Phase 4 EUCTR2013-003884-71-DE Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2014 Phase 3;Phase 4 EUCTR2013-003884-71-CZ Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2014 - EUCTR2013-003884-71-ES Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;
- Phase 3 EUCTR2016-003100-30-PL Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
- Phase 3 EUCTR2016-003100-30-Outside-EU/EEA Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
- Phase 3 EUCTR2016-003100-30-FR Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
- Phase 3 EUCTR2016-003100-30-BG Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
Genzyme GmbH
2016 Phase 3 EUCTR2016-000464-42-DE Germany;
Gabapentin
Hospices Civils de Lyon
2012 Phase 2 NCT01744444 France;
Gabapentine
Charité University Medicine Berlin
2010 Phase 4 EUCTR2008-005167-33-DE Germany;
HOSPICES CIVILS DE LYON
2015 Phase 2 EUCTR2014-005548-17-FR France;
Gadobenate Dimeglumine
University of Southern California
2011 - NCT02967380 United States;
Gadobutrol
University of Southern California
2011 - NCT02967380 United States;
Gadolinium
Rennes University Hospital
2009 - NCT01567553 France;
Gadolinium-based contrast
Stanford University
2014 - NCT01973517 United States;
Gadopentetate
University of Southern California
2011 - NCT02967380 United States;
Gadoteric acid
Universitätsklinikum Erlangen
2010 - EUCTR2009-014857-34-DE Germany;
Gadoteridol
University of Maryland, Baltimore
2018 - NCT03396822 United States;
Gadovist 1.0 mmol/ml Injektionslösung
Universitätsklinikum Erlangen
2010 - EUCTR2009-014857-34-DE Germany;
Genotropin
University of Leipzig
- Phase 2 EUCTR2006-006465-16-DE Germany;
GentleCath™ Air catheter
ConvaTec Inc.
2021 - NCT04847609 -
Gilenya
Biogen Idec Research Limited
2015 Phase 4 EUCTR2013-004622-29-DK Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2015 Phase 4 EUCTR2013-004622-29-DE Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2014 Phase 4 EUCTR2013-004622-29-SE Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2014 Phase 4 EUCTR2013-004622-29-GB Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2014 Phase 4 EUCTR2013-004622-29-ES Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2014 Phase 4 EUCTR2013-004622-29-CZ Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2014 - EUCTR2013-004622-29-IT Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
F. Hoffmann-La Roche Ltd
2022 Phase 3 EUCTR2020-004128-41-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004128-41-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004128-41-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004128-41-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004128-41-GR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004128-41-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2020-004128-41-FR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2020-004128-41-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2020-004128-41-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
Jochen Vehoff
2013 Phase 4 NCT02048072 Switzerland;
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden;
2017 Phase 4 EUCTR2016-003587-39-SE Sweden;
McGill University
2012 - NCT02137707 Canada;
NOVARTIS FARMA
2011 - EUCTR2011-001442-15-IT Australia;Austria;Czech Republic;Finland;Germany;Greece;Hungary;Israel;Italy;Spain;Sweden;United Kingdom;
NOVARTIS FARMA S.p.A
2013 - EUCTR2012-005507-40-IT Italy;
Northwestern University
2013 Phase 2 EUCTR2012-004165-41-GB United Kingdom;United States;
Novartis Farma
2013 - EUCTR2011-005677-23-IT Brazil;Canada;Italy;Latvia;Lithuania;Mexico;Spain;United States;Venezuela, Bolivarian Republic of;
Novartis Farma S.p.A.
2012 - EUCTR2010-023023-19-DE Germany;Italy;
Novartis Farma SpA
2014 - EUCTR2013-002660-17-IT Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom;
Novartis Farmaceutica S.A.
2013 - EUCTR2011-005677-23-ES Brazil;Canada;Latvia;Lithuania;Mexico;Spain;United States;Venezuela, Bolivarian Republic of;
Novartis Farmacéutica S.A.
2011 Phase 3 EUCTR2011-003484-30-ES Australia;Spain;
Novartis Pharma AG
2012 Phase 3 EUCTR2012-000835-18-FR Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2008 - EUCTR2007-002627-32-NL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2008 - EUCTR2007-002627-32-BE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Pharma GmbH
2012 Phase 4 EUCTR2012-000674-31-DE Germany;Switzerland;
2012 Phase 4 EUCTR2012-000653-32-DE Germany;
2012 - EUCTR2012-002637-11-DE Germany;
2011 Phase 3 EUCTR2010-022066-28-DE Germany;
2011 - EUCTR2011-002969-38-DE Germany;
- - EUCTR2011-001692-39-DE Germany;
Novartis Pharma S.A.S
2011 Phase 4 EUCTR2011-001280-49-FR France;
Novartis Pharma Service AG
2015 Phase 3 EUCTR2011-005677-23-HR Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005677-23-GB Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005677-23-EE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 - EUCTR2011-005677-23-RO Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2011-005677-23-DE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2011-005677-23-BG Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of;
2013 - EUCTR2011-005677-23-LV Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Novartis Pharma Services AG
2015 - EUCTR2013-002660-17-PT Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom;
2015 - EUCTR2013-002660-17-DK Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom;
2014 Phase 3 EUCTR2012-000835-18-DK Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005677-23-PL Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005677-23-NL Austria;Brazil;Bulgaria;Canada;Croatia;Estonia;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005677-23-AT Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 - EUCTR2012-000835-18-PL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2014 - EUCTR2011-005677-23-SE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-000835-18-DE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2011-005677-23-SK Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2011-005677-23-LT Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2013 - EUCTR2012-000835-18-NL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 - EUCTR2012-000835-18-HU Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 - EUCTR2012-000835-18-SE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 - EUCTR2011-001442-15-SE Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom;
2012 - EUCTR2011-001437-16-DE Australia;Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020515-37-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2011 - EUCTR2011-001442-15-GR Austria;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Spain;Sweden;Switzerland;United Kingdom;
2011 - EUCTR2011-001442-15-GB Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom;
2011 - EUCTR2011-001442-15-DE Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom;
2011 - EUCTR2011-001442-15-AT Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom;
2010 Phase 3 EUCTR2010-020515-37-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;Comoros;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2010 Phase 3 EUCTR2010-020515-37-HU Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-FI Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2009 - EUCTR2007-002627-32-CZ Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;
Novartis Services Pharma AG
2008 - EUCTR2007-002627-32-SE Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
Sakari Simula
2012 Phase 4 EUCTR2012-002694-66-FI Finland;
Sheffield Teaching Hospitals NHS Foundation Trust
2013 Phase 2/Phase 3 NCT03133403 United Kingdom;
Turku University Hospital
2014 Phase 4 EUCTR2014-000296-12-FI Finland;
2013 Phase 4 EUCTR2013-004626-28-FI Finland;
University of Southern California
2013 - NCT02225977 United States;
Universitätsklinikum Münster
2014 - EUCTR2013-004616-21-DE Germany;
VU University Medical Center
2014 - EUCTR2014-001012-19-NL Netherlands;
Gilenya / Imusera
Novartis Pharma K.K.
2019 - JPRN-JapicCTI-194838 Japan;
Gilenya 0,5 mg Hartkapseln
Novartis Pharma Services AG
2010 Phase 3 EUCTR2010-020515-37-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
- - EUCTR2007-002627-32-DE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Gilenya®
Charite Universitaetsmedizin Berlin
2012 Phase 3 EUCTR2011-004787-30-DE Germany;
Charité - Universitätsmedizin Berlin
2013 Phase 4 EUCTR2012-000411-91-DE Germany;
Universitätsklinikum Hamburg-Eppendorf
2013 - NCT03216915 Germany;
Gileyna
Stony Brook University
2013 - NCT02141022 United States;
Ginkgo biloba
National Center for Complementary and Integrative Health (NCCIH)
1999 Phase 1/Phase 2 NCT00010842 United States;
VA Office of Research and Development
2009 Phase 2 NCT00841321 United States;
Ginseng
Isfahan University of Medical Sciences
2010 Phase 2 NCT01712373 Iran, Islamic Republic of;
Glatiramer Acetate
Biogen
2007 Phase 3 NCT00451451 Australia;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Costa Rica;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Ireland;Israel;Italy;Kazakhstan;Latvia;Lithuania;Macedonia, The Former Yugoslav Republic of;Mexico;Moldova, Republic of;New Zealand;Poland;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United States;
Biogen Idec Ltd.
2008 - EUCTR2006-003697-10-BG Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 - EUCTR2006-003697-10-IE Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 - EUCTR2006-003697-10-GR Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 - EUCTR2006-003697-10-DE Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 - EUCTR2006-003697-10-CZ Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
Cinnagen
2015 - NCT04928313 -
Isfahan University of Medical Sciences
2017 Phase 2/Phase 3 NCT03315923 Iran, Islamic Republic of;
Teva Pharmaceutical Industries
2012 Phase 3 NCT01578785 Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Greece;Latvia;Lithuania;Macedonia, The Former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
2005 Phase 4 NCT00203047 Canada;United States;
2004 Phase 4 NCT00202995 Canada;United States;
The Walton Centre for Neurology and Neurosurgery
2005 Phase 4 EUCTR2004-004903-39-GB United Kingdom;
University of Colorado, Denver
2012 Phase 2 NCT01569451 United States;
Glatiramer Acetate (Copaxone®)
Synthon BV
2011 Phase 3 NCT01489254 Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Italy;Kazakhstan;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;South Africa;Ukraine;United Kingdom;United States;
Glatiramer Acetate (DB)
Teva Pharmaceutical Industries
2004 Phase 3 NCT00666224 Argentina;Australia;Austria;Denmark;Finland;France;Germany;Hungary;Israel;Italy;New Zealand;Norway;Romania;Spain;Sweden;United Kingdom;United States;
Glatiramer Acetate (GA)
Sanofi
2007 Phase 2 NCT00475865 Austria;Canada;Germany;Italy;United Kingdom;United States;
Teva Pharmaceutical Industries
2006 Phase 3 NCT00337779 Argentina;Canada;France;Germany;Hungary;Israel;Italy;Netherlands;Spain;United Kingdom;United States;
Glatiramer Acetate (GTR)
Synthon BV
2011 Phase 3 NCT01489254 Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Italy;Kazakhstan;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;South Africa;Ukraine;United Kingdom;United States;
Glatiramer Acetate (OL)
Teva Pharmaceutical Industries
2004 Phase 3 NCT00666224 Argentina;Australia;Austria;Denmark;Finland;France;Germany;Hungary;Israel;Italy;New Zealand;Norway;Romania;Spain;Sweden;United Kingdom;United States;
Glatiramer Acetate [GA]
Sanofi
2007 Phase 2 NCT00811395 Austria;Canada;Germany;Italy;Spain;United Kingdom;United States;
Glatiramer Acetate, IFN-beta 1a (IM), IFN-beta 1a (Subcutaneous), and IFN-beta 1b
Teva Neuroscience, Inc.
2008 - NCT00819000 United States;
Glatiramer Acetate, N-Acetylcysteine
Teva Pharmaceutical Industries
2004 Phase 2 NCT00203099 Canada;
Glatiramer acetate
AZIENDA OSPEDALIERA UNIVERSITARIA DELLA SECONDA UNIVERSITA` DEGLI STUDI DI NAPOLI
2009 - EUCTR2009-010661-23-IT Italy;
Amphia Hospital
2009 Phase 4 NCT00910598 Netherlands;
BIOGEN IDEC LTD
2010 - EUCTR2009-015556-15-IT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
Biogen
2021 Phase 2 NCT04079088 -
2010 Phase 3 NCT01058005 Australia;Canada;Czech Republic;Finland;France;Hungary;Italy;Latvia;Poland;Slovenia;Spain;Sweden;United States;
2010 Phase 2 NCT01071083 Germany;Spain;United States;
Biogen Idec Ltd.
2007 Phase 3 EUCTR2006-003697-10-ES Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
FONDAZIONE DON CARLO GNOCCHI ONLUS
2011 - EUCTR2011-000150-31-IT Italy;
Fred Lublin
2005 Phase 3 NCT00211887 Canada;United States;
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
Glostrup Hospital, Dep. of Neurology
2009 - EUCTR2006-001827-21-DK Denmark;
ISTITUTO C. MONDINO
2007 - EUCTR2008-007162-32-IT Italy;
NOVARTIS FARMA
2011 - EUCTR2010-024017-31-IT Italy;
National Institute of Allergy and Infectious Diseases (NIAID)
2001 - NCT00039988 United States;
Novartis Pharmaceuticals
2012 Phase 3 NCT01633112 Argentina;Brazil;Canada;Chile;Mexico;Puerto Rico;United States;
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy;
Philipps-Universität Marburg
2010 - EUCTR2009-011088-35-DE Germany;
Sanofi
2003 Phase 4 NCT00267319 Czech Republic;
Sheba Medical Center
2006 - NCT00331747 Israel;
TEVA
2004 - EUCTR2004-000759-40-IT Italy;
2004 - EUCTR2004-000463-94-IT Hungary;Italy;
2004 - EUCTR2004-000462-13-IT Hungary;Italy;
TEVA ITALIA srl
2004 - EUCTR2004-000762-13-IT Italy;
Takeda
2015 - NCT03209479 Japan;
Teva Branded Pharmaceutical Products R&D, Inc.
1994 Phase 4 NCT00203021 United States;
Teva Pharmaceutical Industries
2003 Phase 2 NCT00202982 United States;
Teva Pharmaceuticals Industries Ltd.
2006 - EUCTR2006-002037-20-IT Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
University of California, San Francisco
2008 - NCT00819195 United States;
VU University Medical Center
2014 - EUCTR2014-001012-19-NL Netherlands;
Glatiramer acetate (GA)
Novartis Pharmaceuticals
2012 Phase 4 NCT01534182 Russian Federation;
Teva Branded Pharmaceutical Products R&D, Inc.
2010 Phase 3 NCT01067521 Bulgaria;Croatia;Czech Republic;Czechia;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Turkey;Ukraine;United Kingdom;United States;
Glatiramer acetate 150mg enteric coated tablets
TEVA Pharmaceutical Industries Ltd.
2007 - EUCTR2004-000463-94-HU Hungary;Italy;
Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets
TEVA Pharmaceutical Industries Ltd.
2004 - EUCTR2004-000462-13-HU Hungary;Italy;
Glatiramer acetate 20 mg, with mitoxantrone
Teva Pharmaceutical Industries
2003 Phase 2 NCT00203073 Canada;United States;
Glatiramer acetate injection with oral cetirizine hydrochloride
Teva Pharmaceutical Industries
2004 Phase 4 NCT00240032 United States;
Glatiramer acetate with minocycline
Teva Pharmaceutical Industries
2004 Phase 2 NCT00203112 Canada;
Glatiramer acetate, (Copaxone®)
Neurognostics
2006 - NCT00398528 United States;
Glatiramer acetato
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain;
Teva Pharmaceutical Industries, Ltd.
2006 Phase 3 EUCTR2006-002037-20-ES Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
Teva Pharmaceuticals Industries Ltd.
2006 - EUCTR2006-002037-20-IT Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
Glicerol-1,3-didecanoato-2-octadeca-(6Z,9Z,12Z)-trienoato
BTG International Ltd
2009 - EUCTR2009-011585-28-ES Belgium;France;Germany;Spain;
Glucose
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
1999 Phase 3 NCT00062972 United States;
Slovak Academy of Sciences
2017 - NCT03052595 Slovakia;
Glutamate and aspartate
University Hospital, Caen
2007 - NCT02523703 -
Glycerol-1,3-didecanoate-2-octadeca-(6Z,9Z,12Z)-trienoate
BTG International Ltd
2009 Phase 2 EUCTR2009-011585-28-BE Belgium;European Union;France;Germany;Russian Federation;Spain;
2009 - EUCTR2009-011585-28-FR Belgium;France;Germany;Spain;
2009 - EUCTR2009-011585-28-DE Belgium;European Union;France;Germany;Russian Federation;Spain;
Gold
Children's Hospital of Chongqing Medical University
2017 - ChiCTR-DND-17013749 China;
Huashan Hospital, Fudan University
2020 - ChiCTR2000040363 China;
The First Hospital of Jilin University
2020 Phase 0 ChiCTR2000034098 China;
Gold nanocrystals
Clene Nanomedicine
2019 Phase 2 NCT03993171 United States;
Granulocyte-colony stimulating factor (G-CSF) and prednisone
National Institute of Allergy and Infectious Diseases (NIAID)
2006 Phase 2 NCT00288626 United States;
Guanabenz
National Institute of Neurological Disorders and Stroke (NINDS)
2015 Phase 1 NCT02423083 United States;
H.P. Acthar Gel (repository corticotropin injection)
The University of Texas Health Science Center, Houston
2013 Phase 4 NCT01888354 United States;
H5G1.1-mAb
Alexion Pharmaceuticals Inc.
2020 Phase 2;Phase 3 EUCTR2019-001829-26-DE Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States;
2019 Phase 2;Phase 3 EUCTR2019-001829-26-ES Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States;
HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE)
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 2;Phase 3 EUCTR2019-001829-26-IT Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States;
HB-adMSCs
Hope Biosciences Stem Cell Research Foundation
2021 Phase 2 NCT05116540 United States;
HBM9161 Injection
Harbour BioMed (Guangzhou) Co. Ltd.
2020 Phase 1 NCT04227470 China;
HMR 1726D
Sanofi-Aventis recherche & développement
2008 - EUCTR2007-003997-24-GB Austria;Italy;Spain;United Kingdom;
2007 - EUCTR2007-003997-24-ES Austria;Italy;Spain;United Kingdom;
2007 - EUCTR2007-003997-24-AT Austria;Italy;Spain;United Kingdom;
Sanofi-aventis recherche & développement
2010 - EUCTR2007-004452-36-SK Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2009 Phase 3 EUCTR2007-004452-36-SE Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2009 Phase 3 EUCTR2007-004452-36-GR Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2009 Phase 3 EUCTR2007-004452-36-GB Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-004452-36-FR Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-004452-36-ES Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-004452-36-EE Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-004452-36-DE Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
sanofi-aventis recherche & développement
2009 - EUCTR2007-004452-36-AT Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2008 Phase 3 EUCTR2007-004452-36-BE Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-004452-36-NL Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-004452-36-CZ Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
HMR1726
Aventis Pharmaceuticals Inc.
2006 - EUCTR2004-000555-42-PT Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
GENZYME CORPORATION
2020 Phase 3 EUCTR2020-000637-41-IT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2017 Phase 3 EUCTR2011-005249-12-IT Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;United Kingdom;United States;
Genzyme Corporation
2021 Phase 3 EUCTR2020-000644-55-DE Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000637-41-AT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000644-55-SK Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-PT Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-NL Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-LV Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-HU Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-GR Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-GB Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-FR Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-CZ Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000637-41-SE Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-PL Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-LT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-FI Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-DK Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-DE Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-CZ Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-BG Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2017 Phase 3 EUCTR2011-005249-12-SI Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;China;Egypt;Estonia;France;Greece;Ireland;Israel;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2011-005249-12-PT Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;China;Egypt;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2011-005249-12-NL Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;United Kingdom;United States;
2015 Phase 3 EUCTR2011-005249-12-LT Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2015 - EUCTR2011-005249-12-PL Australia;Belgium;Canada;China;Estonia;Greece;Israel;Lebanon;Lithuania;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States;
2014 Phase 4 EUCTR2013-001439-34-IT Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Italy;Spain;Sweden;Switzerland;United Kingdom;United States;
2014 Phase 4 EUCTR2013-001439-34-GR Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
2014 Phase 4 EUCTR2013-001439-34-GB Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005249-12-GR Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005249-12-GB Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005249-12-ES Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Lebanon;Lithuania;Netherlands;Poland;Portugal;Russian Federation;Slovenia;Spain;Turkey;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005249-12-EE Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Netherlands;Poland;Portugal;Russian Federation;Slovenia;Spain;Turkey;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005249-12-BE Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2014 - EUCTR2013-001439-34-DE Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
2014 - EUCTR2013-001439-34-BE Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
2014 - EUCTR2013-001439-34-AT Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
2013 Phase 4 EUCTR2013-001439-34-SE Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
2013 Phase 4 EUCTR2013-001439-34-FI Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
2013 Phase 4 EUCTR2013-001439-34-ES Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Italy;Spain;Sweden;Switzerland;United Kingdom;United States;
2013 - EUCTR2012-005324-16-NL Belgium;Germany;Netherlands;
2013 - EUCTR2012-005324-16-DE Belgium;Germany;Netherlands;
2013 - EUCTR2012-005324-16-BE Belgium;Germany;Netherlands;
- Phase 3 EUCTR2011-005249-12-Outside-EU/EEA Australia;Bosnia and Herzegovina;Canada;China;Israel;Lebanon;Morocco;Russian Federation;Tunisia;Turkey;United States;
- Phase 3 EUCTR2011-005249-12-IE Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Slovenia;Spain;Tunisia;Turkey;United Kingdom;United States;
- Phase 3 EUCTR2011-005249-12-FR Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Netherlands;Poland;Portugal;Russian Federation;Slovenia;Spain;Turkey;United Kingdom;United States;
- Phase 3 EUCTR2011-005249-12-BG Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States;
Sanofi-Aventis US, Inc.
2004 - EUCTR2004-000555-42-AT Austria;Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
Sanofi-aventis US, Inc
2008 Phase 3 EUCTR2004-000555-42-GB Austria;Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
2005 - EUCTR2004-000555-42-DK Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
2004 - EUCTR2004-000555-42-SE Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
2004 - EUCTR2004-000555-42-NO Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
sanofi-aventis Recherche & De`veloppement
2004 - EUCTR2004-000555-42-IT Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
sanofi-aventis Recherche & Dévelopment
2009 - EUCTR2008-006226-34-FR Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom;
sanofi-aventis U.S Inc
2007 - EUCTR2004-000555-42-CZ Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
sanofi-aventis group
2011 - EUCTR2010-023172-12-GR Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom;
sanofi-aventis recherche et development
2012 - EUCTR2010-023172-12-LT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
2011 Phase 3 EUCTR2010-023172-12-SK Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2011 Phase 3 EUCTR2010-023172-12-HU Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
2011 Phase 3 EUCTR2010-023172-12-BE Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-023172-12-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
2011 - EUCTR2010-023172-12-PT Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-023172-12-NO Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
2011 - EUCTR2010-023172-12-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
2011 - EUCTR2010-023172-12-IT Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-023172-12-GB Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-023172-12-FI Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
2011 - EUCTR2010-023172-12-ES Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-023172-12-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
2011 - EUCTR2010-023172-12-DK Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-023172-12-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
2011 - EUCTR2010-023172-12-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
2009 Phase 3 EUCTR2008-006226-34-GR Belgium;Czech Republic;France;Germany;Greece;Hungary;Italy;Spain;United Kingdom;
2009 - EUCTR2008-006226-34-IT Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom;
2009 - EUCTR2008-006226-34-ES Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom;
2009 - EUCTR2008-006226-34-BE Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom;
sanofi-aventis recherche et developpement
2010 - EUCTR2008-006226-34-GB Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom;
2009 - EUCTR2008-006226-34-HU Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom;
2009 - EUCTR2008-006226-34-DE Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom;
2009 - EUCTR2008-006226-34-CZ Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom;
HMR1726D
Sanofi-Aventis recherche & de'veloppement
2008 - EUCTR2007-003997-24-IT Austria;Italy;Spain;United Kingdom;
Sanofi-Aventis recherche & développement
2008 - EUCTR2007-003997-24-GB Austria;Italy;Spain;United Kingdom;
2007 - EUCTR2007-003997-24-ES Austria;Italy;Spain;United Kingdom;
2007 - EUCTR2007-003997-24-AT Austria;Italy;Spain;United Kingdom;
Sanofi-aventis U.S. Inc
2007 - EUCTR2006-003134-14-IT Germany;Italy;Spain;
2007 - EUCTR2004-000555-42-EE Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
Sanofi-aventis U.S. Inc.
2007 Phase 2 EUCTR2006-004893-29-GB Austria;Germany;Italy;United Kingdom;
2007 Phase 2 EUCTR2006-003134-14-ES Germany;Italy;Spain;
2007 - EUCTR2006-004893-29-IT Austria;Germany;Italy;United Kingdom;
2007 - EUCTR2006-004893-29-AT Austria;Germany;Italy;United Kingdom;
2007 - EUCTR2006-003134-14-DE Germany;Italy;Spain;
- - EUCTR2006-004893-29-DE Austria;Germany;Italy;United Kingdom;
Sanofi-aventis recherche & développement
2010 - EUCTR2007-004452-36-SK Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2009 Phase 3 EUCTR2007-004452-36-SE Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2009 Phase 3 EUCTR2007-004452-36-GR Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2009 Phase 3 EUCTR2007-004452-36-GB Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2008 Phase 3 EUCTR2006-001152-12-FR Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom;
2008 - EUCTR2007-004452-36-FR Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-004452-36-ES Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-004452-36-EE Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-004452-36-DE Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2008 - EUCTR2006-001152-12-SK Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom;
sanofi-aventis recherche de veloppement
2007 - EUCTR2006-003361-14-IT Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom;
sanofi-aventis recherche & developpement
2011 - EUCTR2011-001160-21-DE Austria;Canada;Germany;Russian Federation;Ukraine;
2011 - EUCTR2011-001160-21-AT Austria;Canada;Germany;Russian Federation;Ukraine;
sanofi-aventis recherche & développement
2009 - EUCTR2007-004452-36-AT Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2009 - EUCTR2006-003361-14-EE Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom;
2009 - EUCTR2006-003361-14-CZ Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2009 - EUCTR2006-001152-12-LT Australia;Austria;Belarus;Bulgaria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States;
2009 - EUCTR2006-001152-12-DE Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom;
2008 Phase 3 EUCTR2007-004452-36-BE Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2008 Phase 3 EUCTR2006-003361-14-PT Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom;
2008 Phase 3 EUCTR2006-001152-12-BG Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom;
2008 - EUCTR2007-004452-36-NL Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-004452-36-CZ Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2008 - EUCTR2006-003361-14-NL Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2008 - EUCTR2006-003361-14-DK Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom;
2008 - EUCTR2006-001152-12-HU Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States;
2008 - EUCTR2006-001152-12-EE Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States;
2007 Phase 3 EUCTR2006-003361-14-SE Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom;
2007 Phase 3 EUCTR2006-003361-14-GB Austria;Canada;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2007 Phase 3 EUCTR2006-001152-12-GB Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States;
2007 Phase 3 EUCTR2006-001152-12-FI Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom;
2007 Phase 3 EUCTR2006-001152-12-CZ Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States;
2007 - EUCTR2006-003361-14-DE Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Poland;Portugal;Russian Federation;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2007 - EUCTR2006-001152-12-DK Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States;
2007 - EUCTR2006-001152-12-AT Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom;
2006 Phase 3 EUCTR2006-003361-14-FI Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom;
2006 - EUCTR2006-003361-14-AT Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
HP184
sanofi-aventis Recherche & Développement
2009 Phase 2 EUCTR2008-001999-67-FR Finland;France;Germany;Spain;
2009 Phase 2 EUCTR2008-001999-67-ES Finland;France;Germany;Spain;
2009 - EUCTR2008-001999-67-FI Finland;France;Germany;Spain;
2009 - EUCTR2008-001999-67-DE Finland;France;Germany;Spain;
HUMAN LEUCOCYTE INTERFERON-ALPHA
Dansk Multipel Sclerose Center
2010 - EUCTR2009-016824-29-DK Denmark;
Helminth ova
University of Wisconsin, Madison
2008 Phase 1 NCT00645749 United States;
Hematopoetic stem cell infusion
Talaris Therapeutics Inc.
2007 Phase 1/Phase 2 NCT00497952 United States;
Hematopoietic Stem Cell Therapy
Northwestern University
2005 Phase 2 NCT00273364 United States;
Hematopoietic stem cell transplantation
Northwestern University
2003 Phase 1/Phase 2 NCT00278655 United States;
Hematopoietic stem cell transplantation (HSCT)
Sheffield Teaching Hospitals NHS Foundation Trust
2013 Phase 2/Phase 3 NCT03133403 United Kingdom;
Heterologous booster
Griffin Hospital
2021 - NCT05081271 -
Hiberix
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 2;Phase 3 EUCTR2019-001829-26-IT Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States;
Hidrocloruro de fingolimod
Novartis Farmacéutica, S.A.
2011 - EUCTR2011-001442-15-ES Austria;Czech Republic;Finland;France;Germany;Greece;Hungary;Israel;Italy;Spain;Sweden;Switzerland;United Kingdom;
High Dose Aspirin (1300 mg/day)
Mayo Clinic
2007 Phase 3 NCT00467584 United States;
High Phenolic Extra Virgin Olive Oil
University of Cyprus
2021 - NCT04787497 -
High/Low Sodium Diet
Yale University
2014 - NCT02282878 United States;
Histamine
University of Nottingham
2008 Phase 2 NCT00630383 United Kingdom;
Home based balance training
University of Arizona
2014 - NCT02777060 United States;
Homologous booster
Griffin Hospital
2021 - NCT05081271 -
Hookworm larvae
University of Nottingham
2011 Phase 2 NCT01470521 United Kingdom;
HuL001
HuniLife Biotechnology, Inc.
2021 Phase 1 NCT04540770 Taiwan;
HuMax-CD20
Genmab A/S
2008 Phase 2 EUCTR2007-004223-38-DE Belgium;Czech Republic;Denmark;Germany;Sweden;United Kingdom;
2008 - EUCTR2007-004223-38-BE Belgium;Czech Republic;Denmark;Germany;Sweden;United Kingdom;
GlaxoSmithKline
2008 - EUCTR2007-004223-38-DK Czech Republic;Denmark;Germany;Sweden;United Kingdom;
GlaxoSmithKline AB
2008 - EUCTR2007-004223-38-SE Czech Republic;Denmark;Germany;Sweden;United Kingdom;
GlaxoSmithKline UK
2009 Phase 2 EUCTR2007-004223-38-GB Belgium;Czech Republic;Denmark;Germany;Sweden;United Kingdom;
GlaxoSmithKline s.r.o.
2008 - EUCTR2007-004223-38-CZ Czech Republic;Denmark;Germany;Sweden;United Kingdom;
Human Neural Stem Cells
Casa Sollievo della Sofferenza IRCCS
2017 Phase 1 NCT03282760 Italy;Switzerland;
Human anti-IL-12 IgG1 Mab
Centocor B.V.
2005 Phase 2 EUCTR2004-000145-38-GB Czech Republic;Hungary;United Kingdom;
2004 Phase 2 EUCTR2004-000145-38-CZ Czech Republic;Hungary;United Kingdom;
2004 - EUCTR2004-000145-38-HU Czech Republic;Hungary;United Kingdom;
Human anti-IL-12 Mab
Centocor B.V.
2005 Phase 2 EUCTR2004-000145-38-GB Czech Republic;Hungary;United Kingdom;
2004 Phase 2 EUCTR2004-000145-38-CZ Czech Republic;Hungary;United Kingdom;
2004 - EUCTR2004-000145-38-HU Czech Republic;Hungary;United Kingdom;
Human anti-LINGO-1 monoclonal antibody
Biogen Idec Research Limited
2013 Phase 2 EUCTR2011-006262-40-NL Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
2013 Phase 2 EUCTR2011-006262-40-IT Canada;Czech Republic;Hungary;Italy;Netherlands;Russian Federation;Serbia;Spain;United Kingdom;United States;
2013 Phase 2 EUCTR2011-006262-40-HU Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
2013 Phase 2 EUCTR2011-006262-40-GB Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
2013 Phase 2 EUCTR2011-006262-40-CZ Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
Human autologous mesenchymal stem cells
SALK - Gemeinnützige Salzburger Landeskliniken Betriebsges. m.b.H., Christian-Doppler-Klinik, UK für Neurologie der PMU
- - EUCTR2015-000137-78-AT Austria;
Human fetal-derived Neural Stem Cells (hNSCs)
IRCCS San Raffaele
2017 Phase 1 NCT03269071 Italy;
Human interferon beta 1a (Rebif)
Aaron Boster
2006 Phase 0 NCT00618527 United States;
Human interferon beta-1a and glatiramer acetate
EMD Serono
2004 Phase 4 NCT00078338 Argentina;Austria;Brazil;France;Germany;Italy;Netherlands;Russian Federation;Spain;Switzerland;United Kingdom;United States;
Human monoclonal antibody (CNTO 1275) to interleukin-12p40
Centocor B.V.
2005 Phase 2 EUCTR2004-000145-38-GB Czech Republic;Hungary;United Kingdom;
2004 Phase 2 EUCTR2004-000145-38-CZ Czech Republic;Hungary;United Kingdom;
2004 - EUCTR2004-000145-38-HU Czech Republic;Hungary;United Kingdom;
Human normal immunoglobulin
Octapharma AG
2015 Phase 3 EUCTR2012-005086-12-PL Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;Serbia;Ukraine;
2013 - EUCTR2012-005086-12-HU Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-DE Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-BG Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-AT Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
Human recombinant growth hormone
University of Leipzig
- Phase 2 EUCTR2006-006465-16-DE Germany;
Hydrogen peroxide
Tehran University of Medical Sciences
2012 - NCT02463318 Iran, Islamic Republic of;
Hydroxychloroquine
University of Calgary
2016 Phase 2 NCT02913157 Canada;
Hydroxychloroquine and Indapamide
University of Calgary
2021 Phase 2 NCT05013463 -
Hydroxyurea
S. Andrea Hospital
2011 Phase 2/Phase 3 NCT01103583 Italy;
Hyperimmune caprine serum against HIV lysate
Daval International Limited
2009 Phase 2 NCT01228396 United Kingdom;
IFA Incomplete Freund's Adjuvant
Immune Response BioPharma, Inc.
2020 Phase 2 NCT02149706 United States;
2020 Phase 1 NCT02200718 United States;
IFN beta 1a 44 mcg TIW
Merck KGaA, Darmstadt, Germany
2012 Phase 2 NCT01514370 Italy;
IFN beta-1a
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-003008-38-IT Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
Biogen Idec Research Limited
2020 Phase 3 EUCTR2018-003008-38-DE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-SK Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-PT Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-HU Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-HR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-GR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-ES Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;
2019 Phase 3 EUCTR2018-003008-38-CZ Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;
2019 Phase 3 EUCTR2018-003008-38-BG Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-BE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
- Phase 3 EUCTR2018-003008-38-FR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
Merck KGaA, Darmstadt, Germany
2018 Phase 2 NCT03387046 Germany;Italy;
IFN ß-1a
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-003008-38-IT Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
Biogen Idec Research Limited
2020 Phase 3 EUCTR2018-003008-38-DE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-SK Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-PT Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-HU Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-HR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-GR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-ES Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;
2019 Phase 3 EUCTR2018-003008-38-CZ Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;
2019 Phase 3 EUCTR2018-003008-38-BG Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-BE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
- Phase 3 EUCTR2018-003008-38-FR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
IFN-beta-1a (Rebif®)
Waukesha Memorial Hospital
2008 - NCT00391352 United States;
IFN-beta-1a, (Avonex®)
Neurognostics
2006 - NCT00398528 United States;
IFN-ß-1a (Rebif®)
Waukesha Memorial Hospital
2008 - NCT00391352 United States;
IFN-ß-1a, (Avonex®)
Neurognostics
2006 - NCT00398528 United States;
IL2
Assistance Publique - Hôpitaux de Paris
2016 Phase 2 NCT02424396 France;
IM90838
Immunic AG
2022 Phase 2 EUCTR2021-000048-23-NL Bulgaria;Canada;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
2022 Phase 2 EUCTR2021-000048-23-DE Bulgaria;Canada;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
2021 Phase 2 EUCTR2021-000048-23-BG Bulgaria;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine;
IMATINIB MESILATE
Department of Clinical Neuroscience, Karolinska Institutet
2020 Phase 2 EUCTR2018-000620-34-DE Germany;Sweden;
2018 Phase 2 EUCTR2018-000620-34-SE Sweden;
IMMUNOGLOBULIN G
Octapharma AG
2015 Phase 3 EUCTR2012-005086-12-PL Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;Serbia;Ukraine;
2013 - EUCTR2012-005086-12-HU Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-DE Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-BG Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-AT Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
IMMUNOSUPPRESSIVE AGENTS
Actelion Pharmaceuticals Ltd
2010 - EUCTR2009-011470-15-IT Austria;Bulgaria;Czech Republic;Finland;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
IMS001
ImStem Biotechnology
2021 Phase 1 NCT04956744 United States;
IMU-838
Immunic AG
2022 Phase 3 EUCTR2021-000028-36-BG Albania;Belarus;Bulgaria;Colombia;Georgia;Greece;India;Lithuania;Mexico;Moldova, Republic of;North Macedonia;Poland;Russian Federation;Ukraine;United States;
2022 Phase 2 EUCTR2021-000048-23-NL Bulgaria;Canada;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
2022 Phase 2 EUCTR2021-000048-23-DE Bulgaria;Canada;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
2021 Phase 2 NCT05054140 Bulgaria;Poland;Ukraine;United States;
2021 Phase 2 EUCTR2021-000048-23-BG Bulgaria;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine;
2018 Phase 2 EUCTR2018-001896-19-BG Bulgaria;Poland;Romania;Ukraine;
IMU-838 (30 mg/day)
Immunic AG
2019 Phase 2 NCT03846219 Bulgaria;Poland;Romania;Ukraine;
IMU-838 (45 mg/day)
Immunic AG
2019 Phase 2 NCT03846219 Bulgaria;Poland;Romania;Ukraine;
IMU-838 tablets
Immunic AG
2022 Phase 3 NCT05201638 -
2021 Phase 3 NCT05134441 -
INF beta-1a
Bosnalijek D.D
2019 Phase 3 NCT03283397 Turkey;
INN COLECALCIFEROL
Merja Soilu Häninen
2007 - EUCTR2007-001958-99-FI Finland;
INT131
InteKrin Therapeutics, Inc.
2015 Phase 2 NCT02638038 -
INTERFERON BETA - 1A
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-003008-38-IT Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy;
INTERFERON BETA-1A (Avonex®)
Teva Pharmaceutical Industries Ltd
2008 - EUCTR2007-005450-23-LT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
INTERFERON BETA1A
Biogen Idec Limited
2010 - EUCTR2009-015556-15-ES Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
Biogen Idec Ltd
2010 Phase 3 EUCTR2009-012500-11-ES Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom;
Merck Serono International, a branch of Laboratoires Serono SA an affiliate of Merck KGaA, Darmstadt
2009 Phase 3 EUCTR2008-004954-34-ES Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Slovakia;Spain;
Merck Serono S.A. - Geneva, an affiliate of Merck KGaA Darmstadt, Germany
2006 - EUCTR2006-002982-38-ES Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain;
sanofi-aventis recherche et development
2009 - EUCTR2008-006226-34-ES Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom;
INTERFERONE BETA 1B
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy;
IPX056
Impax Laboratories, LLC
2009 Phase 2 NCT00914290 United States;
2007 Phase 3 NCT00488839 Canada;Estonia;Latvia;Ukraine;United States;
IPX056-
IMPAX Laboratories, Inc.
2007 - EUCTR2007-000236-16-LV Estonia;Latvia;
2007 - EUCTR2007-000236-16-EE Estonia;Latvia;
IR902
The Immune Response Corporation
2007 Phase 2 EUCTR2006-003384-30-SK Slovakia;
IS (B cell depletion therapy)
National Institute of Allergy and Infectious Diseases (NIAID)
2021 Phase 2 NCT05000216 United States;
IS (MMF or MPA)
National Institute of Allergy and Infectious Diseases (NIAID)
2021 Phase 2 NCT05000216 United States;
IS (MTX)
National Institute of Allergy and Infectious Diseases (NIAID)
2021 Phase 2 NCT05000216 United States;
IV methylprednisolone
Biogen Idec
2003 Phase 4 NCT00112034 United States;
Fred Lublin
2003 Phase 3 NCT00418145 United States;
IV methylprednisolone (steroids)
University of Colorado, Denver
2013 Phase 4 NCT01838174 United States;
IVIg
Northwestern University
2019 Phase 2/Phase 3 NCT03829566 United States;
2017 Phase 3 NCT03342638 United States;
Ibudilast
MediciNova
2013 Phase 2 NCT01982942 United States;
Ibuprofen
Genzyme, a Sanofi Company
2014 Phase 4 NCT02205489 Belgium;France;Netherlands;Spain;
Ibuprofen Sandoz 400 mg Filmtabletten
Merck Serono International SA
2007 - EUCTR2006-005972-42-DE France;Germany;
Idebenone
National Institute of Allergy and Infectious Diseases (NIAID)
2013 Phase 1/Phase 2 NCT01854359 United States;
2009 Phase 1/Phase 2 NCT00950248 United States;
Imatinib Mesylate
Tomas Olsson
2018 Phase 2 NCT03674099 Denmark;Germany;Norway;Sweden;
Immune Globulin IV [Human], Caprylate/Chromatography Purified
Grifols Therapeutics Inc.
2002 Phase 2 NCT00220779 Austria;Canada;Czech Republic;Germany;Greece;Hungary;Israel;Poland;Slovakia;Sweden;United Kingdom;United States;
Immune globulin
National Institute of Neurological Disorders and Stroke (NINDS)
1993 Phase 3 NCT00004744 -
Immunoadsorption
University Hospital Muenster
2018 - NCT04450030 Germany;
Immunoglobulin
Octapharma AG
2008 - EUCTR2008-004579-22-AT Austria;
Impact
Fondazione Don Carlo Gnocchi Onlus
2018 - NCT04881422 Italy;
Nelson Mandela Metropolitan University
2011 Phase 0 NCT01453868 United States;
University Hospital, Strasbourg, France
2019 Phase 2 NCT03910738 France;
University of Alabama at Birmingham
2022 - NCT05165238 -
IncabotulinumtoxinA
Multiple Sclerosis Center of Northeastern New York
2013 Phase 4 NCT01968902 United States;
Incobotulinum toxin A
Pôle Saint Hélier
2014 - NCT04265092 -
Inebilizumab
MedImmune LLC
2018 Phase 2;Phase 3 EUCTR2014-000253-36-NL Australia;Bulgaria;Canada;China;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;India;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
2017 Phase 2;Phase 3 EUCTR2014-000253-36-HU Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
2015 Phase 2;Phase 3 EUCTR2014-000253-36-DE Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
2015 Phase 2;Phase 3 EUCTR2014-000253-36-BG Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
2015 Phase 2/Phase 3 NCT02200770 Australia;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;Estonia;Germany;Greece;Hong Kong;Hungary;India;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
2014 Phase 2;Phase 3 EUCTR2014-000253-36-PL Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
2014 Phase 2;Phase 3 EUCTR2014-000253-36-EE Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
2014 Phase 2;Phase 3 EUCTR2014-000253-36-CZ Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
Sato Toshiyuki
2020 Phase 3 JPRN-jRCT2051210017 Japan;
Influenza Vaccine
Hoffmann-La Roche
2015 Phase 3 NCT02545868 Canada;United States;
Influenza vaccine
Sanofi
2011 Phase 2 NCT01403376 Austria;Canada;Germany;Russian Federation;Ukraine;
Inhaled Cannabis
University of California, Davis
2004 Phase 1/Phase 2 NCT00682929 United States;
Injectable MS DMT
Biogen
2015 Phase 4 NCT02471560 Norway;
Injection of autologous bone marrow derived mesenchymal stem cells
Hadassah Medical Organization
2006 Phase 1/Phase 2 NCT00781872 -
Injection of cell free media
Royan Institute
2011 Phase 1/Phase 2 NCT01377870 Iran, Islamic Republic of;
Inosine
National Center for Complementary and Integrative Health (NCCIH)
2002 Phase 2 NCT00067327 United States;
Tsukuba International Clinical Pharmacology Clinic
2016 - JPRN-UMIN000024312 Japan;
Insulin
Johns Hopkins University
2017 Phase 1/Phase 2 NCT02988401 United States;
Inteferone Beta-1A
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy;
Interferon Beta 1
University of Turin, Italy
1999 Phase 3 NCT00473213 -
Interferon Beta 1a pegilado
Biogen Idec Limited
2011 - EUCTR2010-024477-39-ES Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Interferon Beta Therapy
Biogen
2021 - NCT04655222 Germany;
Interferon Beta-1A Prefilled Syringe
Cinnagen
2017 Phase 3 NCT05242133 Iran, Islamic Republic of;
Interferon beta
Heidelberg University
2006 Phase 3 NCT00344253 Germany;
Interferon beta - 1a (IFN)
Novartis Pharmaceuticals
2012 Phase 4 NCT01534182 Russian Federation;
Interferon beta -1b
EMD Serono
2006 Phase 3 NCT00428584 United States;
Interferon beta 1-a
Biogen
2010 Phase 2 NCT01071083 Germany;Spain;United States;
Fred Lublin
2005 Phase 3 NCT00211887 Canada;United States;
Merck Healthcare KGaA
2020 Phase 3 EUCTR2018-004701-11-BG Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Montenegro;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-004700-19-BG Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;Italy;Kuwait;Lebanon;Lithuania;Mexico;Moldova, Republic of;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
Interferon beta 1-b (Betaferon/Betaseron, BAY86-5046)
Bayer
2011 - NCT01071694 Korea, Republic of;
Interferon beta 1B
Charite Universitaetsmedizin Berlin
2012 Phase 3 EUCTR2011-004787-30-DE Germany;
Interferon beta 1a
Biogen Idec Limited
2012 Phase 3 EUCTR2010-024477-39-GR Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2010-024477-39-GB Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2012 - EUCTR2010-024477-39-CZ Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-024477-39-DE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-024477-39-BG Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-024477-39-LV Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-024477-39-EE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-024477-39-BE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2010 - EUCTR2008-006333-27-CZ Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2008-006333-27-GB Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2009 - EUCTR2008-006333-27-NL Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2009 - EUCTR2008-006333-27-EE Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2009 - EUCTR2008-006333-27-BG Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2009 - EUCTR2008-006333-27-BE Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
- - EUCTR2008-006333-27-DE Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
Biogen Idec Ltd
2009 - EUCTR2008-003098-42-CZ Czech Republic;
Merck KGaA
2005 - NCT01142518 -
2005 - NCT01142453 -
MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute
2002 Phase 4 NCT00037115 United States;
2001 Phase 4 NCT00037102 United States;
Rennes University Hospital
2010 Phase 3 NCT02937285 France;
Revalesio Corporation
2013 Phase 2 NCT01714089 United States;
Trio Medicines Ltd.
2001 Phase 1 NCT01863069 United Kingdom;
UCL Biomedicine R&D Unit
2006 - EUCTR2005-005751-18-GB United Kingdom;
Interferon beta 1a 30 ug IM once weekly
Beth Israel Deaconess Medical Center
2001 Phase 4 NCT00179478 Canada;United States;
Interferon beta 1a, oral doxycycline
Louisiana State University Health Sciences Center Shreveport
2003 Phase 4 NCT00246324 United States;
Interferon beta 1b
Novartis Pharmaceuticals
2011 Phase 4 NCT01333501 Germany;Italy;
Schering AG
2007 Phase 3 EUCTR2006-005270-47-ES Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
UCL Biomedicine R&D Unit
2006 - EUCTR2005-005751-18-GB United Kingdom;
University Hospital Inselspital, Berne
2005 Phase 2 NCT00942591 Switzerland;
Interferon beta 1b (Betaseron, BAY86-5046)
Bayer
2003 Phase 2 NCT00235989 United States;
Interferon beta treatment to add-on atorvastatin treatment
Charite University, Berlin, Germany
2003 Phase 2 NCT00616187 -
Interferon beta type 1a
Biogen
2019 Phase 3 NCT03958877 Argentina;Australia;Belgium;Bulgaria;Croatia;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
Interferon beta-1 a
Serono GmbH
2005 - EUCTR2005-001026-89-DE Germany;
Interferon beta-1a
BIOGEN IDEC LTD
2010 - EUCTR2009-015556-15-IT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-012500-11-IT Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom;
BIOGEN-DOMPE` SRL
2010 - EUCTR2009-017003-28-IT Italy;
Biogen
2017 Phase 4 NCT03177083 Portugal;
2014 Phase 3 NCT02283853 Argentina;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Romania;Serbia;Spain;Sweden;Turkey;United Kingdom;United States;
2013 - NCT02076841 Czech Republic;Switzerland;
2012 - NCT01272128 Belgium;United States;
2010 Phase 3 NCT01064401 Argentina;Australia;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Egypt;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 3 NCT01058005 Australia;Canada;Czech Republic;Finland;France;Hungary;Italy;Latvia;Poland;Slovenia;Spain;Sweden;United States;
Biogen Idec
2007 Phase 4 NCT00574041 Australia;
2005 Phase 3 NCT00915577 -
2003 Phase 2 NCT00912860 -
2002 - NCT00599274 Australia;Austria;Canada;United States;
1999 Phase 4 NCT00534261 Belgium;Luxembourg;United Kingdom;
Biogen Idec GmbH
2005 - EUCTR2004-004130-14-AT Austria;
Biogen Idec Research Limited
2013 Phase 2 EUCTR2011-006262-40-NL Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
2013 Phase 2 EUCTR2011-006262-40-IT Canada;Czech Republic;Hungary;Italy;Netherlands;Russian Federation;Serbia;Spain;United Kingdom;United States;
2013 Phase 2 EUCTR2011-006262-40-HU Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
2013 Phase 2 EUCTR2011-006262-40-GB Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
2013 Phase 2 EUCTR2011-006262-40-CZ Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
Celgene
2014 Phase 3 NCT02294058 Argentina;Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2013 Phase 3 NCT02047734 Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Centre Hospitalier Universitaire Vaudois
2005 Phase 1 NCT02515695 -
Genzyme Corporation
2008 - EUCTR2007-001162-32-IT Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
Genzyme, a Sanofi Company
2007 Phase 3 NCT00548405 Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2007 Phase 3 NCT00530348 Argentina;Australia;Brazil;Canada;Croatia;Czech Republic;Former Serbia and Montenegro;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom;United States;
2002 Phase 2 NCT00050778 Croatia;Poland;Russian Federation;United Kingdom;United States;
Hoffmann-La Roche
2011 Phase 3 NCT01412333 Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;France;Germany;Ireland;Italy;Mexico;Morocco;Norway;Poland;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 NCT01247324 Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Czechia;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
ISTITUTO C. MONDINO
2007 - EUCTR2008-007162-32-IT Italy;
MERCK SERONO SA
2010 - EUCTR2009-016087-37-IT France;Ireland;Italy;Spain;United Kingdom;
2009 - EUCTR2008-004954-34-IT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Spain;
2009 - EUCTR2008-003706-33-IT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2008 - EUCTR2008-000499-25-IT Germany;Italy;Spain;Sweden;
MERCK SERONO SPA
2009 - EUCTR2009-013333-24-IT Italy;
MedImmune LLC
2012 - EUCTR2011-005475-16-GB Austria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
Merck KGaA
2005 Phase 4 NCT01201343 -
2005 - NCT01142492 -
Merck Serono International SA
2007 - EUCTR2006-005972-42-DE France;Germany;
NOVARTIS FARMA
2011 - EUCTR2010-024017-31-IT Italy;
2006 - EUCTR2006-000704-17-IT Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
Novartis Pharma AG
2021 Phase 3 EUCTR2020-004505-32-FR France;Germany;
2021 Phase 3 EUCTR2020-004505-32-DE France;Germany;Italy;Spain;
Novartis Pharma Services AG
2006 Phase 3 EUCTR2006-000704-17-GR Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
2006 - EUCTR2006-000704-17-PT Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
2006 - EUCTR2006-000704-17-GB Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
Novartis Pharmaceuticals
2013 Phase 3 NCT01892722 Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
OSPEDALE S. RAFFAELE
2004 - EUCTR2004-001601-10-IT France;Italy;
Sahlgrenska University Hospital
2005 - EUCTR2005-001008-37-SE Sweden;
Sanofi
2009 Phase 3 NCT00883337 Belgium;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Poland;Spain;Switzerland;Tunisia;United Kingdom;
Serono International SA
2004 - EUCTR2004-000337-12-HU Hungary;
TEVA ITALIA srl
2008 - EUCTR2007-005450-23-IT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
Teva Pharmaceutical Industries Ltd
2008 - EUCTR2007-005450-23-EE Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
Universita di Firenze
2006 - EUCTR2006-004937-13-IT Italy;
Universitätsklinikum Heidelberg
2006 Phase 3 EUCTR2004-004403-37-DE Germany;
VU University Medical Center
2011 - EUCTR2011-003570-89-NL Netherlands;
Interferon beta-1a (Avonex)
Biogen Idec
2002 Phase 4 NCT00913666 -
1999 Phase 4 NCT00915460 -
Interferon beta-1a (Rebif)
Merck KGaA
2010 - NCT01101776 Australia;
2005 Phase 4 NCT01142466 -
2004 - NCT01142557 Germany;
Interferon beta-1a (Rebif®) alone
Merck KGaA
2011 Phase 2 NCT01285401 Austria;Belgium;Denmark;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
Interferon beta-1a (current approved manufacturing process invloving FBS)
Biogen Idec
2012 Phase 1 NCT01500408 United States;
Interferon beta-1a (new process, manufactured without FBS)
Biogen Idec
2012 Phase 1 NCT01500408 United States;
Interferon beta-1a 30 µg
Novartis
2006 Phase 3 NCT00340834 Argentina;Australia;Austria;Belgium;Brazil;Canada;Egypt;France;Germany;Greece;Hungary;Italy;Korea, Republic of;Portugal;Puerto Rico;Spain;Switzerland;United Kingdom;United States;
Interferon beta-1a FBS-free/HSA free, RNF
Serono International, S.A.
2007 - EUCTR2006-003366-33-ES Italy;Spain;
Interferon beta-1a FBS-free/HSA-free
Merck Serono International
2010 - EUCTR2008-003706-33-GR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2009 Phase 3 EUCTR2008-003706-33-FR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-003706-33-ES Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
Merck Serono S.A. - Geneva
2009 Phase 3 EUCTR2008-003706-33-GB Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2009 Phase 3 EUCTR2008-003706-33-BE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2009 - EUCTR2008-003706-33-SE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2009 - EUCTR2008-003706-33-NO Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-003706-33-DE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2009 - EUCTR2008-003706-33-CZ Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2009 - EUCTR2008-003706-33-BG Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2009 - EUCTR2008-003706-33-AT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2008 - EUCTR2008-003706-33-FI Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2008 - EUCTR2008-003706-33-EE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
Merck Serono SA - Geneva
2009 - EUCTR2008-003706-33-PT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
Interferon beta-1a FBS-free/HSA-free, RNF
MERCK SERONO INTERNATIONAL SA
2007 - EUCTR2006-003037-32-IT Estonia;Germany;Italy;Lithuania;Spain;
Merck Serono International SA
2007 Phase 3 EUCTR2006-003037-32-ES Estonia;Germany;Italy;Lithuania;Spain;
2007 - EUCTR2006-003037-32-LT Estonia;Germany;Italy;Lithuania;Spain;
2007 - EUCTR2006-003037-32-EE Estonia;Germany;Italy;Lithuania;Spain;
Merck Serono SA
2007 - EUCTR2006-003037-32-DE Estonia;Germany;Italy;Lithuania;Spain;
Serono International SA
2006 - EUCTR2006-002982-38-IT Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain;
Interferon beta-1a HSA+ biosimilar
Centre Hospitalier Universitaire Vaudois
2006 Phase 1 NCT02517788 -
Interferon beta-1a HSA-free biosimilar
Centre Hospitalier Universitaire Vaudois
2006 Phase 1 NCT02517788 -
Interferon beta-1a original
Centre Hospitalier Universitaire Vaudois
2006 Phase 1 NCT02517788 -
Interferon beta-1a, 30 µg/0.5 ml
Biogen Idec Research Limited
2019 Phase 3 EUCTR2018-003008-38-BG Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
Interferon beta-1b
AZIENDA OSPEDALIERA S. LUIGI GONZAGA
2011 - EUCTR2010-023677-19-IT Italy;
Bayer AB, Bayer Health Care, Bayer Schering Pharma
2007 - EUCTR2006-005270-47-SE Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Bayer Schering Pharma
2007 - EUCTR2006-005270-47-SI Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-HU Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
- - EUCTR2006-005270-47-DE Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Bayer Schering Pharma AG
2007 - EUCTR2006-005270-47-LV Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-GR Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-BE Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Biogen
2017 Phase 4 NCT03177083 Portugal;
Claudio Gobbi
2012 Phase 4 NCT01701856 Switzerland;
2010 Phase 4 NCT01144052 Switzerland;
NOVARTIS FARMA
2011 - EUCTR2010-024017-31-IT Italy;
2010 - EUCTR2010-023023-19-IT Germany;Italy;
S. Andrea Hospital
2005 Phase 2/Phase 3 NCT00270816 Italy;
SCHERING
2007 - EUCTR2006-005270-47-IT Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Schering AG
2007 Phase 3 EUCTR2006-005270-47-FR Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 Phase 3 EUCTR2006-005270-47-FI Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-NL Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-AT Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Universita di Firenze
2006 - EUCTR2006-004937-13-IT Italy;
Interferon beta-1b (Betaferon, BAY 86-5046)
Bayer
2014 - NCT02121444 Germany;
2012 - NCT01766063 Germany;
Interferon beta-1b (Betaferon, BAY86-5046)
Bayer
2017 - NCT03134573 Germany;
2015 - NCT02486640 Germany;
2010 - NCT01354665 Poland;
Interferon beta-1b (Betaferon/Betaseron, BAY86-5046)
Bayer
2005 Phase 3 NCT00313976 Denmark;Sweden;
2003 Phase 3 NCT00099502 Argentina;Australia;Austria;Belgium;Brazil;Canada;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;Norway;Poland;Russian Federation;Slovenia;Spain;Sweden;Switzerland;Ukraine;United States;
Interferon beta-1b (Betaferon®, BAY 86-5046)
Bayer
2014 - NCT02247310 Austria;Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Czechia;France;Greece;Hungary;Italy;Netherlands;Spain;Switzerland;
Interferon beta-1b (Betaseron, BAY86-5046)
Bayer
2016 - NCT02652091 United States;
2012 - NCT01706055 Poland;
2012 - NCT01491100 Albania;Algeria;Argentina;Belgium;Bosnia and Herzegovina;Czech Republic;Czechia;Egypt;France;Germany;Greece;Hungary;Israel;Jordan;Kazakhstan;Lebanon;Mexico;Netherlands;Poland;Portugal;Saudi Arabia;Syrian Arab Republic;Tunisia;Turkey;
2012 - NCT01436838 China;
2010 - NCT01076595 France;
2009 - NCT03408093 -
2009 - NCT00963833 Austria;Belgium;Finland;Germany;Israel;Italy;Portugal;United Kingdom;
2009 - NCT00902135 Germany;
2008 - NCT01414816 Korea, Republic of;
2008 - NCT01184833 Poland;
2008 - NCT00787657 Argentina;Bahrain;Belgium;Bosnia and Herzegovina;Canada;China;Colombia;Czech Republic;Egypt;Estonia;France;Germany;Iran, Islamic Republic of;Israel;Italy;Jordan;Korea, Republic of;Kuwait;Lebanon;Libyan Arab Jamahiriya;Mexico;Netherlands;New Zealand;Norway;Pakistan;Portugal;Saudi Arabia;Singapore;Slovakia;Slovenia;Sweden;Syrian Arab Republic;Taiwan;United Arab Emirates;United Kingdom;Venezuela;
2007 Phase 3 NCT00459667 Argentina;Australia;Austria;Belgium;Brazil;Canada;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;Norway;Poland;Russian Federation;Slovenia;Spain;Sweden;Switzerland;Ukraine;United States;
2007 - NCT01235455 Portugal;
2007 - NCT00544037 Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2006 Phase 3 NCT00370071 China;
2006 - NCT00882453 Australia;Austria;Bahrain;Belgium;Canada;Colombia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Indonesia;Israel;Italy;Jordan;Kazakhstan;Korea, Republic of;Kuwait;Lebanon;Mexico;Netherlands;Norway;Oman;Portugal;Slovenia;Spain;Sweden;Switzerland;Taiwan;Thailand;United Arab Emirates;United Kingdom;
2005 - NCT00206635 Canada;United Kingdom;United States;
2004 - NCT01233245 Czech Republic;France;Germany;Iran, Islamic Republic of;Israel;Italy;Jordan;Korea, Republic of;Lebanon;Netherlands;Portugal;Saudi Arabia;Spain;Taiwan;Turkey;
2002 Phase 3 NCT00185211 Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
Interferon beta-1b (Betaseron, Betaferon, BAY86-5046)
Bayer
2008 - NCT03577977 Russian Federation;
Interferon beta-1b (PF530, Betaferon)
Pfenex, Inc
2015 Phase 1 NCT02474134 Australia;
Interferon beta-1b and Tacrolimus
Clinique de sclérose en plaques et neuromusculaire de l'Outaouais
2003 Phase 2 NCT00298662 Canada;
Interferon beta-1b group
University Hospital Inselspital, Berne
2007 Phase 2 NCT01111656 Switzerland;
Interferon beta-1b, (Betaseron BAY86-5046)
Bayer
2007 - NCT00928967 France;
Interferon beta-1b, FRP about 6 weeks after randomization
Bayer
2008 Phase 4 NCT00780455 France;
Interferon beta-1b, FRP within 15 days after randomization
Bayer
2008 Phase 4 NCT00780455 France;
Interferon beta-1b/Atorvastatin group
University Hospital Inselspital, Berne
2007 Phase 2 NCT01111656 Switzerland;
Interferon or glatiramer acetate
Novartis Pharmaceuticals
2021 Phase 4 NCT04878211 United States;
Interferon ß-1a
Biogen
2014 Phase 3 NCT02283853 Argentina;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Romania;Serbia;Spain;Sweden;Turkey;United Kingdom;United States;
Celgene
2013 Phase 3 NCT02047734 Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Novartis Pharma AG
2021 Phase 3 EUCTR2020-004505-32-FR France;Germany;
2021 Phase 3 EUCTR2020-004505-32-DE France;Germany;Italy;Spain;
Sanofi
2009 Phase 3 NCT00883337 Belgium;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Poland;Spain;Switzerland;Tunisia;United Kingdom;
Interferon ß-1a 30 µg
Novartis
2006 Phase 3 NCT00340834 Argentina;Australia;Austria;Belgium;Brazil;Canada;Egypt;France;Germany;Greece;Hungary;Italy;Korea, Republic of;Portugal;Puerto Rico;Spain;Switzerland;United Kingdom;United States;
Interferon ß-1b
Novartis Pharma AG
2021 Phase 3 EUCTR2020-004505-32-FR France;Germany;
2021 Phase 3 EUCTR2020-004505-32-DE France;Germany;Italy;Spain;
S. Andrea Hospital
2005 Phase 2/Phase 3 NCT00270816 Italy;
Interferon-1beta (Betaseron, BAY86-5046)
Bayer
2007 - NCT00873340 Colombia;
2007 - NCT00461396 United States;
Interferon-beta
Fundació Institut Germans Trias i Pujol
2017 Phase 1 NCT02903537 Spain;
Sanofi
2007 Phase 2 NCT00489489 Canada;Germany;Italy;Poland;Spain;United States;
Interferon-beta (IFN-beta)
EMD Serono Research & Development Institute, Inc.
2006 Phase 2 NCT00436826 Italy;Russian Federation;Spain;United States;
Sanofi
2011 Phase 3 NCT01252355 Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
Interferon-beta 1a
Medizinische Universität Innsbruck
2014 Phase 4 EUCTR2012-005450-30-AT Austria;Sweden;
Merck Serono International SA
2007 Phase 3 EUCTR2006-003037-32-ES Estonia;Germany;Italy;Lithuania;Spain;
2007 - EUCTR2006-003037-32-LT Estonia;Germany;Italy;Lithuania;Spain;
2007 - EUCTR2006-003037-32-EE Estonia;Germany;Italy;Lithuania;Spain;
Merck Serono International, a branch of Laboratoires Serono SA an affiliate of Merck KGaA, Darmstadt
2009 - EUCTR2008-004954-34-GR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Spain;
Merck Serono S.A. - Geneva, an affiliate of Merck KGaA, Darmstadt, Germany
2010 - EUCTR2008-004954-34-AT Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;
2009 Phase 3 EUCTR2008-004954-34-SK Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;
2009 Phase 3 EUCTR2008-004954-34-PT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Spain;
2009 Phase 3 EUCTR2008-004954-34-BE Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;
2009 - EUCTR2008-004954-34-PL Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;
2009 - EUCTR2008-004954-34-LV Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Spain;
2009 - EUCTR2008-004954-34-FI Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;
2009 - EUCTR2008-004954-34-EE Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;
2009 - EUCTR2008-004954-34-DE Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;
2009 - EUCTR2008-004954-34-BG Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;
2008 - EUCTR2008-004954-34-CZ Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;
Merck Serono S.A.- Geneva, an affiliate of Merck KGaA, Darmstadt, Germany
2009 Phase 3 EUCTR2008-004954-34-FR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Slovakia;Spain;
Merck Serono SA
2007 - EUCTR2006-003037-32-DE Estonia;Germany;Italy;Lithuania;Spain;
Nancy Hammond, MD
2007 - NCT00490906 United States;
S. Andrea Hospital
2002 Phase 2 NCT00151801 Italy;
Interferon-beta 1a FBS-free/HSA free, RNF
Merck Serono International S.A.
2007 - EUCTR2006-002982-38-LT Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain;
2007 - EUCTR2006-002982-38-GR Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain;
2006 - EUCTR2006-002982-38-DK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain;
2006 - EUCTR2006-002982-38-AT Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain;
Merck Serono International, a branch of Laboratoires Serono SA An affiliate of Merck KGaA
2007 Phase 3 EUCTR2006-002982-38-SK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Slovakia;Spain;
2007 - EUCTR2006-002982-38-EE Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain;
Merck Serono S.A. - Geneva, an affiliate of Merck KGaA Darmstadt, Germany
2007 - EUCTR2006-002982-38-PT Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain;
2007 - EUCTR2006-002982-38-DE Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain;
2006 - EUCTR2006-002982-38-FI Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain;
2006 - EUCTR2006-002982-38-CZ Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain;
Merck Serono S.A.-Geneva, an affiliate of Merck KGaA Darmstadt, Germany
2006 Phase 3 EUCTR2006-002982-38-BE Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Slovakia;Spain;
Serono International SA
2007 Phase 3 EUCTR2006-002982-38-FR Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Slovakia;Spain;
Interferon-beta 1a FBS-free/HSA-free, RNF
Merck Serono International SA
2007 Phase 3 EUCTR2006-005972-42-FR France;Germany;
2007 - EUCTR2006-005972-42-DE France;Germany;
Interferon-beta 1b
Medizinische Universität Innsbruck
2014 Phase 4 EUCTR2012-005450-30-AT Austria;Sweden;
Nancy Hammond, MD
2007 - NCT00490906 United States;
Interferon-beta 1b (Betaseron)
Rutgers, The State University of New Jersey
2007 - NCT00468182 United States;
Interferon-beta [IFN-beta]
Sanofi
2007 Phase 2 NCT00811395 Austria;Canada;Germany;Italy;Spain;United Kingdom;United States;
Interferon-beta and human leukocyte Interferon-a
Melinda Magyari
2010 Phase 2 NCT01171209 Denmark;
Interferon-beta-1
Sanofi
2011 Phase 2 NCT01403376 Austria;Canada;Germany;Russian Federation;Ukraine;
Interferon-beta-1a
Biogen Idec
2006 Phase 4 NCT00492765 Denmark;
2003 Phase 4 NCT00493116 Australia;New Zealand;
2003 Phase 4 NCT00492466 Finland;
Merck KGaA
2014 - EUCTR2013-003126-83-BG Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-BG Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2008 - NCT01074346 Korea, Republic of;
Merck, S.L.
2006 - EUCTR2006-000606-23-ES Spain;
Interferon-beta-1a (Avonex) plus methylprednisolone
Biogen Idec
2003 Phase 4 NCT00168766 Belgium;Denmark;Finland;Netherlands;Norway;Sweden;Switzerland;United Kingdom;
Interferon-beta-1a FBS-free/HSA free, RNF
Serono International SA
2005 Phase 3 EUCTR2004-003799-13-GB Denmark;Ireland;Lithuania;Spain;Sweden;United Kingdom;
2005 Phase 3 EUCTR2004-003799-13-ES Denmark;Ireland;Lithuania;Spain;Sweden;United Kingdom;
2005 Phase 3 EUCTR2004-003799-13-DK Denmark;Ireland;Lithuania;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-003799-13-SE Ireland;Lithuania;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-003799-13-LT Ireland;Lithuania;Spain;Sweden;United Kingdom;
- Phase 3 EUCTR2004-003799-13-IE Denmark;Ireland;Lithuania;Spain;Sweden;United Kingdom;
Interferon-beta-1a FBS-free/HSA-free
EMD Serono
2005 Phase 3 NCT00110396 United States;
Interferon-beta-1b
S. Andrea Hospital
2005 Phase 2/Phase 3 NCT00270816 Italy;
Interferon-beta-1b (BETASERON, BAY 86-5046)
Bayer
2020 - NCT04356339 United States;
Interferon-beta1
Biogen
2021 Phase 2 NCT04079088 -
Interferon-ß
Sanofi
2007 Phase 2 NCT00489489 Canada;Germany;Italy;Poland;Spain;United States;
Interferon-ß [IFN-ß]
Sanofi
2007 Phase 2 NCT00811395 Austria;Canada;Germany;Italy;Spain;United Kingdom;United States;
Interferon-ß-1
Sanofi
2011 Phase 2 NCT01403376 Austria;Canada;Germany;Russian Federation;Ukraine;
Interferon-ß-1a
Merck KGaA
2014 - EUCTR2013-003126-83-BG Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-BG Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2008 - NCT01074346 Korea, Republic of;
Interferon-ß-1b
S. Andrea Hospital
2005 Phase 2/Phase 3 NCT00270816 Italy;
Interferone
sanofi-aventis recherche et development
2009 - EUCTR2008-006226-34-IT Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom;
Interferone Beta-1B
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy;
Interferone beta 1a
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain;
Interferone beta-1a
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain;
Interferone beta-1b
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain;
Interferón Beta-1a pegilado
Biogen Idec Limited
2009 Phase 3 EUCTR2008-006333-27-ES Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Latvia;Netherlands;Spain;United Kingdom;
Interferón beta 1a pegilado
Biogen Idec Limited
2011 - EUCTR2010-024477-39-ES Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Intradetrusor injection of Botulinum Toxin-A
Rose Khavari, M.D.
2014 - NCT03033355 United States;
Intranasal Foralumab Solution
Tiziana Life Sciences, PLC
2021 Phase 1 NCT05029609 -
Intratect
Guy's and St Thomas NHS Foundation Trust
2014 Phase 3 EUCTR2014-002335-34-GB United Kingdom;
Intrathecal MSC-NP injection
Tisch Multiple Sclerosis Research Center of New York
2018 Phase 2 NCT03355365 United States;
2011 - NCT03822858 United States;
Intrathecal administration of autologous MSC-NP
Tisch Multiple Sclerosis Research Center of New York
2014 Phase 1 NCT01933802 United States;
Intrathecal methotrexate
Tel-Aviv Sourasky Medical Center
2016 Phase 0 NCT02644044 -
Intravenous (IV) infusions
Polpharma Biologics S.A.
2019 Phase 3 NCT04115488 Belarus;Croatia;Georgia;Moldova, Republic of;Poland;Serbia;Ukraine;
Intravenous Immunoglobulin
Guy's and St Thomas' NHS Foundation Trust
2015 Phase 3 NCT02398994 United Kingdom;
Intravenous Methylprednisolone
Guy's and St Thomas' NHS Foundation Trust
2015 Phase 3 NCT02398994 United Kingdom;
Intravenous injection of mesenchymal stem cells
Royan Institute
2011 Phase 1/Phase 2 NCT01377870 Iran, Islamic Republic of;
Intravenous steroid
Beijing Tiantan Hospital
2019 - NCT04106830 China;
Irradiation
Fred Hutchinson Cancer Research Center
1997 Phase 1 NCT00014755 United States;
Isoxsuprine Hydrochloride
University of New Mexico
2019 Phase 1/Phase 2 NCT03752307 United States;
Ixazomib (NINLARO®) capsules
Queen Mary University of London
2019 Phase 1 NCT03783416 United Kingdom;
JM-4
Cook, Stuart, MD
2019 Early Phase 1 NCT03887065 -
KEPPRA
AZIENDA SANITARIA N. 3 GENOVESE
2007 - EUCTR2007-005414-40-IT Italy;
KLH
Hoffmann-La Roche
2015 Phase 3 NCT02545868 Canada;United States;
Kemstro
UCB Pharma
2005 Phase 3 NCT00139789 United States;
Kepivance
Cambridge University Hospitals NHS Foundation Trust and University of Cambridge
2012 Phase 2 EUCTR2011-005606-30-GB United Kingdom;
Keppra
Søren H. Sindrup, Department of Neurology, Odense University Hospital
2006 - EUCTR2006-000397-71-DK Denmark;
Keppra ®
Newcastle-upon-Tyne Hospitals NHS Trust
2006 Phase 4 EUCTR2005-003903-35-GB United Kingdom;
Kesimpta
Novartis Farmacéutica S.A.
2021 Phase 3 EUCTR2020-002700-39-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Novartis Pharma AG
2021 Phase 3 EUCTR2020-004505-32-FR France;Germany;
2021 Phase 3 EUCTR2020-004505-32-DE France;Germany;Italy;Spain;
2021 Phase 3 EUCTR2020-002700-39-SK Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-LV Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-LT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-HR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-001341-40-SI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States;
2021 Phase 3 EUCTR2019-001341-40-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001341-40-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001341-40-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001341-40-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001341-40-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001341-40-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-FI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-DK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2018 Phase 3 EUCTR2017-004703-51-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2018 Phase 3 EUCTR2017-004703-51-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
- Phase 3 EUCTR2020-002700-39-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2020-002700-39-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Novartis Pharmaceuticals
2021 - NCT04940065 Japan;
Kesimpta 20 mg Injektionslösung im Fertigpen
Novartis Pharma Vertriebs GmbH
2021 Phase 4 EUCTR2021-000307-20-DE Germany;
Kesimpta 20 mg solution for injection in pre-filled pen
Novartis Pharma AG
2021 Phase 3 EUCTR2020-002700-39-PT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Ketamine
Johns Hopkins University
2018 Phase 1/Phase 2 NCT03500289 United States;
Ketoconazole
GlaxoSmithKline
2013 Phase 1 NCT01802931 Australia;
Keyhole limpet hemocyanin (KLH)
Biogen
2008 Phase 4 NCT00536120 United States;
Keyhole limpet hemocyanin (KLH) neo-antigen
Novartis Pharmaceuticals
2018 Phase 3 NCT03650114 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
Kirunal Fish Oil
Terry L. Wahls
2022 - NCT05007483 United States;
L acetyl carnitine
University of Iowa
2010 Phase 1 NCT01381354 United States;
L-000124467
Merck & Co., Inc./Suomen MSD Oy
2004 Phase 2 EUCTR2004-000073-64-FI Finland;
L-Carnitine
University Hospital, Bordeaux
2010 Phase 3 NCT01149525 France;
L-Histidine
University of Miami
2022 Phase 2 NCT04764383 United States;
2018 Phase 1 NCT03266965 United States;
L01BB04
Merck Serono S.A. - Geneva
2009 Phase 3 EUCTR2008-003706-33-BE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
L03 AB
sanofi-aventis recherche et development
2009 - EUCTR2008-006226-34-BE Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom;
L03 AB 08
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France;
L03 AB07
Merck Serono SA – Geneva
2010 - EUCTR2009-015502-19-GB Belgium;Finland;Germany;Sweden;United Kingdom;
L03AB13
BIOGEN IDEC ITALIA S.R.L.
2015 Phase 4 EUCTR2015-002201-11-IT Italy;
L04AA04 - IMMUNOGLOBULINA ANTITIMOCITARIA (DI CONIGLIO) IMMUNOGLOBULINA DI CONIGLIO ANTITIMOCITI UMANI THYMOGLOBULINE
Dipartimento di Neuroscienze Oftalmologia e Genetica DINOG - Universita di Genova
2006 - EUCTR2006-002562-19-IT Italy;
L04AA31
Turku University Hospital
2017 Phase 4 EUCTR2016-003622-16-FI Finland;
LEMTRADA 12 mg Konzentrat zur Herstellung einer Infusionslösung
Universitätsklinikum Münster
2014 Phase 4 EUCTR2014-000709-10-DE Germany;
LEVOFOLENE 4 MG 30 CPR
AZIENDA OSPEDALIERA SAN CAMILLO FORLANINI
2005 - EUCTR2005-006071-12-IT Italy;
LFB-R603
TG Therapeutics
2017 Phase 3 EUCTR2017-000639-15-HR Belarus;Croatia;Georgia;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000639-15-GB Belarus;Croatia;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000639-15-ES Belarus;Croatia;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000638-75-GB Belarus;Georgia;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000638-75-ES Belarus;Georgia;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
TG Therapeutics, Inc.
2017 Phase 3 EUCTR2017-000639-15-PL Belarus;Croatia;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000638-75-PL Belarus;Georgia;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
LFB-R603, TGTX1101
TG Therapeutics, Inc.
2020 Phase 3 EUCTR2019-003625-16-HR Belarus;Croatia;Georgia;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
LOU064
Novartis Farmacéutica S.A.
2022 Phase 3 EUCTR2020-005929-89-ES Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States;
2022 Phase 3 EUCTR2020-005899-36-ES Slovakia;Spain;
Novartis Pharma AG
2022 Phase 3 EUCTR2020-005929-89-SE Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States;
2022 Phase 3 EUCTR2020-005899-36-SK Argentina;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;France;Germany;Guatemala;Hong Kong;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;United Kingdom;United States;
LUTENYL
OSPEDALI CIVILI DI LIONE
2007 - EUCTR2006-005460-30-IT Italy;
LY2127399
Eli Lilly and Company
2010 - EUCTR2008-007459-28-BG Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;
2009 Phase 2 NCT00882999 Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovakia;Switzerland;Ukraine;United States;
2009 Phase 2 EUCTR2008-007459-28-FR Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;
2009 - EUCTR2008-007459-28-HU Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;
2009 - EUCTR2008-007459-28-FI Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;
2009 - EUCTR2008-007459-28-DK Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;
2009 - EUCTR2008-007459-28-DE Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;
2009 - EUCTR2008-007459-28-CZ Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;
2009 - EUCTR2008-007459-28-BE Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;
LY248686
Eli Lilly and Company
2008 - EUCTR2008-002560-34-BE Belgium;
Lactose monohydrate
Queen Mary University of London
2013 - EUCTR2012-004847-61-GB United Kingdom;
Lactulose
Department of Neurology and Neurological Science, Tokyo Medical and Dental University
2021 - JPRN-UMIN000043910 Japan;
Lamotrigine
Cantonal Hospital of St. Gallen
2009 Phase 2 NCT00917839 Switzerland;
University College London Hospitals
2005 Phase 2 NCT00257855 United Kingdom;
Lamotrigine extended release tablets
University College London
2005 Phase 2 EUCTR2005-001949-42-GB United Kingdom;
Laquinimod
TEVA ITALIA srl
2008 - EUCTR2007-005450-23-IT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2007 - EUCTR2007-003226-19-IT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
Teva Branded Pharmaceutical Products R&D, Inc.
2015 Phase 2 NCT02284568 Canada;Germany;Italy;Netherlands;Poland;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2014 Phase 3 NCT01975298 Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
2013 Phase 3 NCT01707992 Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Macedonia, The Former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2010 Phase 3 NCT01047319 Bulgaria;Croatia;Czech Republic;Czechia;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, The Former Yugoslav Republic of;North Macedonia;Poland;Puerto Rico;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States;
2009 Phase 3 NCT00988052 Austria;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2008 Phase 3 NCT00605215 Bulgaria;Croatia;Czech Republic;Czechia;Estonia;Georgia;Germany;Israel;Italy;Latvia;Lithuania;Macedonia, The Former Yugoslav Republic of;Montenegro;North Macedonia;Poland;Puerto Rico;Romania;Russian Federation;Slovakia;South Africa;Spain;Turkey;Ukraine;United States;
Teva Pharmaceutical Industries
2007 Phase 3 NCT00509145 Austria;Bulgaria;Canada;Czech Republic;Estonia;Former Serbia and Montenegro;France;Georgia;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Teva Pharmaceutical Industries Ltd
2010 Phase 3 EUCTR2009-015815-42-IT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Poland;Slovakia;Spain;
2009 Phase 3 EUCTR2009-012989-30-IT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
Teva Pharmaceutical Industries, Ltd.
2005 Phase 2 NCT00745615 Czech Republic;Czechia;Germany;Hungary;Israel;Italy;Poland;Russian Federation;Spain;United Kingdom;
Laquinimod 0.3
Teva Pharmaceutical Industries
2005 Phase 2 NCT00349193 Italy;
Laquinimod 0.6
Teva Pharmaceutical Industries
2012 Phase 2 NCT01404117 -
2005 Phase 2 NCT00349193 Italy;
Laquinimod 1.2
Teva Pharmaceutical Industries
2012 Phase 2 NCT01404117 -
Laquinimod Capsulas
Teva Pharmaceutical Industries Ltd
2009 Phase 3 EUCTR2009-012989-30-ES Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
Laquinimod Capsules
Teva Pharmaceutical Industries Ltd
2010 Phase 3 EUCTR2009-015815-42-SK Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Poland;Slovakia;Spain;
2010 Phase 3 EUCTR2009-015815-42-PL Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States;
2010 Phase 3 EUCTR2009-015815-42-LT Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States;
2010 Phase 3 EUCTR2009-015815-42-EE Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States;
2010 Phase 3 EUCTR2009-015815-42-CZ Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States;
2010 Phase 3 EUCTR2009-015815-42-BG Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States;
2010 Phase 3 EUCTR2009-012989-30-SE Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-012989-30-FR Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2010 Phase 3 EUCTR2009-012989-30-BG Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-012989-30-AT Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-012989-30-NL Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-012989-30-LT Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-012989-30-HU Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-012989-30-GB Austria;Bulgaria;Canada;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-012989-30-EE Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-012989-30-CZ Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 - EUCTR2009-011234-99-DE Germany;
2008 Phase 3 EUCTR2007-005450-23-SK Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Slovakia;Spain;
2008 - EUCTR2007-005450-23-LT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2008 - EUCTR2007-005450-23-EE Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2008 - EUCTR2007-005450-23-DE Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2008 - EUCTR2007-005450-23-CZ Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2008 - EUCTR2007-005450-23-BG Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2008 - EUCTR2007-003226-19-PT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-003226-19-LT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-003226-19-BG Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 Phase 3 EUCTR2007-003226-19-FR Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 Phase 3 EUCTR2007-003226-19-ES Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-SE Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-NL Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-LV Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-HU Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-GB Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-EE Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-DE Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-CZ Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-AT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2006 Phase 2 EUCTR2005-004334-41-GB Czech Republic;Germany;Hungary;Israel;Italy;Poland;Russian Federation;Spain;United Kingdom;
2006 Phase 2 EUCTR2005-004334-41-DE Czech Republic;Germany;Hungary;Israel;Italy;Russian Federation;Spain;United Kingdom;
2006 Phase 2 EUCTR2005-004334-41-CZ Czech Republic;Germany;Hungary;Israel;Italy;Russian Federation;Spain;United Kingdom;
2005 Phase 2 EUCTR2005-004334-41-HU Czech Republic;Germany;Hungary;Israel;Italy;Russian Federation;Spain;United Kingdom;
Laquinimod Sodium (USAN)
TEVA PHARMACEUTICALS INDUSTRIES LTD
2013 Phase 3 EUCTR2012-003647-30-IT Albania;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Poland;Puerto Rico;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Teva Pharmaceutical Industries Ltd
2013 Phase 3 EUCTR2012-003647-30-PL Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003647-30-HU Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003647-30-ES Albania;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003647-30-EE Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003647-30-CZ Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003647-30-BE Albania;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003647-30-AT Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003647-30-SK Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003647-30-LV Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003647-30-GR Albania;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003647-30-GB Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2008 Phase 3 EUCTR2007-005450-23-SK Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Slovakia;Spain;
2008 - EUCTR2007-005450-23-LT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2008 - EUCTR2007-005450-23-ES Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2008 - EUCTR2007-005450-23-EE Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2008 - EUCTR2007-005450-23-DE Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2008 - EUCTR2007-005450-23-CZ Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2008 - EUCTR2007-005450-23-BG Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
Teva Pharmaceutical Industries Ltd.
2015 Phase 2 EUCTR2014-001579-30-DE Canada;Germany;Italy;Netherlands;Poland;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2015 - EUCTR2014-001579-30-NL Canada;Germany;Italy;Netherlands;Poland;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2014 Phase 2 EUCTR2014-001579-30-IT Canada;Germany;Italy;Netherlands;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2014 Phase 2 EUCTR2014-001579-30-GB Canada;Germany;Italy;Netherlands;Poland;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2014 Phase 2 EUCTR2014-001579-30-ES Canada;Germany;Italy;Netherlands;Poland;Russian Federation;Spain;Ukraine;United Kingdom;United States;
Teva Pharmaceutical Industries, Ltd.
2014 - EUCTR2013-002082-19-NL Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
2014 - EUCTR2013-002082-19-ES Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
2013 Phase 3 EUCTR2013-002082-19-GB Belgium;Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
2013 Phase 3 EUCTR2013-002082-19-BE Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2013-002082-19-SE Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2013-002082-19-FI Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2013-002082-19-DK Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
Laquinimod Tablets
Teva Pharmaceutical Industries Ltd
2006 Phase 2 EUCTR2005-004334-41-ES Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
2005 Phase 2 EUCTR2004-003943-28-GB Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
2005 Phase 2 EUCTR2004-003943-28-ES Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
2005 - EUCTR2004-003943-28-HU Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
2005 - EUCTR2004-003943-28-DE Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
2005 - EUCTR2004-003943-28-CZ Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
Laquinimod capsules
TEVA PHARMACEUTICALS INDUSTRIES LTD
2013 Phase 3 EUCTR2012-003647-30-IT Albania;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Poland;Puerto Rico;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Teva Pharmaceutical Industries Ltd
2013 Phase 3 EUCTR2012-003647-30-PL Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003647-30-HU Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003647-30-ES Albania;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003647-30-EE Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003647-30-CZ Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003647-30-BE Albania;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003647-30-AT Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003647-30-SK Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003647-30-LV Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003647-30-GR Albania;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003647-30-GB Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
Teva Pharmaceutical Industries, Ltd.
2014 - EUCTR2013-002082-19-NL Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
2014 - EUCTR2013-002082-19-ES Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
2013 Phase 3 EUCTR2013-002082-19-GB Belgium;Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
2013 Phase 3 EUCTR2013-002082-19-BE Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2013-002082-19-SE Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2013-002082-19-FI Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2013-002082-19-DK Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
Lemtrada
GENZYME CORPORATION
2017 Phase 3 EUCTR2016-003100-30-IT Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
Genzyme Corporation
2017 Phase 3 EUCTR2016-003100-30-PT Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-NO Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-NL Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-GR Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-GB Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-ES Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-DE Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-BE Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-AT Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
2015 Phase 3;Phase 4 EUCTR2013-003884-71-NL Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Czechia;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2015 Phase 3;Phase 4 EUCTR2013-003884-71-DK Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2015 - EUCTR2013-003884-71-BE Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;
2014 Phase 4 EUCTR2014-000092-62-NL Belgium;France;Netherlands;Spain;Switzerland;
2014 Phase 4 EUCTR2014-000092-62-FR Belgium;France;Netherlands;Spain;Switzerland;
2014 Phase 4 EUCTR2014-000092-62-ES Belgium;France;Netherlands;Spain;Switzerland;
2014 Phase 4 EUCTR2014-000092-62-BE Belgium;France;Netherlands;Spain;Switzerland;
2014 Phase 3;Phase 4 EUCTR2013-003884-71-IT Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;
2014 Phase 3;Phase 4 EUCTR2013-003884-71-HR Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2014 Phase 3;Phase 4 EUCTR2013-003884-71-DE Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2014 Phase 3;Phase 4 EUCTR2013-003884-71-CZ Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2014 - EUCTR2013-003884-71-ES Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;
- Phase 3 EUCTR2016-003100-30-PL Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
- Phase 3 EUCTR2016-003100-30-Outside-EU/EEA Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
- Phase 3 EUCTR2016-003100-30-FR Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
- Phase 3 EUCTR2016-003100-30-BG Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
Genzyme GmbH
2016 Phase 3 EUCTR2016-000464-42-DE Germany;
Helse Bergen HF, Haukeland University Hospital
2019 Phase 3 EUCTR2017-001362-25-NL Denmark;Netherlands;
2018 Phase 3 EUCTR2017-001362-25-DK Denmark;Netherlands;
Turku University Hospital
2013 Phase 4 EUCTR2013-004626-28-FI Finland;
University Medical Centre Hamburg-Eppendorf
2020 Phase 2 EUCTR2016-001166-29-DE Germany;
Lenograstim
Sheffield Teaching Hospitals
2020 Phase 3 EUCTR2019-001549-42-GB United Kingdom;
Levetiracetam
AZIENDA SANITARIA N. 3 GENOVESE
2007 - EUCTR2007-005414-40-IT Italy;
Newcastle-upon-Tyne Hospitals NHS Trust
2006 Phase 4 EUCTR2005-003903-35-GB United Kingdom;
Odense University Hospital
2007 Phase 4 NCT00423527 Denmark;
Organisation name was not entered
2005 - EUCTR2005-001776-13-DE Germany;
Søren H. Sindrup, Department of Neurology, Odense University Hospital
2006 - EUCTR2006-000397-71-DK Denmark;
Levitra
Unidad de Neuroinmunología
2005 Phase 4 EUCTR2004-003761-33-ES Spain;
Levocarnil
CHU de Bordeaux
2010 Phase 3 EUCTR2009-015934-30-FR France;
Lidocaine patch
University of Rochester
2007 Phase 4 NCT00414453 United States;
Linoleic Acid/Oleic Acid
University of Rochester
2008 Phase 1 NCT00638196 United States;
Liofen XL
Sun Pharma Advanced Research Company Ltd.
2016 Phase 3 EUCTR2016-001356-22-HU Germany;Hungary;Russian Federation;Ukraine;United States;
Liothyronine
Johns Hopkins University
2015 Phase 1 NCT02506751 United States;
Liothyronine sodium
Oregon Health and Science University
2016 Phase 1 NCT02760056 United States;
Lipoic acid
VA Office of Research and Development
2018 Phase 2 NCT03161028 Canada;United States;
2010 Phase 2/Phase 3 NCT01188811 United States;
Lipoic acid (LA) with fish oil and LA without fish oil
Oregon Health and Science University
2005 Phase 1 NCT00676156 United States;
Lipoic acid and omega-3 fatty acids
Oregon Health and Science University
2014 Phase 1/Phase 2 NCT02133664 United States;
Lisdexamfetamine sulfate
State University of New York at Buffalo
2009 Phase 2 NCT01615887 United States;
Listed for each disorder below, up to three drugs per disorder (too many characters to list in this field
NorthShore University HealthSystem
2016 Phase 4 NCT02670161 -
Live Hookworm Larvae
University of Nottingham
2008 Phase 2 NCT00630383 United Kingdom;
Live Necator americanus larvae
University of Nottingham
2011 Phase 2 EUCTR2008-005008-24-GB United Kingdom;
Locally approved intravenous contrast medium for contrast enhanced magnetic resonance imaging (MRI)
Sanofi
2019 Phase 2 NCT03889639 Canada;Czechia;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States;
Lodosyn
University of Miami
2022 Phase 2 NCT04764383 United States;
Lokomat training
IRCCS Centro Neurolesi Bonino-Pulejo
2016 - NCT03186664 Italy;
Loperamide
Rocky Mountain MS Research Group, LLC
2014 Phase 4 NCT02217982 United States;
Loratadine
Genzyme, a Sanofi Company
2015 Phase 1 NCT02583594 Spain;
Low Dose Aspirin (162 mg/day)
Mayo Clinic
2007 Phase 3 NCT00467584 United States;
Low dose arm receiving neutral oil and 400 IU/g of Vitamin D every second day
Charite University, Berlin, Germany
2011 Phase 2 NCT01440062 Germany;
Low dose cannabis
University of California, Davis
2009 Phase 1/Phase 2 NCT01037088 United States;
Low immunogenic interferon-beta-1a
Biogen Idec
2004 Phase 4 NCT00493077 Sweden;
Lu AG06466
H. Lundbeck A/S
2021 Phase 1 NCT04990219 United States;
Lubiprostone
University of Rochester
2010 Phase 4 NCT01236534 United States;
Lumbar Puncture
Genentech, Inc.
2016 Phase 3 NCT02688985 Canada;Germany;Sweden;United States;
Lumbar puncture
Centre Hospitalier Universitaire de Nimes
2013 Phase 3 NCT01817166 France;
Lutein
University of Illinois at Urbana-Champaign
2021 - NCT04843813 United States;
M2951
EMD Serono Research & Development Institute, Inc.
2017 Phase 2 NCT02975349 Bulgaria;Czechia;Germany;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United States;
MERCK HEALTHCARE KGaA
2020 Phase 3 EUCTR2019-004980-36-IT Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004972-20-IT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
Merck Healthcare KGaA
2021 Phase 3 EUCTR2019-004980-36-SI Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-SK Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-PT Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-NO Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-LV Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-LT Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-GR Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-DE Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-BG Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004972-20-HU Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-004972-20-GB Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-004972-20-FI Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-004972-20-DE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-004972-20-CZ Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-004972-20-BG Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-004972-20-AT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-004701-11-BG Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Montenegro;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-004700-19-BG Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;Italy;Kuwait;Lebanon;Lithuania;Mexico;Moldova, Republic of;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
- Phase 3 EUCTR2019-004972-20-BE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
Merck KGaA
2017 Phase 2 EUCTR2016-001448-21-SK Bulgaria;Croatia;Czech Republic;Czechia;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-001448-21-PL Bulgaria;Croatia;Czech Republic;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-001448-21-ES Bulgaria;Croatia;Czech Republic;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-001448-21-CZ Bulgaria;Croatia;Czech Republic;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-001448-21-BG Bulgaria;Croatia;Czech Republic;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
MABCAMPATH 10 mg/ml concentrado para solución para perfusión
Genzyme Corporation
2010 Phase 3 EUCTR2009-010788-18-ES Austria;Belgium;Czech Republic;Denmark;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
MANTADAN*20CPR
FONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR
2011 - EUCTR2010-023678-38-IT Italy;
MAVENCLAD - 10 MG - COMPRESSA - USO ORALE - BLISTER (AL/AL) - 6 COMPRESSE
MERCK KGAA
2021 Phase 4 EUCTR2020-003995-42-IT Australia;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland;
2021 Phase 4 EUCTR2020-003874-30-IT Austria;Czechia;Denmark;France;Hungary;Italy;Netherlands;Poland;Slovakia;Spain;
MAVENCLAD 10 mg tablets
Westfälische Wilhelms-Universität Münster c/o Universitätsklinikum Münster, Geschäftsbereich Recht u. Drittmittel
2019 Phase 4 EUCTR2018-004557-24-DE Germany;
MBP peptide
Centrum Neurologii Krzysztof Selmaj
2016 Phase 2 EUCTR2016-002180-33-PL Poland;
MBP8298
BioMS Technology Corp.
2007 Phase 3 NCT00468611 United States;
MBP8298 Synthetic Peptide
BioMS Technology Corp
2007 - EUCTR2004-002571-16-GB Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2006 - EUCTR2004-002571-16-NL Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2006 - EUCTR2004-002571-16-LV Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2006 - EUCTR2004-002571-16-LT Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2006 - EUCTR2004-002571-16-FI Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2006 - EUCTR2004-002571-16-ES Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2006 - EUCTR2004-002571-16-EE Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2006 - EUCTR2004-002571-16-DK Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-002571-16-SE Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
BioMS Technology Corp.
2006 Phase 2 EUCTR2006-001947-70-SK Slovakia;
MD1003
MEDDAY PHARMACEUTICALS
2017 Phase 3 EUCTR2016-000700-29-IT Australia;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States;
MEDDAY PHARMACEUTICALS SA
2018 Phase 3 EUCTR2016-000700-29-PL Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States;
2018 Phase 3 EUCTR2016-000700-29-HU Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States;
2018 Phase 3 EUCTR2016-000700-29-BE Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-000700-29-SE Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-000700-29-ES Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Poland;Spain;Sweden;United Kingdom;United States;
2017 Phase 3 EUCTR2016-000700-29-DE Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-000700-29-CZ Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States;
MEDDAY Pharmaceuticals SA
2014 Phase 3 EUCTR2013-002112-27-GB France;United Kingdom;
MEDDAY SAS
- - EUCTR2013-002113-35-FR France;
- - EUCTR2013-002112-27-FR France;
MD1003 100mg capsule
MedDay Pharmaceuticals SA
2016 Phase 3 NCT02936037 Australia;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States;
2013 Phase 3 NCT02220933 France;
2013 Phase 3 NCT02220244 France;United Kingdom;
MEDI-551
MedImmune LLC
2018 Phase 2;Phase 3 EUCTR2014-000253-36-NL Australia;Bulgaria;Canada;China;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;India;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
2017 Phase 2;Phase 3 EUCTR2014-000253-36-HU Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
2017 Phase 2;Phase 3 EUCTR2014-000253-36-GR Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
2015 Phase 2;Phase 3 EUCTR2014-000253-36-ES Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
2015 Phase 2;Phase 3 EUCTR2014-000253-36-DE Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
2015 Phase 2;Phase 3 EUCTR2014-000253-36-BG Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
2014 Phase 2;Phase 3 EUCTR2014-000253-36-PL Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
2014 Phase 2;Phase 3 EUCTR2014-000253-36-EE Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
2014 Phase 2;Phase 3 EUCTR2014-000253-36-CZ Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
2012 - EUCTR2011-005475-16-GB Austria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
MEDI-551 100 MG-IV
MedImmune LLC
2012 Phase 1 NCT01585766 Czech Republic;Poland;Spain;Ukraine;United Kingdom;United States;
MEDI-551 30 MG-IV
MedImmune LLC
2012 Phase 1 NCT01585766 Czech Republic;Poland;Spain;Ukraine;United Kingdom;United States;
MEDI-551 300 MG-SC
MedImmune LLC
2012 Phase 1 NCT01585766 Czech Republic;Poland;Spain;Ukraine;United Kingdom;United States;
MEDI-551 60 MG-SC
MedImmune LLC
2012 Phase 1 NCT01585766 Czech Republic;Poland;Spain;Ukraine;United Kingdom;United States;
MEDI-551 600 MG-IV
MedImmune LLC
2012 Phase 1 NCT01585766 Czech Republic;Poland;Spain;Ukraine;United Kingdom;United States;
METHYLPHENIDATE HYDROCHLORIDE
Medizinische Universität Wien
2012 - EUCTR2012-003418-15-AT Austria;
METHYLPREDNISOLONE SODIUM HEMISUCCINATE
Servicio de Neurología, HU. Germans Trias i Pujol
2012 Phase 4 EUCTR2012-001965-34-ES Spain;
METHYLPREDNISOLONE SODIUM SUCCINATE
Danish Multiple Sclerosis Research Centre
2009 Phase 2 EUCTR2009-011516-37-DK Denmark;
Department of Clinical Neuroscience, Karolinska Institutet
2020 Phase 2 EUCTR2018-000620-34-DE Germany;Sweden;
2018 Phase 2 EUCTR2018-000620-34-SE Sweden;
Enceladus Pharmaceuticals BV
2010 - EUCTR2009-013884-21-PL Belgium;Germany;Poland;
2009 Phase 2 EUCTR2009-013884-21-BE Belgium;Germany;Poland;
2009 - EUCTR2009-013884-21-DE Belgium;Germany;Poland;
MIS416
Innate Immunotherapeutics
2014 Phase 2 NCT02228213 Australia;New Zealand;
2010 Phase 1/Phase 2 NCT01191996 New Zealand;
MK0812
Merck Sharp & Dohme Corp.
2004 Phase 2 NCT00239655 Canada;Finland;Germany;United Kingdom;United States;
MLN1202
Millennium Pharmaceuticals, Inc.
2006 Phase 2 EUCTR2004-002567-24-GB Czech Republic;Hungary;United Kingdom;
2005 Phase 2 NCT01199640 -
2005 - EUCTR2004-002567-24-HU Czech Republic;Hungary;United Kingdom;
2005 - EUCTR2004-002567-24-CZ Czech Republic;Hungary;United Kingdom;
MOG peptide
Centrum Neurologii Krzysztof Selmaj
2016 Phase 2 EUCTR2016-002180-33-PL Poland;
MOR103
MorphoSys AG
2012 Phase 1/Phase 2 NCT01517282 Germany;Poland;United Kingdom;
MRI
University Hospital, Strasbourg, France
2019 Phase 2 NCT03910738 France;
MRI contrast-enhancing preparations
Sanofi
2021 Phase 2 NCT04879628 Bulgaria;Canada;Czechia;France;Germany;Spain;Turkey;Ukraine;United States;
MRNA COVID-19 vaccine
Novartis Pharmaceuticals
2021 Phase 4 NCT04878211 United States;
MSC2015
SALK - Gemeinnützige Salzburger Landeskliniken Betriebsges. m.b.H., Christian-Doppler-Klinik, UK für Neurologie der PMU
- - EUCTR2015-000137-78-AT Austria;
MSC2304479A
Merck KGaA
2013 Phase 2 EUCTR2013-002916-28-LV Latvia;Russian Federation;
MSC2304480A
Merck KGaA
2013 Phase 2 EUCTR2013-002916-28-LV Latvia;Russian Federation;
MSC2304481A
Merck KGaA
2013 Phase 2 EUCTR2013-002916-28-LV Latvia;Russian Federation;
MSC2304482A
Merck KGaA
2013 Phase 2 EUCTR2013-002916-28-LV Latvia;Russian Federation;
MSC2358825A
Merck KGaA
2013 Phase 2 EUCTR2013-002916-28-LV Latvia;Russian Federation;
MSC2364447C
MERCK HEALTHCARE KGaA
2020 Phase 3 EUCTR2019-004980-36-IT Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004972-20-IT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
Merck Healthcare KGaA
2021 Phase 3 EUCTR2019-004980-36-SI Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-SK Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-PT Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-NO Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-LV Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-LT Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-GR Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-DE Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-BG Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004972-20-HU Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-004972-20-GB Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-004972-20-FI Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-004972-20-DE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-004972-20-CZ Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-004972-20-BG Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-004972-20-AT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-004701-11-BG Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Montenegro;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-004700-19-BG Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;Italy;Kuwait;Lebanon;Lithuania;Mexico;Moldova, Republic of;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
- Phase 3 EUCTR2019-004972-20-BE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
MSC2430913A or ONO-4641 (to be used as synonyms)
Merck KGaA
2014 Phase 3 EUCTR2013-002351-15-AT Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-003126-83-HU Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-003126-83-GR Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-003126-83-ES Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-003126-83-DE Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-003126-83-BG Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-PT Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-LV Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-HU Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-ES Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-EE Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-BG Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
MSC2491529A
Merck KGaA
2014 Phase 2 EUCTR2013-002283-25-GB Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2014 - EUCTR2013-002283-25-PL Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2014 - EUCTR2013-002283-25-GR Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2014 - EUCTR2013-002283-25-ES Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2014 - EUCTR2013-002283-25-BG Bulgaria;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States;
2013 - EUCTR2013-002283-25-IT Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2013 - EUCTR2013-002283-25-HU Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2013 - EUCTR2013-002283-25-HR Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2013 - EUCTR2013-002283-25-FI Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2013 - EUCTR2013-002283-25-CZ Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
MSDMDs other than Betaseron (Interferon beta-1b, BAY86-5046)
Bayer
2016 - NCT02749396 Finland;
MSTC-001 (MS-STAT)
Imperial College London
2007 Phase 2 EUCTR2006-006347-31-GB United Kingdom;
MSmonitor, a self-management/education program with e-health interventions
Isala
2021 - NCT05242731 Netherlands;
MT-1303
MITSUBISHI PHARMA CORPORATION
2013 - EUCTR2012-002470-31-IT Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Hungary;Italy;Lithuania;Poland;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;
Mitsubishi Tanabe Pharma Corporation
2014 Phase 1 NCT02293967 United Kingdom;
Mitsubishi Tanabe Pharma Corporation (MTPC)
2013 Phase 2 EUCTR2012-002639-27-PL Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;
2013 Phase 2 EUCTR2012-002639-27-LT Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;
2013 Phase 2 EUCTR2012-002639-27-HU Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;
2013 Phase 2 EUCTR2012-002639-27-GB Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;
2013 Phase 2 EUCTR2012-002639-27-FI Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;
2013 Phase 2 EUCTR2012-002639-27-ES Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;
2013 Phase 2 EUCTR2012-002639-27-CZ Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;
2013 Phase 2 EUCTR2012-002639-27-BG Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;
2013 Phase 2 EUCTR2012-002639-27-BE Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;
2013 - EUCTR2012-002470-31-LT Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;
2013 - EUCTR2012-002470-31-FI Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;
2013 - EUCTR2012-002470-31-ES Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;
2013 - EUCTR2012-002470-31-BG Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;
2013 - EUCTR2012-002470-31-BE Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;
2012 - EUCTR2012-002470-31-PL Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;
2012 - EUCTR2012-002470-31-HU Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;
2012 - EUCTR2012-002470-31-GB Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;
2012 - EUCTR2012-002470-31-CZ Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;
MT-1303 [0.1]
MITSUBISHI TANABE PHARMA CORPORATION
2013 Phase 2 EUCTR2012-002639-27-IT Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;
MT-1303 [0.2]
MITSUBISHI TANABE PHARMA CORPORATION
2013 Phase 2 EUCTR2012-002639-27-IT Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;
MT-1303 [0.4]
MITSUBISHI TANABE PHARMA CORPORATION
2013 Phase 2 EUCTR2012-002639-27-IT Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;
MT-1303-FormA
Mitsubishi Tanabe Pharma Corporation
2014 Phase 1 NCT02310048 United Kingdom;
MT-1303-FormB
Mitsubishi Tanabe Pharma Corporation
2014 Phase 1 NCT02310048 United Kingdom;
MT-1303-High
Mitsubishi Tanabe Pharma Corporation
2014 Phase 1 NCT02193217 United Kingdom;
2013 Phase 2 NCT01890655 Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Turkey;Ukraine;United Kingdom;
2013 Phase 2 NCT01742052 Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;
MT-1303-Low
Mitsubishi Tanabe Pharma Corporation
2014 Phase 1 NCT02193217 United Kingdom;
2013 Phase 2 NCT01890655 Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Turkey;Ukraine;United Kingdom;
2013 Phase 2 NCT01742052 Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;
MT-1303-Middle
Mitsubishi Tanabe Pharma Corporation
2013 Phase 2 NCT01890655 Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Turkey;Ukraine;United Kingdom;
2013 Phase 2 NCT01742052 Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;
MabCampath ®
Genzyme Corporation
2010 Phase 3 EUCTR2009-010788-18-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-010788-18-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-010788-18-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2008 Phase 3 EUCTR2007-001162-32-FR Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2008 Phase 3 EUCTR2007-001162-32-ES Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2008 Phase 3 EUCTR2007-001162-32-CZ Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2008 Phase 3 EUCTR2007-001162-32-BE Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2008 Phase 3 EUCTR2007-001161-14-FR Czech Republic;France;Germany;Poland;Sweden;United Kingdom;
2008 - EUCTR2007-001162-32-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-001162-32-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-001162-32-NL Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-001162-32-DK Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-001162-32-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-001162-32-AT Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-001161-14-SE Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom;
2008 - EUCTR2007-001161-14-PL Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom;
2008 - EUCTR2007-001161-14-DE Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom;
2007 Phase 3 EUCTR2007-001162-32-GB Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-001161-14-GB Czech Republic;France;Germany;Poland;Sweden;United Kingdom;
R&D Addenbrookes Hospital
2008 Phase 2 EUCTR2005-002305-23-GB United Kingdom;
MabCampath-1h
University of British Columbia
2011 Phase 3 NCT01307332 Canada;
MabCampath®
Genzyme Corporation
2009 Phase 3 EUCTR2009-010788-18-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-001161-14-PL Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom;
2008 - EUCTR2007-001161-14-CZ Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom;
MabThera (Rituximab)
Odense University Hospital
2013 Phase 2 EUCTR2012-004436-36-DK Denmark;
Mabthera or biosimilar rituximab product
Medical University of Vienna - Department of Neurology
2018 Phase 2 EUCTR2017-000426-35-AT Austria;
Mabthera®
Västerbottens Läns Landsting
2014 Phase 2 EUCTR2013-002378-26-SE Sweden;
Magnetic Resonance Imaging
University of Nottingham
2017 - NCT02481882 United Kingdom;
Maltodextrin
Medical University of Vienna
2012 Phase 2 NCT01879202 Austria;
Maltodextrin fiber supplement
University of Iowa
2010 Phase 1 NCT01381354 United States;
Mangafodipir (Teslascan)
National Institute of Neurological Disorders and Stroke (NINDS)
2013 Phase 1 NCT01326715 United States;
Mannitol
Department of Neurology and Neurological Science, Tokyo Medical and Dental University
2021 - JPRN-UMIN000043910 Japan;
Marijuana
Colorado State University
2016 - NCT02898974 United States;
Masitinb mesylate
AB Science
2015 Phase 3 EUCTR2012-003735-32-GR Argentina;Belgium;Brazil;Bulgaria;Czech Republic;Germany;Greece;Hungary;Italy;Mexico;Slovakia;Spain;United Kingdom;
2013 Phase 3 EUCTR2010-021219-17-GR Bulgaria;Germany;Greece;Poland;Slovakia;Spain;Turkey;
2013 - EUCTR2010-021219-17-PL Czech Republic;France;Germany;Greece;Poland;Romania;Slovakia;Spain;
2011 Phase 3 EUCTR2010-021219-17-DE Argentina;Bosnia and Herzegovina;Brazil;Bulgaria;France;Germany;Greece;Hungary;Italy;Mexico;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Tunisia;Ukraine;United Kingdom;United States;
Masitinib
AB Science
2011 Phase 3 NCT01433497 Bulgaria;France;Germany;Greece;Poland;Romania;Spain;United States;
2005 Phase 2 NCT01450488 -
Masitinib mesilate
AB Science
2022 Phase 3 EUCTR2021-000639-30-ES Bulgaria;Canada;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
Masitinib mesylate
AB Science
2015 Phase 3 EUCTR2012-003735-32-SK Argentina;Belgium;Brazil;Bulgaria;Canada;Colombia;Germany;Greece;Italy;Mexico;Slovakia;Spain;Switzerland;United Kingdom;
2015 Phase 3 EUCTR2012-003735-32-GR Argentina;Belgium;Brazil;Bulgaria;Czech Republic;Germany;Greece;Hungary;Italy;Mexico;Slovakia;Spain;United Kingdom;
2015 Phase 3 EUCTR2010-021219-17-BG Argentina;Bosnia and Herzegovina;Brazil;Bulgaria;France;Germany;Greece;Hungary;Italy;Mexico;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Tunisia;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2010-021219-17-GR Bulgaria;Germany;Greece;Poland;Slovakia;Spain;Turkey;
2013 - EUCTR2010-021219-17-PL Czech Republic;France;Germany;Greece;Poland;Romania;Slovakia;Spain;
2012 Phase 3 EUCTR2010-021219-17-SK Argentina;Bosnia and Herzegovina;Brazil;Bulgaria;France;Germany;Greece;Hungary;Italy;Mexico;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-021219-17-ES Bulgaria;Czech Republic;France;Germany;Greece;Poland;Romania;Slovakia;Spain;United States;
2011 Phase 3 EUCTR2010-021219-17-DE Argentina;Bosnia and Herzegovina;Brazil;Bulgaria;France;Germany;Greece;Hungary;Italy;Mexico;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Tunisia;Ukraine;United Kingdom;United States;
Mastinib
AB Science
2015 Phase 3 EUCTR2012-003735-32-SK Argentina;Belgium;Brazil;Bulgaria;Canada;Colombia;Germany;Greece;Italy;Mexico;Slovakia;Spain;Switzerland;United Kingdom;
2015 Phase 3 EUCTR2012-003735-32-GR Argentina;Belgium;Brazil;Bulgaria;Czech Republic;Germany;Greece;Hungary;Italy;Mexico;Slovakia;Spain;United Kingdom;
2013 Phase 3 EUCTR2010-021219-17-GR Bulgaria;Germany;Greece;Poland;Slovakia;Spain;Turkey;
2013 - EUCTR2010-021219-17-PL Czech Republic;France;Germany;Greece;Poland;Romania;Slovakia;Spain;
2012 Phase 3 EUCTR2010-021219-17-SK Argentina;Bosnia and Herzegovina;Brazil;Bulgaria;France;Germany;Greece;Hungary;Italy;Mexico;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-021219-17-DE Argentina;Bosnia and Herzegovina;Brazil;Bulgaria;France;Germany;Greece;Hungary;Italy;Mexico;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Tunisia;Ukraine;United Kingdom;United States;
Mavenclad
Helse Bergen HF, Haukeland University Hospital
2019 Phase 3 EUCTR2017-001362-25-NL Denmark;Netherlands;
2018 Phase 3 EUCTR2017-001362-25-DK Denmark;Netherlands;
Merck Healthcare KGaA
2021 Phase 4 EUCTR2020-003995-42-HU Australia;Canada;Czech Republic;Finland;Germany;Hungary;Israel;
2021 Phase 4 EUCTR2020-003995-42-CZ Australia;Canada;Czech Republic;Finland;Germany;Hungary;Israel;
2021 Phase 4 EUCTR2020-003874-30-HU Hungary;
2021 Phase 4 EUCTR2020-003874-30-DK Denmark;Hungary;
2021 Phase 4 EUCTR2020-003874-30-CZ Czech Republic;Denmark;Hungary;Italy;
2020 Phase 4 EUCTR2020-003995-42-FI Australia;Canada;Finland;Germany;Israel;
2020 Phase 4 EUCTR2020-003995-42-DE Australia;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Poland;
Turku PET centre
2019 Phase 4 EUCTR2019-001960-31-FI Finland;
Mavenclad tabletter
Department of Neurology, Division of Clinical Neuroscience, Oslo University Hospital
2019 Phase 3 EUCTR2019-001505-24-NO Norway;
Mavenclad®
MERCK KGAA
2018 Phase 4 EUCTR2017-002632-17-IT Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;Finland;France;Greece;Hungary;Ireland;Italy;Lithuania;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 EUCTR2017-002631-42-IT Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
2021 Phase 4 NCT04783935 Australia;Austria;Canada;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Poland;Spain;Sweden;United Kingdom;
2021 Phase 4 NCT04776213 Austria;Czechia;Denmark;France;Hungary;Italy;Netherlands;Poland;Slovakia;Spain;
Merck KGaA
2018 Phase 4 EUCTR2017-002632-17-SK Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-SE Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-PT Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-NL Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-LT Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-HU Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Ireland;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-GR Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-GB Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-FR Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-FI Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-ES Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-DK Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-CZ Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-BE Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-AT Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 EUCTR2017-002631-42-SE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002631-42-HU Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002631-42-GB Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002631-42-FR Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002631-42-FI Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002631-42-CZ Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002631-42-BE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002631-42-AT Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;
Merck KGaA, Darmstadt, Germany
2018 Phase 4 NCT03369665 Austria;Belgium;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 NCT03364036 Australia;Austria;Belgium;Canada;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Poland;Spain;Sweden;United Kingdom;
Mayzent
Novartis Farmacéutica S.A.
2021 Phase 3 EUCTR2020-002700-39-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Novartis Pharma AG
2021 Phase 3 EUCTR2020-002700-39-SK Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-LV Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-LT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-HR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2020-002700-39-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2020-002700-39-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Novartis Pharmaceuticals
2020 - NCT04593927 Japan;
Robert Zivadinov, MD, PhD
2021 Phase 4 NCT04925557 United States;
Mayzent 0,25 mg Filmtabletten
Novartis Pharma GmbH
2021 Phase 4 EUCTR2020-005752-38-DE Germany;
Mayzent 0.25 mg fi
Novartis Pharma AG
2021 Phase 3 EUCTR2020-002700-39-PT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Mayzent 2 mg Filmtabletten
Novartis Pharma GmbH
2021 Phase 4 EUCTR2020-005752-38-DE Germany;
Mayzent 2 mg film-coated tablets
Novartis Pharma AG
2021 Phase 3 EUCTR2020-002700-39-PT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Medical Marijuana
Colorado State University
2017 Phase 2/Phase 3 NCT03172741 -
Medication Event Monitoring System (MEMS)
Biogen
2015 Phase 4 NCT02343159 United States;
Medrol
Scleroseklinikken, Rigshospitalet
2011 - EUCTR2010-024561-43-DK Denmark;
Megadose oral methylprednisolone
Fred Lublin
2003 Phase 3 NCT00418145 United States;
Melatonin
Isfahan University of Medical Sciences
2012 Phase 2 NCT01718678 Iran, Islamic Republic of;
Providence Health & Services
2018 Early Phase 1 NCT03498131 United States;
Tehran University of Medical Sciences
2012 - NCT02463318 Iran, Islamic Republic of;
2010 Phase 2 NCT01279876 Iran, Islamic Republic of;
University of California, San Francisco
2019 - NCT04035889 United States;
Melphalan
Fred Hutchinson Cancer Research Center
2008 Phase 2 NCT00716066 United States;
Memantine
AZ. OSPEDALIERA GARIBALDI, S.LUIGI CURRO , ASCOLI TOMASELLI
2007 - EUCTR2007-000503-15-IT Italy;
Clinica Universidad de Navarra, Universidad de Navarra
2007 Phase 2 NCT00638833 Spain;
Hospices Civils de Lyon
2012 Phase 2 NCT01744444 France;
OSPEDALE S. RAFFAELE
2008 Phase 2 EUCTR2008-000490-37-IT Italy;
Oregon Health and Science University
2004 Phase 2/Phase 3 NCT00300716 United States;
University Hospital, Caen
2005 Phase 3 NCT01074619 France;
University of Rochester
2006 Phase 4 NCT00638027 United States;
Meningococcal polysaccharide diphtheria conjugate vaccine (quadrivalent)
Biogen
2015 Phase 2 NCT02097849 United States;
Menitorix
R & D, Cambridge University Hospitals
2009 - EUCTR2009-011523-31-GB United Kingdom;
Mesenchymal Stem Cells
Ottawa Hospital Research Institute
2015 Phase 2 NCT02239393 Canada;
Mesenchymal Stem Cells (MSC)
Hadassah Medical Organization
2013 Phase 1/Phase 2 NCT04823000 -
Mesenchymal stem cells
Dimitrios Karussis
2015 Phase 2 NCT02166021 Israel;
Imperial College London
2013 Phase 1/Phase 2 NCT01606215 United Kingdom;
University Hospital, Toulouse
2015 Phase 1/Phase 2 NCT02403947 France;
Mesenchymal stem cells (MSCs)
Prof. Per Soelberg Sørensen
2012 Phase 2 EUCTR2012-000518-13-DK Denmark;
Mesenchymal stem/stromal cells
Prof. Per Soelberg Sørensen
2012 Phase 2 EUCTR2012-000518-13-DK Denmark;
Mesna
Northwestern University
2019 Phase 2/Phase 3 NCT03829566 United States;
2017 Phase 3 NCT03342638 United States;
Metabolic fatigue
Centre Hospitalier Universitaire de Saint Etienne
2020 Phase 2 NCT03983720 France;
Metex
Universitätsklinikum Heidelberg
2006 Phase 3 EUCTR2004-004403-37-DE Germany;
Metformin
The Hospital for Sick Children
2020 Phase 1/Phase 2 NCT04121468 Canada;
Methelphenidate
Kessler Foundation
2014 Phase 2 NCT02286557 -
Methotrexat
Universitätsklinikum Heidelberg
2006 Phase 3 EUCTR2004-004403-37-DE Germany;
Methotrexate
Biogen Idec
2003 Phase 4 NCT00112034 United States;
Heidelberg University
2006 Phase 3 NCT00344253 Germany;
MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute
2002 Phase 4 NCT00037115 United States;
2001 Phase 4 NCT00037102 United States;
Methyl B12
University of Iowa
2010 Phase 1 NCT01381354 United States;
Methyl Prednisolonate
University Hospital Muenster
2018 - NCT04450030 Germany;
Methyl folate
University of Iowa
2010 Phase 1 NCT01381354 United States;
Methyloprednisolone
Genentech, Inc.
2016 Phase 3 NCT02688985 Canada;Germany;Sweden;United States;
Methylphenidate
Johns Hopkins University
2017 Phase 3 NCT03185065 United States;
Oregon Health and Science University
2013 Phase 2/Phase 3 NCT01896700 United States;
Methylphenidate modified release
Medical University of Vienna
2012 Phase 2 NCT01879202 Austria;
Medizinische Universität Wien
2012 - EUCTR2012-003418-15-AT Austria;
Methylprednisolon-21-hydrogensuccinat, Natriumsalz
IFSgGmbH, Institute for clinical research
2006 - EUCTR2005-005592-14-DE Germany;
Methylprednisolone
ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
2008 - EUCTR2007-002179-15-FR France;
Beijing Tongren Hospital
2020 - NCT04601142 China;
Biogen
2010 Phase 2 NCT01071083 Germany;Spain;United States;
Biogen Idec
2003 Phase 4 NCT00493116 Australia;New Zealand;
2003 Phase 4 NCT00492466 Finland;
Galapagos NV
2009 Phase 2 NCT01039103 Belgium;Germany;Poland;
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
2015 Phase 1 NCT02583594 Spain;
2014 Phase 4 NCT02205489 Belgium;France;Netherlands;Spain;
Germans Trias i Pujol Hospital
2008 Phase 4 NCT00753792 Spain;
Hoffmann-La Roche
2020 Phase 3 NCT04548999 Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Peru;Poland;Portugal;Puerto Rico;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 NCT04544436 Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
IFSgGmbH, Institute for clinical research
2006 - EUCTR2005-005592-14-DE Germany;
Jena University Hospital
2020 - NCT04832269 Germany;
Merck KGaA, Darmstadt, Germany
2018 Phase 2 NCT03387046 Germany;Italy;
MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute
2002 Phase 4 NCT00037115 United States;
National Eye Institute (NEI)
1988 Phase 3 NCT00000146 United States;
1988 - NCT00000147 United States;
National Institute of Neurological Disorders and Stroke (NINDS)
2016 Phase 2 NCT02784210 United States;
Neurologique Foundation, Inc.
2009 Phase 2/Phase 3 NCT00947895 United States;
Northwestern Memorial Hospital
2001 Phase 1 NCT00017628 United States;
Northwestern University
2019 Phase 2/Phase 3 NCT03829566 United States;
2017 Phase 3 NCT03342638 United States;
Rigshospitalet, Denmark
2021 Phase 3 NCT04688788 Denmark;
2011 Phase 2 NCT01305837 Denmark;
Stanford University
2014 Phase 1 NCT02087813 United States;
Sykehuset Innlandet HF
2009 - NCT00764413 Norway;
Tomas Olsson
2018 Phase 2 NCT03674099 Denmark;Germany;Norway;Sweden;
University Hospital, Clermont-Ferrand
2016 Phase 4 NCT02769689 France;
University of Southern California
2009 Phase 1 NCT01049451 United States;
University of Texas Southwestern Medical Center
2013 Phase 2 NCT01710228 United States;
Methylprednisolone (drug)
University Hospital, Bordeaux
2005 Phase 3 NCT00241254 France;
Methylprednisolone 1250 mg/24h x3 days
Germans Trias i Pujol Hospital
2013 Phase 4 NCT01986998 Spain;
Methylprednisolone IV
Centre Hospitalier de PAU
2015 Phase 2 NCT02545959 France;
Hoffmann-La Roche
2022 Phase 3 NCT05232825 Brazil;Canada;Czechia;Italy;Poland;Russian Federation;Spain;Turkey;Ukraine;United States;
Rennes University Hospital
2008 Phase 3 NCT00984984 France;
Methylprednisolone PO
Rennes University Hospital
2008 Phase 3 NCT00984984 France;
Methylprednisolone hemisuccinate
BBB-Therapeutics B.V.
2013 Phase 1 NCT02048358 Netherlands;
Methylprednisolone succinate
Mazandaran University of Medical Sciences
2021 Phase 2 NCT04979650 Iran, Islamic Republic of;
Metilprednisolone sodio succinato
NOVARTIS PHARMA AG
2018 Phase 2 EUCTR2017-004702-17-IT Austria;Bulgaria;Czech Republic;Czechia;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
Microgynon
Novartis Pharma Services AG
2012 - EUCTR2011-006043-30-NL Netherlands;
Microgynon®
Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany
2019 Phase 1 NCT04086225 Germany;Poland;
Merck KGaA, Darmstadt, Germany
2019 Phase 1 NCT03745144 Germany;Poland;
Micropirin
Biogen Idec Research Limited
2014 - EUCTR2013-001895-40-IE Ireland;United Kingdom;
Midazolam
Biogen
2011 Phase 3 NCT01462318 Czech Republic;Hungary;Poland;Russian Federation;United States;
Johns Hopkins University
2018 Phase 1/Phase 2 NCT03500289 United States;
Mild dose cannabis
University of California, Davis
2009 Phase 1/Phase 2 NCT01037088 United States;
Mineral boost (magnesium)
University of Iowa
2010 Phase 1 NCT01381354 United States;
Minocycline
Dr. Luanne Metz
2009 Phase 3 NCT00666887 Canada;
Merck KGaA
2006 Phase 2 NCT01134627 Denmark;
University of Calgary
2020 Phase 3 NCT04291456 Canada;
2010 Phase 2 NCT01073813 Canada;
Minocycline 100 mg Film-coated Tablets
E. Merck AB
2005 - EUCTR2005-004289-18-DK Denmark;Finland;Sweden;
Merck AB
2006 - EUCTR2005-004289-18-SE Finland;Sweden;
2006 - EUCTR2005-004289-18-FI Finland;Sweden;
Minocycline Hydrochloride
E. Merck AB
2005 - EUCTR2005-004289-18-DK Denmark;Finland;Sweden;
Merck AB
2006 - EUCTR2005-004289-18-SE Finland;Sweden;
2006 - EUCTR2005-004289-18-FI Finland;Sweden;
Mirabegron
Theodore R. Brown, MD MPH
2014 Phase 4 NCT02086188 United States;
Mitoquinone
Oregon Health and Science University
2018 Phase 1/Phase 2 NCT03166800 United States;
Mitoxantrone
AZIENDA OSPEDALIERA UNIVERSITARIA DELLA SECONDA UNIVERSITA` DEGLI STUDI DI NAPOLI
2009 - EUCTR2009-010661-23-IT Italy;
Fundación Española de Esclerosis Múltiple (FEDEM)
2006 - EUCTR2004-001286-17-PT Portugal;
OSPEDALE S. RAFFAELE
2004 - EUCTR2004-001601-10-IT France;Italy;
Queen Mary, University of London
2009 - EUCTR2008-000256-26-GB United Kingdom;
Rennes University Hospital
2010 Phase 3 NCT02937285 France;
2010 - NCT01065727 France;
1999 Phase 2 NCT00219908 France;Italy;
State University of New York at Buffalo
2001 Phase 4 NCT00304291 United States;
The Walton Centre for Neurology and Neurosurgery
2005 Phase 4 EUCTR2004-004903-39-GB United Kingdom;
University Medical Center Hamburg Eppendorf
2007 - EUCTR2007-001962-34-DE Germany;
Wyeth is now a wholly owned subsidiary of Pfizer
2005 Phase 3 NCT00146159 Germany;
Xuanwu Hospital, Beijing
2009 Phase 4 NCT02021825 China;
Modafinil
Johns Hopkins University
2017 Phase 3 NCT03185065 United States;
Kessler Foundation
2003 - NCT00142402 United States;
University of Michigan
2018 Phase 4 NCT03621761 United States;
Moderna mRNA-1273
National Institute of Allergy and Infectious Diseases (NIAID)
2021 Phase 2 NCT05000216 United States;
Monoclonal antibody M-T412
National Center for Research Resources (NCRR)
1995 Phase 1 NCT00004816 -
Monomethyl fumarate
Banner Life Sciences LLC
2021 - NCT04925778 -
2017 Phase 1 NCT04570670 -
Montelukast
Biogen
2015 Phase 4 NCT02410278 United States;
Most recent vaccine to seasonal influenza
Heinrich-Heine University, Duesseldorf
2020 - NCT05019248 Germany;
Multiferon
Dansk Multipel Sclerose Center
2010 - EUCTR2009-016824-29-DK Denmark;
Multiple (4 autologous subcutaneous T cell vaccinations with T cell lines reactive to nine myelin peptides)
Hadassah Medical Organization
2002 Phase 1/Phase 2 NCT01448252 Israel;
Mutagrip
sanofi-aventis recherche & developpement
2011 - EUCTR2011-001160-21-DE Austria;Canada;Germany;Russian Federation;Ukraine;
2011 - EUCTR2011-001160-21-AT Austria;Canada;Germany;Russian Federation;Ukraine;
MyBETAapp
Bayer
2017 - NCT03134573 Germany;
Mycophenolate Mofetil (CellCept)
University of Texas Southwestern Medical Center
2006 Phase 2 NCT00324506 United States;
Mycophenolate Mofetil (cellcept)
University of Texas Southwestern Medical Center
2004 Phase 2/Phase 3 NCT00223301 United States;
Mycophenolate mofetil
Kobe University Hospital
2018 - JPRN-UMIN000031135 Japan;
Sekiguchi Kenji
2018 Phase 2 JPRN-jRCTs051180080 Japan;
Shandong University Qilu Hospital
2021 Phase 4 ChiCTR2100043013 China;
The Ophthalmology Department of the Chinese Peoples Liberation Army Hospital
2019 Phase 4 ChiCTR1900025744 China;
2014 - ChiCTR-ICR-15007177 China;
The third affiliated hospital,Sun Yat-sen university
2016 - ChiCTR-OPB-16007730 China;
Third Affiliated Hospital, Sun Yat-Sen University
2016 Phase 4 NCT02809079 -
Mycophenolate mofetil (Cellcept)
Aaron Boster
2006 Phase 0 NCT00618527 United States;
Mycophenolate mofetil (MMF)
Hoffmann-La Roche
2021 Phase 3 NCT04660539 Bulgaria;Canada;Croatia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Puerto Rico;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Méthylprednisolone Mylan
Centre Hospitalier de Pau
2015 Phase 2 EUCTR2014-005493-11-FR France;
N acetylcysteine
University of Iowa
2010 Phase 1 NCT01381354 United States;
N-acetyl Cysteine
Thomas Jefferson University
2017 - NCT03032601 United States;
N-acetyl cysteine
Emmanuelle Waubant
2021 Phase 2 NCT05122559 -
University of California, San Francisco
2016 Phase 2 NCT02804594 United States;
N-acetylcysteine
ISTITUTO C. MONDINO
2007 - EUCTR2008-000955-90-IT Italy;
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine
N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM197
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 2;Phase 3 EUCTR2019-001829-26-IT Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States;
N.A.
Genzyme Corporation
2010 Phase 3 EUCTR2009-010788-18-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-010788-18-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-010788-18-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
N02BG10
JOSE MANUEL GARCIA DOMINGUEZ
2013 - EUCTR2011-000985-36-ES Spain;
N03AX12
HOSPICES CIVILS DE LYON
2015 Phase 2 EUCTR2014-005548-17-FR France;
N06DX01
HOSPICES CIVILS DE LYON
2015 Phase 2 EUCTR2014-005548-17-FR France;
NBI-5788
Neurocrine Biosciences
2003 Phase 2 NCT00079495 -
NBT-NM108 (60 g/day)
Suhayl Dhib-Jalbut, MD
2021 Phase 1/Phase 2 NCT04574024 United States;
NEUPOGEN
OSPEDALE S. RAFFAELE
2007 Phase 2 EUCTR2007-000586-38-IT Italy;
NEUROASPIS PLP10®
PALUPA Medical Ltd
2016 Phase 3 EUCTR2015-003147-19-GR Greece;
NEURONTIN
HOSPICES CIVILS DE LYON
2015 Phase 2 EUCTR2014-005548-17-FR France;
NIRS after bosentan administration
Universitair Ziekenhuis Brussel
2014 - NCT02389426 Belgium;
NIRS baseline
Universitair Ziekenhuis Brussel
2014 - NCT02389426 Belgium;
NO
Carol Davila University of Medicine and Pharmacy
2012 - NCT03001284 -
NOVANTRONE*INF 2MG/ML 5ML
OSPEDALE S. RAFFAELE
2004 - EUCTR2004-001601-10-IT France;Italy;
NOVATREX
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France;
NPB-01
Nihon Pharmaceutical Co., Ltd
2013 Phase 2 NCT01845584 Japan;
NT-KO-003
Neurotec Pharma
2011 Phase 2 NCT01428726 Germany;Spain;
NU100
NURON BIOTECH INC.
2012 - EUCTR2011-002683-24-IT Belarus;Bulgaria;Hungary;Italy;Russian Federation;Spain;
Nuron Biotech Inc.
2011 Phase 3 NCT01464905 Belarus;Bulgaria;Croatia;Georgia;Hungary;India;Italy;Lebanon;Poland;Russian Federation;Serbia;Spain;Ukraine;
Nuron Biotech, Inc.
2012 - EUCTR2011-002683-24-HU Belarus;Bulgaria;Croatia;Georgia;Hungary;Italy;Lebanon;Poland;Russian Federation;Spain;Ukraine;
2012 - EUCTR2011-002683-24-ES Belarus;Bulgaria;Croatia;Georgia;Hungary;Italy;Poland;Russian Federation;Spain;Ukraine;
2012 - EUCTR2011-002683-24-BG Belarus;Bulgaria;Croatia;Georgia;Hungary;Italy;Lebanon;Poland;Russian Federation;Spain;Ukraine;
NVF233
Novartis Farma S.p.A.
2012 - EUCTR2010-023023-19-DE Germany;Italy;
Na18F
AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA
2016 Phase 2 EUCTR2015-001202-34-IT Italy;
Nabilone
University of Manitoba
2007 Phase 4 NCT00480181 Canada;
Nabiximols
GW Pharmaceuticals Ltd.
2021 Phase 3 NCT04984278 -
2020 Phase 3 NCT04657666 Czechia;Poland;
2020 Phase 3 NCT04203498 Czechia;Poland;United States;
Nabiximols - Sativex
GW Pharma Limited
2022 Phase 3 EUCTR2020-004306-58-LT Bulgaria;Canada;Hungary;Italy;Lithuania;Spain;United Kingdom;United States;
2021 Phase 3 EUCTR2020-003271-18-ES Australia;Belgium;Czech Republic;Czechia;Poland;Spain;Sweden;United Kingdom;
2021 Phase 3 EUCTR2020-003271-18-CZ Australia;Belgium;Czech Republic;Czechia;Poland;Spain;Sweden;United Kingdom;
2021 Phase 3 EUCTR2019-002625-29-CZ Czech Republic;Czechia;Poland;United Kingdom;
2020 Phase 3 EUCTR2019-002625-29-PL Czech Republic;Czechia;Poland;United Kingdom;
Naltrexone
OSPEDALE S. RAFFAELE
2006 - EUCTR2005-005679-13-IT Italy;
University of California, San Francisco
2007 Phase 3 NCT00501696 United States;
Namisol
Echo Pharmaceuticals B.V.
2011 - EUCTR2010-022033-28-NL Netherlands;
Nanocort
Enceladus Pharmaceuticals BV
2010 - EUCTR2009-013884-21-PL Belgium;Germany;Poland;
2009 Phase 2 EUCTR2009-013884-21-BE Belgium;Germany;Poland;
2009 - EUCTR2009-013884-21-DE Belgium;Germany;Poland;
Nanocurcumin
Tabriz University of Medical Sciences
2016 Phase 2 NCT03150966 Iran, Islamic Republic of;
Naproxen
Biogen
2013 Phase 3 NCT01939002 United States;
Natalizumab
Amir Hadi Maghzi
2022 Phase 3 JPRN-jRCT2051210146 Japan;
Amsterdam University Medical Center
2019 Phase 4 EUCTR2019-002566-13-NL Netherlands;
BIOGEN IDEC LTD
2010 - EUCTR2009-015556-15-IT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2006 - EUCTR2005-004061-41-IT Australia;Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;New Zealand;Spain;Sweden;Switzerland;Turkey;United Kingdom;
Biogen
2022 Phase 3 NCT05265728 -
2019 - NCT05236777 Czechia;
2018 Phase 3 NCT03689972 Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Spain;United Kingdom;United States;
2015 - NCT02677077 Belgium;Czech Republic;Czechia;
2015 - NCT02386566 Switzerland;
2014 Phase 4 NCT02342704 Australia;Czech Republic;Czechia;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2014 Phase 4 NCT02241785 Germany;United States;
2014 Phase 2 NCT02142192 Belgium;Denmark;Germany;Italy;
2014 - NCT02159573 United States;
2014 - NCT02137109 -
2013 Phase 1 NCT01884935 Italy;
2013 - NCT04832399 Portugal;
2012 - NCT01485003 United States;
2011 Phase 3 NCT01416181 Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 - NCT01943526 Ireland;
2010 Phase 2 NCT01416155 China;Japan;
2010 Phase 2 NCT01071083 Germany;Spain;United States;
2010 - NCT01070836 Puerto Rico;United States;
2009 - NCT00884481 Austria;Denmark;Norway;Sweden;United States;
2007 - NCT00493298 Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Italy;Mexico;Netherlands;Norway;Portugal;Slovakia;Spain;Switzerland;United Kingdom;
2006 Phase 3 NCT00297232 Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2001 Phase 3 NCT00027300 Belgium;Canada;Czech Republic;France;Germany;Netherlands;United Kingdom;United States;
Biogen Idec
2008 Phase 4 NCT00744679 United States;
2007 Phase 1 NCT00559702 United States;
2003 Phase 3 NCT00276172 United States;
2003 Phase 2 NCT00097760 -
2002 Phase 3 NCT00030966 Austria;Belgium;France;Germany;Israel;Italy;United States;
Biogen Idec GmbH
2005 - EUCTR2004-004130-14-AT Austria;
Biogen Idec International GmbH
2010 Phase 4 EUCTR2009-009503-19-BE Belgium;
Biogen Idec Ltd.
2004 - EUCTR2004-000047-18-SE Sweden;
Claudio Gobbi
2010 Phase 4 NCT01144052 Switzerland;
Multiple Sclerosis Center of Northeastern New York
2021 - NCT04964700 United States;
Nantes University Hospital
2021 - NCT04777539 France;
Northwestern University
2013 Phase 2 EUCTR2012-004165-41-GB United Kingdom;United States;
Rennes University Hospital
2010 - NCT01065727 France;
Rigshospitalet, Denmark
2010 Phase 2 NCT01077466 Denmark;
State University of New York at Buffalo
2015 Phase 4 NCT03046251 United States;
University Hospital Muenster
2014 Phase 4 NCT02325440 Germany;
University Hospital, Toulouse
2009 Phase 4 NCT00942214 France;
University at Buffalo
2012 Phase 4 NCT02775110 United States;
VU University Medical Center
2016 Phase 4 NCT03516526 Netherlands;
Natalizumab (BG00002)
Biogen
2010 Phase 2/Phase 3 NCT01440101 China;Japan;
Natalizumab (NTZ)
University Hospital, Clermont-Ferrand
2016 Phase 4 NCT02769689 France;
Natalizumab (Tysabri)
Cornerstone Health Care, PA
2012 Phase 4 NCT01591551 United States;
Natalizumab 300 MG in 15 ML Injection
Vanderbilt University Medical Center
2022 Phase 4 NCT05177718 United States;
Natalizumab IV
Biogen
2011 Phase 2 NCT01405820 Belgium;France;Germany;Italy;Spain;
Natalizumab Injection [Tysabri]
University Hospital, Caen
2020 - NCT04580381 France;
Natalizumab SC
Biogen
2011 Phase 2 NCT01405820 Belgium;France;Germany;Italy;Spain;
Natalizumab for IV Infusion
Biogen Idec Limited
2011 - EUCTR2010-024000-10-ES Belgium;Germany;Italy;Spain;
2011 - EUCTR2010-024000-10-DE Belgium;Germany;Italy;Spain;
2011 - EUCTR2010-024000-10-BE Belgium;Germany;Italy;Spain;
Natalizumab for Subcutaneous Injection
Biogen Idec Limited
2011 - EUCTR2010-024000-10-ES Belgium;Germany;Italy;Spain;
2011 - EUCTR2010-024000-10-DE Belgium;Germany;Italy;Spain;
2011 - EUCTR2010-024000-10-BE Belgium;Germany;Italy;Spain;
Biogen Idec Research Limited
2014 Phase 2 EUCTR2014-000917-30-DE Belgium;Denmark;Germany;Italy;
2014 - EUCTR2014-000917-30-IT Belgium;Denmark;Italy;
2014 - EUCTR2014-000917-30-DK Belgium;Denmark;Italy;
2014 - EUCTR2014-000917-30-BE Belgium;Denmark;Italy;
Natalizumab treatment
Biogen Idec
2007 Phase 0 NCT00424788 United States;
Nebido® Testosterone Undecanoate 1000 Mg/4 mL Solution for Injection
University Hospital, Strasbourg, France
2019 Phase 2 NCT03910738 France;
NeoRecormon
Danish Multiple Sclerosis Research Centre
2009 Phase 2 EUCTR2009-011516-37-DK Denmark;
Neorecormon
Walton Centre for Neurology and Neurosurgery
2008 - EUCTR2008-005125-11-GB United Kingdom;
Neramexane mesylate
Merz Pharmaceuticals GmbH
2009 Phase 2 NCT00799942 United Kingdom;
Nerispirdine (HP184)
Sanofi
2008 Phase 2 NCT00811902 Canada;Finland;France;Germany;Norway;Spain;United States;
2008 Phase 2 NCT00772525 United States;
Nerispirdine hydrochloride
sanofi-aventis Recherche & Développement
2009 Phase 2 EUCTR2008-001999-67-FR Finland;France;Germany;Spain;
2009 Phase 2 EUCTR2008-001999-67-ES Finland;France;Germany;Spain;
2009 - EUCTR2008-001999-67-FI Finland;France;Germany;Spain;
2009 - EUCTR2008-001999-67-DE Finland;France;Germany;Spain;
Neupogen
Uppsala l?ns landsting
2011 - EUCTR2010-023560-40-SE Brazil;Canada;Sweden;United States;
NeuroVax
Immune Response BioPharma, Inc.
2020 Phase 2/Phase 3 NCT02057159 United States;
2020 Phase 2 NCT02149706 United States;
2020 Phase 1 NCT02200718 United States;
NeuroVax 300ug/mL Dose for IM Injection
The Immune Response Corporation
2007 Phase 2 EUCTR2006-003384-30-SK Slovakia;
Neuromuscular electrical stimulation delivered using the electrical therapy device EMPI 300 PV
University of Iowa
2010 Phase 1 NCT01381354 United States;
Neurontin 300 mg hard capsule
Charité University Medicine Berlin
2010 Phase 4 EUCTR2008-005167-33-DE Germany;
New Formulation of rebif - human interferon beta-1a
EMD Serono
2006 Phase 3 NCT00428584 United States;
Niacinamide
University of Iowa
2010 Phase 1 NCT01381354 United States;
Nicotine dependence
University of Jordan
2021 - NCT05046535 -
Nintendo Wii Fit Balance Board
University Hospital of Ferrara
2014 - NCT02287948 Italy;
Nitrofurantoin
University College London
2010 Phase 4 EUCTR2009-017939-18-GB United Kingdom;
Nivolumab
Alliance Foundation Trials, LLC.
2019 Phase 1 NCT03656627 United States;
National Cancer Institute (NCI)
2019 Phase 1 NCT03816345 Canada;United States;
Nomegestrol
OSPEDALI CIVILI DI LIONE
2007 - EUCTR2006-005460-30-IT Italy;
Nomegestrol acetate
Hospices Civils de Lyon
2005 Phase 3 NCT00127075 France;
Non applicabile
MERCK HEALTHCARE KGaA
2020 Phase 3 EUCTR2019-004980-36-IT Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004972-20-IT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
Non-pegylated interferon
Biogen
2015 Phase 2 NCT02097849 United States;
Norethindrone
University of California, Los Angeles
2011 Phase 2 NCT01466114 United States;
Normal Saline for Injection
University of Manitoba
2013 Phase 2 NCT01911377 Canada;
Normal saline
Mazandaran University of Medical Sciences
2021 Phase 2 NCT04979650 Iran, Islamic Republic of;
Novartis Pharmaceuticals Corporation
Universitätsklinikum Hamburg-Eppendorf
2013 - NCT03216915 Germany;
NurOwn (MSC-NTF cells)
Brainstorm-Cell Therapeutics
2019 Phase 2 NCT03799718 United States;
OCH-NCNP1
National Center of Neurology and Psychiatry, Japan
2019 Phase 2 NCT04211740 Japan;
OCR
Hoffmann-La Roche
2015 Phase 3 NCT02545868 Canada;United States;
OMB 157
NOVARTIS PHARMA SERVICES AG
2017 Phase 3 EUCTR2015-005419-33-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
OMB157
NOVARTIS PHARMA AG
2018 Phase 2 EUCTR2017-004702-17-IT Austria;Bulgaria;Czech Republic;Czechia;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
NOVARTIS PHARMA SERVICES AG
2021 Phase 3 EUCTR2020-002700-39-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2015-005418-31-IT Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
Novartis Farmacéutica S.A.
2021 Phase 3 EUCTR2020-002700-39-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001341-40-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Spain;Switzerland;Turkey;United Kingdom;United States;
Novartis Farmacéutica, S.A
2019 Phase 3 EUCTR2017-004703-51-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
Novartis Farmacéutica, S.A.
2018 Phase 2 EUCTR2017-004702-17-ES Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
2016 Phase 3 EUCTR2015-005419-33-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-ES Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
Novartis Pharma Services AG
2016 Phase 3 EUCTR2015-005419-33-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
Novartis Pharma AG
2021 Phase 3 EUCTR2020-004505-32-FR France;Germany;
2021 Phase 3 EUCTR2020-004505-32-DE France;Germany;Italy;Spain;
2021 Phase 3 EUCTR2020-002700-39-SK Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-PT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-LV Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-LT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-HR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-001341-40-SI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States;
2021 Phase 3 EUCTR2019-001341-40-PL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States;
2021 Phase 3 EUCTR2019-001341-40-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001341-40-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Spain;Switzerland;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001341-40-IT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Spain;Switzerland;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001341-40-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001341-40-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001341-40-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001341-40-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Spain;Switzerland;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001341-40-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001341-40-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001341-40-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-HR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-FR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-FI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-DK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 2 EUCTR2017-004702-17-PL Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
2018 Phase 3 EUCTR2017-004703-51-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2018 Phase 3 EUCTR2017-004703-51-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2018 Phase 3 EUCTR2017-004703-51-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2018 Phase 3 EUCTR2017-004703-51-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2018 Phase 2 EUCTR2017-004702-17-LV Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
2018 Phase 2 EUCTR2017-004702-17-LT Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
2018 Phase 2 EUCTR2017-004702-17-EE Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
2018 Phase 2 EUCTR2017-004702-17-CZ Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
2018 Phase 2 EUCTR2017-004702-17-BG Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
2018 Phase 2 EUCTR2017-004702-17-AT Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
2017 Phase 3 EUCTR2015-005418-31-FR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;European Union;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-FR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;European Union;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-HU Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-GR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-BE Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
- Phase 3 EUCTR2020-002700-39-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2020-002700-39-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Novartis Pharma Services AG
2017 Phase 3 EUCTR2015-005419-33-HR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2015-005419-33-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2015-005418-31-NL Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2015-005418-31-CZ Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-FI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-SK Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-SE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-PL Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-HR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-GB Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-EE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-DK Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-BG Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
OMB157G
Novartis Pharma Services AG
2017 Phase 3 EUCTR2015-005419-33-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-DE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
Novartis Pharma Vertriebs GmbH
2021 Phase 4 EUCTR2021-000307-20-DE Germany;
ONO-4641
EMD Serono
2010 Phase 2 NCT01226745 Belgium;Canada;Czech Republic;Germany;Greece;Japan;Poland;Russian Federation;Spain;Ukraine;United States;
ONO Pharmaceutical Co., Ltd.
2011 - EUCTR2010-018705-11-GR Belgium;Canada;Czech Republic;Germany;Greece;Japan;Russian Federation;Spain;Ukraine;United States;
2010 Phase 2 EUCTR2009-014339-19-ES Czech Republic;Germany;Greece;Spain;
2010 - EUCTR2010-018705-11-ES Belgium;Czech Republic;Germany;Greece;Spain;
2010 - EUCTR2009-014339-19-GR Czech Republic;Germany;Greece;Spain;
2010 - EUCTR2009-014339-19-DE Canada;Czech Republic;Germany;Greece;Japan;Russian Federation;Spain;Ukraine;United States;
2010 - EUCTR2009-014339-19-CZ Czech Republic;Germany;Greece;Spain;
Ono Pharma USA Inc
2010 Phase 2 NCT01081782 Belgium;Canada;Czech Republic;Germany;Greece;Japan;Poland;Russian Federation;Spain;Ukraine;United States;
ONO-4641/ MSC2430913A
Merck KGaA
- - EUCTR2010-018705-11-DE Belgium;Canada;Czech Republic;Germany;Greece;Japan;Russian Federation;Spain;Ukraine;United States;
ONO-4641/MSC2430913A
Merck KGaA
2010 - EUCTR2010-018705-11-CZ Belgium;Canada;Czech Republic;Germany;Greece;Japan;Russian Federation;Spain;Ukraine;United States;
Merck Serono S.A. - Geneva
2010 - EUCTR2010-018705-11-BE Belgium;Canada;Czech Republic;Germany;Greece;Japan;Russian Federation;Spain;Ukraine;United States;
ORY2001
Oryzon Genomics S. A
2017 Phase 2 EUCTR2017-002838-23-ES Spain;
OS440
Osmotica Pharmaceutical US LLC
2018 Phase 3 EUCTR2017-004101-40-PL Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2018 Phase 3 EUCTR2017-004101-40-HR Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2018 Phase 3 EUCTR2017-004101-40-BG Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2018 Phase 3 EUCTR2017-004100-22-PL Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2018 Phase 3 EUCTR2017-004100-22-HR Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2018 Phase 3 EUCTR2017-004100-22-BG Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
Oclelizumab
Hoffman La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-BG Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
Ocrelizumab
ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
2018 Phase 3 EUCTR2017-004158-40-FR France;
Assistance Publique - Hôpitaux de Paris
2018 Phase 3 NCT03691077 France;
Brigham and Women's Hospital
2021 - NCT05131984 United States;
Claudio Gobbi
2020 - NCT04640818 Switzerland;
Dr Recai Turkoglu
2021 - NCT04874597 Turkey;
F. HOFFMANN - LA ROCHE LTD.
2021 Phase 3 EUCTR2020-005448-48-IT Brazil;Czechia;France;Italy;Spain;
2021 Phase 3 EUCTR2020-004128-41-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000893-69-IT Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-001511-73-IT Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2016-002667-34-IT Italy;Poland;United States;
F. Hoffman-La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-DE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
F. Hoffmann - La Roche
2010 - EUCTR2010-020338-25-IT Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;Greece;Hungary;Italy;Lithuania;Portugal;Spain;United Kingdom;
F.Hoffmann-La Roche
2012 Phase 3 EUCTR2010-020315-36-CZ Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020338-25-BG Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-SK Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-SE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-IE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-GB Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-FR Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-DE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-BG Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-BE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-020338-25-DK Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Portugal;Spain;United Kingdom;
2011 - EUCTR2010-020337-99-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-020315-36-ES Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Colombia;Croatia;Ireland;Italy;Mexico;Peru;Russian Federation;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020337-99-FI Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;United Kingdom;United States;
2010 - EUCTR2010-020338-25-HU Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2010 - EUCTR2010-020338-25-ES Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;Greece;Hungary;Italy;Lithuania;Portugal;Spain;United Kingdom;
2010 - EUCTR2010-020337-99-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
F.Hoffmann-La Roche Ltd.
2008 - EUCTR2007-006338-32-IT Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Russian Federation;Spain;Switzerland;Ukraine;United Kingdom;United States;
Genentech, Inc.
2020 Phase 4 NCT04377555 Kenya;Puerto Rico;United States;
2016 Phase 3 NCT02688985 Canada;Germany;Sweden;United States;
2016 Phase 3 NCT02637856 Canada;United States;
2016 - NCT02807285 United States;
2008 Phase 2 NCT00676715 Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
Georgia State University
2021 Phase 4 NCT04387734 United States;
Haukeland University Hospital
2020 Phase 3 NCT04578639 Norway;
Helse Bergen HF, Haukeland University Hospital
2022 Phase 3 EUCTR2020-001205-23-SE Sweden;
2018 Phase 3 EUCTR2017-001362-25-DK Denmark;Netherlands;
Hoffman La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-GB Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 Phase 2 EUCTR2007-006338-32-FR Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Slovakia;Spain;United Kingdom;
2008 Phase 2 EUCTR2007-006338-32-ES Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Slovakia;Spain;United Kingdom;
2008 Phase 2 EUCTR2007-006338-32-DK Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 Phase 2 EUCTR2007-006338-32-CZ Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 Phase 2 EUCTR2007-006338-32-BG Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 Phase 2 EUCTR2007-006338-32-BE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-006338-32-NL Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Spain;United Kingdom;
2008 - EUCTR2007-006338-32-FI Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Spain;United Kingdom;
Hoffmann-La Roche
2022 Phase 4 NCT05208840 Russian Federation;
2022 Phase 4 NCT04998812 Canada;France;Germany;Italy;Spain;Switzerland;United Kingdom;United States;
2022 Phase 3 NCT05269004 -
2022 Phase 3 NCT05123703 Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 4 NCT04998851 Australia;Canada;France;Germany;Italy;Spain;Switzerland;United Kingdom;United States;
2020 Phase 3 NCT04548999 Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Peru;Poland;Portugal;Puerto Rico;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 NCT04544449 Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Puerto Rico;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 NCT04544436 Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 2 NCT04075266 Italy;Poland;United States;
2019 Phase 3 NCT04035005 Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 1 NCT03972306 Canada;United States;
2018 Phase 4 NCT03589105 France;
2018 Phase 3 NCT03599245 Argentina;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Kuwait;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2018 Phase 3 NCT03523858 Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Saudi Arabia;Spain;United Arab Emirates;United States;
2018 - NCT03593590 Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Dominican Republic;Egypt;Israel;Italy;Kuwait;Montenegro;Netherlands;Panama;Paraguay;Poland;Portugal;Qatar;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Turkey;United Arab Emirates;United Kingdom;
2017 Phase 3 NCT03085810 Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2016 Phase 3 NCT02861014 Australia;Belgium;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Hong Kong;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2011 Phase 3 NCT01412333 Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;France;Germany;Ireland;Italy;Mexico;Morocco;Norway;Poland;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 NCT01247324 Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Czechia;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 NCT01194570 Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;Uruguay;
Hospital Italiano de Buenos Aires
2019 - NCT03784547 Argentina;
Johns Hopkins University
2020 Phase 4 NCT04261790 United States;
2019 Phase 4 NCT03853746 United States;
2019 - NCT03873389 United States;
NYU Langone Health
2020 - NCT04855617 United States;
National Institute of Allergy and Infectious Diseases (NIAID)
2022 Phase 4 NCT05285891 -
Novartis Pharmaceuticals
2022 - NCT05266469 -
2021 - NCT04676555 Australia;United Kingdom;United States;
Rigshospitalet, Denmark
2021 Phase 3 NCT04688788 Denmark;
Sheffield Teaching Hospitals
2020 Phase 3 EUCTR2019-001549-42-GB United Kingdom;
University at Buffalo
2017 - NCT03025269 United States;
University of California, San Francisco
2020 Phase 4 NCT04466150 United States;
2020 - NCT04387110 United States;
University of Chicago
2017 - NCT03344094 United States;
University of Colorado, Denver
2017 Phase 3 NCT02980042 United States;
University of Michigan
2020 - NCT04459988 United States;
University of South Florida
2018 - NCT03562975 United States;
Universitätsklinikum Hamburg-Eppendorf
2021 Phase 2 NCT04971005 Germany;
VU medical center
2022 Phase 4 EUCTR2021-004791-34-NL Netherlands;
Wayne State University
2020 - NCT04458688 -
Yale University
2022 Phase 4 NCT04877457 United States;
Ocrelizumab (CinnaGen, Iran)
Cinnagen
2019 Phase 3 NCT04966338 Iran, Islamic Republic of;
Ocrelizumab (Roche, Switzerland)
Cinnagen
2019 Phase 3 NCT04966338 Iran, Islamic Republic of;
Ocrelizumab 300mg /10ml
F.Hoffmann-La Roche
2012 Phase 3 EUCTR2010-020337-99-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
Ocrelizumab 300mg/10 ml
F.Hoffmann-La Roche
2011 Phase 3 EUCTR2010-020338-25-DE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
Ocrelizumab 300mg/10ml
F.Hoffmann-La Roche
2013 Phase 3 EUCTR2010-020338-25-NL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020338-25-PT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020338-25-PL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020338-25-GR Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020338-25-CZ Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020338-25-BE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020338-25-AT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-SK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-LT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-CZ Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020338-25-LT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020338-25-GB Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020338-25-FI Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020337-99-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020337-99-EE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
GENENTECH Inc.
2016 Phase 3 EUCTR2015-004616-37-SE Germany;Sweden;Switzerland;United States;
2016 Phase 3 EUCTR2015-004616-37-DE Germany;Sweden;Switzerland;United States;
Ocrelizumab Dose 1
Genentech, Inc.
2018 Phase 3 NCT03606460 United States;
Ocrelizumab Dose 2 and Dose 3
Genentech, Inc.
2018 Phase 3 NCT03606460 United States;
Ocrelizumab IV
Hoffmann-La Roche
2022 Phase 3 NCT05232825 Brazil;Canada;Czechia;Italy;Poland;Russian Federation;Spain;Turkey;Ukraine;United States;
Ocrelizumab SC
Hoffmann-La Roche
2022 Phase 3 NCT05232825 Brazil;Canada;Czechia;Italy;Poland;Russian Federation;Spain;Turkey;Ukraine;United States;
Ocrelizumab at home
University of Colorado, Denver
2021 Phase 4 NCT04650321 United States;
Ocrevus
ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
2018 Phase 3 EUCTR2017-004158-40-FR France;
Danish Multiple Sclerosis Center, Rigshospitalet
2020 Phase 3 EUCTR2020-002981-15-DK Denmark;
F. HOFFMANN - LA ROCHE LTD.
2021 Phase 3 EUCTR2020-005448-48-IT Brazil;Czechia;France;Italy;Spain;
2021 Phase 3 EUCTR2020-004128-41-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000894-26-IT Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000893-69-IT Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-001511-73-IT Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2016-002667-34-IT Italy;Poland;United States;
F. Hoffman-La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-DE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
F. Hoffmann-La Roche Ltd
2022 Phase 3 EUCTR2020-005448-48-CZ Australia;Brazil;Canada;Czech Republic;Czechia;France;Italy;New Zealand;Poland;Russian Federation;Spain;Turkey;Ukraine;United States;
2022 Phase 3 EUCTR2020-004128-41-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 4 EUCTR2021-000063-79-ES Australia;Canada;France;Germany;Italy;Spain;Switzerland;United Kingdom;United States;
2021 Phase 4 EUCTR2021-000062-14-ES Australia;Canada;France;Germany;Italy;Spain;Switzerland;United Kingdom;United States;
2021 Phase 3 EUCTR2020-005448-48-PL Australia;Brazil;Canada;Czechia;France;Italy;New Zealand;Poland;Russian Federation;Spain;Turkey;Ukraine;United States;
2021 Phase 3 EUCTR2020-004128-41-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004128-41-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004128-41-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004128-41-GR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004128-41-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000894-26-GR Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000894-26-DK Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000894-26-BG Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000893-69-GR Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000893-69-DK Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-003919-53-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-003919-53-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-003919-53-GR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-003919-53-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-003919-53-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-003919-53-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-003919-53-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2017-004886-29-SK Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2021 Phase 3 EUCTR2017-004886-29-SI Argentina;Belgium;Brazil;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Mexico;Netherlands;Poland;Portugal;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2021 Phase 3 EUCTR2017-004886-29-PT Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2021 Phase 3 EUCTR2017-004886-29-PL Argentina;Belgium;Brazil;Bulgaria;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2021 Phase 3 EUCTR2017-004886-29-HU Argentina;Belgium;Brazil;Bulgaria;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2021 Phase 3 EUCTR2017-004886-29-HR Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2021 Phase 3 EUCTR2017-004886-29-BG Argentina;Belgium;Brazil;Bulgaria;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2021 Phase 3 EUCTR2017-004886-29-BE Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2020 Phase 3 EUCTR2020-000894-26-PT Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000894-26-HU Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000894-26-GB Argentina;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000894-26-FR Argentina;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000894-26-DE Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000893-69-PT Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000893-69-PL Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000893-69-NL Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000893-69-HU Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000893-69-GB Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000893-69-DE Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000893-69-BE Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-003919-53-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-001511-73-RO Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-001511-73-PT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-001511-73-IE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-001511-73-DE Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2017-001313-93-DE Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates;
2020 Phase 2 EUCTR2016-002667-34-PL Italy;Poland;United States;
2019 Phase 3 EUCTR2018-001511-73-PL Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-001511-73-HU Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-001511-73-HR Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-001511-73-GB Bulgaria;Croatia;Germany;Hungary;Ireland;Poland;Portugal;Spain;United Kingdom;
2019 Phase 3 EUCTR2018-001511-73-ES Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-001511-73-BG Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004886-29-IE Argentina;Belgium;Brazil;Bulgaria;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2018 Phase 3 EUCTR2017-004886-29-SE Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2018 Phase 3 EUCTR2017-004886-29-NL Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2018 Phase 3 EUCTR2017-004886-29-GB Czech Republic;Denmark;Estonia;Finland;France;Ireland;Netherlands;Spain;Sweden;United Kingdom;
2018 Phase 3 EUCTR2017-004886-29-FI Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Turkey;United Kingdom;
2018 Phase 3 EUCTR2017-004886-29-EE Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Turkey;United Kingdom;
2018 Phase 3 EUCTR2017-004886-29-DK Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2018 Phase 3 EUCTR2017-004886-29-CZ Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2018 Phase 3 EUCTR2017-001313-93-PL Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates;
2018 Phase 3 EUCTR2017-001313-93-IE Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates;
2018 Phase 3 EUCTR2017-001313-93-DK Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates;
2018 Phase 3 EUCTR2017-001313-93-CZ Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates;
2017 Phase 3 EUCTR2016-002937-31-SK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-SI Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-SE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-NO Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-HR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
- Phase 4 EUCTR2021-000063-79-DE Canada;France;Germany;Italy;Spain;Switzerland;United Kingdom;United States;
- Phase 3 EUCTR2020-004128-41-FR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2020-004128-41-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2020-004128-41-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
F.Hoffmann-La Roche
2013 Phase 3 EUCTR2010-020338-25-NL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2010-020315-36-CZ Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020338-25-PL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020338-25-GR Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020338-25-DE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020338-25-CZ Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020338-25-BE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020338-25-AT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-SK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-LT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-CZ Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-SK Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-SE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-IE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-GB Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-DE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-BG Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020338-25-LT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020338-25-GB Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020338-25-FI Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020337-99-EE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
GENENTECH Inc.
2016 Phase 3 EUCTR2015-004616-37-SE Germany;Sweden;Switzerland;United States;
2016 Phase 3 EUCTR2015-004616-37-DE Germany;Sweden;Switzerland;United States;
Helse Bergen HF, Haukeland University Hospital
2022 Phase 3 EUCTR2020-001205-23-SE Sweden;
2019 Phase 3 EUCTR2017-001362-25-NL Denmark;Netherlands;
2018 Phase 3 EUCTR2017-001362-25-DK Denmark;Netherlands;
Hoffman La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-SK Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 Phase 2 EUCTR2007-006338-32-GB Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 Phase 2 EUCTR2007-006338-32-DK Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 Phase 2 EUCTR2007-006338-32-CZ Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 Phase 2 EUCTR2007-006338-32-BG Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 Phase 2 EUCTR2007-006338-32-BE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
Kessler Foundation
2021 - NCT04448977 United States;
Robert Zivadinov, MD, PhD
2021 Phase 4 NCT04925557 United States;
Roche Farma S. A. U. que realiza el ensayo en España y que actúa como representante F. Hoffmann-La Roche Ltd
2021 Phase 3 EUCTR2020-005448-48-ES Brazil;Czechia;France;Italy;Spain;
University Medical Centre Hamburg-Eppendorf
2020 Phase 2 EUCTR2016-001166-29-DE Germany;
VU medical center
2022 Phase 4 EUCTR2021-004791-34-NL Netherlands;
Ocrevus 300 mg, solution à diluer pour perfusion
ROCHE
2018 Phase 4 EUCTR2018-000780-91-FR France;
Ocrrelizumab
F. Hoffman-La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-DE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
Octagam
Octapharma AG
2009 - EUCTR2008-004579-22-DE Austria;Germany;
2008 - EUCTR2008-004579-22-AT Austria;
Octagam 50 mg/ml
Octapharma AG
2015 Phase 3 EUCTR2012-005086-12-PL Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;Serbia;Ukraine;
2013 - EUCTR2012-005086-12-HU Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-DE Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-BG Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-AT Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
Ocufolin
University of Miami
2007 - NCT03135327 United States;
Ofatumumab
Brigham and Women's Hospital
2020 Phase 3 NCT04510220 United States;
Genmab A/S
2008 Phase 2 EUCTR2007-004223-38-DE Belgium;Czech Republic;Denmark;Germany;Sweden;United Kingdom;
2008 - EUCTR2007-004223-38-BE Belgium;Czech Republic;Denmark;Germany;Sweden;United Kingdom;
GlaxoSmithKline
2011 Phase 2 NCT01457924 Bulgaria;Canada;Czech Republic;Czechia;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States;
2008 - EUCTR2007-004223-38-DK Czech Republic;Denmark;Germany;Sweden;United Kingdom;
GlaxoSmithKline AB
2008 - EUCTR2007-004223-38-SE Czech Republic;Denmark;Germany;Sweden;United Kingdom;
GlaxoSmithKline UK
2009 Phase 2 EUCTR2007-004223-38-GB Belgium;Czech Republic;Denmark;Germany;Sweden;United Kingdom;
GlaxoSmithKline s.r.o.
2008 - EUCTR2007-004223-38-CZ Czech Republic;Denmark;Germany;Sweden;United Kingdom;
NOVARTIS PHARMA SERVICES AG
2021 Phase 3 EUCTR2020-002700-39-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2015-005419-33-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
2017 Phase 3 EUCTR2015-005418-31-IT Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
Novartis Pharma K.K.
2018 Phase 2 JPRN-JapicCTI-173711 Japan, Russia;
Novartis Pharmaceuticals
2022 Phase 4 NCT05090371 United States;
2022 Phase 4 NCT05084638 United States;
2022 - NCT05285904 -
2022 - NCT05266469 -
2022 - NCT05090033 -
2021 Phase 4 NCT04878211 United States;
2021 Phase 4 NCT04869358 Germany;
2021 Phase 4 NCT04667117 United States;
2021 Phase 3 NCT04926818 Australia;Austria;Belgium;France;Germany;India;Latvia;Mexico;Poland;Portugal;Russian Federation;Slovakia;Spain;Turkey;United States;
2021 Phase 3 NCT04788615 France;Germany;Spain;United Kingdom;
2021 - NCT04847596 Puerto Rico;United States;
2021 - NCT04676555 Australia;United Kingdom;United States;
2020 Phase 3 NCT04486716 Puerto Rico;United States;
2020 Phase 3 NCT04353492 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czechia;Estonia;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States;
2018 Phase 3 NCT03650114 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2018 Phase 2 NCT03249714 Japan;Russian Federation;
University of Southern California
2022 - NCT05171972 United States;
Ofatumumab 100
GlaxoSmithKline
2008 Phase 2 NCT00640328 Belgium;Czech Republic;Denmark;Former Serbia and Montenegro;Germany;Poland;Serbia;Sweden;United Kingdom;
Ofatumumab 300
GlaxoSmithKline
2008 Phase 2 NCT00640328 Belgium;Czech Republic;Denmark;Former Serbia and Montenegro;Germany;Poland;Serbia;Sweden;United Kingdom;
Ofatumumab 700
GlaxoSmithKline
2008 Phase 2 NCT00640328 Belgium;Czech Republic;Denmark;Former Serbia and Montenegro;Germany;Poland;Serbia;Sweden;United Kingdom;
Ofatumumab subcutaneous injection
Novartis Pharmaceuticals
2016 Phase 3 NCT02792231 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Finland;France;Germany;Hungary;India;Italy;Latvia;Lithuania;Mexico;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 NCT02792218 Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Mexico;Netherlands;Poland;Puerto Rico;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
Oleovit D3 14.400 IU/ml oral drops, solution
University medical centre Maribor
2017 Phase 4 EUCTR2017-004846-31-SI Slovenia;
Olesoxime (TRO19622)
Hoffmann-La Roche
2013 Phase 1 NCT01808885 France;
Olive oil
Terry L. Wahls
2022 - NCT05007483 United States;
Omega 3 fatty acids
University of Iowa
2010 Phase 1 NCT01381354 United States;
Omeprazole
Biogen
2011 Phase 3 NCT01462318 Czech Republic;Hungary;Poland;Russian Federation;United States;
OnabotulinumtoxinA
Allergan
2012 Phase 3 NCT01600716 Belgium;Canada;Czech Republic;Czechia;France;Poland;Portugal;Russian Federation;United States;
Opicinumab
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 2 EUCTR2017-001224-22-IT Australia;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
Biogen Idec Research Limited
2018 Phase 2 EUCTR2017-001224-22-PL Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
2018 Phase 2 EUCTR2017-001224-22-NL Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
2018 Phase 2 EUCTR2017-001224-22-DE Australia;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
2018 Phase 2 EUCTR2017-001224-22-BE Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
2017 Phase 2 EUCTR2017-001224-22-HU Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
2017 Phase 2 EUCTR2017-001224-22-GB Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
2017 Phase 2 EUCTR2017-001224-22-ES Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
2017 Phase 2 EUCTR2017-001224-22-CZ Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
Optical coherence tomography (OCT)
Medical University of Vienna
2018 - NCT03401879 Austria;
Optical coherence tomography angiography (OCTA)
Medical University of Vienna
2018 - NCT03401879 Austria;
Oral Methylprednisolone 625 mg/24h x3 days
Germans Trias i Pujol Hospital
2013 Phase 4 NCT01986998 Spain;
Oral THC
University of California, Davis
2004 Phase 1/Phase 2 NCT00682929 United States;
Oral corticosteroids
Hoffmann-La Roche
2021 Phase 3 NCT04660539 Bulgaria;Canada;Croatia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Puerto Rico;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Oral lipoic acid (LA)
Oregon Health and Science University
2005 Phase 1 NCT00676156 United States;
Orelabrutinib
Beijing InnoCare Pharma Tech Co., Ltd.
2021 Phase 2 NCT04711148 China;Poland;Ukraine;United States;
Peking Union Medical College Hospital
2022 - NCT05284175 China;
Other H1 antagonist
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
Other analgesics and antipyretics
GW PHARMA LTD
2008 - EUCTR2006-005910-11-IT Germany;Italy;Spain;United Kingdom;
Other disease-modifying therapy
Novartis Pharmaceuticals
2011 - NCT01442194 Argentina;Australia;Canada;Chile;Mexico;Puerto Rico;United States;
Other nervous system drugs
NOVARTIS FARMA
2011 - EUCTR2011-000770-60-IT Italy;
Ovastat 1000
medac Gesellschaft für klinische Spezialpräparate mbH
2007 - EUCTR2006-002856-14-DE Germany;
Ovastat 5000
medac Gesellschaft für klinische Spezialpräparate mbH
2007 - EUCTR2006-002856-14-DE Germany;
Oxcarbazepine
Queen Mary University London
2014 Phase 2 EUCTR2013-002419-87-GB United Kingdom;
Queen Mary University of London
2014 Phase 2 NCT02104661 United Kingdom;
Oxybutynin Hydrochloride
Astellas Pharma Inc
2008 Phase 4 NCT00629642 Australia;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Portugal;Russian Federation;Spain;United Kingdom;
Ozanimod
Celgene
2014 Phase 3 NCT02294058 Argentina;Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2013 Phase 3 NCT02047734 Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Celgene International II Sàrl (CIS II)
2015 Phase 3 EUCTR2015-002500-91-HU Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-002500-91-GB Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-002500-91-BE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-PL Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-LV Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-LT Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-HU Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-HR Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-GB Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-BG Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2014-002320-27-PT Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2014-002320-27-EE Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 Phase 2;Phase 3 EUCTR2012-002714-40-HU Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2013 Phase 2;Phase 3 EUCTR2012-002714-40-BG Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2013 Phase 2;Phase 3 EUCTR2012-002714-40-BE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
Receptos, Inc.
2015 Phase 3 EUCTR2014-002320-27-SE Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-NL Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-ES Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 - EUCTR2015-002500-91-ES Argentina;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
Ozanimod HCI
Celgene International II Sàrl (CIS II)
2016 Phase 3 EUCTR2015-002500-91-PT Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-002500-91-GR Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
Ozanimod HCL
CELGENE INTERNATIONAL II SàRL
2016 Phase 3 EUCTR2015-002500-91-IT Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
Ozanimod HCl
Celgene International II Sàrl (CIS II)
2017 Phase 3 EUCTR2015-002500-91-SE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-002500-91-SK Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-002500-91-PL Argentina;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-002500-91-LV Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-002500-91-LT Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-002500-91-HR Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-002500-91-EE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-002500-91-BG Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
Ozanimod hydrochloride
Celgene International II Sàrl
2016 Phase 1 EUCTR2016-003073-18-GB United Kingdom;
PAT
University of Ottawa
2020 - NCT04267185 Canada;
PB006
Polpharma Biologics S.A.
2019 Phase 3 EUCTR2018-004751-20-PL Belarus;Croatia;Georgia;Moldova, Republic of;Poland;Serbia;Ukraine;
2019 Phase 3 EUCTR2018-004751-20-HR Belarus;Croatia;Georgia;Moldova, Republic of;Poland;Serbia;Ukraine;
PEG-liposomal Prednisolone Sodium Phosphate
Enceladus Pharmaceuticals BV
2010 - EUCTR2009-013884-21-PL Belgium;Germany;Poland;
2009 Phase 2 EUCTR2009-013884-21-BE Belgium;Germany;Poland;
2009 - EUCTR2009-013884-21-DE Belgium;Germany;Poland;
PEG-liposomal prednisolone sodium phosphate
Galapagos NV
2009 Phase 2 NCT01039103 Belgium;Germany;Poland;
PEGINTERFERONE BETA-1A
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-003008-38-IT Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
PEGINTERFERONE LAMBDA-1A
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-003008-38-IT Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
PEGylated Intereron Beta-1a
Biogen Idec Limited
2012 Phase 3 EUCTR2010-024477-39-GR Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2010-024477-39-GB Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2012 - EUCTR2010-024477-39-CZ Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-024477-39-DE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-024477-39-BG Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-024477-39-LV Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-024477-39-EE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-024477-39-BE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
PEGylated Interferon Beta-1a
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-003008-38-IT Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
Biogen Idec LTD
2009 - EUCTR2008-006333-27-LV Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Latvia;Netherlands;Spain;United Kingdom;
Biogen Idec Limited
2012 Phase 3 EUCTR2010-024477-39-GR Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2010-024477-39-GB Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2012 - EUCTR2010-024477-39-CZ Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-024477-39-DE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-024477-39-BG Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-024477-39-LV Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-024477-39-EE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-024477-39-BE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2010 - EUCTR2008-006333-27-GR Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Latvia;Netherlands;Spain;United Kingdom;
2010 - EUCTR2008-006333-27-CZ Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2008-006333-27-GB Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2009 - EUCTR2008-006333-27-NL Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2009 - EUCTR2008-006333-27-EE Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2009 - EUCTR2008-006333-27-BG Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2009 - EUCTR2008-006333-27-BE Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
- - EUCTR2008-006333-27-DE Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
Biogen Idec Research Limited
2020 Phase 3 EUCTR2018-003008-38-DE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-SK Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-PT Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-HU Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-HR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-GR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-ES Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;
2019 Phase 3 EUCTR2018-003008-38-CZ Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;
2019 Phase 3 EUCTR2018-003008-38-BG Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-BE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-000516-22-PT Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-000516-22-HU Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-000516-22-EE Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States;
- Phase 3 EUCTR2018-003008-38-FR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
PET with 11C-Flumazenil
Assistance Publique - Hôpitaux de Paris
2013 - NCT01651520 France;
PET-MRI with [18F]-Florbetaben and PET-MRI with [18F]-DPA-714
Assistance Publique - Hôpitaux de Paris
2022 - NCT05147532 -
PF-06342674
Pfizer
2014 Phase 1 NCT02045732 United States;
PHENYLCYCLOPROPYLAMINE DERIVATIVES AND DUAL LSD1/MAO-B (LYSINE-SPECIFIC DEMETHYLASE 1 AND MONOAMINE OXIDASE-B) INHIBITOR
Oryzon Genomics S. A
2017 Phase 2 EUCTR2017-002838-23-ES Spain;
PI-2301
PEPTIMMUNE Inc
2008 - EUCTR2007-007759-15-HU Hungary;
Peptimmune Inc.
2010 Phase 2 EUCTR2009-012716-40-SK Bulgaria;Czech Republic;Estonia;France;Germany;Poland;Slovakia;
2010 Phase 2 EUCTR2009-012716-40-DE Bulgaria;Czech Republic;Estonia;France;Germany;Poland;Slovakia;
2010 - EUCTR2009-012716-40-PL Bulgaria;Czech Republic;Estonia;France;Germany;Poland;
2010 - EUCTR2009-012716-40-FR Bulgaria;Czech Republic;Estonia;France;Germany;Poland;
2010 - EUCTR2009-012716-40-CZ Bulgaria;Czech Republic;Estonia;France;Germany;Poland;
2010 - EUCTR2009-012716-40-BG Bulgaria;Czech Republic;Estonia;France;Germany;Poland;
2009 - EUCTR2009-012716-40-EE Bulgaria;Czech Republic;Estonia;France;Germany;Poland;
PIPE-307
Pipeline Therapeutics, Inc.
2021 Phase 1 NCT04941781 United Kingdom;
2021 Phase 1 NCT04725175 Australia;
PL 04515/0127
Queen Mary, University of London
2009 - EUCTR2008-000256-26-GB United Kingdom;
PL 12762/0049
University College London
2010 Phase 4 EUCTR2009-017939-18-GB United Kingdom;
PLEDIGRY
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France;
PLEGRIDY - 125 MCG - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - PENNA PRERIEMPITA - 0,5 ML - 6 PENNE PRERIEMPITE
BIOGEN IDEC ITALIA S.R.L.
2015 Phase 4 EUCTR2015-002201-11-IT Italy;
PLP peptide
Centrum Neurologii Krzysztof Selmaj
2016 Phase 2 EUCTR2016-002180-33-PL Poland;
PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED)
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 2;Phase 3 EUCTR2019-001829-26-IT Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States;
PNU-215062 sodium salt
Teva Pharmaceutical Industries Ltd
2006 Phase 2 EUCTR2005-004334-41-ES Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
2005 Phase 2 EUCTR2004-003943-28-GB Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
2005 Phase 2 EUCTR2004-003943-28-ES Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
2005 - EUCTR2004-003943-28-HU Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
2005 - EUCTR2004-003943-28-DE Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
2005 - EUCTR2004-003943-28-CZ Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
PO
Actelion Pharmaceuticals Ltd.
2018 Phase 3 EUCTR2016-004719-10-PT Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004719-10-GR Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004719-10-GB Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004719-10-FI Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004719-10-CZ Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004719-10-BG Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-004719-10-SE Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-004719-10-PL Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-004719-10-LT Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
PRD806998
Biogen Idec Research Limited
2013 Phase 2 EUCTR2011-006262-40-NL Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
PRN2246
GENZYME CORPORATION
2020 Phase 3 EUCTR2020-000647-30-IT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000645-14-IT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000637-41-IT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
Genzyme Corporation
2021 Phase 3 EUCTR2020-000647-30-PT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000645-14-PT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000645-14-NL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000645-14-HU Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000645-14-HR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000645-14-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000645-14-BE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000644-55-DE Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000637-41-AT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000647-30-PL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000647-30-NL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000647-30-LT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000647-30-GR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000647-30-GB Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000647-30-FI Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000647-30-DK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000647-30-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000647-30-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000647-30-BG Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000645-14-GR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000645-14-GB Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000645-14-FR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000645-14-EE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000645-14-DK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000645-14-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000645-14-BG Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-SK Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-PT Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-NL Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-LV Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-HU Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-GR Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-GB Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-FR Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-CZ Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000637-41-SE Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-PL Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-LT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-FI Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-DK Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-DE Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-CZ Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-BG Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2019 Phase 2 EUCTR2018-004731-76-SK Canada;Czech Republic;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States;
2019 Phase 2 EUCTR2018-004731-76-NL Canada;Czech Republic;Czechia;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States;
2019 Phase 2 EUCTR2018-004731-76-ES Canada;Czech Republic;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States;
2019 Phase 2 EUCTR2018-004731-76-EE Canada;Czech Republic;Czechia;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States;
2019 Phase 2 EUCTR2018-004731-76-CZ Canada;Czech Republic;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States;
2019 Phase 2 EUCTR2018-003927-12-SK Canada;Czech Republic;Estonia;France;Netherlands;Norway;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States;
2019 Phase 2 EUCTR2018-003927-12-SE Canada;Czech Republic;Estonia;France;Netherlands;Norway;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States;
2019 Phase 2 EUCTR2018-003927-12-NL Canada;Czech Republic;Estonia;France;Netherlands;Norway;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States;
2019 Phase 2 EUCTR2018-003927-12-ES Canada;Czech Republic;Estonia;France;Netherlands;Norway;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States;
2019 Phase 2 EUCTR2018-003927-12-EE Canada;Czech Republic;Estonia;France;Netherlands;Norway;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States;
PTL201
PhytoTech Therapeutics, Ltd.
2018 Phase 2 NCT03005119 Israel;
Paired associative stimulation (PAS)
Shirley Ryan AbilityLab
2017 - NCT03723434 United States;
Palifermin
Cambridge University Hospitals NHS Foundation Trust
2012 Phase 1/Phase 2 NCT01712945 United Kingdom;
Cambridge University Hospitals NHS Foundation Trust and University of Cambridge
2012 Phase 2 EUCTR2011-005606-30-GB United Kingdom;
Pantoprazole
Merck KGaA
2008 Phase 1 NCT00938366 -
Paracetamol
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
2015 Phase 1 NCT02583594 Spain;
2014 Phase 4 NCT02205489 Belgium;France;Netherlands;Spain;
Rigshospitalet, Denmark
2021 Phase 3 NCT04688788 Denmark;
Paracetamolo
NOVARTIS PHARMA AG
2018 Phase 2 EUCTR2017-004702-17-IT Austria;Bulgaria;Czech Republic;Czechia;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
Paroxetine
University of Manitoba
2006 Phase 3 NCT00291148 Canada;
Part A: 100 mg/mL GSK2618960
GlaxoSmithKline
2013 Phase 1 NCT01808482 United Kingdom;
Part B: Dose of GSK2618960 decided from Part A
GlaxoSmithKline
2013 Phase 1 NCT01808482 United Kingdom;
Part C: Dose of GSK2618960 decided from Part A and B
GlaxoSmithKline
2013 Phase 1 NCT01808482 United Kingdom;
Peanut
Rocky Mountain MS Research Group, LLC
2014 Phase 4 NCT02217982 United States;
Peginterferon beta-1a
Biogen
2017 Phase 4 NCT03177083 Portugal;
2016 Phase 4 NCT02587065 Italy;
2016 Phase 4 NCT02568111 -
2014 - NCT02230969 Australia;Austria;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;Switzerland;United Kingdom;United States;
2013 - NCT01911767 Australia;Canada;France;Germany;Ireland;Italy;Poland;Spain;United Kingdom;United States;
2011 Phase 3 NCT01332019 Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Biogen Idec
2014 Phase 1 NCT02269930 United States;
Peginterferone beta 1a
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain;
Pegylated interferon beta-1a
Cinnagen
2017 Phase 3 NCT05242133 Iran, Islamic Republic of;
Pending
JOSE MANUEL GARCIA DOMINGUEZ
2013 - EUCTR2011-000985-36-ES Spain;
Peripheral Blood Stem Cell Transplantation
Fred Hutchinson Cancer Research Center
2008 Phase 2 NCT00716066 United States;
Peripheral blood stem cell transplantation
Fred Hutchinson Cancer Research Center
1997 Phase 1 NCT00014755 United States;
Personalized extended interval dosing of natalizumab
VU University Medical Center
2020 Phase 4 NCT04225312 Netherlands;
Phenytoin
University College, London
2011 Phase 2 NCT01451593 United Kingdom;
Pioglitazone
National Institute of Allergy and Infectious Diseases (NIAID)
2017 Phase 1/Phase 2 NCT03109288 United States;
Pirfenidone
National Institute of Allergy and Infectious Diseases (NIAID)
2017 Phase 1/Phase 2 NCT03109288 United States;
Pixantrone
Fondation Charcot Stichting
2009 Phase 1;Phase 2 EUCTR2007-003086-40-BE Belgium;France;
2008 - EUCTR2007-003086-40-FR France;
Placebo
Novartis Pharma K.K.
2018 Phase 2 JPRN-JapicCTI-173711 Japan, Russia;
2014 Phase 3 JPRN-JapicCTI-142447 -
2013 Phase 2 JPRN-JapicCTI-132178 -
Plasma exchange
Biogen Idec
2007 Phase 0 NCT00424788 United States;
Platelet transfusion
Region Skane
2016 - NCT02601131 Sweden;
Platform
Georgia State University
2021 Phase 4 NCT04387734 United States;
Plegridy
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-003008-38-IT Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
Biogen Idec Research Limited
2020 Phase 3 EUCTR2018-003008-38-DE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-SK Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-PT Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-HU Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-HR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-GR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-ES Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;
2019 Phase 3 EUCTR2018-003008-38-CZ Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;
2019 Phase 3 EUCTR2018-003008-38-BG Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-BE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-000516-22-PT Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-000516-22-HU Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-000516-22-EE Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States;
- Phase 3 EUCTR2018-003008-38-FR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
Holy Name Medical Center, Inc.
2017 Phase 4 NCT03424733 United States;
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain;
Plegridy (peginterferon beta-1a), Biogen Idec Ltd
Bayer
2016 - NCT02749396 Finland;
Plegridy 125 micrograms
Biogen Portugal
2016 Phase 4 EUCTR2016-000434-21-PT Portugal;
Plegridy 63 micrograms
Biogen Portugal
2016 Phase 4 EUCTR2016-000434-21-PT Portugal;
Pleneva TM BGC20-0134
BTG International Inc.
2009 Phase 2 NCT01037907 Belgium;France;Germany;Italy;Poland;Russian Federation;Spain;
Plovamer acetate
Merck KGaA
2014 Phase 2 EUCTR2013-002283-25-GB Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2014 - EUCTR2013-002283-25-PL Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2014 - EUCTR2013-002283-25-GR Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2014 - EUCTR2013-002283-25-ES Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2014 - EUCTR2013-002283-25-BG Bulgaria;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States;
2013 - EUCTR2013-002283-25-IT Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2013 - EUCTR2013-002283-25-HU Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2013 - EUCTR2013-002283-25-HR Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2013 - EUCTR2013-002283-25-FI Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2013 - EUCTR2013-002283-25-CZ Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
Plovamer acetate 0.5 milligram (mg)
EMD Serono
2013 Phase 2 NCT01963611 Bulgaria;Croatia;Czech Republic;Finland;Germany;Greece;Hungary;Italy;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States;
Pneumococcal polysaccharide vaccine
Celgene
2021 Phase 3 NCT05028634 Germany;United States;
Pneumovax II
R & D, Cambridge University Hospitals
2009 - EUCTR2009-011523-31-GB United Kingdom;
Polyphenon E
Louisiana State University Health Sciences Center in New Orleans
2011 Phase 2 NCT01451723 United States;
2009 Phase 1 NCT00836719 United States;
Ponesimod
ACTELION Pharmaceuticals Ltd
2010 Phase 2 EUCTR2009-011470-15-HU Australia;Austria;Bulgaria;Canada;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
Actelion
2017 Phase 3 NCT03232073 Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 NCT02907177 Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Mexico;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;United Kingdom;United States;
2015 Phase 3 NCT02425644 Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2010 Phase 2 NCT01093326 Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
Pravastatin
Nantes University Hospital
2004 Phase 3 NCT00200655 France;
Prebiotics (Prebiotin Prebiotic Fiber Stick Pac)
Columbia University
2020 - NCT04038541 United States;
Prednisolone
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
Tohoku University Hospital
2013 Phase 1,2 JPRN-UMIN000010094 Japan;
Prednisone
Claudio Gobbi
2011 Phase 4 NCT01411514 Switzerland;
Fred Hutchinson Cancer Research Center
2008 Phase 2 NCT00716066 United States;
1997 Phase 1 NCT00014755 United States;
Holy Name Medical Center, Inc.
2017 Phase 4 NCT03424733 United States;
National Eye Institute (NEI)
1988 Phase 3 NCT00000146 United States;
1988 - NCT00000147 United States;
National Institute of Neurological Disorders and Stroke (NINDS)
2016 Phase 2 NCT02784210 United States;
Teva Pharmaceutical Industries
2005 Phase 4 NCT00203047 Canada;United States;
Third Affiliated Hospital, Sun Yat-Sen University
2016 Phase 4 NCT02809079 -
Pregabalin
Pfizer Japan Inc.
2010 Phase 3 JPRN-JapicCTI-101335 -
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
2010 Phase 3 NCT01202227 Japan;
University of Manitoba
2006 Phase 3 NCT00291148 Canada;
Prepulsid
Department of Neurology UMCG
2006 - EUCTR2006-004318-42-NL Netherlands;
Prevenar 13
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 2;Phase 3 EUCTR2019-001829-26-IT Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States;
Probiotics (Visbiome®)
Columbia University
2020 - NCT04038541 United States;
Prohance (Gadoteridol)
University of Nottingham
2017 - NCT02481882 United Kingdom;
Prolonged-release Fampridine
University of Zurich
2012 Phase 2 NCT01576354 Switzerland;
Prophylactic vaccine (tetanus, diphtheria, pertussis, poliomyelitis, influenza, hepatitis A, hepatitis B, tick-borne encephalitis, meningococcal, pneumococcal)
Dr. med. Micha Loebermann
2009 - NCT02275741 Germany;
Provigil
Sheba Medical Center
2005 - NCT00220506 Israel;
Provigil (modafinil)
Institute for Clinical Research
2003 - NCT00210301 United States;
Pure ECGC capsules
Louisiana State University Health Sciences Center in New Orleans
2015 Phase 2 NCT02011451 United States;
Quadrivalent influenza vaccine
Novartis Pharmaceuticals
2021 Phase 4 NCT04667117 United States;
Quality of life
University Hospital, Strasbourg, France
2019 Phase 2 NCT03910738 France;
Quinidina sulfato
Avanir Pharmaceuticals, Inc.
2011 Phase 2 EUCTR2011-002178-22-ES Argentina;Bulgaria;Czech Republic;Poland;Spain;United Kingdom;United States;
Quinidine Sulfate
Avanir Pharmaceuticals, Inc.
2012 Phase 2 EUCTR2011-002178-22-GB Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States;
2012 - EUCTR2011-002178-22-PL Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States;
2012 - EUCTR2011-002178-22-CZ Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States;
R lipoic acid
Oregon Health and Science University
2005 Phase 1 NCT00676156 United States;
RABBIT HUMAN T LYMPHOCYTE IMMUNOGLOBULIN
Uppsala l?ns landsting
2011 - EUCTR2010-023560-40-SE Brazil;Canada;Sweden;United States;
RAS
The Cleveland Clinic
2014 - NCT02065284 United States;
RATG
Northwestern University
2019 Phase 2/Phase 3 NCT03829566 United States;
2017 Phase 3 NCT03342638 United States;
RC18
RemeGen Co., Ltd.
2021 Phase 2 NCT04625153 China;
2018 Phase 3 NCT03330418 China;
REBIF - 44 MCG(12 MILIONI UI) -SOLUZ INIETTABILE- USO SOTTOCUTANEO-PENNA PRERIEMPITA 0.5 ML (24 MILIONI UI/ML)12 PENNE PRERIEMPITE
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy;
REBIF 44 microgramos solución inyectable
Merck Serono International, a branch of Laboratoires Serono SA an affiliate of Merck KGaA, Darmstadt
2009 Phase 3 EUCTR2008-004954-34-ES Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Slovakia;Spain;
Merck Serono S.A. - Geneva, an affiliate of Merck KGaA Darmstadt, Germany
2006 - EUCTR2006-002982-38-ES Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain;
sanofi-aventis recherche et development
2009 - EUCTR2008-006226-34-ES Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom;
REBIF 44 microgramos solución inyectable en jeringa precargada
Biogen Idec Limited
2010 - EUCTR2009-015556-15-ES Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
REBIF SC 12SIR 12000000UI44MCG
Universita di Firenze
2006 - EUCTR2006-004937-13-IT Italy;
REBIF SC 12SIR 6000000UI 22MCG
Universita di Firenze
2006 - EUCTR2006-004937-13-IT Italy;
REBIF*SC 12SIR 12000000UI44MCG
MERCK SERONO INTERNATIONAL SA
2008 - EUCTR2006-003366-33-IT Italy;Spain;
MERCK SERONO SA
2009 - EUCTR2008-004954-34-IT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Spain;
2009 - EUCTR2008-003706-33-IT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
OSPEDALE S. RAFFAELE
2004 - EUCTR2004-001601-10-IT France;Italy;
REBIF*SC 12SIR 6000000UI 22MCG
BIOGEN IDEC LTD
2010 - EUCTR2009-015556-15-IT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
RECOMBINANT INTERFERON BE
Novartis Pharma GmbH
2021 Phase 4 EUCTR2020-005752-38-DE Germany;
RECOMBINANT INTERFERON BETA-1B
Bayer AG
2018 Phase 4 EUCTR2017-001176-31-PT Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2017 Phase 4 EUCTR2017-001176-31-GB Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2017 Phase 4 EUCTR2017-001176-31-FR Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2017 Phase 4 EUCTR2017-001176-31-FI Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2017 Phase 4 EUCTR2017-001176-31-ES Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2017 Phase 4 EUCTR2017-001176-31-DK Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2017 Phase 4 EUCTR2017-001176-31-CZ Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2017 Phase 4 EUCTR2017-001176-31-AT Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 2;Phase 3 EUCTR2019-001829-26-IT Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States;
REVAXIS
R & D, Cambridge University Hospitals
2009 - EUCTR2009-011523-31-GB United Kingdom;
RG2077 (CTLA4-IgG4m)
National Institute of Allergy and Infectious Diseases (NIAID)
2003 Phase 1 NCT00076934 United States;
RHB-104
RedHill Biopharma Limited
2013 Phase 2 NCT01717664 Israel;
RHIgM22
Acorda Therapeutics
2015 Phase 1 NCT02398461 United States;
2013 Phase 1 NCT01803867 United States;
RHuPH20
Hoffmann-La Roche
2019 Phase 1 NCT03972306 Canada;United States;
RIPK1 inhibitor
Sanofi
2021 Phase 1 NCT04982991 United Kingdom;
RNF
Merck KGaA
2008 Phase 3 NCT00813709 Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Turkey;
2006 Phase 3 NCT00404352 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Turkey;
RNS60
University Hospital Zürich
2014 Phase 2 EUCTR2014-000221-20-AT Austria;Switzerland;
RNS60 125 ml
Revalesio Corporation
2013 Phase 2 NCT01714089 United States;
RNS60 250 ml
Revalesio Corporation
2013 Phase 2 NCT01714089 United States;
RO0506997
F. Hoffmann-La Roche Ltd
2007 Phase 2 EUCTR2004-004519-43-SK Czech Republic;Germany;Slovakia;Spain;United Kingdom;
2007 - EUCTR2004-004519-43-GB Czech Republic;Germany;Spain;United Kingdom;
2007 - EUCTR2004-004519-43-DE Czech Republic;Germany;Spain;United Kingdom;
2005 - EUCTR2004-004519-43-CZ Czech Republic;Germany;Spain;United Kingdom;
RO4964913
F. HOFFMANN - LA ROCHE LTD.
2021 Phase 3 EUCTR2020-005448-48-IT Brazil;Czechia;France;Italy;Spain;
2018 Phase 3;Phase 4 EUCTR2017-004886-29-IT Belgium;Bulgaria;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
F. Hoffmann-La Roche Ltd
2022 Phase 3 EUCTR2020-005448-48-CZ Australia;Brazil;Canada;Czech Republic;Czechia;France;Italy;New Zealand;Poland;Russian Federation;Spain;Turkey;Ukraine;United States;
2021 Phase 3 EUCTR2020-005448-48-PL Australia;Brazil;Canada;Czechia;France;Italy;New Zealand;Poland;Russian Federation;Spain;Turkey;Ukraine;United States;
2021 Phase 3 EUCTR2019-003919-53-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-003919-53-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-003919-53-GR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-003919-53-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-003919-53-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-003919-53-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-003919-53-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2017-004886-29-SI Argentina;Belgium;Brazil;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Mexico;Netherlands;Poland;Portugal;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2021 Phase 3 EUCTR2017-004886-29-PT Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2021 Phase 3 EUCTR2017-004886-29-PL Argentina;Belgium;Brazil;Bulgaria;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2021 Phase 3 EUCTR2017-004886-29-HU Argentina;Belgium;Brazil;Bulgaria;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2021 Phase 3 EUCTR2017-004886-29-HR Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2021 Phase 3 EUCTR2017-004886-29-BG Argentina;Belgium;Brazil;Bulgaria;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2021 Phase 3 EUCTR2017-004886-29-BE Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2020 Phase 3 EUCTR2019-003919-53-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2017-001313-93-DE Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates;
2019 Phase 3 EUCTR2017-004886-29-IE Argentina;Belgium;Brazil;Bulgaria;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2018 Phase 3 EUCTR2017-004886-29-SE Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2018 Phase 3 EUCTR2017-004886-29-NL Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2018 Phase 3 EUCTR2017-004886-29-GB Czech Republic;Denmark;Estonia;Finland;France;Ireland;Netherlands;Spain;Sweden;United Kingdom;
2018 Phase 3 EUCTR2017-004886-29-FR Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Turkey;United Kingdom;
2018 Phase 3 EUCTR2017-004886-29-FI Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Turkey;United Kingdom;
2018 Phase 3 EUCTR2017-004886-29-EE Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Turkey;United Kingdom;
2018 Phase 3 EUCTR2017-004886-29-DK Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2018 Phase 3 EUCTR2017-004886-29-CZ Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2018 Phase 3 EUCTR2017-001313-93-PL Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates;
2018 Phase 3 EUCTR2017-001313-93-IE Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates;
2018 Phase 3 EUCTR2017-001313-93-HU Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Denmark;Egypt;France;Guatemala;Hungary;Ireland;Italy;Kuwait;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Saudi Arabia;Spain;United Arab Emirates;
2018 Phase 3 EUCTR2017-001313-93-DK Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates;
2018 Phase 3 EUCTR2017-001313-93-CZ Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates;
F.Hoffmann-La Roche
2011 Phase 3 EUCTR2010-020315-36-FR Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-020338-25-DK Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Portugal;Spain;United Kingdom;
2011 - EUCTR2010-020337-99-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-020315-36-ES Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Colombia;Croatia;Ireland;Italy;Mexico;Peru;Russian Federation;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020337-99-FI Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;United Kingdom;United States;
2010 - EUCTR2010-020338-25-ES Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;Greece;Hungary;Italy;Lithuania;Portugal;Spain;United Kingdom;
2010 - EUCTR2010-020337-99-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
F.Hoffmann-La Roche Ltd.
2008 - EUCTR2007-006338-32-IT Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Russian Federation;Spain;Switzerland;Ukraine;United Kingdom;United States;
Hoffman La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-ES Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Slovakia;Spain;United Kingdom;
2008 - EUCTR2007-006338-32-NL Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Spain;United Kingdom;
2008 - EUCTR2007-006338-32-FI Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Spain;United Kingdom;
ROCHE
2018 Phase 4 EUCTR2018-000780-91-FR France;
2011 - EUCTR2010-020337-99-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;New Zealand;Peru;Poland;Portugal;Russian Federation;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-020315-36-IT Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Colombia;Croatia;Ireland;Italy;Mexico;Peru;Russian Federation;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Roche Farma S. A. U. que realiza el ensayo en España y que actúa como representante F. Hoffmann-La Roche Ltd
2021 Phase 3 EUCTR2020-005448-48-ES Brazil;Czechia;France;Italy;Spain;
Roche Farma S.A(Soc. Unipersonal) que realiza el ensayo en España y actúa como representante de F. Hoffmann-La Roche LTD
2018 Phase 3 EUCTR2017-001313-93-ES Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Denmark;Egypt;France;Guatemala;Hungary;Ireland;Italy;Kuwait;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Saudi Arabia;Spain;United Arab Emirates;
Roche Farma SA (Soc unipersonal) que realiza el ensayo en España y que actúa como representante F.Hoffmann-La Roche Ltd
2018 Phase 3 EUCTR2017-004886-29-ES Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Turkey;United Kingdom;
RO4964913 F07
F.Hoffmann-La Roche
2012 Phase 3 EUCTR2010-020337-99-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
RO4964913/F03
Hoffman La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-FR Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Slovakia;Spain;United Kingdom;
RO4964913/F07
F. HOFFMANN - LA ROCHE LTD.
2016 Phase 3 EUCTR2015-005597-38-IT Belgium;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom;
F. Hoffman-La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-DE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
F. Hoffmann-La Roche Ltd
2016 Phase 3 EUCTR2015-005597-38-SE Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2016 Phase 3 EUCTR2015-005597-38-NL Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2016 Phase 3 EUCTR2015-005597-38-IE Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2016 Phase 3 EUCTR2015-005597-38-GB Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2016 Phase 3 EUCTR2015-005597-38-FR Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2016 Phase 3 EUCTR2015-005597-38-FI Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2016 Phase 3 EUCTR2015-005597-38-EE Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2016 Phase 3 EUCTR2015-005597-38-DK Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2016 Phase 3 EUCTR2015-005597-38-DE Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2016 Phase 3 EUCTR2015-005597-38-CZ Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2016 Phase 3 EUCTR2015-005597-38-BE Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom;
F.Hoffmann-La Roche
2012 Phase 3 EUCTR2010-020315-36-CZ Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-SK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-LT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-CZ Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-SK Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-SE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-IE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-GB Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-DE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-BG Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-BE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020337-99-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020337-99-EE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
GENENTECH Inc.
2016 Phase 3 EUCTR2015-004616-37-SE Germany;Sweden;Switzerland;United States;
2016 Phase 3 EUCTR2015-004616-37-DE Germany;Sweden;Switzerland;United States;
Hoffman La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-SK Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 Phase 2 EUCTR2007-006338-32-GB Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 Phase 2 EUCTR2007-006338-32-DK Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 Phase 2 EUCTR2007-006338-32-CZ Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 Phase 2 EUCTR2007-006338-32-BG Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 Phase 2 EUCTR2007-006338-32-BE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
Roche Farma S.A. que representa en España a F. Hoffmann-La Roche Ltd
2016 Phase 3 EUCTR2015-005597-38-ES Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom;
RO4964913/F07-01
F. HOFFMANN - LA ROCHE LTD.
2020 Phase 3 EUCTR2020-000894-26-IT Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000893-69-IT Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-001511-73-IT Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2016-002667-34-IT Italy;Poland;United States;
2017 Phase 3 EUCTR2016-002937-31-IT Austria;Belgium;Brazil;Bulgaria;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
F. Hoffmann-La Roche Ltd
2021 Phase 3 EUCTR2020-000894-26-GR Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000894-26-DK Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000894-26-BG Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000893-69-GR Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000893-69-DK Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000894-26-PT Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000894-26-HU Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000894-26-GB Argentina;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000894-26-FR Argentina;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000894-26-DE Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000893-69-PT Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000893-69-PL Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000893-69-NL Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000893-69-HU Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000893-69-GB Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000893-69-DE Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000893-69-BE Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-001511-73-RO Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-001511-73-PT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-001511-73-IE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-001511-73-DE Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2016-002667-34-PL Italy;Poland;United States;
2019 Phase 3 EUCTR2018-001511-73-PL Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-001511-73-HU Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-001511-73-HR Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-001511-73-GB Bulgaria;Croatia;Germany;Hungary;Ireland;Poland;Portugal;Spain;United Kingdom;
2019 Phase 3 EUCTR2018-001511-73-ES Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-001511-73-BG Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-SK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-SI Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-SE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-NO Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-HR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-FR Austria;Belgium;Brazil;Bulgaria;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Roche Farma S.A. (Soc.unipersonal)que realiza el ensayo en España y que actúa como representante de F.Hoffmann-La Roche
2017 Phase 3 EUCTR2016-002937-31-ES Austria;Belgium;Brazil;Bulgaria;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
RO5333787
F. HOFFMANN - LA ROCHE LTD.
2021 Phase 3 EUCTR2021-001088-26-IT Canada;France;Germany;India;Italy;Korea, Republic of;Turkey;United States;
2021 Phase 3 EUCTR2020-003413-35-IT Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
F. Hoffmann-La Roche Ltd
2021 Phase 3 EUCTR2020-003413-35-HU Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-003413-35-HR Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-003413-35-DE Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-003413-35-BG Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2020-003413-35-PL Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
RO7010939
F. HOFFMANN - LA ROCHE LTD.
2021 Phase 3 EUCTR2020-001168-28-IT Bulgaria;Denmark;Finland;France;Italy;Netherlands;United States;
2021 Phase 3 EUCTR2019-004857-10-IT Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States;
F. Hoffman-La Roche
2021 Phase 3 EUCTR2020-001168-28-DK Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Greece;India;Italy;Korea, Republic of;Mexico;Poland;Portugal;Russian Federation;Turkey;United Kingdom;United States;
F. Hoffmann-La Roche Ltd
2022 Phase 2 EUCTR2021-003772-14-HR Croatia;Czechia;Egypt;Japan;Kenya;Morocco;Norway;Serbia;Slovakia;Slovenia;
2021 Phase 3 EUCTR2020-001168-28-BG Bulgaria;Finland;France;Netherlands;United States;
2021 Phase 3 EUCTR2019-004857-10-PT Finland;France;Germany;Netherlands;Portugal;United States;
2021 Phase 3 EUCTR2019-004857-10-NL Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States;
2021 Phase 3 EUCTR2019-004857-10-HU Finland;France;Germany;Hungary;Netherlands;Portugal;United States;
2021 Phase 3 EUCTR2019-004857-10-DE Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States;
2020 Phase 3 EUCTR2019-004857-10-FI Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States;
RPC-1063
Celgene
2020 Phase 3 NCT04140305 Canada;Puerto Rico;United States;
RPC1063
CELGENE INTERNATIONAL II SàRL
2016 Phase 3 EUCTR2015-002500-91-IT Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
Celgene
2016 Phase 1 NCT02797015 United States;
2015 Phase 3 NCT02576717 Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2012 Phase 2/Phase 3 NCT01628393 Belgium;Bulgaria;Georgia;Greece;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States;
Celgene International II Sàrl (CIS II)
2017 Phase 3 EUCTR2015-002500-91-SE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-002500-91-SK Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-002500-91-PT Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-002500-91-PL Argentina;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-002500-91-LV Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-002500-91-LT Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-002500-91-HR Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-002500-91-EE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-002500-91-BG Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-002500-91-HU Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-002500-91-GR Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-002500-91-GB Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-002500-91-BE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-PL Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-LV Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-LT Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-HU Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-HR Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-GB Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-BG Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2014-002320-27-PT Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2014-002320-27-EE Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2014 Phase 2;Phase 3 EUCTR2012-002714-40-SK Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2014 Phase 2;Phase 3 EUCTR2012-002714-40-GB Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2013 Phase 2;Phase 3 EUCTR2012-002714-40-HU Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2013 Phase 2;Phase 3 EUCTR2012-002714-40-BG Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2013 Phase 2;Phase 3 EUCTR2012-002714-40-BE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
Receptos, Inc.
2015 Phase 3 EUCTR2014-002320-27-SE Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-NL Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-ES Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 - EUCTR2015-002500-91-ES Argentina;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2014 Phase 2;Phase 3 EUCTR2012-002714-40-HR Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Ukraine;United Kingdom;United States;
2013 Phase 2;Phase 3 EUCTR2012-002714-40-IT Belgium;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Israel;Italy;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2013 Phase 2;Phase 3 EUCTR2012-002714-40-GR Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States;
2013 Phase 2;Phase 3 EUCTR2012-002714-40-ES Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States;
RTL1000 (recombinant T cell receptor ligand)
Artielle ImmunoTherapeutics
2006 Phase 1 NCT00411723 United States;
RYAH-Medtech Inhaler
OMNI Medical Services, LLC
2018 Phase 2 NCT03944447 United States;
Rabbit anti-human thymocyte immunoglobulin
Sheffield Teaching Hospitals
2020 Phase 3 EUCTR2019-001549-42-GB United Kingdom;
Radiation therapy
Baylor College of Medicine
1999 Phase 2 NCT00040482 United States;
Ralenova
University Medical Center Hamburg Eppendorf
2007 - EUCTR2007-001962-34-DE Germany;
Raltegravir
Queen Mary University of London
2013 Phase 2 NCT01767701 United Kingdom;
2013 - EUCTR2012-004847-61-GB United Kingdom;
Ramatroban
Iou hospital
2008 - JPRN-UMIN000002725 Japan;
Ranitidine
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
2014 Phase 4 NCT02205489 Belgium;France;Netherlands;Spain;
Raptiva 100 mg/ml powder and solvent for solution for injection
Merck Serono International S.A.
2009 - EUCTR2007-001377-28-PT Austria;France;Germany;Netherlands;Portugal;
2008 - EUCTR2007-001377-28-NL Austria;France;Germany;Netherlands;Portugal;
2008 - EUCTR2007-001377-28-FR Austria;France;Germany;Netherlands;Portugal;
2008 - EUCTR2007-001377-28-DE Austria;France;Germany;Netherlands;Portugal;
2008 - EUCTR2007-001377-28-AT Austria;France;Germany;Netherlands;Portugal;
Ravulizumab
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 3 EUCTR2019-003352-37-IT Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States;
Alexion Pharmaceuticals
2019 Phase 3 NCT04201262 Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Poland;Spain;United Kingdom;United States;
Rebif
Bayer
2006 Phase 4 NCT00317941 France;
Biogen Idec
2014 Phase 1 NCT02269930 United States;
Dansk Multipel Sclerose Center
2010 - EUCTR2009-016824-29-DK Denmark;
EMD Serono
2010 Phase 4 NCT01085318 United States;
2004 Phase 4 NCT00101959 United States;
F.Hoffmann-La Roche
2012 Phase 3 EUCTR2010-020337-99-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2010-020315-36-CZ Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-SK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-LT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-CZ Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-SK Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-SE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-IE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-GB Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-FR Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-DE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-BG Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-BE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-020337-99-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-020315-36-ES Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Colombia;Croatia;Ireland;Italy;Mexico;Peru;Russian Federation;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020337-99-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020337-99-FI Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020337-99-EE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2010 - EUCTR2010-020337-99-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
Genzyme Corporation
2008 Phase 3 EUCTR2007-001162-32-FR Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2008 Phase 3 EUCTR2007-001162-32-ES Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2008 Phase 3 EUCTR2007-001162-32-CZ Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2008 Phase 3 EUCTR2007-001162-32-BE Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2008 Phase 3 EUCTR2007-001161-14-FR Czech Republic;France;Germany;Poland;Sweden;United Kingdom;
2008 - EUCTR2007-001162-32-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-001162-32-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-001162-32-NL Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-001162-32-DK Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-001162-32-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-001162-32-AT Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-001161-14-SE Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom;
2008 - EUCTR2007-001161-14-DE Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom;
2007 Phase 3 EUCTR2007-001162-32-GB Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-001161-14-GB Czech Republic;France;Germany;Poland;Sweden;United Kingdom;
IMS HEALTH GmbH & Co. OHG
2016 - NCT02823951 Canada;United States;
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden;
2017 Phase 4 EUCTR2016-003587-39-SE Sweden;
Medizinische Universität Innsbruck
2014 Phase 4 EUCTR2012-005450-30-AT Austria;Sweden;
2014 - EUCTR2012-005450-30-SE Austria;Sweden;
Merck KGaA
2012 - NCT01601119 United Kingdom;
2009 Phase 2 NCT01198132 France;
Merck KGaA, Darmstadt, Germany
2017 - NCT02949908 Germany;
2014 Phase 4 NCT02254304 Germany;
Merck Serono International SA
2007 Phase 3 EUCTR2006-003037-32-ES Estonia;Germany;Italy;Lithuania;Spain;
2007 - EUCTR2006-003037-32-LT Estonia;Germany;Italy;Lithuania;Spain;
2007 - EUCTR2006-003037-32-EE Estonia;Germany;Italy;Lithuania;Spain;
Merck Serono International, a branch of Laboratoires Serono SA An affiliate of Merck KGaA
2007 Phase 3 EUCTR2006-002982-38-SK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Slovakia;Spain;
2007 - EUCTR2006-002982-38-EE Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain;
Merck Serono International, a branch of Laboratoires Serono SA an affiliate of Merck KGaA, Darmstadt
2009 - EUCTR2008-004954-34-GR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Spain;
Merck Serono S.A. - Geneva
2010 - EUCTR2009-016087-37-GB France;Ireland;Italy;Spain;United Kingdom;
2009 - EUCTR2009-016087-37-ES France;Ireland;Italy;Spain;United Kingdom;
Merck Serono S.A. - Geneva, an affiliate of Merck KGaA Darmstadt, Germany
2007 - EUCTR2006-002982-38-PT Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain;
2007 - EUCTR2006-002982-38-DE Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain;
2006 - EUCTR2006-002982-38-FI Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain;
2006 - EUCTR2006-002982-38-CZ Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain;
Merck Serono S.A. - Geneva, an affiliate of Merck KGaA, Darmstadt, Germany
2010 - EUCTR2008-004954-34-AT Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;
2009 Phase 3 EUCTR2008-004954-34-SK Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;
2009 Phase 3 EUCTR2008-004954-34-PT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Spain;
2009 Phase 3 EUCTR2008-004954-34-BE Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;
2009 - EUCTR2008-004954-34-PL Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;
2009 - EUCTR2008-004954-34-LV Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Spain;
2009 - EUCTR2008-004954-34-FI Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;
2009 - EUCTR2008-004954-34-EE Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;
2009 - EUCTR2008-004954-34-DE Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;
2009 - EUCTR2008-004954-34-BG Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;
2008 - EUCTR2008-004954-34-CZ Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;
Merck Serono S.A.- Geneva, an affiliate of Merck KGaA, Darmstadt, Germany
2009 Phase 3 EUCTR2008-004954-34-FR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Slovakia;Spain;
Merck Serono S.A.-Geneva, an affiliate of Merck KGaA Darmstadt, Germany
2006 Phase 3 EUCTR2006-002982-38-BE Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Slovakia;Spain;
Merck Serono SA
2007 - EUCTR2006-003037-32-DE Estonia;Germany;Italy;Lithuania;Spain;
Merck Serono SA – Geneva
2010 - EUCTR2009-015502-19-GB Belgium;Finland;Germany;Sweden;United Kingdom;
2010 - EUCTR2009-015502-19-DE Belgium;Finland;Germany;Sweden;United Kingdom;
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain;
ROCHE
2011 - EUCTR2010-020337-99-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;New Zealand;Peru;Poland;Portugal;Russian Federation;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-020315-36-IT Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Colombia;Croatia;Ireland;Italy;Mexico;Peru;Russian Federation;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Serono International SA
2005 Phase 3 EUCTR2004-003799-13-ES Denmark;Ireland;Lithuania;Spain;Sweden;United Kingdom;
2004 - EUCTR2004-000337-12-HU Hungary;
Teva Pharmaceutical Industries
2004 Phase 4 NCT00202995 Canada;United States;
The Multiple Sclerosis Research Group, Department of Clinical Neuroscience
2009 - EUCTR2008-008554-23-SE Sweden;
University of North Carolina, Chapel Hill
2004 - NCT00137176 United States;
Universitätsklinikum Heidelberg
2006 Phase 3 EUCTR2004-004403-37-DE Germany;
VU University Medical Center
2011 - EUCTR2011-003570-89-NL Netherlands;
sanofi-aventis Recherche & Dévelopment
2009 - EUCTR2008-006226-34-FR Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom;
sanofi-aventis recherche et development
2009 Phase 3 EUCTR2008-006226-34-GR Belgium;Czech Republic;France;Germany;Greece;Hungary;Italy;Spain;United Kingdom;
2009 - EUCTR2008-006226-34-BE Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom;
sanofi-aventis recherche et developpement
2010 - EUCTR2008-006226-34-GB Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom;
2009 - EUCTR2008-006226-34-HU Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom;
2009 - EUCTR2008-006226-34-DE Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom;
2009 - EUCTR2008-006226-34-CZ Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom;
Rebif (IFN beta-1a subcutaneous three times per week)
Brigham and Women's Hospital
2015 - NCT02419638 United States;
Rebif (IFN ß-1a subcutaneous three times per week)
Brigham and Women's Hospital
2015 - NCT02419638 United States;
Rebif (Interferon beta-1a)
Merck KGaA
2009 - NCT01075880 Czech Republic;
Merck KGaA, Darmstadt, Germany
2016 - NCT02921035 Algeria;Argentina;Bahrain;Bulgaria;Egypt;Germany;Hungary;Iran, Islamic Republic of;Korea, Republic of;Kuwait;Lebanon;Morocco;Poland;Saudi Arabia;Tunisia;United Arab Emirates;
Rebif (interferon beta 1a)
Biocad
2014 Phase 2/Phase 3 NCT02727907 Russian Federation;
Rebif (interferon beta-1a), Merck Serono Europe Ltd
Bayer
2016 - NCT02749396 Finland;
Rebif 22
UCL Biomedicine R&D Unit
2006 - EUCTR2005-005751-18-GB United Kingdom;
Rebif 22 micrograms
Biogen Portugal
2016 Phase 4 EUCTR2016-000434-21-PT Portugal;
Rebif 22 y 44 mcg
Merck, S.L.
2006 - EUCTR2006-000606-23-ES Spain;
Rebif 22®
University Hospital Motol
2011 Phase 4 EUCTR2011-001956-12-CZ Czech Republic;
Rebif 44
The Walton Centre for Neurology and Neurosurgery
2005 Phase 4 EUCTR2004-004903-39-GB United Kingdom;
UCL Biomedicine R&D Unit
2006 - EUCTR2005-005751-18-GB United Kingdom;
Rebif 44 micrograms
Biogen Idec GmbH
2005 - EUCTR2004-004130-14-AT Austria;
Biogen Portugal
2016 Phase 4 EUCTR2016-000434-21-PT Portugal;
Octapharma AG
2015 Phase 3 EUCTR2012-005086-12-PL Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;Serbia;Ukraine;
2013 - EUCTR2012-005086-12-HU Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-DE Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-BG Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-AT Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
Rebif 44 micrograms solution for injection
Merck Serono International
2010 - EUCTR2008-003706-33-GR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2009 Phase 3 EUCTR2008-003706-33-FR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-003706-33-ES Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
Merck Serono S.A. - Geneva
2009 Phase 3 EUCTR2008-003706-33-GB Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2009 Phase 3 EUCTR2008-003706-33-BE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2009 - EUCTR2008-003706-33-SE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2009 - EUCTR2008-003706-33-NO Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-003706-33-DE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2009 - EUCTR2008-003706-33-CZ Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2009 - EUCTR2008-003706-33-BG Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2009 - EUCTR2008-003706-33-AT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2008 - EUCTR2008-003706-33-FI Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2008 - EUCTR2008-003706-33-EE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
Merck Serono SA - Geneva
2009 - EUCTR2008-003706-33-PT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
Rebif 44 micrograms solution for injection in pre-filled syringe
Biogen Idec Limited
2010 - EUCTR2009-015556-15-NL Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
Rebif 44 µg
Serono GmbH
2005 - EUCTR2005-001026-89-DE Germany;
Rebif 44®
University Hospital Motol
2011 Phase 4 EUCTR2011-001956-12-CZ Czech Republic;
Rebif 8,8 µg, Rebif 22µg
Serono GmbH
2005 - EUCTR2005-001026-89-DE Germany;
Rebif 8.8 micrograms and 22 micrograms solution for injection in pre-filled syringe initiation pack
Biogen Idec Limited
2010 - EUCTR2009-015556-15-SI Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States;
2010 - EUCTR2009-015556-15-PT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-NL Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-LV Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States;
2010 - EUCTR2009-015556-15-HU Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-GR Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-GB Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-FI Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-ES Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-DK Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-DE Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-CZ Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States;
2010 - EUCTR2009-015556-15-AT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
Rebif 8.8 micrograms and 22 micrograms solution for injection in pre-filled syringe initiation pack.
Biogen Idec Limited
2010 - EUCTR2009-015556-15-SE Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States;
Rebif New Formulation + ibuprofen PRN
Merck KGaA
2007 Phase 3 NCT00619307 France;Germany;
Rebif New Formulation + prophylactic Ibuprofen
Merck KGaA
2007 Phase 3 NCT00619307 France;Germany;
Rebif New Formulation 44mcg multidose cartridge
Merck Serono International S.A.
2008 - EUCTR2008-000499-25-SE Germany;Italy;Spain;Sweden;
2008 - EUCTR2008-000499-25-ES Germany;Italy;Spain;Sweden;
- - EUCTR2008-000499-25-DE Germany;Italy;Spain;Sweden;
Rebif New Formulation Non Titrated
EMD Serono
2007 Phase 3 NCT00472797 United States;
Rebif New Formulation Titrated
EMD Serono
2007 Phase 3 NCT00472797 United States;
Rebif®
EMD Serono
2014 Phase 4 NCT02117050 United States;
2010 - NCT01207648 Argentina;Canada;France;Italy;Russian Federation;Tunisia;United States;Venezuela;
1999 Phase 3 NCT00292266 -
Genzyme Corporation
2008 - EUCTR2007-001161-14-PL Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom;
2008 - EUCTR2007-001161-14-CZ Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom;
Merck KGaA
2013 Phase 4 NCT01791244 Germany;Sweden;
Merck KGaA, Darmstadt, Germany
2014 Phase 4 NCT02064816 Germany;
PD Dr. Marcus Müller
2015 Phase 1 NCT02364986 Germany;
Queen Mary, University of London
2009 - EUCTR2008-000256-26-GB United Kingdom;
Sahlgrenska University Hospital
2005 - EUCTR2005-001008-37-SE Sweden;
Rebif® (clone 484-39)
Merck KGaA
2004 Phase 4 NCT00367484 -
Rebif® New Formulation
Merck KGaA
2008 - NCT01080027 Greece;
Rebif® New Formulation (IFN-beta-1a, RNF)
Merck KGaA
2006 Phase 3 NCT00441103 Canada;Germany;Italy;Russian Federation;Spain;Switzerland;
Rebif® New Formulation (RNF) using RebiSmartTM
EMD Serono
2008 Phase 3 NCT00735007 Canada;Germany;Italy;Spain;Sweden;United States;
Rebif® new formulation (RNF)
EMD Serono
2008 Phase 3 NCT00725985 Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czechia;Estonia;Finland;France;Georgia;Germany;India;Italy;Korea, Republic of;Lebanon;Macedonia, The Former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
Recombinant Human Erythropoietin
Walton Centre for Neurology and Neurosurgery
2008 - EUCTR2008-005125-11-GB United Kingdom;
Recombinant human IFN beta
Merck Serono International SA
2007 - EUCTR2006-005972-42-DE France;Germany;
Recombinant human alpha B-crystallin
Delta Crystallon B.V.
2012 - EUCTR2011-004475-36-BG Bulgaria;
Delta Crystallon BV
2012 Phase 2 NCT02442570 Bulgaria;
2009 Phase 1 NCT02442557 Netherlands;
Recombinant human interferon beta
Serono International SA
2004 - EUCTR2004-000337-12-HU Hungary;
Recombinant humanized anti-alpha 4 integrin antibody
BIOGEN IDEC LTD
2007 - EUCTR2005-004061-41-SE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2007 - EUCTR2005-004061-41-AT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Ireland;Italy;Spain;Sweden;United Kingdom;
2006 Phase 3 EUCTR2005-004061-41-GB Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 Phase 3 EUCTR2005-004061-41-BE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 - EUCTR2005-004061-41-IE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 - EUCTR2005-004061-41-HU Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 - EUCTR2005-004061-41-GR Austria;Czech Republic;Denmark;Finland;Germany;Greece;Ireland;Italy;Spain;Sweden;United Kingdom;
2006 - EUCTR2005-004061-41-FI Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 - EUCTR2005-004061-41-DK Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 - EUCTR2005-004061-41-DE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 - EUCTR2005-004061-41-CZ Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
Recombinant interferon beta-1b
Bayer HealthCare AG
2013 Phase 4 EUCTR2012-005262-35-GB Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2013 Phase 4 EUCTR2012-005262-35-ES Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2013 Phase 4 EUCTR2012-005262-35-CZ Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2012-005262-35-SI Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2012-005262-35-IT Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2012-005262-35-FI Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2012-005262-35-AT Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
Remibrutinib
Novartis Farmacéutica S.A.
2022 Phase 3 EUCTR2020-005929-89-ES Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States;
2022 Phase 3 EUCTR2020-005899-36-ES Slovakia;Spain;
Novartis Pharma AG
2022 Phase 3 EUCTR2020-005929-89-SE Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States;
2022 Phase 3 EUCTR2020-005899-36-SK Argentina;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;France;Germany;Guatemala;Hong Kong;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;United Kingdom;United States;
Novartis Pharmaceuticals
2021 Phase 3 NCT05156281 United States;
2021 Phase 3 NCT05147220 United States;
Repetitive transcranial magnetic stimulation (rTMS)
Shirley Ryan AbilityLab
2017 - NCT03723434 United States;
Repository Corticotropin Injection
Mallinckrodt
2017 Phase 4 NCT03126760 United States;
Repository corticotropin injection
University at Buffalo
2009 Phase 2 NCT00986960 United States;
Researchmanager program
Isala
2021 - NCT05242731 Netherlands;
Revaxis
University of Nottingham
2010 Phase 2 EUCTR2007-001496-11-GB United Kingdom;
RhEPO
Walton Centre for Neurology and Neurosurgery
2008 - EUCTR2008-005125-11-GB United Kingdom;
RhIFN beta-1b
Nuron Biotech Inc.
2011 Phase 3 NCT01464905 Belarus;Bulgaria;Croatia;Georgia;Hungary;India;Italy;Lebanon;Poland;Russian Federation;Serbia;Spain;Ukraine;
RhIGF-1 (CEP-151)
National Institute of Neurological Disorders and Stroke (NINDS)
1997 Phase 2 NCT00001669 United States;
RhuMab 2H7
Hoffman La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-FR Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Slovakia;Spain;United Kingdom;
2008 Phase 2 EUCTR2007-006338-32-ES Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Slovakia;Spain;United Kingdom;
2008 - EUCTR2007-006338-32-NL Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Spain;United Kingdom;
2008 - EUCTR2007-006338-32-FI Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Spain;United Kingdom;
RhumAb to IL-17A igG1-k-class
Novartis Pharma Services AG
2012 - EUCTR2011-001629-25-CZ Czech Republic;Russian Federation;Ukraine;
RhumAb to Il-17A (IgG1-k-class)
Novartis Pharma Services AG
2009 Phase 2 EUCTR2009-011626-34-SE Czech Republic;Sweden;
2009 - EUCTR2009-011626-34-CZ Czech Republic;Russian Federation;Serbia;Sweden;Ukraine;
Riboflavin
University of Iowa
2010 Phase 1 NCT01381354 United States;
Rifampin
National Center for Research Resources (NCRR)
2001 Phase 2 NCT00043264 United States;
Rilutek
UCL
2014 Phase 2 EUCTR2012-005394-31-GB United Kingdom;
Riluzole
S. Andrea Hospital
2005 Phase 2 NCT00202397 Italy;
UCL
2014 Phase 2 EUCTR2012-005394-31-GB United Kingdom;
University College, London
2014 Phase 2 NCT01910259 United Kingdom;
University of California, San Francisco
2006 Phase 2 NCT00501943 United States;
RimabotulinumtoxinB
Supernus Pharmaceuticals, Inc.
2021 Phase 2/Phase 3 NCT04815967 -
Ritalin
Sheba Medical Center
2003 Phase 1 NCT00220493 Israel;
Ritalin LA 20mg capsules
Medizinische Universität Wien
2012 - EUCTR2012-003418-15-AT Austria;
Ritalin LA 30mg capsules
Medizinische Universität Wien
2012 - EUCTR2012-003418-15-AT Austria;
Ritalin LA 40mg capsules
Medizinische Universität Wien
2012 - EUCTR2012-003418-15-AT Austria;
Rituximab
AZIENDA OSPEDALIERA DI PADOVA
- Phase 1 EUCTR2008-005773-35-IT Italy;
Anders Svenningsson
2016 Phase 3 NCT02746744 Sweden;
2009 Phase 2 NCT01719159 Sweden;
Centre Hospitalier de Pau
2015 Phase 2 EUCTR2014-005493-11-FR France;
Claudio Gobbi
2020 - NCT04640818 Switzerland;
Clinical Research Center, NHO Utano National Hospital
2014 Phase 2,3 JPRN-UMIN000013453 Japan;
Clinical Research Center, Utano National Hospital, National Hospital Organization
2015 Phase 2,3 JPRN-UMIN000017217 Japan;
Department of Pediatrics, Kobe Universtiy Graduate School of Medicine
2012 - JPRN-UMIN000009421 Japan;
Genentech, Inc.
2004 Phase 2/Phase 3 NCT00087529 Canada;United States;
2004 Phase 2 NCT00097188 United States;
Haukeland University Hospital
2020 Phase 3 NCT04578639 Norway;
Helse Bergen HF, Haukeland University Hospital
2022 Phase 3 EUCTR2020-001205-23-SE Sweden;
Isfahan University of Medical Sciences
2017 Phase 2/Phase 3 NCT03315923 Iran, Islamic Republic of;
2015 Phase 2/Phase 3 NCT03002038 Iran, Islamic Republic of;
Johns Hopkins University
2014 Phase 1 NCT02253264 United States;
Karolinska Institutet
2018 Phase 3 NCT03979456 Sweden;
2017 - NCT03193866 Sweden;
National Institute of Neurological Disorders and Stroke (NINDS)
2010 Phase 1/Phase 2 NCT01212094 United States;
Northwestern University
2019 Phase 2/Phase 3 NCT03829566 United States;
Oslo University Hospital
2019 Phase 3 NCT04121403 Norway;
Rigshospitalet, Denmark
2021 Phase 3 NCT04688788 Denmark;
Shandong University Qilu Hospital
2021 Phase 4 ChiCTR2100043013 China;
Tang-Du Hospital
2014 Phase 4 NCT04256252 -
The Ophthalmology Department of the Chinese Peoples Liberation Army Hospital
2019 Phase 4 ChiCTR1900025744 China;
2014 - ChiCTR-ICR-15007177 China;
University of California, San Francisco
2004 Phase 1 NCT00501748 United States;
University of Colorado, Denver
2017 Phase 3 NCT02980042 United States;
2012 Phase 2 NCT01569451 United States;
Rituximab IT
Centre Hospitalier de PAU
2015 Phase 2 NCT02545959 France;
Rituximab IV
Centre Hospitalier de PAU
2015 Phase 2 NCT02545959 France;
Rituximab Infusion
Wake Forest University Health Sciences
2013 Phase 4 NCT02040116 United States;
Rituximab konsentrat til infusjonsvaeske oppløsning 10 mg/ml
Department of Neurology, Division of Clinical Neuroscience, Oslo University Hospital
2019 Phase 3 EUCTR2019-001505-24-NO Norway;
Rivastigmin
Novartis Pharma GmbH
- - EUCTR2008-007015-32-DE Germany;
Rivastigmine transdermal patch
Novartis Pharmaceuticals
2009 Phase 4 NCT00881205 Germany;
Ro 496-4913/F03
F.Hoffmann-La Roche
2011 Phase 3 EUCTR2010-020338-25-BG Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2010 - EUCTR2010-020338-25-HU Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
Ro 496-4913/F07
F.Hoffmann-La Roche
2013 Phase 3 EUCTR2010-020338-25-NL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020338-25-PT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020338-25-PL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020338-25-GR Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020338-25-DE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020338-25-CZ Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020338-25-BE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020338-25-AT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020338-25-LT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020338-25-GB Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020338-25-FI Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
Rolipram
National Institute of Neurological Disorders and Stroke (NINDS)
2001 Phase 2 NCT00011375 United States;
Ruxience
Danish Multiple Sclerosis Center, Rigshospitalet
2020 Phase 3 EUCTR2020-002981-15-DK Denmark;
SA237
Chugai Pharmaceutical Co. Ltd
2015 Phase 3 EUCTR2013-003752-21-HU France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States;
2015 - EUCTR2013-003752-21-ES France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003752-21-IT France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;
Chugai Pharmaceutical Co., Ltd.
2019 - JPRN-JapicCTI-205119 Japan;
2014 Phase 3 JPRN-JapicCTI-132397 Japan, Asia except Japan, North America, Europe;
SAR339658
Genzyme Corporation
2015 Phase 2 EUCTR2014-003265-19-PL Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States;
2015 Phase 2 EUCTR2014-001643-20-SE Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States;
2015 Phase 2 EUCTR2014-001643-20-PL Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States;
2015 Phase 2 EUCTR2014-001643-20-DE Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States;
SAR441344
Sanofi-Aventis Recherche et Développement
2021 Phase 2 EUCTR2020-004785-19-DE Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Russian Federation;Spain;Turkey;United States;
2021 Phase 2 EUCTR2020-004785-19-CZ Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Russian Federation;Spain;Turkey;United States;
2021 Phase 2 EUCTR2020-004785-19-BG Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Russian Federation;Spain;Turkey;United States;
SAR441344 IV
Sanofi
2021 Phase 2 NCT04879628 Bulgaria;Canada;Czechia;France;Germany;Spain;Turkey;Ukraine;United States;
SAR441344 SC
Sanofi
2021 Phase 2 NCT04879628 Bulgaria;Canada;Czechia;France;Germany;Spain;Turkey;Ukraine;United States;
SAR442168
GENZYME CORPORATION
2020 Phase 3 EUCTR2020-000647-30-IT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000645-14-IT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000637-41-IT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
Genzyme Corporation
2021 Phase 3 EUCTR2020-000647-30-PT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000645-14-PT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000645-14-NL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000645-14-HU Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000645-14-HR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000645-14-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000645-14-BE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000644-55-DE Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000637-41-AT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000647-30-PL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000647-30-NL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000647-30-LT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000647-30-GR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000647-30-GB Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000647-30-FI Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000647-30-DK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000647-30-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000647-30-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000647-30-BG Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000645-14-GR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000645-14-GB Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000645-14-FR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000645-14-EE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000645-14-DK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000645-14-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000645-14-BG Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-SK Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-PT Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-NL Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-LV Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-HU Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-GR Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-GB Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-FR Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-CZ Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000637-41-SE Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-PL Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-LT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-FI Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-DK Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-DE Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-CZ Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-BG Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2019 Phase 2 EUCTR2018-004731-76-SK Canada;Czech Republic;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States;
2019 Phase 2 EUCTR2018-004731-76-NL Canada;Czech Republic;Czechia;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States;
2019 Phase 2 EUCTR2018-004731-76-ES Canada;Czech Republic;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States;
2019 Phase 2 EUCTR2018-004731-76-EE Canada;Czech Republic;Czechia;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States;
2019 Phase 2 EUCTR2018-004731-76-CZ Canada;Czech Republic;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States;
2019 Phase 2 EUCTR2018-003927-12-SK Canada;Czech Republic;Estonia;France;Netherlands;Norway;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States;
2019 Phase 2 EUCTR2018-003927-12-SE Canada;Czech Republic;Estonia;France;Netherlands;Norway;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States;
2019 Phase 2 EUCTR2018-003927-12-NL Canada;Czech Republic;Estonia;France;Netherlands;Norway;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States;
2019 Phase 2 EUCTR2018-003927-12-ES Canada;Czech Republic;Estonia;France;Netherlands;Norway;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States;
2019 Phase 2 EUCTR2018-003927-12-EE Canada;Czech Republic;Estonia;France;Netherlands;Norway;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States;
Peking University Third Hospital
2020 - NCT04964791 China;
Sanofi
2019 Phase 2 NCT03889639 Canada;Czechia;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States;
2019 Phase 1 NCT04171310 United Kingdom;
SB-683699
GlaxoSmithKline Research & Development Ltd
2007 Phase 2 EUCTR2006-007057-42-CZ Belgium;Czech Republic;Denmark;Sweden;
2007 - EUCTR2006-007057-42-SE Czech Republic;Denmark;Sweden;
2007 - EUCTR2006-007057-42-DK Czech Republic;Denmark;Sweden;
2007 - EUCTR2006-007057-42-BE Belgium;Czech Republic;Denmark;Sweden;
SB683699
GlaxoSmithKline
2004 Phase 2 NCT00097331 Belgium;Canada;France;Germany;Italy;Poland;Romania;Russian Federation;Spain;United States;
GlaxoSmithKline Research & Development Ltd
2007 Phase 2 EUCTR2006-002633-20-GB Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom;
2007 Phase 2 EUCTR2006-002633-20-FR Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom;
2007 - EUCTR2006-002633-20-LT Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom;
2007 - EUCTR2006-002633-20-IT Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom;
2006 - EUCTR2006-002633-20-NL Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom;
2006 - EUCTR2006-002633-20-FI Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom;
2006 - EUCTR2006-002633-20-DE Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom;
2006 - EUCTR2006-002633-20-AT Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom;
GlaxoSmithKline S.A
2006 Phase 2 EUCTR2006-002633-20-ES Australia;Austria;Canada;Finland;France;Germany;Italy;Lithuania;Netherlands;New Zealand;Norway;Poland;Russian Federation;Spain;United Kingdom;
SC Peginterferon beta-1a
Biogen
2017 - NCT03347370 Germany;
SC interferon beta-1a
Biogen
2017 - NCT03347370 Germany;
SC interferon beta-1b
Biogen
2017 - NCT03347370 Germany;
SCLEROLYM
ImCyse S.A
2014 Phase 1;Phase 2 EUCTR2014-001081-99-BE Belgium;
SCM-010
Stem Cell Medicine Ltd.
2019 Phase 1/Phase 2 NCT03696485 Israel;
SH U 555 C
C.H.U. de RENNES
2008 - EUCTR2007-005363-10-FR France;
2008 - EUCTR2007-005362-12-FR France;
Max-Planck-Institute of Psychiatry
2007 - EUCTR2006-001337-17-DE Germany;
SIPONIMOD FUMARIC ACID
NOVARTIS PHARMA SERVICES AG
2021 Phase 3 EUCTR2020-002700-39-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Novartis Farmacéutica S.A.
2021 Phase 3 EUCTR2020-002700-39-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Novartis Pharma AG
2021 Phase 3 EUCTR2020-002700-39-SK Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-PT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-LV Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-LT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-HR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2020-002700-39-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2020-002700-39-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
SMderpept
Centrum Neurologii Krzysztof Selmaj
2016 Phase 2 EUCTR2016-002180-33-PL Poland;
SOLIRIS - 300 MG CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO 1 FLACONCINO (VETRO) 30 ML (10 MG/ML)
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 2;Phase 3 EUCTR2019-001829-26-IT Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States;
SOLU MEDROL - 125 MG/2 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONE A DOPPIA CAMERA DA 125 MG/2 ML
NOVARTIS PHARMA AG
2018 Phase 2 EUCTR2017-004702-17-IT Austria;Bulgaria;Czech Republic;Czechia;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
SOLU-MODERIN 1 g
Servicio de Neurología
2008 - EUCTR2007-000888-15-ES Spain;
SPARC0921
Sun Pharma Advanced Research Company Ltd.
2016 Phase 3 EUCTR2016-001356-22-HU Germany;Hungary;Russian Federation;Ukraine;United States;
SR-fampridine
University of Southern Denmark
2014 Phase 4 NCT02143167 Denmark;
SUB0750MIG
St. Vincent's University Hospital
2012 Phase 4 EUCTR2011-002561-38-IE Ireland;
SUB175614
Celgene International II Sàrl (CIS II)
2015 Phase 3 EUCTR2014-002320-27-PL Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
SUB22282
Biogen Idec Limited
2012 Phase 3 EUCTR2010-021978-11-IE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2012 - EUCTR2010-021978-11-BE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 Phase 3 EUCTR2010-021978-11-GB Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 Phase 3 EUCTR2010-021978-11-ES Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 Phase 3 EUCTR2010-021978-11-DK Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 Phase 3 EUCTR2010-021978-11-CZ Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 - EUCTR2010-021978-11-SE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 - EUCTR2010-021978-11-PL Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 - EUCTR2010-021978-11-FI Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 - EUCTR2010-021978-11-DE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Iraq;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
Saline
Haukeland University Hospital
2021 Phase 1/Phase 2 NCT04749667 Norway;
Innate Immunotherapeutics
2014 Phase 2 NCT02228213 Australia;New Zealand;
University at Buffalo
2009 Phase 2 NCT00986960 United States;
Sativex
GW PHARMA LTD
2008 - EUCTR2006-005910-11-IT Germany;Italy;Spain;United Kingdom;
GW Pharma Ltd
2020 Phase 3 EUCTR2019-002623-14-PL Czech Republic;Czechia;Poland;Romania;United Kingdom;United States;
2007 Phase 3 EUCTR2006-005910-11-CZ Czech Republic;Germany;Italy;Spain;United Kingdom;
2006 Phase 3 EUCTR2005-005265-11-GB Czech Republic;France;United Kingdom;
2006 Phase 3 EUCTR2005-005265-11-FR Czech Republic;France;United Kingdom;
2006 - EUCTR2005-005265-11-CZ Czech Republic;France;United Kingdom;
2005 Phase 3 EUCTR2004-002509-63-GB Czech Republic;United Kingdom;
2005 - EUCTR2004-002509-63-CZ Czech Republic;United Kingdom;
GW Pharma Ltd.
2008 Phase 3 EUCTR2006-005910-11-GB Czech Republic;Germany;Italy;Spain;United Kingdom;
2008 - EUCTR2006-005910-11-DE Germany;Italy;Spain;United Kingdom;
2007 - EUCTR2007-002138-13-GB United Kingdom;
GW Pharmaceuticals Ltd.
2012 Phase 4 NCT01964547 Czech Republic;
2007 Phase 3 NCT00702468 United Kingdom;
2006 Phase 3 NCT00391079 Canada;
2005 Phase 3 NCT01599234 United Kingdom;
2002 Phase 3 NCT01604265 United Kingdom;
GW Research Ltd
2013 Phase 3 NCT01868048 -
IRCCS Centro Neurolesi Bonino-Pulejo
2016 - NCT03186664 Italy;
S. Andrea Hospital
2005 Phase 2 NCT00202423 Italy;
Sativex 2,7mg/2,5 mg Solucion para pulverizacion bucal
GW Pharma Limited
2021 Phase 3 EUCTR2020-003271-18-ES Australia;Belgium;Czech Republic;Czechia;Poland;Spain;Sweden;United Kingdom;
Sativex Oromucosal Spray
GW Pharma Limited
2021 Phase 3 EUCTR2020-003271-18-CZ Australia;Belgium;Czech Republic;Czechia;Poland;Spain;Sweden;United Kingdom;
2021 Phase 3 EUCTR2019-002625-29-CZ Czech Republic;Czechia;Poland;United Kingdom;
2020 Phase 3 EUCTR2019-002625-29-PL Czech Republic;Czechia;Poland;United Kingdom;
2020 Phase 3 EUCTR2019-002625-29-GB Poland;United Kingdom;
GW Pharma Ltd.
2011 - EUCTR2011-000926-31-CZ Czech Republic;
Sativex Oromucosal Spray (non-marketed)
GW Pharma Ltd
2020 Phase 3 EUCTR2019-002623-14-CZ Czech Republic;Czechia;Poland;Romania;United Kingdom;United States;
Sativex®
Almirall, S.A.
2012 Phase 3 NCT01538225 Italy;
GW Pharmaceuticals Ltd.
2011 - NCT02073474 -
2008 Phase 3 NCT00681538 United Kingdom;
2002 Phase 3 NCT00711646 United Kingdom;
2002 Phase 3 NCT00678795 United Kingdom;
Satralizumab
Chugai Pharmaceutical Co., Ltd.
2019 - JPRN-JapicCTI-205119 Japan;
2014 Phase 3 JPRN-JapicCTI-132397 Japan, Asia except Japan, North America, Europe;
F. HOFFMANN - LA ROCHE LTD.
2021 Phase 3 EUCTR2021-001088-26-IT Canada;France;Germany;India;Italy;Korea, Republic of;Turkey;United States;
Hans-Christian von Buedingen
2021 Phase 4 JPRN-jRCT2031200333 Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Hoffmann-La Roche
2022 Phase 3 NCT05199688 Argentina;Italy;Mexico;Ukraine;United States;
2021 Phase 3 NCT04660539 Bulgaria;Canada;Croatia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Puerto Rico;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 NCT02073279 Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Italy;Korea, Republic of;Malaysia;Philippines;Poland;Puerto Rico;Romania;Singapore;Taiwan;Turkey;Ukraine;United States;
2014 Phase 3 NCT02028884 France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;Ukraine;United Kingdom;United States;
Satralizumab (120 mg/PFS with NSD)
F. Hoffmann-La Roche Ltd.
2017 Phase 3 EUCTR2015-005431-41-PL Bulgaria;Canada;Croatia;Georgia;Italy;Korea, Republic of;Malaysia;Poland;Romania;Russian Federation;Taiwan;Turkey;Ukraine;United States;
2016 Phase 3 EUCTR2015-005431-41-HR Bulgaria;Canada;Croatia;Georgia;Italy;Korea, Republic of;Malaysia;Poland;Romania;Taiwan;Turkey;Ukraine;United States;
2014 Phase 3 EUCTR2013-003752-21-PL France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003752-21-GB France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003752-21-DE France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States;
Satralizumab (120 mg/vial)
F. Hoffmann-La Roche Ltd.
2017 Phase 3 EUCTR2015-005431-41-PL Bulgaria;Canada;Croatia;Georgia;Italy;Korea, Republic of;Malaysia;Poland;Romania;Russian Federation;Taiwan;Turkey;Ukraine;United States;
2016 Phase 3 EUCTR2015-005431-41-HR Bulgaria;Canada;Croatia;Georgia;Italy;Korea, Republic of;Malaysia;Poland;Romania;Taiwan;Turkey;Ukraine;United States;
2014 Phase 3 EUCTR2013-003752-21-GB France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003752-21-DE France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States;
Satralizumab (120mg/vial)
F. Hoffmann-La Roche Ltd.
2014 Phase 3 EUCTR2013-003752-21-PL France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;Ukraine;United Kingdom;United States;
Satralizumab (RO5333787/Enspryng /SA237)
F. Hoffmann-La Roche Ltd.
2014 Phase 3 EUCTR2013-003752-21-PL France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;Ukraine;United Kingdom;United States;
Satralizumab (RO5333787/Enspryng/SA237)
F. Hoffmann-La Roche Ltd.
2014 Phase 3 EUCTR2013-003752-21-GB France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003752-21-DE France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States;
Satralizumab (RO5333787/SA237)
F. Hoffmann-La Roche Ltd.
2017 Phase 3 EUCTR2015-005431-41-PL Bulgaria;Canada;Croatia;Georgia;Italy;Korea, Republic of;Malaysia;Poland;Romania;Russian Federation;Taiwan;Turkey;Ukraine;United States;
2016 Phase 3 EUCTR2015-005431-41-HR Bulgaria;Canada;Croatia;Georgia;Italy;Korea, Republic of;Malaysia;Poland;Romania;Taiwan;Turkey;Ukraine;United States;
Satralizumab (r-INN)
F. Hoffmann-La Roche Ltd.
2017 Phase 3 EUCTR2015-005431-41-PL Bulgaria;Canada;Croatia;Georgia;Italy;Korea, Republic of;Malaysia;Poland;Romania;Russian Federation;Taiwan;Turkey;Ukraine;United States;
2016 Phase 3 EUCTR2015-005431-41-HR Bulgaria;Canada;Croatia;Georgia;Italy;Korea, Republic of;Malaysia;Poland;Romania;Taiwan;Turkey;Ukraine;United States;
2014 Phase 3 EUCTR2013-003752-21-PL France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003752-21-GB France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003752-21-DE France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States;
Satrazlizumab (RO5333787/ Enspryng /SA237)
F. Hoffmann-La Roche Ltd.
2014 Phase 3 EUCTR2013-003752-21-PL France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;Ukraine;United Kingdom;United States;
Seasonal Quadrivalent influenza vaccine
Novartis Pharmaceuticals
2018 Phase 3 NCT03650114 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
Seasonal influenza vaccine
Celgene
2021 Phase 3 NCT05028634 Germany;United States;
Novartis
2010 Phase 3 NCT01199861 Austria;Belgium;Canada;Finland;France;Guatemala;Poland;Spain;Switzerland;United Kingdom;
Second-generation fumaric acid
Biogen Idec Inc.
2004 - EUCTR2004-000663-99-SE Hungary;Sweden;
2004 - EUCTR2004-000663-99-HU Hungary;Sweden;
2004 - EUCTR2004-000663-99-CZ Czech Republic;Hungary;Sweden;
Secukinumab
NOVARTIS FARMA
2013 - EUCTR2012-004019-29-IT Argentina;Canada;Colombia;Finland;Germany;Italy;Japan;Poland;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
Novartis Pharma AG
2013 - EUCTR2012-004019-29-SE Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
2013 - EUCTR2012-004019-29-PT Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
2013 - EUCTR2012-004019-29-PL Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
2013 - EUCTR2012-004019-29-FI Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
2013 - EUCTR2012-004019-29-DE Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
Novartis Pharma K.K.
2013 Phase 2 JPRN-JapicCTI-132178 -
Novartis Pharma Services AG
2012 - EUCTR2011-001629-25-CZ Czech Republic;Russian Federation;Ukraine;
See Intervention Description)
NorthShore University HealthSystem
2016 Phase 4 NCT02670161 -
Sendoxan
Uppsala l?ns landsting
2011 - EUCTR2010-023560-40-SE Brazil;Canada;Sweden;United States;
Sendoxane
Helse Bergen HF, Haukeland University Hospital
2018 Phase 3 EUCTR2017-001362-25-DK Denmark;Netherlands;
Serum Free Avonex
Biogen Idec
2003 Phase 1 NCT00913250 -
Serum containing Avonex
Biogen Idec
2003 Phase 1 NCT00913250 -
Sham Transcranial Direct Current Stimulation (tDCS)
University of Iowa
2020 - NCT04391023 United States;
Short-course Ocrelizumab
Johns Hopkins University
2021 Phase 2 NCT04767698 United States;
Silodyx
Erasmus MC Dept. Urology
2016 Phase 3 EUCTR2015-002820-20-NL Netherlands;
Simethicone
Rocky Mountain MS Research Group, LLC
2014 Phase 4 NCT02217982 United States;
SimvaHEXAL® 40 mg Filmtabletten
University College London Comprehensive Clinical Trials Unit
2017 Phase 3 EUCTR2017-003328-56-GB United Kingdom;
Simvastatin
Alabama Neurology Associates, PC
2005 Phase 3 NCT00242268 United States;
Anna Tsakiri
2008 Phase 3 NCT00429442 Denmark;
Biogen Idec
2006 Phase 4 NCT00492765 Denmark;
Glostrup Hospital, Dep. of Neurology
2009 - EUCTR2006-001827-21-DK Denmark;
Glostrup University Hospital, Copenhagen
2006 Phase 3 NCT00261326 Denmark;
Imperial College London
2008 Phase 2 NCT00647348 United Kingdom;
Tehran University of Medical Sciences
2005 Phase 3 NCT00668343 Iran, Islamic Republic of;
University College, London
2019 Phase 2 NCT03896217 United Kingdom;
2018 Phase 3 NCT03387670 Ireland;United Kingdom;
Simvastatin 40 mg film-coated tablets
University College London
2020 Phase 2 EUCTR2017-003008-30-GB United Kingdom;
University College London Comprehensive Clinical Trials Unit
2017 Phase 3 EUCTR2017-003328-56-GB United Kingdom;
Simvastatin Alternova
Biogen Idec A/S
2006 - EUCTR2005-003930-16-SE Finland;Sweden;
2006 - EUCTR2005-003930-16-FI Finland;Sweden;
2005 - EUCTR2005-003930-16-DK Denmark;Finland;Sweden;
Simvastatin in relapsing remitting multiple sclerosis
Assiut University
2020 Phase 1 NCT04178980 -
Simvastatina Sandoz 40 mg comprimidos recubiertos con película EFG
University College London Comprehensive Clinical Trials Unit
2017 Phase 3 EUCTR2017-003328-56-GB United Kingdom;
Simvastatine
VUmc Neurology Department
2020 Phase 2 EUCTR2019-003127-38-NL Netherlands;
Simvastatine Sandoz 40 mg filmomhulde tabletten
University College London Comprehensive Clinical Trials Unit
2017 Phase 3 EUCTR2017-003328-56-GB United Kingdom;
Simvastatine Sandoz 40mg deelbare filmomhulde tabletten
University College London Comprehensive Clinical Trials Unit
2017 Phase 3 EUCTR2017-003328-56-GB United Kingdom;
Single-point cane (SPC)
Rowan University
2014 - NCT02227524 United States;
Single-pulse transcranial magnetic stimulation (spTMS)
Shirley Ryan AbilityLab
2017 - NCT03723434 United States;
Single-use autoinjector
Biogen Idec
2005 Phase 3 NCT00915577 -
Single-use autoinjector with a prefilled liquid Avonex syringe
Biogen
2009 Phase 3 NCT00828204 United States;
Sinvastatina Sandoz 40 mg comprimidos revestidos por película
University College London Comprehensive Clinical Trials Unit
2017 Phase 3 EUCTR2017-003328-56-GB United Kingdom;
Siponimob
NOVARTIS PHARMA SERVICES AG
2021 Phase 3 EUCTR2020-002700-39-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Siponimod
NOVARTIS FARMA
2012 - EUCTR2012-003056-36-IT Argentina;Australia;Austria;Bulgaria;Canada;Czech Republic;Egypt;Estonia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Pharma K.K.
2014 Phase 3 JPRN-JapicCTI-142447 -
Novartis Pharma Services AG
2010 Phase 2 EUCTR2009-014392-51-PL Canada;Finland;Germany;Hungary;Italy;Poland;Russian Federation;Spain;Turkey;United States;
2010 Phase 2 EUCTR2009-014392-51-HU Canada;Finland;Germany;Hungary;Italy;Poland;Russian Federation;Spain;Turkey;United States;
2010 Phase 2 EUCTR2009-014392-51-FI Canada;Finland;Germany;Hungary;Italy;Poland;Russian Federation;Spain;Turkey;United States;
2010 - EUCTR2009-014392-51-DE Canada;Finland;Germany;Hungary;Italy;Poland;Russian Federation;Spain;Turkey;United States;
Novartis Pharmaceuticals
2021 Phase 3 NCT04926818 Australia;Austria;Belgium;France;Germany;India;Latvia;Mexico;Poland;Portugal;Russian Federation;Slovakia;Spain;Turkey;United States;
2021 - NCT04933552 United States;
2021 - NCT04895202 Switzerland;
2021 - NCT04540861 -
2019 Phase 3 NCT03623243 Puerto Rico;United States;
Siponimod 0,
AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA
2021 Phase 4 EUCTR2020-005947-22-IT Italy;
Siponimod 0.25 mg tablet
Novartis Farmacéutica S.A
2012 - EUCTR2012-003056-36-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Pharma Services AG
2015 - EUCTR2012-003056-36-FR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-PL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-IE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-EE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 - EUCTR2012-003056-36-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
- Phase 3 EUCTR2012-003056-36-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Siponimod 0.5 mg tablet
Novartis Farmacéutica S.A
2012 - EUCTR2012-003056-36-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Pharma Services AG
2015 - EUCTR2012-003056-36-FR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-PL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-IE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-EE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 - EUCTR2012-003056-36-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
- Phase 3 EUCTR2012-003056-36-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Siponimod 1 mg tablet
Novartis Farmacéutica S.A
2012 - EUCTR2012-003056-36-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Pharma Services AG
2015 - EUCTR2012-003056-36-FR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-PL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-IE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-EE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 - EUCTR2012-003056-36-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
- Phase 3 EUCTR2012-003056-36-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Siponimod 2 mg tablet
Novartis Farmacéutica S.A
2012 - EUCTR2012-003056-36-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Pharma Services AG
2015 - EUCTR2012-003056-36-FR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-PL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-IE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-EE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 - EUCTR2012-003056-36-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
- Phase 3 EUCTR2012-003056-36-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Sirolimus
National Institute of Allergy and Infectious Diseases (NIAID)
2003 Phase 1/Phase 2 NCT00095329 United States;
Sivatin 40 mg film-coated tablets
University College London Comprehensive Clinical Trials Unit
2017 Phase 3 EUCTR2017-003328-56-GB United Kingdom;
Sivelestat
Tohoku University Hospital
2013 Phase 1,2 JPRN-UMIN000010094 Japan;
Sleep assessment
Centre Hospitalier Universitaire de Saint Etienne
2020 Phase 2 NCT03983720 France;
Smoked Cannabis
Center for Medicinal Cannabis Research
2003 Phase 1/Phase 2 NCT00260741 United States;
2001 Phase 1/Phase 2 NCT00248378 United States;
Sodium Chloride solution
Anders Svenningsson
2016 Phase 3 NCT02746744 Sweden;
Sodium chlorid
Sykehuset Innlandet HF
2009 - NCT00764413 Norway;
Solifenacin Succinate
Astellas Pharma Inc
2008 Phase 4 NCT00629642 Australia;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Portugal;Russian Federation;Spain;United Kingdom;
Soliris
Alexion Pharmaceuticals Inc.
2020 Phase 2;Phase 3 EUCTR2019-001829-26-DE Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States;
2019 Phase 2;Phase 3 EUCTR2019-001829-26-ES Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States;
SoluMedrol
University of Utah
2014 - NCT02296346 United States;
Solumedrol IM 125mg/2ml
NOVARTIS PHARMA AG
2018 Phase 2 EUCTR2017-004702-17-IT Austria;Bulgaria;Czech Republic;Czechia;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
Somatorelin
UNIVERSITA' DEGLI STUDI DI NAPOLI FEDERICO II
2009 - EUCTR2008-007447-14-IT Italy;
Spikevax
Novartis Pharma GmbH
2021 Phase 4 EUCTR2020-005752-38-DE Germany;
Novartis Pharma Vertriebs GmbH
2021 Phase 4 EUCTR2021-000307-20-DE Germany;
Spiropent
Department of Neurology UMCG
2006 - EUCTR2006-004318-42-NL Netherlands;
Ss-interferon
Sun Yat-sen University
2006 - NCT00818103 China;
Standard MS DMT
Novartis Pharmaceuticals
2011 Phase 4 NCT01317004 Italy;
Standard MS DMTs
Novartis Pharmaceuticals
2010 Phase 4 NCT01216072 Canada;Puerto Rico;United States;
Standard gadolinium contrast
National Center for Research Resources (NCRR)
1999 - NCT00006060 United States;
Standard interval dosing
VU University Medical Center
2020 Phase 4 NCT04225312 Netherlands;
Standard treatment with a conventional drug
Northwestern University
2005 Phase 2 NCT00273364 United States;
Standardized cannabis extract
Institut fur Klinische Forschung, Germany
2006 Phase 3 NCT00552604 United Kingdom;
Statin
Università Popolare Homo & Natura
2015 Phase 1 NCT02632591 Italy;
Stem Cell Transplantation
Stem Cells Arabia
2016 Phase 1 NCT03069170 Jordan;
Steroid Cream
University of Nebraska
2010 Phase 4 NCT00988988 United States;
Study Drug
Biogen
2014 Phase 1 NCT02201849 United States;
Sublingual tizanidine
Teva GTC
2008 Phase 1/Phase 2 NCT00464958 Israel;
Sunphenon EGCG
Friedemann Paul
2009 Phase 2/Phase 3 NCT00799890 Germany;
Sunphenon EGCg
Charite Universitätsmedizin Berlin
- Phase 2;Phase 3 EUCTR2008-005213-22-DE Germany;
Sunphenon EGCg TM
Charité-Universitätsmedizin Berlin
2007 - EUCTR2006-006323-39-DE Germany;
Suspension media
University Hospital, Toulouse
2015 Phase 1/Phase 2 NCT02403947 France;
Sustained-release oral dalfampridine
Sheba Medical Center
2014 Phase 4 NCT02259361 Israel;
Suvorexant
Theodore R. Brown, MD MPH
2017 Phase 4 NCT03110315 United States;
Syngeneic Bone Marrow Transplantation
Fred Hutchinson Cancer Research Center
2008 Phase 2 NCT00716066 United States;
T cell vaccination
Hadassah Medical Organization
2002 Phase 1/Phase 2 NCT01448252 Israel;
Sheba Medical Center
2002 Phase 3 NCT00228228 Israel;
T-Cell Vaccination
Sheba Medical Center
1998 Phase 1/Phase 2 NCT00220428 Israel;
TACHIPIRINA - 500 MG COMPRESSE20 COMPRESSE
NOVARTIS PHARMA AG
2018 Phase 2 EUCTR2017-004702-17-IT Austria;Bulgaria;Czech Republic;Czechia;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
TACI-Fc5
Merck Serono Geneva- an affiliate of Merck KGaA, Darmstadt Germany
2008 - EUCTR2007-003936-50-SE Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
Merck Serono International
2009 Phase 2 EUCTR2008-005021-11-FR Belgium;Czech Republic;France;Sweden;
2009 Phase 2 EUCTR2008-005021-11-CZ Belgium;Czech Republic;France;Sweden;
2009 - EUCTR2008-005021-11-SE Belgium;Czech Republic;France;Sweden;
Merck Serono International S.A.
2008 Phase 2 EUCTR2007-003936-50-FR Austria;Belgium;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2008 Phase 2 EUCTR2007-003936-50-ES Austria;Belgium;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-003936-50-NL Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
Merck Serono S.A. - Geneva
2008 - EUCTR2007-003936-50-GB Australia;Austria;Canada;Czech Republic;France;Lebanon;Lithuania;Netherlands;Russian Federation;Spain;Sweden;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-003936-50-AT Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
Merck Serono SA - Geneva, An affiliate of Merck KGaA, Darmstadt, Germany
2009 - EUCTR2008-005021-11-BE Belgium;Czech Republic;France;Sweden;
Merck Serono SA - Geneva, an affiliate of Merck KGaA, Darmstadt, Germany
2008 - EUCTR2007-003936-50-CZ Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-003936-50-BE Austria;Belgium;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
Merck Serono SA-Geneva
2008 - EUCTR2007-003936-50-LT Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
TCD after bosentan administration
Universitair Ziekenhuis Brussel
2014 - NCT02389426 Belgium;
TCD baseline
Universitair Ziekenhuis Brussel
2014 - NCT02389426 Belgium;
TECFIDERA
Biogen Idec Research Limited
2019 Phase 3 EUCTR2018-000516-22-PT Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-000516-22-HU Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-000516-22-EE Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States;
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France;
TECFIDERA - 240 MG - CAPSULA RIGIDA GASTRORESISTENTE - USO ORALE - BLISTER (PVC/PE/PVDC-PVC ALLUMINIO) - 56 CAPSULE
FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA
2017 Phase 4 EUCTR2017-000559-26-IT Israel;Italy;Switzerland;United States;
TENOFOVIR ALAFENAMIDE FUMARATE 25 Mg ORAL TABLET [VEMLIDY]
Harvard Medical School
2022 Phase 2 NCT04880577 -
TERIFLUNOMIDE HMR1726
Sanofi
2019 Phase 4 NCT03856619 India;
TETRAHYDROCANNABINOL Botanical Drug Substance (THC BDS)
Almirall Hermal GmbH
2016 Phase 4 EUCTR2015-004451-40-AT Austria;Czech Republic;
TG-1101
TG Therapeutics
2017 Phase 3 EUCTR2017-000639-15-HR Belarus;Croatia;Georgia;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000639-15-GB Belarus;Croatia;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000639-15-ES Belarus;Croatia;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000638-75-GB Belarus;Georgia;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000638-75-ES Belarus;Georgia;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
TG Therapeutics, Inc.
2020 Phase 3 EUCTR2019-003625-16-HR Belarus;Croatia;Georgia;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
2017 Phase 3 EUCTR2017-000639-15-PL Belarus;Croatia;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000638-75-PL Belarus;Georgia;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
THC
Aarhus Universitetshospital
2018 Phase 2 EUCTR2018-002315-98-DK Denmark;
TMP001
Dr. Frank Behrens
2015 Phase 2 NCT02686788 Germany;
Fraunhofer Gesellschaft for its Institute Fraunhofer Institute for Molecular Biology and Applied Ecology (IME)
2015 Phase 2 EUCTR2014-004483-38-DE Germany;
TORVAST*10CPR
DR DIMENSIONE RICERCA
2005 - EUCTR2005-001009-25-IT Italy;
TSO
Charite Universitätsmedizin Berlin
2011 Phase 2 EUCTR2009-015319-41-DE Germany;
Danish Multiple Sclerosis Research Center
2009 Phase 2 EUCTR2008-007549-29-DK Denmark;
TT Vaccine
Hoffmann-La Roche
2015 Phase 3 NCT02545868 Canada;United States;
TV-5010
TEVA
2004 - EUCTR2004-000759-40-IT Italy;
TEVA ITALIA srl
2004 - EUCTR2004-000762-13-IT Italy;
TV-5600
TEVA ITALIA srl
2008 - EUCTR2007-005450-23-IT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2007 - EUCTR2007-003226-19-IT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
TEVA PHARMACEUTICALS INDUSTRIES LTD
2013 Phase 3 EUCTR2012-003647-30-IT Albania;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Poland;Puerto Rico;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Teva Pharmaceutical Industries Ltd
2013 Phase 3 EUCTR2012-003647-30-PL Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003647-30-HU Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003647-30-ES Albania;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003647-30-EE Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003647-30-CZ Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003647-30-BE Albania;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003647-30-AT Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003647-30-SK Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003647-30-LV Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003647-30-GR Albania;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003647-30-GB Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-015815-42-SK Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Poland;Slovakia;Spain;
2010 Phase 3 EUCTR2009-015815-42-PL Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States;
2010 Phase 3 EUCTR2009-015815-42-LT Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States;
2010 Phase 3 EUCTR2009-015815-42-IT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Poland;Slovakia;Spain;
2010 Phase 3 EUCTR2009-015815-42-EE Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States;
2010 Phase 3 EUCTR2009-015815-42-CZ Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States;
2010 Phase 3 EUCTR2009-015815-42-BG Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States;
2010 Phase 3 EUCTR2009-012989-30-SE Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-012989-30-FR Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2010 Phase 3 EUCTR2009-012989-30-BG Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-012989-30-AT Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-012989-30-NL Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-012989-30-LT Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-012989-30-HU Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-012989-30-GB Austria;Bulgaria;Canada;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-012989-30-ES Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2009 Phase 3 EUCTR2009-012989-30-EE Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-012989-30-CZ Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 - EUCTR2009-011234-99-DE Germany;
2008 Phase 3 EUCTR2007-005450-23-SK Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Slovakia;Spain;
2008 - EUCTR2007-005450-23-LT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2008 - EUCTR2007-005450-23-ES Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2008 - EUCTR2007-005450-23-EE Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2008 - EUCTR2007-005450-23-DE Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2008 - EUCTR2007-005450-23-CZ Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2008 - EUCTR2007-005450-23-BG Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2008 - EUCTR2007-003226-19-PT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-003226-19-LT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-003226-19-BG Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 Phase 3 EUCTR2007-003226-19-FR Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 Phase 3 EUCTR2007-003226-19-ES Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-SE Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-NL Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-LV Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-HU Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-GB Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-EE Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-DE Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-CZ Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-AT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2006 Phase 2 EUCTR2005-004334-41-GB Czech Republic;Germany;Hungary;Israel;Italy;Poland;Russian Federation;Spain;United Kingdom;
2006 Phase 2 EUCTR2005-004334-41-DE Czech Republic;Germany;Hungary;Israel;Italy;Russian Federation;Spain;United Kingdom;
2006 Phase 2 EUCTR2005-004334-41-CZ Czech Republic;Germany;Hungary;Israel;Italy;Russian Federation;Spain;United Kingdom;
2005 Phase 2 EUCTR2005-004334-41-HU Czech Republic;Germany;Hungary;Israel;Italy;Russian Federation;Spain;United Kingdom;
Teva Pharmaceutical Industries Ltd.
2015 Phase 2 EUCTR2014-001579-30-DE Canada;Germany;Italy;Netherlands;Poland;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2015 - EUCTR2014-001579-30-NL Canada;Germany;Italy;Netherlands;Poland;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2014 Phase 2 EUCTR2014-001579-30-IT Canada;Germany;Italy;Netherlands;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2014 Phase 2 EUCTR2014-001579-30-GB Canada;Germany;Italy;Netherlands;Poland;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2014 Phase 2 EUCTR2014-001579-30-ES Canada;Germany;Italy;Netherlands;Poland;Russian Federation;Spain;Ukraine;United Kingdom;United States;
Teva Pharmaceutical Industries, Ltd.
2014 - EUCTR2013-002082-19-NL Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
2014 - EUCTR2013-002082-19-ES Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
2013 Phase 3 EUCTR2013-002082-19-GB Belgium;Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
2013 Phase 3 EUCTR2013-002082-19-BE Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2013-002082-19-SE Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2013-002082-19-FI Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2013-002082-19-DK Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
TYSABRI 300 mg concentrado para solución para perfusión
Biogen Idec Limited
2010 - EUCTR2009-015556-15-ES Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
TYSABRI 300 mg concentrate for solution for infusion
BIOGEN IDEC LTD
2006 Phase 3 EUCTR2005-004061-41-GB Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
TYSABRI 300 mg solution à diluer pour perfusion
Hôpitaux Universitaires de Strasbourg
2014 - EUCTR2014-003209-14-FR France;
TYSABRI and AVONEX
Biogen Idec
2008 Phase 4 NCT00771043 United States;
TYSABRI*IV 1FL 300MG 15ML
BIOGEN IDEC LTD
2011 - EUCTR2010-024000-10-IT Belgium;Germany;Italy;Spain;
2011 - EUCTR2010-021978-11-IT Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Ireland;Italy;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
TYSABRI®
BIOGEN IDEC LTD
2007 - EUCTR2005-004061-41-SE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 Phase 3 EUCTR2005-004061-41-BE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 - EUCTR2005-004061-41-IE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 - EUCTR2005-004061-41-HU Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 - EUCTR2005-004061-41-GR Austria;Czech Republic;Denmark;Finland;Germany;Greece;Ireland;Italy;Spain;Sweden;United Kingdom;
2006 - EUCTR2005-004061-41-FI Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 - EUCTR2005-004061-41-DK Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 - EUCTR2005-004061-41-DE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 - EUCTR2005-004061-41-CZ Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
Tachipirina CPR
NOVARTIS PHARMA AG
2018 Phase 2 EUCTR2017-004702-17-IT Austria;Bulgaria;Czech Republic;Czechia;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
Tarenflurbil
Fraunhofer Gesellschaft for its Institute Fraunhofer Institute for Molecular Biology and Applied Ecology (IME)
2015 Phase 2 EUCTR2014-004483-38-DE Germany;
Targretin
Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge
2015 Phase 2 EUCTR2014-003145-99-GB United Kingdom;
Taurine
University of Iowa
2010 Phase 1 NCT01381354 United States;
Tcelna
Opexa Therapeutics, Inc.
2012 Phase 2 NCT01684761 Canada;United States;
Tecfidera
Banner Life Sciences LLC
2019 Phase 1 NCT04022473 United States;
Biogen GmbH
2015 Phase 4 EUCTR2014-000395-26-DE Germany;
Biogen Idec Ltd.
2009 Phase 3 EUCTR2008-004753-14-DE Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
Biogen Idec Norway
2015 Phase 4 EUCTR2015-001197-18-NO Norway;
Biogen Idec Research Limited
2014 Phase 4 EUCTR2013-001656-35-SK Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2014 Phase 4 EUCTR2013-001656-35-SI Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2014 Phase 4 EUCTR2013-001656-35-PT Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2014 Phase 4 EUCTR2013-001656-35-IT Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2014 Phase 4 EUCTR2013-001656-35-HU Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2014 Phase 4 EUCTR2013-001656-35-FR Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2014 Phase 4 EUCTR2013-001656-35-ES Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2014 Phase 4 EUCTR2013-001656-35-CZ Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2014 Phase 4 EUCTR2013-001656-35-BE Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2014 Phase 4 EUCTR2013-001656-35-AT Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2014 - EUCTR2013-001895-40-IE Ireland;United Kingdom;
2014 - EUCTR2013-001486-17-DE Germany;
Department of Clinical Sciences, Danderyd Hospital
2015 Phase 3 EUCTR2015-004116-38-SE Sweden;
EMD Serono Research & Development Institute, Inc.
2017 Phase 2 NCT02975349 Bulgaria;Czechia;Germany;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United States;
Finn Sellebjerg
2016 Phase 2 EUCTR2016-000283-41-DK Denmark;
IMS HEALTH GmbH & Co. OHG
2016 - NCT02823951 Canada;United States;
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden;
2017 Phase 4 EUCTR2016-003587-39-SE Sweden;
Merck KGaA
2017 Phase 2 EUCTR2016-001448-21-SK Bulgaria;Croatia;Czech Republic;Czechia;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-001448-21-PL Bulgaria;Croatia;Czech Republic;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-001448-21-ES Bulgaria;Croatia;Czech Republic;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-001448-21-CZ Bulgaria;Croatia;Czech Republic;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-001448-21-BG Bulgaria;Croatia;Czech Republic;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
Northwestern University
2013 Phase 2 EUCTR2012-004165-41-GB United Kingdom;United States;
University of Texas Southwestern Medical Center
2016 Phase 4 NCT02739542 United States;
Yale University
2014 - NCT02218879 United States;
Tecfidera (BG00012)
Biogen Idec Research Limited
2015 Phase 4 EUCTR2013-001025-53-DK Denmark;Finland;Netherlands;Norway;Spain;United Kingdom;
2015 - EUCTR2013-001025-53-ES Denmark;Finland;Netherlands;Norway;Spain;United Kingdom;
Tecfidera (BG12)
Sheffield Teaching Hospitals NHS Foundation Trust
2013 Phase 2/Phase 3 NCT03133403 United Kingdom;
Tecfidera®
Alkermes, Inc.
2019 Phase 3 EUCTR2017-001294-16-DE Germany;Poland;United States;
2017 Phase 3 EUCTR2017-001294-16-PL Germany;Poland;United States;
Biogen Idec Italia S.r.l.
2015 - EUCTR2015-000303-21-IT Italy;
Biogen Idec Research Limited
2015 Phase 3 EUCTR2014-004562-22-DE Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States;
Tecfidera® 120mg magensaftresistente Hartkapseln
Universitätsklinikum Münster
2015 Phase 4 EUCTR2014-003481-25-DE Germany;
Tecfidera® 240mg magensaftresistente Hartkapseln
Universitätsklinikum Münster
2015 Phase 4 EUCTR2014-003481-25-DE Germany;
Tecifdera (dimethyl fumarate)
Brigham and Women's Hospital
2015 - NCT02419638 United States;
Temelimab
GeNeuro Innovation SAS
2021 Phase 2 NCT05049161 Sweden;
2020 Phase 2 NCT04480307 Sweden;
2020 Phase 2 EUCTR2019-004822-15-SE Sweden;
Temsirolimus Tablets
Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development
2005 - EUCTR2005-000171-18-FI Finland;
Teriflunomide
Actelion
2015 Phase 3 NCT02425644 Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Aventis Pharmaceuticals Inc.
2006 - EUCTR2004-000555-42-PT Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
Biocad
2019 Phase 2 NCT04056897 Russian Federation;
Centre Hospitalier Universitaire de Nice
2015 Phase 3 NCT02587195 France;
Centre hospitalier de l'Université de Montréal (CHUM)
2015 - NCT02490982 Canada;
Genzyme, a Sanofi Company
2014 Phase 3 NCT02201108 Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Israel;Lebanon;Lithuania;Macedonia, The Former Yugoslav Republic of;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States;
Hoffmann-La Roche
2021 Phase 3 NCT04586023 Austria;Brazil;Bulgaria;Canada;Denmark;France;Greece;Guatemala;India;Italy;Korea, Republic of;Mexico;Poland;Russian Federation;Turkey;United Kingdom;United States;
2021 Phase 3 NCT04586010 Argentina;China;Finland;Germany;Hong Kong;Hungary;Italy;Netherlands;Peru;Portugal;Russian Federation;Spain;Switzerland;Taiwan;Ukraine;United States;
Jan Lycke
2019 Phase 4 NCT04129736 Sweden;
McGill University
2016 - NCT03561402 Canada;
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
2020 Phase 3 NCT04338061 Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Latvia;Lithuania;Malaysia;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Turkey;Ukraine;United States;
2020 Phase 3 NCT04338022 Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Czechia;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
NOVARTIS PHARMA SERVICES AG
2017 Phase 3 EUCTR2015-005419-33-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
2017 Phase 3 EUCTR2015-005418-31-IT Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
Novartis Farmacéutica S.A.
2022 Phase 3 EUCTR2020-005929-89-ES Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States;
2022 Phase 3 EUCTR2020-005899-36-ES Slovakia;Spain;
Novartis Pharma AG
2022 Phase 3 EUCTR2020-005929-89-SE Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States;
2022 Phase 3 EUCTR2020-005899-36-SK Argentina;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;France;Germany;Guatemala;Hong Kong;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;United Kingdom;United States;
Novartis Pharmaceuticals
2021 Phase 3 NCT05156281 United States;
2021 Phase 3 NCT05147220 United States;
Providence Health & Services
2013 Phase 4 NCT01970410 United States;
Sanofi
2013 Phase 4 NCT01895335 Austria;Belgium;Canada;Chile;Finland;France;Germany;Greece;Italy;Norway;Spain;Sweden;United Kingdom;United States;
2011 Phase 3 NCT01252355 Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
2011 Phase 2 NCT01403376 Austria;Canada;Germany;Russian Federation;Ukraine;
2009 Phase 3 NCT00883337 Belgium;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Poland;Spain;Switzerland;Tunisia;United Kingdom;
2008 Phase 3 NCT00751881 Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;South Africa;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2008 Phase 3 NCT00622700 Australia;Austria;Brazil;Bulgaria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Italy;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States;
2007 Phase 2 NCT00811395 Austria;Canada;Germany;Italy;Spain;United Kingdom;United States;
2007 Phase 2 NCT00489489 Canada;Germany;Italy;Poland;Spain;United States;
2007 Phase 2 NCT00475865 Austria;Canada;Germany;Italy;United Kingdom;United States;
2004 Phase 3 NCT00134563 Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2001 Phase 2 NCT01487096 Canada;France;
Sanofi-Aventis US, Inc.
2004 - EUCTR2004-000555-42-AT Austria;Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
Sanofi-Aventis recherche & de'veloppement
2008 - EUCTR2007-003997-24-IT Austria;Italy;Spain;United Kingdom;
Sanofi-Aventis recherche & développement
2008 - EUCTR2007-003997-24-GB Austria;Italy;Spain;United Kingdom;
2007 - EUCTR2007-003997-24-ES Austria;Italy;Spain;United Kingdom;
2007 - EUCTR2007-003997-24-AT Austria;Italy;Spain;United Kingdom;
Sanofi-aventis U.S. Inc
2007 - EUCTR2006-003134-14-IT Germany;Italy;Spain;
2007 - EUCTR2004-000555-42-EE Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
Sanofi-aventis U.S. Inc.
2007 Phase 2 EUCTR2006-004893-29-GB Austria;Germany;Italy;United Kingdom;
2007 Phase 2 EUCTR2006-003134-14-ES Germany;Italy;Spain;
2007 - EUCTR2006-004893-29-IT Austria;Germany;Italy;United Kingdom;
2007 - EUCTR2006-004893-29-AT Austria;Germany;Italy;United Kingdom;
2007 - EUCTR2006-003134-14-DE Germany;Italy;Spain;
- - EUCTR2006-004893-29-DE Austria;Germany;Italy;United Kingdom;
Sanofi-aventis US, Inc
2008 Phase 3 EUCTR2004-000555-42-GB Austria;Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
2005 - EUCTR2004-000555-42-DK Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
2004 - EUCTR2004-000555-42-SE Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
2004 - EUCTR2004-000555-42-NO Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
Sanofi-aventis recherche & développement
2010 - EUCTR2007-004452-36-SK Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2009 Phase 3 EUCTR2007-004452-36-SE Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2009 Phase 3 EUCTR2007-004452-36-GR Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2009 Phase 3 EUCTR2007-004452-36-GB Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2008 Phase 3 EUCTR2006-001152-12-FR Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom;
2008 - EUCTR2007-004452-36-FR Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-004452-36-ES Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-004452-36-EE Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-004452-36-DE Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2008 - EUCTR2006-001152-12-SK Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom;
TG Therapeutics, Inc.
2017 Phase 3 NCT03277261 United States;
2017 Phase 3 NCT03277248 United States;
Tanaka Tomoyuki
2021 Phase 3 JPRN-jRCT2021200035 Belarus;Bulgaria;Canada;China;Czechia;Denmark;Estonia;Finland;Germany;Italy;Japan;Lithuania;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
Turku University Hospital
2017 Phase 4 EUCTR2016-003622-16-FI Finland;
UNIVERSITÀ CATTOLICA DEL SACRO CUORE- POLICLINICO A. GEMELLI
2016 Phase 4 EUCTR2016-001515-20-IT Italy;
University at Buffalo
2018 - NCT03526224 United States;
University of Michigan
2018 - NCT03464448 United States;
sanofi-aventis Recherche & Dévelopment
2009 - EUCTR2008-006226-34-FR Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom;
sanofi-aventis U.S Inc
2007 - EUCTR2004-000555-42-CZ Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
sanofi-aventis group
2011 - EUCTR2010-023172-12-GR Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom;
sanofi-aventis recherche de veloppement
2007 - EUCTR2006-003361-14-IT Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom;
sanofi-aventis recherche & developpement
2011 - EUCTR2011-001160-21-DE Austria;Canada;Germany;Russian Federation;Ukraine;
2011 - EUCTR2011-001160-21-AT Austria;Canada;Germany;Russian Federation;Ukraine;
sanofi-aventis recherche & développement
2009 - EUCTR2007-004452-36-AT Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2009 - EUCTR2006-003361-14-EE Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom;
2009 - EUCTR2006-003361-14-CZ Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2009 - EUCTR2006-001152-12-LT Australia;Austria;Belarus;Bulgaria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States;
2009 - EUCTR2006-001152-12-DE Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom;
2008 Phase 3 EUCTR2007-004452-36-BE Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2008 Phase 3 EUCTR2006-003361-14-PT Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom;
2008 Phase 3 EUCTR2006-001152-12-BG Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom;
2008 - EUCTR2007-004452-36-NL Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-004452-36-CZ Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2008 - EUCTR2006-003361-14-NL Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2008 - EUCTR2006-003361-14-DK Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom;
2008 - EUCTR2006-001152-12-HU Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States;
2008 - EUCTR2006-001152-12-EE Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States;
2007 Phase 3 EUCTR2006-003361-14-SE Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom;
2007 Phase 3 EUCTR2006-003361-14-GB Austria;Canada;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2007 Phase 3 EUCTR2006-001152-12-GB Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States;
2007 Phase 3 EUCTR2006-001152-12-FI Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom;
2007 Phase 3 EUCTR2006-001152-12-CZ Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States;
2007 - EUCTR2006-003361-14-DE Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Poland;Portugal;Russian Federation;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2007 - EUCTR2006-001152-12-DK Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States;
2007 - EUCTR2006-001152-12-AT Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom;
2006 Phase 3 EUCTR2006-003361-14-FI Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom;
2006 - EUCTR2006-003361-14-AT Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
sanofi-aventis recherche et development
2012 - EUCTR2010-023172-12-LT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
2011 Phase 3 EUCTR2010-023172-12-SK Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2011 Phase 3 EUCTR2010-023172-12-HU Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
2011 Phase 3 EUCTR2010-023172-12-BE Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-023172-12-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
2011 - EUCTR2010-023172-12-PT Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-023172-12-NO Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
2011 - EUCTR2010-023172-12-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
2011 - EUCTR2010-023172-12-IT Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-023172-12-GB Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-023172-12-FI Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
2011 - EUCTR2010-023172-12-ES Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-023172-12-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
2011 - EUCTR2010-023172-12-DK Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-023172-12-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
2011 - EUCTR2010-023172-12-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
2009 Phase 3 EUCTR2008-006226-34-GR Belgium;Czech Republic;France;Germany;Greece;Hungary;Italy;Spain;United Kingdom;
2009 - EUCTR2008-006226-34-IT Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom;
2009 - EUCTR2008-006226-34-ES Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom;
2009 - EUCTR2008-006226-34-BE Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom;
sanofi-aventis recherche et developpement
2010 - EUCTR2008-006226-34-GB Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom;
2009 - EUCTR2008-006226-34-HU Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom;
2009 - EUCTR2008-006226-34-DE Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom;
2009 - EUCTR2008-006226-34-CZ Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom;
Teriflunomide (HMR1726)
Sanofi
2013 - NCT03198351 Canada;United States;
2006 Phase 3 NCT00803049 Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2002 Phase 2 NCT00228163 Canada;France;
Teriflunomide 14 MG Oral Tablet [Aubagio]
Centre Hospitalier Universitaire de Nice
2017 Phase 3 NCT03122652 France;Germany;Martinique;Sweden;Switzerland;Turkey;United Kingdom;
Teriflunomide HMR1726
Sanofi
2020 Phase 3 NCT04410991 Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 NCT04410978 Austria;Belarus;Bulgaria;Canada;China;Czechia;Denmark;Estonia;Finland;Germany;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2014 Phase 1 NCT02046629 China;
2013 Phase 3 NCT01863888 Belgium;Germany;Netherlands;
Teriflunomide capsule
Novartis Pharmaceuticals
2016 Phase 3 NCT02792231 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Finland;France;Germany;Hungary;India;Italy;Latvia;Lithuania;Mexico;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 NCT02792218 Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Mexico;Netherlands;Poland;Puerto Rico;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
Testosterone
University of California, Los Angeles
2014 Phase 2 NCT02317263 -
Testosterone undecanoate
Health Sciences Centre, Winnipeg, Manitoba
2012 Phase 2 NCT01516554 Canada;
Tetanus diphtheria toxoid vaccine (Td)
Biogen
2008 Phase 4 NCT00536120 United States;
Tetanus diphtheria toxoids vaccine
Biogen
2015 Phase 2 NCT02097849 United States;
Tetanus toxoid (TT) containing vaccine (Td, Tdap)
Novartis Pharmaceuticals
2018 Phase 3 NCT03650114 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
Tetanus toxoid vaccine
Novartis
2010 Phase 3 NCT01199861 Austria;Belgium;Canada;Finland;France;Guatemala;Poland;Spain;Switzerland;United Kingdom;
Tetanus, diphtheria, and acellular pertussis vaccine
Celgene
2021 Phase 3 NCT05028634 Germany;United States;
Tetracycline
Università Popolare Homo & Natura
2015 Phase 1 NCT02632591 Italy;
Tetracycline - Statin - Antimycotic
Università Popolare Homo & Natura
2015 Phase 0 NCT02606929 Italy;
Tetrahydrocannabinol (THC)
Tiffany J. Braley, MD, MS
2022 Phase 2 NCT05269628 United States;
Tetrahydrocannabinol Botanical Drug Substance (THC BDS)
GW Pharma Limited
2022 Phase 3 EUCTR2020-004306-58-LT Bulgaria;Canada;Hungary;Italy;Lithuania;Spain;United Kingdom;United States;
2021 Phase 3 EUCTR2020-003271-18-ES Australia;Belgium;Czech Republic;Czechia;Poland;Spain;Sweden;United Kingdom;
2021 Phase 3 EUCTR2020-003271-18-CZ Australia;Belgium;Czech Republic;Czechia;Poland;Spain;Sweden;United Kingdom;
2021 Phase 3 EUCTR2019-002625-29-CZ Czech Republic;Czechia;Poland;United Kingdom;
2020 Phase 3 EUCTR2019-002625-29-PL Czech Republic;Czechia;Poland;United Kingdom;
2020 Phase 3 EUCTR2019-002625-29-GB Poland;United Kingdom;
GW Pharma Ltd
2020 Phase 3 EUCTR2019-002623-14-PL Czech Republic;Czechia;Poland;Romania;United Kingdom;United States;
2020 Phase 3 EUCTR2019-002623-14-GB Czech Republic;Poland;Romania;United Kingdom;United States;
2020 Phase 3 EUCTR2019-002623-14-CZ Czech Republic;Czechia;Poland;Romania;United Kingdom;United States;
Thiamine
University of Iowa
2010 Phase 1 NCT01381354 United States;
Thiotepa
OSPEDALE S. RAFFAELE
2007 Phase 2 EUCTR2007-000586-38-IT Italy;
Thymoglobuline
Sheffield Teaching Hospitals
2020 Phase 3 EUCTR2019-001549-42-GB United Kingdom;
Uppsala l?ns landsting
2011 - EUCTR2010-023560-40-SE Brazil;Canada;Sweden;United States;
Thymoglobuline®
Helse Bergen HF, Haukeland University Hospital
2019 Phase 3 EUCTR2017-001362-25-NL Denmark;Netherlands;
2018 Phase 3 EUCTR2017-001362-25-DK Denmark;Netherlands;
Thymol
Department of Neurology and Neurological Science, Tokyo Medical and Dental University
2021 - JPRN-UMIN000043910 Japan;
Tissue Selective Estrogen Complex
University of California, San Francisco
2016 Phase 2 NCT02710214 United States;
Tizanidine (sublingual or oral)
Teva GTC
2006 Phase 1/Phase 2 NCT00358293 Israel;
Tizanidine hydrochloride capsule
Elan Pharmaceuticals
2002 Phase 3 NCT00047580 United States;
Tocilizumab
Department of Immunology, National Institute of Neuroscience, NCNP
2014 - JPRN-UMIN000012705 Japan;
2012 - JPRN-UMIN000007866 Japan;
2011 - JPRN-UMIN000005889 Japan;
Department of Neurology, Shimane University Hospital
2016 - JPRN-UMIN000022201 Japan;
Fu-Dong Shi
2017 Phase 1/Phase 2 NCT03062579 China;
Yamamura Takashi
2013 - JPRN-jRCTs031180346 Japan;
2012 - JPRN-jRCTs031180152 Japan;
Tocilizumab Injection
Tianjin Medical University General Hospital
2017 Phase 2/Phase 3 NCT03350633 China;
Tolebrutinib
National Institute of Neurological Disorders and Stroke (NINDS)
2021 Phase 2 NCT04742400 United States;
Sanofi
2020 Phase 3 NCT04458051 Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 NCT04411641 Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 NCT04410991 Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 NCT04410978 Austria;Belarus;Bulgaria;Canada;China;Czechia;Denmark;Estonia;Finland;Germany;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2019 Phase 2 NCT03996291 Canada;Czechia;Estonia;France;Netherlands;Russian Federation;Spain;Ukraine;United States;
Tolerogenic Dendritic cells loaded with myelin peptides
Sara Varea
2015 Phase 1 NCT02283671 Spain;
Tolerogenic Fibroblasts
FibroBiologics
2020 Early Phase 1 NCT05080270 Mexico;
Tolerogenic dendritic cells (tolDC)
University Hospital, Antwerp
2017 Phase 1 NCT02618902 Belgium;
Tolperisone HC1
Avigen Inc
2007 Phase 2 EUCTR2007-001031-63-CZ Czech Republic;Germany;
2007 - EUCTR2007-001031-63-DE Germany;
Tolperisone HCl
Avigen
2007 Phase 2 NCT00532532 Czech Republic;Former Serbia and Montenegro;Germany;Russian Federation;Serbia;Ukraine;
Tolpersan
Avigen Inc
2007 Phase 2 EUCTR2007-001031-63-CZ Czech Republic;Germany;
2007 - EUCTR2007-001031-63-DE Germany;
Tolposan
Avigen Inc
2007 Phase 2 EUCTR2007-001031-63-CZ Czech Republic;Germany;
2007 - EUCTR2007-001031-63-DE Germany;
Topical Preparation H arm
New York University School of Medicine
2015 Phase 4 NCT02665221 United States;
Tovaxin
Opexa Therapeutics, Inc.
2007 Phase 2 NCT00595920 United States;
Tovaxin Autologous T Cell Vaccine
Opexa Therapeutics, Inc.
2002 Phase 1/Phase 2 NCT00587691 United States;
Tovaxin Autologous T cell vaccine
Opexa Therapeutics, Inc.
2006 Phase 2 NCT00245622 United States;
Tracleer
UZ Brussel
2017 Phase 2 EUCTR2017-001253-13-BE Belgium;
Trancopal Dolo
Charité-Universitätsmedizin Berlin
2007 Phase 2 EUCTR2006-005262-39-DE Germany;
Transcranial Magnetic Stimulation (TMS)
Maimónides Biomedical Research Institute of Córdoba
2019 Phase 1/Phase 2 NCT04062331 -
Trekking pole (TP).
Rowan University
2014 - NCT02227524 United States;
Trichuris suis Ova
Danish Multiple Sclerosis Research Center
2009 Phase 2 EUCTR2008-007549-29-DK Denmark;
Trichuris suis eggs
Danish Multiple Sclerosis Research Center
2009 Phase 2 EUCTR2008-007549-29-DK Denmark;
Trichuris suis ova
Charite University, Berlin, Germany
2012 Phase 2 NCT01413243 Germany;
Rigshospitalet, Denmark
2010 Phase 2 NCT01006941 Denmark;
Trichuris suis ova (eggs), embryonated, viable
Charite Universitätsmedizin Berlin
2011 Phase 2 EUCTR2009-015319-41-DE Germany;
Trileptal
Queen Mary University London
2014 Phase 2 EUCTR2013-002419-87-GB United Kingdom;
Triomar™ (omega-3 fatty acids)
Haukeland University Hospital
2004 Phase 2/Phase 3 NCT00360906 Norway;
Trivalent seasonal influenza vaccine
Biogen
2010 Phase 2 NCT01051349 Czech Republic;Czechia;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
Trulicity 0,75 mg injekcný roztok naplnený v injekcnom pere.
Lekárska fakulta UK Bratislava
2019 Phase 2 EUCTR2019-003001-94-SK Slovakia;
Tylenol Pill
Holy Name Medical Center, Inc.
2017 Phase 4 NCT03424733 United States;
Tysabri
Amsterdam University Medical Center
2019 Phase 4 EUCTR2019-002566-13-NL Netherlands;
BIOGEN IDEC LTD
2006 - EUCTR2005-004061-41-IT Australia;Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;New Zealand;Spain;Sweden;Switzerland;Turkey;United Kingdom;
Biogen
2018 - NCT03399981 United States;
Biogen Idec
2014 Phase 4 EUCTR2014-003669-97-BE Belgium;
Biogen Idec International GmbH
2010 Phase 4 EUCTR2009-009503-19-BE Belgium;
Biogen Idec Limited
2012 Phase 3 EUCTR2010-021978-11-IE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2012 - EUCTR2010-021978-11-BE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 Phase 3 EUCTR2010-021978-11-GB Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 Phase 3 EUCTR2010-021978-11-ES Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 Phase 3 EUCTR2010-021978-11-DK Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 Phase 3 EUCTR2010-021978-11-CZ Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 - EUCTR2010-021978-11-SE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 - EUCTR2010-021978-11-PL Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 - EUCTR2010-021978-11-FI Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 - EUCTR2010-021978-11-DE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Iraq;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2010 - EUCTR2009-015556-15-SI Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States;
2010 - EUCTR2009-015556-15-SE Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States;
2010 - EUCTR2009-015556-15-PT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-NL Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-LV Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States;
2010 - EUCTR2009-015556-15-HU Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-GR Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-GB Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-FI Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-DK Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-DE Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-CZ Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States;
2010 - EUCTR2009-015556-15-AT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
BiogenIdec A/S
2009 - EUCTR2008-008065-35-SE Sweden;
CHU de Toulouse
2009 - EUCTR2008-005906-38-FR France;
Dansk Multipel Sclerose Center
2010 Phase 2 EUCTR2009-016703-35-DK Denmark;
Imperial College London
2008 Phase 4 EUCTR2007-007394-22-GB United Kingdom;
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden;
2017 Phase 4 EUCTR2016-003587-39-SE Sweden;
Kessler Foundation
2021 - NCT04565431 United States;
Northwestern University
2013 Phase 2 EUCTR2012-004165-41-GB United Kingdom;United States;
Novartis Pharma Services AG
2012 - EUCTR2011-001437-16-DE Australia;Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
Polpharma Biologics S.A.
2019 Phase 3 EUCTR2018-004751-20-PL Belarus;Croatia;Georgia;Moldova, Republic of;Poland;Serbia;Ukraine;
2019 Phase 3 EUCTR2018-004751-20-HR Belarus;Croatia;Georgia;Moldova, Republic of;Poland;Serbia;Ukraine;
Turku University Hospital
2013 Phase 4 EUCTR2013-004626-28-FI Finland;
University at Buffalo
2007 - NCT00937677 United States;
University of Chicago
2010 - NCT01071512 United States;
Universitätsklinikum Münster
2014 - EUCTR2013-004616-21-DE Germany;
Uppsala l?ns landsting
2011 - EUCTR2010-023560-40-SE Brazil;Canada;Sweden;United States;
VU medical center
2016 Phase 4 EUCTR2016-000345-31-NL Netherlands;
Tysabri ® (Natalizumab)
University of South Florida
2011 - NCT01455220 United States;
Tysabri®
Biogen Idec Research Limited
2015 Phase 4 EUCTR2013-004622-29-DK Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2015 Phase 4 EUCTR2013-004622-29-DE Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2015 - EUCTR2013-005586-39-DE Germany;Italy;United States;
2014 Phase 4 EUCTR2013-004622-29-SE Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2014 Phase 4 EUCTR2013-004622-29-GB Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2014 Phase 4 EUCTR2013-004622-29-ES Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2014 Phase 4 EUCTR2013-004622-29-CZ Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2014 - EUCTR2013-004622-29-IT Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
Sheffield Teaching Hospitals NHS Foundation Trust
2013 Phase 2/Phase 3 NCT03133403 United Kingdom;
Tysabri® (natalizumab)
Biogen
2010 - NCT01070823 United States;
UK: Sativex Oromucosal Spray
GW Pharma Ltd
2020 Phase 3 EUCTR2019-002623-14-GB Czech Republic;Poland;Romania;United Kingdom;United States;
UNDIFFERENTIATED AUTOLOGOUS MESENCHYMAL STEM CELLS
SALK - Gemeinnützige Salzburger Landeskliniken Betriebsges. m.b.H., Christian-Doppler-Klinik, UK für Neurologie der PMU
- - EUCTR2015-000137-78-AT Austria;
URBASON 40 mg comprimidos
Servicio de Neurología
2008 - EUCTR2007-000888-15-ES Spain;
UVEDOSE 100 000 UI, solution buvable en ampoule
MERCK SERONO s.a.s
2009 - EUCTR2009-013695-46-FR France;
Ublituximab
Johns Hopkins University
2016 Phase 1 NCT02276963 United States;
TG Therapeutics, Inc.
2019 Phase 3 NCT04130997 Belarus;Croatia;Georgia;Poland;Russian Federation;Serbia;Ukraine;United States;
2017 Phase 3 NCT03277261 United States;
2017 Phase 3 NCT03277248 United States;
2017 Phase 2 NCT03381170 United States;
2016 Phase 2 NCT02738775 United States;
Ubltuximab
TG Therapeutics
2017 Phase 3 EUCTR2017-000639-15-GB Belarus;Croatia;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
Ucb L059
Søren H. Sindrup, Department of Neurology, Odense University Hospital
2006 - EUCTR2006-000397-71-DK Denmark;
Ultomiris
Alexion Pharmaceuticals, Inc.
2020 Phase 3 EUCTR2019-003352-37-PL Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-003352-37-NL Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Russian Federation;Spain;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-003352-37-ES Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Russian Federation;Spain;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-003352-37-DK Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-003352-37-DE Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-003352-37-AT Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States;
Ultra small particles of iron oxide (USPIO)
Max-Planck-Institute of Psychiatry
2007 - EUCTR2006-001337-17-DE Germany;
Ultrasmall particles of iron oxide
Max-Planck-Institute of Psychiatry
2007 - EUCTR2006-001337-17-DE Germany;
Ultromiris
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 3 EUCTR2019-003352-37-IT Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States;
Umbilical cord derived Mesenchymal Stem Cells
University of Jordan
2017 Phase 1/Phase 2 NCT03326505 Jordan;
Umbilical cord mesenchymal stem cells
Translational Biosciences
2014 Phase 1/Phase 2 NCT02034188 Panama;
Untreated to atorvastatin treatment
Charite University, Berlin, Germany
2003 Phase 2 NCT00616187 -
Urbason
Servicio de Neurología, HU. Germans Trias i Pujol
2012 Phase 4 EUCTR2012-001965-34-ES Spain;
Urbason solubile forte
IFSgGmbH, Institute for clinical research
2006 - EUCTR2005-005592-14-DE Germany;
Urbason® solubile forte
University Medical Center Hamburg Eppendorf
2013 Phase 2 EUCTR2012-004807-10-DE Germany;
Urine samples
Centre Hospitalier Universitaire de Nimes
2013 Phase 3 NCT01817166 France;
V08CA02
Universitätsklinikum Erlangen
2010 - EUCTR2009-014857-34-DE Germany;
V08CA09
Universitätsklinikum Erlangen
2010 - EUCTR2009-014857-34-DE Germany;
VARDENAFILO HIDROCLORURO
Unidad de Neuroinmunología
2005 Phase 4 EUCTR2004-003761-33-ES Spain;
VAY736
Novartis Pharma Services AG
2014 Phase 2 EUCTR2013-002324-16-PL Czech Republic;Poland;Russian Federation;Ukraine;United States;
2014 Phase 2 EUCTR2013-002324-16-CZ Czech Republic;Poland;Russian Federation;Ukraine;United States;
Novartis Pharmaceuticals
2013 Phase 2 NCT02038049 Czech Republic;Czechia;Germany;Poland;Russian Federation;Ukraine;United States;
VB13S1
The Immune Response Corporation
2007 Phase 2 EUCTR2006-003384-30-SK Slovakia;
VB5S2
The Immune Response Corporation
2007 Phase 2 EUCTR2006-003384-30-SK Slovakia;
VB6S5
The Immune Response Corporation
2007 Phase 2 EUCTR2006-003384-30-SK Slovakia;
VENLAFAXINE HYDROCHLORIDE
Novartis Pharma GmbH
- - EUCTR2011-001692-39-DE Germany;
VESIcare 10Mg Tablet
Brigitte Schürch
2021 Phase 4 NCT04819360 Switzerland;
VIGANTOL OIL
MERCK SERONO SA
2011 - EUCTR2010-020328-23-IT Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal;
VITAMINA D3 KERN PHARMA SOLUCIÓN OLEOSA
Javier Olascoaga Urtaza
2013 Phase 2 EUCTR2012-004602-97-ES Spain;
VSN16R
Canbex Therapeutics Ltd
2015 Phase 2 NCT02542787 United Kingdom;
2015 Phase 2 EUCTR2014-004412-11-GB United Kingdom;
VX15/2503
Vaccinex Inc.
2012 Phase 1 NCT01764737 United States;
Vaginal estriol
Texas Tech University Health Sciences Center
2019 Phase 2/Phase 3 NCT03774407 United States;
Vardenafil (hidrocloride)
Unidad de Neuroinmunología
2005 Phase 4 EUCTR2004-003761-33-ES Spain;
Vatelizumab
Genzyme Corporation
2015 Phase 2 EUCTR2014-003265-19-PL Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States;
2015 Phase 2 EUCTR2014-001643-20-SE Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States;
2015 Phase 2 EUCTR2014-001643-20-PL Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States;
2015 Phase 2 EUCTR2014-001643-20-DE Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States;
Genzyme, a Sanofi Company
2015 Phase 2 NCT02306811 Canada;Poland;Russian Federation;United States;
2014 Phase 2 NCT02222948 Canada;Poland;Russian Federation;Sweden;United States;
Vehicle Gel
Biogen
2016 Phase 4 NCT02568111 -
Venlafaxin Hexal
Novartis Pharma GmbH
- - EUCTR2011-001692-39-DE Germany;
Venlafaxine
Novartis Pharmaceuticals
2011 Phase 4 NCT01436643 Germany;
Verum arm receiving Gilenya®
Charite University, Berlin, Germany
2013 Phase 2/Phase 3 NCT01647880 Germany;
Verum arm receiving Vitamin D oil
Charite University, Berlin, Germany
2011 Phase 2 NCT01440062 Germany;
Video calling program Better-close
Isala
2021 - NCT05242731 Netherlands;
Video game therapy
University Hospital of Ferrara
2017 - NCT03353974 Italy;
Vidofludimus calcium
Immunic AG
2022 Phase 3 EUCTR2021-000028-36-BG Albania;Belarus;Bulgaria;Colombia;Georgia;Greece;India;Lithuania;Mexico;Moldova, Republic of;North Macedonia;Poland;Russian Federation;Ukraine;United States;
2022 Phase 2 EUCTR2021-000048-23-NL Bulgaria;Canada;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
2022 Phase 2 EUCTR2021-000048-23-DE Bulgaria;Canada;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
2021 Phase 2 EUCTR2021-000048-23-BG Bulgaria;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine;
VigantOL oil plus interferon beta-1a (Rebif)
Merck KGaA
2011 Phase 2 NCT01285401 Austria;Belgium;Denmark;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
Vigantol
University College Dublin
2012 Phase 2 EUCTR2012-000635-68-IE Ireland;
Vigantol Oel
Merck Serono
2011 - EUCTR2010-020328-23-LV Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2011 - EUCTR2010-020328-23-EE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2011 - EUCTR2010-020328-23-DE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2010 Phase 2 EUCTR2010-020328-23-DK Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2010 - EUCTR2010-020328-23-FI Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
Merck Serono SA - Geneva, an affiliate of Merck KGaA
2012 Phase 2 EUCTR2010-020328-23-PT Austria;Belgium;Denmark;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2011 - EUCTR2010-020328-23-AT Austria;Belgium;Denmark;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
Merck Serono SA-Geneva an affiliate of Merck KgaA, Darmstadt
2011 - EUCTR2010-020328-23-BE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal;
Merck Serono The Netherlands - a division of Merck B.V.
2011 - EUCTR2010-020328-23-NL Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal;
Vigantol Oil
Merck Serono
2011 - EUCTR2010-020328-23-LV Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2011 - EUCTR2010-020328-23-LT Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2011 - EUCTR2010-020328-23-EE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2011 - EUCTR2010-020328-23-DE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2010 Phase 2 EUCTR2010-020328-23-DK Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2010 - EUCTR2010-020328-23-FI Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
Merck Serono SA - Geneva, an affiliate of Merck KGaA
2012 Phase 2 EUCTR2010-020328-23-PT Austria;Belgium;Denmark;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2011 - EUCTR2010-020328-23-AT Austria;Belgium;Denmark;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
Merck Serono SA-Geneva an affiliate of Merck KgaA, Darmstadt
2011 - EUCTR2010-020328-23-BE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal;
Merck Serono The Netherlands - a division of Merck B.V.
2011 - EUCTR2010-020328-23-NL Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal;
Vigantol® Oil
Academic MS Center Limburg
- Phase 2 EUCTR2014-000728-97-NL Netherlands;
Vigantol® Öl 20.000 I.E./ml
Charité - Universitätsmedizin Berlin
2011 Phase 2 EUCTR2011-002785-20-DE Germany;
Vitamin A
Tehran University of Medical Sciences
2011 Phase 4 NCT01407211 Iran, Islamic Republic of;
2010 Phase 4 NCT01417273 Iran, Islamic Republic of;
2009 Phase 4 NCT01225289 Iran, Islamic Republic of;
Vitamin D
Centre Hospitalier Universitaire de Nimes
2013 Phase 3 NCT01817166 France;
Mazandaran University of Medical Sciences
2013 Phase 3 NCT01768039 Iran, Islamic Republic of;
University Medical Centre Maribor
2017 Phase 4 NCT03385356 Slovenia;
Vitamin D3
AlJohara M AlQuaiz, M.D.
2013 Phase 2 NCT01753375 Saudi Arabia;
American University of Beirut Medical Center
2018 - NCT03610139 Lebanon;
Carmel Medical Center
2010 Phase 4 NCT01005095 Israel;
Isfahan University of Medical Sciences
2015 - NCT02696590 Iran, Islamic Republic of;
Johns Hopkins University
2012 Phase 3 NCT01490502 United States;
2010 - NCT01667796 United States;
Maastricht University Medical Center
2009 - NCT00940719 Netherlands;
University of Toronto
2006 Phase 1/Phase 2 NCT00644904 Canada;
Vitamin E/Selenium
National Center for Complementary and Integrative Health (NCCIH)
1999 Phase 1/Phase 2 NCT00010842 United States;
Vitamin K
Biogen
2017 Phase 4 NCT03091569 Italy;
2011 Phase 3 NCT01462318 Czech Republic;Hungary;Poland;Russian Federation;United States;
WAY-130799
Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development
2005 - EUCTR2005-000171-18-FI Finland;
Warm compress prior to injection of glatiramer acetate
Teva Neuroscience, Inc.
2005 Phase 4 NCT00239993 United States;
Water
Department of Neurology and Neurological Science, Tokyo Medical and Dental University
2021 - JPRN-UMIN000043910 Japan;
Ohio State University
2017 - NCT03244696 United States;
Wristband physical activity monitor
Oakland University
2015 - NCT02335450 United States;
XBD173
Imperial College London
2018 - NCT03850301 United Kingdom;
XCEL-MC-ALPHA
Banc de Sang i Teixits
2015 Phase 1/Phase 2 NCT02495766 Spain;
2014 - EUCTR2012-000734-19-ES Spain;
XYOSTED 75 milligram (mg) in 0.5 ML Auto-Injector
Tulane University
2021 Phase 4 NCT04601233 United States;
Xeomin
OSPEDALE S. RAFFAELE
2008 - EUCTR2007-006268-32-IT Italy;
ZK 157046
Bayer AB, Bayer Health Care, Bayer Schering Pharma
2007 - EUCTR2006-005270-47-SE Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Bayer Schering Pharma
2007 - EUCTR2006-005270-47-SI Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-HU Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
- - EUCTR2006-005270-47-DE Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Bayer Schering Pharma AG
2007 - EUCTR2006-005270-47-LV Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-GR Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-BE Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
SCHERING
2007 - EUCTR2006-005270-47-IT Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Schering AG
2007 Phase 3 EUCTR2006-005270-47-FR Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 Phase 3 EUCTR2006-005270-47-FI Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 Phase 3 EUCTR2006-005270-47-ES Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-NL Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-IE Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-AT Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
ZOL446H
North Bristol Trust
2009 - EUCTR2008-005304-93-GB United Kingdom;
Novartis Pharma GmbH
2010 - EUCTR2009-011888-37-DE Germany;
ZOLEDRONIC ACID MONOHYDRATE
Novartis Pharma GmbH
2010 - EUCTR2009-011888-37-DE Germany;
Zenapax
National Institute of Neurological Disorders and Stroke (NINDS)
1999 Phase 2 NCT00001934 United States;
Zeposia
Kessler Foundation
2021 - NCT04885894 United States;
Zinbryta
BIOGEN IDEC RESEARCH LIMITED
2017 Phase 3 EUCTR2016-002820-10-IT Canada;Denmark;France;Germany;Italy;United Kingdom;United States;
Biogen Idec Research Limited
2017 Phase 3 EUCTR2016-002820-10-GB Canada;Denmark;France;Germany;Italy;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002820-10-DE Canada;Germany;Italy;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003176-39-CZ Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
[123I]CLINDE
Institute for Neurodegenerative Disorders
2008 Phase 1 NCT00612872 United States;
[18F] PBR06
Institute for Neurodegenerative Disorders
2009 Phase 1 NCT01028209 United States;
[18F]-FEPPA
Institute for Neurodegenerative Disorders
2009 Phase 1 NCT00970333 United States;
[18F]Florbetapir PET imaging
Institute for Neurodegenerative Disorders
2012 Phase 4 NCT01767493 United States;
[C-11]Methylreboxetine
Brigham and Women's Hospital
2020 Phase 1/Phase 2 NCT04144257 United States;
2017 Phase 1/Phase 2 NCT03207464 United States;
[C-11]PBR28
Brigham and Women's Hospital
2016 Phase 1/Phase 2 NCT02649985 United States;
[C11]PK-1195 PET scan
Weill Medical College of Cornell University
2014 - NCT02207075 United States;
[F-18]PBR06
Brigham and Women's Hospital
2020 Phase 3 NCT04510220 United States;
2020 Phase 1/Phase 2 NCT04144257 United States;
2019 Phase 1/Phase 2 NCT03983252 United States;
2016 Phase 1/Phase 2 NCT02649985 United States;
[F-18]SDM-8
Brigham and Women's Hospital
2021 Early Phase 1 NCT04634994 United States;
[Zr-89]Oxine-labeled leukocytes PET/MR
University of Alabama at Birmingham
2021 Phase 1 NCT03807973 -
fampridine-SR (4-aminopyridine, 4-AP)
Acorda Therapeutics
2003 Phase 2 NCT00053417 Canada;United States;
glatiramer acetate
Teva Pharmaceutical Industries, Ltd.
2006 Phase 3 EUCTR2006-002037-20-FI Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 Phase 3 EUCTR2006-002037-20-ES Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 - EUCTR2006-002037-20-HU Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 - EUCTR2006-002037-20-GB Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 - EUCTR2006-002037-20-DE Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 - EUCTR2006-002037-20-CZ Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 - EUCTR2006-002037-20-BE Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
of MitoQ
VA Office of Research and Development
2020 Phase 1/Phase 2 NCT04267926 United States;
Bionorica research GmbH
2007 Phase 3 EUCTR2006-004255-38-DK Austria;Denmark;Germany;
2007 - EUCTR2006-004255-38-DE Austria;Germany;
2007 - EUCTR2006-004255-38-AT Austria;Germany;
(IM) AVONEX®
Trio Medicines Ltd.
2001 Phase 1 NCT01863069 United Kingdom;
(R) 3-(5-Dimethylcarbamoyl-pent-1-enyl)-N-(2-hydroxy-1- methylethyl) benzamide
Canbex Therapeutics Ltd
2015 Phase 2 EUCTR2014-004412-11-GB United Kingdom;
/0.5ml GA
Teva Pharmaceutical Industries Ltd.
2012 - EUCTR2011-005550-57-PL Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
2012 - EUCTR2011-005550-57-LV Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
2012 - EUCTR2011-005550-57-GR Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Greece;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
2012 - EUCTR2011-005550-57-EE Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
2012 - EUCTR2011-005550-57-BG Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
/0.5ml glatiramer acetate
Teva Pharmaceutical Industries Ltd.
2012 - EUCTR2011-005550-57-PL Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
2012 - EUCTR2011-005550-57-LV Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
2012 - EUCTR2011-005550-57-GR Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Greece;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
2012 - EUCTR2011-005550-57-EE Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
2012 - EUCTR2011-005550-57-BG Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Latvia;Lithuania;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
0,5 mg Fingolimod
Novartis Pharmaceuticals
2016 Phase 4 NCT02575365 Turkey;
032166011
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy;
033283045
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy;
034091165
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy;
035418060
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy;
1 - Andrographis paniculata p/st extract
Universidad Austral de Chile
2012 Phase 1/Phase 2 NCT02280876 Chile;
1-{6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-3-pyridinyl}-2-pyrrolidinone
GlaxoSmithKline Research & Development Ltd
2013 Phase 2 EUCTR2012-003627-38-GB Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
2013 Phase 2 EUCTR2012-003627-38-BG Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
2013 - EUCTR2012-003627-38-SE Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
2013 - EUCTR2012-003627-38-DE Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
2013 - EUCTR2012-003627-38-CZ Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
10 milligram (mg) fampridine-SR (4-aminopyridine, 4-AP)
Acorda Therapeutics
2003 Phase 2 NCT00053417 Canada;United States;
10000IU vitamin D
University College Dublin
2012 Phase 1/Phase 2 NCT01728922 Ireland;
11C-ACETATE
department of neurology, Osaka university school of medicine
2015 - JPRN-UMIN000018154 Japan;
11C-BMS-986196
Bristol-Myers Squibb
2021 Phase 1 NCT05064436 United Kingdom;United States;
11C-MCI
National Institute of Mental Health (NIMH)
2022 Phase 2 NCT05062083 United States;
11C-PBR28
Massachusetts General Hospital
2020 Phase 4 NCT04230174 -
11C-PIB
ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
2009 - EUCTR2008-004174-40-FR France;
11C]-PK-11195
AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA
2016 Phase 2 EUCTR2015-001202-34-IT Italy;
11C]flumazenil
VU University medical center Amsterdam
2017 Phase 4 EUCTR2017-002636-16-NL Netherlands;
13-PCV Booster
Hoffmann-La Roche
2015 Phase 3 NCT02545868 Canada;United States;
13-valent pneumococcal conjugate vaccine (13-PCV)
Novartis Pharmaceuticals
2018 Phase 3 NCT03650114 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
1393641-34-3
GENEURO SA
2016 Phase 2 EUCTR2015-004059-29-IT Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
14C]-RPC1063 Solution (0.1 mg/mL) for Oral Administration
Celgene International II Sàrl
2016 Phase 1 EUCTR2016-003073-18-GB United Kingdom;
18F-DPA-714 and 18F-FDG
Assistance Publique - Hôpitaux de Paris
2012 - NCT02305264 France;
18F-PM-PBB3
Chang Gung Memorial Hospital
2020 Phase 1/Phase 2 NCT04242056 -
18F]DPA-714
VU University Medical Center
2014 - EUCTR2014-002547-17-NL Netherlands;
19 nor vitamin d
University of Wisconsin, Madison
1998 Phase 1 NCT01257958 United States;
2 - Excipients
Universidad Austral de Chile
2012 Phase 1/Phase 2 NCT02280876 Chile;
2 mA Transcranial Direct Current Stimulation
University of Iowa
2020 - NCT04391023 United States;
2-(2-(2-Amino-9H-purin-9-yl)ethyl)-1,3-propanediol diacetate ester
Queen Mary University London
2019 Phase 2 EUCTR2019-000169-19-GB United Kingdom;
2-CdA, 2-chloro-2'-deoxy-beta-D-adenosine
MERCK SERONO SA
2011 Phase 3 EUCTR2009-017978-21-IT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Finland;Georgia;Germany;Greece;India;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Portugal;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States Minor Outlying Islands;
2-CdA, 2-chloro-2'-deoxy-ß-D-adenosine
MERCK SERONO SA
2011 Phase 3 EUCTR2009-017978-21-IT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Finland;Georgia;Germany;Greece;India;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Portugal;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States Minor Outlying Islands;
2-CdA, 2-chloro-2?-deoxy-beta-D-adenosine
Merck Serono S.A. - Geneva
2011 Phase 3 EUCTR2009-017978-21-ES Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2-CdA, 2-chloro-2?-deoxy-ß-D-adenosine
Merck Serono S.A. - Geneva
2011 Phase 3 EUCTR2009-017978-21-ES Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2-CdA, 2-chloro-2’-deoxy-beta-D-adenosine
Merck Serono S.A. - Geneva
2012 Phase 3 EUCTR2009-017978-21-PT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2012 Phase 3 EUCTR2009-017978-21-PL Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2012 Phase 3 EUCTR2009-017978-21-GR Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-SE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-LV Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-GB Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-FI Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-EE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-DK Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-BG Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-BE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-AT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 - EUCTR2009-017978-21-LT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 - EUCTR2009-017978-21-CZ Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2010 Phase 3 EUCTR2009-017978-21-DE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2-CdA, 2-chloro-2’-deoxy-ß-D-adenosine
Merck Serono S.A. - Geneva
2012 Phase 3 EUCTR2009-017978-21-PT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2012 Phase 3 EUCTR2009-017978-21-PL Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2012 Phase 3 EUCTR2009-017978-21-GR Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-SE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-LV Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-GB Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-FI Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-EE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-DK Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-BG Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-BE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-AT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 - EUCTR2009-017978-21-LT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 - EUCTR2009-017978-21-CZ Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2010 Phase 3 EUCTR2009-017978-21-DE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2-chloro-2'-deoxy-beta-D-adenosine (2-CdA)
Merck Serono S.A. - Geneva
2009 Phase 3 EUCTR2008-003706-33-GB Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2-chloro-2'-deoxy-ß-D-adenosine (2-CdA)
Merck Serono S.A. - Geneva
2009 Phase 3 EUCTR2008-003706-33-GB Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2-chloro-2'-deoxyadenosine (2-CdA)
MERCK KGAA
2018 Phase 4 EUCTR2017-002631-42-IT Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;
Merck KGaA
2018 Phase 4 EUCTR2017-002632-17-SK Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-SE Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-PT Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-NL Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-LT Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-HU Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Ireland;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-GR Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-GB Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-FR Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-FI Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-ES Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-DK Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-CZ Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-BE Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-AT Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2-chloro-2'-deoxyadenosine, 2CdA
Merck Serono International S.A.
2006 - EUCTR2004-005148-28-LT Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
2005 - EUCTR2004-005148-28-FI Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
2005 - EUCTR2004-005148-28-EE Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
2005 - EUCTR2004-005148-28-DK Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
2005 - EUCTR2004-005148-28-CZ Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
2005 - EUCTR2004-005148-28-BE Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
Merck Serono International, a branch of Laboratoires Serono S.A.
2005 Phase 3 EUCTR2004-005148-28-GB Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Slovakia;United Kingdom;
Merck Serono International, a branch of Laboratories Serono S.A.
2005 - EUCTR2004-005148-28-DE Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
Serono International S.A.
2006 Phase 3 EUCTR2004-005148-28-SK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Slovakia;United Kingdom;
2006 - EUCTR2004-005148-28-LV Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
2005 - EUCTR2004-005148-28-AT Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
2-chloro-2?-deoxy-beta-D-adenosine
Merck Serono International
2009 - EUCTR2008-003706-33-ES Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2-chloro-2?-deoxy-ß-D-adenosine
Merck Serono International
2009 - EUCTR2008-003706-33-ES Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2-chloro-2’-deoxy-beta-D-adenosine
Merck Serono International
2010 - EUCTR2008-003706-33-GR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2009 Phase 3 EUCTR2008-003706-33-FR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
Merck Serono S.A. - Geneva
2009 - EUCTR2008-003706-33-NO Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-003706-33-AT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2-chloro-2’-deoxy-beta-D-adenosine (2-CdA)
Merck Serono S.A. - Geneva
2009 Phase 3 EUCTR2008-003706-33-BE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2009 - EUCTR2008-003706-33-SE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2009 - EUCTR2008-003706-33-DE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2009 - EUCTR2008-003706-33-CZ Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2009 - EUCTR2008-003706-33-BG Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2008 - EUCTR2008-003706-33-FI Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2008 - EUCTR2008-003706-33-EE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
Merck Serono SA - Geneva
2009 - EUCTR2008-003706-33-PT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2-chloro-2’-deoxy-ß-D-adenosine
Merck Serono International
2010 - EUCTR2008-003706-33-GR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2009 Phase 3 EUCTR2008-003706-33-FR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
Merck Serono S.A. - Geneva
2009 - EUCTR2008-003706-33-NO Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-003706-33-AT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2-chloro-2’-deoxy-ß-D-adenosine (2-CdA)
Merck Serono S.A. - Geneva
2009 Phase 3 EUCTR2008-003706-33-BE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2009 - EUCTR2008-003706-33-SE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2009 - EUCTR2008-003706-33-DE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2009 - EUCTR2008-003706-33-CZ Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2009 - EUCTR2008-003706-33-BG Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2008 - EUCTR2008-003706-33-FI Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2008 - EUCTR2008-003706-33-EE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
Merck Serono SA - Geneva
2009 - EUCTR2008-003706-33-PT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2-chloro-2’-deoxyadenosine (2-CdA)
Merck KGaA
2018 Phase 4 EUCTR2017-002631-42-SE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002631-42-HU Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002631-42-GB Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002631-42-FR Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002631-42-FI Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002631-42-CZ Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002631-42-BE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002631-42-AT Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;
Merck Serono International S.A.
2008 - EUCTR2007-000381-20-NL Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Netherlands;Portugal;United Kingdom;
2008 - EUCTR2007-000381-20-GR Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Netherlands;Portugal;United Kingdom;
2007 Phase 3 EUCTR2007-000381-20-FR Austria;Belgium;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lithuania;Netherlands;Portugal;United Kingdom;
Merck Serono S.A. - Geneva
2008 Phase 3 EUCTR2007-000381-20-GB Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2008 Phase 3 EUCTR2007-000381-20-BE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-000381-20-PT Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Netherlands;Portugal;United Kingdom;
2008 - EUCTR2007-000381-20-LV Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-000381-20-LT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-000381-20-EE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-000381-20-DK Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-000381-20-DE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-000381-20-CZ Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-000381-20-BG Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2007 - EUCTR2007-000381-20-FI Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2007 - EUCTR2007-000381-20-AT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Turkey;Ukraine;United Kingdom;United States;
200106 or EMD 28162
Merck Serono
2011 - EUCTR2010-020328-23-LV Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2011 - EUCTR2010-020328-23-LT Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2010 Phase 2 EUCTR2010-020328-23-DK Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2010 - EUCTR2010-020328-23-FI Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
Merck Serono SA - Geneva, an affiliate of Merck KGaA
2012 Phase 2 EUCTR2010-020328-23-PT Austria;Belgium;Denmark;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2011 - EUCTR2010-020328-23-AT Austria;Belgium;Denmark;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
23-PPV
Hoffmann-La Roche
2015 Phase 3 NCT02545868 Canada;United States;
23-valent pneumococcal polysaccharide vaccine
Biogen
2015 Phase 2 NCT02097849 United States;
23-valent pneumococcal polysaccharide vaccine (23-PPV)
Novartis Pharmaceuticals
2018 Phase 3 NCT03650114 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
25OH-Vitamin D
Charité - Universitätsmedizin Berlin
2011 Phase 2 EUCTR2011-002785-20-DE Germany;
2B3-201
BBB-Therapeutics B.V.
2013 Phase 1 NCT02048358 Netherlands;
3,4-diaminopyridine
Assistance Publique - Hôpitaux de Paris
2005 Phase 3 NCT00190268 France;
University of Aarhus
2006 Phase 2 NCT00342381 Denmark;
4 mA Transcranial Direct Current Stimulation
University of Iowa
2020 - NCT04391023 United States;
5000IU vitamin D
University College Dublin
2012 Phase 1/Phase 2 NCT01728922 Ireland;
52069.00.01
Philipps-Universität Marburg
2010 - EUCTR2009-011088-35-DE Germany;
9060X
Allergan
2008 - EUCTR2006-006299-39-NL France;Netherlands;
2008 - EUCTR2006-006299-39-FR France;Netherlands;
Allergan Ltd.
2013 - EUCTR2012-000957-30-PT Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States;
2013 - EUCTR2012-000957-30-GB Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States;
2012 - EUCTR2012-000957-30-CZ Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States;
2012 - EUCTR2012-000957-30-BE Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States;
A4I Antagonist
Hoffmann-La Roche
2007 Phase 2 NCT00104143 Bulgaria;Canada;Czech Republic;Finland;Germany;Poland;Russian Federation;Slovakia;Spain;United Kingdom;United States;
AB1010
AB Science
2022 Phase 3 EUCTR2021-000639-30-ES Bulgaria;Canada;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-003735-32-SK Argentina;Belgium;Brazil;Bulgaria;Canada;Colombia;Germany;Greece;Italy;Mexico;Slovakia;Spain;Switzerland;United Kingdom;
2015 Phase 3 EUCTR2012-003735-32-GR Argentina;Belgium;Brazil;Bulgaria;Czech Republic;Germany;Greece;Hungary;Italy;Mexico;Slovakia;Spain;United Kingdom;
2015 Phase 3 EUCTR2010-021219-17-BG Argentina;Bosnia and Herzegovina;Brazil;Bulgaria;France;Germany;Greece;Hungary;Italy;Mexico;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Tunisia;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2010-021219-17-GR Bulgaria;Germany;Greece;Poland;Slovakia;Spain;Turkey;
2013 - EUCTR2010-021219-17-PL Czech Republic;France;Germany;Greece;Poland;Romania;Slovakia;Spain;
2012 Phase 3 EUCTR2010-021219-17-SK Argentina;Bosnia and Herzegovina;Brazil;Bulgaria;France;Germany;Greece;Hungary;Italy;Mexico;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-021219-17-ES Bulgaria;Czech Republic;France;Germany;Greece;Poland;Romania;Slovakia;Spain;United States;
2011 Phase 3 EUCTR2010-021219-17-DE Argentina;Bosnia and Herzegovina;Brazil;Bulgaria;France;Germany;Greece;Hungary;Italy;Mexico;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Tunisia;Ukraine;United Kingdom;United States;
ABR-215062
TEVA
2005 - EUCTR2004-003943-28-IT Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
Teva Pharmaceutical Industries Ldt
2005 Phase 2 EUCTR2005-004334-41-IT Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
ABR-215062 sodium salt
Teva Pharmaceutical Industries Ltd
2010 Phase 3 EUCTR2009-015815-42-SK Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Poland;Slovakia;Spain;
2010 Phase 3 EUCTR2009-015815-42-PL Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States;
2010 Phase 3 EUCTR2009-015815-42-LT Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States;
2010 Phase 3 EUCTR2009-015815-42-EE Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States;
2010 Phase 3 EUCTR2009-015815-42-CZ Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States;
2010 Phase 3 EUCTR2009-015815-42-BG Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States;
2010 Phase 3 EUCTR2009-012989-30-SE Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-012989-30-FR Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2010 Phase 3 EUCTR2009-012989-30-BG Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-012989-30-AT Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-012989-30-NL Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-012989-30-LT Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-012989-30-HU Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-012989-30-GB Austria;Bulgaria;Canada;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-012989-30-ES Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2009 Phase 3 EUCTR2009-012989-30-EE Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-012989-30-CZ Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 - EUCTR2009-011234-99-DE Germany;
2008 - EUCTR2007-003226-19-PT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-003226-19-LT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-003226-19-BG Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 Phase 3 EUCTR2007-003226-19-FR Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 Phase 3 EUCTR2007-003226-19-ES Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-SE Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-NL Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-LV Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-HU Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-GB Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-EE Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-DE Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-CZ Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-AT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2006 Phase 2 EUCTR2005-004334-41-GB Czech Republic;Germany;Hungary;Israel;Italy;Poland;Russian Federation;Spain;United Kingdom;
2006 Phase 2 EUCTR2005-004334-41-ES Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
2006 Phase 2 EUCTR2005-004334-41-DE Czech Republic;Germany;Hungary;Israel;Italy;Russian Federation;Spain;United Kingdom;
2006 Phase 2 EUCTR2005-004334-41-CZ Czech Republic;Germany;Hungary;Israel;Italy;Russian Federation;Spain;United Kingdom;
2005 Phase 2 EUCTR2005-004334-41-HU Czech Republic;Germany;Hungary;Israel;Italy;Russian Federation;Spain;United Kingdom;
2005 Phase 2 EUCTR2004-003943-28-GB Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
2005 Phase 2 EUCTR2004-003943-28-ES Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
2005 - EUCTR2004-003943-28-HU Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
2005 - EUCTR2004-003943-28-DE Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
2005 - EUCTR2004-003943-28-CZ Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
ABT-555
AbbVie
2016 Phase 1 NCT02601885 United States;
2015 Phase 1 NCT02606630 United Kingdom;
ABT-874/Human monoclonal antibody against IL-12
AbbVie (prior sponsor, Abbott)
2004 Phase 2 NCT00086671 Canada;Germany;Netherlands;United Kingdom;United States;
ABX-1431 HCl
Abide Therapeutics
2017 Phase 1 NCT03138421 United Kingdom;
ACT-1
Actelion Pharmaceuticals Ltd
2015 Phase 3 EUCTR2012-000540-10-LV Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-LT Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-GR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-FR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-FI Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-CZ Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
ACT-128800
ACTELION Pharmaceuticals Ltd
2010 Phase 2 EUCTR2009-011470-15-PL Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 2 EUCTR2009-011470-15-NL Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 2 EUCTR2009-011470-15-HU Australia;Austria;Bulgaria;Canada;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 2 EUCTR2009-011470-15-GB Austria;Bulgaria;Canada;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 2 EUCTR2009-011470-15-FI Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 2 EUCTR2009-011470-15-DE Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 2 EUCTR2009-011470-15-CZ Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 2 EUCTR2009-011470-15-BG Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 2 EUCTR2009-011470-15-AT Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 - EUCTR2009-011470-15-ES Austria;Bulgaria;Czech Republic;Finland;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
ACTELION Pharmaceuticals Ltd.
2010 Phase 2 EUCTR2009-011470-15-SE Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
Actelion Pharmaceuticals Ltd
2015 Phase 3 EUCTR2012-000540-10-SE Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-PT Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-PL Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-LV Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-LT Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-HU Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-HR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-GR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-FR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-FI Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-ES Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-DE Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-CZ Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2010 Phase 2 EUCTR2008-006786-92-FR Austria;Belgium;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-011470-15-IT Austria;Bulgaria;Czech Republic;Finland;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2009 Phase 2 EUCTR2008-006786-92-ES Austria;Belgium;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2009 Phase 2 EUCTR2008-006786-92-CZ Austria;Belgium;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2009 Phase 2 EUCTR2008-006786-92-BE Austria;Belgium;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-006786-92-SE Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-006786-92-PL Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-006786-92-NL Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-006786-92-HU Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-006786-92-GB Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-006786-92-FI Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-006786-92-BG Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-006786-92-AT Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
Actelion Pharmaceuticals Ltd.
2019 Phase 3 EUCTR2012-000541-12-HR Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Mexico;Poland;Portugal;Russian Federation;Spain;Switzerland;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004719-10-PT Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004719-10-LV Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004719-10-HU Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004719-10-HR Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004719-10-GR Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004719-10-GB Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004719-10-FI Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004719-10-CZ Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004719-10-BG Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2012-000541-12-BE Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States;
2017 Phase 3 EUCTR2016-004719-10-SE Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-004719-10-PL Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-004719-10-LT Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-004719-10-ES Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2012-000541-12-PL Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States;
2017 Phase 3 EUCTR2012-000541-12-FR Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States;
2017 Phase 3 EUCTR2012-000541-12-FI Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States;
2017 Phase 3 EUCTR2012-000541-12-BG Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States;
2016 Phase 3 EUCTR2012-000541-12-PT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States;
2016 Phase 3 EUCTR2012-000541-12-HU Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States;
2016 Phase 3 EUCTR2012-000541-12-GR Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States;
2016 Phase 3 EUCTR2012-000541-12-ES Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States;
2016 Phase 3 EUCTR2012-000541-12-DK Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States;
2016 Phase 3 EUCTR2012-000541-12-DE Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States;
2016 Phase 3 EUCTR2012-000541-12-CZ Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States;
2016 Phase 3 EUCTR2012-000541-12-AT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Spain;United States;
2009 - EUCTR2008-006786-92-IT Austria;Bulgaria;Czech Republic;Finland;France;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
ACT-128800 Dose 1
Actelion
2009 Phase 2 NCT01006265 Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
ACT-128800 Dose 2
Actelion
2009 Phase 2 NCT01006265 Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
ACT-128800 Dose 3
Actelion
2009 Phase 2 NCT01006265 Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
ACTH
Neurologique Foundation, Inc.
2009 Phase 2/Phase 3 NCT00947895 United States;
Providence Health & Services
2015 Phase 3 NCT02315872 United States;
University of Minnesota
2013 Phase 2 NCT01950234 United States;
University of Southern California
2009 Phase 1 NCT01049451 United States;
ACTHAR Gel (ACTH)
University of Colorado, Denver
2013 Phase 4 NCT01838174 United States;
ACTOS (Pioglitazone)
University of Illinois at Chicago
2003 Phase 1 NCT00242177 United States;
ADS-5102
Adamas Pharmaceuticals, Inc.
2015 Phase 2 NCT02471222 United States;
ADS-5102,
Adamas Pharmaceuticals, Inc.
2018 Phase 3 NCT03567057 Canada;United States;
2018 Phase 3 NCT03436199 Canada;United States;
AERT, (R)-Baclofen
Osmotica Pharmaceutical US LLC
2018 Phase 3 EUCTR2017-004101-40-PL Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2018 Phase 3 EUCTR2017-004101-40-HR Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2018 Phase 3 EUCTR2017-004101-40-BG Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2018 Phase 3 EUCTR2017-004100-22-PL Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2018 Phase 3 EUCTR2017-004100-22-HR Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2018 Phase 3 EUCTR2017-004100-22-BG Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
AGEE cream
University of Nebraska
2010 Phase 4 NCT00988988 United States;
AHSC
University Medical Centre Hamburg-Eppendorf
2020 Phase 2 EUCTR2016-001166-29-DE Germany;
AIMSPRO
Daval International Limited
2008 Phase 2 EUCTR2006-006872-39-GB United Kingdom;
AIN
NOVARTIS FARMA
2013 - EUCTR2012-004019-29-IT Argentina;Canada;Colombia;Finland;Germany;Italy;Japan;Poland;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
AIN457
NOVARTIS FARMA
2013 - EUCTR2012-004019-29-IT Argentina;Canada;Colombia;Finland;Germany;Italy;Japan;Poland;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
Novartis Farmacéutica, S.A.
2013 - EUCTR2012-004019-29-ES Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
Novartis Pharma AG
2013 Phase 2 EUCTR2012-004019-29-CZ Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
2013 Phase 2 EUCTR2012-004019-29-BE Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
2013 - EUCTR2012-004019-29-SE Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
2013 - EUCTR2012-004019-29-PT Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
2013 - EUCTR2012-004019-29-PL Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
2013 - EUCTR2012-004019-29-FI Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
2013 - EUCTR2012-004019-29-DE Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
Novartis Pharma K.K.
2013 Phase 2 JPRN-JapicCTI-132178 -
Novartis Pharma Services AG
2012 - EUCTR2011-001629-25-CZ Czech Republic;Russian Federation;Ukraine;
2009 Phase 2 EUCTR2009-011626-34-SE Czech Republic;Sweden;
2009 - EUCTR2009-011626-34-CZ Czech Republic;Russian Federation;Serbia;Sweden;Ukraine;
Novartis Pharmaceuticals
2013 Phase 2 NCT01874340 Belgium;Canada;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
2012 Phase 2 NCT01433250 Czech Republic;Russian Federation;Ukraine;
2009 Phase 2 NCT01051817 Czech Republic;Russian Federation;Serbia;Sweden;Ukraine;
ALKS 8700
Biogen
2017 Phase 3 NCT03093324 Germany;Poland;United States;
2015 Phase 3 NCT02634307 Belgium;Bulgaria;Canada;Germany;Poland;Russian Federation;Serbia;Spain;Ukraine;United States;
ALKS 8700 Delayed Release (DR)
Alkermes, Inc.
2019 Phase 3 EUCTR2017-001294-16-DE Germany;Poland;United States;
2017 Phase 3 EUCTR2017-001294-16-PL Germany;Poland;United States;
ALKS 8700 Delayed Release (DR) Capsule
Alkermes, Inc.
2016 Phase 3 EUCTR2015-005160-41-PL Belgium;Bulgaria;Canada;Germany;Poland;Russian Federation;Serbia;Spain;Ukraine;United States;
2016 Phase 3 EUCTR2015-005160-41-ES Belgium;Bulgaria;Canada;Germany;Poland;Russian Federation;Serbia;Spain;Ukraine;United States;
2016 Phase 3 EUCTR2015-005160-41-BG Belgium;Bulgaria;Canada;Germany;Poland;Russian Federation;Serbia;Spain;Ukraine;United States;
2016 Phase 3 EUCTR2015-005160-41-BE Belgium;Bulgaria;Canada;Germany;Poland;Russian Federation;Serbia;Spain;Ukraine;United States;
Biogen Idec Research Limited
2016 Phase 3 EUCTR2015-005160-41-DE Belgium;Bulgaria;Canada;Germany;Poland;Russian Federation;Serbia;Spain;Ukraine;United States;
ALTRI FARMACI DEL SISTEMA NERVOSO
GLAXO SMITHKLINE
2004 - EUCTR2004-000374-31-IT Italy;
ALXN1210
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 3 EUCTR2019-003352-37-IT Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States;
Alexion Pharmaceuticals, Inc.
2020 Phase 3 EUCTR2019-003352-37-PL Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-003352-37-NL Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Russian Federation;Spain;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-003352-37-ES Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Russian Federation;Spain;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-003352-37-DK Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-003352-37-DE Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-003352-37-AT Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States;
AMILORIDE HYDROCHLORIDE, 2 H2O
Universitätsklinik für Neurologie, Medizinische Universität Wien
2013 - EUCTR2012-005113-39-AT Austria;
AN100226
Biogen Idec Limited
2011 - EUCTR2010-024000-10-ES Belgium;Germany;Italy;Spain;
2011 - EUCTR2010-024000-10-DE Belgium;Germany;Italy;Spain;
2011 - EUCTR2010-024000-10-BE Belgium;Germany;Italy;Spain;
Biogen Idec Ltd.
2004 - EUCTR2004-000047-18-SE Sweden;
AN100226, BG00002
Biogen Idec Limited
2012 Phase 3 EUCTR2010-021978-11-IE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2012 - EUCTR2010-021978-11-BE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 Phase 3 EUCTR2010-021978-11-GB Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 Phase 3 EUCTR2010-021978-11-ES Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 Phase 3 EUCTR2010-021978-11-DK Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 Phase 3 EUCTR2010-021978-11-CZ Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 - EUCTR2010-021978-11-SE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 - EUCTR2010-021978-11-PL Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 - EUCTR2010-021978-11-FI Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 - EUCTR2010-021978-11-DE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Iraq;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
Biogen Idec Research Limited
2019 Phase 3 EUCTR2018-002145-11-NL Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States;
2019 Phase 3 EUCTR2018-002145-11-FR Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Spain;United Kingdom;United States;
2019 Phase 3 EUCTR2018-002145-11-ES Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States;
2019 Phase 3 EUCTR2018-002145-11-DE Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States;
2015 Phase 4 EUCTR2013-004622-29-DK Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2015 Phase 4 EUCTR2013-004622-29-DE Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2015 - EUCTR2013-005586-39-DE Germany;Italy;United States;
2014 Phase 4 EUCTR2013-004622-29-SE Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2014 Phase 4 EUCTR2013-004622-29-GB Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2014 Phase 4 EUCTR2013-004622-29-ES Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2014 Phase 4 EUCTR2013-004622-29-CZ Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2014 - EUCTR2013-004622-29-IT Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2013 - EUCTR2012-005082-13-IT Italy;
ANK-700
Anokion SA
2020 Phase 1 NCT04602390 United States;
ARICEPT
OSPEDALE S. RAFFAELE
2008 - EUCTR2008-001940-38-IT Italy;
ARN-6039
Arrien Pharmaceuticals
2016 Phase 1 NCT03237832 -
ARZERRA - 100 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONE(VETRO) - 5 ML(20MG/ML) 3 FLACONI
NOVARTIS PHARMA SERVICES AG
2017 Phase 3 EUCTR2015-005419-33-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
ARZERRA - 1000 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) - 50 ML (20 MG/ML) 1 FLACONCINO + 2 KIT DI PROLUNGA
NOVARTIS PHARMA SERVICES AG
2017 Phase 3 EUCTR2015-005418-31-IT Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
ASA
Biogen Idec Research Limited
2014 - EUCTR2013-001895-40-IE Ireland;United Kingdom;
ASB-683699
GLAXO SMITHKLINE
2004 - EUCTR2004-000374-31-IT Italy;
ATA188
Atara Biotherapeutics
2017 Phase 1/Phase 2 NCT03283826 Australia;United States;
ATG
Baylor College of Medicine
1999 Phase 2 NCT00040482 United States;
ATL1102
Antisense Therapeutics Ltd.
2007 Phase 2 EUCTR2006-004736-79-SK Czech Republic;Slovakia;
2007 - EUCTR2006-004736-79-CZ Czech Republic;
ATX-MS-1467
Apitope Technology (Bristol) Ltd.
2010 Phase 1 NCT01097668 Russian Federation;United Kingdom;
Merck KGaA
2014 Phase 2 NCT01973491 Germany;
2013 Phase 2 EUCTR2013-002916-28-LV Latvia;Russian Federation;
AUBAGIO - 14 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BISTER (ALU/ALU) PERFORATO MONODOSE - 10 X 1 COMPRESSA
NOVARTIS PHARMA SERVICES AG
2017 Phase 3 EUCTR2015-005419-33-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
2017 Phase 3 EUCTR2015-005418-31-IT Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
AUBAGIO - 14 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (ALU/ALU) - 28 COMPRESSE
UNIVERSITÀ CATTOLICA DEL SACRO CUORE- POLICLINICO A. GEMELLI
2016 Phase 4 EUCTR2016-001515-20-IT Italy;
AUTOLOGOUS T-LYMPHOCYTES
ImCyse S.A
2014 Phase 1;Phase 2 EUCTR2014-001081-99-BE Belgium;
AV605
Avigen Inc
2007 Phase 2 EUCTR2007-001031-63-CZ Czech Republic;Germany;
2007 - EUCTR2007-001031-63-DE Germany;
AVONEX - 30 MCG (6 MILIONI UI) POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 4 FLACONI CON DISPOSITIVO BIOSET + 4 SIRINGHE PRERIEMPITE USO INTRAMUSCOLARE
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy;
AVONEX 30 microgramos/0,5 ml (Interferón Beta - 1a) Solución inyectable
Biogen Idec Ltd
2010 Phase 3 EUCTR2009-012500-11-ES Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom;
AVONEX 30 µg/0,5 ml solution for injection
Università degli Studi Aldo Moro
2019 Phase 3 EUCTR2017-005129-18-IT Italy;
AVONEX IM 4SIR 30MCG/0,5ML 4AG
Universita di Firenze
2006 - EUCTR2006-004937-13-IT Italy;
AVONEX*IM 4SIR 30MCG/0,5ML+4AG
TEVA ITALIA srl
2008 - EUCTR2007-005450-23-IT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
AVONEX®
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-003008-38-IT Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
Biogen Idec Research Limited
2020 Phase 3 EUCTR2018-003008-38-DE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-SK Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-PT Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-HU Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-HR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-GR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-ES Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;
2019 Phase 3 EUCTR2018-003008-38-CZ Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;
2019 Phase 3 EUCTR2018-003008-38-BG Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-BE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
- Phase 3 EUCTR2018-003008-38-FR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
AVP-923
Avanir Pharmaceuticals
2011 Phase 2 NCT01324232 Argentina;Czech Republic;Czechia;Germany;Poland;Spain;United Kingdom;United States;
2002 Phase 3 NCT00050232 United States;
Avanir Pharmaceuticals, Inc.
2012 Phase 2 EUCTR2011-002178-22-GB Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States;
2012 - EUCTR2011-002178-22-PL Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States;
2012 - EUCTR2011-002178-22-CZ Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States;
2011 Phase 2 EUCTR2011-002178-22-ES Argentina;Bulgaria;Czech Republic;Poland;Spain;United Kingdom;United States;
AZATIOPRINA HEX. 50CPR 50MG BL
Universita di Firenze
2006 - EUCTR2006-004937-13-IT Italy;
Abatacept
National Institute of Allergy and Infectious Diseases (NIAID)
2010 Phase 2 NCT01116427 Canada;United States;
Abobotulinumtoxin A
Neurology Center of New England P.C.
2018 Phase 3 NCT03585569 United States;
Acetaminophen Tab
Columbia University
2019 Phase 1/Phase 2 NCT03824938 United States;
Acetazolamide
The University of Texas Health Science Center, Houston
2016 Phase 2 NCT02466074 United States;
Acetylsalicylic acid
Biogen
2014 Phase 4 NCT02090413 Ireland;United Kingdom;
Acetylsalicylic acid at 1st visit,
Columbia University
2017 Early Phase 1 NCT03051646 United States;
Aciclovir
Genzyme, a Sanofi Company
2014 Phase 4 NCT02205489 Belgium;France;Netherlands;Spain;
Aclasta 5 mg Infusionslösung
Novartis Pharma GmbH
2010 - EUCTR2009-011888-37-DE Germany;
Aclasta 5mg solution for infusion
North Bristol Trust
2009 - EUCTR2008-005304-93-GB United Kingdom;
Acthar
OhioHealth
2014 - NCT02258217 United States;
Acthar Gel
Aaron Miller
2013 - NCT01900093 United States;
Tanner Foundation for Multiple Sclerosis
2013 - NCT01906684 United States;
Active Comparator receiving Extavia®
Charite University, Berlin, Germany
2013 Phase 2/Phase 3 NCT01647880 Germany;
Active Control
Biogen
2014 Phase 1 NCT02201849 United States;
Acyclovir
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
2015 Phase 1 NCT02583594 Spain;
2014 Phase 1 NCT02282826 Germany;
Sanofi
2016 Phase 1 NCT02977533 Germany;
Ad26.COV2.S
National Institute of Allergy and Infectious Diseases (NIAID)
2021 Phase 2 NCT05000216 United States;
Adderall XR
London Health Sciences Centre
2012 Phase 2/Phase 3 NCT01667484 Canada;
Sarah Morrow
2016 Phase 2/Phase 3 NCT02676739 Canada;
Adrenocorticotropic hormone (ACTH) gel (H.P. Acthar®)
Weill Medical College of Cornell University
2016 Phase 4 NCT02446886 United States;
Albumin (Human) , United States Pharmacopeia (USP)
Grifols Therapeutics Inc.
2002 Phase 2 NCT00220779 Austria;Canada;Czech Republic;Germany;Greece;Hungary;Israel;Poland;Slovakia;Sweden;United Kingdom;United States;
Albuterol
National Institute of Allergy and Infectious Diseases (NIAID)
2001 - NCT00039988 United States;
Alcohol Wipes vs. No Alcohol Wipes
Teva Neuroscience, Inc.
2004 Phase 4 NCT00220922 United States;
Alemtuzumab
Cambridge University Hospitals NHS Foundation Trust
2012 Phase 1/Phase 2 NCT01712945 United Kingdom;
Cambridge University Hospitals NHS Foundation Trust and University of Cambridge
2012 Phase 2 EUCTR2011-005606-30-GB United Kingdom;
Central Texas Neurology Consultants
2011 Phase 3 NCT01333358 -
GENZYME CORPORATION
2017 Phase 3 EUCTR2016-003100-30-IT Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
Genzyme Corporation
2017 Phase 3 EUCTR2016-003100-30-PT Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-NO Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-NL Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-GR Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-GB Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-ES Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-DE Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-BE Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-AT Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
2015 Phase 3;Phase 4 EUCTR2013-003884-71-NL Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Czechia;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2015 Phase 3;Phase 4 EUCTR2013-003884-71-DK Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2009-010788-18-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2015 - EUCTR2013-003884-71-BE Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;
2014 Phase 4 EUCTR2014-000092-62-NL Belgium;France;Netherlands;Spain;Switzerland;
2014 Phase 4 EUCTR2014-000092-62-FR Belgium;France;Netherlands;Spain;Switzerland;
2014 Phase 4 EUCTR2014-000092-62-ES Belgium;France;Netherlands;Spain;Switzerland;
2014 Phase 4 EUCTR2014-000092-62-BE Belgium;France;Netherlands;Spain;Switzerland;
2014 Phase 3;Phase 4 EUCTR2013-003884-71-IT Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;
2014 Phase 3;Phase 4 EUCTR2013-003884-71-HR Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2014 Phase 3;Phase 4 EUCTR2013-003884-71-DE Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2014 Phase 3;Phase 4 EUCTR2013-003884-71-CZ Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2014 - EUCTR2013-003884-71-ES Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;
2011 Phase 3 EUCTR2009-010788-18-IT Austria;Belgium;Czech Republic;Denmark;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2010 Phase 3 EUCTR2009-010788-18-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-010788-18-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-010788-18-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-010788-18-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-010788-18-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-010788-18-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-010788-18-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 - EUCTR2009-010788-18-DK Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2008 Phase 3 EUCTR2007-001162-32-FR Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2008 Phase 3 EUCTR2007-001162-32-ES Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2008 Phase 3 EUCTR2007-001162-32-CZ Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2008 Phase 3 EUCTR2007-001162-32-BE Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2008 Phase 3 EUCTR2007-001161-14-FR Czech Republic;France;Germany;Poland;Sweden;United Kingdom;
2008 - EUCTR2007-001162-32-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-001162-32-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-001162-32-NL Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-001162-32-IT Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-001162-32-DK Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-001162-32-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-001162-32-AT Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-001161-14-SE Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom;
2008 - EUCTR2007-001161-14-PL Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom;
2008 - EUCTR2007-001161-14-DE Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom;
2008 - EUCTR2007-001161-14-CZ Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom;
2007 Phase 3 EUCTR2007-001162-32-GB Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-001161-14-GB Czech Republic;France;Germany;Poland;Sweden;United Kingdom;
- Phase 3 EUCTR2016-003100-30-PL Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
- Phase 3 EUCTR2016-003100-30-Outside-EU/EEA Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
- Phase 3 EUCTR2016-003100-30-FR Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
- Phase 3 EUCTR2016-003100-30-BG Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
Genzyme, a Sanofi Company
2009 Phase 3 NCT00930553 Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2007 Phase 3 NCT00548405 Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2007 Phase 3 NCT00530348 Argentina;Australia;Brazil;Canada;Croatia;Czech Republic;Former Serbia and Montenegro;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom;United States;
2002 Phase 2 NCT00050778 Croatia;Poland;Russian Federation;United Kingdom;United States;
Glostrup University Hospital, Copenhagen
2017 - NCT03193086 Denmark;
Hadassah Medical Organization
2015 - NCT02529839 -
Haukeland University Hospital
2018 Phase 3 NCT03477500 Denmark;Netherlands;Norway;Sweden;
Helse Bergen HF, Haukeland University Hospital
2018 Phase 3 EUCTR2017-001362-25-DK Denmark;Netherlands;
Queen Mary University of London
2017 - NCT03250169 United Kingdom;
R&D Addenbrookes Hospital
2008 Phase 2 EUCTR2005-002305-23-GB United Kingdom;
Seah Lim M.D.
2012 Phase 2 NCT01679041 United States;
Sheffield Teaching Hospitals
2020 Phase 3 EUCTR2019-001549-42-GB United Kingdom;
University Hospital Muenster
2015 Phase 4 NCT02419378 Germany;
University of Aarhus
2017 - NCT03806387 Denmark;
University of Chicago
2011 Phase 4 NCT01395316 -
University of Texas Southwestern Medical Center
2018 Phase 4 NCT03135249 United States;
Universitätsklinikum Hamburg-Eppendorf
2021 Phase 2 NCT04971005 Germany;
Alemtuzumab (GZ402673)
Genzyme, a Sanofi Company
2015 - NCT03774914 Austria;Belgium;Canada;Denmark;Germany;Italy;Spain;Sweden;United Kingdom;United States;
Alemtuzumab GZ402673
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
2015 Phase 4 NCT02255656 Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;Czechia;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Spain;Sweden;Ukraine;United Kingdom;United States;
2015 Phase 1 NCT02583594 Spain;
2014 Phase 4 NCT02205489 Belgium;France;Netherlands;Spain;
Alemtuzumab Injection
Maritime Neurology
2016 - NCT04633967 Canada;
Alemtuzumab Injection [Lemtrada]
University Hospital Muenster
2017 - NCT04082260 Germany;
Alemtuzumab immunotherapy
Samuel Forrester Hunter, MD, PhD
2012 Phase 1 NCT01624714 United States;
Alfuzosin
Capital District Health Authority, Canada
2007 Phase 2/Phase 3 NCT00688948 Canada;
All patients in the study will be treated with ocrelizumab
Providence Health & Services
2020 - NCT05081700 United States;
AlloRx
The Foundation for Orthopaedics and Regenerative Medicine
2022 Phase 1 NCT05003388 Antigua and Barbuda;
Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells
Genesis Limited
2015 Phase 1/Phase 2 NCT02418325 Trinidad and Tobago;
Novo Cellular Medicine Institute LLP
2015 Phase 1/Phase 2 NCT02587715 Trinidad and Tobago;
Allogeneic fecal microbiota
St. Petersburg State Pavlov Medical University
2019 Phase 1 NCT04203017 Russian Federation;
Alpha Lipoic Acid
Rebecca Spain
2018 Phase 1 NCT03493841 United States;
Alpha lipoic acid
University of Iowa
2010 Phase 1 NCT01381354 United States;
Alpha-lipoic acid
National Center for Complementary and Integrative Health (NCCIH)
1999 Phase 1/Phase 2 NCT00010842 United States;
Alpha1-antitrypsin
Stanford University
2014 Phase 1 NCT02087813 United States;
Amantadine
FONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR
2011 - EUCTR2010-023678-38-IT Italy;
Johns Hopkins University
2017 Phase 3 NCT03185065 United States;
American ginseng extract HT-1001
Oregon Health and Science University
2005 Phase 2 NCT00754832 United States;
Amiloride
UCL
2014 Phase 2 EUCTR2012-005394-31-GB United Kingdom;
University College, London
2014 Phase 2 NCT01910259 United Kingdom;
University of Oxford
2013 Phase 2 NCT01802489 United Kingdom;
Amiloride Hydrochloride
Oxford Racliffe NHS Trust
2008 - EUCTR2007-004051-11-GB United Kingdom;
Amilostad HCT tablets
Universitätsklinik für Neurologie, Medizinische Universität Wien
2013 - EUCTR2012-005113-39-AT Austria;
Amyvid radiopharmaceutical
Brain Health Alliance
2021 Early Phase 1 NCT04390009 United States;
Anakinra
National Institute of Neurological Disorders and Stroke (NINDS)
2019 Phase 1/Phase 2 NCT04025554 United States;
AndroGel Topical Gel
University of California, Los Angeles
2018 Phase 2 NCT03000127 United States;
Androgel 10 grams of gel containing 100 mg of testosterone
University of California, Los Angeles
2002 Phase 1/Phase 2 NCT00405353 United States;
Andrographolides
Innobioscience SpA
2014 Phase 1/Phase 2 NCT02273635 Chile;
Anesthetic Topical Adhesive Synera
Brown, Theodore R., M.D., MPH
2013 Phase 4 NCT01834586 United States;
Anti LP40 antibody, subclass IgG4 LA294
Eli Lilly and Company
2010 - EUCTR2008-007459-28-BG Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;
2009 Phase 2 EUCTR2008-007459-28-FR Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;
2009 - EUCTR2008-007459-28-HU Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;
2009 - EUCTR2008-007459-28-FI Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;
2009 - EUCTR2008-007459-28-DK Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;
2009 - EUCTR2008-007459-28-DE Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;
2009 - EUCTR2008-007459-28-CZ Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;
2009 - EUCTR2008-007459-28-BE Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;
Anti-CD25 Humanized Monoclonal Antibody
Protein Design Labs, Inc.
2006 - EUCTR2005-001567-55-DE Germany;Spain;United Kingdom;
2005 Phase 2 EUCTR2005-001567-55-GB Austria;Germany;Spain;United Kingdom;
2005 - EUCTR2005-001567-55-ES Germany;Spain;United Kingdom;
2005 - EUCTR2005-001567-55-AT Austria;Germany;Spain;United Kingdom;
Anti-CD52 monoclonal antibody
Cambridge University Hospitals NHS Foundation Trust and University of Cambridge
2012 Phase 2 EUCTR2011-005606-30-GB United Kingdom;
Anti-Thymocyte Globulin
Fred Hutchinson Cancer Research Center
2008 Phase 2 NCT00716066 United States;
Anti-thymocyte globulin
Fred Hutchinson Cancer Research Center
1997 Phase 1 NCT00014755 United States;
Anticholinergic medication
Wellspect HealthCare
2009 - NCT00913510 Belgium;France;Germany;Netherlands;United Kingdom;
Anticuerpo monoclonal anti-LINGO-1 humano
Biogen Idec Research Limited
2013 Phase 2 EUCTR2011-006262-40-ES Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
Antihistamine
Genentech, Inc.
2016 Phase 3 NCT02688985 Canada;Germany;Sweden;United States;
Hoffmann-La Roche
2020 Phase 3 NCT04548999 Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Peru;Poland;Portugal;Puerto Rico;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 NCT04544436 Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
Providence Health & Services
2020 Phase 3 NCT04175834 United States;
Antimycotic
Università Popolare Homo & Natura
2015 Phase 1 NCT02632591 Italy;
Antithymocyte
Dipartimento di Neuroscienze Oftalmologia e Genetica DINOG - Universita di Genova
2006 - EUCTR2006-002562-19-IT Italy;
Antithymocyte immunoglobulin (rabbit)
AZIENDA OSPEDALIERA DI PADOVA
- Phase 1 EUCTR2008-005773-35-IT Italy;
Anxiety/depression and work and activities
University Hospital, Strasbourg, France
2019 Phase 2 NCT03910738 France;
Apitox - pure honeybee toxin
Apimeds, Inc.
2019 Phase 3 NCT03710655 -
Arbaclofen
Osmotica Pharmaceutical US LLC
2018 Phase 3 NCT03319732 United States;
2018 Phase 3 NCT03290131 Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Serbia;United States;
2013 Phase 3 NCT01844232 Russian Federation;Ukraine;United States;
2012 Phase 3 NCT01743651 Russian Federation;Ukraine;United States;
Arbaclofen ER Tablets
Osmotica Pharmaceutical US LLC
2016 Phase 3 NCT02869425 United States;
Arbaclofen Extended Release Tablets
Osmotica Pharmaceutical US LLC
2018 Phase 3 EUCTR2017-004101-40-PL Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2018 Phase 3 EUCTR2017-004101-40-HR Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2018 Phase 3 EUCTR2017-004101-40-BG Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2018 Phase 3 EUCTR2017-004100-22-PL Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2018 Phase 3 EUCTR2017-004100-22-HR Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2018 Phase 3 EUCTR2017-004100-22-BG Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
Arbaclofen placarbil 15 mg BID
XenoPort, Inc.
2011 Phase 3 NCT01359566 United States;
Arbaclofen placarbil 30 mg BID
XenoPort, Inc.
2011 Phase 3 NCT01359566 United States;
Arbaclofen placarbil 45 mg BID
XenoPort, Inc.
2011 Phase 3 NCT01359566 United States;
Aricept 10 mg filmdragerade tabletter
Neurology Unit
2005 - EUCTR2005-003410-15-SE Sweden;
Aricept 5 mg filmdragerade tabletter
Neurology Unit
2005 - EUCTR2005-003410-15-SE Sweden;
Arm 1 - GEH120714 (18F) Injection
GE Healthcare
2013 Phase 1 NCT01738347 Canada;United States;
Armodafinil
University of Missouri, Kansas City
2009 Phase 2/Phase 3 NCT00981084 United States;
Arzerra
GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LTD.
2012 - EUCTR2011-002333-19-IT Canada;Czech Republic;Germany;Italy;Netherlands;Russian Federation;Spain;United States;
NOVARTIS PHARMA AG
2018 Phase 2 EUCTR2017-004702-17-IT Austria;Bulgaria;Czech Republic;Czechia;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
Novartis Farmacéutica S.A.
2020 Phase 3 EUCTR2019-001341-40-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Spain;Switzerland;Turkey;United Kingdom;United States;
Novartis Farmacéutica, S.A
2019 Phase 3 EUCTR2017-004703-51-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
Novartis Farmacéutica, S.A.
2018 Phase 2 EUCTR2017-004702-17-ES Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
2016 Phase 3 EUCTR2015-005419-33-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-ES Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
Novartis Pharma Services AG
2016 Phase 3 EUCTR2015-005419-33-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
Novartis Pharma AG
2021 Phase 3 EUCTR2019-001341-40-PL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001341-40-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Spain;Switzerland;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001341-40-IT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Spain;Switzerland;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001341-40-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Spain;Switzerland;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001341-40-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-HR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-FR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-FI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-DK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 2 EUCTR2017-004702-17-PL Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
2018 Phase 3 EUCTR2017-004703-51-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2018 Phase 3 EUCTR2017-004703-51-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2018 Phase 3 EUCTR2017-004703-51-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2018 Phase 3 EUCTR2017-004703-51-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2018 Phase 2 EUCTR2017-004702-17-LV Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
2018 Phase 2 EUCTR2017-004702-17-LT Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
2018 Phase 2 EUCTR2017-004702-17-EE Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
2018 Phase 2 EUCTR2017-004702-17-CZ Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
2018 Phase 2 EUCTR2017-004702-17-BG Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
2018 Phase 2 EUCTR2017-004702-17-AT Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
2017 Phase 3 EUCTR2015-005418-31-FR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;European Union;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-FR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;European Union;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-HU Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-GR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-BE Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
Novartis Pharma Services AG
2017 Phase 3 EUCTR2015-005419-33-HR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2015-005419-33-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2015-005419-33-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2015-005418-31-NL Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2015-005418-31-CZ Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-FI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-SK Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-SE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-PL Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-HR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-GB Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-EE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-DE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-BG Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
Arzerra®
GlaxoSmithKline Research and Development Limited
2012 - EUCTR2011-002333-19-CZ Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States;
2011 Phase 2 EUCTR2011-002333-19-DK Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States;
2011 - EUCTR2011-002333-19-NL Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States;
GlaxoSmithKline SA
2011 Phase 2 EUCTR2011-002333-19-ES Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States;
Aspirin 650mg Oral Capsule
Columbia University
2019 Phase 1/Phase 2 NCT03824938 United States;
Atacicept
EMD Serono
2009 Phase 2 NCT00853762 Australia;Belgium;Canada;Czech Republic;France;Germany;Lebanon;Lithuania;Netherlands;New Caledonia;Russian Federation;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2008 Phase 2 NCT00642902 Australia;Austria;Belgium;Canada;Czech Republic;France;Germany;Lebanon;Lithuania;Netherlands;Russian Federation;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
Merck Serono Geneva- an affiliate of Merck KGaA, Darmstadt Germany
2008 - EUCTR2007-003936-50-SE Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
Merck Serono International
2009 Phase 2 EUCTR2008-005021-11-FR Belgium;Czech Republic;France;Sweden;
2009 Phase 2 EUCTR2008-005021-11-CZ Belgium;Czech Republic;France;Sweden;
2009 - EUCTR2008-005021-11-SE Belgium;Czech Republic;France;Sweden;
Merck Serono International S.A.
2008 Phase 2 EUCTR2007-003936-50-FR Austria;Belgium;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2008 Phase 2 EUCTR2007-003936-50-ES Austria;Belgium;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-003936-50-NL Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
Merck Serono S.A. - Geneva
2008 - EUCTR2007-003936-50-GB Australia;Austria;Canada;Czech Republic;France;Lebanon;Lithuania;Netherlands;Russian Federation;Spain;Sweden;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-003936-50-AT Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
Merck Serono SA - Geneva, An affiliate of Merck KGaA, Darmstadt, Germany
2009 - EUCTR2008-005021-11-BE Belgium;Czech Republic;France;Sweden;
Merck Serono SA - Geneva, an affiliate of Merck KGaA, Darmstadt, Germany
2008 - EUCTR2007-003936-50-CZ Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-003936-50-BE Austria;Belgium;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
Merck Serono SA-Geneva
2008 - EUCTR2007-003936-50-LT Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
Atomoxetine
Icahn School of Medicine at Mount Sinai
2017 Phase 2 NCT03091400 United States;
Atorvastatin
DR DIMENSIONE RICERCA
2005 - EUCTR2005-001009-25-IT Italy;
National Institute of Allergy and Infectious Diseases (NIAID)
2005 Phase 2 NCT00094172 Canada;United States;
Sun Yat-sen University
2006 - NCT00818103 China;
University Hospital Inselspital, Berne
2005 Phase 2 NCT00942591 Switzerland;
Aubagio
F. HOFFMANN - LA ROCHE LTD.
2021 Phase 3 EUCTR2020-001168-28-IT Bulgaria;Denmark;Finland;France;Italy;Netherlands;United States;
2021 Phase 3 EUCTR2019-004857-10-IT Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States;
F. Hoffman-La Roche
2021 Phase 3 EUCTR2020-001168-28-DK Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Greece;India;Italy;Korea, Republic of;Mexico;Poland;Portugal;Russian Federation;Turkey;United Kingdom;United States;
F. Hoffmann-La Roche Ltd
2021 Phase 3 EUCTR2020-001168-28-BG Bulgaria;Finland;France;Netherlands;United States;
2021 Phase 3 EUCTR2019-004857-10-NL Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States;
2021 Phase 3 EUCTR2019-004857-10-HU Finland;France;Germany;Hungary;Netherlands;Portugal;United States;
2021 Phase 3 EUCTR2019-004857-10-DE Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States;
2020 Phase 3 EUCTR2019-004857-10-FI Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States;
GENZYME CORPORATION
2020 Phase 3 EUCTR2020-000637-41-IT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
Genzyme Corporation
2021 Phase 3 EUCTR2020-000644-55-DE Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000637-41-AT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000644-55-SK Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-PT Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-NL Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-LV Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-HU Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-GR Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-GB Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-FR Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-CZ Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000637-41-SE Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-PL Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-LT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-FI Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-DK Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-DE Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-CZ Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-BG Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2014 Phase 4 EUCTR2013-001439-34-IT Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Italy;Spain;Sweden;Switzerland;United Kingdom;United States;
2014 Phase 4 EUCTR2013-001439-34-GR Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
2014 Phase 4 EUCTR2013-001439-34-GB Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
2014 - EUCTR2013-001439-34-DE Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
2014 - EUCTR2013-001439-34-BE Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
2014 - EUCTR2013-001439-34-AT Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
2013 Phase 4 EUCTR2013-001439-34-SE Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
2013 Phase 4 EUCTR2013-001439-34-FI Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
2013 Phase 4 EUCTR2013-001439-34-ES Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Italy;Spain;Sweden;Switzerland;United Kingdom;United States;
MERCK HEALTHCARE KGaA
2020 Phase 3 EUCTR2019-004980-36-IT Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
MS Centrum, Department of Neurology, Sshlgrenska University Hospital
2018 Phase 4 EUCTR2016-004414-10-SE Sweden;
Merck Healthcare KGaA
2021 Phase 3 EUCTR2019-004980-36-SI Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-SK Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-PT Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-NO Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-LV Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-LT Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-GR Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-DE Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-BG Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004972-20-HU Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-004972-20-GB Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-004972-20-FI Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-004972-20-DE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-004972-20-CZ Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-004972-20-BG Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-004972-20-AT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2019-004972-20-BE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
Novartis Farmacéutica S.A.
2022 Phase 3 EUCTR2020-005929-89-ES Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States;
2022 Phase 3 EUCTR2020-005899-36-ES Slovakia;Spain;
Novartis Farmacéutica, S.A.
2016 Phase 3 EUCTR2015-005419-33-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-ES Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
Novartis Pharma Services AG
2016 Phase 3 EUCTR2015-005419-33-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
Novartis Pharma AG
2022 Phase 3 EUCTR2020-005929-89-SE Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States;
2022 Phase 3 EUCTR2020-005899-36-SK Argentina;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;France;Germany;Guatemala;Hong Kong;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;United Kingdom;United States;
2017 Phase 3 EUCTR2015-005418-31-FR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;European Union;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-FR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;European Union;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-HU Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-GR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-BE Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
Novartis Pharma Services AG
2017 Phase 3 EUCTR2015-005419-33-HR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2015-005419-33-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2015-005419-33-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2015-005418-31-NL Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2015-005418-31-CZ Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-FI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-SK Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-SE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-PL Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-HR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-GB Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-EE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-DK Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-DE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-BG Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
Aubagio 14 mg film-coated tablets
F. Hoffmann-La Roche Ltd
2021 Phase 3 EUCTR2019-004857-10-PT Finland;France;Germany;Netherlands;Portugal;United States;
Aubagio®
Actelion Pharmaceuticals Ltd
2015 Phase 3 EUCTR2012-000540-10-SE Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-PT Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-PL Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-LV Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-LT Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-HU Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-HR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-GR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-FR Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-FI Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-ES Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-DE Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2012-000540-10-CZ Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Autologous Bone Marrow-Derived Mononuclear Stem Cells
Genesis Limited
2015 Phase 1/Phase 2 NCT02418351 India;Trinidad and Tobago;
Novo Cellular Medicine Institute LLP
2015 Phase 1/Phase 2 NCT02587806 India;Trinidad and Tobago;
Autologous CD4+T cells stimulated and expanded ex vivo by a MOG peptide modified by the introduction of a thioreductase motif into the flanking residues of the T cell epitope
Imcyse SA
2015 Phase 1/Phase 2 NCT02427776 Belgium;
Autologous Hematopoietic Stem Cell
Makati Medical Center
2015 Phase 1 NCT03113162 Philippines;
Autologous Hematopoietic Stem Cell Transplantation
Fred Hutchinson Cancer Research Center
2008 Phase 2 NCT00716066 United States;
National Institute of Allergy and Infectious Diseases (NIAID)
2019 Phase 3 NCT04047628 United Kingdom;United States;
Universitätsklinikum Hamburg-Eppendorf
2021 Phase 2 NCT04971005 Germany;
Autologous Mesenchymal Cell Product
Imperial College London
2012 Phase 2 EUCTR2012-002357-35-GB United Kingdom;
Autologous Mesenchymal Stem Cells
Antonio Uccelli
2012 Phase 1/Phase 2 NCT01854957 Italy;
University of Jordan
2012 Phase 1/Phase 2 NCT01895439 Jordan;
Autologous Stem Cell Transplantation
Northwestern Memorial Hospital
2001 Phase 1 NCT00017628 United States;
Autologous Stem Cells
Northwestern University
2019 Phase 2/Phase 3 NCT03829566 United States;
2017 Phase 3 NCT03342638 United States;
Autologous VitD3 tolerogenic monocyte-derived dendritic cells loaded with a pool of myelin peptides (tolDC-VitD3)
Fundació Institut Germans Trias i Pujol
2017 Phase 1 NCT02903537 Spain;
Autologous adipose derived mesenchymal cells
American CryoStem Corporation
2014 Phase 1 NCT02326935 Cayman Islands;
Autologous adult mesenchymal stem cells from bone marrow expanded and cryopreserved
Banc de Sang i Teixits
2014 - EUCTR2012-000734-19-ES Spain;
Autologous bone marrow transplantation
Hadassah Medical Organization
2015 - NCT02529839 -
Autologous hematopoietic stem cell transplant
National Institute of Allergy and Infectious Diseases (NIAID)
2006 Phase 2 NCT00288626 United States;
Autologous hematopoietic stem cells
University Medical Centre Hamburg-Eppendorf
2020 Phase 2 EUCTR2016-001166-29-DE Germany;
Autologous mesenchymal stem cell transplantation
The Cleveland Clinic
2011 Phase 1 NCT00813969 United States;
Autologous mesenchymal stem cells
Albert Saiz
2010 Phase 2 NCT01228266 Spain;
Karolinska Institutet
2013 Phase 1/Phase 2 NCT01730547 Sweden;
2012 Phase 1 NCT03778333 Sweden;
Tianjin Medical University General Hospital
2013 Phase 2 NCT02249676 China;
Avonex
Biogen
2013 Phase 2 NCT01864148 Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
Biogen Idec
2010 Phase 3 NCT01181115 China;
Biogen Idec Research Limited
2013 Phase 2 EUCTR2011-006262-40-NL Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
Celgene International II Sàrl (CIS II)
2015 Phase 3 EUCTR2014-002320-27-PL Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-LV Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-LT Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-HU Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-HR Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-GB Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-BG Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2014-002320-27-PT Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2014-002320-27-EE Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2014 Phase 2;Phase 3 EUCTR2012-002714-40-SK Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2014 Phase 2;Phase 3 EUCTR2012-002714-40-GB Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2013 Phase 2;Phase 3 EUCTR2012-002714-40-HU Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2013 Phase 2;Phase 3 EUCTR2012-002714-40-BG Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2013 Phase 2;Phase 3 EUCTR2012-002714-40-BE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
Centrum Neurologii Krzysztof Selmaj
2016 Phase 2 EUCTR2016-002180-33-PL Poland;
F. Hoffman-La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-DE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
F.Hoffmann-La Roche Ltd.
2008 - EUCTR2007-006338-32-IT Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Russian Federation;Spain;Switzerland;Ukraine;United Kingdom;United States;
Genentech, Inc.
2008 Phase 2 NCT00676715 Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
Hoffman La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-SK Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 Phase 2 EUCTR2007-006338-32-GB Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 Phase 2 EUCTR2007-006338-32-FR Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Slovakia;Spain;United Kingdom;
2008 Phase 2 EUCTR2007-006338-32-ES Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Slovakia;Spain;United Kingdom;
2008 Phase 2 EUCTR2007-006338-32-DK Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 Phase 2 EUCTR2007-006338-32-CZ Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 Phase 2 EUCTR2007-006338-32-BG Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 Phase 2 EUCTR2007-006338-32-BE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-006338-32-NL Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Spain;United Kingdom;
2008 - EUCTR2007-006338-32-FI Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Spain;United Kingdom;
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden;
2017 Phase 4 EUCTR2016-003587-39-SE Sweden;
MedImmune LLC
2012 - EUCTR2011-005475-16-GB Austria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
Medizinische Universität Innsbruck
2014 Phase 4 EUCTR2012-005450-30-AT Austria;Sweden;
2014 - EUCTR2012-005450-30-SE Austria;Sweden;
Merck Healthcare KGaA
2020 Phase 3 EUCTR2018-004701-11-BG Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Montenegro;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-004700-19-BG Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;Italy;Kuwait;Lebanon;Lithuania;Mexico;Moldova, Republic of;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
Merck KGaA
2014 Phase 3 EUCTR2013-002351-15-AT Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-003126-83-HU Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-003126-83-GR Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-003126-83-ES Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-003126-83-DE Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-003126-83-BG Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-PT Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-LV Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-HU Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-ES Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-EE Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-BG Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain;
Novartis Farma
2013 - EUCTR2011-005677-23-IT Brazil;Canada;Italy;Latvia;Lithuania;Mexico;Spain;United States;Venezuela, Bolivarian Republic of;
Novartis Farmaceutica S.A.
2013 - EUCTR2011-005677-23-ES Brazil;Canada;Latvia;Lithuania;Mexico;Spain;United States;Venezuela, Bolivarian Republic of;
Novartis Pharma Service AG
2015 Phase 3 EUCTR2011-005677-23-HR Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005677-23-GB Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005677-23-EE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 - EUCTR2011-005677-23-RO Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2011-005677-23-DE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2011-005677-23-BG Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of;
2013 - EUCTR2011-005677-23-LV Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Novartis Pharma Services AG
2014 Phase 3 EUCTR2011-005677-23-PL Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005677-23-NL Austria;Brazil;Bulgaria;Canada;Croatia;Estonia;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005677-23-AT Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 - EUCTR2011-005677-23-SE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2011-005677-23-SK Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2011-005677-23-LT Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-001437-16-DE Australia;Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
2006 - EUCTR2006-000704-17-PT Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
PD Dr. Marcus Müller
2015 Phase 1 NCT02364986 Germany;
Receptos, Inc.
2015 Phase 3 EUCTR2014-002320-27-SE Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-NL Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-ES Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2014 Phase 2;Phase 3 EUCTR2012-002714-40-HR Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Ukraine;United Kingdom;United States;
2013 Phase 2;Phase 3 EUCTR2012-002714-40-IT Belgium;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Israel;Italy;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2013 Phase 2;Phase 3 EUCTR2012-002714-40-GR Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States;
2013 Phase 2;Phase 3 EUCTR2012-002714-40-ES Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States;
Saint Francis Care
2012 - NCT01641120 United States;
Teva Pharmaceutical Industries, Ltd.
2014 - EUCTR2013-002082-19-NL Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
2014 - EUCTR2013-002082-19-ES Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
2013 Phase 3 EUCTR2013-002082-19-GB Belgium;Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
2013 Phase 3 EUCTR2013-002082-19-BE Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2013-002082-19-SE Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2013-002082-19-FI Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2013-002082-19-DK Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
Turku University Hospital
2013 Phase 4 EUCTR2013-004626-28-FI Finland;
Avonex (Interferon beta 1a)
University of California, San Francisco
2006 Phase 2 NCT00501943 United States;
Avonex (interferon beta-1a), Biogen Idec Ltd
Bayer
2016 - NCT02749396 Finland;
Avonex 30 microgram/0.5 ml Solution for Injection
Teva Pharmaceutical Industries Ltd
2008 Phase 3 EUCTR2007-005450-23-SK Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Slovakia;Spain;
2008 - EUCTR2007-005450-23-LT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2008 - EUCTR2007-005450-23-EE Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2008 - EUCTR2007-005450-23-DE Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2008 - EUCTR2007-005450-23-CZ Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2008 - EUCTR2007-005450-23-BG Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
Avonex 30 microgramos/0.5 ml Solución para inyección
Teva Pharmaceutical Industries Ltd
2008 - EUCTR2007-005450-23-ES Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
Avonex and Topamax
Multiple Sclerosis Institute
2004 Phase 2 NCT00217295 United States;
Avonex prefilled syringe via manual IM injection
Biogen
2009 Phase 3 NCT00828204 United States;
Avonex/Betaseron/Copaxone/Rebif
Sheffield Teaching Hospitals NHS Foundation Trust
2013 Phase 2/Phase 3 NCT03133403 United Kingdom;
Avonex/Zocor
University of North Carolina
2004 Phase 4 NCT00146068 United States;
Avonex®
Biocad
2017 Phase 2/Phase 3 NCT02744222 Russian Federation;
EMD Serono
1999 Phase 3 NCT00292266 -
EMD Serono Research & Development Institute, Inc.
2019 Phase 3 NCT04032171 Germany;United States;
2019 Phase 3 NCT04032158 Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czechia;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Montenegro;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
Teva Branded Pharmaceutical Products R&D, Inc.
2014 Phase 3 NCT01975298 Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
2008 Phase 3 NCT00605215 Bulgaria;Croatia;Czech Republic;Czechia;Estonia;Georgia;Germany;Israel;Italy;Latvia;Lithuania;Macedonia, The Former Yugoslav Republic of;Montenegro;North Macedonia;Poland;Puerto Rico;Romania;Russian Federation;Slovakia;South Africa;Spain;Turkey;Ukraine;United States;
University Hospital Motol
2011 Phase 4 EUCTR2011-001956-12-CZ Czech Republic;
Avonex® monotherapy ( administered i.m. each week)
State University of New York at Buffalo
2005 - NCT00463710 United States;
Azathioprine
Isfahan University of Medical Sciences
2015 Phase 2/Phase 3 NCT03002038 Iran, Islamic Republic of;
The Ophthalmology Department of the Chinese Peoples Liberation Army Hospital
2019 Phase 4 ChiCTR1900025744 China;
2014 - ChiCTR-ICR-15007177 China;
Tianjin Medical University General Hospital
2017 Phase 2/Phase 3 NCT03350633 China;
Universita di Firenze
2006 - EUCTR2006-004937-13-IT Italy;
Azathioprine (AZA)
Hoffmann-La Roche
2021 Phase 3 NCT04660539 Bulgaria;Canada;Croatia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Puerto Rico;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Azithromycin
National Center for Research Resources (NCRR)
2001 Phase 2 NCT00043264 United States;
B001 injection
Shanghai Pharmaceuticals Holding Co., Ltd
2022 Early Phase 1 NCT05145361 China;
BAF312
NOVARTIS FARMA
2010 - EUCTR2009-014392-51-IT Finland;Germany;Hungary;Italy;Poland;Spain;
2009 - EUCTR2008-008719-25-IT Finland;Germany;Hungary;Italy;Spain;
NOVARTIS PHARMA SERVICES AG
2021 Phase 3 EUCTR2020-002700-39-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Novartis Farmacéutica S.A.
2021 Phase 3 EUCTR2020-002700-39-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Novartis Farmacéutica, S.A
2009 - EUCTR2008-008719-25-ES Finland;Germany;Hungary;Italy;Spain;
Novartis Pharma AG
2021 Phase 3 EUCTR2020-002700-39-SK Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-PT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-LV Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-LT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-HR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2020-002700-39-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2020-002700-39-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Novartis Pharma K.K.
2014 Phase 3 JPRN-JapicCTI-142447 -
Novartis Pharma Services AG
2010 Phase 2 EUCTR2009-014392-51-PL Canada;Finland;Germany;Hungary;Italy;Poland;Russian Federation;Spain;Turkey;United States;
2010 Phase 2 EUCTR2009-014392-51-HU Canada;Finland;Germany;Hungary;Italy;Poland;Russian Federation;Spain;Turkey;United States;
2010 Phase 2 EUCTR2009-014392-51-FI Canada;Finland;Germany;Hungary;Italy;Poland;Russian Federation;Spain;Turkey;United States;
2010 - EUCTR2009-014392-51-DE Canada;Finland;Germany;Hungary;Italy;Poland;Russian Federation;Spain;Turkey;United States;
2009 - EUCTR2008-008719-25-HU Finland;Germany;Hungary;Italy;Spain;
2009 - EUCTR2008-008719-25-FI Finland;Germany;Hungary;Italy;Spain;
- - EUCTR2008-008719-25-DE Finland;Germany;Hungary;Italy;Spain;
Novartis Pharmaceuticals
2021 Phase 4 NCT04792567 Germany;
2012 Phase 3 NCT01665144 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 2 NCT01185821 Canada;Finland;Germany;Hungary;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;Turkey;United States;
2009 Phase 2 NCT00879658 Canada;Finland;Germany;Hungary;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;Turkey;United States;
BAF312 0,25 mg tablet
Novartis Pharma Services AG
2012 - EUCTR2011-006043-30-NL Netherlands;
BAF312 1 mg tablet
Novartis Pharma Services AG
2012 - EUCTR2011-006043-30-NL Netherlands;
BAF312 4 mg tablet
Novartis Pharma Services AG
2012 - EUCTR2011-006043-30-NL Netherlands;
BAF312 hemifumarate
NOVARTIS FARMA
2012 - EUCTR2012-003056-36-IT Argentina;Australia;Austria;Bulgaria;Canada;Czech Republic;Egypt;Estonia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Farmacéutica S.A
2012 - EUCTR2012-003056-36-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Pharma Services AG
2015 - EUCTR2012-003056-36-FR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-PL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-IE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-EE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 - EUCTR2012-003056-36-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 - EUCTR2011-006043-30-NL Netherlands;
- Phase 3 EUCTR2012-003056-36-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
BAF312A
NOVARTIS FARMA
2012 - EUCTR2012-003056-36-IT Argentina;Australia;Austria;Bulgaria;Canada;Czech Republic;Egypt;Estonia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Farmacéutica S.A
2012 - EUCTR2012-003056-36-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Pharma GmbH
2021 Phase 4 EUCTR2020-005752-38-DE Germany;
Novartis Pharma Services AG
2015 - EUCTR2012-003056-36-FR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-PL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-IE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-EE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 - EUCTR2012-003056-36-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
- Phase 3 EUCTR2012-003056-36-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
BAT4406F
Bio-Thera Solutions
2019 Phase 1 NCT04146285 China;
BAY 79-4998
Bayer Vital GmbH
2006 - EUCTR2006-002361-39-DE Germany;
BAY86-5046
Bayer AG
2017 Phase 4 EUCTR2017-001176-31-GB Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2017 Phase 4 EUCTR2017-001176-31-FI Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2017 Phase 4 EUCTR2017-001176-31-DK Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2017 Phase 4 EUCTR2017-001176-31-CZ Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2017 Phase 4 EUCTR2017-001176-31-AT Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
Bayer HealthCare AG
2013 Phase 4 EUCTR2012-005262-35-GB Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2012-005262-35-IT Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
- - EUCTR2014-004613-93-Outside-EU/EEA China;
BAY86-5046_Interferon-beta-1b
Bayer
2007 - NCT01158183 United States;
BBR 2778
Fondation Charcot Stichting
2009 Phase 1;Phase 2 EUCTR2007-003086-40-BE Belgium;France;
2008 - EUCTR2007-003086-40-FR France;
BCD-033 (interferon beta 1a)
Biocad
2014 Phase 2/Phase 3 NCT02727907 Russian Federation;
BCD-054 180 mcg
Biocad
2017 Phase 2/Phase 3 NCT02744222 Russian Federation;
BCD-054 240 mcg
Biocad
2017 Phase 2/Phase 3 NCT02744222 Russian Federation;
BCD-063
Biocad
2013 Phase 3 NCT02753088 -
BCD-132
Biocad
2018 Phase 1 NCT03551275 Russian Federation;
BCD-132,
Biocad
2019 Phase 2 NCT04056897 Russian Federation;
BCG20-0134
BTG International Ltd
2009 Phase 2 EUCTR2009-011585-28-BE Belgium;European Union;France;Germany;Russian Federation;Spain;
2009 - EUCTR2009-011585-28-FR Belgium;France;Germany;Spain;
2009 - EUCTR2009-011585-28-DE Belgium;European Union;France;Germany;Russian Federation;Spain;
BEAM Regimen
Makati Medical Center
2015 Phase 1 NCT03113162 Philippines;
BETACONNECT
Bayer
2019 - NCT03808142 Germany;
2014 - NCT02247310 Austria;Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Czechia;France;Greece;Hungary;Italy;Netherlands;Spain;Switzerland;
BETACONNECT auto-injector.
Bayer
2014 - NCT02121444 Germany;
BETACONNECT device
Bayer
2016 - NCT02652091 United States;
BETAFERON - 15 FLACONCINI 0.25 MG + 15 FLACONCINI 2 ML
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy;
BETAFERON 250 mcg
SCHERING
2007 - EUCTR2006-005270-47-IT Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
BETAFERON 500 mcg
SCHERING
2007 - EUCTR2006-005270-47-IT Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
BETAFERON SC 15F 0,25MG 15SIR
Universita di Firenze
2006 - EUCTR2006-004937-13-IT Italy;
BETAFERON*15CONFEZ 0,25MG/ML+
AZIENDA OSPEDALIERA S. LUIGI GONZAGA
2011 - EUCTR2010-023677-19-IT Italy;
BETAFERON® (interferon beta-1b)
Ospedale Regionale di Lugano
2013 - EUCTR2012-004040-30-AT Austria;Switzerland;
BG-12 120
Northwestern University
2013 Phase 2 EUCTR2012-004165-41-GB United Kingdom;United States;
BG00002
BIOGEN IDEC LTD
2007 - EUCTR2005-004061-41-SE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2007 - EUCTR2005-004061-41-AT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Ireland;Italy;Spain;Sweden;United Kingdom;
2006 Phase 3 EUCTR2005-004061-41-GB Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 Phase 3 EUCTR2005-004061-41-BE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 - EUCTR2005-004061-41-IE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 - EUCTR2005-004061-41-HU Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 - EUCTR2005-004061-41-GR Austria;Czech Republic;Denmark;Finland;Germany;Greece;Ireland;Italy;Spain;Sweden;United Kingdom;
2006 - EUCTR2005-004061-41-FI Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 - EUCTR2005-004061-41-DK Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 - EUCTR2005-004061-41-DE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 - EUCTR2005-004061-41-CZ Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
Biogen Idec
2012 Phase 4 NCT02142205 Russian Federation;
Biogen Idec Limited
2011 - EUCTR2010-024000-10-ES Belgium;Germany;Italy;Spain;
2011 - EUCTR2010-024000-10-DE Belgium;Germany;Italy;Spain;
2011 - EUCTR2010-024000-10-BE Belgium;Germany;Italy;Spain;
Biogen Idec Research Limited
2019 Phase 3 EUCTR2018-002145-11-GB Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;New Zealand;Spain;United Kingdom;United States;
BG00002 (natalizumab)
Biogen
2010 Phase 3 NCT01058005 Australia;Canada;Czech Republic;Finland;France;Hungary;Italy;Latvia;Poland;Slovenia;Spain;Sweden;United States;
2009 Phase 4 NCT00871780 Belgium;Mexico;Poland;Romania;Saudi Arabia;Ukraine;Venezuela;
2008 Phase 4 NCT00536120 United States;
2006 Phase 3 NCT00306592 Canada;United States;
BG00002-E (natalizumab high titer)
Biogen
2006 Phase 2 NCT00516893 United States;
BG00012
BIOGEN IDEC LTD
2010 Phase 3 EUCTR2008-004753-14-IT Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Ireland;Italy;Latvia;Netherlands;Slovakia;Spain;United Kingdom;
2008 - EUCTR2006-003696-12-IT Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;
BIOGEN IDEC RESEARCH LIMITED
2015 Phase 3 EUCTR2014-005624-98-IT Argentina;Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Kuwait;Lebanon;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States;
Biogen
2009 Phase 1 NCT00837785 Germany;United Kingdom;
2007 Phase 3 NCT00451451 Australia;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Costa Rica;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Ireland;Israel;Italy;Kazakhstan;Latvia;Lithuania;Macedonia, The Former Yugoslav Republic of;Mexico;Moldova, Republic of;New Zealand;Poland;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United States;
2007 Phase 3 NCT00420212 Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;France;Germany;Greece;Guatemala;India;Israel;Italy;Kazakhstan;Macedonia, The Former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;Virgin Islands (U.S.);
Biogen Idec
2004 Phase 2 NCT00168701 Czech Republic;Germany;Hungary;Netherlands;Poland;Russian Federation;Sweden;Switzerland;Turkey;United Kingdom;
Biogen Idec Inc.
2004 - EUCTR2004-000663-99-SE Hungary;Sweden;
2004 - EUCTR2004-000663-99-HU Hungary;Sweden;
2004 - EUCTR2004-000663-99-CZ Czech Republic;Hungary;Sweden;
Biogen Idec Italia S.r.l.
2015 - EUCTR2015-000303-21-IT Italy;
2013 Phase 3 EUCTR2013-001422-25-IT Italy;
Biogen Idec Limited
2010 Phase 3 EUCTR2008-004753-14-BG Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2008-004753-14-SK Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2008-004753-14-LV Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2008-004753-14-IE Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2008-004753-14-GB Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2008-004753-14-EE Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2008-004753-14-CZ Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2008-004753-14-BE Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2008-004753-14-AT Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
Biogen Idec LtD.
2007 Phase 3 EUCTR2006-003696-12-SK Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Slovakia;Sweden;United Kingdom;
Biogen Idec Ltd.
2010 Phase 3 EUCTR2008-004753-14-NL Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2008-004753-14-GR Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Ireland;Italy;Latvia;Netherlands;Slovakia;Spain;United Kingdom;
2009 Phase 3 EUCTR2008-004753-14-FR Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Ireland;Italy;Latvia;Netherlands;Slovakia;Spain;United Kingdom;
2009 Phase 3 EUCTR2008-004753-14-ES Austria;Belgium;Bulgaria;Czech Republic;Estonia;France;Germany;Greece;Ireland;Italy;Latvia;Netherlands;Slovakia;Spain;United Kingdom;
2009 Phase 3 EUCTR2008-004753-14-DE Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
2009 - EUCTR2006-003696-12-BG Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;
2008 - EUCTR2006-003697-10-BG Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2008 - EUCTR2006-003696-12-NL Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;
2008 - EUCTR2006-003696-12-DE Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;
2007 Phase 3 EUCTR2006-003697-10-ES Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 Phase 3 EUCTR2006-003697-10-BE Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 Phase 3 EUCTR2006-003696-12-GB Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Slovakia;Sweden;United Kingdom;
2007 - EUCTR2006-003697-10-LV Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 - EUCTR2006-003697-10-IE Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 - EUCTR2006-003697-10-GR Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 - EUCTR2006-003697-10-EE Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 - EUCTR2006-003697-10-DE Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 - EUCTR2006-003697-10-CZ Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 - EUCTR2006-003696-12-SE Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;
2007 - EUCTR2006-003696-12-GR Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;
2007 - EUCTR2006-003696-12-CZ Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;
2007 - EUCTR2006-003696-12-BE Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;
2007 - EUCTR2006-003696-12-AT Austria;Belgium;Bulgaria;Czech Republic;Germany;Greece;Italy;Netherlands;Sweden;United Kingdom;
Biogen Idec Research Limited
2019 Phase 3 EUCTR2018-000516-22-PT Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-000516-22-HU Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-000516-22-EE Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States;
2017 Phase 3 EUCTR2013-002318-11-FR Belgium;Czech Republic;Denmark;France;Germany;Hungary;Italy;Poland;Serbia;Spain;Sweden;Ukraine;United Kingdom;
2016 Phase 3 EUCTR2015-003282-29-LV Belgium;Bulgaria;Czech Republic;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States;
2016 Phase 3 EUCTR2015-003282-29-DE Belgium;Bulgaria;Czech Republic;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States;
2016 Phase 3 EUCTR2015-003282-29-CZ Belgium;Bulgaria;Czech Republic;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States;
2016 Phase 3 EUCTR2015-003282-29-BG Belgium;Bulgaria;Czech Republic;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States;
2016 Phase 3 EUCTR2015-003282-29-BE Belgium;Bulgaria;Czech Republic;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States;
2016 Phase 3 EUCTR2015-001973-42-PL Belgium;Bulgaria;Croatia;Kuwait;Lithuania;Poland;United States;
2016 Phase 3 EUCTR2015-001973-42-LT Belgium;Bulgaria;Croatia;Kuwait;Lithuania;Poland;United States;
2016 Phase 3 EUCTR2015-001973-42-HR Austria;Belgium;Bulgaria;Canada;Croatia;Kuwait;Lithuania;Poland;Slovakia;Sweden;Turkey;United States;
2016 Phase 3 EUCTR2015-001973-42-BG Belgium;Bulgaria;Croatia;Kuwait;Lithuania;Poland;United States;
2016 Phase 3 EUCTR2013-002318-11-DE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States;
2016 - EUCTR2013-002318-11-ES Argentina;Belgium;Canada;Croatia;Czech Republic;Denmark;France;Hungary;Israel;Italy;Poland;Portugal;Romania;Serbia;Spain;Sweden;Turkey;United Kingdom;
2015 Phase 3 EUCTR2015-001973-42-BE Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Kuwait;Lithuania;Poland;Turkey;United States;
2015 Phase 3 EUCTR2014-004562-22-IT Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States;
2015 Phase 3 EUCTR2014-004562-22-DE Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States;
2015 Phase 3 EUCTR2014-004562-22-CZ Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States;
2015 Phase 3 EUCTR2014-004562-22-BE Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States;
2015 Phase 3 EUCTR2014-003021-18-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States;
2015 Phase 3 EUCTR2013-002318-11-PL Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States;
2015 Phase 2 EUCTR2014-005003-24-PL Australia;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Lithuania;Poland;Turkey;United Kingdom;
2015 Phase 2 EUCTR2014-005003-24-LV Australia;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Lithuania;Poland;Turkey;United Kingdom;
2015 Phase 2 EUCTR2014-005003-24-DE Australia;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Lithuania;Poland;Turkey;United Kingdom;
2015 Phase 2 EUCTR2014-005003-24-CZ Australia;Belgium;Bulgaria;Czech Republic;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Lithuania;Poland;Turkey;United States;
2015 Phase 2 EUCTR2014-005003-24-BG Australia;Belgium;Bulgaria;Czech Republic;France;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Poland;Turkey;United Kingdom;United States;
2015 Phase 2 EUCTR2014-005003-24-BE Australia;Belgium;Bulgaria;Czech Republic;Finland;France;Germany;Israel;Italy;Kuwait;Latvia;Lebanon;Lithuania;Poland;Turkey;United Kingdom;
2015 - EUCTR2014-005624-98-HU Argentina;Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Kuwait;Lebanon;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States;
2015 - EUCTR2014-004562-22-HU Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States;
2015 - EUCTR2014-003021-18-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States;
2015 - EUCTR2014-003021-18-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States;
2015 - EUCTR2014-003021-18-PL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States;
2015 - EUCTR2014-003021-18-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States;
2015 - EUCTR2014-003021-18-IT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States;
2015 - EUCTR2014-003021-18-FI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States;
2015 - EUCTR2014-003021-18-DK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States;
2015 - EUCTR2014-003021-18-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States;
2015 - EUCTR2014-003021-18-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States;
2015 - EUCTR2014-003021-18-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Norway;Poland;Russian Federation;Serbia;Slovakia;Spain;Sweden;Switzerland;United Kingdom;United States;
2014 Phase 4 EUCTR2013-001656-35-SK Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2014 Phase 4 EUCTR2013-001656-35-SI Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2014 Phase 4 EUCTR2013-001656-35-PT Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2014 Phase 4 EUCTR2013-001656-35-IT Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2014 Phase 4 EUCTR2013-001656-35-HU Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2014 Phase 4 EUCTR2013-001656-35-FR Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2014 Phase 4 EUCTR2013-001656-35-ES Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2014 Phase 4 EUCTR2013-001656-35-CZ Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2014 Phase 4 EUCTR2013-001656-35-BE Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2014 Phase 4 EUCTR2013-001656-35-AT Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2014 Phase 3 EUCTR2013-004533-32-PL Czech Republic;Japan;Korea, Republic of;Poland;Taiwan;
2014 Phase 3 EUCTR2013-004533-32-CZ Czech Republic;Japan;Korea, Republic of;Poland;Taiwan;
2014 Phase 3 EUCTR2013-002318-11-SE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States;
2014 Phase 3 EUCTR2013-002318-11-HU Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;
2014 Phase 3 EUCTR2013-002318-11-GB Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States;
2014 Phase 3 EUCTR2013-002318-11-DK Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States;
2014 Phase 3 EUCTR2013-002318-11-CZ Belgium;Bulgaria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States;
2014 Phase 3 EUCTR2013-002318-11-BE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Serbia;Spain;Sweden;Turkey;United Kingdom;United States;
2014 - EUCTR2013-002318-11-IT Belgium;Czech Republic;Denmark;France;Hungary;Italy;Poland;Serbia;Sweden;Ukraine;United Kingdom;
2014 - EUCTR2013-001895-40-IE Ireland;United Kingdom;
2014 - EUCTR2013-001486-17-DE Germany;
- Phase 3 EUCTR2014-005624-98-EE Argentina;Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Kuwait;Lebanon;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States;
- Phase 3 EUCTR2014-005624-98-AT Argentina;Austria;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Israel;Italy;Kuwait;Lebanon;Mexico;Netherlands;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Switzerland;Turkey;United Kingdom;United States;
BG00012 (DMF)
Biogen
2013 Phase 4 NCT01873417 United States;
BG00012 (DMF) (Tecfidera®.)
Multiple Sclerosis Center of Northeastern New York
2015 Phase 4 NCT02683863 United States;
BG0002 (natalizumab)
Biogen Idec
2009 - NCT00818038 United States;
BG9418 (interferon beta 1-a)
Biogen
2008 Phase 3 NCT00784836 United States;
BG9418 (interferon beta-1a)
Biogen
2009 Phase 3 NCT00828204 United States;
Biogen Idec
2004 - NCT00168714 United States;
BGC20-0134
BTG International Ltd
2009 - EUCTR2009-011585-28-ES Belgium;France;Germany;Spain;
BGG492
Novartis Pharmaceuticals
2016 Phase 2 NCT01649050 Germany;Russian Federation;
BHT-3009
Bayhill Therapeutics
2006 Phase 2 NCT00382629 -
2006 - EUCTR2005-001340-22-CZ Czech Republic;Finland;United Kingdom;
2005 Phase 2 EUCTR2005-001340-22-SK Czech Republic;Finland;Slovakia;United Kingdom;
2005 - EUCTR2005-001340-22-GB Czech Republic;Finland;United Kingdom;
2005 - EUCTR2005-001340-22-FI Czech Republic;Finland;United Kingdom;
BHT-3009-01
Bayhill Therapeutics
2004 Phase 1 NCT00103974 Canada;United States;
BIIB 017
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-003008-38-IT Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
BIIB017
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-003008-38-IT Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
Biogen
2013 Phase 3 NCT01939002 United States;
Biogen Idec LTD
2009 - EUCTR2008-006333-27-LV Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Latvia;Netherlands;Spain;United Kingdom;
Biogen Idec Limited
2012 Phase 3 EUCTR2010-024477-39-GR Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2010-024477-39-GB Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2012 - EUCTR2010-024477-39-CZ Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-024477-39-DE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-024477-39-BG Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-024477-39-LV Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-024477-39-ES Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-024477-39-EE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-024477-39-BE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2010 - EUCTR2008-006333-27-GR Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Latvia;Netherlands;Spain;United Kingdom;
2010 - EUCTR2008-006333-27-CZ Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2008-006333-27-GB Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2008-006333-27-ES Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Latvia;Netherlands;Spain;United Kingdom;
2009 - EUCTR2008-006333-27-NL Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2009 - EUCTR2008-006333-27-EE Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2009 - EUCTR2008-006333-27-BG Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2009 - EUCTR2008-006333-27-BE Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
- - EUCTR2008-006333-27-DE Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
Biogen Idec Research Limited
2020 Phase 3 EUCTR2018-003008-38-DE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-SK Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-PT Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-HU Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-HR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-GR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-ES Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;
2019 Phase 3 EUCTR2018-003008-38-CZ Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;
2019 Phase 3 EUCTR2018-003008-38-BG Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-BE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-000516-22-PT Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-000516-22-HU Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-000516-22-EE Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States;
- Phase 3 EUCTR2018-003008-38-FR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
Johns Hopkins University
2010 Phase 3 NCT01337427 United States;
BIIB017 (Peginterferon beta-1a)
Biogen Idec
2014 Phase 4 NCT02234869 -
BIIB017 (peginterferon beta-1a)
Biogen
2019 Phase 3 NCT03958877 Argentina;Australia;Belgium;Bulgaria;Croatia;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2009 Phase 3 NCT00906399 Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
BIIB017 (peginterferon beta-1a) Autoinjector
Biogen Idec
2012 Phase 1 NCT01610310 United States;
BIIB017 (peginterferon beta-1a) Pre-filled syringe (PFS)
Biogen Idec
2012 Phase 1 NCT01610310 United States;
BIIB019
BIOGEN IDEC RESEARCH LIMITED
2017 Phase 3 EUCTR2016-002820-10-IT Canada;Denmark;France;Germany;Italy;United Kingdom;United States;
BIOGEN IDEC RESEARCH LTD
2013 Phase 3 EUCTR2012-003176-39-IT Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Russian Federation;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
Biogen
2013 Phase 3 EUCTR2012-003176-39-HU Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 2 EUCTR2009-015318-23-GB Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom;
Biogen Idec Limited
2011 - EUCTR2010-023856-97-PL Czech Republic;Hungary;Poland;Russian Federation;United States;
2011 - EUCTR2010-023856-97-HU Czech Republic;Hungary;Poland;Russian Federation;United States;
2011 - EUCTR2010-023856-97-CZ Czech Republic;Hungary;Poland;United States;
Biogen Idec Ltd
2012 Phase 3 EUCTR2009-012500-11-SI Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-012500-11-GB Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-012500-11-FI Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 - EUCTR2009-012500-11-SE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 - EUCTR2009-012500-11-IE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 - EUCTR2009-012500-11-HU Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 - EUCTR2009-012500-11-DK Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 - EUCTR2009-012500-11-DE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 - EUCTR2009-012500-11-CZ Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
Biogen Idec Ltd.
2011 Phase 2 EUCTR2009-015318-23-DE Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom;
2010 Phase 2 EUCTR2009-015318-23-HU Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom;
2010 Phase 2 EUCTR2009-015318-23-CZ Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom;
2009 Phase 2 EUCTR2008-005559-46-GB Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
2009 - EUCTR2008-005559-46-HU Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
2009 - EUCTR2008-005559-46-DE Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
2009 - EUCTR2008-005559-46-CZ Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
Biogen Idec Research Limited
2017 Phase 3 EUCTR2016-002820-10-GB Canada;Denmark;France;Germany;Italy;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002820-10-DE Canada;Germany;Italy;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003176-39-SE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003176-39-PL Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003176-39-IE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003176-39-GR Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003176-39-GB Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003176-39-FR Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003176-39-ES Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003176-39-DK Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003176-39-DE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003176-39-CZ Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 - EUCTR2012-003176-39-FI Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
BIIB019 (Daclizumab High Yield Process)
Biogen
2010 Phase 3 NCT01064401 Argentina;Australia;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Egypt;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2009 Phase 2 NCT00870740 Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
2008 Phase 2 NCT00390221 Australia;Czech Republic;Former Serbia and Montenegro;Germany;Hungary;India;Poland;Russian Federation;Sweden;Turkey;Ukraine;United Kingdom;
BIIB019 (Daclizumab)
Biogen
2013 Phase 3 NCT01797965 Argentina;Australia;Brazil;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 NCT01462318 Czech Republic;Hungary;Poland;Russian Federation;United States;
2010 Phase 2 NCT01051349 Czech Republic;Czechia;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
BIIB033
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 2 EUCTR2017-001224-22-IT Australia;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
Biogen
2016 Phase 1 NCT02641041 United Kingdom;
2013 Phase 2 NCT01864148 Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
2010 Phase 1 NCT01244139 United States;
Biogen Idec Research Limited
2013 Phase 2 EUCTR2011-006262-40-NL Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
2013 Phase 2 EUCTR2011-006262-40-IT Canada;Czech Republic;Hungary;Italy;Netherlands;Russian Federation;Serbia;Spain;United Kingdom;United States;
2013 Phase 2 EUCTR2011-006262-40-HU Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
2013 Phase 2 EUCTR2011-006262-40-GB Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
2013 Phase 2 EUCTR2011-006262-40-ES Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
2013 Phase 2 EUCTR2011-006262-40-CZ Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
BIIB033 (ANTI-LINGO)
Biogen Idec Research Limited
2018 Phase 2 EUCTR2017-001224-22-PL Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
2018 Phase 2 EUCTR2017-001224-22-NL Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
2018 Phase 2 EUCTR2017-001224-22-DE Australia;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
2018 Phase 2 EUCTR2017-001224-22-BE Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
2017 Phase 2 EUCTR2017-001224-22-HU Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
2017 Phase 2 EUCTR2017-001224-22-ES Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
2017 Phase 2 EUCTR2017-001224-22-CZ Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
BIIB033 (ANTI-LINGO) - EV Substance Code SUB118957
Biogen Idec Research Limited
2017 Phase 2 EUCTR2017-001224-22-GB Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
BIIB033 (opicinumab)
Biogen
2017 Phase 2 NCT03222973 Australia;Belgium;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
2016 Phase 1 NCT02833142 United States;
BIIB041
Biogen Idec Research Limited
2015 Phase 3 EUCTR2013-003600-40-NL Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003600-40-GB Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003600-40-CZ Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003600-40-BG Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States;
2014 - EUCTR2013-003600-40-LT Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States;
2014 - EUCTR2013-003600-40-IT Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States;
2014 - EUCTR2013-003600-40-FI Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States;
2012 Phase 4 EUCTR2011-003507-38-GB Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom;
2012 Phase 4 EUCTR2011-003507-38-BE Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom;
2012 Phase 2 EUCTR2012-000368-90-BE Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom;
2012 - EUCTR2012-000368-90-NL Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom;
2012 - EUCTR2012-000368-90-GB Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom;
2012 - EUCTR2011-003507-38-PT Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom;
2012 - EUCTR2011-003507-38-NL Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom;
2012 - EUCTR2011-003507-38-DK Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom;
Cliniques Universitaires Saint-Luc, Neurologie
2013 - EUCTR2012-005076-34-BE Belgium;
BIIB041 (Fampridine-SR)
Biogen Idec
2010 Phase 3 NCT01235221 Canada;
BIIB041 (PR Fampridine)
Biogen
2012 Phase 2 NCT01597297 Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom;
BIIB041 (fampridine)
Biogen
2013 Phase 3 NCT01917019 Japan;
BIIB061
Biogen
2021 Phase 2 NCT04079088 -
2015 Phase 1 NCT02521545 United States;
BIIB133
Biogen Idec Research Limited
2020 Phase 2 EUCTR2019-001967-58-PL Belgium;France;Germany;Italy;Poland;Serbia;Spain;Switzerland;United States;
2020 Phase 2 EUCTR2019-001967-58-FR Belgium;France;Germany;Italy;Poland;Serbia;Spain;Switzerland;United States;
BIRT 2584 XX
BOEHRINGER ING.
2006 - EUCTR2005-005985-35-IT Czech Republic;Italy;Netherlands;
Boehringer Ingelheim
2006 - EUCTR2005-005985-35-NL Czech Republic;Italy;Netherlands;
Boehringer Ingelheim Ltd
2006 - EUCTR2005-005985-35-CZ Czech Republic;Italy;Netherlands;
BIRT 2584XX
BOEHRINGER ING.
2006 - EUCTR2005-005985-35-IT Czech Republic;Italy;Netherlands;
BMMNC
Chaitanya Hospital, Pune
2014 Phase 1/Phase 2 NCT01883661 India;
BMS 188667 (Abatacept)
Bristol-Myers Squibb
2001 Phase 2 NCT00035529 United States;
BNT162b2
National Institute of Allergy and Infectious Diseases (NIAID)
2021 Phase 2 NCT05000216 United States;
BORAGE OIL GLA
PALUPA Medical Ltd
2016 Phase 3 EUCTR2015-003147-19-GR Greece;
BOSWELAN
University Medical Center Eppendorf
- Phase 2 EUCTR2009-014724-32-DE Germany;
BOTOX®
Allergan
2008 - EUCTR2006-006299-39-NL France;Netherlands;
2008 - EUCTR2006-006299-39-FR France;Netherlands;
Allergan Ltd.
2013 - EUCTR2012-000957-30-PT Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States;
2013 - EUCTR2012-000957-30-GB Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States;
2012 - EUCTR2012-000957-30-CZ Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States;
2012 - EUCTR2012-000957-30-BE Belgium;Canada;Czech Republic;France;Poland;Portugal;Russian Federation;United Kingdom;United States;
BOTULINUM TOXIN A - HAEMAGGLUTININ COMPLEX
Ipsen Innovation
2016 Phase 3 EUCTR2015-003471-30-PT Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
2016 Phase 3 EUCTR2015-003471-30-PL Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
2016 Phase 3 EUCTR2015-003471-30-NL Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
2016 Phase 3 EUCTR2015-003471-30-IT Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
2016 Phase 3 EUCTR2015-003471-30-CZ Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
2016 Phase 3 EUCTR2015-000507-44-LT Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
2016 Phase 3 EUCTR2015-000507-44-FR Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
2016 Phase 3 EUCTR2015-000507-44-ES Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
2016 Phase 3 EUCTR2015-000507-44-DE Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
2016 Phase 3 EUCTR2015-000507-44-BE Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
BX-1
Bionorica SE
2020 Phase 3 EUCTR2018-000001-23-CZ Czech Republic;Hungary;Spain;
2019 Phase 3 NCT03756974 Czechia;Germany;Hungary;Poland;Spain;
2018 Phase 3 EUCTR2018-000001-23-HU Czech Republic;Hungary;Spain;
2018 Phase 3 EUCTR2018-000001-23-ES Hungary;Spain;
Bacille Calmette-Guerin vaccine
S. Andrea Hospital
2019 Phase 2 NCT03888924 Italy;
Bacille of Calmette-Guerin
S. Andrea Hospital
2001 Phase 2/Phase 3 NCT00202410 Italy;
Baclofen
DAIICHI SANKYO COMPANY, LIMITED
- Phase 4 JPRN-JapicCTI-050031 -
Osmotica Pharmaceutical US LLC
2012 Phase 3 NCT01743651 Russian Federation;Ukraine;United States;
Baclofen ER Capsules (GRS)
Sun Pharma Advanced Research Company Ltd.
2016 Phase 3 EUCTR2016-001356-22-HU Germany;Hungary;Russian Federation;Ukraine;United States;
Baclofen IR
Impax Laboratories, LLC
2009 Phase 2 NCT00914290 United States;
Baclofen Tablets USP
Sun Pharma Advanced Research Company Ltd.
2016 Phase 3 EUCTR2016-001356-22-HU Germany;Hungary;Russian Federation;Ukraine;United States;
Bafiertam
Banner Life Sciences LLC
2019 Phase 1 NCT04022473 United States;
Balance
Ankara Yildirim Beyazit University
2019 - NCT04408742 Turkey;
2019 - NCT04286828 Turkey;
2019 - NCT03945006 Turkey;
2016 - NCT03566251 Turkey;
Biruni University
2016 - NCT03436927 -
East Kent Hospitals University NHS Foundation Trust
2017 Phase 1 NCT05102682 United Kingdom;
Gazi University
2018 - NCT03584672 -
2018 - NCT03501342 Turkey;
Lama Saad El-Din Mahmoud
2020 - NCT04528121 Egypt;
Marquette University
2017 - NCT04719494 -
October 6 University
2017 - NCT03670459 Egypt;
Somogy Megyei Kaposi Mór Teaching Hospital
2018 - NCT04550650 Hungary;
University of Aarhus
2016 - NCT02870023 Denmark;
University of Colorado, Denver
2012 - NCT01698086 United States;
University of Iowa
2020 - NCT04391023 United States;
University of Nebraska
2013 - NCT01816100 United States;
Wayne State University
2020 - NCT03404388 United States;
Örebro County Council
2014 - NCT02209467 Sweden;
2012 - NCT01582126 Sweden;
Balance platform therapy
University Hospital of Ferrara
2017 - NCT03353974 Italy;
Baminercept
Biogen Idec
2010 Phase 1/Phase 2 NCT01181089 Canada;United Kingdom;
Baseline Treatment
Hoffmann-La Roche
2014 Phase 3 NCT02028884 France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;Ukraine;United Kingdom;United States;
Baseline disease modifying therapies (DMTs)
Novartis Pharmaceuticals
2021 Phase 4 NCT04792567 Germany;
Bazedoxifene Acetate
Riley Bove, MD
2019 Phase 2 NCT04002934 United States;
Beetainterferoni -1a
Turku University Hospital
2013 Phase 4 EUCTR2013-004626-28-FI Finland;
Belimumab
Johns Hopkins University
2021 Phase 2 NCT04767698 United States;
Tianjin Medical University General Hospital
2021 Phase 1/Phase 2 NCT05154734 China;
Best Available Therapy (BAT)
National Institute of Allergy and Infectious Diseases (NIAID)
2019 Phase 3 NCT04047628 United Kingdom;United States;
Beta-1b interferoni
Schering Oy
2006 - EUCTR2005-005211-21-FI Finland;
Beta-Interferon
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
Beta-alanine supplementation
Hasselt University
2017 - NCT03418376 Belgium;
Beta-interferon
Sun Yat-sen University
2006 - NCT00818103 China;
Betaconnect Autoinjector
Bayer
2015 - NCT02486640 Germany;
Betaconnect auto-injector
Bayer
2017 - NCT03134573 Germany;
Betaferon
Dansk Multipel Sclerose Center
2010 - EUCTR2009-016824-29-DK Denmark;
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden;
2017 Phase 4 EUCTR2016-003587-39-SE Sweden;
Medical University Innsbruck
2009 - EUCTR2009-013284-19-AT Austria;
Medizinische Universität Innsbruck
2014 Phase 4 EUCTR2012-005450-30-AT Austria;Sweden;
2014 - EUCTR2012-005450-30-SE Austria;Sweden;
NURON BIOTECH INC.
2012 - EUCTR2011-002683-24-IT Belarus;Bulgaria;Hungary;Italy;Russian Federation;Spain;
Nuron Biotech, Inc.
2012 - EUCTR2011-002683-24-HU Belarus;Bulgaria;Croatia;Georgia;Hungary;Italy;Lebanon;Poland;Russian Federation;Spain;Ukraine;
2012 - EUCTR2011-002683-24-ES Belarus;Bulgaria;Croatia;Georgia;Hungary;Italy;Poland;Russian Federation;Spain;Ukraine;
2012 - EUCTR2011-002683-24-BG Belarus;Bulgaria;Croatia;Georgia;Hungary;Italy;Lebanon;Poland;Russian Federation;Spain;Ukraine;
Schering Nordiska AB
2006 - EUCTR2005-001540-23-SE Denmark;Sweden;
2005 - EUCTR2005-001540-23-DK Denmark;Sweden;
Schering Oy
2006 - EUCTR2005-005211-21-FI Finland;
Turku University Hospital
2013 Phase 4 EUCTR2013-004626-28-FI Finland;
Betaferon 250 microgram/mL, powder and solvent for solution for injection.
Bayer HealthCare AG
2013 Phase 4 EUCTR2012-005262-35-ES Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
Betaferon 250 microgram/ml
Biogen Portugal
2016 Phase 4 EUCTR2016-000434-21-PT Portugal;
Octapharma AG
2015 Phase 3 EUCTR2012-005086-12-PL Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;Serbia;Ukraine;
2013 - EUCTR2012-005086-12-HU Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-DE Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-BG Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-AT Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
Betaferon 250 microgram/ml, powder and solvent for solution for injection
Bayer AG
2018 Phase 4 EUCTR2017-001176-31-PT Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2017 Phase 4 EUCTR2017-001176-31-GB Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2017 Phase 4 EUCTR2017-001176-31-FR Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2017 Phase 4 EUCTR2017-001176-31-FI Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2017 Phase 4 EUCTR2017-001176-31-ES Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2017 Phase 4 EUCTR2017-001176-31-DK Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2017 Phase 4 EUCTR2017-001176-31-CZ Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2017 Phase 4 EUCTR2017-001176-31-AT Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
Bayer HealthCare AG
2013 Phase 4 EUCTR2012-005262-35-GB Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2013 Phase 4 EUCTR2012-005262-35-CZ Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2012-005262-35-SI Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2012-005262-35-IT Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2012-005262-35-FI Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2012-005262-35-AT Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
Betaferon 250 microgramos
Schering AG
2007 Phase 3 EUCTR2006-005270-47-ES Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Betaferon 250mcg
Schering AG
2007 - EUCTR2006-005270-47-IE Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Betaferon 250µg
Bayer AB, Bayer Health Care, Bayer Schering Pharma
2007 - EUCTR2006-005270-47-SE Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Bayer Schering Pharma
2007 - EUCTR2006-005270-47-SI Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-HU Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
- - EUCTR2006-005270-47-DE Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Bayer Schering Pharma AG
2007 - EUCTR2006-005270-47-LV Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-GR Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-BE Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Schering AG
2007 Phase 3 EUCTR2006-005270-47-FR Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 Phase 3 EUCTR2006-005270-47-FI Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-NL Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-AT Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Betaferon 500 µg
Schering AG
2007 Phase 3 EUCTR2006-005270-47-ES Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Betaferon 500mcg
Schering AG
2007 - EUCTR2006-005270-47-IE Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
UCL Biomedicine R&D Unit
2006 - EUCTR2005-005751-18-GB United Kingdom;
Betaferon 500µg
Bayer AB, Bayer Health Care, Bayer Schering Pharma
2007 - EUCTR2006-005270-47-SE Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Bayer Schering Pharma
2007 - EUCTR2006-005270-47-SI Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-HU Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
- - EUCTR2006-005270-47-DE Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Bayer Schering Pharma AG
2007 - EUCTR2006-005270-47-LV Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-GR Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-BE Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Schering AG
2007 Phase 3 EUCTR2006-005270-47-FR Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 Phase 3 EUCTR2006-005270-47-FI Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-NL Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-AT Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Betaferon, BAY86-5046
Bayer
2019 - NCT03808142 Germany;
Betaferon/Betaseron
Bayer
2006 Phase 4 NCT00317941 France;
2003 Phase 4 NCT00206648 Canada;United States;
Betaferon®
University Hospital Motol
2011 Phase 4 EUCTR2011-001956-12-CZ Czech Republic;
Betaseron
Bayer HealthCare AG
- - EUCTR2014-004613-93-Outside-EU/EEA China;
Stuart D Cook MD
2003 Phase 4 NCT00176592 United States;
Teva Pharmaceutical Industries
2004 Phase 4 NCT00202995 Canada;United States;
Betaseron (Interferon beta-1b, BAY86-5046)
Bayer
2010 - NCT01031459 Canada;United States;
2002 Phase 2 NCT00893217 United States;
Betaseron (Interferon beta-1b, BAY86-5046), Bayer HealthCare AG
Bayer
2016 - NCT02749396 Finland;
Bevacizumab
Johns Hopkins University
2013 Phase 1 NCT01777412 United States;
Bexarotene
Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge
2015 Phase 2 EUCTR2014-003145-99-GB United Kingdom;
Bexsero
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 2;Phase 3 EUCTR2019-001829-26-IT Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States;
Biological samples
Centre Hospitalier Régional d'Orléans
2021 Phase 4 NCT04952766 France;
Biotin
University Hospital, Clermont-Ferrand
2018 - NCT03552211 France;
Bisacodyl
David Levinthal
2016 Phase 2 NCT02609607 United States;
Blood sample
Centre Hospitalier Universitaire de Saint Etienne
2020 Phase 2 NCT03983720 France;
University Hospital, Bordeaux
2021 - NCT04798651 France;
Blood samples
University Hospital, Bordeaux
2014 - NCT02142764 France;
Blood sampling
Centre Hospitalier Universitaire de Nimes
2013 Phase 3 NCT01817166 France;
Rennes University Hospital
2021 - NCT04697407 France;
BodyBio Balance Oil
Terry L. Wahls
2022 - NCT05007483 United States;
BodyBio PC
Terry L. Wahls
2022 - NCT05007483 United States;
Bone marrow autologous mesenchymal stem cells transplantation
Germans Trias i Pujol Hospital
2013 Phase 1/Phase 2 NCT02035514 Spain;
Bortezomib
Tianjin Medical University General Hospital
2015 Phase 2 NCT02893111 China;
Boswellia serrata extract PS0201Bo capsules
University Medical Center Eppendorf
- Phase 2 EUCTR2009-014724-32-DE Germany;
Boswellic acids (BOSWELAN)
Universitätsklinikum Hamburg-Eppendorf
2011 Phase 2 NCT01450124 Germany;
Botox
Krajská nemocnice Liberec, a.s.
2010 - EUCTR2009-012431-15-CZ Czech Republic;
Botox 100 UNT Injection
Brigitte Schürch
2021 Phase 4 NCT04819360 Switzerland;
Botulinum Toxin Type A 200U
Allergan
2009 Phase 3 NCT00876447 Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Czechia;France;Germany;Italy;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Singapore;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Botulinum Toxin Type A 300U
Allergan
2009 Phase 3 NCT00876447 Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Czechia;France;Germany;Italy;Netherlands;New Zealand;Poland;Portugal;Russian Federation;Singapore;Slovakia;South Africa;Spain;Taiwan;Ukraine;United Kingdom;United States;
Botulinum toxin
ALLERGAN
2008 - EUCTR2007-000192-42-IT France;Germany;Italy;Netherlands;Portugal;Spain;United Kingdom;
Botulinum toxin A
Sunnybrook Health Sciences Centre
2006 Phase 3 NCT01091727 Canada;
Botulinum toxin type A
Allergan
2008 - EUCTR2006-006299-39-NL France;Netherlands;
2008 - EUCTR2006-006299-39-FR France;Netherlands;
Ipsen
2016 Phase 3 NCT02660359 Argentina;Australia;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
2016 Phase 3 NCT02660138 Canada;Czech Republic;Czechia;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Turkey;United States;
2011 Phase 2 NCT01357980 Austria;Czech Republic;Czechia;France;Germany;Italy;Poland;
Botulinum toxin type A infiltrations
Aránzazu Vázquez Doce
2019 Phase 3 NCT04595045 Spain;
Brimonidine tartrate
Biogen
2016 Phase 4 NCT02568111 -
C1-esterase inhibitor (Cinryze)
Michael Levy
2013 Phase 1 NCT01759602 United States;
C105
Cognition Pharmaceuticals, LLC
2006 Phase 2 NCT00529581 United States;
CALCIO FOLINATO DC.IT
AZIENDA OSPEDALIERA SAN CAMILLO FORLANINI
2005 - EUCTR2005-006071-12-IT Italy;
CBD
Aarhus Universitetshospital
2018 Phase 2 EUCTR2018-002315-98-DK Denmark;
CC
University of Washington
2014 - NCT02137044 United States;
CCI-779
Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development
2005 - EUCTR2005-000171-18-FI Finland;
Wyeth is now a wholly owned subsidiary of Pfizer
2003 Phase 2 NCT00228397 -
CD
Sato Toshiyuki
2020 Phase 3 JPRN-jRCT2051210017 Japan;
CDP323
UCB Pharma
2008 Phase 1/Phase 2 NCT00726648 United Kingdom;
2007 Phase 2 NCT00484536 Belgium;Canada;Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom;United States;
2007 Phase 2 EUCTR2006-002204-33-ES Belgium;Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom;
2007 - EUCTR2006-002204-33-FI Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom;
UCB Pharma S.A.
2007 Phase 2 EUCTR2006-002204-33-GB Belgium;Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom;
2007 Phase 2 EUCTR2006-002204-33-FR Belgium;Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom;
2007 - EUCTR2006-002204-33-SE Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom;
2007 - EUCTR2006-002204-33-NL Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom;
2007 - EUCTR2006-002204-33-HU Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom;
2007 - EUCTR2006-002204-33-DE Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom;
2007 - EUCTR2006-002204-33-BE Belgium;Finland;France;Germany;Hungary;Netherlands;Spain;Sweden;United Kingdom;
CELLCEPT
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France;
CETIRIZINE HYDROCHLORIDE
Biogen Idec Italia S.r.l.
2015 - EUCTR2013-001055-12-IT Italy;
CGP 77116
National Institute of Neurological Disorders and Stroke (NINDS)
1998 Phase 2 NCT00001781 United States;
CHR-1103 / GBR500
Genzyme Corporation
2015 Phase 2 EUCTR2014-003265-19-PL Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States;
2015 Phase 2 EUCTR2014-001643-20-SE Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States;
2015 Phase 2 EUCTR2014-001643-20-PL Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States;
2015 Phase 2 EUCTR2014-001643-20-DE Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States;
CIANOCOBALAMINA FU DC.IT
AZIENDA OSPEDALIERA SAN CAMILLO FORLANINI
2005 - EUCTR2005-006071-12-IT Italy;
CIC using LoFric Primo
Wellspect HealthCare
2009 - NCT00913510 Belgium;France;Germany;Netherlands;United Kingdom;
CITOCHINE ED IMMUNOMODULATORI
TEVA
2005 - EUCTR2004-003943-28-IT Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
CLOSTRIDIUM BOTULINUM TOXIN TYPE A
Ipsen Innovation
2016 Phase 3 EUCTR2015-003471-30-PT Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
2016 Phase 3 EUCTR2015-003471-30-PL Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
2016 Phase 3 EUCTR2015-003471-30-NL Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
2016 Phase 3 EUCTR2015-003471-30-IT Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
2016 Phase 3 EUCTR2015-003471-30-CZ Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
2016 Phase 3 EUCTR2015-000507-44-LT Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
2016 Phase 3 EUCTR2015-000507-44-FR Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
2016 Phase 3 EUCTR2015-000507-44-ES Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
2016 Phase 3 EUCTR2015-000507-44-DE Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
2016 Phase 3 EUCTR2015-000507-44-BE Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
2012 - EUCTR2010-023210-31-LT Austria;Czech Republic;Germany;Italy;Lithuania;
2012 - EUCTR2010-023210-31-DE Austria;Czech Republic;Germany;Italy;Lithuania;
2012 - EUCTR2010-023210-31-CZ Austria;Czech Republic;Germany;Italy;Lithuania;
2012 - EUCTR2010-023210-31-AT Austria;Czech Republic;Germany;Italy;Lithuania;
CNM-Au8
Clene Nanomedicine
2020 Phase 2/Phase 3 NCT04626921 Australia;
2018 Phase 2 NCT03536559 Australia;Canada;United States;
CNTO 1275
Centocor, Inc.
2004 Phase 2 NCT00207727 Australia;Canada;Czech Republic;Hungary;Poland;United Kingdom;United States;
CO-14
PEPTIMMUNE Inc
2008 - EUCTR2007-007759-15-HU Hungary;
COLECALCIFEROL CONCENTRATE (OILY FORM)
Javier Olascoaga Urtaza
2013 Phase 2 EUCTR2012-004602-97-ES Spain;
COP-1/Copolymer-1
TEVA Pharmaceutical Industries Ltd.
2007 - EUCTR2004-000463-94-HU Hungary;Italy;
2004 - EUCTR2004-000462-13-HU Hungary;Italy;
COPAXONE - 20 MG/ML SOLUZIONE INIETTABILE 28 SIRINGHE PRERIEMPITE
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain;
COPAXONE - 20 MG/ML SOLUZIONE INIETTABILE IN SIRINGHE PRERIEMPITE 30 SIRINGHE
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC
2015 Phase 4 EUCTR2015-000922-12-IT Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
COPAXONE - 40 MG/ML SOLUZIONE INIETTABILE IN
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain;
COPAXONE - 40 MG/ML SOLUZIONE INIETTABILE IN SIRINGA PRERIEMPITA 12 SIRINGHE PRERIEMPITE DA 1 ML CON AGO
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy;
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC
2015 Phase 4 EUCTR2015-000922-12-IT Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
COPAXONE 20 mg/ml solución inyectable en jeringa precargada
Biogen Idec Limited
2010 - EUCTR2009-015556-15-ES Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
COPAXONE*SC 28SIR 20MG/ML
Teva Pharmaceuticals Industries Ltd.
2006 - EUCTR2006-002037-20-IT Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
COVID-19 mRNA Vaccine (nucleoside modified)
Novartis Pharma GmbH
2021 Phase 4 EUCTR2020-005752-38-DE Germany;
Novartis Pharma Vertriebs GmbH
2021 Phase 4 EUCTR2021-000307-20-DE Germany;
COVID-19 mRNA vaccine (nucleoside-modified)
Novartis Pharma Vertriebs GmbH
2021 Phase 4 EUCTR2021-000307-20-DE Germany;
COVID-19 mRNA vaccine Moderna (CX-024414)
Novartis Pharma GmbH
2021 Phase 4 EUCTR2020-005752-38-DE Germany;
Novartis Pharma Vertriebs GmbH
2021 Phase 4 EUCTR2021-000307-20-DE Germany;
COVID-19 vaccination
Sheba Medical Center
2021 - NCT05075499 Israel;
COVID19 vaccine
Yale University
2021 - NCT05286242 United States;
CS-0777 tablets
Daiichi Sankyo Inc.
2008 Phase 1 NCT00616733 United States;
CSF sampling
Rennes University Hospital
2021 - NCT04697407 France;
CT103A cells
Tongji Hospital
2020 Early Phase 1 NCT04561557 China;
CYCLOPHOSPHAMIDE MONOHYDRATE
Uppsala l?ns landsting
2011 - EUCTR2010-023560-40-SE Brazil;Canada;Sweden;United States;
Caffeine
Biogen
2011 Phase 3 NCT01462318 Czech Republic;Hungary;Poland;Russian Federation;United States;
Calcium
Centre Hospitalier Universitaire de Nimes
2016 - NCT02636829 France;
Calcium and Vitamin D combination
Novartis
2010 Phase 3 NCT01166178 Germany;
Calcium carbonate
University Hospital of North Norway
2008 Phase 4 NCT00785473 Norway;
Calcium levofolinate
AZIENDA OSPEDALIERA SAN CAMILLO FORLANINI
2005 - EUCTR2005-006071-12-IT Italy;
Cannabidiol
GW Pharma Ltd
2007 Phase 3 EUCTR2006-005910-11-CZ Czech Republic;Germany;Italy;Spain;United Kingdom;
2006 Phase 3 EUCTR2005-005265-11-GB Czech Republic;France;United Kingdom;
2006 Phase 3 EUCTR2005-005265-11-FR Czech Republic;France;United Kingdom;
2006 - EUCTR2005-005265-11-CZ Czech Republic;France;United Kingdom;
2005 Phase 3 EUCTR2004-002509-63-GB Czech Republic;United Kingdom;
2005 - EUCTR2004-002509-63-CZ Czech Republic;United Kingdom;
GW Pharma Ltd.
2011 - EUCTR2011-000926-31-CZ Czech Republic;
2008 Phase 3 EUCTR2006-005910-11-GB Czech Republic;Germany;Italy;Spain;United Kingdom;
2008 - EUCTR2006-005910-11-DE Germany;Italy;Spain;United Kingdom;
2007 - EUCTR2007-002138-13-GB United Kingdom;
Cannabidiol (CBD)
Tiffany J. Braley, MD, MS
2022 Phase 2 NCT05269628 United States;
Cannabidiol / Dronabinol capsule 5 mg+2,
Aarhus Universitetshospital
2018 Phase 2 EUCTR2018-002315-98-DK Denmark;
Cannabidiol Botanical Drug Substance (CBD BDS)
Almirall Hermal GmbH
2016 Phase 4 EUCTR2015-004451-40-AT Austria;Czech Republic;
GW Pharma Limited
2022 Phase 3 EUCTR2020-004306-58-LT Bulgaria;Canada;Hungary;Italy;Lithuania;Spain;United Kingdom;United States;
2021 Phase 3 EUCTR2020-003271-18-ES Australia;Belgium;Czech Republic;Czechia;Poland;Spain;Sweden;United Kingdom;
2021 Phase 3 EUCTR2020-003271-18-CZ Australia;Belgium;Czech Republic;Czechia;Poland;Spain;Sweden;United Kingdom;
2021 Phase 3 EUCTR2019-002625-29-CZ Czech Republic;Czechia;Poland;United Kingdom;
2020 Phase 3 EUCTR2019-002625-29-PL Czech Republic;Czechia;Poland;United Kingdom;
2020 Phase 3 EUCTR2019-002625-29-GB Poland;United Kingdom;
GW Pharma Ltd
2020 Phase 3 EUCTR2019-002623-14-PL Czech Republic;Czechia;Poland;Romania;United Kingdom;United States;
2020 Phase 3 EUCTR2019-002623-14-GB Czech Republic;Poland;Romania;United Kingdom;United States;
2020 Phase 3 EUCTR2019-002623-14-CZ Czech Republic;Czechia;Poland;Romania;United Kingdom;United States;
Cannabidiol capsule
Aarhus Universitetshospital
2018 Phase 2 EUCTR2018-002315-98-DK Denmark;
Cannabis
Centre hospitalier de l'Université de Montréal (CHUM)
2021 Phase 3 NCT05092191 -
Cannabis Based Medicine Extract (Sativex)
AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA
2004 - EUCTR2005-000393-47-IT Italy;
Cannabis, Medical
OMNI Medical Services, LLC
2018 Phase 2 NCT03944447 United States;
Cannador
Gesellschaft fuer klinische Forschung e.V. (Society for Clinical Research)
2006 Phase 3 EUCTR2005-005263-29-GB United Kingdom;
Capacity of muscular oxygen extraction
Centre Hospitalier Universitaire de Saint Etienne
2020 Phase 2 NCT03983720 France;
Capsules with 160 mg Teavigo (at least EGCG)
Charite University, Berlin, Germany
2011 - NCT01417312 Germany;
Carbamazepine
Stine Maarbjerg, MD PhD
2012 - NCT04371575 -
Carbidopa
University of Miami
2018 Phase 1 NCT03266965 United States;
Carmustine
Fred Hutchinson Cancer Research Center
2008 Phase 2 NCT00716066 United States;
Carmustine, etoposide, cytarabine, and melphalan (BEAM)
National Institute of Allergy and Infectious Diseases (NIAID)
2006 Phase 2 NCT00288626 United States;
Carnosine, capsulle, 2 g/day, 8 weeks
University of Novi Sad, Faculty of Sport and Physical Education
2019 - NCT03995810 Serbia;
Cellular therapy with EBV specific autologous CTL infusion
Nantes University Hospital
2021 Phase 1 NCT02912897 France;
Ceralifimod
Merck KGaA
2014 Phase 3 EUCTR2013-002351-15-AT Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-003126-83-HU Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-003126-83-GR Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-003126-83-ES Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-003126-83-DE Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-003126-83-BG Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-PT Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-LV Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-HU Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-ES Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-EE Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-BG Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
Ceralifmod
Merck KGaA
2014 Phase 3 EUCTR2013-002351-15-AT Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-PT Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-LV Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-HU Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-ES Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-EE Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-BG Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
Cerebro-spinal fluid
University Hospital, Bordeaux
2021 - NCT04798651 France;
Cesamet™ (nabilone)
NEMA Research, Inc.
2006 Phase 4 NCT00381264 United States;
Ceterizine
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
2015 Phase 1 NCT02583594 Spain;
Cetirizina Mylan Generics
Biogen Idec Italia S.r.l.
2015 - EUCTR2013-001055-12-IT Italy;
Cetirizine
Genzyme, a Sanofi Company
2014 Phase 4 NCT02205489 Belgium;France;Netherlands;Spain;
Icahn School of Medicine at Mount Sinai
2014 Phase 1/Phase 2 NCT02865018 United States;
Charcoal
Sanofi
2013 Phase 3 NCT01863888 Belgium;Germany;Netherlands;
Cholecalciferol
Academic MS Center Limburg
2014 Phase 2 NCT02096133 Netherlands;
Johns Hopkins University
2010 Phase 1 NCT01024777 United States;
University Hospital of North Norway
2008 Phase 4 NCT00785473 Norway;
Cholecalciferol (Vitamin D3)
Merck KGaA
2009 Phase 2 NCT01198132 France;
Cholecalciferol, Vitamin D3
Merck Serono
2011 - EUCTR2010-020328-23-LV Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2011 - EUCTR2010-020328-23-LT Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2011 - EUCTR2010-020328-23-EE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2011 - EUCTR2010-020328-23-DE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2010 Phase 2 EUCTR2010-020328-23-DK Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2010 - EUCTR2010-020328-23-FI Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
Merck Serono SA - Geneva, an affiliate of Merck KGaA
2012 Phase 2 EUCTR2010-020328-23-PT Austria;Belgium;Denmark;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2011 - EUCTR2010-020328-23-AT Austria;Belgium;Denmark;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
Merck Serono SA-Geneva an affiliate of Merck KgaA, Darmstadt
2011 - EUCTR2010-020328-23-BE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal;
Merck Serono The Netherlands - a division of Merck B.V.
2011 - EUCTR2010-020328-23-NL Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal;
Cholestyramine
Sanofi
2014 Phase 1 NCT02046629 China;
2013 Phase 3 NCT01863888 Belgium;Germany;Netherlands;
Circadin ( INN= Melatonin)
North Bristol NHS Trust
2013 Phase 2 EUCTR2012-004183-21-GB United Kingdom;
Citalopram
Novartis Pharmaceuticals
2011 Phase 4 NCT01436643 Germany;
Cladribina
MERCK KGAA
2019 Phase 4 EUCTR2019-000069-19-IT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
Cladribina oral
Serono International, S.A.
2007 - EUCTR2006-003366-33-ES Italy;Spain;
Cladribine
Department of Neurology, Division of Clinical Neuroscience, Oslo University Hospital
2019 Phase 3 EUCTR2019-001505-24-NO Norway;
EMD Serono
2008 Phase 3 NCT00725985 Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czechia;Estonia;Finland;France;Georgia;Germany;India;Italy;Korea, Republic of;Lebanon;Macedonia, The Former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2005 Phase 3 NCT00213135 Canada;Switzerland;
EMD Serono Research & Development Institute, Inc.
2019 Phase 4 NCT03961204 Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Estonia;Finland;France;Georgia;Germany;Italy;Korea, Republic of;Lebanon;Lithuania;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2008 Phase 3 NCT00641537 Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;Former Serbia and Montenegro;France;Germany;Greece;Italy;Latvia;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Switzerland;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2006 Phase 2 NCT00436826 Italy;Russian Federation;Spain;United States;
Helse Bergen HF, Haukeland University Hospital
2018 Phase 3 EUCTR2017-001362-25-DK Denmark;Netherlands;
MERCK SERONO INTERNATIONAL SA
2008 - EUCTR2006-003366-33-IT Italy;Spain;
MERCK SERONO SA
2008 - EUCTR2007-000381-20-IT Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Netherlands;Portugal;United Kingdom;
2005 - EUCTR2004-005148-28-IT Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany
2019 Phase 1 NCT04086225 Germany;Poland;
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
2019 - NCT04934800 Austria;Greece;Italy;Norway;Poland;Portugal;Switzerland;
Merck KGaA
2008 Phase 1 NCT00938366 -
Merck KGaA, Darmstadt, Germany
2019 Phase 1 NCT03745144 Germany;Poland;
Merck Serono International S.A.
2006 - EUCTR2004-005148-28-LT Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
2005 - EUCTR2004-005148-28-FI Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
2005 - EUCTR2004-005148-28-EE Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
2005 - EUCTR2004-005148-28-DK Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
2005 - EUCTR2004-005148-28-CZ Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
2005 - EUCTR2004-005148-28-BE Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
Merck Serono International, a branch of Laboratoires Serono S.A.
2005 Phase 3 EUCTR2004-005148-28-GB Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Slovakia;United Kingdom;
Merck Serono International, a branch of Laboratories Serono S.A.
2005 - EUCTR2004-005148-28-DE Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
Oslo University Hospital
2019 Phase 3 NCT04121403 Norway;
Queen Mary University of London
2020 Phase 2 EUCTR2018-005038-39-GB United Kingdom;
Serono International S.A.
2006 Phase 3 EUCTR2004-005148-28-SK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Slovakia;United Kingdom;
2006 - EUCTR2004-005148-28-LV Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
2005 - EUCTR2004-005148-28-AT Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;United Kingdom;
Serono International, S.A.
2007 - EUCTR2006-003366-33-ES Italy;Spain;
University of Texas Southwestern Medical Center
2020 Phase 4 NCT04178005 United States;
Washington University School of Medicine
2019 Phase 4 NCT03963375 United States;
Cladribine (MAVENCLAD®)
Queen Mary University of London
2021 Phase 2/Phase 3 NCT04695080 United Kingdom;
Cladribine Oral Tablet
Claudio Gobbi
2020 - NCT04640818 Switzerland;
Cladribine Tablet
MERCK SERONO SA
2011 Phase 3 EUCTR2009-017978-21-IT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Estonia;Finland;Georgia;Germany;Greece;India;Italy;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Portugal;Russian Federation;Saudi Arabia;Singapore;Spain;Sweden;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States Minor Outlying Islands;
Cladribine Tablets
EMD Serono Research & Development Institute, Inc.
2019 - NCT03933215 United States;
2019 - NCT03933202 United States;
Keith Edwards, M.D.
2020 Phase 4 NCT04550455 United States;
Cladribine tablets
MERCK KGAA
2021 Phase 4 EUCTR2020-003995-42-IT Australia;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland;
2021 Phase 4 EUCTR2020-003874-30-IT Austria;Czechia;Denmark;France;Hungary;Italy;Netherlands;Poland;Slovakia;Spain;
Merck Healthcare KGaA
2021 Phase 4 EUCTR2020-003995-42-HU Australia;Canada;Czech Republic;Finland;Germany;Hungary;Israel;
2021 Phase 4 EUCTR2020-003995-42-CZ Australia;Canada;Czech Republic;Finland;Germany;Hungary;Israel;
2021 Phase 4 EUCTR2020-003874-30-HU Hungary;
2021 Phase 4 EUCTR2020-003874-30-DK Denmark;Hungary;
2021 Phase 4 EUCTR2020-003874-30-CZ Czech Republic;Denmark;Hungary;Italy;
2020 Phase 4 EUCTR2020-003995-42-FI Australia;Canada;Finland;Germany;Israel;
2020 Phase 4 EUCTR2020-003995-42-DE Australia;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Poland;
Merck KGaA
2019 Phase 4 EUCTR2019-000069-19-SE Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2019 Phase 4 EUCTR2019-000069-19-PT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2019 Phase 4 EUCTR2019-000069-19-PL Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2019 Phase 4 EUCTR2019-000069-19-LT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2019 Phase 4 EUCTR2019-000069-19-HR Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2019 Phase 4 EUCTR2019-000069-19-ES Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2019 Phase 4 EUCTR2019-000069-19-EE Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2019 Phase 4 EUCTR2019-000069-19-CZ Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Italy;Korea, Republic of;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2019 Phase 4 EUCTR2019-000069-19-BG Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
Merck Serono S.A. - Geneva
2012 Phase 3 EUCTR2009-017978-21-PT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2012 Phase 3 EUCTR2009-017978-21-PL Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2012 Phase 3 EUCTR2009-017978-21-GR Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-SE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-LV Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-GB Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-FI Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-ES Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-EE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-DK Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-BG Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-BE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 Phase 3 EUCTR2009-017978-21-AT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 - EUCTR2009-017978-21-LT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2011 - EUCTR2009-017978-21-CZ Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2010 Phase 3 EUCTR2009-017978-21-DE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Latvia;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Switzerland;Taiwan;Thailand;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
Merck, S.L.
2019 Phase 4 EUCTR2019-000069-19-AT Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Italy;Korea, Republic of;Lebanon;Lithuania;Morocco;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
Clemastine
University of California, San Francisco
2014 Phase 2 NCT02040298 United States;
Clemastine Milstein 1 mg, tabletten
Amsterdam University Medical Center
2022 Phase 3 EUCTR2021-003677-66-NL Netherlands;
Clemastine fumarate
National Institute of Allergy and Infectious Diseases (NIAID)
2017 Phase 1/Phase 2 NCT03109288 United States;
Cnp-MS-0601
Bionorica research GmbH
2007 Phase 3 EUCTR2006-004255-38-DK Austria;Denmark;Germany;
2007 - EUCTR2006-004255-38-DE Austria;Germany;
2007 - EUCTR2006-004255-38-AT Austria;Germany;
Coconut oil
University of Iowa
2010 Phase 1 NCT01381354 United States;
Coconut oil and epigallocatechin gallate
Fundación Universidad Católica de Valencia San Vicente Mártir
2018 Phase 2 NCT03740295 Spain;
Coenzyme Q
University of Iowa
2010 Phase 1 NCT01381354 United States;
Colecalciferol
AZIENDA OSPEDALIERA S. LUIGI GONZAGA
2011 - EUCTR2010-023677-19-IT Italy;
MERCK SERONO SA
2011 - EUCTR2010-020328-23-IT Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal;
University of Turku
2008 Phase 4 NCT01339676 Finland;
2008 Phase 2/Phase 3 NCT01432704 -
Combination Product: ofatumumab with AI
Novartis Pharmaceuticals
2018 Phase 2 NCT03560739 Austria;Bulgaria;Czechia;Estonia;Latvia;Lithuania;Russian Federation;Spain;United States;
Combination Product: ofatumumab with PRF
Novartis Pharmaceuticals
2018 Phase 2 NCT03560739 Austria;Bulgaria;Czechia;Estonia;Latvia;Lithuania;Russian Federation;Spain;United States;
Comirnaty Konzentrat zur Herstellung einer Injektionsdispersion
Novartis Pharma Vertriebs GmbH
2021 Phase 4 EUCTR2021-000307-20-DE Germany;
Continued Ocrelizumab
Johns Hopkins University
2021 Phase 2 NCT04767698 United States;
Copaxone
Amphia Ziekenhuis
2009 - EUCTR2009-013129-41-NL Netherlands;
Bayer
2003 Phase 3 NCT00099502 Argentina;Australia;Austria;Belgium;Brazil;Canada;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;Norway;Poland;Russian Federation;Slovenia;Spain;Sweden;Switzerland;Ukraine;United States;
Biogen Idec Limited
2010 - EUCTR2009-015556-15-SI Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States;
2010 - EUCTR2009-015556-15-SE Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States;
2010 - EUCTR2009-015556-15-PT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-NL Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-LV Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States;
2010 - EUCTR2009-015556-15-HU Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-GR Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-GB Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-FI Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-DK Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-DE Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-CZ Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States;
2010 - EUCTR2009-015556-15-AT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
Biogen Idec Ltd.
2008 - EUCTR2006-003697-10-BG Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 Phase 3 EUCTR2006-003697-10-ES Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 Phase 3 EUCTR2006-003697-10-BE Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 - EUCTR2006-003697-10-LV Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 - EUCTR2006-003697-10-IE Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 - EUCTR2006-003697-10-GR Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 - EUCTR2006-003697-10-EE Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 - EUCTR2006-003697-10-DE Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 - EUCTR2006-003697-10-CZ Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
EMD Serono
2013 Phase 2 NCT01963611 Bulgaria;Croatia;Czech Republic;Finland;Germany;Greece;Hungary;Italy;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States;
Glostrup Hospital, Dep. of Neurology
2009 - EUCTR2006-001827-21-DK Denmark;
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden;
2017 Phase 4 EUCTR2016-003587-39-SE Sweden;
Merck KGaA
2014 Phase 2 EUCTR2013-002283-25-GB Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2014 - EUCTR2013-002283-25-PL Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2014 - EUCTR2013-002283-25-GR Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2014 - EUCTR2013-002283-25-ES Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2014 - EUCTR2013-002283-25-BG Bulgaria;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States;
2013 - EUCTR2013-002283-25-IT Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2013 - EUCTR2013-002283-25-HU Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2013 - EUCTR2013-002283-25-FI Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2013 - EUCTR2013-002283-25-CZ Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
Merck Serono S.A. - Geneva
2010 - EUCTR2009-016087-37-GB France;Ireland;Italy;Spain;United Kingdom;
2009 - EUCTR2009-016087-37-ES France;Ireland;Italy;Spain;United Kingdom;
Nancy Hammond, MD
2007 - NCT00490906 United States;
Novartis Pharma Services AG
2012 - EUCTR2011-001437-16-DE Australia;Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
Peptimmune Inc.
2010 Phase 2 EUCTR2009-012716-40-SK Bulgaria;Czech Republic;Estonia;France;Germany;Poland;Slovakia;
2010 Phase 2 EUCTR2009-012716-40-DE Bulgaria;Czech Republic;Estonia;France;Germany;Poland;Slovakia;
2010 - EUCTR2009-012716-40-PL Bulgaria;Czech Republic;Estonia;France;Germany;Poland;
2010 - EUCTR2009-012716-40-FR Bulgaria;Czech Republic;Estonia;France;Germany;Poland;
2010 - EUCTR2009-012716-40-CZ Bulgaria;Czech Republic;Estonia;France;Germany;Poland;
2010 - EUCTR2009-012716-40-BG Bulgaria;Czech Republic;Estonia;France;Germany;Poland;
2009 - EUCTR2009-012716-40-EE Bulgaria;Czech Republic;Estonia;France;Germany;Poland;
Philipps-Universität Marburg
2010 - EUCTR2009-011088-35-DE Germany;
SYNTHON BV
2011 - EUCTR2011-000888-27-IT Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Romania;Russian Federation;Ukraine;United Kingdom;United States;
Stuart D Cook MD
2003 Phase 4 NCT00176592 United States;
Synthon BV
2012 - EUCTR2011-000888-27-GR Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-000888-27-DE Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2011-000888-27-RO Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2011-000888-27-GB Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2011-000888-27-EE Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2011-000888-27-CZ Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2011-000888-27-BG Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
The Walton Centre for Neurology and Neurosurgery
2005 Phase 4 EUCTR2004-004903-39-GB United Kingdom;
Turku University Hospital
2013 Phase 4 EUCTR2013-004626-28-FI Finland;
University at Buffalo
2007 - NCT00937157 United States;
University of California, Los Angeles
2007 Phase 2 NCT00451204 Canada;United States;
Università Popolare Homo & Natura
2015 Phase 1 NCT02632591 Italy;
VU University Medical Center
2014 - EUCTR2014-001012-19-NL Netherlands;
Copaxone 20 mg/ml
Octapharma AG
2015 Phase 3 EUCTR2012-005086-12-PL Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;Serbia;Ukraine;
2013 - EUCTR2012-005086-12-HU Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-DE Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-BG Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-AT Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
Teva Pharmaceutical Industries, Ltd
2016 Phase 4 EUCTR2015-000922-12-PL Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2016 Phase 4 EUCTR2015-000922-12-FR Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2016 Phase 4 EUCTR2015-000922-12-ES Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2016 Phase 4 EUCTR2015-000922-12-DE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2016 Phase 4 EUCTR2015-000922-12-BE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2015 Phase 4 EUCTR2015-000922-12-IE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2015 Phase 4 EUCTR2015-000922-12-HR Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2015 Phase 4 EUCTR2015-000922-12-FI Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2015 Phase 4 EUCTR2015-000922-12-AT Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
Copaxone 20 mg/ml Solution for Injection, pre-filled syringe
Teva Pharmaceutical Industries, Ltd.
2007 - EUCTR2006-002037-20-EE Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 Phase 3 EUCTR2006-002037-20-FI Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 Phase 3 EUCTR2006-002037-20-ES Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 - EUCTR2006-002037-20-LV Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 - EUCTR2006-002037-20-LT Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 - EUCTR2006-002037-20-HU Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 - EUCTR2006-002037-20-GB Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 - EUCTR2006-002037-20-DE Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 - EUCTR2006-002037-20-CZ Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 - EUCTR2006-002037-20-BE Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
Copaxone 20 mg/ml solución para inyección en jeringa precargada
Teva Pharmaceutical Industries, Ltd.
2006 Phase 3 EUCTR2006-002037-20-ES Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
Copaxone 20 mg/ml, Solution for Injection, pre-filled syringes
Teva Pharmaceutical Industries, Ltd.
2006 - EUCTR2006-002037-20-CZ Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
Copaxone 20mg/ml Solution for Injection, pre-filled syringe
Teva Pharmaceutical Industries, Ltd.
2006 - EUCTR2006-002037-20-LT Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
Copaxone 40 mg/ml
Teva Pharmaceutical Industries, Ltd
2016 Phase 4 EUCTR2015-000922-12-PL Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2016 Phase 4 EUCTR2015-000922-12-FR Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2016 Phase 4 EUCTR2015-000922-12-ES Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2016 Phase 4 EUCTR2015-000922-12-DE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2016 Phase 4 EUCTR2015-000922-12-BE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2015 Phase 4 EUCTR2015-000922-12-IE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2015 Phase 4 EUCTR2015-000922-12-HR Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2015 Phase 4 EUCTR2015-000922-12-FI Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2015 Phase 4 EUCTR2015-000922-12-AT Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
Copaxone 40 mg/ml solution for injection, pre-filled syringe
Università degli Studi Aldo Moro
2019 Phase 3 EUCTR2017-005129-18-IT Italy;
Copaxone subcutaneous injection syringe
TAKEDA PHARMACEUTICAL COMPANY LTD.
2015 - JPRN-JapicCTI-153058 -
Copaxone-Teva
Biocad
2013 Phase 3 NCT02753088 -
Copaxone®
Teva Branded Pharmaceutical Products R&D, Inc.
2015 Phase 4 NCT02499900 Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Italy;Mexico;Poland;Puerto Rico;Russian Federation;Spain;Turkey;United States;
Copolymer 1
National Center for Research Resources (NCRR)
1991 Phase 3 NCT00004814 -
Corticosteroid
University of New Mexico
2019 Phase 1/Phase 2 NCT03752307 United States;
Corticosteroids & tanCART19/20
Chinese PLA General Hospital
2018 Phase 1 NCT03605238 China;
Cranberry
Rennes University Hospital
2006 Phase 3 NCT00280592 France;
Creatine
University of Iowa
2010 Phase 1 NCT01381354 United States;
Curcumin
Merck KGaA, Darmstadt, Germany
2012 Phase 2 NCT01514370 Italy;
Cyclophosfamide
Dipartimento di Neuroscienze Oftalmologia e Genetica DINOG - Universita di Genova
2006 - EUCTR2006-002562-19-IT Italy;
Cyclophosphamide
AZIENDA OSPEDALIERA DI PADOVA
- Phase 1 EUCTR2008-005773-35-IT Italy;
Baylor College of Medicine
1999 Phase 2 NCT00040482 United States;
Fred Hutchinson Cancer Research Center
1997 Phase 1 NCT00014755 United States;
Hadassah Medical Organization
2015 - NCT02529839 -
Helse Bergen HF, Haukeland University Hospital
2018 Phase 3 EUCTR2017-001362-25-DK Denmark;Netherlands;
Northwestern Memorial Hospital
2001 Phase 1 NCT00017628 United States;
Northwestern University
2019 Phase 2/Phase 3 NCT03829566 United States;
2017 Phase 3 NCT03342638 United States;
OSPEDALE S. RAFFAELE
2007 Phase 2 EUCTR2007-000586-38-IT Italy;
Seah Lim M.D.
2012 Phase 2 NCT01679041 United States;
Stony Brook University
2003 Phase 2 NCT00296205 United States;
Cyclophosphamide (drug)
University Hospital, Bordeaux
2005 Phase 3 NCT00241254 France;
Cyclophosphamide and ATG
Haukeland University Hospital
2018 Phase 3 NCT03477500 Denmark;Netherlands;Norway;Sweden;
Cyclophosphamide and fludarabine
Tongji Hospital
2020 Early Phase 1 NCT04561557 China;
Cyclophosphamide monohydrate
Sheffield Teaching Hospitals
2020 Phase 3 EUCTR2019-001549-42-GB United Kingdom;
Cyclophosphamide/Glatiramer acetate
Johns Hopkins University
2010 Phase 2 NCT00939549 United States;
Cymbalta
Eli Lilly and Company
2008 - EUCTR2008-002560-34-BE Belgium;
Cytarabine
Fred Hutchinson Cancer Research Center
2008 Phase 2 NCT00716066 United States;
Cytolytic CD4+ T cells
ImCyse S.A
2014 Phase 1;Phase 2 EUCTR2014-001081-99-BE Belgium;
Cápsulas de Laquinimod
Teva Pharmaceutical Industries Ltd
2008 - EUCTR2007-005450-23-ES Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
Células madre mesenquimales
Fundació Clínic per a la Recerca Biomèdica
- - EUCTR2009-016442-74-ES Spain;
D Mannose
University College, London
2015 Phase 1 NCT02490046 United Kingdom;
D-BIOTINA
MEDDAY PHARMACEUTICALS
2017 Phase 3 EUCTR2016-000700-29-IT Australia;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States;
D-Biotin
MEDDAY PHARMACEUTICALS
2017 Phase 3 EUCTR2016-000700-29-IT Australia;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States;
D-aspartate
Merck KGaA, Darmstadt, Germany
2018 Phase 2 NCT03387046 Germany;Italy;
DAC HYP
BIOGEN IDEC RESEARCH LIMITED
2017 Phase 3 EUCTR2016-002820-10-IT Canada;Denmark;France;Germany;Italy;United Kingdom;United States;
Biogen Idec Research Limited
2017 Phase 3 EUCTR2016-002820-10-GB Canada;Denmark;France;Germany;Italy;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002820-10-DE Canada;Germany;Italy;United Kingdom;United States;
DAC-HYP
National Institute of Neurological Disorders and Stroke (NINDS)
2010 Phase 1 NCT01143441 United States;
DC-TAB
Delta Crystallon B.V.
2012 - EUCTR2011-004475-36-BG Bulgaria;
DEMESTRIL SEPTEM
OSPEDALI CIVILI DI LIONE
2007 - EUCTR2006-005460-30-IT Italy;
DEXTROMETHORPHAN HYDROBROMIDE
Avanir Pharmaceuticals, Inc.
2012 Phase 2 EUCTR2011-002178-22-GB Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States;
2012 - EUCTR2011-002178-22-PL Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States;
2012 - EUCTR2011-002178-22-CZ Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States;
DIBASE
AZIENDA OSPEDALIERA S. LUIGI GONZAGA
2011 - EUCTR2010-023677-19-IT Italy;
DIMETIL-FUMARATO
FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA
2017 Phase 4 EUCTR2017-000559-26-IT Israel;Italy;Switzerland;United States;
DMT
Merck KGaA
2012 - NCT01601119 United Kingdom;
VU University Medical Center
2020 - NCT04260711 Netherlands;
DMT continuation
Rennes University Hospital
2019 Phase 3 NCT03653273 France;
DPA-714 PET/MRI
University of Alabama at Birmingham
2019 Phase 1 NCT03759522 United States;
DUOC-01
Joanne Kurtzberg, MD
2021 Phase 1 NCT04943289 United States;
DYSPORT*SC IM 2FL 500U
IPSEN INNOVATION
2012 - EUCTR2010-023210-31-IT Austria;Czech Republic;Germany;Italy;Lithuania;
DYSPORT®
Ipsen Innovation
2016 Phase 3 EUCTR2015-003471-30-PT Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
2016 Phase 3 EUCTR2015-003471-30-PL Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
2016 Phase 3 EUCTR2015-003471-30-NL Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
2016 Phase 3 EUCTR2015-003471-30-IT Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
2016 Phase 3 EUCTR2015-003471-30-CZ Canada;Czech Republic;Italy;Korea, Republic of;Malaysia;Netherlands;Poland;Portugal;Romania;Taiwan;Turkey;United States;
Daclizumab
Biogen
2017 Phase 3 NCT02881567 Canada;France;Germany;Italy;Puerto Rico;United Kingdom;United States;
Biogen Idec Research Limited
2017 Phase 3 EUCTR2016-002820-10-GB Canada;Denmark;France;Germany;Italy;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002820-10-DE Canada;Germany;Italy;United Kingdom;United States;
National Institute of Neurological Disorders and Stroke (NINDS)
2003 Phase 2 NCT00071838 United States;
Protein Design Labs, Inc.
2006 - EUCTR2005-001567-55-DE Germany;Spain;United Kingdom;
2005 Phase 2 EUCTR2005-001567-55-GB Austria;Germany;Spain;United Kingdom;
2005 - EUCTR2005-001567-55-ES Germany;Spain;United Kingdom;
2005 - EUCTR2005-001567-55-AT Austria;Germany;Spain;United Kingdom;
Daclizumab (Anti-CD25 Humanized Monoclonal Antibody)
PDL BioPharma, Inc.
2005 Phase 2 NCT00109161 Canada;United States;
Daclizumab HYP
BIOGEN IDEC LTD
2010 - EUCTR2009-012500-11-IT Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom;
Daclizumab HYP (DAC HYP
BIOGEN IDEC RESEARCH LTD
2013 Phase 3 EUCTR2012-003176-39-IT Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Russian Federation;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
Daclizumab HYP (DAC HYP)
Biogen
2013 Phase 3 EUCTR2012-003176-39-HU Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 2 EUCTR2009-015318-23-GB Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom;
Biogen Idec Limited
2011 - EUCTR2010-023856-97-PL Czech Republic;Hungary;Poland;Russian Federation;United States;
2011 - EUCTR2010-023856-97-HU Czech Republic;Hungary;Poland;Russian Federation;United States;
2011 - EUCTR2010-023856-97-CZ Czech Republic;Hungary;Poland;United States;
Biogen Idec Ltd
2012 Phase 3 EUCTR2009-012500-11-SI Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-012500-11-GB Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-012500-11-FR Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom;
2010 Phase 3 EUCTR2009-012500-11-FI Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-012500-11-ES Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-012500-11-SE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 - EUCTR2009-012500-11-IE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 - EUCTR2009-012500-11-HU Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 - EUCTR2009-012500-11-GR Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-012500-11-DK Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 - EUCTR2009-012500-11-DE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 - EUCTR2009-012500-11-CZ Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2006 Phase 2 EUCTR2006-001161-42-GB Czech Republic;Germany;Hungary;Sweden;United Kingdom;
Biogen Idec Ltd.
2011 Phase 2 EUCTR2009-015318-23-DE Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom;
2010 Phase 2 EUCTR2009-015318-23-HU Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom;
2010 Phase 2 EUCTR2009-015318-23-CZ Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom;
2009 Phase 2 EUCTR2008-005559-46-GB Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
2009 - EUCTR2008-005559-46-HU Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
2009 - EUCTR2008-005559-46-DE Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
2009 - EUCTR2008-005559-46-CZ Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
2008 - EUCTR2006-001161-42-HU Germany;Hungary;Sweden;United Kingdom;
2008 - EUCTR2006-001161-42-DE Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Sweden;Ukraine;United Kingdom;
2006 - EUCTR2006-001161-42-SE Germany;Hungary;Sweden;United Kingdom;
2006 - EUCTR2006-001161-42-CZ Czech Republic;Germany;Hungary;Sweden;United Kingdom;
Biogen Idec Research Limited
2013 Phase 3 EUCTR2012-003176-39-SE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003176-39-PL Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003176-39-IE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003176-39-GR Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003176-39-GB Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003176-39-FR Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003176-39-ES Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003176-39-DK Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003176-39-DE Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003176-39-CZ Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 - EUCTR2012-003176-39-FI Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
Daclizumab High Yield Process
Biogen Idec Ltd.
2011 Phase 2 EUCTR2009-015318-23-DE Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom;
2010 Phase 2 EUCTR2009-015318-23-HU Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom;
2010 Phase 2 EUCTR2009-015318-23-CZ Czech Republic;Germany;Hungary;India;Russian Federation;Ukraine;United Kingdom;
Daclizumab wih Greek suffix
Biogen Idec Ltd
2012 Phase 3 EUCTR2009-012500-11-SI Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
Daclizumab with Greek suufix
Biogen Idec Ltd.
2009 Phase 2 EUCTR2008-005559-46-GB Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
2009 - EUCTR2008-005559-46-HU Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
2009 - EUCTR2008-005559-46-DE Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
2009 - EUCTR2008-005559-46-CZ Czech Republic;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
Dalfampridine
Acorda Therapeutics
2012 - NCT01535664 United States;
Johns Hopkins University
2014 Phase 2 NCT02166346 United States;
Oregon Health and Science University
2011 Phase 2 NCT01444300 United States;
State University of New York at Buffalo
2011 Phase 2/Phase 3 NCT02006160 United States;
VA Office of Research and Development
2015 Phase 2 NCT02391961 United States;
Washington University School of Medicine
2011 Phase 2/Phase 3 NCT01337986 United States;
Dalfampridine ER
Brown, Theodore R., M.D., MPH
2010 Phase 4 NCT01356940 United States;
Dalfampridine-ER
Acorda Therapeutics
2011 Phase 3 NCT01328379 United States;
Dantrolene
National Institute of Allergy and Infectious Diseases (NIAID)
2017 Phase 1/Phase 2 NCT03109288 United States;
Darifenacin
Bayer Vital GmbH
2006 - EUCTR2006-002361-39-DE Germany;
Darifenacin (BAY79-4998)
Bayer
2007 Phase 2 NCT00845338 Germany;
Dekristol 20000 IE
Merja Soilu Häninen
2007 - EUCTR2007-001958-99-FI Finland;
Dekristol® 400-Tabletten
Charité - Universitätsmedizin Berlin
2011 Phase 2 EUCTR2011-002785-20-DE Germany;
Dekristol®-Tablette 1 (400 IE)
Charité - Universitätsmedizin Berlin
2011 Phase 2 EUCTR2011-002785-20-DE Germany;
Delta-9-tetrahydrocannabinol
GW Pharma Ltd
2007 Phase 3 EUCTR2006-005910-11-CZ Czech Republic;Germany;Italy;Spain;United Kingdom;
2006 Phase 3 EUCTR2005-005265-11-GB Czech Republic;France;United Kingdom;
2006 Phase 3 EUCTR2005-005265-11-FR Czech Republic;France;United Kingdom;
2006 - EUCTR2005-005265-11-CZ Czech Republic;France;United Kingdom;
2005 Phase 3 EUCTR2004-002509-63-GB Czech Republic;United Kingdom;
2005 - EUCTR2004-002509-63-CZ Czech Republic;United Kingdom;
GW Pharma Ltd.
2011 - EUCTR2011-000926-31-CZ Czech Republic;
2008 Phase 3 EUCTR2006-005910-11-GB Czech Republic;Germany;Italy;Spain;United Kingdom;
2008 - EUCTR2006-005910-11-DE Germany;Italy;Spain;United Kingdom;
2007 - EUCTR2007-002138-13-GB United Kingdom;
Desloratadine given orally
Hoffmann-La Roche
2022 Phase 3 NCT05232825 Brazil;Canada;Czechia;Italy;Poland;Russian Federation;Spain;Turkey;Ukraine;United States;
Dexamethason
Department of Neurology UMCG
2006 - EUCTR2006-003113-40-NL Netherlands;
Dexamethasone
Department of Neurology UMCG
2006 - EUCTR2006-003113-40-NL Netherlands;
Dexamethasone given orally
Hoffmann-La Roche
2022 Phase 3 NCT05232825 Brazil;Canada;Czechia;Italy;Poland;Russian Federation;Spain;Turkey;Ukraine;United States;
Dexamethasone soduim phosphate
Hadassah Medical Organization
2008 Phase 1 NCT00674141 Israel;
Dexchlorpheniramine
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
2015 Phase 1 NCT02583594 Spain;
Dexrazoxane (DRZ) plus Mitoxantrone (MX)
PD Dr. Andrew Chan
2012 Phase 2 NCT01627938 Germany;
Dextromethorphan
Biogen
2011 Phase 3 NCT01462318 Czech Republic;Hungary;Poland;Russian Federation;United States;
Dextromethorphan hydrobromide 20 mg and quinidine sulfate
Avanir Pharmaceuticals
2007 Phase 3 NCT00573443 Argentina;Brazil;United States;
Dextromethorphan hydrobromide 30 mg and quinidine sulfate
Avanir Pharmaceuticals
2007 Phase 3 NCT00573443 Argentina;Brazil;United States;
Dextromethorphan/Quinidine
Avanir Pharmaceuticals, Inc.
2012 Phase 2 EUCTR2011-002178-22-GB Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States;
2012 - EUCTR2011-002178-22-PL Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States;
2012 - EUCTR2011-002178-22-CZ Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States;
Dextrometorfano/Quinidina
Avanir Pharmaceuticals, Inc.
2011 Phase 2 EUCTR2011-002178-22-ES Argentina;Bulgaria;Czech Republic;Poland;Spain;United Kingdom;United States;
Diazoxide
NEUROTEC PHARMA, S.L
2011 - EUCTR2010-023048-34-DE Germany;Spain;
Diclofenac sodium topical gel
Brown, Theodore R., M.D., MPH
2011 Phase 4 NCT01454791 United States;
Dietary Supplement: vitamin A
Tehran University of Medical Sciences
2010 Phase 4 NCT01705457 Iran, Islamic Republic of;
Dimethyl Fumarate (DMF)
Genesis Pharma CNS & Specialty
2016 - NCT03101735 Greece;
Hikma Pharmaceuticals LLC
2021 - NCT04468165 Algeria;Egypt;Jordan;
Dimethyl fumarate
Anders Svenningsson
2016 Phase 3 NCT02746744 Sweden;
Banner Life Sciences LLC
2017 Phase 1 NCT04570670 -
Biogen
2021 - NCT04756687 France;
2016 Phase 3 NCT02555215 Belgium;Bulgaria;Czech Republic;Czechia;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States;
2016 Phase 3 NCT02428218 -
2016 - NCT02969304 Germany;
2015 Phase 4 NCT02472938 -
2015 Phase 4 NCT02471560 Norway;
2015 Phase 4 NCT02410278 United States;
2015 Phase 4 NCT02343159 United States;
2015 Phase 4 NCT02090348 -
2015 Phase 3 NCT02525874 Belgium;Bulgaria;Croatia;Kuwait;Lithuania;Poland;Turkey;United States;
2015 Phase 3 NCT02430532 Austria;Belgium;Czech Republic;Netherlands;Poland;Slovakia;Sweden;United States;
2015 Phase 3 NCT02428231 Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States;
2015 Phase 2 NCT02410200 Belgium;Bulgaria;Czech Republic;Czechia;Germany;Kuwait;Latvia;Lebanon;Poland;Turkey;United States;
2015 Phase 2 NCT02097849 United States;
2015 - NCT02519413 United States;
2015 - NCT02323269 Canada;
2014 Phase 4 NCT02125604 Germany;
2014 Phase 4 NCT02090413 Ireland;United Kingdom;
2014 Phase 3 NCT02579681 Italy;
2014 Phase 3 NCT02283853 Argentina;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Romania;Serbia;Spain;Sweden;Turkey;United Kingdom;United States;
2014 - NCT02159573 United States;
2013 Phase 4 NCT01930708 Austria;Belgium;Canada;Czech Republic;Czechia;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2013 Phase 3 NCT01838668 Czech Republic;Czechia;Japan;Korea, Republic of;Poland;Taiwan;
2013 - NCT02047097 Argentina;Australia;Austria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Puerto Rico;Slovakia;Spain;Switzerland;United Kingdom;United States;
2013 - NCT01911767 Australia;Canada;France;Germany;Ireland;Italy;Poland;Spain;United Kingdom;United States;
2013 - NCT01903291 United States;
2010 Phase 2 NCT01156311 United States;
2009 Phase 3 NCT00835770 Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, The Former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;North Macedonia;Poland;Puerto Rico;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
Biogen Idec Inc.
2004 - EUCTR2004-000663-99-SE Hungary;Sweden;
2004 - EUCTR2004-000663-99-HU Hungary;Sweden;
2004 - EUCTR2004-000663-99-CZ Czech Republic;Hungary;Sweden;
Biogen Idec Italia S.r.l.
2015 - EUCTR2015-000303-21-IT Italy;
Fondation Ophtalmologique Adolphe de Rothschild
2017 Phase 4 NCT02901106 France;
Multiple Sclerosis Center of Northeastern New York
2015 Phase 4 NCT03092544 United States;
Northwestern University
2013 Phase 2 EUCTR2012-004165-41-GB United Kingdom;United States;
Oregon Health and Science University
2016 - NCT02644083 United States;
University Hospital Muenster
2015 Phase 4 NCT02461069 Germany;
University at Buffalo
2015 - NCT02686684 -
Virginia Simnad
2015 - NCT02736279 United States;
Dimethyl fumarate [DMF]
Biogen Idec Italia S.r.l.
2013 Phase 3 EUCTR2013-001422-25-IT Italy;
Dimetilfumarato
Biogen Idec Italia S.r.l.
2013 Phase 3 EUCTR2013-001422-25-IT Italy;
Diphenhydramine IV
Hoffmann-La Roche
2022 Phase 3 NCT05232825 Brazil;Canada;Czechia;Italy;Poland;Russian Federation;Spain;Turkey;Ukraine;United States;
Diphenydramine
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
Diroximel Fumarate (DRF)
Alkermes, Inc.
2017 Phase 3 EUCTR2017-001294-16-PL Germany;Poland;United States;
Diroximel fumarate
Alkermes, Inc.
2019 Phase 3 EUCTR2017-001294-16-DE Germany;Poland;United States;
Hanna Jerome Thomas
2021 Phase 3 JPRN-jRCT2051210115 China;Japan;
Dirucotide
Eli Lilly and Company
2007 Phase 2/Phase 3 NCT00870155 Canada;Denmark;Estonia;Finland;Germany;Latvia;Netherlands;Spain;Sweden;United Kingdom;
2006 Phase 2/Phase 3 NCT00869986 Bulgaria;Poland;Russian Federation;Serbia;Slovakia;Ukraine;
2004 Phase 2/Phase 3 NCT00869726 Canada;Denmark;Estonia;Finland;Germany;Latvia;Netherlands;Spain;Sweden;United Kingdom;
Dirucotide acetate
BioMS Technology Corp
2007 - EUCTR2004-002571-16-GB Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2006 - EUCTR2004-002571-16-FI Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2006 - EUCTR2004-002571-16-EE Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2006 - EUCTR2004-002571-16-DK Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-002571-16-SE Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
Discontinuation of disease modifying therapy
University of Colorado, Denver
2017 Phase 4 NCT03073603 United States;
Disease Modifying therapy
Novartis Pharmaceuticals
2012 Phase 4 NCT01623596 Puerto Rico;United States;
Disease modifying treatment (DMT)
Novartis Pharmaceuticals
2022 Phase 4 NCT05090371 United States;
Domperidone
University of Calgary
2015 Phase 2 NCT02493049 Canada;
2015 Phase 2 NCT02308137 Canada;
Donepezil
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
1999 Phase 3 NCT00062972 United States;
Neurology Unit
2005 - EUCTR2005-003410-15-SE Sweden;
OSPEDALE S. RAFFAELE
2008 - EUCTR2008-001940-38-IT Italy;
Donepezil HCI (drug)
Neurognostics
2004 Phase 4 NCT00315367 United States;
Dosing Interruption of Natalizumab
Berkovich, Regina MD, PhD Inc.
2019 Phase 4 NCT04048577 United States;
Dotarem 0,5mmol/ml,
Universitätsklinikum Erlangen
2010 - EUCTR2009-014857-34-DE Germany;
Dronabinol
Bionorica Research GmbH
2007 Phase 3 NCT00959218 Germany;
Bionorica SE
2018 Phase 3 EUCTR2018-000001-23-ES Hungary;Spain;
Bionorica research GmbH
2007 Phase 3 EUCTR2006-004255-38-DK Austria;Denmark;Germany;
2007 - EUCTR2006-004255-38-DE Austria;Germany;
2007 - EUCTR2006-004255-38-AT Austria;Germany;
Echo Pharmaceuticals B.V.
2011 - EUCTR2010-022033-28-NL Netherlands;
Plymouth Hospitals NHS Trust
2006 - EUCTR2005-002728-33-GB United Kingdom;
Dronabinol 25 mg/ml, oral drops
Bionorica SE
2020 Phase 3 EUCTR2018-000001-23-CZ Czech Republic;Hungary;Spain;
2018 Phase 3 EUCTR2018-000001-23-HU Czech Republic;Hungary;Spain;
Dronabinol capsule 2,
Aarhus Universitetshospital
2018 Phase 2 EUCTR2018-002315-98-DK Denmark;
Drug - SHR1459
Reistone Biopharma Company Limited
2020 Phase 2 NCT04670770 China;
Duloxetine
Brown, Theodore R., M.D., MPH
2007 Phase 2/Phase 3 NCT00457730 United States;
Duloxetine Hydrochloride (HCI)
Eli Lilly and Company
2008 Phase 3 NCT00755807 Belgium;Canada;Poland;United States;
Dynamic Contrast-Enhanced Magnetic Resonance Imaging
University of Southern California
2011 - NCT02967380 United States;
Dynamic Vessel Analyzer (DVA)
Medical University of Vienna
2018 - NCT03401879 Austria;
Dysport
Aránzazu Vázquez Doce
2018 Phase 3 EUCTR2018-003231-30-ES Spain;
Ipsen Innovation
2012 - EUCTR2010-023210-31-LT Austria;Czech Republic;Germany;Italy;Lithuania;
2012 - EUCTR2010-023210-31-DE Austria;Czech Republic;Germany;Italy;Lithuania;
2012 - EUCTR2010-023210-31-CZ Austria;Czech Republic;Germany;Italy;Lithuania;
2012 - EUCTR2010-023210-31-AT Austria;Czech Republic;Germany;Italy;Lithuania;
Dysport®
Ipsen Innovation
2016 Phase 3 EUCTR2015-000507-44-LT Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
2016 Phase 3 EUCTR2015-000507-44-FR Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
2016 Phase 3 EUCTR2015-000507-44-ES Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
2016 Phase 3 EUCTR2015-000507-44-DE Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
2016 Phase 3 EUCTR2015-000507-44-BE Argentina;Belgium;Brazil;Chile;Colombia;France;Germany;Israel;Lithuania;Mexico;New Zealand;Peru;Russian Federation;Spain;Ukraine;United Kingdom;
EBIXA
AZ. OSPEDALIERA GARIBALDI, S.LUIGI CURRO , ASCOLI TOMASELLI
2007 - EUCTR2007-000503-15-IT Italy;
HOSPICES CIVILS DE LYON
2015 Phase 2 EUCTR2014-005548-17-FR France;
OSPEDALE S. RAFFAELE
2008 Phase 2 EUCTR2008-000490-37-IT Italy;
ECP002A
Echo Pharmaceuticals B.V.
2011 - EUCTR2010-022033-28-NL Netherlands;
EGb 761® (Tanakan®)
Ipsen
2003 Phase 3 NCT00276341 France;
EHP-101 25 mg BID
Emerald Health Pharmaceuticals
2021 Phase 2 NCT04909502 -
EHP-101 25 mg OD
Emerald Health Pharmaceuticals
2021 Phase 2 NCT04909502 -
EHP-101 50 mg BID
Emerald Health Pharmaceuticals
2021 Phase 2 NCT04909502 -
EHP-101 50 mg OD
Emerald Health Pharmaceuticals
2021 Phase 2 NCT04909502 -
EK-12
Bosnalijek D.D
2019 Phase 3 NCT03283397 Turkey;
ELND002
Elan Pharmaceuticals
2010 Phase 1 NCT01318421 -
2010 Phase 1 NCT01144351 Canada;United States;
EMD 28162
Academic MS Center Limburg
- Phase 2 EUCTR2014-000728-97-NL Netherlands;
Merck Serono
2011 - EUCTR2010-020328-23-EE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2011 - EUCTR2010-020328-23-DE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
Merck Serono SA-Geneva an affiliate of Merck KgaA, Darmstadt
2011 - EUCTR2010-020328-23-BE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal;
Merck Serono The Netherlands - a division of Merck B.V.
2011 - EUCTR2010-020328-23-NL Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal;
EMSELEX 15 mg Retardtabletten
Bayer Vital GmbH
2006 - EUCTR2006-002361-39-DE Germany;
EMSELEX 7,5 mg Retardtabletten
Bayer Vital GmbH
2006 - EUCTR2006-002361-39-DE Germany;
ENA713
Novartis Pharma GmbH
- - EUCTR2008-007015-32-DE Germany;
ENDOXAN BAXTER
AZIENDA OSPEDALIERA DI PADOVA
- Phase 1 EUCTR2008-005773-35-IT Italy;
OSPEDALE S. RAFFAELE
2007 Phase 2 EUCTR2007-000586-38-IT Italy;
EPARMEFOLIN 30 CPR 0,1/0,
AZIENDA OSPEDALIERA SAN CAMILLO FORLANINI
2005 - EUCTR2005-006071-12-IT Italy;
EPO
Sun Yat-sen University
2006 - NCT00818103 China;
ESTRADIOL HEMIHYDRATE
Irina Elovaara
2015 - EUCTR2014-005129-10-FI Finland;
ETIMS
Universitätsklinikum Hamburg-Eppendorf
2010 Phase 1/Phase 2 NCT01414634 -
ETIMS (EDC-fixed autologous PBMCs coupled with 7 immunodominant myelin peptides in MS patients)
University Medical Center Hamburg-Eppendorf
2009 - EUCTR2008-004408-29-DE Germany;
EU/1/08/454/001-002, EU/1/08/454/005-007
University Hospital Motol
2011 Phase 4 EUCTR2011-001956-12-CZ Czech Republic;
EU/1/95/003/005-010
University Hospital Motol
2011 Phase 4 EUCTR2011-001956-12-CZ Czech Republic;
EU/1/97/033/002
University Hospital Motol
2011 Phase 4 EUCTR2011-001956-12-CZ Czech Republic;
EU/1/98/063/001-003
University Hospital Motol
2011 Phase 4 EUCTR2011-001956-12-CZ Czech Republic;
EU/1/98/063/004-006
University Hospital Motol
2011 Phase 4 EUCTR2011-001956-12-CZ Czech Republic;
EXTAVIA*SC 15FL 250MCG/ML+15SI
AZIENDA OSPEDALIERA S. LUIGI GONZAGA
2011 - EUCTR2010-023677-19-IT Italy;
Early Harvest Extra Virgin Olive Oil
Aristotle University Of Thessaloniki
2018 - NCT04120675 Greece;
Early Highly Effective Therapies Group
The Cleveland Clinic
2019 Phase 4 NCT03535298 United Kingdom;United States;
Eculizumab
Alexion Pharmaceuticals
2020 Phase 2/Phase 3 NCT04155424 Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States;
2015 Phase 3 NCT02003144 Argentina;Australia;Austria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Malaysia;Russian Federation;Singapore;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States;
2014 Phase 3 NCT01892345 Argentina;Australia;Austria;Canada;Colombia;Croatia;Czech Republic;Czechia;Denmark;France;Germany;Hong Kong;Italy;Japan;Korea, Republic of;Malaysia;Russian Federation;Singapore;Spain;Taiwan;Thailand;Turkey;United Kingdom;United States;
Mayo Clinic
2009 Phase 1/Phase 2 NCT00904826 United States;
Elezanumab
AbbVie
2019 Phase 2 NCT03737812 Canada;United States;
2018 Phase 2 NCT03737851 Canada;United States;
Encapsulated Baclofen
Impax Laboratories, LLC
2007 Phase 3 NCT00488839 Canada;Estonia;Latvia;Ukraine;United States;
Encapsulated Simvastatin tablets
Imperial College London
2007 Phase 2 EUCTR2006-006347-31-GB United Kingdom;
Endoxan - ciclofosfamide
Dipartimento di Neuroscienze Oftalmologia e Genetica DINOG - Universita di Genova
2006 - EUCTR2006-002562-19-IT Italy;
Enriched Hematopoetic Stem Cell Infusion
Talaris Therapeutics Inc.
2014 - NCT02084121 United States;
Enspryng
F. HOFFMANN - LA ROCHE LTD.
2021 Phase 3 EUCTR2021-001088-26-IT Canada;France;Germany;India;Italy;Korea, Republic of;Turkey;United States;
2021 Phase 3 EUCTR2020-003413-35-IT Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
F. Hoffmann-La Roche Ltd
2021 Phase 3 EUCTR2020-003413-35-HU Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-003413-35-BG Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2020-003413-35-PL Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Epigallocatechin-gallate (Sunphenon)
Charite University, Berlin, Germany
2007 Phase 1/Phase 2 NCT00525668 Germany;
Epo
IFSgGmbH, Institute for clinical research
2006 - EUCTR2005-005592-14-DE Germany;
Epoetin alfa
IFSgGmbH, Institute for clinical research
2006 - EUCTR2005-005592-14-DE Germany;
Epoetin beta
Walton Centre for Neurology and Neurosurgery
2008 - EUCTR2008-005125-11-GB United Kingdom;
Equal
GENEURO SA
2016 Phase 2 EUCTR2015-004059-29-IT Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
Erypo/Erypo FS
IFSgGmbH, Institute for clinical research
2006 - EUCTR2005-005592-14-DE Germany;
Erythropoietin
Rigshospitalet, Denmark
2009 Phase 2 NCT01144117 Denmark;
Escalation Therapies Group
The Cleveland Clinic
2019 Phase 4 NCT03535298 United Kingdom;United States;
Escitalopram
University of South Carolina
2009 Phase 3 NCT00965497 United States;
Escitalopram oxalate antidepressant
Weill Medical College of Cornell University
2004 Phase 4 NCT00151294 United States;
Esomeprazole
Genzyme, a Sanofi Company
2014 Phase 4 NCT02205489 Belgium;France;Netherlands;Spain;
Essential - hydroxytyrosol
University of Iowa
2010 Phase 1 NCT01381354 United States;
Essential fatty acids
National Center for Complementary and Integrative Health (NCCIH)
1999 Phase 1/Phase 2 NCT00010842 United States;
Estradiol
Hospices Civils de Lyon
2005 Phase 3 NCT00127075 France;
OSPEDALI CIVILI DI LIONE
2007 - EUCTR2006-005460-30-IT Italy;
Estriol
University of California, Los Angeles
2011 Phase 2 NCT01466114 United States;
2007 Phase 2 NCT00451204 Canada;United States;
Estroprogestins
S. Andrea Hospital
2002 Phase 2 NCT00151801 Italy;
Eszopiclone
University of Vermont
2006 - NCT00594087 United States;
Etifoxine
Imperial College London
2018 - NCT03850301 United Kingdom;
Etoposide
Fred Hutchinson Cancer Research Center
2008 Phase 2 NCT00716066 United States;
Evobrutinib
EMD Serono Research & Development Institute, Inc.
2019 Phase 3 NCT04032171 Germany;United States;
2019 Phase 3 NCT04032158 Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czechia;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Montenegro;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
MERCK HEALTHCARE KGaA
2020 Phase 3 EUCTR2019-004980-36-IT Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
2020 Phase 3 NCT04338061 Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Latvia;Lithuania;Malaysia;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Turkey;Ukraine;United States;
2020 Phase 3 NCT04338022 Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Czechia;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
Exelon transdermales Pflaster
Novartis Pharma GmbH
- - EUCTR2008-007015-32-DE Germany;
Exergame
University of Arizona
2014 - NCT02777060 United States;
Experimental Glatiramer Acetate
Teva Pharmaceutical Industries
2009 Phase 3 NCT00947752 United States;
Exposure to one or more disease-modifying drug(s)(DMDs) used to treat MS
University of British Columbia
1996 - NCT04472975 -
Extavia
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden;
2017 Phase 4 EUCTR2016-003587-39-SE Sweden;
Medizinische Universität Innsbruck
2014 Phase 4 EUCTR2012-005450-30-AT Austria;Sweden;
2014 - EUCTR2012-005450-30-SE Austria;Sweden;
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain;
Novartis Farma S.p.A.
2012 - EUCTR2010-023023-19-DE Germany;Italy;
Novartis Pharma Services AG
2012 - EUCTR2011-001437-16-DE Australia;Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
Extavia (interferon beta-1b), Novartis Pharma AG
Bayer
2016 - NCT02749396 Finland;
Extavia 250 microgram/ml
Octapharma AG
2013 - EUCTR2012-005086-12-HU Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-DE Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-BG Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-AT Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
Extavia 250 micrograms/ml
Biogen Portugal
2016 Phase 4 EUCTR2016-000434-21-PT Portugal;
Extavia®
Charite Universitaetsmedizin Berlin
2012 Phase 3 EUCTR2011-004787-30-DE Germany;
University Hospital Motol
2011 Phase 4 EUCTR2011-001956-12-CZ Czech Republic;
Extended release fampridine
Clinique Neuro-Outaouais
2013 Phase 4 NCT02146534 Canada;
Extended-release oxycodone
University of Rochester
2007 Phase 4 NCT00414453 United States;
Extended-release quetiapine fumarate
University of Calgary
2014 Phase 1/Phase 2 NCT02087631 Canada;
Extracorporeal Photopheresis
University of Utah
2014 - NCT02296346 United States;
F-18 3F4AP
Massachusetts General Hospital
2021 Phase 1 NCT04699747 United States;
F-18 FEDAA1106 (BAY85-8101)
Bayer
2009 Phase 1 NCT01031199 Australia;Sweden;
FAMPYRA - 10 MG - COMPRESSA A RILASCIO PROLUNGATO - USO ORALE - FLACONE (HDPE) 56 COMPRESSE (4 FLACONI DA 14)
IRCCS FONDAZIONE ISTITUTO NEUROLOGICO NAZIONALE C. MONDINO
2016 Phase 4 EUCTR2014-004650-34-IT Italy;
FINGOLIMOD HYDROCHLORIDE
Biogen Idec Research Limited
2015 Phase 4 EUCTR2013-004622-29-DK Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2015 Phase 4 EUCTR2013-004622-29-DE Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2014 Phase 4 EUCTR2013-004622-29-SE Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2014 Phase 4 EUCTR2013-004622-29-GB Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2014 Phase 4 EUCTR2013-004622-29-ES Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2014 Phase 4 EUCTR2013-004622-29-CZ Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2014 - EUCTR2013-004622-29-IT Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
NOVARTIS FARMA
2013 - EUCTR2012-000835-18-IT Australia;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
NOVARTIS FARMA S.p.A
2013 - EUCTR2012-005507-40-IT Italy;
NOVARTIS PHARMA SERVICES AG
2021 Phase 3 EUCTR2020-002700-39-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Novartis Farma
2013 - EUCTR2011-005677-23-IT Brazil;Canada;Italy;Latvia;Lithuania;Mexico;Spain;United States;Venezuela, Bolivarian Republic of;
Novartis Farma S.p.A.
2012 - EUCTR2010-023023-19-DE Germany;Italy;
Novartis Farma SpA
2014 - EUCTR2013-002660-17-IT Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom;
Novartis Farmaceutica S.A.
2013 - EUCTR2011-005677-23-ES Brazil;Canada;Latvia;Lithuania;Mexico;Spain;United States;Venezuela, Bolivarian Republic of;
Novartis Pharma GmbH
- - EUCTR2011-001692-39-DE Germany;
Novartis Pharma S.A.S
2011 Phase 4 EUCTR2011-001280-49-FR France;
Novartis Pharma Service AG
2015 Phase 3 EUCTR2011-005677-23-HR Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005677-23-GB Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005677-23-EE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 - EUCTR2011-005677-23-RO Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2011-005677-23-DE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2011-005677-23-BG Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of;
2013 - EUCTR2011-005677-23-LV Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Novartis Pharma Services AG
2015 - EUCTR2013-002660-17-PT Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom;
2015 - EUCTR2013-002660-17-DK Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom;
2014 Phase 3 EUCTR2011-005677-23-PL Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005677-23-NL Austria;Brazil;Bulgaria;Canada;Croatia;Estonia;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005677-23-AT Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 - EUCTR2011-005677-23-SE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2011-005677-23-SK Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2011-005677-23-LT Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-001442-15-SE Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom;
2012 - EUCTR2011-001437-16-DE Australia;Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
2011 - EUCTR2011-001442-15-HU Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom;
2011 - EUCTR2011-001442-15-GR Austria;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Spain;Sweden;Switzerland;United Kingdom;
2011 - EUCTR2011-001442-15-GB Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom;
2011 - EUCTR2011-001442-15-FI Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom;
2011 - EUCTR2011-001442-15-DE Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom;
2011 - EUCTR2011-001442-15-CZ Austria;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Spain;Sweden;Switzerland;United Kingdom;
2011 - EUCTR2011-001442-15-AT Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom;
Universitätsklinikum Münster
2014 - EUCTR2013-004616-21-DE Germany;
FISH OIL, RICH IN OMEGA-3-ACIDS
PALUPA Medical Ltd
2016 Phase 3 EUCTR2015-003147-19-GR Greece;
FISH OIL,RICH IN OMEGA 3 ACIDS
PALUPA Medical Ltd
2016 Phase 3 EUCTR2015-003147-19-GR Greece;
FLUOXETINE HYDROCHLORIDE
Novartis Pharma GmbH
- - EUCTR2011-001692-39-DE Germany;
FORMISTIN - 10 MG COMPRESSE RIVESTITE CON FILM 20 COMPRESSE
NOVARTIS PHARMA AG
2018 Phase 2 EUCTR2017-004702-17-IT Austria;Bulgaria;Czech Republic;Czechia;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
FTY720
NOVARTIS FARMA S.p.A
2013 - EUCTR2012-005507-40-IT Italy;
NOVARTIS PHARMA SERVICES AG
2021 Phase 3 EUCTR2020-002700-39-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Novartis
2010 Phase 3 NCT01127750 Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2007 Phase 2 NCT00537082 Japan;
2003 Phase 2 NCT00333138 Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom;
Novartis Farma
2013 - EUCTR2011-005677-23-IT Brazil;Canada;Italy;Latvia;Lithuania;Mexico;Spain;United States;Venezuela, Bolivarian Republic of;
Novartis Farma S.p.A.
2012 - EUCTR2010-023023-19-DE Germany;Italy;
Novartis Farmaceutica S.A.
2013 - EUCTR2012-000835-18-ES Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 - EUCTR2011-005677-23-ES Brazil;Canada;Latvia;Lithuania;Mexico;Spain;United States;Venezuela, Bolivarian Republic of;
Novartis Farmacéutica S.A
2008 - EUCTR2007-002627-32-ES Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
Novartis Farmacéutica, S.A.
2011 - EUCTR2011-001442-15-ES Austria;Czech Republic;Finland;France;Germany;Greece;Hungary;Israel;Italy;Spain;Sweden;Switzerland;United Kingdom;
2010 Phase 3 EUCTR2010-020515-37-ES Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
Novartis Pharma AG
2013 - EUCTR2012-000835-18-BE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-000835-18-FR Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 - EUCTR2007-002627-32-HU Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
2010 - EUCTR2007-002627-32-DK Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2009 Phase 3 EUCTR2007-002627-32-GB Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2009 - EUCTR2007-004122-24-HU Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2009 - EUCTR2007-004122-24-GR Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2009 - EUCTR2007-004122-24-EE Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2008 Phase 3 EUCTR2007-002627-32-FR Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-004122-24-NL Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2008 - EUCTR2007-004122-24-CZ Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2008 - EUCTR2007-004122-24-BE Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2008 - EUCTR2007-002627-32-NL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2008 - EUCTR2007-002627-32-FI Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2008 - EUCTR2007-002627-32-BE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2007 - EUCTR2005-000365-19-HU Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom;
2006 - EUCTR2005-000365-19-CZ Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom;
Novartis Pharma GmbH
2012 Phase 4 EUCTR2012-000674-31-DE Germany;Switzerland;
2012 Phase 4 EUCTR2012-000653-32-DE Germany;
2012 - EUCTR2012-002637-11-DE Germany;
2011 - EUCTR2011-002969-38-DE Germany;
Novartis Pharma S.A.S
2011 Phase 4 EUCTR2011-001280-49-FR France;
Novartis Pharma Service AG
2015 Phase 3 EUCTR2011-005677-23-HR Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005677-23-GB Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005677-23-EE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 - EUCTR2011-005677-23-RO Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2011-005677-23-DE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2011-005677-23-BG Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of;
2013 - EUCTR2011-005677-23-LV Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Novartis Pharma Services AG
2014 Phase 3 EUCTR2012-000835-18-DK Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005677-23-PL Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005677-23-NL Austria;Brazil;Bulgaria;Canada;Croatia;Estonia;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005677-23-AT Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 - EUCTR2012-000835-18-PL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2014 - EUCTR2011-005677-23-SE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-000835-18-DE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2011-005677-23-SK Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2011-005677-23-LT Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2013 - EUCTR2012-000835-18-NL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 - EUCTR2012-000835-18-HU Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 - EUCTR2012-000835-18-GB Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 - EUCTR2012-000835-18-CZ Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2010-020515-37-NO Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2012 - EUCTR2012-000835-18-SE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 - EUCTR2012-000835-18-FI Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020515-37-IE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020515-37-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2011 - EUCTR2011-001442-15-DE Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom;
2011 - EUCTR2010-020515-37-DK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-019029-32-SK Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 Phase 3 EUCTR2010-020515-37-SK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 Phase 3 EUCTR2010-020515-37-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-PT Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;Comoros;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2010 Phase 3 EUCTR2010-020515-37-HU Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-GR Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 Phase 3 EUCTR2010-020515-37-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-FR Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 Phase 3 EUCTR2010-020515-37-FI Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;Venezuela, Bolivarian Republic of;
2010 Phase 3 EUCTR2010-020515-37-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 2 EUCTR2010-019029-32-GR Austria;Belgium;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 Phase 2 EUCTR2010-019029-32-BE Austria;Belgium;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-SE Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-PT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-NL Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-IE Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-HU Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-GB Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-FI Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-DK Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-DE Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-CZ Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-AT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019028-30-GB Finland;France;Spain;United Kingdom;
2010 - EUCTR2010-019028-30-FR Belgium;Finland;France;Spain;United Kingdom;
2010 - EUCTR2010-019028-30-FI Finland;France;Spain;United Kingdom;
2010 - EUCTR2010-019028-30-BE Belgium;Finland;France;Spain;United Kingdom;
2009 - EUCTR2008-002096-27-AT Austria;Lithuania;Poland;United Kingdom;
2009 - EUCTR2007-002627-32-CZ Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2008 Phase 3 EUCTR2005-000365-19-GB Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Slovakia;Sweden;United Kingdom;
2008 - EUCTR2008-002096-27-PL Austria;Lithuania;Poland;United Kingdom;
2008 - EUCTR2008-002096-27-LT Austria;Lithuania;Poland;United Kingdom;
2008 - EUCTR2008-002096-27-GB Austria;Lithuania;Poland;United Kingdom;
2007 - EUCTR2006-000704-17-HU Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
2007 - EUCTR2006-000704-17-BE Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
2007 - EUCTR2005-000365-19-IE Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom;
2007 - EUCTR2005-000365-19-GR Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom;
2007 - EUCTR2005-000365-19-EE Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom;
2006 Phase 3 EUCTR2006-000704-17-GR Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
2006 Phase 3 EUCTR2005-000365-19-SK Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Slovakia;Sweden;United Kingdom;
2006 - EUCTR2006-000704-17-PT Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
2006 - EUCTR2006-000704-17-GB Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
2006 - EUCTR2006-000704-17-DE Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
2006 - EUCTR2006-000704-17-AT Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
2006 - EUCTR2005-000365-19-FI Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom;
2006 - EUCTR2005-000365-19-DE Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom;
2005 - EUCTR2005-000365-19-SE Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom;
- - EUCTR2007-002627-32-DE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Pharmaceuticals
2013 Phase 3 NCT01779934 Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 4 NCT01585298 Germany;
2008 Phase 3 NCT00731692 Australia;Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Services Pharma AG
2008 - EUCTR2007-002627-32-SE Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
NovartisPharma Services AG
2007 - EUCTR2005-000365-19-LT Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom;
Universitätsklinikum Münster
2014 - EUCTR2013-004616-21-DE Germany;
FTY720D
NOVARTIS FARMA
2013 - EUCTR2012-000835-18-IT Australia;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2011 - EUCTR2011-000770-60-IT Italy;
2011 - EUCTR2010-024017-31-IT Italy;
2010 Phase 3 EUCTR2010-020515-37-IT Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-023023-19-IT Germany;Italy;
2010 - EUCTR2010-019029-32-IT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-002627-32-IT Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
2006 - EUCTR2006-000704-17-IT Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
Novartis Farma SpA
2014 - EUCTR2013-002660-17-IT Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom;
Novartis Farmaceutica S.A.
2013 - EUCTR2012-000835-18-ES Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Farmacéutica S.A
2008 - EUCTR2007-002627-32-ES Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
Novartis Farmacéutica, S.A.
2010 Phase 3 EUCTR2010-020515-37-ES Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
Novartis Pharma AG
2013 - EUCTR2012-000835-18-BE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-000835-18-FR Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 - EUCTR2007-002627-32-HU Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
2010 - EUCTR2007-002627-32-DK Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2009 Phase 3 EUCTR2007-002627-32-GB Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2009 - EUCTR2007-004122-24-HU Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2009 - EUCTR2007-004122-24-GR Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2009 - EUCTR2007-004122-24-FI Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2008 Phase 3 EUCTR2007-002627-32-FR Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-004122-24-NL Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2008 - EUCTR2007-004122-24-FR Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2008 - EUCTR2007-004122-24-CZ Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2008 - EUCTR2007-004122-24-BE Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2008 - EUCTR2007-002627-32-NL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2008 - EUCTR2007-002627-32-FI Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2008 - EUCTR2007-002627-32-BE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2007 - EUCTR2005-000365-19-HU Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom;
2006 - EUCTR2005-000365-19-CZ Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom;
Novartis Pharma Services AG
2015 - EUCTR2013-002660-17-PT Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom;
2015 - EUCTR2013-002660-17-DK Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom;
2013 Phase 3 EUCTR2012-000835-18-DE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 - EUCTR2012-000835-18-NL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 - EUCTR2012-000835-18-GB Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 - EUCTR2012-000835-18-CZ Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2010-020515-37-NO Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2012 - EUCTR2012-000835-18-SE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 - EUCTR2012-000835-18-FI Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020515-37-IE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020515-37-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2011 - EUCTR2010-020515-37-DK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-019029-32-SK Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 Phase 3 EUCTR2010-020515-37-SK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 Phase 3 EUCTR2010-020515-37-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-PT Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;Comoros;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2010 Phase 3 EUCTR2010-020515-37-HU Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-GR Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 Phase 3 EUCTR2010-020515-37-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-FR Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 Phase 3 EUCTR2010-020515-37-FI Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;Venezuela, Bolivarian Republic of;
2010 Phase 3 EUCTR2010-020515-37-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 2 EUCTR2010-019029-32-GR Austria;Belgium;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 Phase 2 EUCTR2010-019029-32-BE Austria;Belgium;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-SE Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-PT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-NL Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-IE Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-HU Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-GB Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-FI Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-DK Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-DE Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-CZ Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-AT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019028-30-GB Finland;France;Spain;United Kingdom;
2010 - EUCTR2010-019028-30-FR Belgium;Finland;France;Spain;United Kingdom;
2010 - EUCTR2010-019028-30-FI Finland;France;Spain;United Kingdom;
2010 - EUCTR2010-019028-30-BE Belgium;Finland;France;Spain;United Kingdom;
2009 - EUCTR2008-002096-27-AT Austria;Lithuania;Poland;United Kingdom;
2009 - EUCTR2007-002627-32-CZ Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2008 Phase 3 EUCTR2005-000365-19-GB Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Slovakia;Sweden;United Kingdom;
2008 - EUCTR2008-002096-27-PL Austria;Lithuania;Poland;United Kingdom;
2008 - EUCTR2008-002096-27-LT Austria;Lithuania;Poland;United Kingdom;
2008 - EUCTR2008-002096-27-GB Austria;Lithuania;Poland;United Kingdom;
- - EUCTR2007-002627-32-DE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Services Pharma AG
2008 - EUCTR2007-002627-32-SE Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
Famciclovir
Queen Mary University London
2019 Phase 2 EUCTR2019-000169-19-GB United Kingdom;
Queen Mary University of London
2020 Phase 2 NCT05283551 United Kingdom;
Fampridine
Amsterdam University Medical Center
2022 Phase 3 EUCTR2021-003677-66-NL Netherlands;
Biogen
2015 - NCT01532154 France;Germany;United Kingdom;United States;
2014 Phase 3 NCT02219932 Argentina;Bulgaria;Czech Republic;Finland;Germany;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States;
2012 Phase 4 NCT01480076 Australia;Belgium;Denmark;France;Germany;Italy;Netherlands;Portugal;United Kingdom;United States;
2012 - NCT01480063 Argentina;Australia;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Ireland;Israel;Lebanon;Netherlands;Norway;Portugal;Spain;United Arab Emirates;
Centre Hospitalier Universitaire de Besancon
2014 Phase 4 NCT02849782 France;
Cliniques Universitaires Saint-Luc, Neurologie
2013 - EUCTR2012-005076-34-BE Belgium;
Genesis Pharma CNS & Specialty
2017 - NCT03164018 Greece;
University College Dublin
2014 Phase 4 NCT02208050 Ireland;
University of Southern Denmark
2018 - NCT03847545 Denmark;
Fampridine SR
London Health Sciences Centre
2012 Phase 2/Phase 3 NCT01667497 Canada;
Fampridine-SR
Acorda Therapeutics
2007 Phase 3 NCT00649792 Canada;United States;
2007 Phase 3 NCT00483652 Canada;United States;
2006 Phase 3 NCT00648908 Canada;United States;
2005 Phase 3 NCT00127530 Canada;United States;
University of Southern Denmark
2012 Phase 4 NCT01656148 Denmark;
Fampridine-SR b.i.d. (Twice Daily)
Acorda Therapeutics
2003 Phase 3 NCT00654927 Canada;United States;
Fampyra
BIOGEN IDEC RESEARCH LTD
2012 - EUCTR2012-000368-90-IT Belgium;Canada;Italy;Netherlands;Switzerland;United Kingdom;
2012 - EUCTR2011-003507-38-IT Australia;Denmark;Italy;Netherlands;Portugal;United Kingdom;
Biogen Idec Research Limited
2015 Phase 3 EUCTR2013-003600-40-NL Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003600-40-GB Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003600-40-CZ Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003600-40-BG Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States;
2014 - EUCTR2013-003600-40-LT Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States;
2014 - EUCTR2013-003600-40-IT Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States;
2014 - EUCTR2013-003600-40-FI Bulgaria;Czech Republic;Finland;Italy;Lithuania;Netherlands;Poland;Russian Federation;Serbia;Switzerland;United Kingdom;United States;
2012 Phase 4 EUCTR2011-003507-38-GB Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom;
2012 Phase 4 EUCTR2011-003507-38-BE Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom;
2012 Phase 2 EUCTR2012-000368-90-BE Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom;
2012 - EUCTR2012-000368-90-NL Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom;
2012 - EUCTR2012-000368-90-GB Belgium;Canada;Italy;Netherlands;Sweden;United Kingdom;
2012 - EUCTR2011-003507-38-PT Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom;
2012 - EUCTR2011-003507-38-NL Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom;
2012 - EUCTR2011-003507-38-DK Australia;Belgium;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Sweden;United Kingdom;
Cliniques Universitaires Saint-Luc, Neurologie
2013 - EUCTR2012-005076-34-BE Belgium;
Medical University of Vienna
2015 - EUCTR2014-003498-41-AT Austria;
Odense University Hospital
2013 Phase 4 EUCTR2013-001409-10-DK Denmark;
St. Vincent's University Hospital
2012 Phase 4 EUCTR2011-002561-38-IE Ireland;
Sønderjylland Hospital, department of neurology
2013 Phase 4 EUCTR2011-002959-34-DK Denmark;
2012 - EUCTR2011-006151-10-DK Denmark;
Vestre Viken Hospital Trust
2012 - NCT01720849 Norway;
Fampyra 10 mg prolonged-release tablets
Amsterdam University Medical Center
2022 Phase 3 EUCTR2021-003677-66-NL Netherlands;
CHDR
2015 - EUCTR2015-000182-31-NL Netherlands;
Fampyra 10mg prolonged release tablets
Walton Centre Foundation Trust
2013 Phase 4 EUCTR2013-000529-30-GB United Kingdom;
Fatigue
University Hospital, Strasbourg, France
2019 Phase 2 NCT03910738 France;
Febuxostat
Tsukuba International Clinical Pharmacology Clinic
2016 - JPRN-UMIN000024312 Japan;
Fecal Microbial Transplants
Lawson Health Research Institute
2020 Phase 2 NCT04150549 -
Fecal Microbiota Transplantation (FMT) of FMP30 Donor Stool
Jeffrey Gelfand
2018 Phase 1 NCT03594487 United States;
Fecal microbial transplant (FMT)
Griffin Hospital
2019 Early Phase 1 NCT04096443 United States;
Fecal microbiota
Lawson Health Research Institute
2017 Phase 2 NCT03183869 Canada;
Femoston 1/10
Irina Elovaara
2015 - EUCTR2014-005129-10-FI Finland;
Femoston 2/10
Irina Elovaara
2015 - EUCTR2014-005129-10-FI Finland;
Fenebrutinib
Hoffmann-La Roche
2022 Phase 2 NCT05119569 -
2021 Phase 3 NCT04586023 Austria;Brazil;Bulgaria;Canada;Denmark;France;Greece;Guatemala;India;Italy;Korea, Republic of;Mexico;Poland;Russian Federation;Turkey;United Kingdom;United States;
2021 Phase 3 NCT04586010 Argentina;China;Finland;Germany;Hong Kong;Hungary;Italy;Netherlands;Peru;Portugal;Russian Federation;Spain;Switzerland;Taiwan;Ukraine;United States;
2020 Phase 3 NCT04544449 Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Puerto Rico;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
Feraheme
Stanford University
2014 - NCT01973517 United States;
Ferumoxytol
National Institute of Neurological Disorders and Stroke (NINDS)
2015 Phase 1 NCT02511028 United States;
Fexofenadine
Rigshospitalet, Denmark
2021 Phase 3 NCT04688788 Denmark;
Filgrastim
Fred Hutchinson Cancer Research Center
1997 Phase 1 NCT00014755 United States;
Northwestern Memorial Hospital
2001 Phase 1 NCT00017628 United States;
OSPEDALE S. RAFFAELE
2007 Phase 2 EUCTR2007-000586-38-IT Italy;
Sheffield Teaching Hospitals
2020 Phase 3 EUCTR2019-001549-42-GB United Kingdom;
Fingolimob
NOVARTIS PHARMA SERVICES AG
2021 Phase 3 EUCTR2020-002700-39-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Fingolimob (FTY)
University Hospital, Clermont-Ferrand
2016 Phase 4 NCT02769689 France;
Fingolimod
Biogen
2014 Phase 4 NCT02342704 Australia;Czech Republic;Czechia;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS UNIVERSITA' CATTOLICA DEL SACRO CUORE
2016 Phase 4 EUCTR2016-000708-26-IT Italy;
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
2017 Phase 4 NCT03345940 Italy;
Heinrich-Heine University, Duesseldorf
2013 Phase 4 NCT01755871 Germany;
Hoffmann-La Roche
2022 Phase 3 NCT05123703 Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
Isfahan University of Medical Sciences
2015 Phase 2/Phase 3 NCT02939079 -
Mitsubishi Tanabe Pharma Corporation
2014 Phase 1 NCT02193217 United Kingdom;
NOVARTIS FARMA
2011 - EUCTR2011-000770-60-IT Italy;
2010 Phase 3 EUCTR2010-020515-37-IT Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-IT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-002627-32-IT Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
2006 - EUCTR2006-000704-17-IT Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
Northwestern University
2013 Phase 2 EUCTR2012-004165-41-GB United Kingdom;United States;
Novartis
2011 - NCT01281657 Canada;United States;
2010 Phase 3 NCT01199861 Austria;Belgium;Canada;Finland;France;Guatemala;Poland;Spain;Switzerland;United Kingdom;
2008 Phase 3 NCT00662649 Australia;Belgium;Canada;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Netherlands;Poland;Romania;Russian Federation;Slovakia;South Africa;Sweden;Switzerland;Turkey;United Kingdom;
2008 Phase 2 NCT00670449 Japan;
2006 Phase 3 NCT00355134 Australia;Austria;Canada;Lithuania;Poland;Romania;Turkey;United Kingdom;United States;
2006 Phase 3 NCT00340834 Argentina;Australia;Austria;Belgium;Brazil;Canada;Egypt;France;Germany;Greece;Hungary;Italy;Korea, Republic of;Portugal;Puerto Rico;Spain;Switzerland;United Kingdom;United States;
2006 Phase 3 NCT00289978 Australia;Belgium;Canada;Czech Republic;Finland;France;Germany;Greece;Israel;Italy;Lithuania;Netherlands;Poland;Russian Federation;Slovakia;South Africa;Sweden;Switzerland;Turkey;United Kingdom;
Novartis Farmaceutica S.A.
2013 - EUCTR2012-000835-18-ES Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Farmacéutica S.A
2008 - EUCTR2007-002627-32-ES Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
Novartis Farmacéutica S.A.
2011 Phase 3 EUCTR2011-003484-30-ES Australia;Spain;
Novartis Farmacéutica, S.A.
2010 Phase 3 EUCTR2010-020515-37-ES Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
Novartis Pharma AG
2013 - EUCTR2012-000835-18-BE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-000835-18-FR Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 - EUCTR2007-002627-32-HU Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
2010 - EUCTR2007-002627-32-DK Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2009 Phase 3 EUCTR2007-002627-32-GB Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2009 - EUCTR2007-004122-24-IE Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2009 - EUCTR2007-004122-24-EE Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2008 Phase 3 EUCTR2007-002627-32-FR Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-002627-32-NL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2008 - EUCTR2007-002627-32-FI Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2008 - EUCTR2007-002627-32-BE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2007 - EUCTR2005-000365-19-HU Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom;
2006 - EUCTR2005-000365-19-CZ Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Sweden;United Kingdom;
Novartis Pharma GmbH
2011 Phase 3 EUCTR2010-022066-28-DE Germany;
Novartis Pharma K.K.
2019 - JPRN-JapicCTI-194838 Japan;
Novartis Pharma Services AG
2014 Phase 3 EUCTR2012-000835-18-DK Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-000835-18-DE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 - EUCTR2012-000835-18-NL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 - EUCTR2012-000835-18-HU Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 - EUCTR2012-000835-18-GB Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 - EUCTR2012-000835-18-CZ Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2010-020515-37-NO Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2012 - EUCTR2012-000835-18-SE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 - EUCTR2012-000835-18-FI Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020515-37-IE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020515-37-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2011 - EUCTR2010-020515-37-DK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2010 Phase 3 EUCTR2010-020515-37-SK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 Phase 3 EUCTR2010-020515-37-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-PT Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;Comoros;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2010 Phase 3 EUCTR2010-020515-37-HU Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-GR Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 Phase 3 EUCTR2010-020515-37-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-FR Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 Phase 3 EUCTR2010-020515-37-FI Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;Venezuela, Bolivarian Republic of;
2010 Phase 3 EUCTR2010-020515-37-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 - EUCTR2010-019028-30-GB Finland;France;Spain;United Kingdom;
2010 - EUCTR2010-019028-30-FR Belgium;Finland;France;Spain;United Kingdom;
2010 - EUCTR2010-019028-30-FI Finland;France;Spain;United Kingdom;
2010 - EUCTR2010-019028-30-BE Belgium;Finland;France;Spain;United Kingdom;
2009 - EUCTR2008-002096-27-AT Austria;Lithuania;Poland;United Kingdom;
2009 - EUCTR2007-002627-32-CZ Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2008 Phase 3 EUCTR2005-000365-19-GB Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Slovakia;Sweden;United Kingdom;
2008 - EUCTR2008-002096-27-PL Austria;Lithuania;Poland;United Kingdom;
2008 - EUCTR2008-002096-27-LT Austria;Lithuania;Poland;United Kingdom;
2008 - EUCTR2008-002096-27-GB Austria;Lithuania;Poland;United Kingdom;
2007 - EUCTR2006-000704-17-HU Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
2007 - EUCTR2006-000704-17-BE Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
2006 Phase 3 EUCTR2006-000704-17-GR Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
2006 Phase 3 EUCTR2005-000365-19-SK Czech Republic;Estonia;Finland;Germany;Greece;Hungary;Ireland;Lithuania;Slovakia;Sweden;United Kingdom;
2006 - EUCTR2006-000704-17-PT Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
2006 - EUCTR2006-000704-17-GB Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
2006 - EUCTR2006-000704-17-DE Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
2006 - EUCTR2006-000704-17-AT Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
- - EUCTR2007-002627-32-DE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Pharmaceuticals
2021 Phase 4 NCT04667949 China;
2021 Phase 3 NCT04926818 Australia;Austria;Belgium;France;Germany;India;Latvia;Mexico;Poland;Portugal;Russian Federation;Slovakia;Spain;Turkey;United States;
2020 Phase 4 NCT04480853 Taiwan;
2020 - NCT05141669 United States;
2017 Phase 4 NCT03257358 United States;
2016 Phase 4 NCT02720107 Germany;
2015 Phase 4 NCT02373098 Turkey;
2014 Phase 4 NCT02232061 Belgium;Germany;Italy;
2014 Phase 3 NCT01941004 -
2013 Phase 4 NCT01621269 Germany;
2013 Phase 3 NCT01892722 Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2012 Phase 4 NCT01705236 Germany;Switzerland;
2012 Phase 4 NCT01623596 Puerto Rico;United States;
2012 Phase 4 NCT01578330 Turkey;
2012 Phase 4 NCT01534182 Russian Federation;
2012 Phase 3 NCT01633112 Argentina;Brazil;Canada;Chile;Mexico;Puerto Rico;United States;
2012 Phase 3 NCT01497262 Argentina;Brazil;Colombia;Costa Rica;Jordan;Malaysia;Mexico;Panama;Peru;
2011 Phase 4 NCT01436643 Germany;
2011 Phase 4 NCT01420055 France;
2011 Phase 4 NCT01333501 Germany;Italy;
2011 Phase 4 NCT01317004 Italy;
2011 Phase 4 NCT01310166 Germany;
2011 Phase 3 NCT01499667 Australia;Austria;Czech Republic;Finland;Germany;Greece;Hungary;Israel;Italy;Spain;Switzerland;
2011 - NCT01442194 Argentina;Australia;Canada;Chile;Mexico;Puerto Rico;United States;
2011 - NCT01285479 Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Cyprus;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Sweden;Switzerland;United Arab Emirates;United Kingdom;United States;
2010 Phase 4 NCT01216072 Canada;Puerto Rico;United States;
2010 Phase 3 NCT01201356 Argentina;Australia;Austria;Belgium;Brazil;Canada;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Services Pharma AG
2008 - EUCTR2007-002627-32-SE Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
University Hospital Muenster
2014 Phase 4 NCT02325440 Germany;
Università Popolare Homo & Natura
2015 Phase 1 NCT02632591 Italy;
VU University Medical Center
2014 - EUCTR2014-001012-19-NL Netherlands;
Fingolimod (FTY720)
Novartis Pharmaceuticals
2011 Phase 4 NCT01498887 Australia;Spain;
Fingolimod Hydrochloride
Novartis Pharma GmbH
2012 Phase 4 EUCTR2012-000674-31-DE Germany;Switzerland;
2012 Phase 4 EUCTR2012-000653-32-DE Germany;
2012 - EUCTR2012-002637-11-DE Germany;
2011 - EUCTR2011-002969-38-DE Germany;
Fingolimod hydrochloride
Novartis Pharma AG
2009 - EUCTR2007-004122-24-HU Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2009 - EUCTR2007-004122-24-GR Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2009 - EUCTR2007-004122-24-FI Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2008 - EUCTR2007-004122-24-SE Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2008 - EUCTR2007-004122-24-NL Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2008 - EUCTR2007-004122-24-GB Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2008 - EUCTR2007-004122-24-FR Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2008 - EUCTR2007-004122-24-CZ Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2008 - EUCTR2007-004122-24-BE Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
Novartis Pharma Services AG
2014 - EUCTR2012-000835-18-PL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2011 - EUCTR2010-019029-32-SK Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 Phase 2 EUCTR2010-019029-32-GR Austria;Belgium;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 Phase 2 EUCTR2010-019029-32-BE Austria;Belgium;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-SE Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-PT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-NL Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-IE Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-HU Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-GB Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-FI Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-DK Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-DE Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-CZ Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2010 - EUCTR2010-019029-32-AT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;Netherlands;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-004122-24-SK Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
2008 - EUCTR2007-004122-24-DE Belgium;Czech Republic;Estonia;Finland;France;Germany;Greece;Hungary;Ireland;Netherlands;Slovakia;Sweden;United Kingdom;
Fingolimodi
Turku University Hospital
2014 Phase 4 EUCTR2014-000296-12-FI Finland;
2013 Phase 4 EUCTR2013-004626-28-FI Finland;
Fingolmod
Novartis Farma SpA
2014 - EUCTR2013-002660-17-IT Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom;
Novartis Pharma Services AG
2015 - EUCTR2013-002660-17-PT Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom;
2015 - EUCTR2013-002660-17-DK Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom;
Firategrast
GlaxoSmithKline
2007 Phase 2 NCT00469378 Belgium;Czech Republic;Denmark;Norway;Sweden;
2006 Phase 2 NCT00395317 Australia;Austria;Canada;Finland;France;Germany;Italy;Lithuania;Netherlands;New Zealand;Norway;Poland;Russian Federation;Spain;United Kingdom;
Firategrast (USAN approved name)
GlaxoSmithKline Research & Development Ltd
2007 Phase 2 EUCTR2006-007057-42-CZ Belgium;Czech Republic;Denmark;Sweden;
2007 Phase 2 EUCTR2006-002633-20-GB Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom;
2007 Phase 2 EUCTR2006-002633-20-FR Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom;
2007 - EUCTR2006-007057-42-SE Czech Republic;Denmark;Sweden;
2007 - EUCTR2006-007057-42-DK Czech Republic;Denmark;Sweden;
2007 - EUCTR2006-007057-42-BE Belgium;Czech Republic;Denmark;Sweden;
2007 - EUCTR2006-002633-20-LT Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom;
2007 - EUCTR2006-002633-20-IT Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom;
2006 - EUCTR2006-002633-20-NL Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom;
2006 - EUCTR2006-002633-20-FI Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom;
2006 - EUCTR2006-002633-20-DE Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom;
2006 - EUCTR2006-002633-20-AT Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom;
GlaxoSmithKline S.A
2006 Phase 2 EUCTR2006-002633-20-ES Australia;Austria;Canada;Finland;France;Germany;Italy;Lithuania;Netherlands;New Zealand;Norway;Poland;Russian Federation;Spain;United Kingdom;
Firategrast gastro-retentive solution
GlaxoSmithKline
2011 Phase 1 NCT01416363 Australia;
Firategrast immediate release tablet
GlaxoSmithKline
2011 Phase 1 NCT01416363 Australia;
Firategrast modified release tablet
GlaxoSmithKline
2011 Phase 1 NCT01416363 Australia;
First line DMT
Novartis Pharmaceuticals
2021 Phase 3 NCT04788615 France;Germany;Spain;United Kingdom;
Fish oil concentrate
Oregon Health and Science University
2005 Phase 1/Phase 2 NCT00122954 United States;
Fludarabine
AZIENDA OSPEDALIERA DI PADOVA
- Phase 1 EUCTR2008-005773-35-IT Italy;
Hadassah Medical Organization
2015 - NCT02529839 -
Seah Lim M.D.
2012 Phase 2 NCT01679041 United States;
Flumazenil
Institut National de la Santé Et de la Recherche Médicale, France
2019 - NCT03825601 -
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
2013 - JPRN-UMIN000011111 Japan;
Fluoxetin Hexal
Novartis Pharma GmbH
- - EUCTR2011-001692-39-DE Germany;
Fluoxetine
Novartis Pharmaceuticals
2011 Phase 4 NCT01436643 Germany;
University College, London
2014 Phase 2 NCT01910259 United Kingdom;
Fluoxetine hydrochloride
UCL
2014 Phase 2 EUCTR2012-005394-31-GB United Kingdom;
Flupirtin
Charité-Universitätsmedizin Berlin
2007 Phase 2 EUCTR2006-005262-39-DE Germany;
Flupirtine
Charite University, Berlin, Germany
2007 Phase 2 NCT00623415 Germany;
Flupirtinmaleat
Charité-Universitätsmedizin Berlin
2007 Phase 2 EUCTR2006-005262-39-DE Germany;
FolateScan (Technetium Tc 99mEC20)
Mayo Clinic
2006 Phase 2 NCT00588393 United States;
Formulation A
GlaxoSmithKline
2007 Phase 1 NCT00548769 Czech Republic;Czechia;Germany;Poland;
Formulation B
GlaxoSmithKline
2007 Phase 1 NCT00548769 Czech Republic;Czechia;Germany;Poland;
Formulation C
GlaxoSmithKline
2007 Phase 1 NCT00548769 Czech Republic;Czechia;Germany;Poland;
Formulation D
GlaxoSmithKline
2007 Phase 1 NCT00548769 Czech Republic;Czechia;Germany;Poland;
Four-point cane (FPC)
Rowan University
2014 - NCT02227524 United States;
Fourier Domain Doppler Optical Coherence Tomography (FDOCT)
Medical University of Vienna
2018 - NCT03401879 Austria;
Full Spectrum vitamin
University of Iowa
2010 Phase 1 NCT01381354 United States;
Fully humanized anti-human IL-6 receptor (IL-6R) neutralizing monoclonal antibody
Chugai Pharmaceutical Co. Ltd
2015 Phase 3 EUCTR2013-003752-21-HU France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States;
2015 - EUCTR2013-003752-21-ES France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003752-21-IT France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;
G-CSF
Northwestern University
2019 Phase 2/Phase 3 NCT03829566 United States;
2017 Phase 3 NCT03342638 United States;
G2-SFM (IFN-beta-1a from clone 484-39,FBS-free process)
Serono International SA
2005 Phase 3 EUCTR2004-003799-13-GB Denmark;Ireland;Lithuania;Spain;Sweden;United Kingdom;
2005 Phase 3 EUCTR2004-003799-13-ES Denmark;Ireland;Lithuania;Spain;Sweden;United Kingdom;
2005 Phase 3 EUCTR2004-003799-13-DK Denmark;Ireland;Lithuania;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-003799-13-SE Ireland;Lithuania;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-003799-13-LT Ireland;Lithuania;Spain;Sweden;United Kingdom;
- Phase 3 EUCTR2004-003799-13-IE Denmark;Ireland;Lithuania;Spain;Sweden;United Kingdom;
GA
TEVA
2004 - EUCTR2004-000463-94-IT Hungary;Italy;
2004 - EUCTR2004-000462-13-IT Hungary;Italy;
Teva Pharmaceutical Industries Ltd.
2010 Phase 3 EUCTR2009-018084-27-IT Bulgaria;Czech Republic;Estonia;Germany;Hungary;Italy;Lithuania;United Kingdom;
Teva Pharmaceutical Industries, Ltd.
2010 Phase 3 EUCTR2009-018084-27-LT Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-018084-27-HU Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-018084-27-GB Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-018084-27-EE Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-018084-27-DE Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-018084-27-CZ Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-018084-27-BG Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Ukraine;United Kingdom;United States;
2007 - EUCTR2006-002037-20-EE Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 Phase 3 EUCTR2006-002037-20-FI Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 Phase 3 EUCTR2006-002037-20-ES Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 - EUCTR2006-002037-20-LV Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 - EUCTR2006-002037-20-LT Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 - EUCTR2006-002037-20-HU Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 - EUCTR2006-002037-20-GB Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 - EUCTR2006-002037-20-DE Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 - EUCTR2006-002037-20-CZ Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 - EUCTR2006-002037-20-BE Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
Teva Pharmaceuticals Industries Ltd.
2006 - EUCTR2006-002037-20-IT Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
GA 20 mg/mL
Teva Pharmaceutical Industries
2013 Phase 3 NCT01874145 United States;
GA 40 mg/mL
Teva Pharmaceutical Industries
2013 Phase 3 NCT01874145 United States;
GA Depot
Mapi Pharma Ltd.
2019 Phase 3 NCT04121221 Belarus;Bosnia and Herzegovina;Bulgaria;Estonia;Georgia;Israel;Moldova, Republic of;Russian Federation;Ukraine;United States;
2019 Phase 3 EUCTR2018-000284-93-EE Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Israel;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
2019 Phase 3 EUCTR2018-000284-93-BG Belarus;Bosnia and Herzegovina;Bulgaria;Estonia;Georgia;Israel;Moldova, Republic of;Montenegro;Russian Federation;Ukraine;United States;
2014 Phase 1/Phase 2 NCT02212886 Israel;
GA Depot 25mg once monthly
Mapi Pharma Ltd.
2017 Phase 2 NCT03362294 Israel;Moldova, Republic of;
GA Depot 40mg once monthly
Mapi Pharma Ltd.
2017 Phase 2 NCT03362294 Israel;Moldova, Republic of;
GADOVIST 1 mmol/ml solución inyectable en jeringa precargada/ cartucho precargado
Institut Diagnostic per la Imatge
2010 - EUCTR2009-016140-39-ES Spain;
GBP
Charité University Medicine Berlin
2010 Phase 4 EUCTR2008-005167-33-DE Germany;
GDC-0853
F. Hoffmann-La Roche Ltd
2022 Phase 2 EUCTR2021-003772-14-HR Croatia;Czechia;Egypt;Japan;Kenya;Morocco;Norway;Serbia;Slovakia;Slovenia;
GDC-0853 RO7010939
F. Hoffmann-La Roche Ltd
2021 Phase 3 EUCTR2019-003919-53-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-003919-53-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-003919-53-GR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-003919-53-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-003919-53-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-003919-53-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-003919-53-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-003919-53-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
GILENYA
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France;
GILENYA - 0.25 MG - CAPSULE RIGIDE - USO ORALE
F. HOFFMANN - LA ROCHE LTD.
2021 Phase 3 EUCTR2020-004128-41-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE
F. HOFFMANN - LA ROCHE LTD.
2021 Phase 3 EUCTR2020-004128-41-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE - BLISTER DIVISIBILE PER DOSE UNITARIA(PVC/PVDC/ALU) SCATOLA DA 7X1 CAPSULE
FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA
2017 Phase 4 EUCTR2017-000559-26-IT Israel;Italy;Switzerland;United States;
GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE - BLISTER(PVC/PVDC/ALU) SCATOLA DA 28 CAPSULE
FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS UNIVERSITA' CATTOLICA DEL SACRO CUORE
2016 Phase 4 EUCTR2016-000708-26-IT Italy;
GLATIRAMER ACETATE
Amphia Ziekenhuis
2009 - EUCTR2009-013129-41-NL Netherlands;
Biogen Idec
2010 - EUCTR2009-017490-38-DE Germany;Spain;
Biogen Idec Limited
2010 - EUCTR2009-015556-15-SI Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States;
2010 - EUCTR2009-015556-15-SE Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States;
2010 - EUCTR2009-015556-15-PT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-NL Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-LV Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States;
2010 - EUCTR2009-015556-15-HU Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-GR Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-GB Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-FI Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-ES Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-DK Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-DE Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-CZ Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States;
2010 - EUCTR2009-015556-15-AT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
Biogen Idec Ltd.
2007 Phase 3 EUCTR2006-003697-10-BE Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 - EUCTR2006-003697-10-LV Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden;
2017 Phase 4 EUCTR2016-003587-39-SE Sweden;
Mapi Pharma Ltd.
2019 Phase 3 EUCTR2018-000284-93-EE Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Israel;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
2019 Phase 3 EUCTR2018-000284-93-BG Belarus;Bosnia and Herzegovina;Bulgaria;Estonia;Georgia;Israel;Moldova, Republic of;Montenegro;Russian Federation;Ukraine;United States;
Novartis Pharma GmbH
2021 Phase 4 EUCTR2020-005752-38-DE Germany;
Peptimmune Inc.
2010 Phase 2 EUCTR2009-012716-40-SK Bulgaria;Czech Republic;Estonia;France;Germany;Poland;Slovakia;
2010 Phase 2 EUCTR2009-012716-40-DE Bulgaria;Czech Republic;Estonia;France;Germany;Poland;Slovakia;
2010 - EUCTR2009-012716-40-PL Bulgaria;Czech Republic;Estonia;France;Germany;Poland;
2010 - EUCTR2009-012716-40-FR Bulgaria;Czech Republic;Estonia;France;Germany;Poland;
2010 - EUCTR2009-012716-40-CZ Bulgaria;Czech Republic;Estonia;France;Germany;Poland;
2010 - EUCTR2009-012716-40-BG Bulgaria;Czech Republic;Estonia;France;Germany;Poland;
2009 - EUCTR2009-012716-40-EE Bulgaria;Czech Republic;Estonia;France;Germany;Poland;
Teva Pharmaceutical Industries, Ltd
2016 Phase 4 EUCTR2015-000922-12-PL Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2016 Phase 4 EUCTR2015-000922-12-FR Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2016 Phase 4 EUCTR2015-000922-12-ES Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2016 Phase 4 EUCTR2015-000922-12-DE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2016 Phase 4 EUCTR2015-000922-12-BE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2015 Phase 4 EUCTR2015-000922-12-IE Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2015 Phase 4 EUCTR2015-000922-12-HR Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2015 Phase 4 EUCTR2015-000922-12-FI Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
2015 Phase 4 EUCTR2015-000922-12-AT Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
Turku University Hospital
2013 Phase 4 EUCTR2013-004626-28-FI Finland;
GLATIRAMER ACETATO
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC
2015 Phase 4 EUCTR2015-000922-12-IT Argentina;Austria;Belgium;Croatia;Finland;France;Germany;Ireland;Israel;Italy;Mexico;Poland;Russian Federation;Spain;Turkey;United States;
GLATIRAMERO ACETATO
Biogen Idec Limited
2010 - EUCTR2009-015556-15-ES Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
Teva Pharmaceutical Industries, Ltd.
2006 Phase 3 EUCTR2006-002037-20-ES Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
GNbAC1
GENEURO SA
2017 Phase 2 EUCTR2016-004935-18-IT Bulgaria;Croatia;Czech Republic;Czechia;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
GeNeuro Australia PTY Ltd
2018 Phase 1 NCT03574428 Australia;
GeNeuro Innovation SAS
2021 Phase 2 EUCTR2021-001973-21-SE Sweden;
2020 Phase 2 EUCTR2019-004822-15-SE Sweden;
2012 Phase 2 NCT01639300 Switzerland;
2011 Phase 1 NCT01699555 -
GeNeuro SA
2017 Phase 2 EUCTR2016-004935-18-PL Bulgaria;Croatia;Czech Republic;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
2017 Phase 2 EUCTR2016-004935-18-HU Bulgaria;Croatia;Czech Republic;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
2017 Phase 2 EUCTR2016-004935-18-HR Bulgaria;Croatia;Czech Republic;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
2017 Phase 2 EUCTR2016-004935-18-ES Bulgaria;Croatia;Czech Republic;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
2017 Phase 2 EUCTR2016-004935-18-DE Bulgaria;Croatia;Czech Republic;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
2017 Phase 2 EUCTR2016-004935-18-CZ Bulgaria;Croatia;Czech Republic;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
2017 Phase 2 EUCTR2016-004935-18-BG Bulgaria;Croatia;Czech Republic;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
2016 Phase 2 NCT02782858 Bulgaria;Croatia;Czechia;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
2016 Phase 2 EUCTR2015-004059-29-PL Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
2016 Phase 2 EUCTR2015-004059-29-HU Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
2016 Phase 2 EUCTR2015-004059-29-HR Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
2016 Phase 2 EUCTR2015-004059-29-ES Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
2016 Phase 2 EUCTR2015-004059-29-EE Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
2016 Phase 2 EUCTR2015-004059-29-DE Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
2016 Phase 2 EUCTR2015-004059-29-CZ Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
2016 Phase 2 EUCTR2015-004059-29-BG Bulgaria;Croatia;Czech Republic;Estonia;France;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
GNbAC1 Monoclonal Antibody
GeNeuro SA
2017 Phase 2 NCT03239860 Bulgaria;Croatia;Czechia;Estonia;Germany;Hungary;Italy;Poland;Russian Federation;Serbia;Spain;Ukraine;
GSK1223249
GlaxoSmithKline
2011 Phase 1 NCT01435993 Germany;Italy;Norway;
2010 Phase 1 NCT01424423 Australia;
GSK1841157
GlaxoSmithKline Research and Development Limited
2012 - EUCTR2011-002333-19-CZ Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States;
2011 Phase 2 EUCTR2011-002333-19-DK Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States;
2011 - EUCTR2011-002333-19-NL Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States;
2011 - EUCTR2011-002333-19-DE Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States;
GlaxoSmithKline SA
2011 Phase 2 EUCTR2011-002333-19-ES Bulgaria;Canada;Czech Republic;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States;
GSK2018682
GlaxoSmithKline
2010 Phase 1 NCT01431937 Australia;
2010 Phase 1 NCT01387217 Australia;
GSK2018682 CD2 Capsule
GlaxoSmithKline
2010 Phase 1 NCT01466322 Australia;
GSK2018682 CD3 micronised Tablet
GlaxoSmithKline
2010 Phase 1 NCT01466322 Australia;
GSK2018682 CD3 non-micronised Tablet in fed state
GlaxoSmithKline
2010 Phase 1 NCT01466322 Australia;
GSK239512
GlaxoSmithKline
2013 Phase 2 NCT01772199 Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
2013 Phase 1 NCT01802931 Australia;
GlaxoSmithKline Research & Development Ltd
2013 Phase 2 EUCTR2012-003627-38-GB Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
2013 Phase 2 EUCTR2012-003627-38-BG Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
2013 - EUCTR2012-003627-38-SE Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
2013 - EUCTR2012-003627-38-DE Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
2013 - EUCTR2012-003627-38-CZ Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
GlaxoSmithKline, S.A.
2012 - EUCTR2012-003627-38-ES Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
GSK2395612
GlaxoSmithKline Research & Development Ltd
2013 Phase 2 EUCTR2012-003627-38-BG Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
2013 - EUCTR2012-003627-38-SE Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
2013 - EUCTR2012-003627-38-DE Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
2013 - EUCTR2012-003627-38-CZ Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
GlaxoSmithKline, S.A.
2012 - EUCTR2012-003627-38-ES Bulgaria;Canada;Czech Republic;Germany;Spain;Sweden;Ukraine;United Kingdom;
GSK3888130B
GlaxoSmithKline
2021 Phase 1 NCT05131971 United Kingdom;
GTR.ace
SYNTHON BV
2011 - EUCTR2011-000888-27-IT Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Romania;Russian Federation;Ukraine;United Kingdom;United States;
Synthon BV
2012 - EUCTR2011-000888-27-GR Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-000888-27-DE Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2011-000888-27-RO Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2011-000888-27-GB Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2011-000888-27-EE Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2011-000888-27-CZ Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2011-000888-27-BG Belarus;Bulgaria;Croatia;Czech Republic;Estonia;Germany;Greece;Italy;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
GW-1000-02
GW Pharma Ltd
2007 Phase 3 EUCTR2006-005910-11-CZ Czech Republic;Germany;Italy;Spain;United Kingdom;
2006 Phase 3 EUCTR2005-005265-11-GB Czech Republic;France;United Kingdom;
2006 Phase 3 EUCTR2005-005265-11-FR Czech Republic;France;United Kingdom;
2006 - EUCTR2005-005265-11-CZ Czech Republic;France;United Kingdom;
2005 Phase 3 EUCTR2004-002509-63-GB Czech Republic;United Kingdom;
2005 - EUCTR2004-002509-63-CZ Czech Republic;United Kingdom;
GW Pharma Ltd.
2008 Phase 3 EUCTR2006-005910-11-GB Czech Republic;Germany;Italy;Spain;United Kingdom;
2008 - EUCTR2006-005910-11-DE Germany;Italy;Spain;United Kingdom;
2007 - EUCTR2007-002138-13-GB United Kingdom;
GW Pharmaceuticals Ltd.
2002 Phase 3 NCT01606176 United Kingdom;
2002 Phase 3 NCT01606137 United Kingdom;
2001 Phase 3 NCT01610713 United Kingdom;
2001 Phase 3 NCT01610700 United Kingdom;
2001 Phase 3 NCT01610687 United Kingdom;
GYLENIA
NOVARTIS FARMA
2011 - EUCTR2011-001442-15-IT Australia;Austria;Czech Republic;Finland;Germany;Greece;Hungary;Israel;Italy;Spain;Sweden;United Kingdom;
GYLENIA 0,
Novartis Farmaceutica S.A.
2013 - EUCTR2012-000835-18-ES Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
GZ402668
Genzyme, a Sanofi Company
2014 Phase 1 NCT02282826 Germany;
Sanofi
2016 Phase 1 NCT02977533 Germany;
GZ402673
Genzyme Corporation
2017 Phase 3 EUCTR2016-003100-30-PT Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-NO Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-NL Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-GR Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-GB Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-ES Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-DE Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-BE Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-AT Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
2015 Phase 3;Phase 4 EUCTR2013-003884-71-NL Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Czechia;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2015 Phase 3;Phase 4 EUCTR2013-003884-71-DK Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2015 - EUCTR2013-003884-71-BE Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;
2014 Phase 4 EUCTR2014-000092-62-NL Belgium;France;Netherlands;Spain;Switzerland;
2014 Phase 4 EUCTR2014-000092-62-FR Belgium;France;Netherlands;Spain;Switzerland;
2014 Phase 4 EUCTR2014-000092-62-ES Belgium;France;Netherlands;Spain;Switzerland;
2014 Phase 4 EUCTR2014-000092-62-BE Belgium;France;Netherlands;Spain;Switzerland;
2014 Phase 3;Phase 4 EUCTR2013-003884-71-IT Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;
2014 Phase 3;Phase 4 EUCTR2013-003884-71-HR Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2014 Phase 3;Phase 4 EUCTR2013-003884-71-DE Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2014 Phase 3;Phase 4 EUCTR2013-003884-71-CZ Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2014 - EUCTR2013-003884-71-ES Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;
- Phase 3 EUCTR2016-003100-30-PL Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
- Phase 3 EUCTR2016-003100-30-Outside-EU/EEA Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
- Phase 3 EUCTR2016-003100-30-FR Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
- Phase 3 EUCTR2016-003100-30-BG Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
Genzyme GmbH
2016 Phase 3 EUCTR2016-000464-42-DE Germany;
Gabapentin
Hospices Civils de Lyon
2012 Phase 2 NCT01744444 France;
Gabapentine
Charité University Medicine Berlin
2010 Phase 4 EUCTR2008-005167-33-DE Germany;
HOSPICES CIVILS DE LYON
2015 Phase 2 EUCTR2014-005548-17-FR France;
Gadobenate Dimeglumine
University of Southern California
2011 - NCT02967380 United States;
Gadobutrol
University of Southern California
2011 - NCT02967380 United States;
Gadolinium
Rennes University Hospital
2009 - NCT01567553 France;
Gadolinium-based contrast
Stanford University
2014 - NCT01973517 United States;
Gadopentetate
University of Southern California
2011 - NCT02967380 United States;
Gadoteric acid
Universitätsklinikum Erlangen
2010 - EUCTR2009-014857-34-DE Germany;
Gadoteridol
University of Maryland, Baltimore
2018 - NCT03396822 United States;
Gadovist 1.0 mmol/ml Injektionslösung
Universitätsklinikum Erlangen
2010 - EUCTR2009-014857-34-DE Germany;
Genotropin
University of Leipzig
- Phase 2 EUCTR2006-006465-16-DE Germany;
GentleCath™ Air catheter
ConvaTec Inc.
2021 - NCT04847609 -
Gilenya
Biogen Idec Research Limited
2015 Phase 4 EUCTR2013-004622-29-DK Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2015 Phase 4 EUCTR2013-004622-29-DE Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2014 Phase 4 EUCTR2013-004622-29-SE Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2014 Phase 4 EUCTR2013-004622-29-GB Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2014 Phase 4 EUCTR2013-004622-29-ES Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2014 Phase 4 EUCTR2013-004622-29-CZ Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2014 - EUCTR2013-004622-29-IT Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
F. Hoffmann-La Roche Ltd
2022 Phase 3 EUCTR2020-004128-41-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004128-41-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004128-41-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004128-41-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004128-41-GR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004128-41-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2020-004128-41-FR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2020-004128-41-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2020-004128-41-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
Jochen Vehoff
2013 Phase 4 NCT02048072 Switzerland;
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden;
2017 Phase 4 EUCTR2016-003587-39-SE Sweden;
McGill University
2012 - NCT02137707 Canada;
NOVARTIS FARMA
2011 - EUCTR2011-001442-15-IT Australia;Austria;Czech Republic;Finland;Germany;Greece;Hungary;Israel;Italy;Spain;Sweden;United Kingdom;
NOVARTIS FARMA S.p.A
2013 - EUCTR2012-005507-40-IT Italy;
Northwestern University
2013 Phase 2 EUCTR2012-004165-41-GB United Kingdom;United States;
Novartis Farma
2013 - EUCTR2011-005677-23-IT Brazil;Canada;Italy;Latvia;Lithuania;Mexico;Spain;United States;Venezuela, Bolivarian Republic of;
Novartis Farma S.p.A.
2012 - EUCTR2010-023023-19-DE Germany;Italy;
Novartis Farma SpA
2014 - EUCTR2013-002660-17-IT Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom;
Novartis Farmaceutica S.A.
2013 - EUCTR2011-005677-23-ES Brazil;Canada;Latvia;Lithuania;Mexico;Spain;United States;Venezuela, Bolivarian Republic of;
Novartis Farmacéutica S.A.
2011 Phase 3 EUCTR2011-003484-30-ES Australia;Spain;
Novartis Pharma AG
2012 Phase 3 EUCTR2012-000835-18-FR Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2008 - EUCTR2007-002627-32-NL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2008 - EUCTR2007-002627-32-BE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Pharma GmbH
2012 Phase 4 EUCTR2012-000674-31-DE Germany;Switzerland;
2012 Phase 4 EUCTR2012-000653-32-DE Germany;
2012 - EUCTR2012-002637-11-DE Germany;
2011 Phase 3 EUCTR2010-022066-28-DE Germany;
2011 - EUCTR2011-002969-38-DE Germany;
- - EUCTR2011-001692-39-DE Germany;
Novartis Pharma S.A.S
2011 Phase 4 EUCTR2011-001280-49-FR France;
Novartis Pharma Service AG
2015 Phase 3 EUCTR2011-005677-23-HR Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005677-23-GB Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005677-23-EE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 - EUCTR2011-005677-23-RO Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2011-005677-23-DE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2011-005677-23-BG Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;Venezuela, Bolivarian Republic of;
2013 - EUCTR2011-005677-23-LV Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Novartis Pharma Services AG
2015 - EUCTR2013-002660-17-PT Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom;
2015 - EUCTR2013-002660-17-DK Canada;Denmark;Finland;France;Germany;Italy;Poland;Portugal;Spain;Switzerland;United Kingdom;
2014 Phase 3 EUCTR2012-000835-18-DK Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005677-23-PL Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005677-23-NL Austria;Brazil;Bulgaria;Canada;Croatia;Estonia;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Slovakia;Spain;Sweden;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005677-23-AT Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 - EUCTR2012-000835-18-PL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2014 - EUCTR2011-005677-23-SE Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-000835-18-DE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2011-005677-23-SK Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2011-005677-23-LT Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2013 - EUCTR2012-000835-18-NL Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 - EUCTR2012-000835-18-HU Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 - EUCTR2012-000835-18-SE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 - EUCTR2011-001442-15-SE Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom;
2012 - EUCTR2011-001437-16-DE Australia;Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020515-37-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2011 - EUCTR2011-001442-15-GR Austria;Czech Republic;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Spain;Sweden;Switzerland;United Kingdom;
2011 - EUCTR2011-001442-15-GB Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom;
2011 - EUCTR2011-001442-15-DE Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom;
2011 - EUCTR2011-001442-15-AT Australia;Austria;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom;
2010 Phase 3 EUCTR2010-020515-37-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;Comoros;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2010 Phase 3 EUCTR2010-020515-37-HU Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-FI Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020515-37-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2009 - EUCTR2007-002627-32-CZ Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;
Novartis Services Pharma AG
2008 - EUCTR2007-002627-32-SE Belgium;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Spain;Sweden;United Kingdom;
Sakari Simula
2012 Phase 4 EUCTR2012-002694-66-FI Finland;
Sheffield Teaching Hospitals NHS Foundation Trust
2013 Phase 2/Phase 3 NCT03133403 United Kingdom;
Turku University Hospital
2014 Phase 4 EUCTR2014-000296-12-FI Finland;
2013 Phase 4 EUCTR2013-004626-28-FI Finland;
University of Southern California
2013 - NCT02225977 United States;
Universitätsklinikum Münster
2014 - EUCTR2013-004616-21-DE Germany;
VU University Medical Center
2014 - EUCTR2014-001012-19-NL Netherlands;
Gilenya / Imusera
Novartis Pharma K.K.
2019 - JPRN-JapicCTI-194838 Japan;
Gilenya 0,5 mg Hartkapseln
Novartis Pharma Services AG
2010 Phase 3 EUCTR2010-020515-37-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Ireland;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Netherlands;Norway;Panama;Peru;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
- - EUCTR2007-002627-32-DE Australia;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Gilenya®
Charite Universitaetsmedizin Berlin
2012 Phase 3 EUCTR2011-004787-30-DE Germany;
Charité - Universitätsmedizin Berlin
2013 Phase 4 EUCTR2012-000411-91-DE Germany;
Universitätsklinikum Hamburg-Eppendorf
2013 - NCT03216915 Germany;
Gileyna
Stony Brook University
2013 - NCT02141022 United States;
Ginkgo biloba
National Center for Complementary and Integrative Health (NCCIH)
1999 Phase 1/Phase 2 NCT00010842 United States;
VA Office of Research and Development
2009 Phase 2 NCT00841321 United States;
Ginseng
Isfahan University of Medical Sciences
2010 Phase 2 NCT01712373 Iran, Islamic Republic of;
Glatiramer Acetate
Biogen
2007 Phase 3 NCT00451451 Australia;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Costa Rica;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Ireland;Israel;Italy;Kazakhstan;Latvia;Lithuania;Macedonia, The Former Yugoslav Republic of;Mexico;Moldova, Republic of;New Zealand;Poland;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United States;
Biogen Idec Ltd.
2008 - EUCTR2006-003697-10-BG Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 - EUCTR2006-003697-10-IE Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 - EUCTR2006-003697-10-GR Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 - EUCTR2006-003697-10-DE Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
2007 - EUCTR2006-003697-10-CZ Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
Cinnagen
2015 - NCT04928313 -
Isfahan University of Medical Sciences
2017 Phase 2/Phase 3 NCT03315923 Iran, Islamic Republic of;
Teva Pharmaceutical Industries
2012 Phase 3 NCT01578785 Albania;Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Greece;Latvia;Lithuania;Macedonia, The Former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
2005 Phase 4 NCT00203047 Canada;United States;
2004 Phase 4 NCT00202995 Canada;United States;
The Walton Centre for Neurology and Neurosurgery
2005 Phase 4 EUCTR2004-004903-39-GB United Kingdom;
University of Colorado, Denver
2012 Phase 2 NCT01569451 United States;
Glatiramer Acetate (Copaxone®)
Synthon BV
2011 Phase 3 NCT01489254 Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Italy;Kazakhstan;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;South Africa;Ukraine;United Kingdom;United States;
Glatiramer Acetate (DB)
Teva Pharmaceutical Industries
2004 Phase 3 NCT00666224 Argentina;Australia;Austria;Denmark;Finland;France;Germany;Hungary;Israel;Italy;New Zealand;Norway;Romania;Spain;Sweden;United Kingdom;United States;
Glatiramer Acetate (GA)
Sanofi
2007 Phase 2 NCT00475865 Austria;Canada;Germany;Italy;United Kingdom;United States;
Teva Pharmaceutical Industries
2006 Phase 3 NCT00337779 Argentina;Canada;France;Germany;Hungary;Israel;Italy;Netherlands;Spain;United Kingdom;United States;
Glatiramer Acetate (GTR)
Synthon BV
2011 Phase 3 NCT01489254 Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Italy;Kazakhstan;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;South Africa;Ukraine;United Kingdom;United States;
Glatiramer Acetate (OL)
Teva Pharmaceutical Industries
2004 Phase 3 NCT00666224 Argentina;Australia;Austria;Denmark;Finland;France;Germany;Hungary;Israel;Italy;New Zealand;Norway;Romania;Spain;Sweden;United Kingdom;United States;
Glatiramer Acetate [GA]
Sanofi
2007 Phase 2 NCT00811395 Austria;Canada;Germany;Italy;Spain;United Kingdom;United States;
Glatiramer Acetate, IFN-beta 1a (IM), IFN-beta 1a (Subcutaneous), and IFN-beta 1b
Teva Neuroscience, Inc.
2008 - NCT00819000 United States;
Glatiramer Acetate, N-Acetylcysteine
Teva Pharmaceutical Industries
2004 Phase 2 NCT00203099 Canada;
Glatiramer acetate
AZIENDA OSPEDALIERA UNIVERSITARIA DELLA SECONDA UNIVERSITA` DEGLI STUDI DI NAPOLI
2009 - EUCTR2009-010661-23-IT Italy;
Amphia Hospital
2009 Phase 4 NCT00910598 Netherlands;
BIOGEN IDEC LTD
2010 - EUCTR2009-015556-15-IT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
Biogen
2021 Phase 2 NCT04079088 -
2010 Phase 3 NCT01058005 Australia;Canada;Czech Republic;Finland;France;Hungary;Italy;Latvia;Poland;Slovenia;Spain;Sweden;United States;
2010 Phase 2 NCT01071083 Germany;Spain;United States;
Biogen Idec Ltd.
2007 Phase 3 EUCTR2006-003697-10-ES Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Ireland;Latvia;Spain;
FONDAZIONE DON CARLO GNOCCHI ONLUS
2011 - EUCTR2011-000150-31-IT Italy;
Fred Lublin
2005 Phase 3 NCT00211887 Canada;United States;
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
Glostrup Hospital, Dep. of Neurology
2009 - EUCTR2006-001827-21-DK Denmark;
ISTITUTO C. MONDINO
2007 - EUCTR2008-007162-32-IT Italy;
NOVARTIS FARMA
2011 - EUCTR2010-024017-31-IT Italy;
National Institute of Allergy and Infectious Diseases (NIAID)
2001 - NCT00039988 United States;
Novartis Pharmaceuticals
2012 Phase 3 NCT01633112 Argentina;Brazil;Canada;Chile;Mexico;Puerto Rico;United States;
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy;
Philipps-Universität Marburg
2010 - EUCTR2009-011088-35-DE Germany;
Sanofi
2003 Phase 4 NCT00267319 Czech Republic;
Sheba Medical Center
2006 - NCT00331747 Israel;
TEVA
2004 - EUCTR2004-000759-40-IT Italy;
2004 - EUCTR2004-000463-94-IT Hungary;Italy;
2004 - EUCTR2004-000462-13-IT Hungary;Italy;
TEVA ITALIA srl
2004 - EUCTR2004-000762-13-IT Italy;
Takeda
2015 - NCT03209479 Japan;
Teva Branded Pharmaceutical Products R&D, Inc.
1994 Phase 4 NCT00203021 United States;
Teva Pharmaceutical Industries
2003 Phase 2 NCT00202982 United States;
Teva Pharmaceuticals Industries Ltd.
2006 - EUCTR2006-002037-20-IT Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
University of California, San Francisco
2008 - NCT00819195 United States;
VU University Medical Center
2014 - EUCTR2014-001012-19-NL Netherlands;
Glatiramer acetate (GA)
Novartis Pharmaceuticals
2012 Phase 4 NCT01534182 Russian Federation;
Teva Branded Pharmaceutical Products R&D, Inc.
2010 Phase 3 NCT01067521 Bulgaria;Croatia;Czech Republic;Czechia;Estonia;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Poland;Romania;Russian Federation;South Africa;Turkey;Ukraine;United Kingdom;United States;
Glatiramer acetate 150mg enteric coated tablets
TEVA Pharmaceutical Industries Ltd.
2007 - EUCTR2004-000463-94-HU Hungary;Italy;
Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets
TEVA Pharmaceutical Industries Ltd.
2004 - EUCTR2004-000462-13-HU Hungary;Italy;
Glatiramer acetate 20 mg, with mitoxantrone
Teva Pharmaceutical Industries
2003 Phase 2 NCT00203073 Canada;United States;
Glatiramer acetate injection with oral cetirizine hydrochloride
Teva Pharmaceutical Industries
2004 Phase 4 NCT00240032 United States;
Glatiramer acetate with minocycline
Teva Pharmaceutical Industries
2004 Phase 2 NCT00203112 Canada;
Glatiramer acetate, (Copaxone®)
Neurognostics
2006 - NCT00398528 United States;
Glatiramer acetato
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain;
Teva Pharmaceutical Industries, Ltd.
2006 Phase 3 EUCTR2006-002037-20-ES Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
Teva Pharmaceuticals Industries Ltd.
2006 - EUCTR2006-002037-20-IT Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
Glicerol-1,3-didecanoato-2-octadeca-(6Z,9Z,12Z)-trienoato
BTG International Ltd
2009 - EUCTR2009-011585-28-ES Belgium;France;Germany;Spain;
Glucose
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
1999 Phase 3 NCT00062972 United States;
Slovak Academy of Sciences
2017 - NCT03052595 Slovakia;
Glutamate and aspartate
University Hospital, Caen
2007 - NCT02523703 -
Glycerol-1,3-didecanoate-2-octadeca-(6Z,9Z,12Z)-trienoate
BTG International Ltd
2009 Phase 2 EUCTR2009-011585-28-BE Belgium;European Union;France;Germany;Russian Federation;Spain;
2009 - EUCTR2009-011585-28-FR Belgium;France;Germany;Spain;
2009 - EUCTR2009-011585-28-DE Belgium;European Union;France;Germany;Russian Federation;Spain;
Gold
Children's Hospital of Chongqing Medical University
2017 - ChiCTR-DND-17013749 China;
Huashan Hospital, Fudan University
2020 - ChiCTR2000040363 China;
The First Hospital of Jilin University
2020 Phase 0 ChiCTR2000034098 China;
Gold nanocrystals
Clene Nanomedicine
2019 Phase 2 NCT03993171 United States;
Granulocyte-colony stimulating factor (G-CSF) and prednisone
National Institute of Allergy and Infectious Diseases (NIAID)
2006 Phase 2 NCT00288626 United States;
Guanabenz
National Institute of Neurological Disorders and Stroke (NINDS)
2015 Phase 1 NCT02423083 United States;
H.P. Acthar Gel (repository corticotropin injection)
The University of Texas Health Science Center, Houston
2013 Phase 4 NCT01888354 United States;
H5G1.1-mAb
Alexion Pharmaceuticals Inc.
2020 Phase 2;Phase 3 EUCTR2019-001829-26-DE Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States;
2019 Phase 2;Phase 3 EUCTR2019-001829-26-ES Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States;
HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE)
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 2;Phase 3 EUCTR2019-001829-26-IT Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States;
HB-adMSCs
Hope Biosciences Stem Cell Research Foundation
2021 Phase 2 NCT05116540 United States;
HBM9161 Injection
Harbour BioMed (Guangzhou) Co. Ltd.
2020 Phase 1 NCT04227470 China;
HMR 1726D
Sanofi-Aventis recherche & développement
2008 - EUCTR2007-003997-24-GB Austria;Italy;Spain;United Kingdom;
2007 - EUCTR2007-003997-24-ES Austria;Italy;Spain;United Kingdom;
2007 - EUCTR2007-003997-24-AT Austria;Italy;Spain;United Kingdom;
Sanofi-aventis recherche & développement
2010 - EUCTR2007-004452-36-SK Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2009 Phase 3 EUCTR2007-004452-36-SE Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2009 Phase 3 EUCTR2007-004452-36-GR Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2009 Phase 3 EUCTR2007-004452-36-GB Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-004452-36-FR Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-004452-36-ES Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-004452-36-EE Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-004452-36-DE Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
sanofi-aventis recherche & développement
2009 - EUCTR2007-004452-36-AT Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2008 Phase 3 EUCTR2007-004452-36-BE Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-004452-36-NL Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-004452-36-CZ Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
HMR1726
Aventis Pharmaceuticals Inc.
2006 - EUCTR2004-000555-42-PT Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
GENZYME CORPORATION
2020 Phase 3 EUCTR2020-000637-41-IT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2017 Phase 3 EUCTR2011-005249-12-IT Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;United Kingdom;United States;
Genzyme Corporation
2021 Phase 3 EUCTR2020-000644-55-DE Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000637-41-AT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000644-55-SK Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-PT Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-NL Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-LV Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-HU Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-GR Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-GB Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-FR Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-CZ Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000637-41-SE Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-PL Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-LT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-FI Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-DK Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-DE Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-CZ Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-BG Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2017 Phase 3 EUCTR2011-005249-12-SI Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;China;Egypt;Estonia;France;Greece;Ireland;Israel;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2011-005249-12-PT Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;China;Egypt;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2011-005249-12-NL Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;United Kingdom;United States;
2015 Phase 3 EUCTR2011-005249-12-LT Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2015 - EUCTR2011-005249-12-PL Australia;Belgium;Canada;China;Estonia;Greece;Israel;Lebanon;Lithuania;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States;
2014 Phase 4 EUCTR2013-001439-34-IT Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Italy;Spain;Sweden;Switzerland;United Kingdom;United States;
2014 Phase 4 EUCTR2013-001439-34-GR Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
2014 Phase 4 EUCTR2013-001439-34-GB Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005249-12-GR Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005249-12-GB Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Lebanon;Lithuania;Macedonia, the former Yugoslav Republic of;Morocco;Netherlands;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005249-12-ES Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Lebanon;Lithuania;Netherlands;Poland;Portugal;Russian Federation;Slovenia;Spain;Turkey;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005249-12-EE Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Netherlands;Poland;Portugal;Russian Federation;Slovenia;Spain;Turkey;United Kingdom;United States;
2014 Phase 3 EUCTR2011-005249-12-BE Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2014 - EUCTR2013-001439-34-DE Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
2014 - EUCTR2013-001439-34-BE Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
2014 - EUCTR2013-001439-34-AT Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
2013 Phase 4 EUCTR2013-001439-34-SE Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
2013 Phase 4 EUCTR2013-001439-34-FI Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Spain;Sweden;Switzerland;United Kingdom;United States;
2013 Phase 4 EUCTR2013-001439-34-ES Austria;Belgium;Canada;Chile;Finland;Germany;Greece;Italy;Spain;Sweden;Switzerland;United Kingdom;United States;
2013 - EUCTR2012-005324-16-NL Belgium;Germany;Netherlands;
2013 - EUCTR2012-005324-16-DE Belgium;Germany;Netherlands;
2013 - EUCTR2012-005324-16-BE Belgium;Germany;Netherlands;
- Phase 3 EUCTR2011-005249-12-Outside-EU/EEA Australia;Bosnia and Herzegovina;Canada;China;Israel;Lebanon;Morocco;Russian Federation;Tunisia;Turkey;United States;
- Phase 3 EUCTR2011-005249-12-IE Australia;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Morocco;Netherlands;Poland;Portugal;Russian Federation;Slovenia;Spain;Tunisia;Turkey;United Kingdom;United States;
- Phase 3 EUCTR2011-005249-12-FR Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Netherlands;Poland;Portugal;Russian Federation;Slovenia;Spain;Turkey;United Kingdom;United States;
- Phase 3 EUCTR2011-005249-12-BG Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Ireland;Israel;Italy;Lebanon;Lithuania;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States;
Sanofi-Aventis US, Inc.
2004 - EUCTR2004-000555-42-AT Austria;Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
Sanofi-aventis US, Inc
2008 Phase 3 EUCTR2004-000555-42-GB Austria;Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
2005 - EUCTR2004-000555-42-DK Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
2004 - EUCTR2004-000555-42-SE Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
2004 - EUCTR2004-000555-42-NO Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
sanofi-aventis Recherche & De`veloppement
2004 - EUCTR2004-000555-42-IT Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
sanofi-aventis Recherche & Dévelopment
2009 - EUCTR2008-006226-34-FR Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom;
sanofi-aventis U.S Inc
2007 - EUCTR2004-000555-42-CZ Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
sanofi-aventis group
2011 - EUCTR2010-023172-12-GR Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom;
sanofi-aventis recherche et development
2012 - EUCTR2010-023172-12-LT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
2011 Phase 3 EUCTR2010-023172-12-SK Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2011 Phase 3 EUCTR2010-023172-12-HU Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
2011 Phase 3 EUCTR2010-023172-12-BE Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-023172-12-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
2011 - EUCTR2010-023172-12-PT Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-023172-12-NO Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
2011 - EUCTR2010-023172-12-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
2011 - EUCTR2010-023172-12-IT Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-023172-12-GB Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-023172-12-FI Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
2011 - EUCTR2010-023172-12-ES Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-023172-12-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
2011 - EUCTR2010-023172-12-DK Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-023172-12-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
2011 - EUCTR2010-023172-12-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
2009 Phase 3 EUCTR2008-006226-34-GR Belgium;Czech Republic;France;Germany;Greece;Hungary;Italy;Spain;United Kingdom;
2009 - EUCTR2008-006226-34-IT Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom;
2009 - EUCTR2008-006226-34-ES Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom;
2009 - EUCTR2008-006226-34-BE Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom;
sanofi-aventis recherche et developpement
2010 - EUCTR2008-006226-34-GB Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom;
2009 - EUCTR2008-006226-34-HU Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom;
2009 - EUCTR2008-006226-34-DE Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom;
2009 - EUCTR2008-006226-34-CZ Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom;
HMR1726D
Sanofi-Aventis recherche & de'veloppement
2008 - EUCTR2007-003997-24-IT Austria;Italy;Spain;United Kingdom;
Sanofi-Aventis recherche & développement
2008 - EUCTR2007-003997-24-GB Austria;Italy;Spain;United Kingdom;
2007 - EUCTR2007-003997-24-ES Austria;Italy;Spain;United Kingdom;
2007 - EUCTR2007-003997-24-AT Austria;Italy;Spain;United Kingdom;
Sanofi-aventis U.S. Inc
2007 - EUCTR2006-003134-14-IT Germany;Italy;Spain;
2007 - EUCTR2004-000555-42-EE Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
Sanofi-aventis U.S. Inc.
2007 Phase 2 EUCTR2006-004893-29-GB Austria;Germany;Italy;United Kingdom;
2007 Phase 2 EUCTR2006-003134-14-ES Germany;Italy;Spain;
2007 - EUCTR2006-004893-29-IT Austria;Germany;Italy;United Kingdom;
2007 - EUCTR2006-004893-29-AT Austria;Germany;Italy;United Kingdom;
2007 - EUCTR2006-003134-14-DE Germany;Italy;Spain;
- - EUCTR2006-004893-29-DE Austria;Germany;Italy;United Kingdom;
Sanofi-aventis recherche & développement
2010 - EUCTR2007-004452-36-SK Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2009 Phase 3 EUCTR2007-004452-36-SE Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2009 Phase 3 EUCTR2007-004452-36-GR Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2009 Phase 3 EUCTR2007-004452-36-GB Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2008 Phase 3 EUCTR2006-001152-12-FR Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom;
2008 - EUCTR2007-004452-36-FR Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-004452-36-ES Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-004452-36-EE Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-004452-36-DE Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2008 - EUCTR2006-001152-12-SK Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom;
sanofi-aventis recherche de veloppement
2007 - EUCTR2006-003361-14-IT Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom;
sanofi-aventis recherche & developpement
2011 - EUCTR2011-001160-21-DE Austria;Canada;Germany;Russian Federation;Ukraine;
2011 - EUCTR2011-001160-21-AT Austria;Canada;Germany;Russian Federation;Ukraine;
sanofi-aventis recherche & développement
2009 - EUCTR2007-004452-36-AT Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2009 - EUCTR2006-003361-14-EE Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom;
2009 - EUCTR2006-003361-14-CZ Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2009 - EUCTR2006-001152-12-LT Australia;Austria;Belarus;Bulgaria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States;
2009 - EUCTR2006-001152-12-DE Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom;
2008 Phase 3 EUCTR2007-004452-36-BE Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2008 Phase 3 EUCTR2006-003361-14-PT Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom;
2008 Phase 3 EUCTR2006-001152-12-BG Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom;
2008 - EUCTR2007-004452-36-NL Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-004452-36-CZ Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2008 - EUCTR2006-003361-14-NL Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2008 - EUCTR2006-003361-14-DK Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom;
2008 - EUCTR2006-001152-12-HU Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States;
2008 - EUCTR2006-001152-12-EE Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States;
2007 Phase 3 EUCTR2006-003361-14-SE Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom;
2007 Phase 3 EUCTR2006-003361-14-GB Austria;Canada;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2007 Phase 3 EUCTR2006-001152-12-GB Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States;
2007 Phase 3 EUCTR2006-001152-12-FI Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom;
2007 Phase 3 EUCTR2006-001152-12-CZ Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States;
2007 - EUCTR2006-003361-14-DE Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Poland;Portugal;Russian Federation;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2007 - EUCTR2006-001152-12-DK Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States;
2007 - EUCTR2006-001152-12-AT Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom;
2006 Phase 3 EUCTR2006-003361-14-FI Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom;
2006 - EUCTR2006-003361-14-AT Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
HP184
sanofi-aventis Recherche & Développement
2009 Phase 2 EUCTR2008-001999-67-FR Finland;France;Germany;Spain;
2009 Phase 2 EUCTR2008-001999-67-ES Finland;France;Germany;Spain;
2009 - EUCTR2008-001999-67-FI Finland;France;Germany;Spain;
2009 - EUCTR2008-001999-67-DE Finland;France;Germany;Spain;
HUMAN LEUCOCYTE INTERFERON-ALPHA
Dansk Multipel Sclerose Center
2010 - EUCTR2009-016824-29-DK Denmark;
Helminth ova
University of Wisconsin, Madison
2008 Phase 1 NCT00645749 United States;
Hematopoetic stem cell infusion
Talaris Therapeutics Inc.
2007 Phase 1/Phase 2 NCT00497952 United States;
Hematopoietic Stem Cell Therapy
Northwestern University
2005 Phase 2 NCT00273364 United States;
Hematopoietic stem cell transplantation
Northwestern University
2003 Phase 1/Phase 2 NCT00278655 United States;
Hematopoietic stem cell transplantation (HSCT)
Sheffield Teaching Hospitals NHS Foundation Trust
2013 Phase 2/Phase 3 NCT03133403 United Kingdom;
Heterologous booster
Griffin Hospital
2021 - NCT05081271 -
Hiberix
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 2;Phase 3 EUCTR2019-001829-26-IT Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States;
Hidrocloruro de fingolimod
Novartis Farmacéutica, S.A.
2011 - EUCTR2011-001442-15-ES Austria;Czech Republic;Finland;France;Germany;Greece;Hungary;Israel;Italy;Spain;Sweden;Switzerland;United Kingdom;
High Dose Aspirin (1300 mg/day)
Mayo Clinic
2007 Phase 3 NCT00467584 United States;
High Phenolic Extra Virgin Olive Oil
University of Cyprus
2021 - NCT04787497 -
High/Low Sodium Diet
Yale University
2014 - NCT02282878 United States;
Histamine
University of Nottingham
2008 Phase 2 NCT00630383 United Kingdom;
Home based balance training
University of Arizona
2014 - NCT02777060 United States;
Homologous booster
Griffin Hospital
2021 - NCT05081271 -
Hookworm larvae
University of Nottingham
2011 Phase 2 NCT01470521 United Kingdom;
HuL001
HuniLife Biotechnology, Inc.
2021 Phase 1 NCT04540770 Taiwan;
HuMax-CD20
Genmab A/S
2008 Phase 2 EUCTR2007-004223-38-DE Belgium;Czech Republic;Denmark;Germany;Sweden;United Kingdom;
2008 - EUCTR2007-004223-38-BE Belgium;Czech Republic;Denmark;Germany;Sweden;United Kingdom;
GlaxoSmithKline
2008 - EUCTR2007-004223-38-DK Czech Republic;Denmark;Germany;Sweden;United Kingdom;
GlaxoSmithKline AB
2008 - EUCTR2007-004223-38-SE Czech Republic;Denmark;Germany;Sweden;United Kingdom;
GlaxoSmithKline UK
2009 Phase 2 EUCTR2007-004223-38-GB Belgium;Czech Republic;Denmark;Germany;Sweden;United Kingdom;
GlaxoSmithKline s.r.o.
2008 - EUCTR2007-004223-38-CZ Czech Republic;Denmark;Germany;Sweden;United Kingdom;
Human Neural Stem Cells
Casa Sollievo della Sofferenza IRCCS
2017 Phase 1 NCT03282760 Italy;Switzerland;
Human anti-IL-12 IgG1 Mab
Centocor B.V.
2005 Phase 2 EUCTR2004-000145-38-GB Czech Republic;Hungary;United Kingdom;
2004 Phase 2 EUCTR2004-000145-38-CZ Czech Republic;Hungary;United Kingdom;
2004 - EUCTR2004-000145-38-HU Czech Republic;Hungary;United Kingdom;
Human anti-IL-12 Mab
Centocor B.V.
2005 Phase 2 EUCTR2004-000145-38-GB Czech Republic;Hungary;United Kingdom;
2004 Phase 2 EUCTR2004-000145-38-CZ Czech Republic;Hungary;United Kingdom;
2004 - EUCTR2004-000145-38-HU Czech Republic;Hungary;United Kingdom;
Human anti-LINGO-1 monoclonal antibody
Biogen Idec Research Limited
2013 Phase 2 EUCTR2011-006262-40-NL Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
2013 Phase 2 EUCTR2011-006262-40-IT Canada;Czech Republic;Hungary;Italy;Netherlands;Russian Federation;Serbia;Spain;United Kingdom;United States;
2013 Phase 2 EUCTR2011-006262-40-HU Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
2013 Phase 2 EUCTR2011-006262-40-GB Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
2013 Phase 2 EUCTR2011-006262-40-CZ Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
Human autologous mesenchymal stem cells
SALK - Gemeinnützige Salzburger Landeskliniken Betriebsges. m.b.H., Christian-Doppler-Klinik, UK für Neurologie der PMU
- - EUCTR2015-000137-78-AT Austria;
Human fetal-derived Neural Stem Cells (hNSCs)
IRCCS San Raffaele
2017 Phase 1 NCT03269071 Italy;
Human interferon beta 1a (Rebif)
Aaron Boster
2006 Phase 0 NCT00618527 United States;
Human interferon beta-1a and glatiramer acetate
EMD Serono
2004 Phase 4 NCT00078338 Argentina;Austria;Brazil;France;Germany;Italy;Netherlands;Russian Federation;Spain;Switzerland;United Kingdom;United States;
Human monoclonal antibody (CNTO 1275) to interleukin-12p40
Centocor B.V.
2005 Phase 2 EUCTR2004-000145-38-GB Czech Republic;Hungary;United Kingdom;
2004 Phase 2 EUCTR2004-000145-38-CZ Czech Republic;Hungary;United Kingdom;
2004 - EUCTR2004-000145-38-HU Czech Republic;Hungary;United Kingdom;
Human normal immunoglobulin
Octapharma AG
2015 Phase 3 EUCTR2012-005086-12-PL Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;Serbia;Ukraine;
2013 - EUCTR2012-005086-12-HU Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-DE Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-BG Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-AT Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
Human recombinant growth hormone
University of Leipzig
- Phase 2 EUCTR2006-006465-16-DE Germany;
Hydrogen peroxide
Tehran University of Medical Sciences
2012 - NCT02463318 Iran, Islamic Republic of;
Hydroxychloroquine
University of Calgary
2016 Phase 2 NCT02913157 Canada;
Hydroxychloroquine and Indapamide
University of Calgary
2021 Phase 2 NCT05013463 -
Hydroxyurea
S. Andrea Hospital
2011 Phase 2/Phase 3 NCT01103583 Italy;
Hyperimmune caprine serum against HIV lysate
Daval International Limited
2009 Phase 2 NCT01228396 United Kingdom;
IFA Incomplete Freund's Adjuvant
Immune Response BioPharma, Inc.
2020 Phase 2 NCT02149706 United States;
2020 Phase 1 NCT02200718 United States;
IFN beta 1a 44 mcg TIW
Merck KGaA, Darmstadt, Germany
2012 Phase 2 NCT01514370 Italy;
IFN beta-1a
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-003008-38-IT Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
Biogen Idec Research Limited
2020 Phase 3 EUCTR2018-003008-38-DE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-SK Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-PT Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-HU Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-HR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-GR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-ES Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;
2019 Phase 3 EUCTR2018-003008-38-CZ Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;
2019 Phase 3 EUCTR2018-003008-38-BG Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-BE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
- Phase 3 EUCTR2018-003008-38-FR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
Merck KGaA, Darmstadt, Germany
2018 Phase 2 NCT03387046 Germany;Italy;
IFN ß-1a
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-003008-38-IT Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
Biogen Idec Research Limited
2020 Phase 3 EUCTR2018-003008-38-DE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-SK Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-PT Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-HU Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-HR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-GR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-ES Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;
2019 Phase 3 EUCTR2018-003008-38-CZ Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;
2019 Phase 3 EUCTR2018-003008-38-BG Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-BE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
- Phase 3 EUCTR2018-003008-38-FR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
IFN-beta-1a (Rebif®)
Waukesha Memorial Hospital
2008 - NCT00391352 United States;
IFN-beta-1a, (Avonex®)
Neurognostics
2006 - NCT00398528 United States;
IFN-ß-1a (Rebif®)
Waukesha Memorial Hospital
2008 - NCT00391352 United States;
IFN-ß-1a, (Avonex®)
Neurognostics
2006 - NCT00398528 United States;
IL2
Assistance Publique - Hôpitaux de Paris
2016 Phase 2 NCT02424396 France;
IM90838
Immunic AG
2022 Phase 2 EUCTR2021-000048-23-NL Bulgaria;Canada;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
2022 Phase 2 EUCTR2021-000048-23-DE Bulgaria;Canada;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
2021 Phase 2 EUCTR2021-000048-23-BG Bulgaria;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine;
IMATINIB MESILATE
Department of Clinical Neuroscience, Karolinska Institutet
2020 Phase 2 EUCTR2018-000620-34-DE Germany;Sweden;
2018 Phase 2 EUCTR2018-000620-34-SE Sweden;
IMMUNOGLOBULIN G
Octapharma AG
2015 Phase 3 EUCTR2012-005086-12-PL Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;Serbia;Ukraine;
2013 - EUCTR2012-005086-12-HU Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-DE Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-BG Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-AT Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
IMMUNOSUPPRESSIVE AGENTS
Actelion Pharmaceuticals Ltd
2010 - EUCTR2009-011470-15-IT Austria;Bulgaria;Czech Republic;Finland;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
IMS001
ImStem Biotechnology
2021 Phase 1 NCT04956744 United States;
IMU-838
Immunic AG
2022 Phase 3 EUCTR2021-000028-36-BG Albania;Belarus;Bulgaria;Colombia;Georgia;Greece;India;Lithuania;Mexico;Moldova, Republic of;North Macedonia;Poland;Russian Federation;Ukraine;United States;
2022 Phase 2 EUCTR2021-000048-23-NL Bulgaria;Canada;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
2022 Phase 2 EUCTR2021-000048-23-DE Bulgaria;Canada;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
2021 Phase 2 NCT05054140 Bulgaria;Poland;Ukraine;United States;
2021 Phase 2 EUCTR2021-000048-23-BG Bulgaria;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine;
2018 Phase 2 EUCTR2018-001896-19-BG Bulgaria;Poland;Romania;Ukraine;
IMU-838 (30 mg/day)
Immunic AG
2019 Phase 2 NCT03846219 Bulgaria;Poland;Romania;Ukraine;
IMU-838 (45 mg/day)
Immunic AG
2019 Phase 2 NCT03846219 Bulgaria;Poland;Romania;Ukraine;
IMU-838 tablets
Immunic AG
2022 Phase 3 NCT05201638 -
2021 Phase 3 NCT05134441 -
INF beta-1a
Bosnalijek D.D
2019 Phase 3 NCT03283397 Turkey;
INN COLECALCIFEROL
Merja Soilu Häninen
2007 - EUCTR2007-001958-99-FI Finland;
INT131
InteKrin Therapeutics, Inc.
2015 Phase 2 NCT02638038 -
INTERFERON BETA - 1A
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-003008-38-IT Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy;
INTERFERON BETA-1A (Avonex®)
Teva Pharmaceutical Industries Ltd
2008 - EUCTR2007-005450-23-LT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
INTERFERON BETA1A
Biogen Idec Limited
2010 - EUCTR2009-015556-15-ES Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
Biogen Idec Ltd
2010 Phase 3 EUCTR2009-012500-11-ES Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom;
Merck Serono International, a branch of Laboratoires Serono SA an affiliate of Merck KGaA, Darmstadt
2009 Phase 3 EUCTR2008-004954-34-ES Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Slovakia;Spain;
Merck Serono S.A. - Geneva, an affiliate of Merck KGaA Darmstadt, Germany
2006 - EUCTR2006-002982-38-ES Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain;
sanofi-aventis recherche et development
2009 - EUCTR2008-006226-34-ES Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom;
INTERFERONE BETA 1B
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy;
IPX056
Impax Laboratories, LLC
2009 Phase 2 NCT00914290 United States;
2007 Phase 3 NCT00488839 Canada;Estonia;Latvia;Ukraine;United States;
IPX056-
IMPAX Laboratories, Inc.
2007 - EUCTR2007-000236-16-LV Estonia;Latvia;
2007 - EUCTR2007-000236-16-EE Estonia;Latvia;
IR902
The Immune Response Corporation
2007 Phase 2 EUCTR2006-003384-30-SK Slovakia;
IS (B cell depletion therapy)
National Institute of Allergy and Infectious Diseases (NIAID)
2021 Phase 2 NCT05000216 United States;
IS (MMF or MPA)
National Institute of Allergy and Infectious Diseases (NIAID)
2021 Phase 2 NCT05000216 United States;
IS (MTX)
National Institute of Allergy and Infectious Diseases (NIAID)
2021 Phase 2 NCT05000216 United States;
IV methylprednisolone
Biogen Idec
2003 Phase 4 NCT00112034 United States;
Fred Lublin
2003 Phase 3 NCT00418145 United States;
IV methylprednisolone (steroids)
University of Colorado, Denver
2013 Phase 4 NCT01838174 United States;
IVIg
Northwestern University
2019 Phase 2/Phase 3 NCT03829566 United States;
2017 Phase 3 NCT03342638 United States;
Ibudilast
MediciNova
2013 Phase 2 NCT01982942 United States;
Ibuprofen
Genzyme, a Sanofi Company
2014 Phase 4 NCT02205489 Belgium;France;Netherlands;Spain;
Ibuprofen Sandoz 400 mg Filmtabletten
Merck Serono International SA
2007 - EUCTR2006-005972-42-DE France;Germany;
Idebenone
National Institute of Allergy and Infectious Diseases (NIAID)
2013 Phase 1/Phase 2 NCT01854359 United States;
2009 Phase 1/Phase 2 NCT00950248 United States;
Imatinib Mesylate
Tomas Olsson
2018 Phase 2 NCT03674099 Denmark;Germany;Norway;Sweden;
Immune Globulin IV [Human], Caprylate/Chromatography Purified
Grifols Therapeutics Inc.
2002 Phase 2 NCT00220779 Austria;Canada;Czech Republic;Germany;Greece;Hungary;Israel;Poland;Slovakia;Sweden;United Kingdom;United States;
Immune globulin
National Institute of Neurological Disorders and Stroke (NINDS)
1993 Phase 3 NCT00004744 -
Immunoadsorption
University Hospital Muenster
2018 - NCT04450030 Germany;
Immunoglobulin
Octapharma AG
2008 - EUCTR2008-004579-22-AT Austria;
Impact
Fondazione Don Carlo Gnocchi Onlus
2018 - NCT04881422 Italy;
Nelson Mandela Metropolitan University
2011 Phase 0 NCT01453868 United States;
University Hospital, Strasbourg, France
2019 Phase 2 NCT03910738 France;
University of Alabama at Birmingham
2022 - NCT05165238 -
IncabotulinumtoxinA
Multiple Sclerosis Center of Northeastern New York
2013 Phase 4 NCT01968902 United States;
Incobotulinum toxin A
Pôle Saint Hélier
2014 - NCT04265092 -
Inebilizumab
MedImmune LLC
2018 Phase 2;Phase 3 EUCTR2014-000253-36-NL Australia;Bulgaria;Canada;China;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;India;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
2017 Phase 2;Phase 3 EUCTR2014-000253-36-HU Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
2015 Phase 2;Phase 3 EUCTR2014-000253-36-DE Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
2015 Phase 2;Phase 3 EUCTR2014-000253-36-BG Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
2015 Phase 2/Phase 3 NCT02200770 Australia;Bulgaria;Canada;China;Colombia;Czech Republic;Czechia;Estonia;Germany;Greece;Hong Kong;Hungary;India;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
2014 Phase 2;Phase 3 EUCTR2014-000253-36-PL Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
2014 Phase 2;Phase 3 EUCTR2014-000253-36-EE Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
2014 Phase 2;Phase 3 EUCTR2014-000253-36-CZ Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
Sato Toshiyuki
2020 Phase 3 JPRN-jRCT2051210017 Japan;
Influenza Vaccine
Hoffmann-La Roche
2015 Phase 3 NCT02545868 Canada;United States;
Influenza vaccine
Sanofi
2011 Phase 2 NCT01403376 Austria;Canada;Germany;Russian Federation;Ukraine;
Inhaled Cannabis
University of California, Davis
2004 Phase 1/Phase 2 NCT00682929 United States;
Injectable MS DMT
Biogen
2015 Phase 4 NCT02471560 Norway;
Injection of autologous bone marrow derived mesenchymal stem cells
Hadassah Medical Organization
2006 Phase 1/Phase 2 NCT00781872 -
Injection of cell free media
Royan Institute
2011 Phase 1/Phase 2 NCT01377870 Iran, Islamic Republic of;
Inosine
National Center for Complementary and Integrative Health (NCCIH)
2002 Phase 2 NCT00067327 United States;
Tsukuba International Clinical Pharmacology Clinic
2016 - JPRN-UMIN000024312 Japan;
Insulin
Johns Hopkins University
2017 Phase 1/Phase 2 NCT02988401 United States;
Inteferone Beta-1A
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy;
Interferon Beta 1
University of Turin, Italy
1999 Phase 3 NCT00473213 -
Interferon Beta 1a pegilado
Biogen Idec Limited
2011 - EUCTR2010-024477-39-ES Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Interferon Beta Therapy
Biogen
2021 - NCT04655222 Germany;
Interferon Beta-1A Prefilled Syringe
Cinnagen
2017 Phase 3 NCT05242133 Iran, Islamic Republic of;
Interferon beta
Heidelberg University
2006 Phase 3 NCT00344253 Germany;
Interferon beta - 1a (IFN)
Novartis Pharmaceuticals
2012 Phase 4 NCT01534182 Russian Federation;
Interferon beta -1b
EMD Serono
2006 Phase 3 NCT00428584 United States;
Interferon beta 1-a
Biogen
2010 Phase 2 NCT01071083 Germany;Spain;United States;
Fred Lublin
2005 Phase 3 NCT00211887 Canada;United States;
Merck Healthcare KGaA
2020 Phase 3 EUCTR2018-004701-11-BG Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Montenegro;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-004700-19-BG Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;Italy;Kuwait;Lebanon;Lithuania;Mexico;Moldova, Republic of;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
Interferon beta 1-b (Betaferon/Betaseron, BAY86-5046)
Bayer
2011 - NCT01071694 Korea, Republic of;
Interferon beta 1B
Charite Universitaetsmedizin Berlin
2012 Phase 3 EUCTR2011-004787-30-DE Germany;
Interferon beta 1a
Biogen Idec Limited
2012 Phase 3 EUCTR2010-024477-39-GR Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2010-024477-39-GB Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2012 - EUCTR2010-024477-39-CZ Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-024477-39-DE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-024477-39-BG Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-024477-39-LV Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-024477-39-EE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-024477-39-BE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2010 - EUCTR2008-006333-27-CZ Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2008-006333-27-GB Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2009 - EUCTR2008-006333-27-NL Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2009 - EUCTR2008-006333-27-EE Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2009 - EUCTR2008-006333-27-BG Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2009 - EUCTR2008-006333-27-BE Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
- - EUCTR2008-006333-27-DE Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
Biogen Idec Ltd
2009 - EUCTR2008-003098-42-CZ Czech Republic;
Merck KGaA
2005 - NCT01142518 -
2005 - NCT01142453 -
MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute
2002 Phase 4 NCT00037115 United States;
2001 Phase 4 NCT00037102 United States;
Rennes University Hospital
2010 Phase 3 NCT02937285 France;
Revalesio Corporation
2013 Phase 2 NCT01714089 United States;
Trio Medicines Ltd.
2001 Phase 1 NCT01863069 United Kingdom;
UCL Biomedicine R&D Unit
2006 - EUCTR2005-005751-18-GB United Kingdom;
Interferon beta 1a 30 ug IM once weekly
Beth Israel Deaconess Medical Center
2001 Phase 4 NCT00179478 Canada;United States;
Interferon beta 1a, oral doxycycline
Louisiana State University Health Sciences Center Shreveport
2003 Phase 4 NCT00246324 United States;
Interferon beta 1b
Novartis Pharmaceuticals
2011 Phase 4 NCT01333501 Germany;Italy;
Schering AG
2007 Phase 3 EUCTR2006-005270-47-ES Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
UCL Biomedicine R&D Unit
2006 - EUCTR2005-005751-18-GB United Kingdom;
University Hospital Inselspital, Berne
2005 Phase 2 NCT00942591 Switzerland;
Interferon beta 1b (Betaseron, BAY86-5046)
Bayer
2003 Phase 2 NCT00235989 United States;
Interferon beta treatment to add-on atorvastatin treatment
Charite University, Berlin, Germany
2003 Phase 2 NCT00616187 -
Interferon beta type 1a
Biogen
2019 Phase 3 NCT03958877 Argentina;Australia;Belgium;Bulgaria;Croatia;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
Interferon beta-1 a
Serono GmbH
2005 - EUCTR2005-001026-89-DE Germany;
Interferon beta-1a
BIOGEN IDEC LTD
2010 - EUCTR2009-015556-15-IT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-012500-11-IT Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Slovenia;Spain;Sweden;United Kingdom;
BIOGEN-DOMPE` SRL
2010 - EUCTR2009-017003-28-IT Italy;
Biogen
2017 Phase 4 NCT03177083 Portugal;
2014 Phase 3 NCT02283853 Argentina;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Romania;Serbia;Spain;Sweden;Turkey;United Kingdom;United States;
2013 - NCT02076841 Czech Republic;Switzerland;
2012 - NCT01272128 Belgium;United States;
2010 Phase 3 NCT01064401 Argentina;Australia;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Egypt;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 3 NCT01058005 Australia;Canada;Czech Republic;Finland;France;Hungary;Italy;Latvia;Poland;Slovenia;Spain;Sweden;United States;
Biogen Idec
2007 Phase 4 NCT00574041 Australia;
2005 Phase 3 NCT00915577 -
2003 Phase 2 NCT00912860 -
2002 - NCT00599274 Australia;Austria;Canada;United States;
1999 Phase 4 NCT00534261 Belgium;Luxembourg;United Kingdom;
Biogen Idec GmbH
2005 - EUCTR2004-004130-14-AT Austria;
Biogen Idec Research Limited
2013 Phase 2 EUCTR2011-006262-40-NL Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
2013 Phase 2 EUCTR2011-006262-40-IT Canada;Czech Republic;Hungary;Italy;Netherlands;Russian Federation;Serbia;Spain;United Kingdom;United States;
2013 Phase 2 EUCTR2011-006262-40-HU Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
2013 Phase 2 EUCTR2011-006262-40-GB Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
2013 Phase 2 EUCTR2011-006262-40-CZ Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
Celgene
2014 Phase 3 NCT02294058 Argentina;Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2013 Phase 3 NCT02047734 Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Centre Hospitalier Universitaire Vaudois
2005 Phase 1 NCT02515695 -
Genzyme Corporation
2008 - EUCTR2007-001162-32-IT Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
Genzyme, a Sanofi Company
2007 Phase 3 NCT00548405 Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2007 Phase 3 NCT00530348 Argentina;Australia;Brazil;Canada;Croatia;Czech Republic;Former Serbia and Montenegro;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom;United States;
2002 Phase 2 NCT00050778 Croatia;Poland;Russian Federation;United Kingdom;United States;
Hoffmann-La Roche
2011 Phase 3 NCT01412333 Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;France;Germany;Ireland;Italy;Mexico;Morocco;Norway;Poland;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 NCT01247324 Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Czechia;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
ISTITUTO C. MONDINO
2007 - EUCTR2008-007162-32-IT Italy;
MERCK SERONO SA
2010 - EUCTR2009-016087-37-IT France;Ireland;Italy;Spain;United Kingdom;
2009 - EUCTR2008-004954-34-IT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Spain;
2009 - EUCTR2008-003706-33-IT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2008 - EUCTR2008-000499-25-IT Germany;Italy;Spain;Sweden;
MERCK SERONO SPA
2009 - EUCTR2009-013333-24-IT Italy;
MedImmune LLC
2012 - EUCTR2011-005475-16-GB Austria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
Merck KGaA
2005 Phase 4 NCT01201343 -
2005 - NCT01142492 -
Merck Serono International SA
2007 - EUCTR2006-005972-42-DE France;Germany;
NOVARTIS FARMA
2011 - EUCTR2010-024017-31-IT Italy;
2006 - EUCTR2006-000704-17-IT Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
Novartis Pharma AG
2021 Phase 3 EUCTR2020-004505-32-FR France;Germany;
2021 Phase 3 EUCTR2020-004505-32-DE France;Germany;Italy;Spain;
Novartis Pharma Services AG
2006 Phase 3 EUCTR2006-000704-17-GR Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
2006 - EUCTR2006-000704-17-PT Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
2006 - EUCTR2006-000704-17-GB Austria;Belgium;Germany;Greece;Hungary;Italy;Portugal;Spain;United Kingdom;
Novartis Pharmaceuticals
2013 Phase 3 NCT01892722 Australia;Austria;Belarus;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Italy;Latvia;Lithuania;Mexico;Netherlands;Poland;Puerto Rico;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
OSPEDALE S. RAFFAELE
2004 - EUCTR2004-001601-10-IT France;Italy;
Sahlgrenska University Hospital
2005 - EUCTR2005-001008-37-SE Sweden;
Sanofi
2009 Phase 3 NCT00883337 Belgium;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Poland;Spain;Switzerland;Tunisia;United Kingdom;
Serono International SA
2004 - EUCTR2004-000337-12-HU Hungary;
TEVA ITALIA srl
2008 - EUCTR2007-005450-23-IT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
Teva Pharmaceutical Industries Ltd
2008 - EUCTR2007-005450-23-EE Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
Universita di Firenze
2006 - EUCTR2006-004937-13-IT Italy;
Universitätsklinikum Heidelberg
2006 Phase 3 EUCTR2004-004403-37-DE Germany;
VU University Medical Center
2011 - EUCTR2011-003570-89-NL Netherlands;
Interferon beta-1a (Avonex)
Biogen Idec
2002 Phase 4 NCT00913666 -
1999 Phase 4 NCT00915460 -
Interferon beta-1a (Rebif)
Merck KGaA
2010 - NCT01101776 Australia;
2005 Phase 4 NCT01142466 -
2004 - NCT01142557 Germany;
Interferon beta-1a (Rebif®) alone
Merck KGaA
2011 Phase 2 NCT01285401 Austria;Belgium;Denmark;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
Interferon beta-1a (current approved manufacturing process invloving FBS)
Biogen Idec
2012 Phase 1 NCT01500408 United States;
Interferon beta-1a (new process, manufactured without FBS)
Biogen Idec
2012 Phase 1 NCT01500408 United States;
Interferon beta-1a 30 µg
Novartis
2006 Phase 3 NCT00340834 Argentina;Australia;Austria;Belgium;Brazil;Canada;Egypt;France;Germany;Greece;Hungary;Italy;Korea, Republic of;Portugal;Puerto Rico;Spain;Switzerland;United Kingdom;United States;
Interferon beta-1a FBS-free/HSA free, RNF
Serono International, S.A.
2007 - EUCTR2006-003366-33-ES Italy;Spain;
Interferon beta-1a FBS-free/HSA-free
Merck Serono International
2010 - EUCTR2008-003706-33-GR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2009 Phase 3 EUCTR2008-003706-33-FR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-003706-33-ES Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
Merck Serono S.A. - Geneva
2009 Phase 3 EUCTR2008-003706-33-GB Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2009 Phase 3 EUCTR2008-003706-33-BE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2009 - EUCTR2008-003706-33-SE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2009 - EUCTR2008-003706-33-NO Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-003706-33-DE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2009 - EUCTR2008-003706-33-CZ Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2009 - EUCTR2008-003706-33-BG Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2009 - EUCTR2008-003706-33-AT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2008 - EUCTR2008-003706-33-FI Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2008 - EUCTR2008-003706-33-EE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
Merck Serono SA - Geneva
2009 - EUCTR2008-003706-33-PT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
Interferon beta-1a FBS-free/HSA-free, RNF
MERCK SERONO INTERNATIONAL SA
2007 - EUCTR2006-003037-32-IT Estonia;Germany;Italy;Lithuania;Spain;
Merck Serono International SA
2007 Phase 3 EUCTR2006-003037-32-ES Estonia;Germany;Italy;Lithuania;Spain;
2007 - EUCTR2006-003037-32-LT Estonia;Germany;Italy;Lithuania;Spain;
2007 - EUCTR2006-003037-32-EE Estonia;Germany;Italy;Lithuania;Spain;
Merck Serono SA
2007 - EUCTR2006-003037-32-DE Estonia;Germany;Italy;Lithuania;Spain;
Serono International SA
2006 - EUCTR2006-002982-38-IT Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain;
Interferon beta-1a HSA+ biosimilar
Centre Hospitalier Universitaire Vaudois
2006 Phase 1 NCT02517788 -
Interferon beta-1a HSA-free biosimilar
Centre Hospitalier Universitaire Vaudois
2006 Phase 1 NCT02517788 -
Interferon beta-1a original
Centre Hospitalier Universitaire Vaudois
2006 Phase 1 NCT02517788 -
Interferon beta-1a, 30 µg/0.5 ml
Biogen Idec Research Limited
2019 Phase 3 EUCTR2018-003008-38-BG Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
Interferon beta-1b
AZIENDA OSPEDALIERA S. LUIGI GONZAGA
2011 - EUCTR2010-023677-19-IT Italy;
Bayer AB, Bayer Health Care, Bayer Schering Pharma
2007 - EUCTR2006-005270-47-SE Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Bayer Schering Pharma
2007 - EUCTR2006-005270-47-SI Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-HU Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
- - EUCTR2006-005270-47-DE Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Bayer Schering Pharma AG
2007 - EUCTR2006-005270-47-LV Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-GR Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-BE Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Biogen
2017 Phase 4 NCT03177083 Portugal;
Claudio Gobbi
2012 Phase 4 NCT01701856 Switzerland;
2010 Phase 4 NCT01144052 Switzerland;
NOVARTIS FARMA
2011 - EUCTR2010-024017-31-IT Italy;
2010 - EUCTR2010-023023-19-IT Germany;Italy;
S. Andrea Hospital
2005 Phase 2/Phase 3 NCT00270816 Italy;
SCHERING
2007 - EUCTR2006-005270-47-IT Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Schering AG
2007 Phase 3 EUCTR2006-005270-47-FR Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 Phase 3 EUCTR2006-005270-47-FI Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-NL Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-AT Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Universita di Firenze
2006 - EUCTR2006-004937-13-IT Italy;
Interferon beta-1b (Betaferon, BAY 86-5046)
Bayer
2014 - NCT02121444 Germany;
2012 - NCT01766063 Germany;
Interferon beta-1b (Betaferon, BAY86-5046)
Bayer
2017 - NCT03134573 Germany;
2015 - NCT02486640 Germany;
2010 - NCT01354665 Poland;
Interferon beta-1b (Betaferon/Betaseron, BAY86-5046)
Bayer
2005 Phase 3 NCT00313976 Denmark;Sweden;
2003 Phase 3 NCT00099502 Argentina;Australia;Austria;Belgium;Brazil;Canada;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;Norway;Poland;Russian Federation;Slovenia;Spain;Sweden;Switzerland;Ukraine;United States;
Interferon beta-1b (Betaferon®, BAY 86-5046)
Bayer
2014 - NCT02247310 Austria;Belgium;Bosnia and Herzegovina;Croatia;Czech Republic;Czechia;France;Greece;Hungary;Italy;Netherlands;Spain;Switzerland;
Interferon beta-1b (Betaseron, BAY86-5046)
Bayer
2016 - NCT02652091 United States;
2012 - NCT01706055 Poland;
2012 - NCT01491100 Albania;Algeria;Argentina;Belgium;Bosnia and Herzegovina;Czech Republic;Czechia;Egypt;France;Germany;Greece;Hungary;Israel;Jordan;Kazakhstan;Lebanon;Mexico;Netherlands;Poland;Portugal;Saudi Arabia;Syrian Arab Republic;Tunisia;Turkey;
2012 - NCT01436838 China;
2010 - NCT01076595 France;
2009 - NCT03408093 -
2009 - NCT00963833 Austria;Belgium;Finland;Germany;Israel;Italy;Portugal;United Kingdom;
2009 - NCT00902135 Germany;
2008 - NCT01414816 Korea, Republic of;
2008 - NCT01184833 Poland;
2008 - NCT00787657 Argentina;Bahrain;Belgium;Bosnia and Herzegovina;Canada;China;Colombia;Czech Republic;Egypt;Estonia;France;Germany;Iran, Islamic Republic of;Israel;Italy;Jordan;Korea, Republic of;Kuwait;Lebanon;Libyan Arab Jamahiriya;Mexico;Netherlands;New Zealand;Norway;Pakistan;Portugal;Saudi Arabia;Singapore;Slovakia;Slovenia;Sweden;Syrian Arab Republic;Taiwan;United Arab Emirates;United Kingdom;Venezuela;
2007 Phase 3 NCT00459667 Argentina;Australia;Austria;Belgium;Brazil;Canada;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Netherlands;Norway;Poland;Russian Federation;Slovenia;Spain;Sweden;Switzerland;Ukraine;United States;
2007 - NCT01235455 Portugal;
2007 - NCT00544037 Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2006 Phase 3 NCT00370071 China;
2006 - NCT00882453 Australia;Austria;Bahrain;Belgium;Canada;Colombia;Czech Republic;Denmark;Egypt;France;Germany;Greece;Indonesia;Israel;Italy;Jordan;Kazakhstan;Korea, Republic of;Kuwait;Lebanon;Mexico;Netherlands;Norway;Oman;Portugal;Slovenia;Spain;Sweden;Switzerland;Taiwan;Thailand;United Arab Emirates;United Kingdom;
2005 - NCT00206635 Canada;United Kingdom;United States;
2004 - NCT01233245 Czech Republic;France;Germany;Iran, Islamic Republic of;Israel;Italy;Jordan;Korea, Republic of;Lebanon;Netherlands;Portugal;Saudi Arabia;Spain;Taiwan;Turkey;
2002 Phase 3 NCT00185211 Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
Interferon beta-1b (Betaseron, Betaferon, BAY86-5046)
Bayer
2008 - NCT03577977 Russian Federation;
Interferon beta-1b (PF530, Betaferon)
Pfenex, Inc
2015 Phase 1 NCT02474134 Australia;
Interferon beta-1b and Tacrolimus
Clinique de sclérose en plaques et neuromusculaire de l'Outaouais
2003 Phase 2 NCT00298662 Canada;
Interferon beta-1b group
University Hospital Inselspital, Berne
2007 Phase 2 NCT01111656 Switzerland;
Interferon beta-1b, (Betaseron BAY86-5046)
Bayer
2007 - NCT00928967 France;
Interferon beta-1b, FRP about 6 weeks after randomization
Bayer
2008 Phase 4 NCT00780455 France;
Interferon beta-1b, FRP within 15 days after randomization
Bayer
2008 Phase 4 NCT00780455 France;
Interferon beta-1b/Atorvastatin group
University Hospital Inselspital, Berne
2007 Phase 2 NCT01111656 Switzerland;
Interferon or glatiramer acetate
Novartis Pharmaceuticals
2021 Phase 4 NCT04878211 United States;
Interferon ß-1a
Biogen
2014 Phase 3 NCT02283853 Argentina;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Israel;Italy;Kuwait;Poland;Romania;Serbia;Spain;Sweden;Turkey;United Kingdom;United States;
Celgene
2013 Phase 3 NCT02047734 Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Novartis Pharma AG
2021 Phase 3 EUCTR2020-004505-32-FR France;Germany;
2021 Phase 3 EUCTR2020-004505-32-DE France;Germany;Italy;Spain;
Sanofi
2009 Phase 3 NCT00883337 Belgium;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Poland;Spain;Switzerland;Tunisia;United Kingdom;
Interferon ß-1a 30 µg
Novartis
2006 Phase 3 NCT00340834 Argentina;Australia;Austria;Belgium;Brazil;Canada;Egypt;France;Germany;Greece;Hungary;Italy;Korea, Republic of;Portugal;Puerto Rico;Spain;Switzerland;United Kingdom;United States;
Interferon ß-1b
Novartis Pharma AG
2021 Phase 3 EUCTR2020-004505-32-FR France;Germany;
2021 Phase 3 EUCTR2020-004505-32-DE France;Germany;Italy;Spain;
S. Andrea Hospital
2005 Phase 2/Phase 3 NCT00270816 Italy;
Interferon-1beta (Betaseron, BAY86-5046)
Bayer
2007 - NCT00873340 Colombia;
2007 - NCT00461396 United States;
Interferon-beta
Fundació Institut Germans Trias i Pujol
2017 Phase 1 NCT02903537 Spain;
Sanofi
2007 Phase 2 NCT00489489 Canada;Germany;Italy;Poland;Spain;United States;
Interferon-beta (IFN-beta)
EMD Serono Research & Development Institute, Inc.
2006 Phase 2 NCT00436826 Italy;Russian Federation;Spain;United States;
Sanofi
2011 Phase 3 NCT01252355 Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
Interferon-beta 1a
Medizinische Universität Innsbruck
2014 Phase 4 EUCTR2012-005450-30-AT Austria;Sweden;
Merck Serono International SA
2007 Phase 3 EUCTR2006-003037-32-ES Estonia;Germany;Italy;Lithuania;Spain;
2007 - EUCTR2006-003037-32-LT Estonia;Germany;Italy;Lithuania;Spain;
2007 - EUCTR2006-003037-32-EE Estonia;Germany;Italy;Lithuania;Spain;
Merck Serono International, a branch of Laboratoires Serono SA an affiliate of Merck KGaA, Darmstadt
2009 - EUCTR2008-004954-34-GR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Spain;
Merck Serono S.A. - Geneva, an affiliate of Merck KGaA, Darmstadt, Germany
2010 - EUCTR2008-004954-34-AT Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;
2009 Phase 3 EUCTR2008-004954-34-SK Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;
2009 Phase 3 EUCTR2008-004954-34-PT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Spain;
2009 Phase 3 EUCTR2008-004954-34-BE Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;
2009 - EUCTR2008-004954-34-PL Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;
2009 - EUCTR2008-004954-34-LV Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Spain;
2009 - EUCTR2008-004954-34-FI Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;
2009 - EUCTR2008-004954-34-EE Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;
2009 - EUCTR2008-004954-34-DE Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;
2009 - EUCTR2008-004954-34-BG Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;
2008 - EUCTR2008-004954-34-CZ Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;
Merck Serono S.A.- Geneva, an affiliate of Merck KGaA, Darmstadt, Germany
2009 Phase 3 EUCTR2008-004954-34-FR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Slovakia;Spain;
Merck Serono SA
2007 - EUCTR2006-003037-32-DE Estonia;Germany;Italy;Lithuania;Spain;
Nancy Hammond, MD
2007 - NCT00490906 United States;
S. Andrea Hospital
2002 Phase 2 NCT00151801 Italy;
Interferon-beta 1a FBS-free/HSA free, RNF
Merck Serono International S.A.
2007 - EUCTR2006-002982-38-LT Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain;
2007 - EUCTR2006-002982-38-GR Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain;
2006 - EUCTR2006-002982-38-DK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain;
2006 - EUCTR2006-002982-38-AT Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain;
Merck Serono International, a branch of Laboratoires Serono SA An affiliate of Merck KGaA
2007 Phase 3 EUCTR2006-002982-38-SK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Slovakia;Spain;
2007 - EUCTR2006-002982-38-EE Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain;
Merck Serono S.A. - Geneva, an affiliate of Merck KGaA Darmstadt, Germany
2007 - EUCTR2006-002982-38-PT Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain;
2007 - EUCTR2006-002982-38-DE Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain;
2006 - EUCTR2006-002982-38-FI Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain;
2006 - EUCTR2006-002982-38-CZ Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain;
Merck Serono S.A.-Geneva, an affiliate of Merck KGaA Darmstadt, Germany
2006 Phase 3 EUCTR2006-002982-38-BE Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Slovakia;Spain;
Serono International SA
2007 Phase 3 EUCTR2006-002982-38-FR Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Slovakia;Spain;
Interferon-beta 1a FBS-free/HSA-free, RNF
Merck Serono International SA
2007 Phase 3 EUCTR2006-005972-42-FR France;Germany;
2007 - EUCTR2006-005972-42-DE France;Germany;
Interferon-beta 1b
Medizinische Universität Innsbruck
2014 Phase 4 EUCTR2012-005450-30-AT Austria;Sweden;
Nancy Hammond, MD
2007 - NCT00490906 United States;
Interferon-beta 1b (Betaseron)
Rutgers, The State University of New Jersey
2007 - NCT00468182 United States;
Interferon-beta [IFN-beta]
Sanofi
2007 Phase 2 NCT00811395 Austria;Canada;Germany;Italy;Spain;United Kingdom;United States;
Interferon-beta and human leukocyte Interferon-a
Melinda Magyari
2010 Phase 2 NCT01171209 Denmark;
Interferon-beta-1
Sanofi
2011 Phase 2 NCT01403376 Austria;Canada;Germany;Russian Federation;Ukraine;
Interferon-beta-1a
Biogen Idec
2006 Phase 4 NCT00492765 Denmark;
2003 Phase 4 NCT00493116 Australia;New Zealand;
2003 Phase 4 NCT00492466 Finland;
Merck KGaA
2014 - EUCTR2013-003126-83-BG Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-BG Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2008 - NCT01074346 Korea, Republic of;
Merck, S.L.
2006 - EUCTR2006-000606-23-ES Spain;
Interferon-beta-1a (Avonex) plus methylprednisolone
Biogen Idec
2003 Phase 4 NCT00168766 Belgium;Denmark;Finland;Netherlands;Norway;Sweden;Switzerland;United Kingdom;
Interferon-beta-1a FBS-free/HSA free, RNF
Serono International SA
2005 Phase 3 EUCTR2004-003799-13-GB Denmark;Ireland;Lithuania;Spain;Sweden;United Kingdom;
2005 Phase 3 EUCTR2004-003799-13-ES Denmark;Ireland;Lithuania;Spain;Sweden;United Kingdom;
2005 Phase 3 EUCTR2004-003799-13-DK Denmark;Ireland;Lithuania;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-003799-13-SE Ireland;Lithuania;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-003799-13-LT Ireland;Lithuania;Spain;Sweden;United Kingdom;
- Phase 3 EUCTR2004-003799-13-IE Denmark;Ireland;Lithuania;Spain;Sweden;United Kingdom;
Interferon-beta-1a FBS-free/HSA-free
EMD Serono
2005 Phase 3 NCT00110396 United States;
Interferon-beta-1b
S. Andrea Hospital
2005 Phase 2/Phase 3 NCT00270816 Italy;
Interferon-beta-1b (BETASERON, BAY 86-5046)
Bayer
2020 - NCT04356339 United States;
Interferon-beta1
Biogen
2021 Phase 2 NCT04079088 -
Interferon-ß
Sanofi
2007 Phase 2 NCT00489489 Canada;Germany;Italy;Poland;Spain;United States;
Interferon-ß [IFN-ß]
Sanofi
2007 Phase 2 NCT00811395 Austria;Canada;Germany;Italy;Spain;United Kingdom;United States;
Interferon-ß-1
Sanofi
2011 Phase 2 NCT01403376 Austria;Canada;Germany;Russian Federation;Ukraine;
Interferon-ß-1a
Merck KGaA
2014 - EUCTR2013-003126-83-BG Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-BG Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2008 - NCT01074346 Korea, Republic of;
Interferon-ß-1b
S. Andrea Hospital
2005 Phase 2/Phase 3 NCT00270816 Italy;
Interferone
sanofi-aventis recherche et development
2009 - EUCTR2008-006226-34-IT Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom;
Interferone Beta-1B
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy;
Interferone beta 1a
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain;
Interferone beta-1a
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain;
Interferone beta-1b
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain;
Interferón Beta-1a pegilado
Biogen Idec Limited
2009 Phase 3 EUCTR2008-006333-27-ES Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Latvia;Netherlands;Spain;United Kingdom;
Interferón beta 1a pegilado
Biogen Idec Limited
2011 - EUCTR2010-024477-39-ES Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Intradetrusor injection of Botulinum Toxin-A
Rose Khavari, M.D.
2014 - NCT03033355 United States;
Intranasal Foralumab Solution
Tiziana Life Sciences, PLC
2021 Phase 1 NCT05029609 -
Intratect
Guy's and St Thomas NHS Foundation Trust
2014 Phase 3 EUCTR2014-002335-34-GB United Kingdom;
Intrathecal MSC-NP injection
Tisch Multiple Sclerosis Research Center of New York
2018 Phase 2 NCT03355365 United States;
2011 - NCT03822858 United States;
Intrathecal administration of autologous MSC-NP
Tisch Multiple Sclerosis Research Center of New York
2014 Phase 1 NCT01933802 United States;
Intrathecal methotrexate
Tel-Aviv Sourasky Medical Center
2016 Phase 0 NCT02644044 -
Intravenous (IV) infusions
Polpharma Biologics S.A.
2019 Phase 3 NCT04115488 Belarus;Croatia;Georgia;Moldova, Republic of;Poland;Serbia;Ukraine;
Intravenous Immunoglobulin
Guy's and St Thomas' NHS Foundation Trust
2015 Phase 3 NCT02398994 United Kingdom;
Intravenous Methylprednisolone
Guy's and St Thomas' NHS Foundation Trust
2015 Phase 3 NCT02398994 United Kingdom;
Intravenous injection of mesenchymal stem cells
Royan Institute
2011 Phase 1/Phase 2 NCT01377870 Iran, Islamic Republic of;
Intravenous steroid
Beijing Tiantan Hospital
2019 - NCT04106830 China;
Irradiation
Fred Hutchinson Cancer Research Center
1997 Phase 1 NCT00014755 United States;
Isoxsuprine Hydrochloride
University of New Mexico
2019 Phase 1/Phase 2 NCT03752307 United States;
Ixazomib (NINLARO®) capsules
Queen Mary University of London
2019 Phase 1 NCT03783416 United Kingdom;
JM-4
Cook, Stuart, MD
2019 Early Phase 1 NCT03887065 -
KEPPRA
AZIENDA SANITARIA N. 3 GENOVESE
2007 - EUCTR2007-005414-40-IT Italy;
KLH
Hoffmann-La Roche
2015 Phase 3 NCT02545868 Canada;United States;
Kemstro
UCB Pharma
2005 Phase 3 NCT00139789 United States;
Kepivance
Cambridge University Hospitals NHS Foundation Trust and University of Cambridge
2012 Phase 2 EUCTR2011-005606-30-GB United Kingdom;
Keppra
Søren H. Sindrup, Department of Neurology, Odense University Hospital
2006 - EUCTR2006-000397-71-DK Denmark;
Keppra ®
Newcastle-upon-Tyne Hospitals NHS Trust
2006 Phase 4 EUCTR2005-003903-35-GB United Kingdom;
Kesimpta
Novartis Farmacéutica S.A.
2021 Phase 3 EUCTR2020-002700-39-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Novartis Pharma AG
2021 Phase 3 EUCTR2020-004505-32-FR France;Germany;
2021 Phase 3 EUCTR2020-004505-32-DE France;Germany;Italy;Spain;
2021 Phase 3 EUCTR2020-002700-39-SK Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-LV Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-LT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-HR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-001341-40-SI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States;
2021 Phase 3 EUCTR2019-001341-40-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001341-40-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001341-40-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001341-40-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001341-40-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001341-40-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-FI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-DK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2018 Phase 3 EUCTR2017-004703-51-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2018 Phase 3 EUCTR2017-004703-51-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
- Phase 3 EUCTR2020-002700-39-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2020-002700-39-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Novartis Pharmaceuticals
2021 - NCT04940065 Japan;
Kesimpta 20 mg Injektionslösung im Fertigpen
Novartis Pharma Vertriebs GmbH
2021 Phase 4 EUCTR2021-000307-20-DE Germany;
Kesimpta 20 mg solution for injection in pre-filled pen
Novartis Pharma AG
2021 Phase 3 EUCTR2020-002700-39-PT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Ketamine
Johns Hopkins University
2018 Phase 1/Phase 2 NCT03500289 United States;
Ketoconazole
GlaxoSmithKline
2013 Phase 1 NCT01802931 Australia;
Keyhole limpet hemocyanin (KLH)
Biogen
2008 Phase 4 NCT00536120 United States;
Keyhole limpet hemocyanin (KLH) neo-antigen
Novartis Pharmaceuticals
2018 Phase 3 NCT03650114 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
Kirunal Fish Oil
Terry L. Wahls
2022 - NCT05007483 United States;
L acetyl carnitine
University of Iowa
2010 Phase 1 NCT01381354 United States;
L-000124467
Merck & Co., Inc./Suomen MSD Oy
2004 Phase 2 EUCTR2004-000073-64-FI Finland;
L-Carnitine
University Hospital, Bordeaux
2010 Phase 3 NCT01149525 France;
L-Histidine
University of Miami
2022 Phase 2 NCT04764383 United States;
2018 Phase 1 NCT03266965 United States;
L01BB04
Merck Serono S.A. - Geneva
2009 Phase 3 EUCTR2008-003706-33-BE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
L03 AB
sanofi-aventis recherche et development
2009 - EUCTR2008-006226-34-BE Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom;
L03 AB 08
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France;
L03 AB07
Merck Serono SA – Geneva
2010 - EUCTR2009-015502-19-GB Belgium;Finland;Germany;Sweden;United Kingdom;
L03AB13
BIOGEN IDEC ITALIA S.R.L.
2015 Phase 4 EUCTR2015-002201-11-IT Italy;
L04AA04 - IMMUNOGLOBULINA ANTITIMOCITARIA (DI CONIGLIO) IMMUNOGLOBULINA DI CONIGLIO ANTITIMOCITI UMANI THYMOGLOBULINE
Dipartimento di Neuroscienze Oftalmologia e Genetica DINOG - Universita di Genova
2006 - EUCTR2006-002562-19-IT Italy;
L04AA31
Turku University Hospital
2017 Phase 4 EUCTR2016-003622-16-FI Finland;
LEMTRADA 12 mg Konzentrat zur Herstellung einer Infusionslösung
Universitätsklinikum Münster
2014 Phase 4 EUCTR2014-000709-10-DE Germany;
LEVOFOLENE 4 MG 30 CPR
AZIENDA OSPEDALIERA SAN CAMILLO FORLANINI
2005 - EUCTR2005-006071-12-IT Italy;
LFB-R603
TG Therapeutics
2017 Phase 3 EUCTR2017-000639-15-HR Belarus;Croatia;Georgia;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000639-15-GB Belarus;Croatia;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000639-15-ES Belarus;Croatia;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000638-75-GB Belarus;Georgia;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000638-75-ES Belarus;Georgia;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
TG Therapeutics, Inc.
2017 Phase 3 EUCTR2017-000639-15-PL Belarus;Croatia;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000638-75-PL Belarus;Georgia;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
LFB-R603, TGTX1101
TG Therapeutics, Inc.
2020 Phase 3 EUCTR2019-003625-16-HR Belarus;Croatia;Georgia;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
LOU064
Novartis Farmacéutica S.A.
2022 Phase 3 EUCTR2020-005929-89-ES Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States;
2022 Phase 3 EUCTR2020-005899-36-ES Slovakia;Spain;
Novartis Pharma AG
2022 Phase 3 EUCTR2020-005929-89-SE Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States;
2022 Phase 3 EUCTR2020-005899-36-SK Argentina;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;France;Germany;Guatemala;Hong Kong;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;United Kingdom;United States;
LUTENYL
OSPEDALI CIVILI DI LIONE
2007 - EUCTR2006-005460-30-IT Italy;
LY2127399
Eli Lilly and Company
2010 - EUCTR2008-007459-28-BG Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;
2009 Phase 2 NCT00882999 Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovakia;Switzerland;Ukraine;United States;
2009 Phase 2 EUCTR2008-007459-28-FR Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;
2009 - EUCTR2008-007459-28-HU Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;
2009 - EUCTR2008-007459-28-FI Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;
2009 - EUCTR2008-007459-28-DK Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;
2009 - EUCTR2008-007459-28-DE Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;
2009 - EUCTR2008-007459-28-CZ Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;
2009 - EUCTR2008-007459-28-BE Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Hungary;
LY248686
Eli Lilly and Company
2008 - EUCTR2008-002560-34-BE Belgium;
Lactose monohydrate
Queen Mary University of London
2013 - EUCTR2012-004847-61-GB United Kingdom;
Lactulose
Department of Neurology and Neurological Science, Tokyo Medical and Dental University
2021 - JPRN-UMIN000043910 Japan;
Lamotrigine
Cantonal Hospital of St. Gallen
2009 Phase 2 NCT00917839 Switzerland;
University College London Hospitals
2005 Phase 2 NCT00257855 United Kingdom;
Lamotrigine extended release tablets
University College London
2005 Phase 2 EUCTR2005-001949-42-GB United Kingdom;
Laquinimod
TEVA ITALIA srl
2008 - EUCTR2007-005450-23-IT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2007 - EUCTR2007-003226-19-IT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
Teva Branded Pharmaceutical Products R&D, Inc.
2015 Phase 2 NCT02284568 Canada;Germany;Italy;Netherlands;Poland;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2014 Phase 3 NCT01975298 Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
2013 Phase 3 NCT01707992 Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Estonia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Macedonia, The Former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;North Macedonia;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2010 Phase 3 NCT01047319 Bulgaria;Croatia;Czech Republic;Czechia;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, The Former Yugoslav Republic of;North Macedonia;Poland;Puerto Rico;Romania;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States;
2009 Phase 3 NCT00988052 Austria;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2008 Phase 3 NCT00605215 Bulgaria;Croatia;Czech Republic;Czechia;Estonia;Georgia;Germany;Israel;Italy;Latvia;Lithuania;Macedonia, The Former Yugoslav Republic of;Montenegro;North Macedonia;Poland;Puerto Rico;Romania;Russian Federation;Slovakia;South Africa;Spain;Turkey;Ukraine;United States;
Teva Pharmaceutical Industries
2007 Phase 3 NCT00509145 Austria;Bulgaria;Canada;Czech Republic;Estonia;Former Serbia and Montenegro;France;Georgia;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Teva Pharmaceutical Industries Ltd
2010 Phase 3 EUCTR2009-015815-42-IT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Poland;Slovakia;Spain;
2009 Phase 3 EUCTR2009-012989-30-IT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
Teva Pharmaceutical Industries, Ltd.
2005 Phase 2 NCT00745615 Czech Republic;Czechia;Germany;Hungary;Israel;Italy;Poland;Russian Federation;Spain;United Kingdom;
Laquinimod 0.3
Teva Pharmaceutical Industries
2005 Phase 2 NCT00349193 Italy;
Laquinimod 0.6
Teva Pharmaceutical Industries
2012 Phase 2 NCT01404117 -
2005 Phase 2 NCT00349193 Italy;
Laquinimod 1.2
Teva Pharmaceutical Industries
2012 Phase 2 NCT01404117 -
Laquinimod Capsulas
Teva Pharmaceutical Industries Ltd
2009 Phase 3 EUCTR2009-012989-30-ES Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
Laquinimod Capsules
Teva Pharmaceutical Industries Ltd
2010 Phase 3 EUCTR2009-015815-42-SK Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Poland;Slovakia;Spain;
2010 Phase 3 EUCTR2009-015815-42-PL Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States;
2010 Phase 3 EUCTR2009-015815-42-LT Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States;
2010 Phase 3 EUCTR2009-015815-42-EE Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States;
2010 Phase 3 EUCTR2009-015815-42-CZ Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States;
2010 Phase 3 EUCTR2009-015815-42-BG Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States;
2010 Phase 3 EUCTR2009-012989-30-SE Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-012989-30-FR Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2010 Phase 3 EUCTR2009-012989-30-BG Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-012989-30-AT Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-012989-30-NL Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-012989-30-LT Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-012989-30-HU Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-012989-30-GB Austria;Bulgaria;Canada;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-012989-30-EE Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-012989-30-CZ Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 - EUCTR2009-011234-99-DE Germany;
2008 Phase 3 EUCTR2007-005450-23-SK Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Slovakia;Spain;
2008 - EUCTR2007-005450-23-LT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2008 - EUCTR2007-005450-23-EE Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2008 - EUCTR2007-005450-23-DE Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2008 - EUCTR2007-005450-23-CZ Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2008 - EUCTR2007-005450-23-BG Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2008 - EUCTR2007-003226-19-PT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-003226-19-LT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-003226-19-BG Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 Phase 3 EUCTR2007-003226-19-FR Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 Phase 3 EUCTR2007-003226-19-ES Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-SE Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-NL Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-LV Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-HU Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-GB Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-EE Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-DE Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-CZ Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-AT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2006 Phase 2 EUCTR2005-004334-41-GB Czech Republic;Germany;Hungary;Israel;Italy;Poland;Russian Federation;Spain;United Kingdom;
2006 Phase 2 EUCTR2005-004334-41-DE Czech Republic;Germany;Hungary;Israel;Italy;Russian Federation;Spain;United Kingdom;
2006 Phase 2 EUCTR2005-004334-41-CZ Czech Republic;Germany;Hungary;Israel;Italy;Russian Federation;Spain;United Kingdom;
2005 Phase 2 EUCTR2005-004334-41-HU Czech Republic;Germany;Hungary;Israel;Italy;Russian Federation;Spain;United Kingdom;
Laquinimod Sodium (USAN)
TEVA PHARMACEUTICALS INDUSTRIES LTD
2013 Phase 3 EUCTR2012-003647-30-IT Albania;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Poland;Puerto Rico;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Teva Pharmaceutical Industries Ltd
2013 Phase 3 EUCTR2012-003647-30-PL Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003647-30-HU Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003647-30-ES Albania;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003647-30-EE Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003647-30-CZ Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003647-30-BE Albania;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003647-30-AT Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003647-30-SK Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003647-30-LV Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003647-30-GR Albania;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003647-30-GB Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2008 Phase 3 EUCTR2007-005450-23-SK Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Slovakia;Spain;
2008 - EUCTR2007-005450-23-LT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2008 - EUCTR2007-005450-23-ES Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2008 - EUCTR2007-005450-23-EE Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2008 - EUCTR2007-005450-23-DE Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2008 - EUCTR2007-005450-23-CZ Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2008 - EUCTR2007-005450-23-BG Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
Teva Pharmaceutical Industries Ltd.
2015 Phase 2 EUCTR2014-001579-30-DE Canada;Germany;Italy;Netherlands;Poland;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2015 - EUCTR2014-001579-30-NL Canada;Germany;Italy;Netherlands;Poland;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2014 Phase 2 EUCTR2014-001579-30-IT Canada;Germany;Italy;Netherlands;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2014 Phase 2 EUCTR2014-001579-30-GB Canada;Germany;Italy;Netherlands;Poland;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2014 Phase 2 EUCTR2014-001579-30-ES Canada;Germany;Italy;Netherlands;Poland;Russian Federation;Spain;Ukraine;United Kingdom;United States;
Teva Pharmaceutical Industries, Ltd.
2014 - EUCTR2013-002082-19-NL Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
2014 - EUCTR2013-002082-19-ES Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
2013 Phase 3 EUCTR2013-002082-19-GB Belgium;Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
2013 Phase 3 EUCTR2013-002082-19-BE Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2013-002082-19-SE Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2013-002082-19-FI Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2013-002082-19-DK Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
Laquinimod Tablets
Teva Pharmaceutical Industries Ltd
2006 Phase 2 EUCTR2005-004334-41-ES Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
2005 Phase 2 EUCTR2004-003943-28-GB Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
2005 Phase 2 EUCTR2004-003943-28-ES Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
2005 - EUCTR2004-003943-28-HU Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
2005 - EUCTR2004-003943-28-DE Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
2005 - EUCTR2004-003943-28-CZ Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
Laquinimod capsules
TEVA PHARMACEUTICALS INDUSTRIES LTD
2013 Phase 3 EUCTR2012-003647-30-IT Albania;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Poland;Puerto Rico;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Teva Pharmaceutical Industries Ltd
2013 Phase 3 EUCTR2012-003647-30-PL Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003647-30-HU Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003647-30-ES Albania;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003647-30-EE Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003647-30-CZ Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003647-30-BE Albania;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003647-30-AT Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003647-30-SK Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003647-30-LV Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003647-30-GR Albania;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003647-30-GB Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
Teva Pharmaceutical Industries, Ltd.
2014 - EUCTR2013-002082-19-NL Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
2014 - EUCTR2013-002082-19-ES Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
2013 Phase 3 EUCTR2013-002082-19-GB Belgium;Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
2013 Phase 3 EUCTR2013-002082-19-BE Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2013-002082-19-SE Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2013-002082-19-FI Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2013-002082-19-DK Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
Lemtrada
GENZYME CORPORATION
2017 Phase 3 EUCTR2016-003100-30-IT Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
Genzyme Corporation
2017 Phase 3 EUCTR2016-003100-30-PT Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-NO Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-NL Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-GR Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-GB Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-ES Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-DE Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-BE Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
2017 Phase 3 EUCTR2016-003100-30-AT Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
2015 Phase 3;Phase 4 EUCTR2013-003884-71-NL Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Czechia;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2015 Phase 3;Phase 4 EUCTR2013-003884-71-DK Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2015 - EUCTR2013-003884-71-BE Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;
2014 Phase 4 EUCTR2014-000092-62-NL Belgium;France;Netherlands;Spain;Switzerland;
2014 Phase 4 EUCTR2014-000092-62-FR Belgium;France;Netherlands;Spain;Switzerland;
2014 Phase 4 EUCTR2014-000092-62-ES Belgium;France;Netherlands;Spain;Switzerland;
2014 Phase 4 EUCTR2014-000092-62-BE Belgium;France;Netherlands;Spain;Switzerland;
2014 Phase 3;Phase 4 EUCTR2013-003884-71-IT Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;
2014 Phase 3;Phase 4 EUCTR2013-003884-71-HR Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2014 Phase 3;Phase 4 EUCTR2013-003884-71-DE Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2014 Phase 3;Phase 4 EUCTR2013-003884-71-CZ Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2014 - EUCTR2013-003884-71-ES Argentina;Australia;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;
- Phase 3 EUCTR2016-003100-30-PL Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
- Phase 3 EUCTR2016-003100-30-Outside-EU/EEA Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
- Phase 3 EUCTR2016-003100-30-FR Austria;Belgium;Bulgaria;Czech Republic;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;
- Phase 3 EUCTR2016-003100-30-BG Austria;Belgium;Bulgaria;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
Genzyme GmbH
2016 Phase 3 EUCTR2016-000464-42-DE Germany;
Helse Bergen HF, Haukeland University Hospital
2019 Phase 3 EUCTR2017-001362-25-NL Denmark;Netherlands;
2018 Phase 3 EUCTR2017-001362-25-DK Denmark;Netherlands;
Turku University Hospital
2013 Phase 4 EUCTR2013-004626-28-FI Finland;
University Medical Centre Hamburg-Eppendorf
2020 Phase 2 EUCTR2016-001166-29-DE Germany;
Lenograstim
Sheffield Teaching Hospitals
2020 Phase 3 EUCTR2019-001549-42-GB United Kingdom;
Levetiracetam
AZIENDA SANITARIA N. 3 GENOVESE
2007 - EUCTR2007-005414-40-IT Italy;
Newcastle-upon-Tyne Hospitals NHS Trust
2006 Phase 4 EUCTR2005-003903-35-GB United Kingdom;
Odense University Hospital
2007 Phase 4 NCT00423527 Denmark;
Organisation name was not entered
2005 - EUCTR2005-001776-13-DE Germany;
Søren H. Sindrup, Department of Neurology, Odense University Hospital
2006 - EUCTR2006-000397-71-DK Denmark;
Levitra
Unidad de Neuroinmunología
2005 Phase 4 EUCTR2004-003761-33-ES Spain;
Levocarnil
CHU de Bordeaux
2010 Phase 3 EUCTR2009-015934-30-FR France;
Lidocaine patch
University of Rochester
2007 Phase 4 NCT00414453 United States;
Linoleic Acid/Oleic Acid
University of Rochester
2008 Phase 1 NCT00638196 United States;
Liofen XL
Sun Pharma Advanced Research Company Ltd.
2016 Phase 3 EUCTR2016-001356-22-HU Germany;Hungary;Russian Federation;Ukraine;United States;
Liothyronine
Johns Hopkins University
2015 Phase 1 NCT02506751 United States;
Liothyronine sodium
Oregon Health and Science University
2016 Phase 1 NCT02760056 United States;
Lipoic acid
VA Office of Research and Development
2018 Phase 2 NCT03161028 Canada;United States;
2010 Phase 2/Phase 3 NCT01188811 United States;
Lipoic acid (LA) with fish oil and LA without fish oil
Oregon Health and Science University
2005 Phase 1 NCT00676156 United States;
Lipoic acid and omega-3 fatty acids
Oregon Health and Science University
2014 Phase 1/Phase 2 NCT02133664 United States;
Lisdexamfetamine sulfate
State University of New York at Buffalo
2009 Phase 2 NCT01615887 United States;
Listed for each disorder below, up to three drugs per disorder (too many characters to list in this field
NorthShore University HealthSystem
2016 Phase 4 NCT02670161 -
Live Hookworm Larvae
University of Nottingham
2008 Phase 2 NCT00630383 United Kingdom;
Live Necator americanus larvae
University of Nottingham
2011 Phase 2 EUCTR2008-005008-24-GB United Kingdom;
Locally approved intravenous contrast medium for contrast enhanced magnetic resonance imaging (MRI)
Sanofi
2019 Phase 2 NCT03889639 Canada;Czechia;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States;
Lodosyn
University of Miami
2022 Phase 2 NCT04764383 United States;
Lokomat training
IRCCS Centro Neurolesi Bonino-Pulejo
2016 - NCT03186664 Italy;
Loperamide
Rocky Mountain MS Research Group, LLC
2014 Phase 4 NCT02217982 United States;
Loratadine
Genzyme, a Sanofi Company
2015 Phase 1 NCT02583594 Spain;
Low Dose Aspirin (162 mg/day)
Mayo Clinic
2007 Phase 3 NCT00467584 United States;
Low dose arm receiving neutral oil and 400 IU/g of Vitamin D every second day
Charite University, Berlin, Germany
2011 Phase 2 NCT01440062 Germany;
Low dose cannabis
University of California, Davis
2009 Phase 1/Phase 2 NCT01037088 United States;
Low immunogenic interferon-beta-1a
Biogen Idec
2004 Phase 4 NCT00493077 Sweden;
Lu AG06466
H. Lundbeck A/S
2021 Phase 1 NCT04990219 United States;
Lubiprostone
University of Rochester
2010 Phase 4 NCT01236534 United States;
Lumbar Puncture
Genentech, Inc.
2016 Phase 3 NCT02688985 Canada;Germany;Sweden;United States;
Lumbar puncture
Centre Hospitalier Universitaire de Nimes
2013 Phase 3 NCT01817166 France;
Lutein
University of Illinois at Urbana-Champaign
2021 - NCT04843813 United States;
M2951
EMD Serono Research & Development Institute, Inc.
2017 Phase 2 NCT02975349 Bulgaria;Czechia;Germany;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United States;
MERCK HEALTHCARE KGaA
2020 Phase 3 EUCTR2019-004980-36-IT Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004972-20-IT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
Merck Healthcare KGaA
2021 Phase 3 EUCTR2019-004980-36-SI Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-SK Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-PT Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-NO Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-LV Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-LT Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-GR Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-DE Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-BG Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004972-20-HU Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-004972-20-GB Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-004972-20-FI Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-004972-20-DE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-004972-20-CZ Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-004972-20-BG Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-004972-20-AT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-004701-11-BG Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Montenegro;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-004700-19-BG Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;Italy;Kuwait;Lebanon;Lithuania;Mexico;Moldova, Republic of;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
- Phase 3 EUCTR2019-004972-20-BE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
Merck KGaA
2017 Phase 2 EUCTR2016-001448-21-SK Bulgaria;Croatia;Czech Republic;Czechia;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-001448-21-PL Bulgaria;Croatia;Czech Republic;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-001448-21-ES Bulgaria;Croatia;Czech Republic;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-001448-21-CZ Bulgaria;Croatia;Czech Republic;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-001448-21-BG Bulgaria;Croatia;Czech Republic;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
MABCAMPATH 10 mg/ml concentrado para solución para perfusión
Genzyme Corporation
2010 Phase 3 EUCTR2009-010788-18-ES Austria;Belgium;Czech Republic;Denmark;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
MANTADAN*20CPR
FONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR
2011 - EUCTR2010-023678-38-IT Italy;
MAVENCLAD - 10 MG - COMPRESSA - USO ORALE - BLISTER (AL/AL) - 6 COMPRESSE
MERCK KGAA
2021 Phase 4 EUCTR2020-003995-42-IT Australia;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Italy;Poland;
2021 Phase 4 EUCTR2020-003874-30-IT Austria;Czechia;Denmark;France;Hungary;Italy;Netherlands;Poland;Slovakia;Spain;
MAVENCLAD 10 mg tablets
Westfälische Wilhelms-Universität Münster c/o Universitätsklinikum Münster, Geschäftsbereich Recht u. Drittmittel
2019 Phase 4 EUCTR2018-004557-24-DE Germany;
MBP peptide
Centrum Neurologii Krzysztof Selmaj
2016 Phase 2 EUCTR2016-002180-33-PL Poland;
MBP8298
BioMS Technology Corp.
2007 Phase 3 NCT00468611 United States;
MBP8298 Synthetic Peptide
BioMS Technology Corp
2007 - EUCTR2004-002571-16-GB Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2006 - EUCTR2004-002571-16-NL Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2006 - EUCTR2004-002571-16-LV Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2006 - EUCTR2004-002571-16-LT Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2006 - EUCTR2004-002571-16-FI Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2006 - EUCTR2004-002571-16-ES Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2006 - EUCTR2004-002571-16-EE Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2006 - EUCTR2004-002571-16-DK Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2005 - EUCTR2004-002571-16-SE Denmark;Estonia;Finland;Latvia;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
BioMS Technology Corp.
2006 Phase 2 EUCTR2006-001947-70-SK Slovakia;
MD1003
MEDDAY PHARMACEUTICALS
2017 Phase 3 EUCTR2016-000700-29-IT Australia;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States;
MEDDAY PHARMACEUTICALS SA
2018 Phase 3 EUCTR2016-000700-29-PL Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States;
2018 Phase 3 EUCTR2016-000700-29-HU Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States;
2018 Phase 3 EUCTR2016-000700-29-BE Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-000700-29-SE Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-000700-29-ES Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Poland;Spain;Sweden;United Kingdom;United States;
2017 Phase 3 EUCTR2016-000700-29-DE Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-000700-29-CZ Australia;Belgium;Canada;Czech Republic;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States;
MEDDAY Pharmaceuticals SA
2014 Phase 3 EUCTR2013-002112-27-GB France;United Kingdom;
MEDDAY SAS
- - EUCTR2013-002113-35-FR France;
- - EUCTR2013-002112-27-FR France;
MD1003 100mg capsule
MedDay Pharmaceuticals SA
2016 Phase 3 NCT02936037 Australia;Belgium;Canada;Czech Republic;Czechia;Germany;Hungary;Italy;Netherlands;Poland;Spain;Sweden;Turkey;United Kingdom;United States;
2013 Phase 3 NCT02220933 France;
2013 Phase 3 NCT02220244 France;United Kingdom;
MEDI-551
MedImmune LLC
2018 Phase 2;Phase 3 EUCTR2014-000253-36-NL Australia;Bulgaria;Canada;China;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;India;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
2017 Phase 2;Phase 3 EUCTR2014-000253-36-HU Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
2017 Phase 2;Phase 3 EUCTR2014-000253-36-GR Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
2015 Phase 2;Phase 3 EUCTR2014-000253-36-ES Argentina;Australia;Brazil;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
2015 Phase 2;Phase 3 EUCTR2014-000253-36-DE Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
2015 Phase 2;Phase 3 EUCTR2014-000253-36-BG Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
2014 Phase 2;Phase 3 EUCTR2014-000253-36-PL Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
2014 Phase 2;Phase 3 EUCTR2014-000253-36-EE Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
2014 Phase 2;Phase 3 EUCTR2014-000253-36-CZ Australia;Bulgaria;Canada;Colombia;Czech Republic;Estonia;Germany;Greece;Hong Kong;Hungary;Israel;Japan;Korea, Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Russian Federation;Serbia;South Africa;Spain;Taiwan;Thailand;Turkey;Ukraine;United States;
2012 - EUCTR2011-005475-16-GB Austria;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
MEDI-551 100 MG-IV
MedImmune LLC
2012 Phase 1 NCT01585766 Czech Republic;Poland;Spain;Ukraine;United Kingdom;United States;
MEDI-551 30 MG-IV
MedImmune LLC
2012 Phase 1 NCT01585766 Czech Republic;Poland;Spain;Ukraine;United Kingdom;United States;
MEDI-551 300 MG-SC
MedImmune LLC
2012 Phase 1 NCT01585766 Czech Republic;Poland;Spain;Ukraine;United Kingdom;United States;
MEDI-551 60 MG-SC
MedImmune LLC
2012 Phase 1 NCT01585766 Czech Republic;Poland;Spain;Ukraine;United Kingdom;United States;
MEDI-551 600 MG-IV
MedImmune LLC
2012 Phase 1 NCT01585766 Czech Republic;Poland;Spain;Ukraine;United Kingdom;United States;
METHYLPHENIDATE HYDROCHLORIDE
Medizinische Universität Wien
2012 - EUCTR2012-003418-15-AT Austria;
METHYLPREDNISOLONE SODIUM HEMISUCCINATE
Servicio de Neurología, HU. Germans Trias i Pujol
2012 Phase 4 EUCTR2012-001965-34-ES Spain;
METHYLPREDNISOLONE SODIUM SUCCINATE
Danish Multiple Sclerosis Research Centre
2009 Phase 2 EUCTR2009-011516-37-DK Denmark;
Department of Clinical Neuroscience, Karolinska Institutet
2020 Phase 2 EUCTR2018-000620-34-DE Germany;Sweden;
2018 Phase 2 EUCTR2018-000620-34-SE Sweden;
Enceladus Pharmaceuticals BV
2010 - EUCTR2009-013884-21-PL Belgium;Germany;Poland;
2009 Phase 2 EUCTR2009-013884-21-BE Belgium;Germany;Poland;
2009 - EUCTR2009-013884-21-DE Belgium;Germany;Poland;
MIS416
Innate Immunotherapeutics
2014 Phase 2 NCT02228213 Australia;New Zealand;
2010 Phase 1/Phase 2 NCT01191996 New Zealand;
MK0812
Merck Sharp & Dohme Corp.
2004 Phase 2 NCT00239655 Canada;Finland;Germany;United Kingdom;United States;
MLN1202
Millennium Pharmaceuticals, Inc.
2006 Phase 2 EUCTR2004-002567-24-GB Czech Republic;Hungary;United Kingdom;
2005 Phase 2 NCT01199640 -
2005 - EUCTR2004-002567-24-HU Czech Republic;Hungary;United Kingdom;
2005 - EUCTR2004-002567-24-CZ Czech Republic;Hungary;United Kingdom;
MOG peptide
Centrum Neurologii Krzysztof Selmaj
2016 Phase 2 EUCTR2016-002180-33-PL Poland;
MOR103
MorphoSys AG
2012 Phase 1/Phase 2 NCT01517282 Germany;Poland;United Kingdom;
MRI
University Hospital, Strasbourg, France
2019 Phase 2 NCT03910738 France;
MRI contrast-enhancing preparations
Sanofi
2021 Phase 2 NCT04879628 Bulgaria;Canada;Czechia;France;Germany;Spain;Turkey;Ukraine;United States;
MRNA COVID-19 vaccine
Novartis Pharmaceuticals
2021 Phase 4 NCT04878211 United States;
MSC2015
SALK - Gemeinnützige Salzburger Landeskliniken Betriebsges. m.b.H., Christian-Doppler-Klinik, UK für Neurologie der PMU
- - EUCTR2015-000137-78-AT Austria;
MSC2304479A
Merck KGaA
2013 Phase 2 EUCTR2013-002916-28-LV Latvia;Russian Federation;
MSC2304480A
Merck KGaA
2013 Phase 2 EUCTR2013-002916-28-LV Latvia;Russian Federation;
MSC2304481A
Merck KGaA
2013 Phase 2 EUCTR2013-002916-28-LV Latvia;Russian Federation;
MSC2304482A
Merck KGaA
2013 Phase 2 EUCTR2013-002916-28-LV Latvia;Russian Federation;
MSC2358825A
Merck KGaA
2013 Phase 2 EUCTR2013-002916-28-LV Latvia;Russian Federation;
MSC2364447C
MERCK HEALTHCARE KGaA
2020 Phase 3 EUCTR2019-004980-36-IT Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004972-20-IT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
Merck Healthcare KGaA
2021 Phase 3 EUCTR2019-004980-36-SI Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-SK Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-PT Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-NO Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-LV Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-LT Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-GR Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-DE Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004980-36-BG Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004972-20-HU Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-004972-20-GB Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-004972-20-FI Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-004972-20-DE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-004972-20-CZ Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-004972-20-BG Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-004972-20-AT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-004701-11-BG Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Korea, Republic of;Mexico;Montenegro;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-004700-19-BG Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;Italy;Kuwait;Lebanon;Lithuania;Mexico;Moldova, Republic of;Poland;Portugal;Romania;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
- Phase 3 EUCTR2019-004972-20-BE Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
MSC2430913A or ONO-4641 (to be used as synonyms)
Merck KGaA
2014 Phase 3 EUCTR2013-002351-15-AT Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-003126-83-HU Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-003126-83-GR Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-003126-83-ES Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-003126-83-DE Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-003126-83-BG Argentina;Belarus;Belgium;Brazil;Bulgaria;Canada;Chile;Colombia;Czech Republic;Denmark;Finland;France;Georgia;Germany;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-PT Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-LV Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-HU Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-ES Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-EE Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2014 - EUCTR2013-002351-15-BG Argentina;Austria;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Denmark;Egypt;Estonia;Finland;France;Georgia;Germany;Hungary;Italy;Japan;Jordan;Latvia;Lebanon;Lithuania;Mexico;Morocco;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Tunisia;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
MSC2491529A
Merck KGaA
2014 Phase 2 EUCTR2013-002283-25-GB Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2014 - EUCTR2013-002283-25-PL Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2014 - EUCTR2013-002283-25-GR Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2014 - EUCTR2013-002283-25-ES Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2014 - EUCTR2013-002283-25-BG Bulgaria;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States;
2013 - EUCTR2013-002283-25-IT Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2013 - EUCTR2013-002283-25-HU Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2013 - EUCTR2013-002283-25-HR Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2013 - EUCTR2013-002283-25-FI Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2013 - EUCTR2013-002283-25-CZ Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
MSDMDs other than Betaseron (Interferon beta-1b, BAY86-5046)
Bayer
2016 - NCT02749396 Finland;
MSTC-001 (MS-STAT)
Imperial College London
2007 Phase 2 EUCTR2006-006347-31-GB United Kingdom;
MSmonitor, a self-management/education program with e-health interventions
Isala
2021 - NCT05242731 Netherlands;
MT-1303
MITSUBISHI PHARMA CORPORATION
2013 - EUCTR2012-002470-31-IT Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Hungary;Italy;Lithuania;Poland;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;
Mitsubishi Tanabe Pharma Corporation
2014 Phase 1 NCT02293967 United Kingdom;
Mitsubishi Tanabe Pharma Corporation (MTPC)
2013 Phase 2 EUCTR2012-002639-27-PL Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;
2013 Phase 2 EUCTR2012-002639-27-LT Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;
2013 Phase 2 EUCTR2012-002639-27-HU Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;
2013 Phase 2 EUCTR2012-002639-27-GB Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;
2013 Phase 2 EUCTR2012-002639-27-FI Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;
2013 Phase 2 EUCTR2012-002639-27-ES Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;
2013 Phase 2 EUCTR2012-002639-27-CZ Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;
2013 Phase 2 EUCTR2012-002639-27-BG Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;
2013 Phase 2 EUCTR2012-002639-27-BE Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;
2013 - EUCTR2012-002470-31-LT Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;
2013 - EUCTR2012-002470-31-FI Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;
2013 - EUCTR2012-002470-31-ES Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;
2013 - EUCTR2012-002470-31-BG Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;
2013 - EUCTR2012-002470-31-BE Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;
2012 - EUCTR2012-002470-31-PL Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;
2012 - EUCTR2012-002470-31-HU Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;
2012 - EUCTR2012-002470-31-GB Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;
2012 - EUCTR2012-002470-31-CZ Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;
MT-1303 [0.1]
MITSUBISHI TANABE PHARMA CORPORATION
2013 Phase 2 EUCTR2012-002639-27-IT Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;
MT-1303 [0.2]
MITSUBISHI TANABE PHARMA CORPORATION
2013 Phase 2 EUCTR2012-002639-27-IT Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;
MT-1303 [0.4]
MITSUBISHI TANABE PHARMA CORPORATION
2013 Phase 2 EUCTR2012-002639-27-IT Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Poland;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;
MT-1303-FormA
Mitsubishi Tanabe Pharma Corporation
2014 Phase 1 NCT02310048 United Kingdom;
MT-1303-FormB
Mitsubishi Tanabe Pharma Corporation
2014 Phase 1 NCT02310048 United Kingdom;
MT-1303-High
Mitsubishi Tanabe Pharma Corporation
2014 Phase 1 NCT02193217 United Kingdom;
2013 Phase 2 NCT01890655 Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Turkey;Ukraine;United Kingdom;
2013 Phase 2 NCT01742052 Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;
MT-1303-Low
Mitsubishi Tanabe Pharma Corporation
2014 Phase 1 NCT02193217 United Kingdom;
2013 Phase 2 NCT01890655 Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Turkey;Ukraine;United Kingdom;
2013 Phase 2 NCT01742052 Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;
MT-1303-Middle
Mitsubishi Tanabe Pharma Corporation
2013 Phase 2 NCT01890655 Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Turkey;Ukraine;United Kingdom;
2013 Phase 2 NCT01742052 Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;Germany;Hungary;Italy;Lithuania;Poland;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;
MabCampath ®
Genzyme Corporation
2010 Phase 3 EUCTR2009-010788-18-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-010788-18-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-010788-18-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2008 Phase 3 EUCTR2007-001162-32-FR Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2008 Phase 3 EUCTR2007-001162-32-ES Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2008 Phase 3 EUCTR2007-001162-32-CZ Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2008 Phase 3 EUCTR2007-001162-32-BE Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2008 Phase 3 EUCTR2007-001161-14-FR Czech Republic;France;Germany;Poland;Sweden;United Kingdom;
2008 - EUCTR2007-001162-32-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-001162-32-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-001162-32-NL Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-001162-32-DK Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-001162-32-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-001162-32-AT Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-001161-14-SE Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom;
2008 - EUCTR2007-001161-14-PL Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom;
2008 - EUCTR2007-001161-14-DE Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom;
2007 Phase 3 EUCTR2007-001162-32-GB Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-001161-14-GB Czech Republic;France;Germany;Poland;Sweden;United Kingdom;
R&D Addenbrookes Hospital
2008 Phase 2 EUCTR2005-002305-23-GB United Kingdom;
MabCampath-1h
University of British Columbia
2011 Phase 3 NCT01307332 Canada;
MabCampath®
Genzyme Corporation
2009 Phase 3 EUCTR2009-010788-18-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-001161-14-PL Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom;
2008 - EUCTR2007-001161-14-CZ Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom;
MabThera (Rituximab)
Odense University Hospital
2013 Phase 2 EUCTR2012-004436-36-DK Denmark;
Mabthera or biosimilar rituximab product
Medical University of Vienna - Department of Neurology
2018 Phase 2 EUCTR2017-000426-35-AT Austria;
Mabthera®
Västerbottens Läns Landsting
2014 Phase 2 EUCTR2013-002378-26-SE Sweden;
Magnetic Resonance Imaging
University of Nottingham
2017 - NCT02481882 United Kingdom;
Maltodextrin
Medical University of Vienna
2012 Phase 2 NCT01879202 Austria;
Maltodextrin fiber supplement
University of Iowa
2010 Phase 1 NCT01381354 United States;
Mangafodipir (Teslascan)
National Institute of Neurological Disorders and Stroke (NINDS)
2013 Phase 1 NCT01326715 United States;
Mannitol
Department of Neurology and Neurological Science, Tokyo Medical and Dental University
2021 - JPRN-UMIN000043910 Japan;
Marijuana
Colorado State University
2016 - NCT02898974 United States;
Masitinb mesylate
AB Science
2015 Phase 3 EUCTR2012-003735-32-GR Argentina;Belgium;Brazil;Bulgaria;Czech Republic;Germany;Greece;Hungary;Italy;Mexico;Slovakia;Spain;United Kingdom;
2013 Phase 3 EUCTR2010-021219-17-GR Bulgaria;Germany;Greece;Poland;Slovakia;Spain;Turkey;
2013 - EUCTR2010-021219-17-PL Czech Republic;France;Germany;Greece;Poland;Romania;Slovakia;Spain;
2011 Phase 3 EUCTR2010-021219-17-DE Argentina;Bosnia and Herzegovina;Brazil;Bulgaria;France;Germany;Greece;Hungary;Italy;Mexico;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Tunisia;Ukraine;United Kingdom;United States;
Masitinib
AB Science
2011 Phase 3 NCT01433497 Bulgaria;France;Germany;Greece;Poland;Romania;Spain;United States;
2005 Phase 2 NCT01450488 -
Masitinib mesilate
AB Science
2022 Phase 3 EUCTR2021-000639-30-ES Bulgaria;Canada;Finland;France;Germany;Greece;Hungary;Israel;Italy;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
Masitinib mesylate
AB Science
2015 Phase 3 EUCTR2012-003735-32-SK Argentina;Belgium;Brazil;Bulgaria;Canada;Colombia;Germany;Greece;Italy;Mexico;Slovakia;Spain;Switzerland;United Kingdom;
2015 Phase 3 EUCTR2012-003735-32-GR Argentina;Belgium;Brazil;Bulgaria;Czech Republic;Germany;Greece;Hungary;Italy;Mexico;Slovakia;Spain;United Kingdom;
2015 Phase 3 EUCTR2010-021219-17-BG Argentina;Bosnia and Herzegovina;Brazil;Bulgaria;France;Germany;Greece;Hungary;Italy;Mexico;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Tunisia;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2010-021219-17-GR Bulgaria;Germany;Greece;Poland;Slovakia;Spain;Turkey;
2013 - EUCTR2010-021219-17-PL Czech Republic;France;Germany;Greece;Poland;Romania;Slovakia;Spain;
2012 Phase 3 EUCTR2010-021219-17-SK Argentina;Bosnia and Herzegovina;Brazil;Bulgaria;France;Germany;Greece;Hungary;Italy;Mexico;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-021219-17-ES Bulgaria;Czech Republic;France;Germany;Greece;Poland;Romania;Slovakia;Spain;United States;
2011 Phase 3 EUCTR2010-021219-17-DE Argentina;Bosnia and Herzegovina;Brazil;Bulgaria;France;Germany;Greece;Hungary;Italy;Mexico;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Tunisia;Ukraine;United Kingdom;United States;
Mastinib
AB Science
2015 Phase 3 EUCTR2012-003735-32-SK Argentina;Belgium;Brazil;Bulgaria;Canada;Colombia;Germany;Greece;Italy;Mexico;Slovakia;Spain;Switzerland;United Kingdom;
2015 Phase 3 EUCTR2012-003735-32-GR Argentina;Belgium;Brazil;Bulgaria;Czech Republic;Germany;Greece;Hungary;Italy;Mexico;Slovakia;Spain;United Kingdom;
2013 Phase 3 EUCTR2010-021219-17-GR Bulgaria;Germany;Greece;Poland;Slovakia;Spain;Turkey;
2013 - EUCTR2010-021219-17-PL Czech Republic;France;Germany;Greece;Poland;Romania;Slovakia;Spain;
2012 Phase 3 EUCTR2010-021219-17-SK Argentina;Bosnia and Herzegovina;Brazil;Bulgaria;France;Germany;Greece;Hungary;Italy;Mexico;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-021219-17-DE Argentina;Bosnia and Herzegovina;Brazil;Bulgaria;France;Germany;Greece;Hungary;Italy;Mexico;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Tunisia;Ukraine;United Kingdom;United States;
Mavenclad
Helse Bergen HF, Haukeland University Hospital
2019 Phase 3 EUCTR2017-001362-25-NL Denmark;Netherlands;
2018 Phase 3 EUCTR2017-001362-25-DK Denmark;Netherlands;
Merck Healthcare KGaA
2021 Phase 4 EUCTR2020-003995-42-HU Australia;Canada;Czech Republic;Finland;Germany;Hungary;Israel;
2021 Phase 4 EUCTR2020-003995-42-CZ Australia;Canada;Czech Republic;Finland;Germany;Hungary;Israel;
2021 Phase 4 EUCTR2020-003874-30-HU Hungary;
2021 Phase 4 EUCTR2020-003874-30-DK Denmark;Hungary;
2021 Phase 4 EUCTR2020-003874-30-CZ Czech Republic;Denmark;Hungary;Italy;
2020 Phase 4 EUCTR2020-003995-42-FI Australia;Canada;Finland;Germany;Israel;
2020 Phase 4 EUCTR2020-003995-42-DE Australia;Canada;Czech Republic;Finland;Germany;Hungary;Israel;Poland;
Turku PET centre
2019 Phase 4 EUCTR2019-001960-31-FI Finland;
Mavenclad tabletter
Department of Neurology, Division of Clinical Neuroscience, Oslo University Hospital
2019 Phase 3 EUCTR2019-001505-24-NO Norway;
Mavenclad®
MERCK KGAA
2018 Phase 4 EUCTR2017-002632-17-IT Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;Finland;France;Greece;Hungary;Ireland;Italy;Lithuania;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 EUCTR2017-002631-42-IT Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
2021 Phase 4 NCT04783935 Australia;Austria;Canada;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Poland;Spain;Sweden;United Kingdom;
2021 Phase 4 NCT04776213 Austria;Czechia;Denmark;France;Hungary;Italy;Netherlands;Poland;Slovakia;Spain;
Merck KGaA
2018 Phase 4 EUCTR2017-002632-17-SK Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-SE Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-PT Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-NL Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-LT Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-HU Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Ireland;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-GR Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-GB Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-FR Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-FI Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-ES Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Israel;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-DK Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-CZ Australia;Austria;Belgium;Czech Republic;Czechia;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-BE Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 EUCTR2017-002632-17-AT Australia;Austria;Belgium;Czech Republic;Denmark;Finland;France;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 EUCTR2017-002631-42-SE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002631-42-HU Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002631-42-GB Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002631-42-FR Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002631-42-FI Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002631-42-CZ Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002631-42-BE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;
2018 Phase 4 EUCTR2017-002631-42-AT Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Hungary;Ireland;Israel;Italy;Netherlands;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;
Merck KGaA, Darmstadt, Germany
2018 Phase 4 NCT03369665 Austria;Belgium;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Poland;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2018 Phase 4 NCT03364036 Australia;Austria;Belgium;Canada;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Poland;Spain;Sweden;United Kingdom;
Mayzent
Novartis Farmacéutica S.A.
2021 Phase 3 EUCTR2020-002700-39-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Novartis Pharma AG
2021 Phase 3 EUCTR2020-002700-39-SK Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-LV Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-LT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-HR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2020-002700-39-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2020-002700-39-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Novartis Pharmaceuticals
2020 - NCT04593927 Japan;
Robert Zivadinov, MD, PhD
2021 Phase 4 NCT04925557 United States;
Mayzent 0,25 mg Filmtabletten
Novartis Pharma GmbH
2021 Phase 4 EUCTR2020-005752-38-DE Germany;
Mayzent 0.25 mg fi
Novartis Pharma AG
2021 Phase 3 EUCTR2020-002700-39-PT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Mayzent 2 mg Filmtabletten
Novartis Pharma GmbH
2021 Phase 4 EUCTR2020-005752-38-DE Germany;
Mayzent 2 mg film-coated tablets
Novartis Pharma AG
2021 Phase 3 EUCTR2020-002700-39-PT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Medical Marijuana
Colorado State University
2017 Phase 2/Phase 3 NCT03172741 -
Medication Event Monitoring System (MEMS)
Biogen
2015 Phase 4 NCT02343159 United States;
Medrol
Scleroseklinikken, Rigshospitalet
2011 - EUCTR2010-024561-43-DK Denmark;
Megadose oral methylprednisolone
Fred Lublin
2003 Phase 3 NCT00418145 United States;
Melatonin
Isfahan University of Medical Sciences
2012 Phase 2 NCT01718678 Iran, Islamic Republic of;
Providence Health & Services
2018 Early Phase 1 NCT03498131 United States;
Tehran University of Medical Sciences
2012 - NCT02463318 Iran, Islamic Republic of;
2010 Phase 2 NCT01279876 Iran, Islamic Republic of;
University of California, San Francisco
2019 - NCT04035889 United States;
Melphalan
Fred Hutchinson Cancer Research Center
2008 Phase 2 NCT00716066 United States;
Memantine
AZ. OSPEDALIERA GARIBALDI, S.LUIGI CURRO , ASCOLI TOMASELLI
2007 - EUCTR2007-000503-15-IT Italy;
Clinica Universidad de Navarra, Universidad de Navarra
2007 Phase 2 NCT00638833 Spain;
Hospices Civils de Lyon
2012 Phase 2 NCT01744444 France;
OSPEDALE S. RAFFAELE
2008 Phase 2 EUCTR2008-000490-37-IT Italy;
Oregon Health and Science University
2004 Phase 2/Phase 3 NCT00300716 United States;
University Hospital, Caen
2005 Phase 3 NCT01074619 France;
University of Rochester
2006 Phase 4 NCT00638027 United States;
Meningococcal polysaccharide diphtheria conjugate vaccine (quadrivalent)
Biogen
2015 Phase 2 NCT02097849 United States;
Menitorix
R & D, Cambridge University Hospitals
2009 - EUCTR2009-011523-31-GB United Kingdom;
Mesenchymal Stem Cells
Ottawa Hospital Research Institute
2015 Phase 2 NCT02239393 Canada;
Mesenchymal Stem Cells (MSC)
Hadassah Medical Organization
2013 Phase 1/Phase 2 NCT04823000 -
Mesenchymal stem cells
Dimitrios Karussis
2015 Phase 2 NCT02166021 Israel;
Imperial College London
2013 Phase 1/Phase 2 NCT01606215 United Kingdom;
University Hospital, Toulouse
2015 Phase 1/Phase 2 NCT02403947 France;
Mesenchymal stem cells (MSCs)
Prof. Per Soelberg Sørensen
2012 Phase 2 EUCTR2012-000518-13-DK Denmark;
Mesenchymal stem/stromal cells
Prof. Per Soelberg Sørensen
2012 Phase 2 EUCTR2012-000518-13-DK Denmark;
Mesna
Northwestern University
2019 Phase 2/Phase 3 NCT03829566 United States;
2017 Phase 3 NCT03342638 United States;
Metabolic fatigue
Centre Hospitalier Universitaire de Saint Etienne
2020 Phase 2 NCT03983720 France;
Metex
Universitätsklinikum Heidelberg
2006 Phase 3 EUCTR2004-004403-37-DE Germany;
Metformin
The Hospital for Sick Children
2020 Phase 1/Phase 2 NCT04121468 Canada;
Methelphenidate
Kessler Foundation
2014 Phase 2 NCT02286557 -
Methotrexat
Universitätsklinikum Heidelberg
2006 Phase 3 EUCTR2004-004403-37-DE Germany;
Methotrexate
Biogen Idec
2003 Phase 4 NCT00112034 United States;
Heidelberg University
2006 Phase 3 NCT00344253 Germany;
MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute
2002 Phase 4 NCT00037115 United States;
2001 Phase 4 NCT00037102 United States;
Methyl B12
University of Iowa
2010 Phase 1 NCT01381354 United States;
Methyl Prednisolonate
University Hospital Muenster
2018 - NCT04450030 Germany;
Methyl folate
University of Iowa
2010 Phase 1 NCT01381354 United States;
Methyloprednisolone
Genentech, Inc.
2016 Phase 3 NCT02688985 Canada;Germany;Sweden;United States;
Methylphenidate
Johns Hopkins University
2017 Phase 3 NCT03185065 United States;
Oregon Health and Science University
2013 Phase 2/Phase 3 NCT01896700 United States;
Methylphenidate modified release
Medical University of Vienna
2012 Phase 2 NCT01879202 Austria;
Medizinische Universität Wien
2012 - EUCTR2012-003418-15-AT Austria;
Methylprednisolon-21-hydrogensuccinat, Natriumsalz
IFSgGmbH, Institute for clinical research
2006 - EUCTR2005-005592-14-DE Germany;
Methylprednisolone
ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
2008 - EUCTR2007-002179-15-FR France;
Beijing Tongren Hospital
2020 - NCT04601142 China;
Biogen
2010 Phase 2 NCT01071083 Germany;Spain;United States;
Biogen Idec
2003 Phase 4 NCT00493116 Australia;New Zealand;
2003 Phase 4 NCT00492466 Finland;
Galapagos NV
2009 Phase 2 NCT01039103 Belgium;Germany;Poland;
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
2015 Phase 1 NCT02583594 Spain;
2014 Phase 4 NCT02205489 Belgium;France;Netherlands;Spain;
Germans Trias i Pujol Hospital
2008 Phase 4 NCT00753792 Spain;
Hoffmann-La Roche
2020 Phase 3 NCT04548999 Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Peru;Poland;Portugal;Puerto Rico;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 NCT04544436 Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
IFSgGmbH, Institute for clinical research
2006 - EUCTR2005-005592-14-DE Germany;
Jena University Hospital
2020 - NCT04832269 Germany;
Merck KGaA, Darmstadt, Germany
2018 Phase 2 NCT03387046 Germany;Italy;
MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute
2002 Phase 4 NCT00037115 United States;
National Eye Institute (NEI)
1988 Phase 3 NCT00000146 United States;
1988 - NCT00000147 United States;
National Institute of Neurological Disorders and Stroke (NINDS)
2016 Phase 2 NCT02784210 United States;
Neurologique Foundation, Inc.
2009 Phase 2/Phase 3 NCT00947895 United States;
Northwestern Memorial Hospital
2001 Phase 1 NCT00017628 United States;
Northwestern University
2019 Phase 2/Phase 3 NCT03829566 United States;
2017 Phase 3 NCT03342638 United States;
Rigshospitalet, Denmark
2021 Phase 3 NCT04688788 Denmark;
2011 Phase 2 NCT01305837 Denmark;
Stanford University
2014 Phase 1 NCT02087813 United States;
Sykehuset Innlandet HF
2009 - NCT00764413 Norway;
Tomas Olsson
2018 Phase 2 NCT03674099 Denmark;Germany;Norway;Sweden;
University Hospital, Clermont-Ferrand
2016 Phase 4 NCT02769689 France;
University of Southern California
2009 Phase 1 NCT01049451 United States;
University of Texas Southwestern Medical Center
2013 Phase 2 NCT01710228 United States;
Methylprednisolone (drug)
University Hospital, Bordeaux
2005 Phase 3 NCT00241254 France;
Methylprednisolone 1250 mg/24h x3 days
Germans Trias i Pujol Hospital
2013 Phase 4 NCT01986998 Spain;
Methylprednisolone IV
Centre Hospitalier de PAU
2015 Phase 2 NCT02545959 France;
Hoffmann-La Roche
2022 Phase 3 NCT05232825 Brazil;Canada;Czechia;Italy;Poland;Russian Federation;Spain;Turkey;Ukraine;United States;
Rennes University Hospital
2008 Phase 3 NCT00984984 France;
Methylprednisolone PO
Rennes University Hospital
2008 Phase 3 NCT00984984 France;
Methylprednisolone hemisuccinate
BBB-Therapeutics B.V.
2013 Phase 1 NCT02048358 Netherlands;
Methylprednisolone succinate
Mazandaran University of Medical Sciences
2021 Phase 2 NCT04979650 Iran, Islamic Republic of;
Metilprednisolone sodio succinato
NOVARTIS PHARMA AG
2018 Phase 2 EUCTR2017-004702-17-IT Austria;Bulgaria;Czech Republic;Czechia;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
Microgynon
Novartis Pharma Services AG
2012 - EUCTR2011-006043-30-NL Netherlands;
Microgynon®
Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany
2019 Phase 1 NCT04086225 Germany;Poland;
Merck KGaA, Darmstadt, Germany
2019 Phase 1 NCT03745144 Germany;Poland;
Micropirin
Biogen Idec Research Limited
2014 - EUCTR2013-001895-40-IE Ireland;United Kingdom;
Midazolam
Biogen
2011 Phase 3 NCT01462318 Czech Republic;Hungary;Poland;Russian Federation;United States;
Johns Hopkins University
2018 Phase 1/Phase 2 NCT03500289 United States;
Mild dose cannabis
University of California, Davis
2009 Phase 1/Phase 2 NCT01037088 United States;
Mineral boost (magnesium)
University of Iowa
2010 Phase 1 NCT01381354 United States;
Minocycline
Dr. Luanne Metz
2009 Phase 3 NCT00666887 Canada;
Merck KGaA
2006 Phase 2 NCT01134627 Denmark;
University of Calgary
2020 Phase 3 NCT04291456 Canada;
2010 Phase 2 NCT01073813 Canada;
Minocycline 100 mg Film-coated Tablets
E. Merck AB
2005 - EUCTR2005-004289-18-DK Denmark;Finland;Sweden;
Merck AB
2006 - EUCTR2005-004289-18-SE Finland;Sweden;
2006 - EUCTR2005-004289-18-FI Finland;Sweden;
Minocycline Hydrochloride
E. Merck AB
2005 - EUCTR2005-004289-18-DK Denmark;Finland;Sweden;
Merck AB
2006 - EUCTR2005-004289-18-SE Finland;Sweden;
2006 - EUCTR2005-004289-18-FI Finland;Sweden;
Mirabegron
Theodore R. Brown, MD MPH
2014 Phase 4 NCT02086188 United States;
Mitoquinone
Oregon Health and Science University
2018 Phase 1/Phase 2 NCT03166800 United States;
Mitoxantrone
AZIENDA OSPEDALIERA UNIVERSITARIA DELLA SECONDA UNIVERSITA` DEGLI STUDI DI NAPOLI
2009 - EUCTR2009-010661-23-IT Italy;
Fundación Española de Esclerosis Múltiple (FEDEM)
2006 - EUCTR2004-001286-17-PT Portugal;
OSPEDALE S. RAFFAELE
2004 - EUCTR2004-001601-10-IT France;Italy;
Queen Mary, University of London
2009 - EUCTR2008-000256-26-GB United Kingdom;
Rennes University Hospital
2010 Phase 3 NCT02937285 France;
2010 - NCT01065727 France;
1999 Phase 2 NCT00219908 France;Italy;
State University of New York at Buffalo
2001 Phase 4 NCT00304291 United States;
The Walton Centre for Neurology and Neurosurgery
2005 Phase 4 EUCTR2004-004903-39-GB United Kingdom;
University Medical Center Hamburg Eppendorf
2007 - EUCTR2007-001962-34-DE Germany;
Wyeth is now a wholly owned subsidiary of Pfizer
2005 Phase 3 NCT00146159 Germany;
Xuanwu Hospital, Beijing
2009 Phase 4 NCT02021825 China;
Modafinil
Johns Hopkins University
2017 Phase 3 NCT03185065 United States;
Kessler Foundation
2003 - NCT00142402 United States;
University of Michigan
2018 Phase 4 NCT03621761 United States;
Moderna mRNA-1273
National Institute of Allergy and Infectious Diseases (NIAID)
2021 Phase 2 NCT05000216 United States;
Monoclonal antibody M-T412
National Center for Research Resources (NCRR)
1995 Phase 1 NCT00004816 -
Monomethyl fumarate
Banner Life Sciences LLC
2021 - NCT04925778 -
2017 Phase 1 NCT04570670 -
Montelukast
Biogen
2015 Phase 4 NCT02410278 United States;
Most recent vaccine to seasonal influenza
Heinrich-Heine University, Duesseldorf
2020 - NCT05019248 Germany;
Multiferon
Dansk Multipel Sclerose Center
2010 - EUCTR2009-016824-29-DK Denmark;
Multiple (4 autologous subcutaneous T cell vaccinations with T cell lines reactive to nine myelin peptides)
Hadassah Medical Organization
2002 Phase 1/Phase 2 NCT01448252 Israel;
Mutagrip
sanofi-aventis recherche & developpement
2011 - EUCTR2011-001160-21-DE Austria;Canada;Germany;Russian Federation;Ukraine;
2011 - EUCTR2011-001160-21-AT Austria;Canada;Germany;Russian Federation;Ukraine;
MyBETAapp
Bayer
2017 - NCT03134573 Germany;
Mycophenolate Mofetil (CellCept)
University of Texas Southwestern Medical Center
2006 Phase 2 NCT00324506 United States;
Mycophenolate Mofetil (cellcept)
University of Texas Southwestern Medical Center
2004 Phase 2/Phase 3 NCT00223301 United States;
Mycophenolate mofetil
Kobe University Hospital
2018 - JPRN-UMIN000031135 Japan;
Sekiguchi Kenji
2018 Phase 2 JPRN-jRCTs051180080 Japan;
Shandong University Qilu Hospital
2021 Phase 4 ChiCTR2100043013 China;
The Ophthalmology Department of the Chinese Peoples Liberation Army Hospital
2019 Phase 4 ChiCTR1900025744 China;
2014 - ChiCTR-ICR-15007177 China;
The third affiliated hospital,Sun Yat-sen university
2016 - ChiCTR-OPB-16007730 China;
Third Affiliated Hospital, Sun Yat-Sen University
2016 Phase 4 NCT02809079 -
Mycophenolate mofetil (Cellcept)
Aaron Boster
2006 Phase 0 NCT00618527 United States;
Mycophenolate mofetil (MMF)
Hoffmann-La Roche
2021 Phase 3 NCT04660539 Bulgaria;Canada;Croatia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Puerto Rico;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Méthylprednisolone Mylan
Centre Hospitalier de Pau
2015 Phase 2 EUCTR2014-005493-11-FR France;
N acetylcysteine
University of Iowa
2010 Phase 1 NCT01381354 United States;
N-acetyl Cysteine
Thomas Jefferson University
2017 - NCT03032601 United States;
N-acetyl cysteine
Emmanuelle Waubant
2021 Phase 2 NCT05122559 -
University of California, San Francisco
2016 Phase 2 NCT02804594 United States;
N-acetylcysteine
ISTITUTO C. MONDINO
2007 - EUCTR2008-000955-90-IT Italy;
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine
N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM197
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 2;Phase 3 EUCTR2019-001829-26-IT Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States;
N.A.
Genzyme Corporation
2010 Phase 3 EUCTR2009-010788-18-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-010788-18-GB Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-010788-18-CZ Argentina;Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
N02BG10
JOSE MANUEL GARCIA DOMINGUEZ
2013 - EUCTR2011-000985-36-ES Spain;
N03AX12
HOSPICES CIVILS DE LYON
2015 Phase 2 EUCTR2014-005548-17-FR France;
N06DX01
HOSPICES CIVILS DE LYON
2015 Phase 2 EUCTR2014-005548-17-FR France;
NBI-5788
Neurocrine Biosciences
2003 Phase 2 NCT00079495 -
NBT-NM108 (60 g/day)
Suhayl Dhib-Jalbut, MD
2021 Phase 1/Phase 2 NCT04574024 United States;
NEUPOGEN
OSPEDALE S. RAFFAELE
2007 Phase 2 EUCTR2007-000586-38-IT Italy;
NEUROASPIS PLP10®
PALUPA Medical Ltd
2016 Phase 3 EUCTR2015-003147-19-GR Greece;
NEURONTIN
HOSPICES CIVILS DE LYON
2015 Phase 2 EUCTR2014-005548-17-FR France;
NIRS after bosentan administration
Universitair Ziekenhuis Brussel
2014 - NCT02389426 Belgium;
NIRS baseline
Universitair Ziekenhuis Brussel
2014 - NCT02389426 Belgium;
NO
Carol Davila University of Medicine and Pharmacy
2012 - NCT03001284 -
NOVANTRONE*INF 2MG/ML 5ML
OSPEDALE S. RAFFAELE
2004 - EUCTR2004-001601-10-IT France;Italy;
NOVATREX
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France;
NPB-01
Nihon Pharmaceutical Co., Ltd
2013 Phase 2 NCT01845584 Japan;
NT-KO-003
Neurotec Pharma
2011 Phase 2 NCT01428726 Germany;Spain;
NU100
NURON BIOTECH INC.
2012 - EUCTR2011-002683-24-IT Belarus;Bulgaria;Hungary;Italy;Russian Federation;Spain;
Nuron Biotech Inc.
2011 Phase 3 NCT01464905 Belarus;Bulgaria;Croatia;Georgia;Hungary;India;Italy;Lebanon;Poland;Russian Federation;Serbia;Spain;Ukraine;
Nuron Biotech, Inc.
2012 - EUCTR2011-002683-24-HU Belarus;Bulgaria;Croatia;Georgia;Hungary;Italy;Lebanon;Poland;Russian Federation;Spain;Ukraine;
2012 - EUCTR2011-002683-24-ES Belarus;Bulgaria;Croatia;Georgia;Hungary;Italy;Poland;Russian Federation;Spain;Ukraine;
2012 - EUCTR2011-002683-24-BG Belarus;Bulgaria;Croatia;Georgia;Hungary;Italy;Lebanon;Poland;Russian Federation;Spain;Ukraine;
NVF233
Novartis Farma S.p.A.
2012 - EUCTR2010-023023-19-DE Germany;Italy;
Na18F
AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA
2016 Phase 2 EUCTR2015-001202-34-IT Italy;
Nabilone
University of Manitoba
2007 Phase 4 NCT00480181 Canada;
Nabiximols
GW Pharmaceuticals Ltd.
2021 Phase 3 NCT04984278 -
2020 Phase 3 NCT04657666 Czechia;Poland;
2020 Phase 3 NCT04203498 Czechia;Poland;United States;
Nabiximols - Sativex
GW Pharma Limited
2022 Phase 3 EUCTR2020-004306-58-LT Bulgaria;Canada;Hungary;Italy;Lithuania;Spain;United Kingdom;United States;
2021 Phase 3 EUCTR2020-003271-18-ES Australia;Belgium;Czech Republic;Czechia;Poland;Spain;Sweden;United Kingdom;
2021 Phase 3 EUCTR2020-003271-18-CZ Australia;Belgium;Czech Republic;Czechia;Poland;Spain;Sweden;United Kingdom;
2021 Phase 3 EUCTR2019-002625-29-CZ Czech Republic;Czechia;Poland;United Kingdom;
2020 Phase 3 EUCTR2019-002625-29-PL Czech Republic;Czechia;Poland;United Kingdom;
Naltrexone
OSPEDALE S. RAFFAELE
2006 - EUCTR2005-005679-13-IT Italy;
University of California, San Francisco
2007 Phase 3 NCT00501696 United States;
Namisol
Echo Pharmaceuticals B.V.
2011 - EUCTR2010-022033-28-NL Netherlands;
Nanocort
Enceladus Pharmaceuticals BV
2010 - EUCTR2009-013884-21-PL Belgium;Germany;Poland;
2009 Phase 2 EUCTR2009-013884-21-BE Belgium;Germany;Poland;
2009 - EUCTR2009-013884-21-DE Belgium;Germany;Poland;
Nanocurcumin
Tabriz University of Medical Sciences
2016 Phase 2 NCT03150966 Iran, Islamic Republic of;
Naproxen
Biogen
2013 Phase 3 NCT01939002 United States;
Natalizumab
Amir Hadi Maghzi
2022 Phase 3 JPRN-jRCT2051210146 Japan;
Amsterdam University Medical Center
2019 Phase 4 EUCTR2019-002566-13-NL Netherlands;
BIOGEN IDEC LTD
2010 - EUCTR2009-015556-15-IT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2006 - EUCTR2005-004061-41-IT Australia;Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;New Zealand;Spain;Sweden;Switzerland;Turkey;United Kingdom;
Biogen
2022 Phase 3 NCT05265728 -
2019 - NCT05236777 Czechia;
2018 Phase 3 NCT03689972 Australia;Belgium;Canada;France;Germany;Israel;Italy;Netherlands;Spain;United Kingdom;United States;
2015 - NCT02677077 Belgium;Czech Republic;Czechia;
2015 - NCT02386566 Switzerland;
2014 Phase 4 NCT02342704 Australia;Czech Republic;Czechia;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2014 Phase 4 NCT02241785 Germany;United States;
2014 Phase 2 NCT02142192 Belgium;Denmark;Germany;Italy;
2014 - NCT02159573 United States;
2014 - NCT02137109 -
2013 Phase 1 NCT01884935 Italy;
2013 - NCT04832399 Portugal;
2012 - NCT01485003 United States;
2011 Phase 3 NCT01416181 Belgium;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 - NCT01943526 Ireland;
2010 Phase 2 NCT01416155 China;Japan;
2010 Phase 2 NCT01071083 Germany;Spain;United States;
2010 - NCT01070836 Puerto Rico;United States;
2009 - NCT00884481 Austria;Denmark;Norway;Sweden;United States;
2007 - NCT00493298 Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Italy;Mexico;Netherlands;Norway;Portugal;Slovakia;Spain;Switzerland;United Kingdom;
2006 Phase 3 NCT00297232 Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2001 Phase 3 NCT00027300 Belgium;Canada;Czech Republic;France;Germany;Netherlands;United Kingdom;United States;
Biogen Idec
2008 Phase 4 NCT00744679 United States;
2007 Phase 1 NCT00559702 United States;
2003 Phase 3 NCT00276172 United States;
2003 Phase 2 NCT00097760 -
2002 Phase 3 NCT00030966 Austria;Belgium;France;Germany;Israel;Italy;United States;
Biogen Idec GmbH
2005 - EUCTR2004-004130-14-AT Austria;
Biogen Idec International GmbH
2010 Phase 4 EUCTR2009-009503-19-BE Belgium;
Biogen Idec Ltd.
2004 - EUCTR2004-000047-18-SE Sweden;
Claudio Gobbi
2010 Phase 4 NCT01144052 Switzerland;
Multiple Sclerosis Center of Northeastern New York
2021 - NCT04964700 United States;
Nantes University Hospital
2021 - NCT04777539 France;
Northwestern University
2013 Phase 2 EUCTR2012-004165-41-GB United Kingdom;United States;
Rennes University Hospital
2010 - NCT01065727 France;
Rigshospitalet, Denmark
2010 Phase 2 NCT01077466 Denmark;
State University of New York at Buffalo
2015 Phase 4 NCT03046251 United States;
University Hospital Muenster
2014 Phase 4 NCT02325440 Germany;
University Hospital, Toulouse
2009 Phase 4 NCT00942214 France;
University at Buffalo
2012 Phase 4 NCT02775110 United States;
VU University Medical Center
2016 Phase 4 NCT03516526 Netherlands;
Natalizumab (BG00002)
Biogen
2010 Phase 2/Phase 3 NCT01440101 China;Japan;
Natalizumab (NTZ)
University Hospital, Clermont-Ferrand
2016 Phase 4 NCT02769689 France;
Natalizumab (Tysabri)
Cornerstone Health Care, PA
2012 Phase 4 NCT01591551 United States;
Natalizumab 300 MG in 15 ML Injection
Vanderbilt University Medical Center
2022 Phase 4 NCT05177718 United States;
Natalizumab IV
Biogen
2011 Phase 2 NCT01405820 Belgium;France;Germany;Italy;Spain;
Natalizumab Injection [Tysabri]
University Hospital, Caen
2020 - NCT04580381 France;
Natalizumab SC
Biogen
2011 Phase 2 NCT01405820 Belgium;France;Germany;Italy;Spain;
Natalizumab for IV Infusion
Biogen Idec Limited
2011 - EUCTR2010-024000-10-ES Belgium;Germany;Italy;Spain;
2011 - EUCTR2010-024000-10-DE Belgium;Germany;Italy;Spain;
2011 - EUCTR2010-024000-10-BE Belgium;Germany;Italy;Spain;
Natalizumab for Subcutaneous Injection
Biogen Idec Limited
2011 - EUCTR2010-024000-10-ES Belgium;Germany;Italy;Spain;
2011 - EUCTR2010-024000-10-DE Belgium;Germany;Italy;Spain;
2011 - EUCTR2010-024000-10-BE Belgium;Germany;Italy;Spain;
Biogen Idec Research Limited
2014 Phase 2 EUCTR2014-000917-30-DE Belgium;Denmark;Germany;Italy;
2014 - EUCTR2014-000917-30-IT Belgium;Denmark;Italy;
2014 - EUCTR2014-000917-30-DK Belgium;Denmark;Italy;
2014 - EUCTR2014-000917-30-BE Belgium;Denmark;Italy;
Natalizumab treatment
Biogen Idec
2007 Phase 0 NCT00424788 United States;
Nebido® Testosterone Undecanoate 1000 Mg/4 mL Solution for Injection
University Hospital, Strasbourg, France
2019 Phase 2 NCT03910738 France;
NeoRecormon
Danish Multiple Sclerosis Research Centre
2009 Phase 2 EUCTR2009-011516-37-DK Denmark;
Neorecormon
Walton Centre for Neurology and Neurosurgery
2008 - EUCTR2008-005125-11-GB United Kingdom;
Neramexane mesylate
Merz Pharmaceuticals GmbH
2009 Phase 2 NCT00799942 United Kingdom;
Nerispirdine (HP184)
Sanofi
2008 Phase 2 NCT00811902 Canada;Finland;France;Germany;Norway;Spain;United States;
2008 Phase 2 NCT00772525 United States;
Nerispirdine hydrochloride
sanofi-aventis Recherche & Développement
2009 Phase 2 EUCTR2008-001999-67-FR Finland;France;Germany;Spain;
2009 Phase 2 EUCTR2008-001999-67-ES Finland;France;Germany;Spain;
2009 - EUCTR2008-001999-67-FI Finland;France;Germany;Spain;
2009 - EUCTR2008-001999-67-DE Finland;France;Germany;Spain;
Neupogen
Uppsala l?ns landsting
2011 - EUCTR2010-023560-40-SE Brazil;Canada;Sweden;United States;
NeuroVax
Immune Response BioPharma, Inc.
2020 Phase 2/Phase 3 NCT02057159 United States;
2020 Phase 2 NCT02149706 United States;
2020 Phase 1 NCT02200718 United States;
NeuroVax 300ug/mL Dose for IM Injection
The Immune Response Corporation
2007 Phase 2 EUCTR2006-003384-30-SK Slovakia;
Neuromuscular electrical stimulation delivered using the electrical therapy device EMPI 300 PV
University of Iowa
2010 Phase 1 NCT01381354 United States;
Neurontin 300 mg hard capsule
Charité University Medicine Berlin
2010 Phase 4 EUCTR2008-005167-33-DE Germany;
New Formulation of rebif - human interferon beta-1a
EMD Serono
2006 Phase 3 NCT00428584 United States;
Niacinamide
University of Iowa
2010 Phase 1 NCT01381354 United States;
Nicotine dependence
University of Jordan
2021 - NCT05046535 -
Nintendo Wii Fit Balance Board
University Hospital of Ferrara
2014 - NCT02287948 Italy;
Nitrofurantoin
University College London
2010 Phase 4 EUCTR2009-017939-18-GB United Kingdom;
Nivolumab
Alliance Foundation Trials, LLC.
2019 Phase 1 NCT03656627 United States;
National Cancer Institute (NCI)
2019 Phase 1 NCT03816345 Canada;United States;
Nomegestrol
OSPEDALI CIVILI DI LIONE
2007 - EUCTR2006-005460-30-IT Italy;
Nomegestrol acetate
Hospices Civils de Lyon
2005 Phase 3 NCT00127075 France;
Non applicabile
MERCK HEALTHCARE KGaA
2020 Phase 3 EUCTR2019-004980-36-IT Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Kuwait;Latvia;Lithuania;Malaysia;Mexico;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Saudi Arabia;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Tunisia;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2019-004972-20-IT Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Mexico;Netherlands;Peru;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
Non-pegylated interferon
Biogen
2015 Phase 2 NCT02097849 United States;
Norethindrone
University of California, Los Angeles
2011 Phase 2 NCT01466114 United States;
Normal Saline for Injection
University of Manitoba
2013 Phase 2 NCT01911377 Canada;
Normal saline
Mazandaran University of Medical Sciences
2021 Phase 2 NCT04979650 Iran, Islamic Republic of;
Novartis Pharmaceuticals Corporation
Universitätsklinikum Hamburg-Eppendorf
2013 - NCT03216915 Germany;
NurOwn (MSC-NTF cells)
Brainstorm-Cell Therapeutics
2019 Phase 2 NCT03799718 United States;
OCH-NCNP1
National Center of Neurology and Psychiatry, Japan
2019 Phase 2 NCT04211740 Japan;
OCR
Hoffmann-La Roche
2015 Phase 3 NCT02545868 Canada;United States;
OMB 157
NOVARTIS PHARMA SERVICES AG
2017 Phase 3 EUCTR2015-005419-33-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
OMB157
NOVARTIS PHARMA AG
2018 Phase 2 EUCTR2017-004702-17-IT Austria;Bulgaria;Czech Republic;Czechia;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
NOVARTIS PHARMA SERVICES AG
2021 Phase 3 EUCTR2020-002700-39-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2015-005418-31-IT Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
Novartis Farmacéutica S.A.
2021 Phase 3 EUCTR2020-002700-39-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001341-40-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Spain;Switzerland;Turkey;United Kingdom;United States;
Novartis Farmacéutica, S.A
2019 Phase 3 EUCTR2017-004703-51-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
Novartis Farmacéutica, S.A.
2018 Phase 2 EUCTR2017-004702-17-ES Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
2016 Phase 3 EUCTR2015-005419-33-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-ES Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
Novartis Pharma Services AG
2016 Phase 3 EUCTR2015-005419-33-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
Novartis Pharma AG
2021 Phase 3 EUCTR2020-004505-32-FR France;Germany;
2021 Phase 3 EUCTR2020-004505-32-DE France;Germany;Italy;Spain;
2021 Phase 3 EUCTR2020-002700-39-SK Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-PT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-LV Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-LT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-HR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-001341-40-SI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States;
2021 Phase 3 EUCTR2019-001341-40-PL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States;
2021 Phase 3 EUCTR2019-001341-40-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001341-40-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Spain;Switzerland;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001341-40-IT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Spain;Switzerland;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001341-40-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001341-40-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001341-40-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001341-40-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Spain;Switzerland;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001341-40-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001341-40-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-001341-40-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-HR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-FR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-FI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-DK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004703-51-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2019 Phase 2 EUCTR2017-004702-17-PL Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
2018 Phase 3 EUCTR2017-004703-51-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2018 Phase 3 EUCTR2017-004703-51-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2018 Phase 3 EUCTR2017-004703-51-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2018 Phase 3 EUCTR2017-004703-51-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2018 Phase 2 EUCTR2017-004702-17-LV Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
2018 Phase 2 EUCTR2017-004702-17-LT Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
2018 Phase 2 EUCTR2017-004702-17-EE Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
2018 Phase 2 EUCTR2017-004702-17-CZ Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
2018 Phase 2 EUCTR2017-004702-17-BG Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
2018 Phase 2 EUCTR2017-004702-17-AT Austria;Bulgaria;Czech Republic;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
2017 Phase 3 EUCTR2015-005418-31-FR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;European Union;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-FR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;European Union;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-HU Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-GR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-BE Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
- Phase 3 EUCTR2020-002700-39-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2020-002700-39-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Novartis Pharma Services AG
2017 Phase 3 EUCTR2015-005419-33-HR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2015-005419-33-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2015-005418-31-NL Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2015-005418-31-CZ Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-FI Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-SK Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-SE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-PL Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-HR Argentina;Australia;Belgium;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Kuwait;Mexico;Netherlands;Poland;Russian Federation;Saudi Arabia;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-GB Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-EE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-DK Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-BG Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
OMB157G
Novartis Pharma Services AG
2017 Phase 3 EUCTR2015-005419-33-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005419-33-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Germany;Hungary;India;Latvia;Lithuania;Mexico;Peru;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 EUCTR2015-005418-31-DE Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
Novartis Pharma Vertriebs GmbH
2021 Phase 4 EUCTR2021-000307-20-DE Germany;
ONO-4641
EMD Serono
2010 Phase 2 NCT01226745 Belgium;Canada;Czech Republic;Germany;Greece;Japan;Poland;Russian Federation;Spain;Ukraine;United States;
ONO Pharmaceutical Co., Ltd.
2011 - EUCTR2010-018705-11-GR Belgium;Canada;Czech Republic;Germany;Greece;Japan;Russian Federation;Spain;Ukraine;United States;
2010 Phase 2 EUCTR2009-014339-19-ES Czech Republic;Germany;Greece;Spain;
2010 - EUCTR2010-018705-11-ES Belgium;Czech Republic;Germany;Greece;Spain;
2010 - EUCTR2009-014339-19-GR Czech Republic;Germany;Greece;Spain;
2010 - EUCTR2009-014339-19-DE Canada;Czech Republic;Germany;Greece;Japan;Russian Federation;Spain;Ukraine;United States;
2010 - EUCTR2009-014339-19-CZ Czech Republic;Germany;Greece;Spain;
Ono Pharma USA Inc
2010 Phase 2 NCT01081782 Belgium;Canada;Czech Republic;Germany;Greece;Japan;Poland;Russian Federation;Spain;Ukraine;United States;
ONO-4641/ MSC2430913A
Merck KGaA
- - EUCTR2010-018705-11-DE Belgium;Canada;Czech Republic;Germany;Greece;Japan;Russian Federation;Spain;Ukraine;United States;
ONO-4641/MSC2430913A
Merck KGaA
2010 - EUCTR2010-018705-11-CZ Belgium;Canada;Czech Republic;Germany;Greece;Japan;Russian Federation;Spain;Ukraine;United States;
Merck Serono S.A. - Geneva
2010 - EUCTR2010-018705-11-BE Belgium;Canada;Czech Republic;Germany;Greece;Japan;Russian Federation;Spain;Ukraine;United States;
ORY2001
Oryzon Genomics S. A
2017 Phase 2 EUCTR2017-002838-23-ES Spain;
OS440
Osmotica Pharmaceutical US LLC
2018 Phase 3 EUCTR2017-004101-40-PL Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2018 Phase 3 EUCTR2017-004101-40-HR Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2018 Phase 3 EUCTR2017-004101-40-BG Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2018 Phase 3 EUCTR2017-004100-22-PL Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2018 Phase 3 EUCTR2017-004100-22-HR Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
2018 Phase 3 EUCTR2017-004100-22-BG Belarus;Bosnia and Herzegovina;Bulgaria;Croatia;Moldova, Republic of;Poland;Russian Federation;Serbia;Ukraine;United States;
Oclelizumab
Hoffman La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-BG Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
Ocrelizumab
ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
2018 Phase 3 EUCTR2017-004158-40-FR France;
Assistance Publique - Hôpitaux de Paris
2018 Phase 3 NCT03691077 France;
Brigham and Women's Hospital
2021 - NCT05131984 United States;
Claudio Gobbi
2020 - NCT04640818 Switzerland;
Dr Recai Turkoglu
2021 - NCT04874597 Turkey;
F. HOFFMANN - LA ROCHE LTD.
2021 Phase 3 EUCTR2020-005448-48-IT Brazil;Czechia;France;Italy;Spain;
2021 Phase 3 EUCTR2020-004128-41-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000893-69-IT Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-001511-73-IT Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2016-002667-34-IT Italy;Poland;United States;
F. Hoffman-La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-DE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
F. Hoffmann - La Roche
2010 - EUCTR2010-020338-25-IT Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;Greece;Hungary;Italy;Lithuania;Portugal;Spain;United Kingdom;
F.Hoffmann-La Roche
2012 Phase 3 EUCTR2010-020315-36-CZ Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020338-25-BG Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-SK Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-SE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-IE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-GB Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-FR Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-DE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-BG Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-BE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-020338-25-DK Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Portugal;Spain;United Kingdom;
2011 - EUCTR2010-020337-99-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-020315-36-ES Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Colombia;Croatia;Ireland;Italy;Mexico;Peru;Russian Federation;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020337-99-FI Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;United Kingdom;United States;
2010 - EUCTR2010-020338-25-HU Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2010 - EUCTR2010-020338-25-ES Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;Greece;Hungary;Italy;Lithuania;Portugal;Spain;United Kingdom;
2010 - EUCTR2010-020337-99-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
F.Hoffmann-La Roche Ltd.
2008 - EUCTR2007-006338-32-IT Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Russian Federation;Spain;Switzerland;Ukraine;United Kingdom;United States;
Genentech, Inc.
2020 Phase 4 NCT04377555 Kenya;Puerto Rico;United States;
2016 Phase 3 NCT02688985 Canada;Germany;Sweden;United States;
2016 Phase 3 NCT02637856 Canada;United States;
2016 - NCT02807285 United States;
2008 Phase 2 NCT00676715 Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
Georgia State University
2021 Phase 4 NCT04387734 United States;
Haukeland University Hospital
2020 Phase 3 NCT04578639 Norway;
Helse Bergen HF, Haukeland University Hospital
2022 Phase 3 EUCTR2020-001205-23-SE Sweden;
2018 Phase 3 EUCTR2017-001362-25-DK Denmark;Netherlands;
Hoffman La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-GB Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 Phase 2 EUCTR2007-006338-32-FR Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Slovakia;Spain;United Kingdom;
2008 Phase 2 EUCTR2007-006338-32-ES Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Slovakia;Spain;United Kingdom;
2008 Phase 2 EUCTR2007-006338-32-DK Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 Phase 2 EUCTR2007-006338-32-CZ Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 Phase 2 EUCTR2007-006338-32-BG Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 Phase 2 EUCTR2007-006338-32-BE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-006338-32-NL Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Spain;United Kingdom;
2008 - EUCTR2007-006338-32-FI Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Spain;United Kingdom;
Hoffmann-La Roche
2022 Phase 4 NCT05208840 Russian Federation;
2022 Phase 4 NCT04998812 Canada;France;Germany;Italy;Spain;Switzerland;United Kingdom;United States;
2022 Phase 3 NCT05269004 -
2022 Phase 3 NCT05123703 Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 4 NCT04998851 Australia;Canada;France;Germany;Italy;Spain;Switzerland;United Kingdom;United States;
2020 Phase 3 NCT04548999 Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Peru;Poland;Portugal;Puerto Rico;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 NCT04544449 Argentina;Australia;Austria;Belgium;Brazil;Canada;Colombia;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Puerto Rico;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 NCT04544436 Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 2 NCT04075266 Italy;Poland;United States;
2019 Phase 3 NCT04035005 Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 1 NCT03972306 Canada;United States;
2018 Phase 4 NCT03589105 France;
2018 Phase 3 NCT03599245 Argentina;Belgium;Brazil;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Kuwait;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2018 Phase 3 NCT03523858 Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Saudi Arabia;Spain;United Arab Emirates;United States;
2018 - NCT03593590 Austria;Belgium;Brazil;Bulgaria;Chile;Colombia;Dominican Republic;Egypt;Israel;Italy;Kuwait;Montenegro;Netherlands;Panama;Paraguay;Poland;Portugal;Qatar;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Turkey;United Arab Emirates;United Kingdom;
2017 Phase 3 NCT03085810 Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2016 Phase 3 NCT02861014 Australia;Belgium;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Hong Kong;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2011 Phase 3 NCT01412333 Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;France;Germany;Ireland;Italy;Mexico;Morocco;Norway;Poland;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 NCT01247324 Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Czechia;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 NCT01194570 Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;Uruguay;
Hospital Italiano de Buenos Aires
2019 - NCT03784547 Argentina;
Johns Hopkins University
2020 Phase 4 NCT04261790 United States;
2019 Phase 4 NCT03853746 United States;
2019 - NCT03873389 United States;
NYU Langone Health
2020 - NCT04855617 United States;
National Institute of Allergy and Infectious Diseases (NIAID)
2022 Phase 4 NCT05285891 -
Novartis Pharmaceuticals
2022 - NCT05266469 -
2021 - NCT04676555 Australia;United Kingdom;United States;
Rigshospitalet, Denmark
2021 Phase 3 NCT04688788 Denmark;
Sheffield Teaching Hospitals
2020 Phase 3 EUCTR2019-001549-42-GB United Kingdom;
University at Buffalo
2017 - NCT03025269 United States;
University of California, San Francisco
2020 Phase 4 NCT04466150 United States;
2020 - NCT04387110 United States;
University of Chicago
2017 - NCT03344094 United States;
University of Colorado, Denver
2017 Phase 3 NCT02980042 United States;
University of Michigan
2020 - NCT04459988 United States;
University of South Florida
2018 - NCT03562975 United States;
Universitätsklinikum Hamburg-Eppendorf
2021 Phase 2 NCT04971005 Germany;
VU medical center
2022 Phase 4 EUCTR2021-004791-34-NL Netherlands;
Wayne State University
2020 - NCT04458688 -
Yale University
2022 Phase 4 NCT04877457 United States;
Ocrelizumab (CinnaGen, Iran)
Cinnagen
2019 Phase 3 NCT04966338 Iran, Islamic Republic of;
Ocrelizumab (Roche, Switzerland)
Cinnagen
2019 Phase 3 NCT04966338 Iran, Islamic Republic of;
Ocrelizumab 300mg /10ml
F.Hoffmann-La Roche
2012 Phase 3 EUCTR2010-020337-99-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
Ocrelizumab 300mg/10 ml
F.Hoffmann-La Roche
2011 Phase 3 EUCTR2010-020338-25-DE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
Ocrelizumab 300mg/10ml
F.Hoffmann-La Roche
2013 Phase 3 EUCTR2010-020338-25-NL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020338-25-PT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020338-25-PL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020338-25-GR Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020338-25-CZ Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020338-25-BE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020338-25-AT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-SK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-LT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-CZ Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020338-25-LT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020338-25-GB Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020338-25-FI Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020337-99-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020337-99-EE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
GENENTECH Inc.
2016 Phase 3 EUCTR2015-004616-37-SE Germany;Sweden;Switzerland;United States;
2016 Phase 3 EUCTR2015-004616-37-DE Germany;Sweden;Switzerland;United States;
Ocrelizumab Dose 1
Genentech, Inc.
2018 Phase 3 NCT03606460 United States;
Ocrelizumab Dose 2 and Dose 3
Genentech, Inc.
2018 Phase 3 NCT03606460 United States;
Ocrelizumab IV
Hoffmann-La Roche
2022 Phase 3 NCT05232825 Brazil;Canada;Czechia;Italy;Poland;Russian Federation;Spain;Turkey;Ukraine;United States;
Ocrelizumab SC
Hoffmann-La Roche
2022 Phase 3 NCT05232825 Brazil;Canada;Czechia;Italy;Poland;Russian Federation;Spain;Turkey;Ukraine;United States;
Ocrelizumab at home
University of Colorado, Denver
2021 Phase 4 NCT04650321 United States;
Ocrevus
ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
2018 Phase 3 EUCTR2017-004158-40-FR France;
Danish Multiple Sclerosis Center, Rigshospitalet
2020 Phase 3 EUCTR2020-002981-15-DK Denmark;
F. HOFFMANN - LA ROCHE LTD.
2021 Phase 3 EUCTR2020-005448-48-IT Brazil;Czechia;France;Italy;Spain;
2021 Phase 3 EUCTR2020-004128-41-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000894-26-IT Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000893-69-IT Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-001511-73-IT Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2016-002667-34-IT Italy;Poland;United States;
F. Hoffman-La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-DE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
F. Hoffmann-La Roche Ltd
2022 Phase 3 EUCTR2020-005448-48-CZ Australia;Brazil;Canada;Czech Republic;Czechia;France;Italy;New Zealand;Poland;Russian Federation;Spain;Turkey;Ukraine;United States;
2022 Phase 3 EUCTR2020-004128-41-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 4 EUCTR2021-000063-79-ES Australia;Canada;France;Germany;Italy;Spain;Switzerland;United Kingdom;United States;
2021 Phase 4 EUCTR2021-000062-14-ES Australia;Canada;France;Germany;Italy;Spain;Switzerland;United Kingdom;United States;
2021 Phase 3 EUCTR2020-005448-48-PL Australia;Brazil;Canada;Czechia;France;Italy;New Zealand;Poland;Russian Federation;Spain;Turkey;Ukraine;United States;
2021 Phase 3 EUCTR2020-004128-41-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004128-41-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004128-41-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004128-41-GR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004128-41-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000894-26-GR Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000894-26-DK Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000894-26-BG Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000893-69-GR Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000893-69-DK Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-003919-53-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-003919-53-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-003919-53-GR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-003919-53-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-003919-53-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-003919-53-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-003919-53-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2017-004886-29-SK Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2021 Phase 3 EUCTR2017-004886-29-SI Argentina;Belgium;Brazil;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Mexico;Netherlands;Poland;Portugal;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2021 Phase 3 EUCTR2017-004886-29-PT Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2021 Phase 3 EUCTR2017-004886-29-PL Argentina;Belgium;Brazil;Bulgaria;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2021 Phase 3 EUCTR2017-004886-29-HU Argentina;Belgium;Brazil;Bulgaria;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2021 Phase 3 EUCTR2017-004886-29-HR Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2021 Phase 3 EUCTR2017-004886-29-BG Argentina;Belgium;Brazil;Bulgaria;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2021 Phase 3 EUCTR2017-004886-29-BE Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2020 Phase 3 EUCTR2020-000894-26-PT Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000894-26-HU Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000894-26-GB Argentina;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000894-26-FR Argentina;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000894-26-DE Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000893-69-PT Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000893-69-PL Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000893-69-NL Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000893-69-HU Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000893-69-GB Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000893-69-DE Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000893-69-BE Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2019-003919-53-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-001511-73-RO Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-001511-73-PT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-001511-73-IE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-001511-73-DE Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2017-001313-93-DE Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates;
2020 Phase 2 EUCTR2016-002667-34-PL Italy;Poland;United States;
2019 Phase 3 EUCTR2018-001511-73-PL Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-001511-73-HU Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-001511-73-HR Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-001511-73-GB Bulgaria;Croatia;Germany;Hungary;Ireland;Poland;Portugal;Spain;United Kingdom;
2019 Phase 3 EUCTR2018-001511-73-ES Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-001511-73-BG Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2017-004886-29-IE Argentina;Belgium;Brazil;Bulgaria;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2018 Phase 3 EUCTR2017-004886-29-SE Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2018 Phase 3 EUCTR2017-004886-29-NL Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2018 Phase 3 EUCTR2017-004886-29-GB Czech Republic;Denmark;Estonia;Finland;France;Ireland;Netherlands;Spain;Sweden;United Kingdom;
2018 Phase 3 EUCTR2017-004886-29-FI Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Turkey;United Kingdom;
2018 Phase 3 EUCTR2017-004886-29-EE Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Turkey;United Kingdom;
2018 Phase 3 EUCTR2017-004886-29-DK Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2018 Phase 3 EUCTR2017-004886-29-CZ Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2018 Phase 3 EUCTR2017-001313-93-PL Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates;
2018 Phase 3 EUCTR2017-001313-93-IE Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates;
2018 Phase 3 EUCTR2017-001313-93-DK Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates;
2018 Phase 3 EUCTR2017-001313-93-CZ Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates;
2017 Phase 3 EUCTR2016-002937-31-SK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-SI Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-SE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-NO Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-HR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
- Phase 4 EUCTR2021-000063-79-DE Canada;France;Germany;Italy;Spain;Switzerland;United Kingdom;United States;
- Phase 3 EUCTR2020-004128-41-FR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2020-004128-41-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2020-004128-41-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;Netherlands;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
F.Hoffmann-La Roche
2013 Phase 3 EUCTR2010-020338-25-NL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2010-020315-36-CZ Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020338-25-PL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020338-25-GR Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020338-25-DE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020338-25-CZ Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020338-25-BE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020338-25-AT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-SK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-LT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-CZ Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-SK Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-SE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-IE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-GB Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-DE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-BG Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020338-25-LT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020338-25-GB Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020338-25-FI Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020337-99-EE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
GENENTECH Inc.
2016 Phase 3 EUCTR2015-004616-37-SE Germany;Sweden;Switzerland;United States;
2016 Phase 3 EUCTR2015-004616-37-DE Germany;Sweden;Switzerland;United States;
Helse Bergen HF, Haukeland University Hospital
2022 Phase 3 EUCTR2020-001205-23-SE Sweden;
2019 Phase 3 EUCTR2017-001362-25-NL Denmark;Netherlands;
2018 Phase 3 EUCTR2017-001362-25-DK Denmark;Netherlands;
Hoffman La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-SK Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 Phase 2 EUCTR2007-006338-32-GB Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 Phase 2 EUCTR2007-006338-32-DK Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 Phase 2 EUCTR2007-006338-32-CZ Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 Phase 2 EUCTR2007-006338-32-BG Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 Phase 2 EUCTR2007-006338-32-BE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
Kessler Foundation
2021 - NCT04448977 United States;
Robert Zivadinov, MD, PhD
2021 Phase 4 NCT04925557 United States;
Roche Farma S. A. U. que realiza el ensayo en España y que actúa como representante F. Hoffmann-La Roche Ltd
2021 Phase 3 EUCTR2020-005448-48-ES Brazil;Czechia;France;Italy;Spain;
University Medical Centre Hamburg-Eppendorf
2020 Phase 2 EUCTR2016-001166-29-DE Germany;
VU medical center
2022 Phase 4 EUCTR2021-004791-34-NL Netherlands;
Ocrevus 300 mg, solution à diluer pour perfusion
ROCHE
2018 Phase 4 EUCTR2018-000780-91-FR France;
Ocrrelizumab
F. Hoffman-La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-DE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
Octagam
Octapharma AG
2009 - EUCTR2008-004579-22-DE Austria;Germany;
2008 - EUCTR2008-004579-22-AT Austria;
Octagam 50 mg/ml
Octapharma AG
2015 Phase 3 EUCTR2012-005086-12-PL Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;Serbia;Ukraine;
2013 - EUCTR2012-005086-12-HU Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-DE Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-BG Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-AT Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
Ocufolin
University of Miami
2007 - NCT03135327 United States;
Ofatumumab
Brigham and Women's Hospital
2020 Phase 3 NCT04510220 United States;
Genmab A/S
2008 Phase 2 EUCTR2007-004223-38-DE Belgium;Czech Republic;Denmark;Germany;Sweden;United Kingdom;
2008 - EUCTR2007-004223-38-BE Belgium;Czech Republic;Denmark;Germany;Sweden;United Kingdom;
GlaxoSmithKline
2011 Phase 2 NCT01457924 Bulgaria;Canada;Czech Republic;Czechia;Denmark;Germany;Italy;Netherlands;Norway;Russian Federation;Spain;United States;
2008 - EUCTR2007-004223-38-DK Czech Republic;Denmark;Germany;Sweden;United Kingdom;
GlaxoSmithKline AB
2008 - EUCTR2007-004223-38-SE Czech Republic;Denmark;Germany;Sweden;United Kingdom;
GlaxoSmithKline UK
2009 Phase 2 EUCTR2007-004223-38-GB Belgium;Czech Republic;Denmark;Germany;Sweden;United Kingdom;
GlaxoSmithKline s.r.o.
2008 - EUCTR2007-004223-38-CZ Czech Republic;Denmark;Germany;Sweden;United Kingdom;
NOVARTIS PHARMA SERVICES AG
2021 Phase 3 EUCTR2020-002700-39-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2015-005419-33-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
2017 Phase 3 EUCTR2015-005418-31-IT Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
Novartis Pharma K.K.
2018 Phase 2 JPRN-JapicCTI-173711 Japan, Russia;
Novartis Pharmaceuticals
2022 Phase 4 NCT05090371 United States;
2022 Phase 4 NCT05084638 United States;
2022 - NCT05285904 -
2022 - NCT05266469 -
2022 - NCT05090033 -
2021 Phase 4 NCT04878211 United States;
2021 Phase 4 NCT04869358 Germany;
2021 Phase 4 NCT04667117 United States;
2021 Phase 3 NCT04926818 Australia;Austria;Belgium;France;Germany;India;Latvia;Mexico;Poland;Portugal;Russian Federation;Slovakia;Spain;Turkey;United States;
2021 Phase 3 NCT04788615 France;Germany;Spain;United Kingdom;
2021 - NCT04847596 Puerto Rico;United States;
2021 - NCT04676555 Australia;United Kingdom;United States;
2020 Phase 3 NCT04486716 Puerto Rico;United States;
2020 Phase 3 NCT04353492 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czechia;Estonia;Germany;Greece;Hungary;Italy;Latvia;Lebanon;Mexico;Norway;Poland;Portugal;Russian Federation;Saudi Arabia;Slovakia;Slovenia;Spain;Switzerland;Turkey;United Kingdom;United States;
2018 Phase 3 NCT03650114 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
2018 Phase 2 NCT03249714 Japan;Russian Federation;
University of Southern California
2022 - NCT05171972 United States;
Ofatumumab 100
GlaxoSmithKline
2008 Phase 2 NCT00640328 Belgium;Czech Republic;Denmark;Former Serbia and Montenegro;Germany;Poland;Serbia;Sweden;United Kingdom;
Ofatumumab 300
GlaxoSmithKline
2008 Phase 2 NCT00640328 Belgium;Czech Republic;Denmark;Former Serbia and Montenegro;Germany;Poland;Serbia;Sweden;United Kingdom;
Ofatumumab 700
GlaxoSmithKline
2008 Phase 2 NCT00640328 Belgium;Czech Republic;Denmark;Former Serbia and Montenegro;Germany;Poland;Serbia;Sweden;United Kingdom;
Ofatumumab subcutaneous injection
Novartis Pharmaceuticals
2016 Phase 3 NCT02792231 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Finland;France;Germany;Hungary;India;Italy;Latvia;Lithuania;Mexico;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 NCT02792218 Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Mexico;Netherlands;Poland;Puerto Rico;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
Oleovit D3 14.400 IU/ml oral drops, solution
University medical centre Maribor
2017 Phase 4 EUCTR2017-004846-31-SI Slovenia;
Olesoxime (TRO19622)
Hoffmann-La Roche
2013 Phase 1 NCT01808885 France;
Olive oil
Terry L. Wahls
2022 - NCT05007483 United States;
Omega 3 fatty acids
University of Iowa
2010 Phase 1 NCT01381354 United States;
Omeprazole
Biogen
2011 Phase 3 NCT01462318 Czech Republic;Hungary;Poland;Russian Federation;United States;
OnabotulinumtoxinA
Allergan
2012 Phase 3 NCT01600716 Belgium;Canada;Czech Republic;Czechia;France;Poland;Portugal;Russian Federation;United States;
Opicinumab
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 2 EUCTR2017-001224-22-IT Australia;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
Biogen Idec Research Limited
2018 Phase 2 EUCTR2017-001224-22-PL Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
2018 Phase 2 EUCTR2017-001224-22-NL Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
2018 Phase 2 EUCTR2017-001224-22-DE Australia;Belgium;Canada;Czech Republic;Czechia;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
2018 Phase 2 EUCTR2017-001224-22-BE Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
2017 Phase 2 EUCTR2017-001224-22-HU Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
2017 Phase 2 EUCTR2017-001224-22-GB Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
2017 Phase 2 EUCTR2017-001224-22-ES Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
2017 Phase 2 EUCTR2017-001224-22-CZ Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;Switzerland;United Kingdom;United States;
Optical coherence tomography (OCT)
Medical University of Vienna
2018 - NCT03401879 Austria;
Optical coherence tomography angiography (OCTA)
Medical University of Vienna
2018 - NCT03401879 Austria;
Oral Methylprednisolone 625 mg/24h x3 days
Germans Trias i Pujol Hospital
2013 Phase 4 NCT01986998 Spain;
Oral THC
University of California, Davis
2004 Phase 1/Phase 2 NCT00682929 United States;
Oral corticosteroids
Hoffmann-La Roche
2021 Phase 3 NCT04660539 Bulgaria;Canada;Croatia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Puerto Rico;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Oral lipoic acid (LA)
Oregon Health and Science University
2005 Phase 1 NCT00676156 United States;
Orelabrutinib
Beijing InnoCare Pharma Tech Co., Ltd.
2021 Phase 2 NCT04711148 China;Poland;Ukraine;United States;
Peking Union Medical College Hospital
2022 - NCT05284175 China;
Other H1 antagonist
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
Other analgesics and antipyretics
GW PHARMA LTD
2008 - EUCTR2006-005910-11-IT Germany;Italy;Spain;United Kingdom;
Other disease-modifying therapy
Novartis Pharmaceuticals
2011 - NCT01442194 Argentina;Australia;Canada;Chile;Mexico;Puerto Rico;United States;
Other nervous system drugs
NOVARTIS FARMA
2011 - EUCTR2011-000770-60-IT Italy;
Ovastat 1000
medac Gesellschaft für klinische Spezialpräparate mbH
2007 - EUCTR2006-002856-14-DE Germany;
Ovastat 5000
medac Gesellschaft für klinische Spezialpräparate mbH
2007 - EUCTR2006-002856-14-DE Germany;
Oxcarbazepine
Queen Mary University London
2014 Phase 2 EUCTR2013-002419-87-GB United Kingdom;
Queen Mary University of London
2014 Phase 2 NCT02104661 United Kingdom;
Oxybutynin Hydrochloride
Astellas Pharma Inc
2008 Phase 4 NCT00629642 Australia;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Portugal;Russian Federation;Spain;United Kingdom;
Ozanimod
Celgene
2014 Phase 3 NCT02294058 Argentina;Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Czechia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2013 Phase 3 NCT02047734 Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Celgene International II Sàrl (CIS II)
2015 Phase 3 EUCTR2015-002500-91-HU Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-002500-91-GB Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-002500-91-BE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-PL Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-LV Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-LT Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-HU Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-HR Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-GB Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-BG Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2014-002320-27-PT Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2014-002320-27-EE Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2013 Phase 2;Phase 3 EUCTR2012-002714-40-HU Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2013 Phase 2;Phase 3 EUCTR2012-002714-40-BG Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2013 Phase 2;Phase 3 EUCTR2012-002714-40-BE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
Receptos, Inc.
2015 Phase 3 EUCTR2014-002320-27-SE Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-NL Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-ES Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 - EUCTR2015-002500-91-ES Argentina;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
Ozanimod HCI
Celgene International II Sàrl (CIS II)
2016 Phase 3 EUCTR2015-002500-91-PT Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-002500-91-GR Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
Ozanimod HCL
CELGENE INTERNATIONAL II SàRL
2016 Phase 3 EUCTR2015-002500-91-IT Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
Ozanimod HCl
Celgene International II Sàrl (CIS II)
2017 Phase 3 EUCTR2015-002500-91-SE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-002500-91-SK Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-002500-91-PL Argentina;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-002500-91-LV Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-002500-91-LT Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-002500-91-HR Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-002500-91-EE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-002500-91-BG Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
Ozanimod hydrochloride
Celgene International II Sàrl
2016 Phase 1 EUCTR2016-003073-18-GB United Kingdom;
PAT
University of Ottawa
2020 - NCT04267185 Canada;
PB006
Polpharma Biologics S.A.
2019 Phase 3 EUCTR2018-004751-20-PL Belarus;Croatia;Georgia;Moldova, Republic of;Poland;Serbia;Ukraine;
2019 Phase 3 EUCTR2018-004751-20-HR Belarus;Croatia;Georgia;Moldova, Republic of;Poland;Serbia;Ukraine;
PEG-liposomal Prednisolone Sodium Phosphate
Enceladus Pharmaceuticals BV
2010 - EUCTR2009-013884-21-PL Belgium;Germany;Poland;
2009 Phase 2 EUCTR2009-013884-21-BE Belgium;Germany;Poland;
2009 - EUCTR2009-013884-21-DE Belgium;Germany;Poland;
PEG-liposomal prednisolone sodium phosphate
Galapagos NV
2009 Phase 2 NCT01039103 Belgium;Germany;Poland;
PEGINTERFERONE BETA-1A
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-003008-38-IT Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
PEGINTERFERONE LAMBDA-1A
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-003008-38-IT Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
PEGylated Intereron Beta-1a
Biogen Idec Limited
2012 Phase 3 EUCTR2010-024477-39-GR Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2010-024477-39-GB Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2012 - EUCTR2010-024477-39-CZ Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-024477-39-DE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-024477-39-BG Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-024477-39-LV Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-024477-39-EE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-024477-39-BE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
PEGylated Interferon Beta-1a
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-003008-38-IT Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
Biogen Idec LTD
2009 - EUCTR2008-006333-27-LV Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Latvia;Netherlands;Spain;United Kingdom;
Biogen Idec Limited
2012 Phase 3 EUCTR2010-024477-39-GR Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2010-024477-39-GB Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2012 - EUCTR2010-024477-39-CZ Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-024477-39-DE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-024477-39-BG Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-024477-39-LV Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-024477-39-EE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-024477-39-BE Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2010 - EUCTR2008-006333-27-GR Belgium;Bulgaria;Czech Republic;Estonia;Germany;Greece;Latvia;Netherlands;Spain;United Kingdom;
2010 - EUCTR2008-006333-27-CZ Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2008-006333-27-GB Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2009 - EUCTR2008-006333-27-NL Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2009 - EUCTR2008-006333-27-EE Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2009 - EUCTR2008-006333-27-BG Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2009 - EUCTR2008-006333-27-BE Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
- - EUCTR2008-006333-27-DE Belarus;Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Kazakhstan;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
Biogen Idec Research Limited
2020 Phase 3 EUCTR2018-003008-38-DE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-SK Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-PT Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-HU Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-HR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-GR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-ES Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;
2019 Phase 3 EUCTR2018-003008-38-CZ Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;
2019 Phase 3 EUCTR2018-003008-38-BG Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-BE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-000516-22-PT Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-000516-22-HU Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-000516-22-EE Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States;
- Phase 3 EUCTR2018-003008-38-FR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
PET with 11C-Flumazenil
Assistance Publique - Hôpitaux de Paris
2013 - NCT01651520 France;
PET-MRI with [18F]-Florbetaben and PET-MRI with [18F]-DPA-714
Assistance Publique - Hôpitaux de Paris
2022 - NCT05147532 -
PF-06342674
Pfizer
2014 Phase 1 NCT02045732 United States;
PHENYLCYCLOPROPYLAMINE DERIVATIVES AND DUAL LSD1/MAO-B (LYSINE-SPECIFIC DEMETHYLASE 1 AND MONOAMINE OXIDASE-B) INHIBITOR
Oryzon Genomics S. A
2017 Phase 2 EUCTR2017-002838-23-ES Spain;
PI-2301
PEPTIMMUNE Inc
2008 - EUCTR2007-007759-15-HU Hungary;
Peptimmune Inc.
2010 Phase 2 EUCTR2009-012716-40-SK Bulgaria;Czech Republic;Estonia;France;Germany;Poland;Slovakia;
2010 Phase 2 EUCTR2009-012716-40-DE Bulgaria;Czech Republic;Estonia;France;Germany;Poland;Slovakia;
2010 - EUCTR2009-012716-40-PL Bulgaria;Czech Republic;Estonia;France;Germany;Poland;
2010 - EUCTR2009-012716-40-FR Bulgaria;Czech Republic;Estonia;France;Germany;Poland;
2010 - EUCTR2009-012716-40-CZ Bulgaria;Czech Republic;Estonia;France;Germany;Poland;
2010 - EUCTR2009-012716-40-BG Bulgaria;Czech Republic;Estonia;France;Germany;Poland;
2009 - EUCTR2009-012716-40-EE Bulgaria;Czech Republic;Estonia;France;Germany;Poland;
PIPE-307
Pipeline Therapeutics, Inc.
2021 Phase 1 NCT04941781 United Kingdom;
2021 Phase 1 NCT04725175 Australia;
PL 04515/0127
Queen Mary, University of London
2009 - EUCTR2008-000256-26-GB United Kingdom;
PL 12762/0049
University College London
2010 Phase 4 EUCTR2009-017939-18-GB United Kingdom;
PLEDIGRY
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France;
PLEGRIDY - 125 MCG - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - PENNA PRERIEMPITA - 0,5 ML - 6 PENNE PRERIEMPITE
BIOGEN IDEC ITALIA S.R.L.
2015 Phase 4 EUCTR2015-002201-11-IT Italy;
PLP peptide
Centrum Neurologii Krzysztof Selmaj
2016 Phase 2 EUCTR2016-002180-33-PL Poland;
PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED)
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 2;Phase 3 EUCTR2019-001829-26-IT Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States;
PNU-215062 sodium salt
Teva Pharmaceutical Industries Ltd
2006 Phase 2 EUCTR2005-004334-41-ES Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
2005 Phase 2 EUCTR2004-003943-28-GB Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
2005 Phase 2 EUCTR2004-003943-28-ES Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
2005 - EUCTR2004-003943-28-HU Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
2005 - EUCTR2004-003943-28-DE Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
2005 - EUCTR2004-003943-28-CZ Czech Republic;Germany;Hungary;Italy;Spain;United Kingdom;
PO
Actelion Pharmaceuticals Ltd.
2018 Phase 3 EUCTR2016-004719-10-PT Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004719-10-GR Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004719-10-GB Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004719-10-FI Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004719-10-CZ Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2016-004719-10-BG Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-004719-10-SE Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-004719-10-PL Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-004719-10-LT Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
PRD806998
Biogen Idec Research Limited
2013 Phase 2 EUCTR2011-006262-40-NL Canada;Czech Republic;France;Hungary;Italy;Netherlands;Poland;Russian Federation;Serbia;Spain;United Kingdom;United States;
PRN2246
GENZYME CORPORATION
2020 Phase 3 EUCTR2020-000647-30-IT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000645-14-IT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000637-41-IT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
Genzyme Corporation
2021 Phase 3 EUCTR2020-000647-30-PT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000645-14-PT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000645-14-NL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000645-14-HU Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000645-14-HR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000645-14-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000645-14-BE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000644-55-DE Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000637-41-AT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000647-30-PL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000647-30-NL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000647-30-LT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000647-30-GR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000647-30-GB Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000647-30-FI Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000647-30-DK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000647-30-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000647-30-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000647-30-BG Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000645-14-GR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000645-14-GB Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000645-14-FR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000645-14-EE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000645-14-DK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000645-14-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000645-14-BG Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-SK Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-PT Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-NL Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-LV Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-HU Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-GR Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-GB Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-FR Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-CZ Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000637-41-SE Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-PL Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-LT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-FI Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-DK Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-DE Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-CZ Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-BG Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2019 Phase 2 EUCTR2018-004731-76-SK Canada;Czech Republic;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States;
2019 Phase 2 EUCTR2018-004731-76-NL Canada;Czech Republic;Czechia;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States;
2019 Phase 2 EUCTR2018-004731-76-ES Canada;Czech Republic;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States;
2019 Phase 2 EUCTR2018-004731-76-EE Canada;Czech Republic;Czechia;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States;
2019 Phase 2 EUCTR2018-004731-76-CZ Canada;Czech Republic;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States;
2019 Phase 2 EUCTR2018-003927-12-SK Canada;Czech Republic;Estonia;France;Netherlands;Norway;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States;
2019 Phase 2 EUCTR2018-003927-12-SE Canada;Czech Republic;Estonia;France;Netherlands;Norway;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States;
2019 Phase 2 EUCTR2018-003927-12-NL Canada;Czech Republic;Estonia;France;Netherlands;Norway;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States;
2019 Phase 2 EUCTR2018-003927-12-ES Canada;Czech Republic;Estonia;France;Netherlands;Norway;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States;
2019 Phase 2 EUCTR2018-003927-12-EE Canada;Czech Republic;Estonia;France;Netherlands;Norway;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States;
PTL201
PhytoTech Therapeutics, Ltd.
2018 Phase 2 NCT03005119 Israel;
Paired associative stimulation (PAS)
Shirley Ryan AbilityLab
2017 - NCT03723434 United States;
Palifermin
Cambridge University Hospitals NHS Foundation Trust
2012 Phase 1/Phase 2 NCT01712945 United Kingdom;
Cambridge University Hospitals NHS Foundation Trust and University of Cambridge
2012 Phase 2 EUCTR2011-005606-30-GB United Kingdom;
Pantoprazole
Merck KGaA
2008 Phase 1 NCT00938366 -
Paracetamol
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
2015 Phase 1 NCT02583594 Spain;
2014 Phase 4 NCT02205489 Belgium;France;Netherlands;Spain;
Rigshospitalet, Denmark
2021 Phase 3 NCT04688788 Denmark;
Paracetamolo
NOVARTIS PHARMA AG
2018 Phase 2 EUCTR2017-004702-17-IT Austria;Bulgaria;Czech Republic;Czechia;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
Paroxetine
University of Manitoba
2006 Phase 3 NCT00291148 Canada;
Part A: 100 mg/mL GSK2618960
GlaxoSmithKline
2013 Phase 1 NCT01808482 United Kingdom;
Part B: Dose of GSK2618960 decided from Part A
GlaxoSmithKline
2013 Phase 1 NCT01808482 United Kingdom;
Part C: Dose of GSK2618960 decided from Part A and B
GlaxoSmithKline
2013 Phase 1 NCT01808482 United Kingdom;
Peanut
Rocky Mountain MS Research Group, LLC
2014 Phase 4 NCT02217982 United States;
Peginterferon beta-1a
Biogen
2017 Phase 4 NCT03177083 Portugal;
2016 Phase 4 NCT02587065 Italy;
2016 Phase 4 NCT02568111 -
2014 - NCT02230969 Australia;Austria;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Portugal;Spain;Switzerland;United Kingdom;United States;
2013 - NCT01911767 Australia;Canada;France;Germany;Ireland;Italy;Poland;Spain;United Kingdom;United States;
2011 Phase 3 NCT01332019 Belgium;Bulgaria;Canada;Chile;Colombia;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;India;Latvia;Mexico;Netherlands;New Zealand;Peru;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
Biogen Idec
2014 Phase 1 NCT02269930 United States;
Peginterferone beta 1a
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain;
Pegylated interferon beta-1a
Cinnagen
2017 Phase 3 NCT05242133 Iran, Islamic Republic of;
Pending
JOSE MANUEL GARCIA DOMINGUEZ
2013 - EUCTR2011-000985-36-ES Spain;
Peripheral Blood Stem Cell Transplantation
Fred Hutchinson Cancer Research Center
2008 Phase 2 NCT00716066 United States;
Peripheral blood stem cell transplantation
Fred Hutchinson Cancer Research Center
1997 Phase 1 NCT00014755 United States;
Personalized extended interval dosing of natalizumab
VU University Medical Center
2020 Phase 4 NCT04225312 Netherlands;
Phenytoin
University College, London
2011 Phase 2 NCT01451593 United Kingdom;
Pioglitazone
National Institute of Allergy and Infectious Diseases (NIAID)
2017 Phase 1/Phase 2 NCT03109288 United States;
Pirfenidone
National Institute of Allergy and Infectious Diseases (NIAID)
2017 Phase 1/Phase 2 NCT03109288 United States;
Pixantrone
Fondation Charcot Stichting
2009 Phase 1;Phase 2 EUCTR2007-003086-40-BE Belgium;France;
2008 - EUCTR2007-003086-40-FR France;
Placebo
Novartis Pharma K.K.
2018 Phase 2 JPRN-JapicCTI-173711 Japan, Russia;
2014 Phase 3 JPRN-JapicCTI-142447 -
2013 Phase 2 JPRN-JapicCTI-132178 -
Plasma exchange
Biogen Idec
2007 Phase 0 NCT00424788 United States;
Platelet transfusion
Region Skane
2016 - NCT02601131 Sweden;
Platform
Georgia State University
2021 Phase 4 NCT04387734 United States;
Plegridy
BIOGEN IDEC RESEARCH LIMITED
2019 Phase 3 EUCTR2018-003008-38-IT Argentina;Australia;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
Biogen Idec Research Limited
2020 Phase 3 EUCTR2018-003008-38-DE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-SK Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-PT Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-HU Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-HR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-GR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-ES Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;
2019 Phase 3 EUCTR2018-003008-38-CZ Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;
2019 Phase 3 EUCTR2018-003008-38-BG Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-003008-38-BE Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-000516-22-PT Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-000516-22-HU Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-000516-22-EE Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States;
- Phase 3 EUCTR2018-003008-38-FR Argentina;Australia;Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Greece;Hungary;Israel;Italy;Kuwait;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Tunisia;Turkey;United States;
Holy Name Medical Center, Inc.
2017 Phase 4 NCT03424733 United States;
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain;
Plegridy (peginterferon beta-1a), Biogen Idec Ltd
Bayer
2016 - NCT02749396 Finland;
Plegridy 125 micrograms
Biogen Portugal
2016 Phase 4 EUCTR2016-000434-21-PT Portugal;
Plegridy 63 micrograms
Biogen Portugal
2016 Phase 4 EUCTR2016-000434-21-PT Portugal;
Pleneva TM BGC20-0134
BTG International Inc.
2009 Phase 2 NCT01037907 Belgium;France;Germany;Italy;Poland;Russian Federation;Spain;
Plovamer acetate
Merck KGaA
2014 Phase 2 EUCTR2013-002283-25-GB Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2014 - EUCTR2013-002283-25-PL Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2014 - EUCTR2013-002283-25-GR Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2014 - EUCTR2013-002283-25-ES Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2014 - EUCTR2013-002283-25-BG Bulgaria;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States;
2013 - EUCTR2013-002283-25-IT Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2013 - EUCTR2013-002283-25-HU Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2013 - EUCTR2013-002283-25-HR Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2013 - EUCTR2013-002283-25-FI Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
2013 - EUCTR2013-002283-25-CZ Bulgaria;Colombia;Croatia;Czech Republic;Finland;Greece;Hungary;Italy;Mexico;Poland;Serbia;South Africa;Spain;Turkey;United Kingdom;United States;
Plovamer acetate 0.5 milligram (mg)
EMD Serono
2013 Phase 2 NCT01963611 Bulgaria;Croatia;Czech Republic;Finland;Germany;Greece;Hungary;Italy;Mexico;Poland;Russian Federation;Serbia;South Africa;Spain;Turkey;Ukraine;United Kingdom;United States;
Pneumococcal polysaccharide vaccine
Celgene
2021 Phase 3 NCT05028634 Germany;United States;
Pneumovax II
R & D, Cambridge University Hospitals
2009 - EUCTR2009-011523-31-GB United Kingdom;
Polyphenon E
Louisiana State University Health Sciences Center in New Orleans
2011 Phase 2 NCT01451723 United States;
2009 Phase 1 NCT00836719 United States;
Ponesimod
ACTELION Pharmaceuticals Ltd
2010 Phase 2 EUCTR2009-011470-15-HU Australia;Austria;Bulgaria;Canada;Czech Republic;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
Actelion
2017 Phase 3 NCT03232073 Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 NCT02907177 Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Italy;Mexico;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;United Kingdom;United States;
2015 Phase 3 NCT02425644 Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2010 Phase 2 NCT01093326 Austria;Bulgaria;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
Pravastatin
Nantes University Hospital
2004 Phase 3 NCT00200655 France;
Prebiotics (Prebiotin Prebiotic Fiber Stick Pac)
Columbia University
2020 - NCT04038541 United States;
Prednisolone
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
Tohoku University Hospital
2013 Phase 1,2 JPRN-UMIN000010094 Japan;
Prednisone
Claudio Gobbi
2011 Phase 4 NCT01411514 Switzerland;
Fred Hutchinson Cancer Research Center
2008 Phase 2 NCT00716066 United States;
1997 Phase 1 NCT00014755 United States;
Holy Name Medical Center, Inc.
2017 Phase 4 NCT03424733 United States;
National Eye Institute (NEI)
1988 Phase 3 NCT00000146 United States;
1988 - NCT00000147 United States;
National Institute of Neurological Disorders and Stroke (NINDS)
2016 Phase 2 NCT02784210 United States;
Teva Pharmaceutical Industries
2005 Phase 4 NCT00203047 Canada;United States;
Third Affiliated Hospital, Sun Yat-Sen University
2016 Phase 4 NCT02809079 -
Pregabalin
Pfizer Japan Inc.
2010 Phase 3 JPRN-JapicCTI-101335 -
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
2010 Phase 3 NCT01202227 Japan;
University of Manitoba
2006 Phase 3 NCT00291148 Canada;
Prepulsid
Department of Neurology UMCG
2006 - EUCTR2006-004318-42-NL Netherlands;
Prevenar 13
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 2;Phase 3 EUCTR2019-001829-26-IT Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States;
Probiotics (Visbiome®)
Columbia University
2020 - NCT04038541 United States;
Prohance (Gadoteridol)
University of Nottingham
2017 - NCT02481882 United Kingdom;
Prolonged-release Fampridine
University of Zurich
2012 Phase 2 NCT01576354 Switzerland;
Prophylactic vaccine (tetanus, diphtheria, pertussis, poliomyelitis, influenza, hepatitis A, hepatitis B, tick-borne encephalitis, meningococcal, pneumococcal)
Dr. med. Micha Loebermann
2009 - NCT02275741 Germany;
Provigil
Sheba Medical Center
2005 - NCT00220506 Israel;
Provigil (modafinil)
Institute for Clinical Research
2003 - NCT00210301 United States;
Pure ECGC capsules
Louisiana State University Health Sciences Center in New Orleans
2015 Phase 2 NCT02011451 United States;
Quadrivalent influenza vaccine
Novartis Pharmaceuticals
2021 Phase 4 NCT04667117 United States;
Quality of life
University Hospital, Strasbourg, France
2019 Phase 2 NCT03910738 France;
Quinidina sulfato
Avanir Pharmaceuticals, Inc.
2011 Phase 2 EUCTR2011-002178-22-ES Argentina;Bulgaria;Czech Republic;Poland;Spain;United Kingdom;United States;
Quinidine Sulfate
Avanir Pharmaceuticals, Inc.
2012 Phase 2 EUCTR2011-002178-22-GB Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States;
2012 - EUCTR2011-002178-22-PL Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States;
2012 - EUCTR2011-002178-22-CZ Argentina;Bulgaria;Czech Republic;Germany;Poland;Spain;United Kingdom;United States;
R lipoic acid
Oregon Health and Science University
2005 Phase 1 NCT00676156 United States;
RABBIT HUMAN T LYMPHOCYTE IMMUNOGLOBULIN
Uppsala l?ns landsting
2011 - EUCTR2010-023560-40-SE Brazil;Canada;Sweden;United States;
RAS
The Cleveland Clinic
2014 - NCT02065284 United States;
RATG
Northwestern University
2019 Phase 2/Phase 3 NCT03829566 United States;
2017 Phase 3 NCT03342638 United States;
RC18
RemeGen Co., Ltd.
2021 Phase 2 NCT04625153 China;
2018 Phase 3 NCT03330418 China;
REBIF - 44 MCG(12 MILIONI UI) -SOLUZ INIETTABILE- USO SOTTOCUTANEO-PENNA PRERIEMPITA 0.5 ML (24 MILIONI UI/ML)12 PENNE PRERIEMPITE
OSPEDALE SAN RAFFAELE
2018 Phase 4 EUCTR2016-004819-12-IT Italy;
REBIF 44 microgramos solución inyectable
Merck Serono International, a branch of Laboratoires Serono SA an affiliate of Merck KGaA, Darmstadt
2009 Phase 3 EUCTR2008-004954-34-ES Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Slovakia;Spain;
Merck Serono S.A. - Geneva, an affiliate of Merck KGaA Darmstadt, Germany
2006 - EUCTR2006-002982-38-ES Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain;
sanofi-aventis recherche et development
2009 - EUCTR2008-006226-34-ES Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom;
REBIF 44 microgramos solución inyectable en jeringa precargada
Biogen Idec Limited
2010 - EUCTR2009-015556-15-ES Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
REBIF SC 12SIR 12000000UI44MCG
Universita di Firenze
2006 - EUCTR2006-004937-13-IT Italy;
REBIF SC 12SIR 6000000UI 22MCG
Universita di Firenze
2006 - EUCTR2006-004937-13-IT Italy;
REBIF*SC 12SIR 12000000UI44MCG
MERCK SERONO INTERNATIONAL SA
2008 - EUCTR2006-003366-33-IT Italy;Spain;
MERCK SERONO SA
2009 - EUCTR2008-004954-34-IT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Spain;
2009 - EUCTR2008-003706-33-IT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
OSPEDALE S. RAFFAELE
2004 - EUCTR2004-001601-10-IT France;Italy;
REBIF*SC 12SIR 6000000UI 22MCG
BIOGEN IDEC LTD
2010 - EUCTR2009-015556-15-IT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
RECOMBINANT INTERFERON BE
Novartis Pharma GmbH
2021 Phase 4 EUCTR2020-005752-38-DE Germany;
RECOMBINANT INTERFERON BETA-1B
Bayer AG
2018 Phase 4 EUCTR2017-001176-31-PT Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2017 Phase 4 EUCTR2017-001176-31-GB Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2017 Phase 4 EUCTR2017-001176-31-FR Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2017 Phase 4 EUCTR2017-001176-31-FI Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2017 Phase 4 EUCTR2017-001176-31-ES Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2017 Phase 4 EUCTR2017-001176-31-DK Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2017 Phase 4 EUCTR2017-001176-31-CZ Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2017 Phase 4 EUCTR2017-001176-31-AT Austria;Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Hungary;Israel;Italy;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 2;Phase 3 EUCTR2019-001829-26-IT Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States;
REVAXIS
R & D, Cambridge University Hospitals
2009 - EUCTR2009-011523-31-GB United Kingdom;
RG2077 (CTLA4-IgG4m)
National Institute of Allergy and Infectious Diseases (NIAID)
2003 Phase 1 NCT00076934 United States;
RHB-104
RedHill Biopharma Limited
2013 Phase 2 NCT01717664 Israel;
RHIgM22
Acorda Therapeutics
2015 Phase 1 NCT02398461 United States;
2013 Phase 1 NCT01803867 United States;
RHuPH20
Hoffmann-La Roche
2019 Phase 1 NCT03972306 Canada;United States;
RIPK1 inhibitor
Sanofi
2021 Phase 1 NCT04982991 United Kingdom;
RNF
Merck KGaA
2008 Phase 3 NCT00813709 Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Turkey;
2006 Phase 3 NCT00404352 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Slovakia;Spain;Switzerland;Turkey;
RNS60
University Hospital Zürich
2014 Phase 2 EUCTR2014-000221-20-AT Austria;Switzerland;
RNS60 125 ml
Revalesio Corporation
2013 Phase 2 NCT01714089 United States;
RNS60 250 ml
Revalesio Corporation
2013 Phase 2 NCT01714089 United States;
RO0506997
F. Hoffmann-La Roche Ltd
2007 Phase 2 EUCTR2004-004519-43-SK Czech Republic;Germany;Slovakia;Spain;United Kingdom;
2007 - EUCTR2004-004519-43-GB Czech Republic;Germany;Spain;United Kingdom;
2007 - EUCTR2004-004519-43-DE Czech Republic;Germany;Spain;United Kingdom;
2005 - EUCTR2004-004519-43-CZ Czech Republic;Germany;Spain;United Kingdom;
RO4964913
F. HOFFMANN - LA ROCHE LTD.
2021 Phase 3 EUCTR2020-005448-48-IT Brazil;Czechia;France;Italy;Spain;
2018 Phase 3;Phase 4 EUCTR2017-004886-29-IT Belgium;Bulgaria;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
F. Hoffmann-La Roche Ltd
2022 Phase 3 EUCTR2020-005448-48-CZ Australia;Brazil;Canada;Czech Republic;Czechia;France;Italy;New Zealand;Poland;Russian Federation;Spain;Turkey;Ukraine;United States;
2021 Phase 3 EUCTR2020-005448-48-PL Australia;Brazil;Canada;Czechia;France;Italy;New Zealand;Poland;Russian Federation;Spain;Turkey;Ukraine;United States;
2021 Phase 3 EUCTR2019-003919-53-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-003919-53-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-003919-53-GR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-003919-53-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-003919-53-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-003919-53-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2019-003919-53-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2017-004886-29-SI Argentina;Belgium;Brazil;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Mexico;Netherlands;Poland;Portugal;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2021 Phase 3 EUCTR2017-004886-29-PT Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2021 Phase 3 EUCTR2017-004886-29-PL Argentina;Belgium;Brazil;Bulgaria;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2021 Phase 3 EUCTR2017-004886-29-HU Argentina;Belgium;Brazil;Bulgaria;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2021 Phase 3 EUCTR2017-004886-29-HR Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2021 Phase 3 EUCTR2017-004886-29-BG Argentina;Belgium;Brazil;Bulgaria;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2021 Phase 3 EUCTR2017-004886-29-BE Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2020 Phase 3 EUCTR2019-003919-53-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Israel;Latvia;Lithuania;Mexico;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;South Africa;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2017-001313-93-DE Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates;
2019 Phase 3 EUCTR2017-004886-29-IE Argentina;Belgium;Brazil;Bulgaria;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2018 Phase 3 EUCTR2017-004886-29-SE Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2018 Phase 3 EUCTR2017-004886-29-NL Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2018 Phase 3 EUCTR2017-004886-29-GB Czech Republic;Denmark;Estonia;Finland;France;Ireland;Netherlands;Spain;Sweden;United Kingdom;
2018 Phase 3 EUCTR2017-004886-29-FR Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Turkey;United Kingdom;
2018 Phase 3 EUCTR2017-004886-29-FI Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Turkey;United Kingdom;
2018 Phase 3 EUCTR2017-004886-29-EE Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Turkey;United Kingdom;
2018 Phase 3 EUCTR2017-004886-29-DK Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2018 Phase 3 EUCTR2017-004886-29-CZ Argentina;Belgium;Brazil;Bulgaria;Croatia;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Hungary;Ireland;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Slovakia;Slovenia;Spain;Sweden;Turkey;United Kingdom;
2018 Phase 3 EUCTR2017-001313-93-PL Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates;
2018 Phase 3 EUCTR2017-001313-93-IE Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates;
2018 Phase 3 EUCTR2017-001313-93-HU Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Denmark;Egypt;France;Guatemala;Hungary;Ireland;Italy;Kuwait;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Saudi Arabia;Spain;United Arab Emirates;
2018 Phase 3 EUCTR2017-001313-93-DK Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates;
2018 Phase 3 EUCTR2017-001313-93-CZ Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Czechia;Denmark;Egypt;France;Germany;Guatemala;Hungary;Ireland;Italy;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Spain;United Arab Emirates;
F.Hoffmann-La Roche
2011 Phase 3 EUCTR2010-020315-36-FR Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-020338-25-DK Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Portugal;Spain;United Kingdom;
2011 - EUCTR2010-020337-99-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-020315-36-ES Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Colombia;Croatia;Ireland;Italy;Mexico;Peru;Russian Federation;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020337-99-FI Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;United Kingdom;United States;
2010 - EUCTR2010-020338-25-ES Austria;Belgium;Bulgaria;Czech Republic;Denmark;Finland;Greece;Hungary;Italy;Lithuania;Portugal;Spain;United Kingdom;
2010 - EUCTR2010-020337-99-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
F.Hoffmann-La Roche Ltd.
2008 - EUCTR2007-006338-32-IT Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Russian Federation;Spain;Switzerland;Ukraine;United Kingdom;United States;
Hoffman La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-ES Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Slovakia;Spain;United Kingdom;
2008 - EUCTR2007-006338-32-NL Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Spain;United Kingdom;
2008 - EUCTR2007-006338-32-FI Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Spain;United Kingdom;
ROCHE
2018 Phase 4 EUCTR2018-000780-91-FR France;
2011 - EUCTR2010-020337-99-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;New Zealand;Peru;Poland;Portugal;Russian Federation;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-020315-36-IT Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Colombia;Croatia;Ireland;Italy;Mexico;Peru;Russian Federation;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Roche Farma S. A. U. que realiza el ensayo en España y que actúa como representante F. Hoffmann-La Roche Ltd
2021 Phase 3 EUCTR2020-005448-48-ES Brazil;Czechia;France;Italy;Spain;
Roche Farma S.A(Soc. Unipersonal) que realiza el ensayo en España y actúa como representante de F. Hoffmann-La Roche LTD
2018 Phase 3 EUCTR2017-001313-93-ES Algeria;Bosnia and Herzegovina;Brazil;Canada;Colombia;Costa Rica;Czech Republic;Denmark;Egypt;France;Guatemala;Hungary;Ireland;Italy;Kuwait;Lebanon;Mexico;Morocco;Netherlands;Panama;Poland;Russian Federation;Saudi Arabia;Spain;United Arab Emirates;
Roche Farma SA (Soc unipersonal) que realiza el ensayo en España y que actúa como representante F.Hoffmann-La Roche Ltd
2018 Phase 3 EUCTR2017-004886-29-ES Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Turkey;United Kingdom;
RO4964913 F07
F.Hoffmann-La Roche
2012 Phase 3 EUCTR2010-020337-99-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
RO4964913/F03
Hoffman La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-FR Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Slovakia;Spain;United Kingdom;
RO4964913/F07
F. HOFFMANN - LA ROCHE LTD.
2016 Phase 3 EUCTR2015-005597-38-IT Belgium;Czech Republic;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom;
F. Hoffman-La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-DE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
F. Hoffmann-La Roche Ltd
2016 Phase 3 EUCTR2015-005597-38-SE Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2016 Phase 3 EUCTR2015-005597-38-NL Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2016 Phase 3 EUCTR2015-005597-38-IE Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2016 Phase 3 EUCTR2015-005597-38-GB Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2016 Phase 3 EUCTR2015-005597-38-FR Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2016 Phase 3 EUCTR2015-005597-38-FI Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2016 Phase 3 EUCTR2015-005597-38-EE Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2016 Phase 3 EUCTR2015-005597-38-DK Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2016 Phase 3 EUCTR2015-005597-38-DE Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2016 Phase 3 EUCTR2015-005597-38-CZ Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2016 Phase 3 EUCTR2015-005597-38-BE Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom;
F.Hoffmann-La Roche
2012 Phase 3 EUCTR2010-020315-36-CZ Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-SK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-LT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-CZ Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-SK Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-SE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-IE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-GB Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-DE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-BG Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-BE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020337-99-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020337-99-EE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
GENENTECH Inc.
2016 Phase 3 EUCTR2015-004616-37-SE Germany;Sweden;Switzerland;United States;
2016 Phase 3 EUCTR2015-004616-37-DE Germany;Sweden;Switzerland;United States;
Hoffman La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-SK Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 Phase 2 EUCTR2007-006338-32-GB Belgium;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 Phase 2 EUCTR2007-006338-32-DK Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 Phase 2 EUCTR2007-006338-32-CZ Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 Phase 2 EUCTR2007-006338-32-BG Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2008 Phase 2 EUCTR2007-006338-32-BE Belgium;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Italy;Mexico;Netherlands;Romania;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
Roche Farma S.A. que representa en España a F. Hoffmann-La Roche Ltd
2016 Phase 3 EUCTR2015-005597-38-ES Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;Turkey;United Kingdom;
RO4964913/F07-01
F. HOFFMANN - LA ROCHE LTD.
2020 Phase 3 EUCTR2020-000894-26-IT Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000893-69-IT Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-001511-73-IT Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 2 EUCTR2016-002667-34-IT Italy;Poland;United States;
2017 Phase 3 EUCTR2016-002937-31-IT Austria;Belgium;Brazil;Bulgaria;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
F. Hoffmann-La Roche Ltd
2021 Phase 3 EUCTR2020-000894-26-GR Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000894-26-DK Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000894-26-BG Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000893-69-GR Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000893-69-DK Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000894-26-PT Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000894-26-HU Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000894-26-GB Argentina;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000894-26-FR Argentina;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000894-26-DE Argentina;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Italy;Mexico;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000893-69-PT Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000893-69-PL Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000893-69-NL Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000893-69-HU Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000893-69-GB Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000893-69-DE Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000893-69-BE Argentina;Australia;Belgium;Brazil;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Mexico;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-001511-73-RO Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-001511-73-PT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-001511-73-IE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-001511-73-DE Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2020 Phase 2 EUCTR2016-002667-34-PL Italy;Poland;United States;
2019 Phase 3 EUCTR2018-001511-73-PL Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-001511-73-HU Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-001511-73-HR Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-001511-73-GB Bulgaria;Croatia;Germany;Hungary;Ireland;Poland;Portugal;Spain;United Kingdom;
2019 Phase 3 EUCTR2018-001511-73-ES Australia;Austria;Belarus;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-001511-73-BG Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Colombia;Croatia;Egypt;France;Georgia;Germany;Hungary;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-SK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-SI Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-SE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-NO Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-HR Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-FR Austria;Belgium;Brazil;Bulgaria;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-DK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002937-31-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Croatia;Denmark;France;Germany;Hungary;Italy;Kuwait;Lebanon;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Roche Farma S.A. (Soc.unipersonal)que realiza el ensayo en España y que actúa como representante de F.Hoffmann-La Roche
2017 Phase 3 EUCTR2016-002937-31-ES Austria;Belgium;Brazil;Bulgaria;Croatia;Denmark;Finland;France;Germany;Hungary;Italy;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Slovenia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
RO5333787
F. HOFFMANN - LA ROCHE LTD.
2021 Phase 3 EUCTR2021-001088-26-IT Canada;France;Germany;India;Italy;Korea, Republic of;Turkey;United States;
2021 Phase 3 EUCTR2020-003413-35-IT Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
F. Hoffmann-La Roche Ltd
2021 Phase 3 EUCTR2020-003413-35-HU Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-003413-35-HR Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-003413-35-DE Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-003413-35-BG Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2020-003413-35-PL Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
RO7010939
F. HOFFMANN - LA ROCHE LTD.
2021 Phase 3 EUCTR2020-001168-28-IT Bulgaria;Denmark;Finland;France;Italy;Netherlands;United States;
2021 Phase 3 EUCTR2019-004857-10-IT Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States;
F. Hoffman-La Roche
2021 Phase 3 EUCTR2020-001168-28-DK Austria;Belgium;Brazil;Bulgaria;Canada;Denmark;France;Greece;India;Italy;Korea, Republic of;Mexico;Poland;Portugal;Russian Federation;Turkey;United Kingdom;United States;
F. Hoffmann-La Roche Ltd
2022 Phase 2 EUCTR2021-003772-14-HR Croatia;Czechia;Egypt;Japan;Kenya;Morocco;Norway;Serbia;Slovakia;Slovenia;
2021 Phase 3 EUCTR2020-001168-28-BG Bulgaria;Finland;France;Netherlands;United States;
2021 Phase 3 EUCTR2019-004857-10-PT Finland;France;Germany;Netherlands;Portugal;United States;
2021 Phase 3 EUCTR2019-004857-10-NL Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States;
2021 Phase 3 EUCTR2019-004857-10-HU Finland;France;Germany;Hungary;Netherlands;Portugal;United States;
2021 Phase 3 EUCTR2019-004857-10-DE Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States;
2020 Phase 3 EUCTR2019-004857-10-FI Finland;France;Germany;Hungary;Italy;Netherlands;Portugal;United States;
RPC-1063
Celgene
2020 Phase 3 NCT04140305 Canada;Puerto Rico;United States;
RPC1063
CELGENE INTERNATIONAL II SàRL
2016 Phase 3 EUCTR2015-002500-91-IT Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
Celgene
2016 Phase 1 NCT02797015 United States;
2015 Phase 3 NCT02576717 Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2012 Phase 2/Phase 3 NCT01628393 Belgium;Bulgaria;Georgia;Greece;Hungary;Italy;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United States;
Celgene International II Sàrl (CIS II)
2017 Phase 3 EUCTR2015-002500-91-SE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-002500-91-SK Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-002500-91-PT Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-002500-91-PL Argentina;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-002500-91-LV Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-002500-91-LT Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-002500-91-HR Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-002500-91-EE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-002500-91-BG Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-002500-91-HU Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-002500-91-GR Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-002500-91-GB Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Mexico;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2015-002500-91-BE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Moldova, Republic of;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-PL Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-LV Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-LT Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-HU Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-HR Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-GB Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-BG Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2014-002320-27-PT Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2014-002320-27-EE Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2014 Phase 2;Phase 3 EUCTR2012-002714-40-SK Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2014 Phase 2;Phase 3 EUCTR2012-002714-40-GB Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2013 Phase 2;Phase 3 EUCTR2012-002714-40-HU Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2013 Phase 2;Phase 3 EUCTR2012-002714-40-BG Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2013 Phase 2;Phase 3 EUCTR2012-002714-40-BE Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
Receptos, Inc.
2015 Phase 3 EUCTR2014-002320-27-SE Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-NL Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2014-002320-27-ES Argentina;Austria;Belarus;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;South Africa;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2015 - EUCTR2015-002500-91-ES Argentina;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Estonia;Georgia;Germany;Greece;Hungary;Italy;Latvia;Lithuania;Mexico;Moldova, Republic of;Netherlands;New Zealand;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;South Africa;Spain;Sweden;Ukraine;United Kingdom;United States;
2014 Phase 2;Phase 3 EUCTR2012-002714-40-HR Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Italy;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;South Africa;Spain;Ukraine;United Kingdom;United States;
2013 Phase 2;Phase 3 EUCTR2012-002714-40-IT Belgium;Bulgaria;Canada;Croatia;Georgia;Greece;Hungary;Israel;Italy;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2013 Phase 2;Phase 3 EUCTR2012-002714-40-GR Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States;
2013 Phase 2;Phase 3 EUCTR2012-002714-40-ES Belgium;Bulgaria;Canada;Croatia;Czech Republic;Georgia;Greece;Hungary;Israel;Italy;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Sweden;Ukraine;United Kingdom;United States;
RTL1000 (recombinant T cell receptor ligand)
Artielle ImmunoTherapeutics
2006 Phase 1 NCT00411723 United States;
RYAH-Medtech Inhaler
OMNI Medical Services, LLC
2018 Phase 2 NCT03944447 United States;
Rabbit anti-human thymocyte immunoglobulin
Sheffield Teaching Hospitals
2020 Phase 3 EUCTR2019-001549-42-GB United Kingdom;
Radiation therapy
Baylor College of Medicine
1999 Phase 2 NCT00040482 United States;
Ralenova
University Medical Center Hamburg Eppendorf
2007 - EUCTR2007-001962-34-DE Germany;
Raltegravir
Queen Mary University of London
2013 Phase 2 NCT01767701 United Kingdom;
2013 - EUCTR2012-004847-61-GB United Kingdom;
Ramatroban
Iou hospital
2008 - JPRN-UMIN000002725 Japan;
Ranitidine
Genzyme, a Sanofi Company
2017 Phase 3 NCT03368664 Austria;Belgium;Bulgaria;Czechia;France;Germany;Greece;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Spain;Switzerland;Turkey;United Kingdom;
2014 Phase 4 NCT02205489 Belgium;France;Netherlands;Spain;
Raptiva 100 mg/ml powder and solvent for solution for injection
Merck Serono International S.A.
2009 - EUCTR2007-001377-28-PT Austria;France;Germany;Netherlands;Portugal;
2008 - EUCTR2007-001377-28-NL Austria;France;Germany;Netherlands;Portugal;
2008 - EUCTR2007-001377-28-FR Austria;France;Germany;Netherlands;Portugal;
2008 - EUCTR2007-001377-28-DE Austria;France;Germany;Netherlands;Portugal;
2008 - EUCTR2007-001377-28-AT Austria;France;Germany;Netherlands;Portugal;
Ravulizumab
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 3 EUCTR2019-003352-37-IT Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States;
Alexion Pharmaceuticals
2019 Phase 3 NCT04201262 Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Poland;Spain;United Kingdom;United States;
Rebif
Bayer
2006 Phase 4 NCT00317941 France;
Biogen Idec
2014 Phase 1 NCT02269930 United States;
Dansk Multipel Sclerose Center
2010 - EUCTR2009-016824-29-DK Denmark;
EMD Serono
2010 Phase 4 NCT01085318 United States;
2004 Phase 4 NCT00101959 United States;
F.Hoffmann-La Roche
2012 Phase 3 EUCTR2010-020337-99-NL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2010-020315-36-CZ Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-SK Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-PT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-PL Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-LT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-GB Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-DE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-CZ Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-BG Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-BE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020337-99-AT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-SK Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-SE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-IE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-GB Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-FR Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-DE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-BG Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020315-36-BE Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Bulgaria;Canada;Colombia;Croatia;Czech Republic;France;Germany;Ireland;Italy;Mexico;Peru;Russian Federation;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-020337-99-ES Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-020315-36-ES Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Colombia;Croatia;Ireland;Italy;Mexico;Peru;Russian Federation;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020337-99-LV Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020337-99-FI Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020337-99-EE Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;Netherlands;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;Slovakia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2010 - EUCTR2010-020337-99-HU Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;New Zealand;Peru;Poland;Portugal;Russian Federation;Serbia;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
Genzyme Corporation
2008 Phase 3 EUCTR2007-001162-32-FR Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2008 Phase 3 EUCTR2007-001162-32-ES Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2008 Phase 3 EUCTR2007-001162-32-CZ Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2008 Phase 3 EUCTR2007-001162-32-BE Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2008 Phase 3 EUCTR2007-001161-14-FR Czech Republic;France;Germany;Poland;Sweden;United Kingdom;
2008 - EUCTR2007-001162-32-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-001162-32-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-001162-32-NL Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-001162-32-DK Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-001162-32-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Croatia;Czech Republic;Denmark;France;Germany;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-001162-32-AT Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-001161-14-SE Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom;
2008 - EUCTR2007-001161-14-DE Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom;
2007 Phase 3 EUCTR2007-001162-32-GB Austria;Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-001161-14-GB Czech Republic;France;Germany;Poland;Sweden;United Kingdom;
IMS HEALTH GmbH & Co. OHG
2016 - NCT02823951 Canada;United States;
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden;
2017 Phase 4 EUCTR2016-003587-39-SE Sweden;
Medizinische Universität Innsbruck
2014 Phase 4 EUCTR2012-005450-30-AT Austria;Sweden;
2014 - EUCTR2012-005450-30-SE Austria;Sweden;
Merck KGaA
2012 - NCT01601119 United Kingdom;
2009 Phase 2 NCT01198132 France;
Merck KGaA, Darmstadt, Germany
2017 - NCT02949908 Germany;
2014 Phase 4 NCT02254304 Germany;
Merck Serono International SA
2007 Phase 3 EUCTR2006-003037-32-ES Estonia;Germany;Italy;Lithuania;Spain;
2007 - EUCTR2006-003037-32-LT Estonia;Germany;Italy;Lithuania;Spain;
2007 - EUCTR2006-003037-32-EE Estonia;Germany;Italy;Lithuania;Spain;
Merck Serono International, a branch of Laboratoires Serono SA An affiliate of Merck KGaA
2007 Phase 3 EUCTR2006-002982-38-SK Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Slovakia;Spain;
2007 - EUCTR2006-002982-38-EE Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain;
Merck Serono International, a branch of Laboratoires Serono SA an affiliate of Merck KGaA, Darmstadt
2009 - EUCTR2008-004954-34-GR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Spain;
Merck Serono S.A. - Geneva
2010 - EUCTR2009-016087-37-GB France;Ireland;Italy;Spain;United Kingdom;
2009 - EUCTR2009-016087-37-ES France;Ireland;Italy;Spain;United Kingdom;
Merck Serono S.A. - Geneva, an affiliate of Merck KGaA Darmstadt, Germany
2007 - EUCTR2006-002982-38-PT Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain;
2007 - EUCTR2006-002982-38-DE Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain;
2006 - EUCTR2006-002982-38-FI Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain;
2006 - EUCTR2006-002982-38-CZ Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Spain;
Merck Serono S.A. - Geneva, an affiliate of Merck KGaA, Darmstadt, Germany
2010 - EUCTR2008-004954-34-AT Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;
2009 Phase 3 EUCTR2008-004954-34-SK Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;
2009 Phase 3 EUCTR2008-004954-34-PT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Spain;
2009 Phase 3 EUCTR2008-004954-34-BE Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;
2009 - EUCTR2008-004954-34-PL Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;
2009 - EUCTR2008-004954-34-LV Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Spain;
2009 - EUCTR2008-004954-34-FI Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;
2009 - EUCTR2008-004954-34-EE Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;
2009 - EUCTR2008-004954-34-DE Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;
2009 - EUCTR2008-004954-34-BG Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;
2008 - EUCTR2008-004954-34-CZ Argentina;Austria;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Germany;Greece;Israel;Italy;Latvia;Lebanon;Morocco;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;
Merck Serono S.A.- Geneva, an affiliate of Merck KGaA, Darmstadt, Germany
2009 Phase 3 EUCTR2008-004954-34-FR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Latvia;Poland;Portugal;Slovakia;Spain;
Merck Serono S.A.-Geneva, an affiliate of Merck KGaA Darmstadt, Germany
2006 Phase 3 EUCTR2006-002982-38-BE Austria;Belgium;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Italy;Lithuania;Portugal;Slovakia;Spain;
Merck Serono SA
2007 - EUCTR2006-003037-32-DE Estonia;Germany;Italy;Lithuania;Spain;
Merck Serono SA – Geneva
2010 - EUCTR2009-015502-19-GB Belgium;Finland;Germany;Sweden;United Kingdom;
2010 - EUCTR2009-015502-19-DE Belgium;Finland;Germany;Sweden;United Kingdom;
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004505-32-IT France;Germany;Italy;Spain;
ROCHE
2011 - EUCTR2010-020337-99-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Chile;Czech Republic;Estonia;Finland;Germany;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Morocco;New Zealand;Peru;Poland;Portugal;Russian Federation;South Africa;Spain;Switzerland;Tunisia;Ukraine;United Kingdom;United States;
2011 - EUCTR2010-020315-36-IT Argentina;Belarus;Belgium;Bosnia and Herzegovina;Brazil;Canada;Colombia;Croatia;Ireland;Italy;Mexico;Peru;Russian Federation;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Serono International SA
2005 Phase 3 EUCTR2004-003799-13-ES Denmark;Ireland;Lithuania;Spain;Sweden;United Kingdom;
2004 - EUCTR2004-000337-12-HU Hungary;
Teva Pharmaceutical Industries
2004 Phase 4 NCT00202995 Canada;United States;
The Multiple Sclerosis Research Group, Department of Clinical Neuroscience
2009 - EUCTR2008-008554-23-SE Sweden;
University of North Carolina, Chapel Hill
2004 - NCT00137176 United States;
Universitätsklinikum Heidelberg
2006 Phase 3 EUCTR2004-004403-37-DE Germany;
VU University Medical Center
2011 - EUCTR2011-003570-89-NL Netherlands;
sanofi-aventis Recherche & Dévelopment
2009 - EUCTR2008-006226-34-FR Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom;
sanofi-aventis recherche et development
2009 Phase 3 EUCTR2008-006226-34-GR Belgium;Czech Republic;France;Germany;Greece;Hungary;Italy;Spain;United Kingdom;
2009 - EUCTR2008-006226-34-BE Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom;
sanofi-aventis recherche et developpement
2010 - EUCTR2008-006226-34-GB Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom;
2009 - EUCTR2008-006226-34-HU Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom;
2009 - EUCTR2008-006226-34-DE Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom;
2009 - EUCTR2008-006226-34-CZ Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom;
Rebif (IFN beta-1a subcutaneous three times per week)
Brigham and Women's Hospital
2015 - NCT02419638 United States;
Rebif (IFN ß-1a subcutaneous three times per week)
Brigham and Women's Hospital
2015 - NCT02419638 United States;
Rebif (Interferon beta-1a)
Merck KGaA
2009 - NCT01075880 Czech Republic;
Merck KGaA, Darmstadt, Germany
2016 - NCT02921035 Algeria;Argentina;Bahrain;Bulgaria;Egypt;Germany;Hungary;Iran, Islamic Republic of;Korea, Republic of;Kuwait;Lebanon;Morocco;Poland;Saudi Arabia;Tunisia;United Arab Emirates;
Rebif (interferon beta 1a)
Biocad
2014 Phase 2/Phase 3 NCT02727907 Russian Federation;
Rebif (interferon beta-1a), Merck Serono Europe Ltd
Bayer
2016 - NCT02749396 Finland;
Rebif 22
UCL Biomedicine R&D Unit
2006 - EUCTR2005-005751-18-GB United Kingdom;
Rebif 22 micrograms
Biogen Portugal
2016 Phase 4 EUCTR2016-000434-21-PT Portugal;
Rebif 22 y 44 mcg
Merck, S.L.
2006 - EUCTR2006-000606-23-ES Spain;
Rebif 22®
University Hospital Motol
2011 Phase 4 EUCTR2011-001956-12-CZ Czech Republic;
Rebif 44
The Walton Centre for Neurology and Neurosurgery
2005 Phase 4 EUCTR2004-004903-39-GB United Kingdom;
UCL Biomedicine R&D Unit
2006 - EUCTR2005-005751-18-GB United Kingdom;
Rebif 44 micrograms
Biogen Idec GmbH
2005 - EUCTR2004-004130-14-AT Austria;
Biogen Portugal
2016 Phase 4 EUCTR2016-000434-21-PT Portugal;
Octapharma AG
2015 Phase 3 EUCTR2012-005086-12-PL Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;Serbia;Ukraine;
2013 - EUCTR2012-005086-12-HU Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-DE Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-BG Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
2013 - EUCTR2012-005086-12-AT Austria;Bulgaria;Germany;Hungary;Poland;Russian Federation;
Rebif 44 micrograms solution for injection
Merck Serono International
2010 - EUCTR2008-003706-33-GR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2009 Phase 3 EUCTR2008-003706-33-FR Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-003706-33-ES Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
Merck Serono S.A. - Geneva
2009 Phase 3 EUCTR2008-003706-33-GB Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2009 Phase 3 EUCTR2008-003706-33-BE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2009 - EUCTR2008-003706-33-SE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2009 - EUCTR2008-003706-33-NO Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2009 - EUCTR2008-003706-33-DE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2009 - EUCTR2008-003706-33-CZ Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2009 - EUCTR2008-003706-33-BG Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2009 - EUCTR2008-003706-33-AT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
2008 - EUCTR2008-003706-33-FI Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
2008 - EUCTR2008-003706-33-EE Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;Finland;France;Georgia;Germany;Greece;India;Italy;Korea, Republic of;Lebanon;Macedonia, the former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
Merck Serono SA - Geneva
2009 - EUCTR2008-003706-33-PT Austria;Belgium;Bulgaria;Czech Republic;Estonia;Finland;France;Germany;Greece;Italy;Norway;Portugal;Spain;Sweden;United Kingdom;
Rebif 44 micrograms solution for injection in pre-filled syringe
Biogen Idec Limited
2010 - EUCTR2009-015556-15-NL Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
Rebif 44 µg
Serono GmbH
2005 - EUCTR2005-001026-89-DE Germany;
Rebif 44®
University Hospital Motol
2011 Phase 4 EUCTR2011-001956-12-CZ Czech Republic;
Rebif 8,8 µg, Rebif 22µg
Serono GmbH
2005 - EUCTR2005-001026-89-DE Germany;
Rebif 8.8 micrograms and 22 micrograms solution for injection in pre-filled syringe initiation pack
Biogen Idec Limited
2010 - EUCTR2009-015556-15-SI Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States;
2010 - EUCTR2009-015556-15-PT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-NL Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-LV Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States;
2010 - EUCTR2009-015556-15-HU Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-GR Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-GB Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-FI Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-ES Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-DK Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-DE Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-CZ Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States;
2010 - EUCTR2009-015556-15-AT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
Rebif 8.8 micrograms and 22 micrograms solution for injection in pre-filled syringe initiation pack.
Biogen Idec Limited
2010 - EUCTR2009-015556-15-SE Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States;
Rebif New Formulation + ibuprofen PRN
Merck KGaA
2007 Phase 3 NCT00619307 France;Germany;
Rebif New Formulation + prophylactic Ibuprofen
Merck KGaA
2007 Phase 3 NCT00619307 France;Germany;
Rebif New Formulation 44mcg multidose cartridge
Merck Serono International S.A.
2008 - EUCTR2008-000499-25-SE Germany;Italy;Spain;Sweden;
2008 - EUCTR2008-000499-25-ES Germany;Italy;Spain;Sweden;
- - EUCTR2008-000499-25-DE Germany;Italy;Spain;Sweden;
Rebif New Formulation Non Titrated
EMD Serono
2007 Phase 3 NCT00472797 United States;
Rebif New Formulation Titrated
EMD Serono
2007 Phase 3 NCT00472797 United States;
Rebif®
EMD Serono
2014 Phase 4 NCT02117050 United States;
2010 - NCT01207648 Argentina;Canada;France;Italy;Russian Federation;Tunisia;United States;Venezuela;
1999 Phase 3 NCT00292266 -
Genzyme Corporation
2008 - EUCTR2007-001161-14-PL Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom;
2008 - EUCTR2007-001161-14-CZ Argentina;Australia;Brazil;Croatia;Czech Republic;France;Germany;Mexico;Poland;Russian Federation;Serbia;Sweden;Ukraine;United Kingdom;
Merck KGaA
2013 Phase 4 NCT01791244 Germany;Sweden;
Merck KGaA, Darmstadt, Germany
2014 Phase 4 NCT02064816 Germany;
PD Dr. Marcus Müller
2015 Phase 1 NCT02364986 Germany;
Queen Mary, University of London
2009 - EUCTR2008-000256-26-GB United Kingdom;
Sahlgrenska University Hospital
2005 - EUCTR2005-001008-37-SE Sweden;
Rebif® (clone 484-39)
Merck KGaA
2004 Phase 4 NCT00367484 -
Rebif® New Formulation
Merck KGaA
2008 - NCT01080027 Greece;
Rebif® New Formulation (IFN-beta-1a, RNF)
Merck KGaA
2006 Phase 3 NCT00441103 Canada;Germany;Italy;Russian Federation;Spain;Switzerland;
Rebif® New Formulation (RNF) using RebiSmartTM
EMD Serono
2008 Phase 3 NCT00735007 Canada;Germany;Italy;Spain;Sweden;United States;
Rebif® new formulation (RNF)
EMD Serono
2008 Phase 3 NCT00725985 Argentina;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czechia;Estonia;Finland;France;Georgia;Germany;India;Italy;Korea, Republic of;Lebanon;Macedonia, The Former Yugoslav Republic of;Norway;Poland;Portugal;Romania;Russian Federation;Saudi Arabia;Serbia;Singapore;Spain;Sweden;Taiwan;Thailand;Turkey;Ukraine;United Arab Emirates;United Kingdom;United States;
Recombinant Human Erythropoietin
Walton Centre for Neurology and Neurosurgery
2008 - EUCTR2008-005125-11-GB United Kingdom;
Recombinant human IFN beta
Merck Serono International SA
2007 - EUCTR2006-005972-42-DE France;Germany;
Recombinant human alpha B-crystallin
Delta Crystallon B.V.
2012 - EUCTR2011-004475-36-BG Bulgaria;
Delta Crystallon BV
2012 Phase 2 NCT02442570 Bulgaria;
2009 Phase 1 NCT02442557 Netherlands;
Recombinant human interferon beta
Serono International SA
2004 - EUCTR2004-000337-12-HU Hungary;
Recombinant humanized anti-alpha 4 integrin antibody
BIOGEN IDEC LTD
2007 - EUCTR2005-004061-41-SE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2007 - EUCTR2005-004061-41-AT Austria;Czech Republic;Denmark;Finland;Germany;Greece;Ireland;Italy;Spain;Sweden;United Kingdom;
2006 Phase 3 EUCTR2005-004061-41-GB Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 Phase 3 EUCTR2005-004061-41-BE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 - EUCTR2005-004061-41-IE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 - EUCTR2005-004061-41-HU Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 - EUCTR2005-004061-41-GR Austria;Czech Republic;Denmark;Finland;Germany;Greece;Ireland;Italy;Spain;Sweden;United Kingdom;
2006 - EUCTR2005-004061-41-FI Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 - EUCTR2005-004061-41-DK Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 - EUCTR2005-004061-41-DE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 - EUCTR2005-004061-41-CZ Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
Recombinant interferon beta-1b
Bayer HealthCare AG
2013 Phase 4 EUCTR2012-005262-35-GB Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2013 Phase 4 EUCTR2012-005262-35-ES Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2013 Phase 4 EUCTR2012-005262-35-CZ Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2012-005262-35-SI Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2012-005262-35-IT Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2012-005262-35-FI Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2012-005262-35-AT Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Poland;Portugal;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
Remibrutinib
Novartis Farmacéutica S.A.
2022 Phase 3 EUCTR2020-005929-89-ES Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States;
2022 Phase 3 EUCTR2020-005899-36-ES Slovakia;Spain;
Novartis Pharma AG
2022 Phase 3 EUCTR2020-005929-89-SE Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States;
2022 Phase 3 EUCTR2020-005899-36-SK Argentina;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;France;Germany;Guatemala;Hong Kong;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;United Kingdom;United States;
Novartis Pharmaceuticals
2021 Phase 3 NCT05156281 United States;
2021 Phase 3 NCT05147220 United States;
Repetitive transcranial magnetic stimulation (rTMS)
Shirley Ryan AbilityLab
2017 - NCT03723434 United States;
Repository Corticotropin Injection
Mallinckrodt
2017 Phase 4 NCT03126760 United States;
Repository corticotropin injection
University at Buffalo
2009 Phase 2 NCT00986960 United States;
Researchmanager program
Isala
2021 - NCT05242731 Netherlands;
Revaxis
University of Nottingham
2010 Phase 2 EUCTR2007-001496-11-GB United Kingdom;
RhEPO
Walton Centre for Neurology and Neurosurgery
2008 - EUCTR2008-005125-11-GB United Kingdom;
RhIFN beta-1b
Nuron Biotech Inc.
2011 Phase 3 NCT01464905 Belarus;Bulgaria;Croatia;Georgia;Hungary;India;Italy;Lebanon;Poland;Russian Federation;Serbia;Spain;Ukraine;
RhIGF-1 (CEP-151)
National Institute of Neurological Disorders and Stroke (NINDS)
1997 Phase 2 NCT00001669 United States;
RhuMab 2H7
Hoffman La Roche Ltd
2008 Phase 2 EUCTR2007-006338-32-FR Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Slovakia;Spain;United Kingdom;
2008 Phase 2 EUCTR2007-006338-32-ES Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Slovakia;Spain;United Kingdom;
2008 - EUCTR2007-006338-32-NL Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Spain;United Kingdom;
2008 - EUCTR2007-006338-32-FI Belgium;Bulgaria;Czech Republic;Denmark;Finland;France;Germany;Italy;Netherlands;Spain;United Kingdom;
RhumAb to IL-17A igG1-k-class
Novartis Pharma Services AG
2012 - EUCTR2011-001629-25-CZ Czech Republic;Russian Federation;Ukraine;
RhumAb to Il-17A (IgG1-k-class)
Novartis Pharma Services AG
2009 Phase 2 EUCTR2009-011626-34-SE Czech Republic;Sweden;
2009 - EUCTR2009-011626-34-CZ Czech Republic;Russian Federation;Serbia;Sweden;Ukraine;
Riboflavin
University of Iowa
2010 Phase 1 NCT01381354 United States;
Rifampin
National Center for Research Resources (NCRR)
2001 Phase 2 NCT00043264 United States;
Rilutek
UCL
2014 Phase 2 EUCTR2012-005394-31-GB United Kingdom;
Riluzole
S. Andrea Hospital
2005 Phase 2 NCT00202397 Italy;
UCL
2014 Phase 2 EUCTR2012-005394-31-GB United Kingdom;
University College, London
2014 Phase 2 NCT01910259 United Kingdom;
University of California, San Francisco
2006 Phase 2 NCT00501943 United States;
RimabotulinumtoxinB
Supernus Pharmaceuticals, Inc.
2021 Phase 2/Phase 3 NCT04815967 -
Ritalin
Sheba Medical Center
2003 Phase 1 NCT00220493 Israel;
Ritalin LA 20mg capsules
Medizinische Universität Wien
2012 - EUCTR2012-003418-15-AT Austria;
Ritalin LA 30mg capsules
Medizinische Universität Wien
2012 - EUCTR2012-003418-15-AT Austria;
Ritalin LA 40mg capsules
Medizinische Universität Wien
2012 - EUCTR2012-003418-15-AT Austria;
Rituximab
AZIENDA OSPEDALIERA DI PADOVA
- Phase 1 EUCTR2008-005773-35-IT Italy;
Anders Svenningsson
2016 Phase 3 NCT02746744 Sweden;
2009 Phase 2 NCT01719159 Sweden;
Centre Hospitalier de Pau
2015 Phase 2 EUCTR2014-005493-11-FR France;
Claudio Gobbi
2020 - NCT04640818 Switzerland;
Clinical Research Center, NHO Utano National Hospital
2014 Phase 2,3 JPRN-UMIN000013453 Japan;
Clinical Research Center, Utano National Hospital, National Hospital Organization
2015 Phase 2,3 JPRN-UMIN000017217 Japan;
Department of Pediatrics, Kobe Universtiy Graduate School of Medicine
2012 - JPRN-UMIN000009421 Japan;
Genentech, Inc.
2004 Phase 2/Phase 3 NCT00087529 Canada;United States;
2004 Phase 2 NCT00097188 United States;
Haukeland University Hospital
2020 Phase 3 NCT04578639 Norway;
Helse Bergen HF, Haukeland University Hospital
2022 Phase 3 EUCTR2020-001205-23-SE Sweden;
Isfahan University of Medical Sciences
2017 Phase 2/Phase 3 NCT03315923 Iran, Islamic Republic of;
2015 Phase 2/Phase 3 NCT03002038 Iran, Islamic Republic of;
Johns Hopkins University
2014 Phase 1 NCT02253264 United States;
Karolinska Institutet
2018 Phase 3 NCT03979456 Sweden;
2017 - NCT03193866 Sweden;
National Institute of Neurological Disorders and Stroke (NINDS)
2010 Phase 1/Phase 2 NCT01212094 United States;
Northwestern University
2019 Phase 2/Phase 3 NCT03829566 United States;
Oslo University Hospital
2019 Phase 3 NCT04121403 Norway;
Rigshospitalet, Denmark
2021 Phase 3 NCT04688788 Denmark;
Shandong University Qilu Hospital
2021 Phase 4 ChiCTR2100043013 China;
Tang-Du Hospital
2014 Phase 4 NCT04256252 -
The Ophthalmology Department of the Chinese Peoples Liberation Army Hospital
2019 Phase 4 ChiCTR1900025744 China;
2014 - ChiCTR-ICR-15007177 China;
University of California, San Francisco
2004 Phase 1 NCT00501748 United States;
University of Colorado, Denver
2017 Phase 3 NCT02980042 United States;
2012 Phase 2 NCT01569451 United States;
Rituximab IT
Centre Hospitalier de PAU
2015 Phase 2 NCT02545959 France;
Rituximab IV
Centre Hospitalier de PAU
2015 Phase 2 NCT02545959 France;
Rituximab Infusion
Wake Forest University Health Sciences
2013 Phase 4 NCT02040116 United States;
Rituximab konsentrat til infusjonsvaeske oppløsning 10 mg/ml
Department of Neurology, Division of Clinical Neuroscience, Oslo University Hospital
2019 Phase 3 EUCTR2019-001505-24-NO Norway;
Rivastigmin
Novartis Pharma GmbH
- - EUCTR2008-007015-32-DE Germany;
Rivastigmine transdermal patch
Novartis Pharmaceuticals
2009 Phase 4 NCT00881205 Germany;
Ro 496-4913/F03
F.Hoffmann-La Roche
2011 Phase 3 EUCTR2010-020338-25-BG Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2010 - EUCTR2010-020338-25-HU Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
Ro 496-4913/F07
F.Hoffmann-La Roche
2013 Phase 3 EUCTR2010-020338-25-NL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020338-25-PT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020338-25-PL Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020338-25-GR Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020338-25-DE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020338-25-CZ Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020338-25-BE Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2011 Phase 3 EUCTR2010-020338-25-AT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020338-25-LT Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020338-25-GB Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2010-020338-25-FI Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Netherlands;New Zealand;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;Spain;Switzerland;Ukraine;United Kingdom;United States;
Rolipram
National Institute of Neurological Disorders and Stroke (NINDS)
2001 Phase 2 NCT00011375 United States;
Ruxience
Danish Multiple Sclerosis Center, Rigshospitalet
2020 Phase 3 EUCTR2020-002981-15-DK Denmark;
SA237
Chugai Pharmaceutical Co. Ltd
2015 Phase 3 EUCTR2013-003752-21-HU France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States;
2015 - EUCTR2013-003752-21-ES France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003752-21-IT France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;
Chugai Pharmaceutical Co., Ltd.
2019 - JPRN-JapicCTI-205119 Japan;
2014 Phase 3 JPRN-JapicCTI-132397 Japan, Asia except Japan, North America, Europe;
SAR339658
Genzyme Corporation
2015 Phase 2 EUCTR2014-003265-19-PL Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States;
2015 Phase 2 EUCTR2014-001643-20-SE Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States;
2015 Phase 2 EUCTR2014-001643-20-PL Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States;
2015 Phase 2 EUCTR2014-001643-20-DE Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States;
SAR441344
Sanofi-Aventis Recherche et Développement
2021 Phase 2 EUCTR2020-004785-19-DE Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Russian Federation;Spain;Turkey;United States;
2021 Phase 2 EUCTR2020-004785-19-CZ Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Russian Federation;Spain;Turkey;United States;
2021 Phase 2 EUCTR2020-004785-19-BG Bulgaria;Canada;Czech Republic;Czechia;France;Germany;Russian Federation;Spain;Turkey;United States;
SAR441344 IV
Sanofi
2021 Phase 2 NCT04879628 Bulgaria;Canada;Czechia;France;Germany;Spain;Turkey;Ukraine;United States;
SAR441344 SC
Sanofi
2021 Phase 2 NCT04879628 Bulgaria;Canada;Czechia;France;Germany;Spain;Turkey;Ukraine;United States;
SAR442168
GENZYME CORPORATION
2020 Phase 3 EUCTR2020-000647-30-IT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000645-14-IT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000637-41-IT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
Genzyme Corporation
2021 Phase 3 EUCTR2020-000647-30-PT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000645-14-PT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000645-14-NL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000645-14-HU Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000645-14-HR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000645-14-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000645-14-BE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000644-55-DE Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000637-41-AT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000647-30-PL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000647-30-NL Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000647-30-LT Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000647-30-GR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000647-30-GB Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000647-30-FI Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000647-30-DK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000647-30-DE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000647-30-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000647-30-BG Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000645-14-GR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000645-14-GB Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000645-14-FR Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000645-14-EE Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000645-14-DK Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000645-14-CZ Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000645-14-BG Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czech Republic;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-SK Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-PT Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-NL Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-LV Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-HU Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-GR Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-GB Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-FR Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000644-55-CZ Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czech Republic;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000637-41-SE Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-PL Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-LT Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-FI Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-DK Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-DE Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-CZ Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2020 Phase 3 EUCTR2020-000637-41-BG Austria;Belarus;Bulgaria;Canada;China;Czech Republic;Czechia;Denmark;Estonia;Finland;Germany;Hong Kong;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2019 Phase 2 EUCTR2018-004731-76-SK Canada;Czech Republic;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States;
2019 Phase 2 EUCTR2018-004731-76-NL Canada;Czech Republic;Czechia;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States;
2019 Phase 2 EUCTR2018-004731-76-ES Canada;Czech Republic;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States;
2019 Phase 2 EUCTR2018-004731-76-EE Canada;Czech Republic;Czechia;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States;
2019 Phase 2 EUCTR2018-004731-76-CZ Canada;Czech Republic;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Ukraine;United States;
2019 Phase 2 EUCTR2018-003927-12-SK Canada;Czech Republic;Estonia;France;Netherlands;Norway;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States;
2019 Phase 2 EUCTR2018-003927-12-SE Canada;Czech Republic;Estonia;France;Netherlands;Norway;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States;
2019 Phase 2 EUCTR2018-003927-12-NL Canada;Czech Republic;Estonia;France;Netherlands;Norway;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States;
2019 Phase 2 EUCTR2018-003927-12-ES Canada;Czech Republic;Estonia;France;Netherlands;Norway;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States;
2019 Phase 2 EUCTR2018-003927-12-EE Canada;Czech Republic;Estonia;France;Netherlands;Norway;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States;
Peking University Third Hospital
2020 - NCT04964791 China;
Sanofi
2019 Phase 2 NCT03889639 Canada;Czechia;Estonia;France;Netherlands;Russian Federation;Slovakia;Spain;Sweden;Ukraine;United States;
2019 Phase 1 NCT04171310 United Kingdom;
SB-683699
GlaxoSmithKline Research & Development Ltd
2007 Phase 2 EUCTR2006-007057-42-CZ Belgium;Czech Republic;Denmark;Sweden;
2007 - EUCTR2006-007057-42-SE Czech Republic;Denmark;Sweden;
2007 - EUCTR2006-007057-42-DK Czech Republic;Denmark;Sweden;
2007 - EUCTR2006-007057-42-BE Belgium;Czech Republic;Denmark;Sweden;
SB683699
GlaxoSmithKline
2004 Phase 2 NCT00097331 Belgium;Canada;France;Germany;Italy;Poland;Romania;Russian Federation;Spain;United States;
GlaxoSmithKline Research & Development Ltd
2007 Phase 2 EUCTR2006-002633-20-GB Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom;
2007 Phase 2 EUCTR2006-002633-20-FR Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom;
2007 - EUCTR2006-002633-20-LT Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom;
2007 - EUCTR2006-002633-20-IT Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom;
2006 - EUCTR2006-002633-20-NL Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom;
2006 - EUCTR2006-002633-20-FI Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom;
2006 - EUCTR2006-002633-20-DE Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom;
2006 - EUCTR2006-002633-20-AT Austria;Finland;France;Germany;Italy;Lithuania;Netherlands;Spain;United Kingdom;
GlaxoSmithKline S.A
2006 Phase 2 EUCTR2006-002633-20-ES Australia;Austria;Canada;Finland;France;Germany;Italy;Lithuania;Netherlands;New Zealand;Norway;Poland;Russian Federation;Spain;United Kingdom;
SC Peginterferon beta-1a
Biogen
2017 - NCT03347370 Germany;
SC interferon beta-1a
Biogen
2017 - NCT03347370 Germany;
SC interferon beta-1b
Biogen
2017 - NCT03347370 Germany;
SCLEROLYM
ImCyse S.A
2014 Phase 1;Phase 2 EUCTR2014-001081-99-BE Belgium;
SCM-010
Stem Cell Medicine Ltd.
2019 Phase 1/Phase 2 NCT03696485 Israel;
SH U 555 C
C.H.U. de RENNES
2008 - EUCTR2007-005363-10-FR France;
2008 - EUCTR2007-005362-12-FR France;
Max-Planck-Institute of Psychiatry
2007 - EUCTR2006-001337-17-DE Germany;
SIPONIMOD FUMARIC ACID
NOVARTIS PHARMA SERVICES AG
2021 Phase 3 EUCTR2020-002700-39-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Novartis Farmacéutica S.A.
2021 Phase 3 EUCTR2020-002700-39-ES Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Novartis Pharma AG
2021 Phase 3 EUCTR2020-002700-39-SK Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-PT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-PL Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-LV Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-LT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-HR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-FR Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-002700-39-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2020-002700-39-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2020-002700-39-BE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
SMderpept
Centrum Neurologii Krzysztof Selmaj
2016 Phase 2 EUCTR2016-002180-33-PL Poland;
SOLIRIS - 300 MG CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO 1 FLACONCINO (VETRO) 30 ML (10 MG/ML)
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 2;Phase 3 EUCTR2019-001829-26-IT Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States;
SOLU MEDROL - 125 MG/2 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONE A DOPPIA CAMERA DA 125 MG/2 ML
NOVARTIS PHARMA AG
2018 Phase 2 EUCTR2017-004702-17-IT Austria;Bulgaria;Czech Republic;Czechia;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
SOLU-MODERIN 1 g
Servicio de Neurología
2008 - EUCTR2007-000888-15-ES Spain;
SPARC0921
Sun Pharma Advanced Research Company Ltd.
2016 Phase 3 EUCTR2016-001356-22-HU Germany;Hungary;Russian Federation;Ukraine;United States;
SR-fampridine
University of Southern Denmark
2014 Phase 4 NCT02143167 Denmark;
SUB0750MIG
St. Vincent's University Hospital
2012 Phase 4 EUCTR2011-002561-38-IE Ireland;
SUB175614
Celgene International II Sàrl (CIS II)
2015 Phase 3 EUCTR2014-002320-27-PL Austria;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Estonia;Georgia;Germany;Hungary;Latvia;Lithuania;Moldova, Republic of;Netherlands;New Zealand;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
SUB22282
Biogen Idec Limited
2012 Phase 3 EUCTR2010-021978-11-IE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2012 - EUCTR2010-021978-11-BE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 Phase 3 EUCTR2010-021978-11-GB Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 Phase 3 EUCTR2010-021978-11-ES Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 Phase 3 EUCTR2010-021978-11-DK Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 Phase 3 EUCTR2010-021978-11-CZ Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 - EUCTR2010-021978-11-SE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 - EUCTR2010-021978-11-PL Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 - EUCTR2010-021978-11-FI Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 - EUCTR2010-021978-11-DE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Iraq;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
Saline
Haukeland University Hospital
2021 Phase 1/Phase 2 NCT04749667 Norway;
Innate Immunotherapeutics
2014 Phase 2 NCT02228213 Australia;New Zealand;
University at Buffalo
2009 Phase 2 NCT00986960 United States;
Sativex
GW PHARMA LTD
2008 - EUCTR2006-005910-11-IT Germany;Italy;Spain;United Kingdom;
GW Pharma Ltd
2020 Phase 3 EUCTR2019-002623-14-PL Czech Republic;Czechia;Poland;Romania;United Kingdom;United States;
2007 Phase 3 EUCTR2006-005910-11-CZ Czech Republic;Germany;Italy;Spain;United Kingdom;
2006 Phase 3 EUCTR2005-005265-11-GB Czech Republic;France;United Kingdom;
2006 Phase 3 EUCTR2005-005265-11-FR Czech Republic;France;United Kingdom;
2006 - EUCTR2005-005265-11-CZ Czech Republic;France;United Kingdom;
2005 Phase 3 EUCTR2004-002509-63-GB Czech Republic;United Kingdom;
2005 - EUCTR2004-002509-63-CZ Czech Republic;United Kingdom;
GW Pharma Ltd.
2008 Phase 3 EUCTR2006-005910-11-GB Czech Republic;Germany;Italy;Spain;United Kingdom;
2008 - EUCTR2006-005910-11-DE Germany;Italy;Spain;United Kingdom;
2007 - EUCTR2007-002138-13-GB United Kingdom;
GW Pharmaceuticals Ltd.
2012 Phase 4 NCT01964547 Czech Republic;
2007 Phase 3 NCT00702468 United Kingdom;
2006 Phase 3 NCT00391079 Canada;
2005 Phase 3 NCT01599234 United Kingdom;
2002 Phase 3 NCT01604265 United Kingdom;
GW Research Ltd
2013 Phase 3 NCT01868048 -
IRCCS Centro Neurolesi Bonino-Pulejo
2016 - NCT03186664 Italy;
S. Andrea Hospital
2005 Phase 2 NCT00202423 Italy;
Sativex 2,7mg/2,5 mg Solucion para pulverizacion bucal
GW Pharma Limited
2021 Phase 3 EUCTR2020-003271-18-ES Australia;Belgium;Czech Republic;Czechia;Poland;Spain;Sweden;United Kingdom;
Sativex Oromucosal Spray
GW Pharma Limited
2021 Phase 3 EUCTR2020-003271-18-CZ Australia;Belgium;Czech Republic;Czechia;Poland;Spain;Sweden;United Kingdom;
2021 Phase 3 EUCTR2019-002625-29-CZ Czech Republic;Czechia;Poland;United Kingdom;
2020 Phase 3 EUCTR2019-002625-29-PL Czech Republic;Czechia;Poland;United Kingdom;
2020 Phase 3 EUCTR2019-002625-29-GB Poland;United Kingdom;
GW Pharma Ltd.
2011 - EUCTR2011-000926-31-CZ Czech Republic;
Sativex Oromucosal Spray (non-marketed)
GW Pharma Ltd
2020 Phase 3 EUCTR2019-002623-14-CZ Czech Republic;Czechia;Poland;Romania;United Kingdom;United States;
Sativex®
Almirall, S.A.
2012 Phase 3 NCT01538225 Italy;
GW Pharmaceuticals Ltd.
2011 - NCT02073474 -
2008 Phase 3 NCT00681538 United Kingdom;
2002 Phase 3 NCT00711646 United Kingdom;
2002 Phase 3 NCT00678795 United Kingdom;
Satralizumab
Chugai Pharmaceutical Co., Ltd.
2019 - JPRN-JapicCTI-205119 Japan;
2014 Phase 3 JPRN-JapicCTI-132397 Japan, Asia except Japan, North America, Europe;
F. HOFFMANN - LA ROCHE LTD.
2021 Phase 3 EUCTR2021-001088-26-IT Canada;France;Germany;India;Italy;Korea, Republic of;Turkey;United States;
Hans-Christian von Buedingen
2021 Phase 4 JPRN-jRCT2031200333 Bulgaria;Canada;Croatia;Georgia;Germany;Hungary;Italy;Japan;Korea;Malaysia;Poland;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Hoffmann-La Roche
2022 Phase 3 NCT05199688 Argentina;Italy;Mexico;Ukraine;United States;
2021 Phase 3 NCT04660539 Bulgaria;Canada;Croatia;Germany;Hungary;Italy;Japan;Korea, Republic of;Malaysia;Poland;Puerto Rico;Romania;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 NCT02073279 Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Georgia;Italy;Korea, Republic of;Malaysia;Philippines;Poland;Puerto Rico;Romania;Singapore;Taiwan;Turkey;Ukraine;United States;
2014 Phase 3 NCT02028884 France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;Ukraine;United Kingdom;United States;
Satralizumab (120 mg/PFS with NSD)
F. Hoffmann-La Roche Ltd.
2017 Phase 3 EUCTR2015-005431-41-PL Bulgaria;Canada;Croatia;Georgia;Italy;Korea, Republic of;Malaysia;Poland;Romania;Russian Federation;Taiwan;Turkey;Ukraine;United States;
2016 Phase 3 EUCTR2015-005431-41-HR Bulgaria;Canada;Croatia;Georgia;Italy;Korea, Republic of;Malaysia;Poland;Romania;Taiwan;Turkey;Ukraine;United States;
2014 Phase 3 EUCTR2013-003752-21-PL France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003752-21-GB France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003752-21-DE France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States;
Satralizumab (120 mg/vial)
F. Hoffmann-La Roche Ltd.
2017 Phase 3 EUCTR2015-005431-41-PL Bulgaria;Canada;Croatia;Georgia;Italy;Korea, Republic of;Malaysia;Poland;Romania;Russian Federation;Taiwan;Turkey;Ukraine;United States;
2016 Phase 3 EUCTR2015-005431-41-HR Bulgaria;Canada;Croatia;Georgia;Italy;Korea, Republic of;Malaysia;Poland;Romania;Taiwan;Turkey;Ukraine;United States;
2014 Phase 3 EUCTR2013-003752-21-GB France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003752-21-DE France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States;
Satralizumab (120mg/vial)
F. Hoffmann-La Roche Ltd.
2014 Phase 3 EUCTR2013-003752-21-PL France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;Ukraine;United Kingdom;United States;
Satralizumab (RO5333787/Enspryng /SA237)
F. Hoffmann-La Roche Ltd.
2014 Phase 3 EUCTR2013-003752-21-PL France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;Ukraine;United Kingdom;United States;
Satralizumab (RO5333787/Enspryng/SA237)
F. Hoffmann-La Roche Ltd.
2014 Phase 3 EUCTR2013-003752-21-GB France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003752-21-DE France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States;
Satralizumab (RO5333787/SA237)
F. Hoffmann-La Roche Ltd.
2017 Phase 3 EUCTR2015-005431-41-PL Bulgaria;Canada;Croatia;Georgia;Italy;Korea, Republic of;Malaysia;Poland;Romania;Russian Federation;Taiwan;Turkey;Ukraine;United States;
2016 Phase 3 EUCTR2015-005431-41-HR Bulgaria;Canada;Croatia;Georgia;Italy;Korea, Republic of;Malaysia;Poland;Romania;Taiwan;Turkey;Ukraine;United States;
Satralizumab (r-INN)
F. Hoffmann-La Roche Ltd.
2017 Phase 3 EUCTR2015-005431-41-PL Bulgaria;Canada;Croatia;Georgia;Italy;Korea, Republic of;Malaysia;Poland;Romania;Russian Federation;Taiwan;Turkey;Ukraine;United States;
2016 Phase 3 EUCTR2015-005431-41-HR Bulgaria;Canada;Croatia;Georgia;Italy;Korea, Republic of;Malaysia;Poland;Romania;Taiwan;Turkey;Ukraine;United States;
2014 Phase 3 EUCTR2013-003752-21-PL France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003752-21-GB France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States;
2014 Phase 3 EUCTR2013-003752-21-DE France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;United Kingdom;United States;
Satrazlizumab (RO5333787/ Enspryng /SA237)
F. Hoffmann-La Roche Ltd.
2014 Phase 3 EUCTR2013-003752-21-PL France;Germany;Hungary;Italy;Japan;Poland;Spain;Taiwan;Ukraine;United Kingdom;United States;
Seasonal Quadrivalent influenza vaccine
Novartis Pharmaceuticals
2018 Phase 3 NCT03650114 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
Seasonal influenza vaccine
Celgene
2021 Phase 3 NCT05028634 Germany;United States;
Novartis
2010 Phase 3 NCT01199861 Austria;Belgium;Canada;Finland;France;Guatemala;Poland;Spain;Switzerland;United Kingdom;
Second-generation fumaric acid
Biogen Idec Inc.
2004 - EUCTR2004-000663-99-SE Hungary;Sweden;
2004 - EUCTR2004-000663-99-HU Hungary;Sweden;
2004 - EUCTR2004-000663-99-CZ Czech Republic;Hungary;Sweden;
Secukinumab
NOVARTIS FARMA
2013 - EUCTR2012-004019-29-IT Argentina;Canada;Colombia;Finland;Germany;Italy;Japan;Poland;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
Novartis Pharma AG
2013 - EUCTR2012-004019-29-SE Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
2013 - EUCTR2012-004019-29-PT Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
2013 - EUCTR2012-004019-29-PL Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
2013 - EUCTR2012-004019-29-FI Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
2013 - EUCTR2012-004019-29-DE Argentina;Belgium;Canada;Colombia;Czech Republic;Finland;France;Germany;Italy;Japan;Poland;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;Turkey;United States;
Novartis Pharma K.K.
2013 Phase 2 JPRN-JapicCTI-132178 -
Novartis Pharma Services AG
2012 - EUCTR2011-001629-25-CZ Czech Republic;Russian Federation;Ukraine;
See Intervention Description)
NorthShore University HealthSystem
2016 Phase 4 NCT02670161 -
Sendoxan
Uppsala l?ns landsting
2011 - EUCTR2010-023560-40-SE Brazil;Canada;Sweden;United States;
Sendoxane
Helse Bergen HF, Haukeland University Hospital
2018 Phase 3 EUCTR2017-001362-25-DK Denmark;Netherlands;
Serum Free Avonex
Biogen Idec
2003 Phase 1 NCT00913250 -
Serum containing Avonex
Biogen Idec
2003 Phase 1 NCT00913250 -
Sham Transcranial Direct Current Stimulation (tDCS)
University of Iowa
2020 - NCT04391023 United States;
Short-course Ocrelizumab
Johns Hopkins University
2021 Phase 2 NCT04767698 United States;
Silodyx
Erasmus MC Dept. Urology
2016 Phase 3 EUCTR2015-002820-20-NL Netherlands;
Simethicone
Rocky Mountain MS Research Group, LLC
2014 Phase 4 NCT02217982 United States;
SimvaHEXAL® 40 mg Filmtabletten
University College London Comprehensive Clinical Trials Unit
2017 Phase 3 EUCTR2017-003328-56-GB United Kingdom;
Simvastatin
Alabama Neurology Associates, PC
2005 Phase 3 NCT00242268 United States;
Anna Tsakiri
2008 Phase 3 NCT00429442 Denmark;
Biogen Idec
2006 Phase 4 NCT00492765 Denmark;
Glostrup Hospital, Dep. of Neurology
2009 - EUCTR2006-001827-21-DK Denmark;
Glostrup University Hospital, Copenhagen
2006 Phase 3 NCT00261326 Denmark;
Imperial College London
2008 Phase 2 NCT00647348 United Kingdom;
Tehran University of Medical Sciences
2005 Phase 3 NCT00668343 Iran, Islamic Republic of;
University College, London
2019 Phase 2 NCT03896217 United Kingdom;
2018 Phase 3 NCT03387670 Ireland;United Kingdom;
Simvastatin 40 mg film-coated tablets
University College London
2020 Phase 2 EUCTR2017-003008-30-GB United Kingdom;
University College London Comprehensive Clinical Trials Unit
2017 Phase 3 EUCTR2017-003328-56-GB United Kingdom;
Simvastatin Alternova
Biogen Idec A/S
2006 - EUCTR2005-003930-16-SE Finland;Sweden;
2006 - EUCTR2005-003930-16-FI Finland;Sweden;
2005 - EUCTR2005-003930-16-DK Denmark;Finland;Sweden;
Simvastatin in relapsing remitting multiple sclerosis
Assiut University
2020 Phase 1 NCT04178980 -
Simvastatina Sandoz 40 mg comprimidos recubiertos con película EFG
University College London Comprehensive Clinical Trials Unit
2017 Phase 3 EUCTR2017-003328-56-GB United Kingdom;
Simvastatine
VUmc Neurology Department
2020 Phase 2 EUCTR2019-003127-38-NL Netherlands;
Simvastatine Sandoz 40 mg filmomhulde tabletten
University College London Comprehensive Clinical Trials Unit
2017 Phase 3 EUCTR2017-003328-56-GB United Kingdom;
Simvastatine Sandoz 40mg deelbare filmomhulde tabletten
University College London Comprehensive Clinical Trials Unit
2017 Phase 3 EUCTR2017-003328-56-GB United Kingdom;
Single-point cane (SPC)
Rowan University
2014 - NCT02227524 United States;
Single-pulse transcranial magnetic stimulation (spTMS)
Shirley Ryan AbilityLab
2017 - NCT03723434 United States;
Single-use autoinjector
Biogen Idec
2005 Phase 3 NCT00915577 -
Single-use autoinjector with a prefilled liquid Avonex syringe
Biogen
2009 Phase 3 NCT00828204 United States;
Sinvastatina Sandoz 40 mg comprimidos revestidos por película
University College London Comprehensive Clinical Trials Unit
2017 Phase 3 EUCTR2017-003328-56-GB United Kingdom;
Siponimob
NOVARTIS PHARMA SERVICES AG
2021 Phase 3 EUCTR2020-002700-39-IT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Croatia;Czechia;Estonia;France;Germany;Guatemala;India;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
Siponimod
NOVARTIS FARMA
2012 - EUCTR2012-003056-36-IT Argentina;Australia;Austria;Bulgaria;Canada;Czech Republic;Egypt;Estonia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Poland;Portugal;Russian Federation;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Pharma K.K.
2014 Phase 3 JPRN-JapicCTI-142447 -
Novartis Pharma Services AG
2010 Phase 2 EUCTR2009-014392-51-PL Canada;Finland;Germany;Hungary;Italy;Poland;Russian Federation;Spain;Turkey;United States;
2010 Phase 2 EUCTR2009-014392-51-HU Canada;Finland;Germany;Hungary;Italy;Poland;Russian Federation;Spain;Turkey;United States;
2010 Phase 2 EUCTR2009-014392-51-FI Canada;Finland;Germany;Hungary;Italy;Poland;Russian Federation;Spain;Turkey;United States;
2010 - EUCTR2009-014392-51-DE Canada;Finland;Germany;Hungary;Italy;Poland;Russian Federation;Spain;Turkey;United States;
Novartis Pharmaceuticals
2021 Phase 3 NCT04926818 Australia;Austria;Belgium;France;Germany;India;Latvia;Mexico;Poland;Portugal;Russian Federation;Slovakia;Spain;Turkey;United States;
2021 - NCT04933552 United States;
2021 - NCT04895202 Switzerland;
2021 - NCT04540861 -
2019 Phase 3 NCT03623243 Puerto Rico;United States;
Siponimod 0,
AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA
2021 Phase 4 EUCTR2020-005947-22-IT Italy;
Siponimod 0.25 mg tablet
Novartis Farmacéutica S.A
2012 - EUCTR2012-003056-36-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Pharma Services AG
2015 - EUCTR2012-003056-36-FR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-PL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-IE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-EE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 - EUCTR2012-003056-36-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
- Phase 3 EUCTR2012-003056-36-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Siponimod 0.5 mg tablet
Novartis Farmacéutica S.A
2012 - EUCTR2012-003056-36-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Pharma Services AG
2015 - EUCTR2012-003056-36-FR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-PL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-IE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-EE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 - EUCTR2012-003056-36-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
- Phase 3 EUCTR2012-003056-36-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Siponimod 1 mg tablet
Novartis Farmacéutica S.A
2012 - EUCTR2012-003056-36-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Pharma Services AG
2015 - EUCTR2012-003056-36-FR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-PL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-IE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-EE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 - EUCTR2012-003056-36-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
- Phase 3 EUCTR2012-003056-36-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Siponimod 2 mg tablet
Novartis Farmacéutica S.A
2012 - EUCTR2012-003056-36-ES Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Pharma Services AG
2015 - EUCTR2012-003056-36-FR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-PL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-IE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-GR Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-GB Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-BG Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003056-36-BE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-SK Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-SE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-PT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-LT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Czechia;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-HU Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-EE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-DE Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-CZ Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003056-36-AT Argentina;Australia;Austria;Belgium;Bulgaria;Canada;China;Czech Republic;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2012 - EUCTR2012-003056-36-LV Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
- Phase 3 EUCTR2012-003056-36-NL Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Czech Republic;Egypt;Estonia;France;Germany;Greece;Hungary;Ireland;Israel;Italy;Latvia;Lithuania;Netherlands;Poland;Portugal;Romania;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Sirolimus
National Institute of Allergy and Infectious Diseases (NIAID)
2003 Phase 1/Phase 2 NCT00095329 United States;
Sivatin 40 mg film-coated tablets
University College London Comprehensive Clinical Trials Unit
2017 Phase 3 EUCTR2017-003328-56-GB United Kingdom;
Sivelestat
Tohoku University Hospital
2013 Phase 1,2 JPRN-UMIN000010094 Japan;
Sleep assessment
Centre Hospitalier Universitaire de Saint Etienne
2020 Phase 2 NCT03983720 France;
Smoked Cannabis
Center for Medicinal Cannabis Research
2003 Phase 1/Phase 2 NCT00260741 United States;
2001 Phase 1/Phase 2 NCT00248378 United States;
Sodium Chloride solution
Anders Svenningsson
2016 Phase 3 NCT02746744 Sweden;
Sodium chlorid
Sykehuset Innlandet HF
2009 - NCT00764413 Norway;
Solifenacin Succinate
Astellas Pharma Inc
2008 Phase 4 NCT00629642 Australia;Belgium;Czech Republic;Czechia;France;Germany;Hungary;Italy;Netherlands;Portugal;Russian Federation;Spain;United Kingdom;
Soliris
Alexion Pharmaceuticals Inc.
2020 Phase 2;Phase 3 EUCTR2019-001829-26-DE Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States;
2019 Phase 2;Phase 3 EUCTR2019-001829-26-ES Canada;Germany;Italy;Japan;Korea, Republic of;Spain;United States;
SoluMedrol
University of Utah
2014 - NCT02296346 United States;
Solumedrol IM 125mg/2ml
NOVARTIS PHARMA AG
2018 Phase 2 EUCTR2017-004702-17-IT Austria;Bulgaria;Czech Republic;Czechia;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
Somatorelin
UNIVERSITA' DEGLI STUDI DI NAPOLI FEDERICO II
2009 - EUCTR2008-007447-14-IT Italy;
Spikevax
Novartis Pharma GmbH
2021 Phase 4 EUCTR2020-005752-38-DE Germany;
Novartis Pharma Vertriebs GmbH
2021 Phase 4 EUCTR2021-000307-20-DE Germany;
Spiropent
Department of Neurology UMCG
2006 - EUCTR2006-004318-42-NL Netherlands;
Ss-interferon
Sun Yat-sen University
2006 - NCT00818103 China;
Standard MS DMT
Novartis Pharmaceuticals
2011 Phase 4 NCT01317004 Italy;
Standard MS DMTs
Novartis Pharmaceuticals
2010 Phase 4 NCT01216072 Canada;Puerto Rico;United States;
Standard gadolinium contrast
National Center for Research Resources (NCRR)
1999 - NCT00006060 United States;
Standard interval dosing
VU University Medical Center
2020 Phase 4 NCT04225312 Netherlands;
Standard treatment with a conventional drug
Northwestern University
2005 Phase 2 NCT00273364 United States;
Standardized cannabis extract
Institut fur Klinische Forschung, Germany
2006 Phase 3 NCT00552604 United Kingdom;
Statin
Università Popolare Homo & Natura
2015 Phase 1 NCT02632591 Italy;
Stem Cell Transplantation
Stem Cells Arabia
2016 Phase 1 NCT03069170 Jordan;
Steroid Cream
University of Nebraska
2010 Phase 4 NCT00988988 United States;
Study Drug
Biogen
2014 Phase 1 NCT02201849 United States;
Sublingual tizanidine
Teva GTC
2008 Phase 1/Phase 2 NCT00464958 Israel;
Sunphenon EGCG
Friedemann Paul
2009 Phase 2/Phase 3 NCT00799890 Germany;
Sunphenon EGCg
Charite Universitätsmedizin Berlin
- Phase 2;Phase 3 EUCTR2008-005213-22-DE Germany;
Sunphenon EGCg TM
Charité-Universitätsmedizin Berlin
2007 - EUCTR2006-006323-39-DE Germany;
Suspension media
University Hospital, Toulouse
2015 Phase 1/Phase 2 NCT02403947 France;
Sustained-release oral dalfampridine
Sheba Medical Center
2014 Phase 4 NCT02259361 Israel;
Suvorexant
Theodore R. Brown, MD MPH
2017 Phase 4 NCT03110315 United States;
Syngeneic Bone Marrow Transplantation
Fred Hutchinson Cancer Research Center
2008 Phase 2 NCT00716066 United States;
T cell vaccination
Hadassah Medical Organization
2002 Phase 1/Phase 2 NCT01448252 Israel;
Sheba Medical Center
2002 Phase 3 NCT00228228 Israel;
T-Cell Vaccination
Sheba Medical Center
1998 Phase 1/Phase 2 NCT00220428 Israel;
TACHIPIRINA - 500 MG COMPRESSE20 COMPRESSE
NOVARTIS PHARMA AG
2018 Phase 2 EUCTR2017-004702-17-IT Austria;Bulgaria;Czech Republic;Czechia;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
TACI-Fc5
Merck Serono Geneva- an affiliate of Merck KGaA, Darmstadt Germany
2008 - EUCTR2007-003936-50-SE Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
Merck Serono International
2009 Phase 2 EUCTR2008-005021-11-FR Belgium;Czech Republic;France;Sweden;
2009 Phase 2 EUCTR2008-005021-11-CZ Belgium;Czech Republic;France;Sweden;
2009 - EUCTR2008-005021-11-SE Belgium;Czech Republic;France;Sweden;
Merck Serono International S.A.
2008 Phase 2 EUCTR2007-003936-50-FR Austria;Belgium;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2008 Phase 2 EUCTR2007-003936-50-ES Austria;Belgium;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-003936-50-NL Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
Merck Serono S.A. - Geneva
2008 - EUCTR2007-003936-50-GB Australia;Austria;Canada;Czech Republic;France;Lebanon;Lithuania;Netherlands;Russian Federation;Spain;Sweden;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-003936-50-AT Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
Merck Serono SA - Geneva, An affiliate of Merck KGaA, Darmstadt, Germany
2009 - EUCTR2008-005021-11-BE Belgium;Czech Republic;France;Sweden;
Merck Serono SA - Geneva, an affiliate of Merck KGaA, Darmstadt, Germany
2008 - EUCTR2007-003936-50-CZ Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-003936-50-BE Austria;Belgium;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
Merck Serono SA-Geneva
2008 - EUCTR2007-003936-50-LT Austria;Czech Republic;France;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
TCD after bosentan administration
Universitair Ziekenhuis Brussel
2014 - NCT02389426 Belgium;
TCD baseline
Universitair Ziekenhuis Brussel
2014 - NCT02389426 Belgium;
TECFIDERA
Biogen Idec Research Limited
2019 Phase 3 EUCTR2018-000516-22-PT Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-000516-22-HU Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States;
2019 Phase 3 EUCTR2018-000516-22-EE Bulgaria;Colombia;Croatia;Estonia;Greece;Hungary;Israel;Italy;Jordan;Korea, Republic of;Malaysia;Mexico;Portugal;Russian Federation;Saudi Arabia;Serbia;Taiwan;Thailand;Tunisia;Turkey;United States;
CHU de Rennes
2018 Phase 3 EUCTR2018-001292-21-FR France;
TECFIDERA - 240 MG - CAPSULA RIGIDA GASTRORESISTENTE - USO ORALE - BLISTER (PVC/PE/PVDC-PVC ALLUMINIO) - 56 CAPSULE
FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA
2017 Phase 4 EUCTR2017-000559-26-IT Israel;Italy;Switzerland;United States;
TENOFOVIR ALAFENAMIDE FUMARATE 25 Mg ORAL TABLET [VEMLIDY]
Harvard Medical School
2022 Phase 2 NCT04880577 -
TERIFLUNOMIDE HMR1726
Sanofi
2019 Phase 4 NCT03856619 India;
TETRAHYDROCANNABINOL Botanical Drug Substance (THC BDS)
Almirall Hermal GmbH
2016 Phase 4 EUCTR2015-004451-40-AT Austria;Czech Republic;
TG-1101
TG Therapeutics
2017 Phase 3 EUCTR2017-000639-15-HR Belarus;Croatia;Georgia;Poland;Romania;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000639-15-GB Belarus;Croatia;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000639-15-ES Belarus;Croatia;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000638-75-GB Belarus;Georgia;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000638-75-ES Belarus;Georgia;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
TG Therapeutics, Inc.
2020 Phase 3 EUCTR2019-003625-16-HR Belarus;Croatia;Georgia;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
2017 Phase 3 EUCTR2017-000639-15-PL Belarus;Croatia;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2017-000638-75-PL Belarus;Georgia;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States;
THC
Aarhus Universitetshospital
2018 Phase 2 EUCTR2018-002315-98-DK Denmark;
TMP001
Dr. Frank Behrens
2015 Phase 2 NCT02686788 Germany;
Fraunhofer Gesellschaft for its Institute Fraunhofer Institute for Molecular Biology and Applied Ecology (IME)
2015 Phase 2 EUCTR2014-004483-38-DE Germany;
TORVAST*10CPR
DR DIMENSIONE RICERCA
2005 - EUCTR2005-001009-25-IT Italy;
TSO
Charite Universitätsmedizin Berlin
2011 Phase 2 EUCTR2009-015319-41-DE Germany;
Danish Multiple Sclerosis Research Center
2009 Phase 2 EUCTR2008-007549-29-DK Denmark;
TT Vaccine
Hoffmann-La Roche
2015 Phase 3 NCT02545868 Canada;United States;
TV-5010
TEVA
2004 - EUCTR2004-000759-40-IT Italy;
TEVA ITALIA srl
2004 - EUCTR2004-000762-13-IT Italy;
TV-5600
TEVA ITALIA srl
2008 - EUCTR2007-005450-23-IT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2007 - EUCTR2007-003226-19-IT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
TEVA PHARMACEUTICALS INDUSTRIES LTD
2013 Phase 3 EUCTR2012-003647-30-IT Albania;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Democratic People's Republic of;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Poland;Puerto Rico;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
Teva Pharmaceutical Industries Ltd
2013 Phase 3 EUCTR2012-003647-30-PL Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003647-30-HU Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003647-30-ES Albania;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003647-30-EE Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003647-30-CZ Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003647-30-BE Albania;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Puerto Rico;Russian Federation;Serbia;Slovakia;South Africa;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003647-30-AT Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003647-30-SK Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003647-30-LV Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Chile;Croatia;Czech Republic;Estonia;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Democratic People's Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003647-30-GR Albania;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Kazakhstan;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Montenegro;Poland;Portugal;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2012 Phase 3 EUCTR2012-003647-30-GB Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Chile;Croatia;Czech Republic;Estonia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Latvia;Macedonia, the former Yugoslav Republic of;Moldova, Republic of;Montenegro;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-015815-42-SK Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Poland;Slovakia;Spain;
2010 Phase 3 EUCTR2009-015815-42-PL Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States;
2010 Phase 3 EUCTR2009-015815-42-LT Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States;
2010 Phase 3 EUCTR2009-015815-42-IT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Poland;Slovakia;Spain;
2010 Phase 3 EUCTR2009-015815-42-EE Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States;
2010 Phase 3 EUCTR2009-015815-42-CZ Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States;
2010 Phase 3 EUCTR2009-015815-42-BG Bulgaria;Czech Republic;Estonia;Georgia;Germany;Israel;Italy;Lithuania;Macedonia, the former Yugoslav Republic of;Poland;Russian Federation;Slovakia;South Africa;Spain;Ukraine;United States;
2010 Phase 3 EUCTR2009-012989-30-SE Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-012989-30-FR Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2010 Phase 3 EUCTR2009-012989-30-BG Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2010 Phase 3 EUCTR2009-012989-30-AT Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-012989-30-NL Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-012989-30-LT Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-012989-30-HU Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-012989-30-GB Austria;Bulgaria;Canada;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-012989-30-ES Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Lithuania;Netherlands;Spain;Sweden;United Kingdom;
2009 Phase 3 EUCTR2009-012989-30-EE Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 Phase 3 EUCTR2009-012989-30-CZ Austria;Bulgaria;Czech Republic;Estonia;France;Georgia;Germany;Hungary;Israel;Italy;Lithuania;Netherlands;Russian Federation;Serbia;Spain;Sweden;Ukraine;United Kingdom;United States;
2009 - EUCTR2009-011234-99-DE Germany;
2008 Phase 3 EUCTR2007-005450-23-SK Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Slovakia;Spain;
2008 - EUCTR2007-005450-23-LT Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2008 - EUCTR2007-005450-23-ES Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2008 - EUCTR2007-005450-23-EE Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2008 - EUCTR2007-005450-23-DE Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2008 - EUCTR2007-005450-23-CZ Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2008 - EUCTR2007-005450-23-BG Bulgaria;Czech Republic;Estonia;Germany;Italy;Lithuania;Spain;
2008 - EUCTR2007-003226-19-PT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-003226-19-LT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-003226-19-BG Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 Phase 3 EUCTR2007-003226-19-FR Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 Phase 3 EUCTR2007-003226-19-ES Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-SE Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-NL Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-LV Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-HU Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-GB Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-EE Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-DE Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-CZ Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003226-19-AT Austria;Bulgaria;Czech Republic;Estonia;France;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Portugal;Spain;Sweden;United Kingdom;
2006 Phase 2 EUCTR2005-004334-41-GB Czech Republic;Germany;Hungary;Israel;Italy;Poland;Russian Federation;Spain;United Kingdom;
2006 Phase 2 EUCTR2005-004334-41-DE Czech Republic;Germany;Hungary;Israel;Italy;Russian Federation;Spain;United Kingdom;
2006 Phase 2 EUCTR2005-004334-41-CZ Czech Republic;Germany;Hungary;Israel;Italy;Russian Federation;Spain;United Kingdom;
2005 Phase 2 EUCTR2005-004334-41-HU Czech Republic;Germany;Hungary;Israel;Italy;Russian Federation;Spain;United Kingdom;
Teva Pharmaceutical Industries Ltd.
2015 Phase 2 EUCTR2014-001579-30-DE Canada;Germany;Italy;Netherlands;Poland;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2015 - EUCTR2014-001579-30-NL Canada;Germany;Italy;Netherlands;Poland;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2014 Phase 2 EUCTR2014-001579-30-IT Canada;Germany;Italy;Netherlands;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2014 Phase 2 EUCTR2014-001579-30-GB Canada;Germany;Italy;Netherlands;Poland;Russian Federation;Spain;Ukraine;United Kingdom;United States;
2014 Phase 2 EUCTR2014-001579-30-ES Canada;Germany;Italy;Netherlands;Poland;Russian Federation;Spain;Ukraine;United Kingdom;United States;
Teva Pharmaceutical Industries, Ltd.
2014 - EUCTR2013-002082-19-NL Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
2014 - EUCTR2013-002082-19-ES Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
2013 Phase 3 EUCTR2013-002082-19-GB Belgium;Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
2013 Phase 3 EUCTR2013-002082-19-BE Belgium;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Norway;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2013-002082-19-SE Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2013-002082-19-FI Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
2013 - EUCTR2013-002082-19-DK Denmark;Finland;Netherlands;Spain;Sweden;Switzerland;United Kingdom;
TYSABRI 300 mg concentrado para solución para perfusión
Biogen Idec Limited
2010 - EUCTR2009-015556-15-ES Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
TYSABRI 300 mg concentrate for solution for infusion
BIOGEN IDEC LTD
2006 Phase 3 EUCTR2005-004061-41-GB Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
TYSABRI 300 mg solution à diluer pour perfusion
Hôpitaux Universitaires de Strasbourg
2014 - EUCTR2014-003209-14-FR France;
TYSABRI and AVONEX
Biogen Idec
2008 Phase 4 NCT00771043 United States;
TYSABRI*IV 1FL 300MG 15ML
BIOGEN IDEC LTD
2011 - EUCTR2010-024000-10-IT Belgium;Germany;Italy;Spain;
2011 - EUCTR2010-021978-11-IT Belgium;Canada;Czech Republic;Denmark;Finland;Germany;Ireland;Italy;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
TYSABRI®
BIOGEN IDEC LTD
2007 - EUCTR2005-004061-41-SE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 Phase 3 EUCTR2005-004061-41-BE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 - EUCTR2005-004061-41-IE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 - EUCTR2005-004061-41-HU Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 - EUCTR2005-004061-41-GR Austria;Czech Republic;Denmark;Finland;Germany;Greece;Ireland;Italy;Spain;Sweden;United Kingdom;
2006 - EUCTR2005-004061-41-FI Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 - EUCTR2005-004061-41-DK Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 - EUCTR2005-004061-41-DE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
2006 - EUCTR2005-004061-41-CZ Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;Turkey;United Kingdom;
Tachipirina CPR
NOVARTIS PHARMA AG
2018 Phase 2 EUCTR2017-004702-17-IT Austria;Bulgaria;Czech Republic;Czechia;Estonia;Germany;Italy;Latvia;Lithuania;Poland;Russian Federation;Spain;United States;
Tarenflurbil
Fraunhofer Gesellschaft for its Institute Fraunhofer Institute for Molecular Biology and Applied Ecology (IME)
2015 Phase 2 EUCTR2014-004483-38-DE Germany;
Targretin
Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge
2015 Phase 2 EUCTR2014-003145-99-GB United Kingdom;
Taurine
University of Iowa
2010 Phase 1 NCT01381354 United States;
Tcelna
Opexa Therapeutics, Inc.
2012 Phase 2 NCT01684761 Canada;United States;
Tecfidera
Banner Life Sciences LLC
2019 Phase 1 NCT04022473 United States;
Biogen GmbH
2015 Phase 4 EUCTR2014-000395-26-DE Germany;
Biogen Idec Ltd.
2009 Phase 3 EUCTR2008-004753-14-DE Australia;Austria;Belarus;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Estonia;France;Germany;Greece;Guatemala;India;Ireland;Israel;Italy;Latvia;Macedonia, the former Yugoslav Republic of;Mexico;Moldova, Republic of;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;South Africa;Spain;Switzerland;Ukraine;United Kingdom;United States;
Biogen Idec Norway
2015 Phase 4 EUCTR2015-001197-18-NO Norway;
Biogen Idec Research Limited
2014 Phase 4 EUCTR2013-001656-35-SK Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2014 Phase 4 EUCTR2013-001656-35-SI Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2014 Phase 4 EUCTR2013-001656-35-PT Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2014 Phase 4 EUCTR2013-001656-35-IT Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2014 Phase 4 EUCTR2013-001656-35-HU Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2014 Phase 4 EUCTR2013-001656-35-FR Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2014 Phase 4 EUCTR2013-001656-35-ES Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2014 Phase 4 EUCTR2013-001656-35-CZ Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2014 Phase 4 EUCTR2013-001656-35-BE Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2014 Phase 4 EUCTR2013-001656-35-AT Austria;Belgium;Canada;Czech Republic;France;Hungary;Italy;Portugal;Slovakia;Slovenia;Spain;
2014 - EUCTR2013-001895-40-IE Ireland;United Kingdom;
2014 - EUCTR2013-001486-17-DE Germany;
Department of Clinical Sciences, Danderyd Hospital
2015 Phase 3 EUCTR2015-004116-38-SE Sweden;
EMD Serono Research & Development Institute, Inc.
2017 Phase 2 NCT02975349 Bulgaria;Czechia;Germany;Poland;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United States;
Finn Sellebjerg
2016 Phase 2 EUCTR2016-000283-41-DK Denmark;
IMS HEALTH GmbH & Co. OHG
2016 - NCT02823951 Canada;United States;
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden;
2017 Phase 4 EUCTR2016-003587-39-SE Sweden;
Merck KGaA
2017 Phase 2 EUCTR2016-001448-21-SK Bulgaria;Croatia;Czech Republic;Czechia;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-001448-21-PL Bulgaria;Croatia;Czech Republic;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-001448-21-ES Bulgaria;Croatia;Czech Republic;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-001448-21-CZ Bulgaria;Croatia;Czech Republic;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 2 EUCTR2016-001448-21-BG Bulgaria;Croatia;Czech Republic;Poland;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United States;
Northwestern University
2013 Phase 2 EUCTR2012-004165-41-GB United Kingdom;United States;
University of Texas Southwestern Medical Center
2016 Phase 4 NCT02739542 United States;
Yale University
2014 - NCT02218879 United States;
Tecfidera (BG00012)
Biogen Idec Research Limited
2015 Phase 4 EUCTR2013-001025-53-DK Denmark;Finland;Netherlands;Norway;Spain;United Kingdom;
2015 - EUCTR2013-001025-53-ES Denmark;Finland;Netherlands;Norway;Spain;United Kingdom;
Tecfidera (BG12)
Sheffield Teaching Hospitals NHS Foundation Trust
2013 Phase 2/Phase 3 NCT03133403 United Kingdom;
Tecfidera®
Alkermes, Inc.
2019 Phase 3 EUCTR2017-001294-16-DE Germany;Poland;United States;
2017 Phase 3 EUCTR2017-001294-16-PL Germany;Poland;United States;
Biogen Idec Italia S.r.l.
2015 - EUCTR2015-000303-21-IT Italy;
Biogen Idec Research Limited
2015 Phase 3 EUCTR2014-004562-22-DE Australia;Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;United States;
Tecfidera® 120mg magensaftresistente Hartkapseln
Universitätsklinikum Münster
2015 Phase 4 EUCTR2014-003481-25-DE Germany;
Tecfidera® 240mg magensaftresistente Hartkapseln
Universitätsklinikum Münster
2015 Phase 4 EUCTR2014-003481-25-DE Germany;
Tecifdera (dimethyl fumarate)
Brigham and Women's Hospital
2015 - NCT02419638 United States;
Temelimab
GeNeuro Innovation SAS
2021 Phase 2 NCT05049161 Sweden;
2020 Phase 2 NCT04480307 Sweden;
2020 Phase 2 EUCTR2019-004822-15-SE Sweden;
Temsirolimus Tablets
Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development
2005 - EUCTR2005-000171-18-FI Finland;
Teriflunomide
Actelion
2015 Phase 3 NCT02425644 Argentina;Belarus;Bosnia and Herzegovina;Bulgaria;Canada;Croatia;Czech Republic;Czechia;Finland;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Latvia;Lithuania;Mexico;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Aventis Pharmaceuticals Inc.
2006 - EUCTR2004-000555-42-PT Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
Biocad
2019 Phase 2 NCT04056897 Russian Federation;
Centre Hospitalier Universitaire de Nice
2015 Phase 3 NCT02587195 France;
Centre hospitalier de l'Université de Montréal (CHUM)
2015 - NCT02490982 Canada;
Genzyme, a Sanofi Company
2014 Phase 3 NCT02201108 Australia;Belgium;Bulgaria;Canada;China;Estonia;France;Greece;Israel;Lebanon;Lithuania;Macedonia, The Former Yugoslav Republic of;Morocco;Netherlands;North Macedonia;Poland;Portugal;Russian Federation;Serbia;Slovenia;Spain;Tunisia;Turkey;Ukraine;United Kingdom;United States;
Hoffmann-La Roche
2021 Phase 3 NCT04586023 Austria;Brazil;Bulgaria;Canada;Denmark;France;Greece;Guatemala;India;Italy;Korea, Republic of;Mexico;Poland;Russian Federation;Turkey;United Kingdom;United States;
2021 Phase 3 NCT04586010 Argentina;China;Finland;Germany;Hong Kong;Hungary;Italy;Netherlands;Peru;Portugal;Russian Federation;Spain;Switzerland;Taiwan;Ukraine;United States;
Jan Lycke
2019 Phase 4 NCT04129736 Sweden;
McGill University
2016 - NCT03561402 Canada;
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
2020 Phase 3 NCT04338061 Belarus;Brazil;Bulgaria;Canada;France;Germany;Greece;India;Italy;Latvia;Lithuania;Malaysia;Moldova, Republic of;Norway;Philippines;Poland;Portugal;Puerto Rico;Romania;Russian Federation;Singapore;Slovakia;Slovenia;South Africa;Spain;Sweden;Switzerland;Thailand;Turkey;Ukraine;United States;
2020 Phase 3 NCT04338022 Argentina;Australia;Austria;Belgium;Bosnia and Herzegovina;Bulgaria;Canada;Colombia;Croatia;Czechia;Estonia;Finland;France;Georgia;Germany;Hong Kong;Hungary;India;Israel;Italy;Korea, Republic of;Netherlands;Poland;Russian Federation;Serbia;Spain;Taiwan;Ukraine;United Kingdom;United States;
NOVARTIS PHARMA SERVICES AG
2017 Phase 3 EUCTR2015-005419-33-IT Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Czech Republic;Egypt;Finland;France;Germany;Hungary;India;Italy;Latvia;Lebanon;Lithuania;Mexico;Peru;Portugal;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Arab Emirates;United Kingdom;United States;
2017 Phase 3 EUCTR2015-005418-31-IT Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czech Republic;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Mexico;Netherlands;Poland;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
Novartis Farmacéutica S.A.
2022 Phase 3 EUCTR2020-005929-89-ES Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States;
2022 Phase 3 EUCTR2020-005899-36-ES Slovakia;Spain;
Novartis Pharma AG
2022 Phase 3 EUCTR2020-005929-89-SE Argentina;Brazil;Bulgaria;Canada;China;Croatia;Czechia;Estonia;France;Germany;Greece;Hungary;India;Italy;Mexico;Poland;Portugal;Romania;Russian Federation;Slovakia;Slovenia;South Africa;Spain;Sweden;Turkey;United Kingdom;United States;
2022 Phase 3 EUCTR2020-005899-36-SK Argentina;Belgium;Bulgaria;Chile;China;Colombia;Croatia;Czechia;France;Germany;Guatemala;Hong Kong;Hungary;India;Italy;Latvia;Lithuania;Malaysia;Netherlands;Poland;Russian Federation;Serbia;Slovakia;Spain;Switzerland;United Kingdom;United States;
Novartis Pharmaceuticals
2021 Phase 3 NCT05156281 United States;
2021 Phase 3 NCT05147220 United States;
Providence Health & Services
2013 Phase 4 NCT01970410 United States;
Sanofi
2013 Phase 4 NCT01895335 Austria;Belgium;Canada;Chile;Finland;France;Germany;Greece;Italy;Norway;Spain;Sweden;United Kingdom;United States;
2011 Phase 3 NCT01252355 Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
2011 Phase 2 NCT01403376 Austria;Canada;Germany;Russian Federation;Ukraine;
2009 Phase 3 NCT00883337 Belgium;Canada;Czech Republic;France;Germany;Greece;Hungary;Italy;Poland;Spain;Switzerland;Tunisia;United Kingdom;
2008 Phase 3 NCT00751881 Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;South Africa;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2008 Phase 3 NCT00622700 Australia;Austria;Brazil;Bulgaria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Italy;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States;
2007 Phase 2 NCT00811395 Austria;Canada;Germany;Italy;Spain;United Kingdom;United States;
2007 Phase 2 NCT00489489 Canada;Germany;Italy;Poland;Spain;United States;
2007 Phase 2 NCT00475865 Austria;Canada;Germany;Italy;United Kingdom;United States;
2004 Phase 3 NCT00134563 Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2001 Phase 2 NCT01487096 Canada;France;
Sanofi-Aventis US, Inc.
2004 - EUCTR2004-000555-42-AT Austria;Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
Sanofi-Aventis recherche & de'veloppement
2008 - EUCTR2007-003997-24-IT Austria;Italy;Spain;United Kingdom;
Sanofi-Aventis recherche & développement
2008 - EUCTR2007-003997-24-GB Austria;Italy;Spain;United Kingdom;
2007 - EUCTR2007-003997-24-ES Austria;Italy;Spain;United Kingdom;
2007 - EUCTR2007-003997-24-AT Austria;Italy;Spain;United Kingdom;
Sanofi-aventis U.S. Inc
2007 - EUCTR2006-003134-14-IT Germany;Italy;Spain;
2007 - EUCTR2004-000555-42-EE Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
Sanofi-aventis U.S. Inc.
2007 Phase 2 EUCTR2006-004893-29-GB Austria;Germany;Italy;United Kingdom;
2007 Phase 2 EUCTR2006-003134-14-ES Germany;Italy;Spain;
2007 - EUCTR2006-004893-29-IT Austria;Germany;Italy;United Kingdom;
2007 - EUCTR2006-004893-29-AT Austria;Germany;Italy;United Kingdom;
2007 - EUCTR2006-003134-14-DE Germany;Italy;Spain;
- - EUCTR2006-004893-29-DE Austria;Germany;Italy;United Kingdom;
Sanofi-aventis US, Inc
2008 Phase 3 EUCTR2004-000555-42-GB Austria;Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
2005 - EUCTR2004-000555-42-DK Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
2004 - EUCTR2004-000555-42-SE Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
2004 - EUCTR2004-000555-42-NO Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
Sanofi-aventis recherche & développement
2010 - EUCTR2007-004452-36-SK Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2009 Phase 3 EUCTR2007-004452-36-SE Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2009 Phase 3 EUCTR2007-004452-36-GR Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2009 Phase 3 EUCTR2007-004452-36-GB Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2008 Phase 3 EUCTR2006-001152-12-FR Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom;
2008 - EUCTR2007-004452-36-FR Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-004452-36-ES Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-004452-36-EE Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2008 - EUCTR2007-004452-36-DE Austria;Belgium;Czech Republic;Estonia;France;Germany;Greece;Netherlands;Slovakia;Spain;Sweden;United Kingdom;
2008 - EUCTR2006-001152-12-SK Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom;
TG Therapeutics, Inc.
2017 Phase 3 NCT03277261 United States;
2017 Phase 3 NCT03277248 United States;
Tanaka Tomoyuki
2021 Phase 3 JPRN-jRCT2021200035 Belarus;Bulgaria;Canada;China;Czechia;Denmark;Estonia;Finland;Germany;Italy;Japan;Lithuania;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
Turku University Hospital
2017 Phase 4 EUCTR2016-003622-16-FI Finland;
UNIVERSITÀ CATTOLICA DEL SACRO CUORE- POLICLINICO A. GEMELLI
2016 Phase 4 EUCTR2016-001515-20-IT Italy;
University at Buffalo
2018 - NCT03526224 United States;
University of Michigan
2018 - NCT03464448 United States;
sanofi-aventis Recherche & Dévelopment
2009 - EUCTR2008-006226-34-FR Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom;
sanofi-aventis U.S Inc
2007 - EUCTR2004-000555-42-CZ Czech Republic;Denmark;Estonia;Italy;Norway;Portugal;Sweden;United Kingdom;
sanofi-aventis group
2011 - EUCTR2010-023172-12-GR Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom;
sanofi-aventis recherche de veloppement
2007 - EUCTR2006-003361-14-IT Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom;
sanofi-aventis recherche & developpement
2011 - EUCTR2011-001160-21-DE Austria;Canada;Germany;Russian Federation;Ukraine;
2011 - EUCTR2011-001160-21-AT Austria;Canada;Germany;Russian Federation;Ukraine;
sanofi-aventis recherche & développement
2009 - EUCTR2007-004452-36-AT Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2009 - EUCTR2006-003361-14-EE Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom;
2009 - EUCTR2006-003361-14-CZ Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2009 - EUCTR2006-001152-12-LT Australia;Austria;Belarus;Bulgaria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States;
2009 - EUCTR2006-001152-12-DE Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom;
2008 Phase 3 EUCTR2007-004452-36-BE Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2008 Phase 3 EUCTR2006-003361-14-PT Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom;
2008 Phase 3 EUCTR2006-001152-12-BG Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom;
2008 - EUCTR2007-004452-36-NL Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2008 - EUCTR2007-004452-36-CZ Australia;Austria;Belarus;Belgium;Canada;Chile;China;Czech Republic;Estonia;France;Germany;Greece;Mexico;Netherlands;Philippines;Poland;Romania;Slovakia;Spain;Sweden;Thailand;Tunisia;Turkey;Ukraine;United Kingdom;United States;
2008 - EUCTR2006-003361-14-NL Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2008 - EUCTR2006-003361-14-DK Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom;
2008 - EUCTR2006-001152-12-HU Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States;
2008 - EUCTR2006-001152-12-EE Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States;
2007 Phase 3 EUCTR2006-003361-14-SE Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom;
2007 Phase 3 EUCTR2006-003361-14-GB Austria;Canada;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2007 Phase 3 EUCTR2006-001152-12-GB Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States;
2007 Phase 3 EUCTR2006-001152-12-FI Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom;
2007 Phase 3 EUCTR2006-001152-12-CZ Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States;
2007 - EUCTR2006-003361-14-DE Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Poland;Portugal;Russian Federation;Sweden;Switzerland;Ukraine;United Kingdom;United States;
2007 - EUCTR2006-001152-12-DK Australia;Austria;Belarus;Bulgaria;Canada;Chile;Croatia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Mexico;Poland;Romania;Russian Federation;Slovakia;Turkey;Ukraine;United Kingdom;United States;
2007 - EUCTR2006-001152-12-AT Austria;Bulgaria;Czech Republic;Denmark;Estonia;Finland;France;Germany;Hungary;Lithuania;Slovakia;United Kingdom;
2006 Phase 3 EUCTR2006-003361-14-FI Austria;Czech Republic;Denmark;Estonia;Finland;Germany;Italy;Netherlands;Portugal;Sweden;United Kingdom;
2006 - EUCTR2006-003361-14-AT Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
sanofi-aventis recherche et development
2012 - EUCTR2010-023172-12-LT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
2011 Phase 3 EUCTR2010-023172-12-SK Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2011 Phase 3 EUCTR2010-023172-12-HU Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
2011 Phase 3 EUCTR2010-023172-12-BE Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Slovakia;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-023172-12-SE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
2011 - EUCTR2010-023172-12-PT Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-023172-12-NO Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
2011 - EUCTR2010-023172-12-NL Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
2011 - EUCTR2010-023172-12-IT Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-023172-12-GB Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-023172-12-FI Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
2011 - EUCTR2010-023172-12-ES Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-023172-12-EE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
2011 - EUCTR2010-023172-12-DK Austria;Belgium;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Lithuania;Netherlands;Norway;Portugal;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-023172-12-DE Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;Germany;Greece;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
2011 - EUCTR2010-023172-12-AT Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;Denmark;Estonia;Finland;France;Germany;Greece;Guatemala;Hungary;Italy;Korea, Republic of;Lithuania;Netherlands;Norway;Portugal;Russian Federation;Slovakia;Spain;Sweden;Tunisia;Turkey;United Kingdom;United States;
2009 Phase 3 EUCTR2008-006226-34-GR Belgium;Czech Republic;France;Germany;Greece;Hungary;Italy;Spain;United Kingdom;
2009 - EUCTR2008-006226-34-IT Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom;
2009 - EUCTR2008-006226-34-ES Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom;
2009 - EUCTR2008-006226-34-BE Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom;
sanofi-aventis recherche et developpement
2010 - EUCTR2008-006226-34-GB Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom;
2009 - EUCTR2008-006226-34-HU Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom;
2009 - EUCTR2008-006226-34-DE Belgium;Czech Republic;France;Germany;Hungary;Italy;Spain;United Kingdom;
2009 - EUCTR2008-006226-34-CZ Belgium;Canada;Czech Republic;France;Germany;Hungary;Italy;Spain;Tunisia;United Kingdom;
Teriflunomide (HMR1726)
Sanofi
2013 - NCT03198351 Canada;United States;
2006 Phase 3 NCT00803049 Austria;Canada;Chile;Czech Republic;Denmark;Estonia;Finland;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Russian Federation;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2002 Phase 2 NCT00228163 Canada;France;
Teriflunomide 14 MG Oral Tablet [Aubagio]
Centre Hospitalier Universitaire de Nice
2017 Phase 3 NCT03122652 France;Germany;Martinique;Sweden;Switzerland;Turkey;United Kingdom;
Teriflunomide HMR1726
Sanofi
2020 Phase 3 NCT04410991 Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 NCT04410978 Austria;Belarus;Bulgaria;Canada;China;Czechia;Denmark;Estonia;Finland;Germany;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2014 Phase 1 NCT02046629 China;
2013 Phase 3 NCT01863888 Belgium;Germany;Netherlands;
Teriflunomide capsule
Novartis Pharmaceuticals
2016 Phase 3 NCT02792231 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Finland;France;Germany;Hungary;India;Italy;Latvia;Lithuania;Mexico;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Switzerland;Taiwan;Turkey;United Kingdom;United States;
2016 Phase 3 NCT02792218 Argentina;Australia;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Mexico;Netherlands;Poland;Puerto Rico;Russian Federation;Slovakia;Spain;Sweden;Switzerland;Thailand;Turkey;United Kingdom;United States;
Testosterone
University of California, Los Angeles
2014 Phase 2 NCT02317263 -
Testosterone undecanoate
Health Sciences Centre, Winnipeg, Manitoba
2012 Phase 2 NCT01516554 Canada;
Tetanus diphtheria toxoid vaccine (Td)
Biogen
2008 Phase 4 NCT00536120 United States;
Tetanus diphtheria toxoids vaccine
Biogen
2015 Phase 2 NCT02097849 United States;
Tetanus toxoid (TT) containing vaccine (Td, Tdap)
Novartis Pharmaceuticals
2018 Phase 3 NCT03650114 Argentina;Australia;Austria;Belgium;Bulgaria;Canada;Croatia;Czechia;Denmark;Estonia;Finland;France;Germany;Greece;Hungary;India;Israel;Japan;Latvia;Lithuania;Mexico;Netherlands;Norway;Peru;Poland;Portugal;Russian Federation;Slovakia;South Africa;Spain;Sweden;Switzerland;Taiwan;Thailand;Turkey;United Kingdom;United States;
Tetanus toxoid vaccine
Novartis
2010 Phase 3 NCT01199861 Austria;Belgium;Canada;Finland;France;Guatemala;Poland;Spain;Switzerland;United Kingdom;
Tetanus, diphtheria, and acellular pertussis vaccine
Celgene
2021 Phase 3 NCT05028634 Germany;United States;
Tetracycline
Università Popolare Homo & Natura
2015 Phase 1 NCT02632591 Italy;
Tetracycline - Statin - Antimycotic
Università Popolare Homo & Natura
2015 Phase 0 NCT02606929 Italy;
Tetrahydrocannabinol (THC)
Tiffany J. Braley, MD, MS
2022 Phase 2 NCT05269628 United States;
Tetrahydrocannabinol Botanical Drug Substance (THC BDS)
GW Pharma Limited
2022 Phase 3 EUCTR2020-004306-58-LT Bulgaria;Canada;Hungary;Italy;Lithuania;Spain;United Kingdom;United States;
2021 Phase 3 EUCTR2020-003271-18-ES Australia;Belgium;Czech Republic;Czechia;Poland;Spain;Sweden;United Kingdom;
2021 Phase 3 EUCTR2020-003271-18-CZ Australia;Belgium;Czech Republic;Czechia;Poland;Spain;Sweden;United Kingdom;
2021 Phase 3 EUCTR2019-002625-29-CZ Czech Republic;Czechia;Poland;United Kingdom;
2020 Phase 3 EUCTR2019-002625-29-PL Czech Republic;Czechia;Poland;United Kingdom;
2020 Phase 3 EUCTR2019-002625-29-GB Poland;United Kingdom;
GW Pharma Ltd
2020 Phase 3 EUCTR2019-002623-14-PL Czech Republic;Czechia;Poland;Romania;United Kingdom;United States;
2020 Phase 3 EUCTR2019-002623-14-GB Czech Republic;Poland;Romania;United Kingdom;United States;
2020 Phase 3 EUCTR2019-002623-14-CZ Czech Republic;Czechia;Poland;Romania;United Kingdom;United States;
Thiamine
University of Iowa
2010 Phase 1 NCT01381354 United States;
Thiotepa
OSPEDALE S. RAFFAELE
2007 Phase 2 EUCTR2007-000586-38-IT Italy;
Thymoglobuline
Sheffield Teaching Hospitals
2020 Phase 3 EUCTR2019-001549-42-GB United Kingdom;
Uppsala l?ns landsting
2011 - EUCTR2010-023560-40-SE Brazil;Canada;Sweden;United States;
Thymoglobuline®
Helse Bergen HF, Haukeland University Hospital
2019 Phase 3 EUCTR2017-001362-25-NL Denmark;Netherlands;
2018 Phase 3 EUCTR2017-001362-25-DK Denmark;Netherlands;
Thymol
Department of Neurology and Neurological Science, Tokyo Medical and Dental University
2021 - JPRN-UMIN000043910 Japan;
Tissue Selective Estrogen Complex
University of California, San Francisco
2016 Phase 2 NCT02710214 United States;
Tizanidine (sublingual or oral)
Teva GTC
2006 Phase 1/Phase 2 NCT00358293 Israel;
Tizanidine hydrochloride capsule
Elan Pharmaceuticals
2002 Phase 3 NCT00047580 United States;
Tocilizumab
Department of Immunology, National Institute of Neuroscience, NCNP
2014 - JPRN-UMIN000012705 Japan;
2012 - JPRN-UMIN000007866 Japan;
2011 - JPRN-UMIN000005889 Japan;
Department of Neurology, Shimane University Hospital
2016 - JPRN-UMIN000022201 Japan;
Fu-Dong Shi
2017 Phase 1/Phase 2 NCT03062579 China;
Yamamura Takashi
2013 - JPRN-jRCTs031180346 Japan;
2012 - JPRN-jRCTs031180152 Japan;
Tocilizumab Injection
Tianjin Medical University General Hospital
2017 Phase 2/Phase 3 NCT03350633 China;
Tolebrutinib
National Institute of Neurological Disorders and Stroke (NINDS)
2021 Phase 2 NCT04742400 United States;
Sanofi
2020 Phase 3 NCT04458051 Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;Chile;China;Colombia;Croatia;Czechia;Denmark;Estonia;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Latvia;Mexico;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 NCT04411641 Argentina;Australia;Austria;Belarus;Belgium;Bulgaria;Canada;China;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;India;Israel;Italy;Japan;Lithuania;Netherlands;Norway;Poland;Portugal;Romania;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 NCT04410991 Argentina;Belgium;Brazil;Canada;Chile;Croatia;Czechia;France;Germany;Greece;Hungary;India;Israel;Korea, Republic of;Latvia;Netherlands;Norway;Portugal;Puerto Rico;Russian Federation;Serbia;Slovakia;Spain;Switzerland;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 NCT04410978 Austria;Belarus;Bulgaria;Canada;China;Czechia;Denmark;Estonia;Finland;Germany;Italy;Japan;Lithuania;Mexico;Poland;Romania;Russian Federation;Spain;Sweden;Taiwan;Turkey;Ukraine;United States;
2019 Phase 2 NCT03996291 Canada;Czechia;Estonia;France;Netherlands;Russian Federation;Spain;Ukraine;United States;
Tolerogenic Dendritic cells loaded with myelin peptides
Sara Varea
2015 Phase 1 NCT02283671 Spain;
Tolerogenic Fibroblasts
FibroBiologics
2020 Early Phase 1 NCT05080270 Mexico;
Tolerogenic dendritic cells (tolDC)
University Hospital, Antwerp
2017 Phase 1 NCT02618902 Belgium;
Tolperisone HC1
Avigen Inc
2007 Phase 2 EUCTR2007-001031-63-CZ Czech Republic;Germany;
2007 - EUCTR2007-001031-63-DE Germany;
Tolperisone HCl
Avigen
2007 Phase 2 NCT00532532 Czech Republic;Former Serbia and Montenegro;Germany;Russian Federation;Serbia;Ukraine;
Tolpersan
Avigen Inc
2007 Phase 2 EUCTR2007-001031-63-CZ Czech Republic;Germany;
2007 - EUCTR2007-001031-63-DE Germany;
Tolposan
Avigen Inc
2007 Phase 2 EUCTR2007-001031-63-CZ Czech Republic;Germany;
2007 - EUCTR2007-001031-63-DE Germany;
Topical Preparation H arm
New York University School of Medicine
2015 Phase 4 NCT02665221 United States;
Tovaxin
Opexa Therapeutics, Inc.
2007 Phase 2 NCT00595920 United States;
Tovaxin Autologous T Cell Vaccine
Opexa Therapeutics, Inc.
2002 Phase 1/Phase 2 NCT00587691 United States;
Tovaxin Autologous T cell vaccine
Opexa Therapeutics, Inc.
2006 Phase 2 NCT00245622 United States;
Tracleer
UZ Brussel
2017 Phase 2 EUCTR2017-001253-13-BE Belgium;
Trancopal Dolo
Charité-Universitätsmedizin Berlin
2007 Phase 2 EUCTR2006-005262-39-DE Germany;
Transcranial Magnetic Stimulation (TMS)
Maimónides Biomedical Research Institute of Córdoba
2019 Phase 1/Phase 2 NCT04062331 -
Trekking pole (TP).
Rowan University
2014 - NCT02227524 United States;
Trichuris suis Ova
Danish Multiple Sclerosis Research Center
2009 Phase 2 EUCTR2008-007549-29-DK Denmark;
Trichuris suis eggs
Danish Multiple Sclerosis Research Center
2009 Phase 2 EUCTR2008-007549-29-DK Denmark;
Trichuris suis ova
Charite University, Berlin, Germany
2012 Phase 2 NCT01413243 Germany;
Rigshospitalet, Denmark
2010 Phase 2 NCT01006941 Denmark;
Trichuris suis ova (eggs), embryonated, viable
Charite Universitätsmedizin Berlin
2011 Phase 2 EUCTR2009-015319-41-DE Germany;
Trileptal
Queen Mary University London
2014 Phase 2 EUCTR2013-002419-87-GB United Kingdom;
Triomar™ (omega-3 fatty acids)
Haukeland University Hospital
2004 Phase 2/Phase 3 NCT00360906 Norway;
Trivalent seasonal influenza vaccine
Biogen
2010 Phase 2 NCT01051349 Czech Republic;Czechia;Germany;Hungary;India;Poland;Russian Federation;Ukraine;United Kingdom;
Trulicity 0,75 mg injekcný roztok naplnený v injekcnom pere.
Lekárska fakulta UK Bratislava
2019 Phase 2 EUCTR2019-003001-94-SK Slovakia;
Tylenol Pill
Holy Name Medical Center, Inc.
2017 Phase 4 NCT03424733 United States;
Tysabri
Amsterdam University Medical Center
2019 Phase 4 EUCTR2019-002566-13-NL Netherlands;
BIOGEN IDEC LTD
2006 - EUCTR2005-004061-41-IT Australia;Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Ireland;Italy;New Zealand;Spain;Sweden;Switzerland;Turkey;United Kingdom;
Biogen
2018 - NCT03399981 United States;
Biogen Idec
2014 Phase 4 EUCTR2014-003669-97-BE Belgium;
Biogen Idec International GmbH
2010 Phase 4 EUCTR2009-009503-19-BE Belgium;
Biogen Idec Limited
2012 Phase 3 EUCTR2010-021978-11-IE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2012 - EUCTR2010-021978-11-BE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 Phase 3 EUCTR2010-021978-11-GB Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 Phase 3 EUCTR2010-021978-11-ES Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 Phase 3 EUCTR2010-021978-11-DK Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 Phase 3 EUCTR2010-021978-11-CZ Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 - EUCTR2010-021978-11-SE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 - EUCTR2010-021978-11-PL Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 - EUCTR2010-021978-11-FI Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2011 - EUCTR2010-021978-11-DE Belgium;Canada;Czech Republic;Denmark;Finland;France;Germany;Iraq;Ireland;Israel;Italy;Netherlands;Poland;Russian Federation;Spain;Sweden;United Kingdom;United States;
2010 - EUCTR2009-015556-15-SI Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States;
2010 - EUCTR2009-015556-15-SE Austria;Canada;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States;
2010 - EUCTR2009-015556-15-PT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-NL Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-LV Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States;
2010 - EUCTR2009-015556-15-HU Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-GR Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-GB Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-FI Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-DK Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-DE Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
2010 - EUCTR2009-015556-15-CZ Austria;Canada;Czech Republic;Denmark;Finland;Germany;Greece;Hungary;Italy;Latvia;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;United States;
2010 - EUCTR2009-015556-15-AT Austria;Denmark;Finland;Germany;Greece;Hungary;Italy;Netherlands;Portugal;Slovenia;Spain;Sweden;United Kingdom;
BiogenIdec A/S
2009 - EUCTR2008-008065-35-SE Sweden;
CHU de Toulouse
2009 - EUCTR2008-005906-38-FR France;
Dansk Multipel Sclerose Center
2010 Phase 2 EUCTR2009-016703-35-DK Denmark;
Imperial College London
2008 Phase 4 EUCTR2007-007394-22-GB United Kingdom;
Karolinska Institutet
2017 Phase 4 EUCTR2017-002634-24-SE Sweden;
2017 Phase 4 EUCTR2016-003587-39-SE Sweden;
Kessler Foundation
2021 - NCT04565431 United States;
Northwestern University
2013 Phase 2 EUCTR2012-004165-41-GB United Kingdom;United States;
Novartis Pharma Services AG
2012 - EUCTR2011-001437-16-DE Australia;Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;
Polpharma Biologics S.A.
2019 Phase 3 EUCTR2018-004751-20-PL Belarus;Croatia;Georgia;Moldova, Republic of;Poland;Serbia;Ukraine;
2019 Phase 3 EUCTR2018-004751-20-HR Belarus;Croatia;Georgia;Moldova, Republic of;Poland;Serbia;Ukraine;
Turku University Hospital
2013 Phase 4 EUCTR2013-004626-28-FI Finland;
University at Buffalo
2007 - NCT00937677 United States;
University of Chicago
2010 - NCT01071512 United States;
Universitätsklinikum Münster
2014 - EUCTR2013-004616-21-DE Germany;
Uppsala l?ns landsting
2011 - EUCTR2010-023560-40-SE Brazil;Canada;Sweden;United States;
VU medical center
2016 Phase 4 EUCTR2016-000345-31-NL Netherlands;
Tysabri ® (Natalizumab)
University of South Florida
2011 - NCT01455220 United States;
Tysabri®
Biogen Idec Research Limited
2015 Phase 4 EUCTR2013-004622-29-DK Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2015 Phase 4 EUCTR2013-004622-29-DE Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2015 - EUCTR2013-005586-39-DE Germany;Italy;United States;
2014 Phase 4 EUCTR2013-004622-29-SE Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2014 Phase 4 EUCTR2013-004622-29-GB Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2014 Phase 4 EUCTR2013-004622-29-ES Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2014 Phase 4 EUCTR2013-004622-29-CZ Australia;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
2014 - EUCTR2013-004622-29-IT Australia;Canada;Czech Republic;Denmark;France;Germany;Italy;Spain;Sweden;United Kingdom;United States;
Sheffield Teaching Hospitals NHS Foundation Trust
2013 Phase 2/Phase 3 NCT03133403 United Kingdom;
Tysabri® (natalizumab)
Biogen
2010 - NCT01070823 United States;
UK: Sativex Oromucosal Spray
GW Pharma Ltd
2020 Phase 3 EUCTR2019-002623-14-GB Czech Republic;Poland;Romania;United Kingdom;United States;
UNDIFFERENTIATED AUTOLOGOUS MESENCHYMAL STEM CELLS
SALK - Gemeinnützige Salzburger Landeskliniken Betriebsges. m.b.H., Christian-Doppler-Klinik, UK für Neurologie der PMU
- - EUCTR2015-000137-78-AT Austria;
URBASON 40 mg comprimidos
Servicio de Neurología
2008 - EUCTR2007-000888-15-ES Spain;
UVEDOSE 100 000 UI, solution buvable en ampoule
MERCK SERONO s.a.s
2009 - EUCTR2009-013695-46-FR France;
Ublituximab
Johns Hopkins University
2016 Phase 1 NCT02276963 United States;
TG Therapeutics, Inc.
2019 Phase 3 NCT04130997 Belarus;Croatia;Georgia;Poland;Russian Federation;Serbia;Ukraine;United States;
2017 Phase 3 NCT03277261 United States;
2017 Phase 3 NCT03277248 United States;
2017 Phase 2 NCT03381170 United States;
2016 Phase 2 NCT02738775 United States;
Ubltuximab
TG Therapeutics
2017 Phase 3 EUCTR2017-000639-15-GB Belarus;Croatia;Poland;Romania;Russian Federation;Spain;Ukraine;United Kingdom;United States;
Ucb L059
Søren H. Sindrup, Department of Neurology, Odense University Hospital
2006 - EUCTR2006-000397-71-DK Denmark;
Ultomiris
Alexion Pharmaceuticals, Inc.
2020 Phase 3 EUCTR2019-003352-37-PL Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-003352-37-NL Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Russian Federation;Spain;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-003352-37-ES Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Russian Federation;Spain;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-003352-37-DK Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-003352-37-DE Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States;
2020 Phase 3 EUCTR2019-003352-37-AT Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States;
Ultra small particles of iron oxide (USPIO)
Max-Planck-Institute of Psychiatry
2007 - EUCTR2006-001337-17-DE Germany;
Ultrasmall particles of iron oxide
Max-Planck-Institute of Psychiatry
2007 - EUCTR2006-001337-17-DE Germany;
Ultromiris
ALEXION PHARMACEUTICALS INCORPORATED
2020 Phase 3 EUCTR2019-003352-37-IT Australia;Austria;Canada;Denmark;France;Germany;Italy;Japan;Korea, Republic of;Netherlands;Poland;Russian Federation;Spain;Turkey;United Kingdom;United States;
Umbilical cord derived Mesenchymal Stem Cells
University of Jordan
2017 Phase 1/Phase 2 NCT03326505 Jordan;
Umbilical cord mesenchymal stem cells
Translational Biosciences
2014 Phase 1/Phase 2 NCT02034188 Panama;
Untreated to atorvastatin treatment
Charite University, Berlin, Germany
2003 Phase 2 NCT00616187 -
Urbason
Servicio de Neurología, HU. Germans Trias i Pujol
2012 Phase 4 EUCTR2012-001965-34-ES Spain;
Urbason solubile forte
IFSgGmbH, Institute for clinical research
2006 - EUCTR2005-005592-14-DE Germany;
Urbason® solubile forte
University Medical Center Hamburg Eppendorf
2013 Phase 2 EUCTR2012-004807-10-DE Germany;
Urine samples
Centre Hospitalier Universitaire de Nimes
2013 Phase 3 NCT01817166 France;
V08CA02
Universitätsklinikum Erlangen
2010 - EUCTR2009-014857-34-DE Germany;
V08CA09
Universitätsklinikum Erlangen
2010 - EUCTR2009-014857-34-DE Germany;
VARDENAFILO HIDROCLORURO
Unidad de Neuroinmunología
2005 Phase 4 EUCTR2004-003761-33-ES Spain;
VAY736
Novartis Pharma Services AG
2014 Phase 2 EUCTR2013-002324-16-PL Czech Republic;Poland;Russian Federation;Ukraine;United States;
2014 Phase 2 EUCTR2013-002324-16-CZ Czech Republic;Poland;Russian Federation;Ukraine;United States;
Novartis Pharmaceuticals
2013 Phase 2 NCT02038049 Czech Republic;Czechia;Germany;Poland;Russian Federation;Ukraine;United States;
VB13S1
The Immune Response Corporation
2007 Phase 2 EUCTR2006-003384-30-SK Slovakia;
VB5S2
The Immune Response Corporation
2007 Phase 2 EUCTR2006-003384-30-SK Slovakia;
VB6S5
The Immune Response Corporation
2007 Phase 2 EUCTR2006-003384-30-SK Slovakia;
VENLAFAXINE HYDROCHLORIDE
Novartis Pharma GmbH
- - EUCTR2011-001692-39-DE Germany;
VESIcare 10Mg Tablet
Brigitte Schürch
2021 Phase 4 NCT04819360 Switzerland;
VIGANTOL OIL
MERCK SERONO SA
2011 - EUCTR2010-020328-23-IT Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal;
VITAMINA D3 KERN PHARMA SOLUCIÓN OLEOSA
Javier Olascoaga Urtaza
2013 Phase 2 EUCTR2012-004602-97-ES Spain;
VSN16R
Canbex Therapeutics Ltd
2015 Phase 2 NCT02542787 United Kingdom;
2015 Phase 2 EUCTR2014-004412-11-GB United Kingdom;
VX15/2503
Vaccinex Inc.
2012 Phase 1 NCT01764737 United States;
Vaginal estriol
Texas Tech University Health Sciences Center
2019 Phase 2/Phase 3 NCT03774407 United States;
Vardenafil (hidrocloride)
Unidad de Neuroinmunología
2005 Phase 4 EUCTR2004-003761-33-ES Spain;
Vatelizumab
Genzyme Corporation
2015 Phase 2 EUCTR2014-003265-19-PL Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States;
2015 Phase 2 EUCTR2014-001643-20-SE Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States;
2015 Phase 2 EUCTR2014-001643-20-PL Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States;
2015 Phase 2 EUCTR2014-001643-20-DE Canada;Czech Republic;Germany;Italy;Mexico;Poland;Russian Federation;Sweden;Switzerland;United States;
Genzyme, a Sanofi Company
2015 Phase 2 NCT02306811 Canada;Poland;Russian Federation;United States;
2014 Phase 2 NCT02222948 Canada;Poland;Russian Federation;Sweden;United States;
Vehicle Gel
Biogen
2016 Phase 4 NCT02568111 -
Venlafaxin Hexal
Novartis Pharma GmbH
- - EUCTR2011-001692-39-DE Germany;
Venlafaxine
Novartis Pharmaceuticals
2011 Phase 4 NCT01436643 Germany;
Verum arm receiving Gilenya®
Charite University, Berlin, Germany
2013 Phase 2/Phase 3 NCT01647880 Germany;
Verum arm receiving Vitamin D oil
Charite University, Berlin, Germany
2011 Phase 2 NCT01440062 Germany;
Video calling program Better-close
Isala
2021 - NCT05242731 Netherlands;
Video game therapy
University Hospital of Ferrara
2017 - NCT03353974 Italy;
Vidofludimus calcium
Immunic AG
2022 Phase 3 EUCTR2021-000028-36-BG Albania;Belarus;Bulgaria;Colombia;Georgia;Greece;India;Lithuania;Mexico;Moldova, Republic of;North Macedonia;Poland;Russian Federation;Ukraine;United States;
2022 Phase 2 EUCTR2021-000048-23-NL Bulgaria;Canada;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
2022 Phase 2 EUCTR2021-000048-23-DE Bulgaria;Canada;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine;United States;
2021 Phase 2 EUCTR2021-000048-23-BG Bulgaria;Czechia;Finland;Germany;Hungary;Moldova, Republic of;Netherlands;North Macedonia;Poland;Romania;Russian Federation;Serbia;Ukraine;
VigantOL oil plus interferon beta-1a (Rebif)
Merck KGaA
2011 Phase 2 NCT01285401 Austria;Belgium;Denmark;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
Vigantol
University College Dublin
2012 Phase 2 EUCTR2012-000635-68-IE Ireland;
Vigantol Oel
Merck Serono
2011 - EUCTR2010-020328-23-LV Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2011 - EUCTR2010-020328-23-EE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2011 - EUCTR2010-020328-23-DE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2010 Phase 2 EUCTR2010-020328-23-DK Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2010 - EUCTR2010-020328-23-FI Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
Merck Serono SA - Geneva, an affiliate of Merck KGaA
2012 Phase 2 EUCTR2010-020328-23-PT Austria;Belgium;Denmark;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2011 - EUCTR2010-020328-23-AT Austria;Belgium;Denmark;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
Merck Serono SA-Geneva an affiliate of Merck KgaA, Darmstadt
2011 - EUCTR2010-020328-23-BE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal;
Merck Serono The Netherlands - a division of Merck B.V.
2011 - EUCTR2010-020328-23-NL Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal;
Vigantol Oil
Merck Serono
2011 - EUCTR2010-020328-23-LV Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2011 - EUCTR2010-020328-23-LT Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2011 - EUCTR2010-020328-23-EE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2011 - EUCTR2010-020328-23-DE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2010 Phase 2 EUCTR2010-020328-23-DK Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2010 - EUCTR2010-020328-23-FI Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
Merck Serono SA - Geneva, an affiliate of Merck KGaA
2012 Phase 2 EUCTR2010-020328-23-PT Austria;Belgium;Denmark;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
2011 - EUCTR2010-020328-23-AT Austria;Belgium;Denmark;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Netherlands;Norway;Portugal;Switzerland;
Merck Serono SA-Geneva an affiliate of Merck KgaA, Darmstadt
2011 - EUCTR2010-020328-23-BE Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal;
Merck Serono The Netherlands - a division of Merck B.V.
2011 - EUCTR2010-020328-23-NL Austria;Belgium;Denmark;Estonia;Finland;Germany;Italy;Latvia;Lithuania;Netherlands;Portugal;
Vigantol® Oil
Academic MS Center Limburg
- Phase 2 EUCTR2014-000728-97-NL Netherlands;
Vigantol® Öl 20.000 I.E./ml
Charité - Universitätsmedizin Berlin
2011 Phase 2 EUCTR2011-002785-20-DE Germany;
Vitamin A
Tehran University of Medical Sciences
2011 Phase 4 NCT01407211 Iran, Islamic Republic of;
2010 Phase 4 NCT01417273 Iran, Islamic Republic of;
2009 Phase 4 NCT01225289 Iran, Islamic Republic of;
Vitamin D
Centre Hospitalier Universitaire de Nimes
2013 Phase 3 NCT01817166 France;
Mazandaran University of Medical Sciences
2013 Phase 3 NCT01768039 Iran, Islamic Republic of;
University Medical Centre Maribor
2017 Phase 4 NCT03385356 Slovenia;
Vitamin D3
AlJohara M AlQuaiz, M.D.
2013 Phase 2 NCT01753375 Saudi Arabia;
American University of Beirut Medical Center
2018 - NCT03610139 Lebanon;
Carmel Medical Center
2010 Phase 4 NCT01005095 Israel;
Isfahan University of Medical Sciences
2015 - NCT02696590 Iran, Islamic Republic of;
Johns Hopkins University
2012 Phase 3 NCT01490502 United States;
2010 - NCT01667796 United States;
Maastricht University Medical Center
2009 - NCT00940719 Netherlands;
University of Toronto
2006 Phase 1/Phase 2 NCT00644904 Canada;
Vitamin E/Selenium
National Center for Complementary and Integrative Health (NCCIH)
1999 Phase 1/Phase 2 NCT00010842 United States;
Vitamin K
Biogen
2017 Phase 4 NCT03091569 Italy;
2011 Phase 3 NCT01462318 Czech Republic;Hungary;Poland;Russian Federation;United States;
WAY-130799
Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development
2005 - EUCTR2005-000171-18-FI Finland;
Warm compress prior to injection of glatiramer acetate
Teva Neuroscience, Inc.
2005 Phase 4 NCT00239993 United States;
Water
Department of Neurology and Neurological Science, Tokyo Medical and Dental University
2021 - JPRN-UMIN000043910 Japan;
Ohio State University
2017 - NCT03244696 United States;
Wristband physical activity monitor
Oakland University
2015 - NCT02335450 United States;
XBD173
Imperial College London
2018 - NCT03850301 United Kingdom;
XCEL-MC-ALPHA
Banc de Sang i Teixits
2015 Phase 1/Phase 2 NCT02495766 Spain;
2014 - EUCTR2012-000734-19-ES Spain;
XYOSTED 75 milligram (mg) in 0.5 ML Auto-Injector
Tulane University
2021 Phase 4 NCT04601233 United States;
Xeomin
OSPEDALE S. RAFFAELE
2008 - EUCTR2007-006268-32-IT Italy;
ZK 157046
Bayer AB, Bayer Health Care, Bayer Schering Pharma
2007 - EUCTR2006-005270-47-SE Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Bayer Schering Pharma
2007 - EUCTR2006-005270-47-SI Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-HU Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
- - EUCTR2006-005270-47-DE Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Bayer Schering Pharma AG
2007 - EUCTR2006-005270-47-LV Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-GR Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-BE Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
SCHERING
2007 - EUCTR2006-005270-47-IT Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
Schering AG
2007 Phase 3 EUCTR2006-005270-47-FR Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 Phase 3 EUCTR2006-005270-47-FI Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 Phase 3 EUCTR2006-005270-47-ES Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-NL Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-IE Austria;Belgium;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
2007 - EUCTR2006-005270-47-AT Austria;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Latvia;Netherlands;Slovenia;Spain;Sweden;
ZOL446H
North Bristol Trust
2009 - EUCTR2008-005304-93-GB United Kingdom;
Novartis Pharma GmbH
2010 - EUCTR2009-011888-37-DE Germany;
ZOLEDRONIC ACID MONOHYDRATE
Novartis Pharma GmbH
2010 - EUCTR2009-011888-37-DE Germany;
Zenapax
National Institute of Neurological Disorders and Stroke (NINDS)
1999 Phase 2 NCT00001934 United States;
Zeposia
Kessler Foundation
2021 - NCT04885894 United States;
Zinbryta
BIOGEN IDEC RESEARCH LIMITED
2017 Phase 3 EUCTR2016-002820-10-IT Canada;Denmark;France;Germany;Italy;United Kingdom;United States;
Biogen Idec Research Limited
2017 Phase 3 EUCTR2016-002820-10-GB Canada;Denmark;France;Germany;Italy;United Kingdom;United States;
2017 Phase 3 EUCTR2016-002820-10-DE Canada;Germany;Italy;United Kingdom;United States;
2013 Phase 3 EUCTR2012-003176-39-CZ Argentina;Australia;Brazil;Canada;Czech Republic;Denmark;Finland;France;Georgia;Germany;Greece;Hungary;India;Ireland;Israel;Italy;Mexico;Moldova, Republic of;Poland;Romania;Russian Federation;Serbia;Spain;Sweden;Switzerland;Ukraine;United Kingdom;United States;
[123I]CLINDE
Institute for Neurodegenerative Disorders
2008 Phase 1 NCT00612872 United States;
[18F] PBR06
Institute for Neurodegenerative Disorders
2009 Phase 1 NCT01028209 United States;
[18F]-FEPPA
Institute for Neurodegenerative Disorders
2009 Phase 1 NCT00970333 United States;
[18F]Florbetapir PET imaging
Institute for Neurodegenerative Disorders
2012 Phase 4 NCT01767493 United States;
[C-11]Methylreboxetine
Brigham and Women's Hospital
2020 Phase 1/Phase 2 NCT04144257 United States;
2017 Phase 1/Phase 2 NCT03207464 United States;
[C-11]PBR28
Brigham and Women's Hospital
2016 Phase 1/Phase 2 NCT02649985 United States;
[C11]PK-1195 PET scan
Weill Medical College of Cornell University
2014 - NCT02207075 United States;
[F-18]PBR06
Brigham and Women's Hospital
2020 Phase 3 NCT04510220 United States;
2020 Phase 1/Phase 2 NCT04144257 United States;
2019 Phase 1/Phase 2 NCT03983252 United States;
2016 Phase 1/Phase 2 NCT02649985 United States;
[F-18]SDM-8
Brigham and Women's Hospital
2021 Early Phase 1 NCT04634994 United States;
[Zr-89]Oxine-labeled leukocytes PET/MR
University of Alabama at Birmingham
2021 Phase 1 NCT03807973 -
fampridine-SR (4-aminopyridine, 4-AP)
Acorda Therapeutics
2003 Phase 2 NCT00053417 Canada;United States;
glatiramer acetate
Teva Pharmaceutical Industries, Ltd.
2006 Phase 3 EUCTR2006-002037-20-FI Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 Phase 3 EUCTR2006-002037-20-ES Belgium;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 - EUCTR2006-002037-20-HU Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 - EUCTR2006-002037-20-GB Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 - EUCTR2006-002037-20-DE Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 - EUCTR2006-002037-20-CZ Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
2006 - EUCTR2006-002037-20-BE Belgium;Czech Republic;Estonia;Germany;Hungary;Italy;Latvia;Lithuania;Spain;United Kingdom;
of MitoQ
VA Office of Research and Development
2020 Phase 1/Phase 2 NCT04267926 United States;